Query 008693
Match_columns 557
No_of_seqs 332 out of 2195
Neff 6.9
Searched_HMMs 46136
Date Thu Mar 28 15:23:47 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/008693.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/008693hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG0456 Aspartate kinase [Amin 100.0 1E-112 3E-117 857.2 39.1 550 2-555 1-554 (559)
2 PLN02551 aspartokinase 100.0 7E-104 1E-108 861.5 51.6 499 41-539 12-510 (521)
3 COG0527 LysC Aspartokinases [A 100.0 6.4E-93 1.4E-97 760.7 48.1 439 80-539 1-447 (447)
4 PRK09084 aspartate kinase III; 100.0 2E-88 4.4E-93 732.6 51.2 440 82-538 1-447 (448)
5 PRK09034 aspartate kinase; Rev 100.0 2.1E-88 4.6E-93 734.0 51.2 440 82-540 1-452 (454)
6 PRK06291 aspartate kinase; Pro 100.0 1E-86 2.2E-91 723.7 51.4 450 81-539 1-464 (465)
7 PRK09181 aspartate kinase; Val 100.0 1.3E-85 2.9E-90 711.3 48.4 434 80-539 2-467 (475)
8 PRK05925 aspartate kinase; Pro 100.0 9.5E-84 2.1E-88 691.5 49.5 436 80-542 1-438 (440)
9 PRK09466 metL bifunctional asp 100.0 1E-82 2.2E-87 725.5 48.5 440 77-540 7-456 (810)
10 PRK09436 thrA bifunctional asp 100.0 2.4E-81 5.3E-86 718.8 49.4 445 82-539 1-462 (819)
11 PRK08961 bifunctional aspartat 100.0 1.1E-79 2.4E-84 711.6 48.2 451 77-540 4-463 (861)
12 TIGR00657 asp_kinases aspartat 100.0 2.4E-76 5.1E-81 639.7 49.1 434 81-538 1-441 (441)
13 PRK08841 aspartate kinase; Val 100.0 1.1E-73 2.3E-78 607.1 43.2 378 80-540 1-380 (392)
14 TIGR00656 asp_kin_monofn aspar 100.0 6.4E-72 1.4E-76 598.6 46.0 394 81-538 1-400 (401)
15 PRK08210 aspartate kinase I; R 100.0 2E-68 4.2E-73 571.8 44.1 388 80-538 1-402 (403)
16 PRK07431 aspartate kinase; Pro 100.0 7.9E-68 1.7E-72 591.8 46.2 395 80-539 1-412 (587)
17 PRK06635 aspartate kinase; Rev 100.0 8E-67 1.7E-71 559.7 45.2 393 80-538 1-403 (404)
18 cd04245 AAK_AKiii-YclM-BS AAK_ 100.0 2.5E-66 5.5E-71 528.1 31.8 281 82-376 1-288 (288)
19 cd04258 AAK_AKiii-LysC-EC AAK_ 100.0 3.9E-66 8.4E-71 527.7 32.3 288 82-376 1-292 (292)
20 cd04244 AAK_AK-LysC-like AAK_A 100.0 1.1E-65 2.4E-70 527.7 31.8 290 83-376 2-298 (298)
21 cd04257 AAK_AK-HSDH AAK_AK-HSD 100.0 5.9E-65 1.3E-69 520.7 32.1 286 82-376 1-294 (294)
22 cd04243 AAK_AK-HSDH-like AAK_A 100.0 1.8E-64 3.9E-69 516.9 31.7 285 82-376 1-293 (293)
23 cd04259 AAK_AK-DapDC AAK_AK-Da 100.0 1.9E-64 4.1E-69 516.8 31.6 284 82-376 1-295 (295)
24 cd04247 AAK_AK-Hom3 AAK_AK-Hom 100.0 2.1E-64 4.5E-69 517.2 31.0 288 82-377 2-305 (306)
25 PRK08373 aspartate kinase; Val 100.0 1.4E-60 3.1E-65 495.1 35.8 322 81-444 4-327 (341)
26 TIGR02078 AspKin_pair Pyrococc 100.0 8.1E-58 1.8E-62 472.1 32.6 289 82-402 1-292 (327)
27 cd04248 AAK_AK-Ectoine AAK_AK- 100.0 5.1E-58 1.1E-62 464.3 29.8 279 83-376 2-304 (304)
28 cd04261 AAK_AKii-LysC-BS AAK_A 100.0 3.8E-47 8.2E-52 380.0 25.9 237 82-376 1-239 (239)
29 cd04234 AAK_AK AAK_AK: Amino A 100.0 3.4E-47 7.3E-52 377.5 23.5 225 82-376 1-227 (227)
30 cd04246 AAK_AK-DapG-like AAK_A 100.0 1.1E-46 2.4E-51 376.6 26.2 237 82-376 1-239 (239)
31 cd04260 AAK_AKi-DapG-BS AAK_AK 100.0 2.9E-46 6.2E-51 374.7 26.0 237 82-376 1-244 (244)
32 cd02115 AAK Amino Acid Kinases 100.0 1.6E-36 3.6E-41 303.8 24.8 237 84-375 1-248 (248)
33 PRK12314 gamma-glutamyl kinase 100.0 1.1E-31 2.3E-36 272.3 21.2 227 79-377 8-264 (266)
34 PF00696 AA_kinase: Amino acid 100.0 1.2E-32 2.5E-37 275.0 12.4 233 81-364 1-242 (242)
35 cd04242 AAK_G5K_ProB AAK_G5K_P 100.0 1.5E-30 3.2E-35 262.2 20.4 215 83-369 2-235 (251)
36 PRK14557 pyrH uridylate kinase 100.0 1.3E-29 2.8E-34 253.8 21.5 219 79-379 3-240 (247)
37 cd04239 AAK_UMPK-like AAK_UMPK 100.0 1E-29 2.2E-34 252.8 19.6 204 83-369 2-213 (229)
38 PRK00358 pyrH uridylate kinase 100.0 2.5E-29 5.3E-34 250.2 20.1 206 81-369 1-215 (231)
39 PRK14558 pyrH uridylate kinase 100.0 8.3E-29 1.8E-33 246.5 21.2 153 190-369 61-213 (231)
40 cd04254 AAK_UMPK-PyrH-Ec UMP k 100.0 3E-29 6.5E-34 249.7 17.3 206 81-369 1-215 (231)
41 TIGR02075 pyrH_bact uridylate 100.0 6.6E-28 1.4E-32 240.3 19.4 213 81-376 2-233 (233)
42 cd04253 AAK_UMPK-PyrH-Pf AAK_U 99.9 5.7E-27 1.2E-31 231.8 19.1 195 83-369 2-205 (221)
43 PRK13402 gamma-glutamyl kinase 99.9 1.3E-26 2.7E-31 244.1 20.6 227 78-379 3-259 (368)
44 TIGR02076 pyrH_arch uridylate 99.9 2.7E-26 5.9E-31 226.9 18.7 196 83-369 1-205 (221)
45 cd04249 AAK_NAGK-NC AAK_NAGK-N 99.9 4E-26 8.7E-31 230.1 18.5 224 83-369 1-237 (252)
46 cd04250 AAK_NAGK-C AAK_NAGK-C: 99.9 3.3E-26 7.2E-31 234.0 16.7 230 81-369 15-263 (279)
47 PRK00942 acetylglutamate kinas 99.9 1.3E-25 2.7E-30 230.2 18.1 237 80-377 23-282 (283)
48 PRK05429 gamma-glutamyl kinase 99.9 2.4E-25 5.1E-30 235.9 20.5 229 79-379 7-263 (372)
49 TIGR00761 argB acetylglutamate 99.9 1.6E-25 3.5E-30 222.8 16.7 215 82-359 1-227 (231)
50 cd04238 AAK_NAGK-like AAK_NAGK 99.9 9.2E-25 2E-29 220.7 15.4 223 83-369 1-240 (256)
51 PLN02418 delta-1-pyrroline-5-c 99.9 2.3E-24 5E-29 245.2 19.4 239 79-380 14-286 (718)
52 TIGR01027 proB glutamate 5-kin 99.9 3.4E-24 7.4E-29 226.3 19.3 225 82-378 2-254 (363)
53 COG0528 PyrH Uridylate kinase 99.9 6.6E-24 1.4E-28 205.9 19.2 207 81-369 6-221 (238)
54 PRK14058 acetylglutamate/acety 99.9 9.3E-24 2E-28 214.7 20.1 174 189-377 66-267 (268)
55 PRK14556 pyrH uridylate kinase 99.9 1.2E-23 2.7E-28 209.1 19.2 214 81-376 16-247 (249)
56 cd04241 AAK_FomA-like AAK_FomA 99.9 5.9E-22 1.3E-26 199.7 21.9 148 203-368 80-236 (252)
57 PLN02512 acetylglutamate kinas 99.9 8.9E-22 1.9E-26 203.9 21.7 227 81-368 48-290 (309)
58 COG0548 ArgB Acetylglutamate k 99.9 3.4E-22 7.3E-27 199.5 15.8 230 80-369 2-247 (265)
59 CHL00202 argB acetylglutamate 99.9 1.4E-21 3E-26 200.3 17.6 235 81-376 24-283 (284)
60 cd04255 AAK_UMPK-MosAB AAK_UMP 99.9 2.4E-20 5.3E-25 188.5 20.5 207 80-369 30-246 (262)
61 cd04251 AAK_NAGK-UC AAK_NAGK-U 99.9 4.7E-20 1E-24 186.5 20.7 221 83-369 1-244 (257)
62 cd04256 AAK_P5CS_ProBA AAK_P5C 99.8 6.2E-19 1.3E-23 180.4 19.7 169 194-375 94-283 (284)
63 TIGR01092 P5CS delta l-pyrroli 99.8 2.6E-19 5.5E-24 204.3 18.6 236 80-381 7-279 (715)
64 PTZ00489 glutamate 5-kinase; P 99.8 2.9E-17 6.3E-22 166.1 21.7 169 194-378 72-260 (264)
65 COG0263 ProB Glutamate 5-kinas 99.7 8E-17 1.7E-21 164.5 20.5 230 79-379 5-261 (369)
66 TIGR01890 N-Ac-Glu-synth amino 99.7 1.3E-16 2.9E-21 172.8 19.9 234 81-378 18-280 (429)
67 cd04237 AAK_NAGS-ABP AAK_NAGS- 99.7 3.4E-16 7.3E-21 160.2 18.9 223 81-368 19-263 (280)
68 cd04236 AAK_NAGS-Urea AAK_NAGS 99.7 8.9E-16 1.9E-20 155.5 19.7 207 78-364 33-253 (271)
69 PRK07431 aspartate kinase; Pro 99.7 5.8E-16 1.3E-20 174.0 18.5 146 382-538 426-582 (587)
70 PRK12353 putative amino acid k 99.7 1.7E-15 3.7E-20 157.2 18.3 122 253-376 177-313 (314)
71 PRK05279 N-acetylglutamate syn 99.7 1.6E-15 3.5E-20 164.8 19.0 234 81-378 26-292 (441)
72 cd04252 AAK_NAGK-fArgBP AAK_NA 99.7 2.9E-15 6.2E-20 150.9 18.1 212 84-364 2-230 (248)
73 PLN02825 amino-acid N-acetyltr 99.6 1.3E-14 2.8E-19 158.7 19.1 196 81-340 18-236 (515)
74 cd04240 AAK_UC AAK_UC: Unchara 99.6 1.7E-14 3.6E-19 141.0 17.0 135 190-369 50-187 (203)
75 PRK12352 putative carbamate ki 99.6 1E-14 2.2E-19 150.7 16.3 240 81-377 3-315 (316)
76 TIGR00746 arcC carbamate kinas 99.6 6.8E-14 1.5E-18 144.4 19.1 118 255-376 176-309 (310)
77 cd04235 AAK_CK AAK_CK: Carbama 99.5 1.9E-13 4.2E-18 140.5 17.8 120 254-375 174-307 (308)
78 PRK12686 carbamate kinase; Rev 99.5 2.4E-12 5.1E-17 132.6 18.1 122 253-376 175-311 (312)
79 cd04918 ACT_AK1-AT_2 ACT domai 99.4 3E-13 6.6E-18 108.0 8.1 64 475-538 2-65 (65)
80 cd04915 ACT_AK-Ectoine_2 ACT d 99.4 4E-13 8.8E-18 107.7 8.8 64 474-538 2-66 (66)
81 COG1608 Predicted archaeal kin 99.4 2.4E-11 5.2E-16 118.7 20.2 156 203-376 81-251 (252)
82 PRK04531 acetylglutamate kinas 99.4 3E-12 6.6E-17 136.7 15.1 109 258-378 126-250 (398)
83 PRK12454 carbamate kinase-like 99.4 4E-11 8.6E-16 123.4 21.1 119 255-376 179-312 (313)
84 PRK12354 carbamate kinase; Rev 99.4 9E-12 2E-16 127.8 15.6 123 253-378 167-301 (307)
85 cd04937 ACT_AKi-DapG-BS_2 ACT 99.3 1.7E-11 3.6E-16 97.5 7.9 63 474-538 1-64 (64)
86 cd04919 ACT_AK-Hom3_2 ACT doma 99.3 2.1E-11 4.6E-16 96.9 8.3 65 474-538 1-66 (66)
87 cd04920 ACT_AKiii-DAPDC_2 ACT 99.3 1.6E-11 3.4E-16 97.5 7.4 62 475-538 1-63 (63)
88 cd04917 ACT_AKiii-LysC-EC_2 AC 99.2 2.5E-11 5.5E-16 96.3 7.9 63 474-538 1-64 (64)
89 cd04922 ACT_AKi-HSDH-ThrA_2 AC 99.2 4.2E-11 9.1E-16 95.0 8.3 65 474-538 1-66 (66)
90 PRK09411 carbamate kinase; Rev 99.2 7.1E-10 1.5E-14 113.1 18.8 117 254-376 169-296 (297)
91 KOG1154 Gamma-glutamyl kinase 99.2 2.4E-10 5.2E-15 110.8 13.3 157 197-372 92-261 (285)
92 cd04916 ACT_AKiii-YclM-BS_2 AC 99.1 2.6E-10 5.5E-15 90.4 8.3 65 474-538 1-66 (66)
93 cd04924 ACT_AK-Arch_2 ACT doma 99.0 9.9E-10 2.1E-14 86.9 8.2 64 474-537 1-65 (66)
94 PF13840 ACT_7: ACT domain ; P 99.0 1.8E-09 3.9E-14 86.3 7.8 62 470-534 2-65 (65)
95 cd04933 ACT_AK1-AT_1 ACT domai 98.9 5.4E-09 1.2E-13 86.5 8.9 75 395-469 1-75 (78)
96 COG2054 Uncharacterized archae 98.8 1.1E-07 2.4E-12 89.1 15.7 88 276-377 113-210 (212)
97 cd04921 ACT_AKi-HSDH-ThrA-like 98.8 3E-08 6.6E-13 81.8 8.1 66 474-539 1-67 (80)
98 cd04923 ACT_AK-LysC-DapG-like_ 98.7 3.7E-08 8E-13 76.9 7.9 61 475-537 1-62 (63)
99 cd04892 ACT_AK-like_2 ACT doma 98.7 3.9E-08 8.4E-13 76.6 8.0 64 475-538 1-65 (65)
100 cd04936 ACT_AKii-LysC-BS-like_ 98.7 4.3E-08 9.3E-13 76.5 7.8 61 475-537 1-62 (63)
101 cd04934 ACT_AK-Hom3_1 CT domai 98.7 5.7E-08 1.2E-12 79.4 8.2 71 395-470 1-71 (73)
102 cd04932 ACT_AKiii-LysC-EC_1 AC 98.7 6.8E-08 1.5E-12 79.4 8.5 72 395-470 1-73 (75)
103 cd04935 ACT_AKiii-DAPDC_1 ACT 98.6 1.6E-07 3.4E-12 77.3 8.5 73 395-470 1-73 (75)
104 TIGR00656 asp_kin_monofn aspar 98.5 5.1E-07 1.1E-11 97.3 11.3 114 411-539 212-326 (401)
105 PRK06291 aspartate kinase; Pro 98.5 8.7E-07 1.9E-11 97.3 11.7 112 412-538 272-386 (465)
106 cd04868 ACT_AK-like ACT domain 98.5 5E-07 1.1E-11 68.8 6.9 59 475-533 1-60 (60)
107 cd04912 ACT_AKiii-LysC-EC-like 98.4 9.8E-07 2.1E-11 72.4 8.3 73 395-470 1-73 (75)
108 COG0549 ArcC Carbamate kinase 98.4 3.4E-05 7.3E-10 77.7 19.1 120 252-376 175-311 (312)
109 PRK09436 thrA bifunctional asp 98.3 2.2E-06 4.8E-11 100.0 11.8 111 412-537 266-379 (819)
110 cd04890 ACT_AK-like_1 ACT doma 98.3 1.6E-06 3.6E-11 68.0 7.1 49 397-445 2-50 (62)
111 cd04937 ACT_AKi-DapG-BS_2 ACT 98.2 4.4E-06 9.5E-11 66.3 7.2 51 395-445 1-51 (64)
112 cd04912 ACT_AKiii-LysC-EC-like 98.2 8.8E-06 1.9E-10 66.7 8.5 63 474-538 1-67 (75)
113 PF13840 ACT_7: ACT domain ; P 98.1 1.6E-05 3.5E-10 63.4 7.9 54 391-445 2-56 (65)
114 cd04891 ACT_AK-LysC-DapG-like_ 98.1 1.6E-05 3.4E-10 61.0 7.3 57 475-532 1-60 (61)
115 cd04913 ACT_AKii-LysC-BS-like_ 98.0 1.6E-05 3.4E-10 63.8 7.4 61 475-536 2-65 (75)
116 cd04933 ACT_AK1-AT_1 ACT domai 98.0 2.5E-05 5.3E-10 64.7 8.3 64 474-539 1-71 (78)
117 cd04919 ACT_AK-Hom3_2 ACT doma 98.0 2E-05 4.4E-10 62.3 7.1 50 395-444 1-52 (66)
118 COG0527 LysC Aspartokinases [A 98.0 3.9E-05 8.5E-10 83.5 11.5 114 411-539 257-373 (447)
119 cd04890 ACT_AK-like_1 ACT doma 98.0 3.2E-05 6.9E-10 60.6 7.5 59 476-536 2-61 (62)
120 cd04922 ACT_AKi-HSDH-ThrA_2 AC 97.9 3E-05 6.6E-10 61.1 7.1 51 395-445 1-53 (66)
121 cd04934 ACT_AK-Hom3_1 CT domai 97.9 4.2E-05 9E-10 62.6 7.7 62 475-538 2-65 (73)
122 cd04911 ACT_AKiii-YclM-BS_1 AC 97.9 2.8E-05 6.1E-10 63.9 6.1 64 396-464 2-65 (76)
123 cd04932 ACT_AKiii-LysC-EC_1 AC 97.9 6.7E-05 1.5E-09 61.6 8.1 61 475-537 2-66 (75)
124 PRK06635 aspartate kinase; Rev 97.8 3.7E-05 8E-10 83.0 8.1 111 411-535 211-325 (404)
125 cd04924 ACT_AK-Arch_2 ACT doma 97.7 0.00011 2.3E-09 57.8 7.0 51 395-445 1-53 (66)
126 cd04936 ACT_AKii-LysC-BS-like_ 97.7 0.00011 2.3E-09 57.1 6.9 49 397-445 2-50 (63)
127 cd04923 ACT_AK-LysC-DapG-like_ 97.7 0.00012 2.7E-09 56.8 6.9 49 397-445 2-50 (63)
128 cd04915 ACT_AK-Ectoine_2 ACT d 97.7 0.00015 3.3E-09 58.0 7.5 50 395-445 2-53 (66)
129 cd04918 ACT_AK1-AT_2 ACT domai 97.7 0.00012 2.7E-09 58.2 6.9 49 396-445 2-52 (65)
130 cd04935 ACT_AKiii-DAPDC_1 ACT 97.7 0.00021 4.6E-09 58.7 8.1 61 475-537 2-66 (75)
131 cd04916 ACT_AKiii-YclM-BS_2 AC 97.7 0.00017 3.7E-09 56.7 7.2 51 395-445 1-53 (66)
132 TIGR00657 asp_kinases aspartat 97.7 0.00012 2.5E-09 80.1 8.4 108 412-534 252-362 (441)
133 cd04868 ACT_AK-like ACT domain 97.6 0.00024 5.1E-09 53.8 6.5 48 397-444 2-51 (60)
134 cd04920 ACT_AKiii-DAPDC_2 ACT 97.6 0.00025 5.5E-09 56.1 6.8 50 396-445 1-50 (63)
135 cd04892 ACT_AK-like_2 ACT doma 97.4 0.00053 1.1E-08 52.9 6.8 50 396-445 1-52 (65)
136 PRK09181 aspartate kinase; Val 97.3 0.0013 2.9E-08 72.4 11.4 111 411-538 279-394 (475)
137 cd04921 ACT_AKi-HSDH-ThrA-like 97.3 0.00091 2E-08 54.9 7.3 51 395-445 1-53 (80)
138 PRK09034 aspartate kinase; Rev 97.3 0.00083 1.8E-08 73.7 8.5 97 347-445 326-437 (454)
139 cd04917 ACT_AKiii-LysC-EC_2 AC 97.2 0.0016 3.4E-08 51.4 7.1 48 395-444 1-50 (64)
140 PLN02551 aspartokinase 97.2 0.0026 5.7E-08 70.8 11.3 100 411-527 316-418 (521)
141 cd04910 ACT_AK-Ectoine_1 ACT d 97.1 0.0027 5.9E-08 51.6 8.1 61 396-464 2-62 (71)
142 cd04914 ACT_AKi-DapG-BS_1 ACT 97.1 0.0018 3.9E-08 51.9 6.6 48 396-445 2-49 (67)
143 cd04914 ACT_AKi-DapG-BS_1 ACT 97.0 0.0031 6.8E-08 50.5 7.7 56 475-533 2-57 (67)
144 PRK09466 metL bifunctional asp 97.0 0.0032 7E-08 73.6 10.7 110 411-536 268-380 (810)
145 PRK09084 aspartate kinase III; 96.9 0.002 4.3E-08 70.6 7.8 106 413-536 259-368 (448)
146 COG4747 ACT domain-containing 96.9 0.035 7.7E-07 49.0 13.5 113 406-535 11-129 (142)
147 PRK05925 aspartate kinase; Pro 96.9 0.0078 1.7E-07 65.8 11.7 96 347-445 316-421 (440)
148 PRK08210 aspartate kinase I; R 96.8 0.0042 9E-08 67.2 8.3 99 344-444 284-388 (403)
149 cd04891 ACT_AK-LysC-DapG-like_ 96.6 0.006 1.3E-07 46.4 6.3 46 397-444 2-52 (61)
150 PRK08961 bifunctional aspartat 96.6 0.0094 2E-07 70.6 10.7 107 413-537 275-387 (861)
151 KOG2436 Acetylglutamate kinase 96.6 0.0072 1.6E-07 65.4 8.8 123 199-339 170-303 (520)
152 PRK08841 aspartate kinase; Val 96.5 0.0083 1.8E-07 64.7 8.6 94 347-445 269-365 (392)
153 cd04910 ACT_AK-Ectoine_1 ACT d 96.3 0.017 3.8E-07 46.9 7.3 63 476-538 3-66 (71)
154 COG3603 Uncharacterized conser 96.2 0.019 4E-07 50.7 7.5 67 466-535 55-122 (128)
155 cd04913 ACT_AKii-LysC-BS-like_ 96.2 0.016 3.5E-07 46.0 6.6 48 396-445 2-54 (75)
156 PF01842 ACT: ACT domain; Int 96.0 0.019 4.2E-07 44.6 5.9 54 483-536 7-65 (66)
157 PRK11589 gcvR glycine cleavage 95.2 0.58 1.3E-05 45.4 14.1 141 393-539 6-172 (190)
158 cd04888 ACT_PheB-BS C-terminal 94.5 0.32 6.9E-06 39.0 8.9 56 406-467 8-68 (76)
159 COG3830 ACT domain-containing 94.3 0.1 2.2E-06 44.1 5.4 63 474-538 3-67 (90)
160 cd04888 ACT_PheB-BS C-terminal 93.9 0.33 7.2E-06 38.9 7.8 55 484-538 8-65 (76)
161 PF01842 ACT: ACT domain; Int 93.1 0.46 1E-05 36.7 7.2 27 405-431 7-33 (66)
162 PRK04435 hypothetical protein; 92.4 0.86 1.9E-05 42.4 9.1 63 395-466 69-136 (147)
163 cd04911 ACT_AKiii-YclM-BS_1 AC 92.3 0.46 1E-05 39.1 6.3 60 477-538 4-69 (76)
164 KOG0456 Aspartate kinase [Amin 92.1 0.37 8.1E-06 50.9 6.8 70 466-537 385-458 (559)
165 cd04908 ACT_Bt0572_1 N-termina 91.7 0.52 1.1E-05 37.2 5.8 53 483-535 8-60 (66)
166 PRK06737 acetolactate synthase 90.8 0.74 1.6E-05 38.0 6.0 52 406-465 10-67 (76)
167 PRK13562 acetolactate synthase 90.4 0.83 1.8E-05 38.3 6.0 52 406-465 10-68 (84)
168 cd02116 ACT ACT domains are co 90.0 1 2.2E-05 32.1 5.7 49 485-533 7-60 (60)
169 PRK11152 ilvM acetolactate syn 88.6 1.3 2.9E-05 36.4 5.9 51 406-465 11-67 (76)
170 COG3830 ACT domain-containing 88.2 2.2 4.7E-05 36.2 7.0 47 394-443 2-52 (90)
171 PRK11895 ilvH acetolactate syn 88.0 11 0.00024 35.6 12.5 91 406-508 10-116 (161)
172 cd04889 ACT_PDH-BS-like C-term 87.7 1.9 4.1E-05 32.5 6.0 50 483-532 5-55 (56)
173 PF13740 ACT_6: ACT domain; PD 87.5 2.3 4.9E-05 34.7 6.7 58 475-536 3-62 (76)
174 TIGR00119 acolac_sm acetolacta 87.1 14 0.0003 34.8 12.5 91 406-508 9-115 (157)
175 PRK08178 acetolactate synthase 86.3 2 4.4E-05 37.0 5.8 51 406-465 16-72 (96)
176 PRK13562 acetolactate synthase 86.1 4.1 9E-05 34.2 7.5 52 484-535 10-68 (84)
177 cd04870 ACT_PSP_1 CT domains f 85.9 2.9 6.2E-05 33.8 6.4 31 398-431 2-32 (75)
178 PRK04435 hypothetical protein; 85.2 4.9 0.00011 37.3 8.4 55 483-537 76-133 (147)
179 PF13710 ACT_5: ACT domain; PD 83.9 2.1 4.6E-05 33.8 4.6 51 407-465 1-57 (63)
180 COG4492 PheB ACT domain-contai 83.8 8.7 0.00019 35.0 8.9 65 406-482 80-149 (150)
181 CHL00100 ilvH acetohydroxyacid 82.5 6.4 0.00014 37.7 8.1 57 477-535 5-67 (174)
182 CHL00100 ilvH acetohydroxyacid 82.4 20 0.00044 34.3 11.5 97 406-508 10-116 (174)
183 cd04882 ACT_Bt0572_2 C-termina 81.6 4.3 9.4E-05 31.1 5.6 53 483-535 6-60 (65)
184 PRK13011 formyltetrahydrofolat 80.8 44 0.00096 34.5 14.3 84 395-482 7-97 (286)
185 PF13740 ACT_6: ACT domain; PD 80.5 12 0.00026 30.3 8.1 44 396-442 3-50 (76)
186 PRK06737 acetolactate synthase 79.4 4.1 8.8E-05 33.6 4.9 40 484-523 10-53 (76)
187 COG3603 Uncharacterized conser 78.7 10 0.00022 33.9 7.3 58 386-444 54-111 (128)
188 PF13291 ACT_4: ACT domain; PD 78.7 8.9 0.00019 31.1 6.8 62 397-468 8-75 (80)
189 PRK00194 hypothetical protein; 77.9 4.4 9.6E-05 33.8 4.9 35 475-511 4-38 (90)
190 cd04883 ACT_AcuB C-terminal AC 77.5 11 0.00023 29.6 6.9 54 483-536 8-65 (72)
191 cd04870 ACT_PSP_1 CT domains f 77.3 7.7 0.00017 31.3 6.0 44 477-522 2-47 (75)
192 PRK03381 PII uridylyl-transfer 76.4 89 0.0019 37.0 16.7 138 393-536 597-772 (774)
193 TIGR01693 UTase_glnD [Protein- 75.2 81 0.0018 37.7 16.2 125 393-522 666-827 (850)
194 PRK08178 acetolactate synthase 74.3 8.8 0.00019 33.1 5.7 51 484-534 16-71 (96)
195 cd04909 ACT_PDH-BS C-terminal 74.0 9.7 0.00021 29.8 5.7 52 483-534 8-64 (69)
196 TIGR00119 acolac_sm acetolacta 73.8 10 0.00022 35.8 6.5 53 483-537 8-64 (157)
197 PRK00194 hypothetical protein; 73.6 15 0.00032 30.6 7.0 33 396-431 4-36 (90)
198 cd04893 ACT_GcvR_1 ACT domains 72.6 12 0.00027 30.3 6.1 34 476-511 3-36 (77)
199 PRK11895 ilvH acetolactate syn 72.5 9.4 0.0002 36.1 6.0 55 483-537 9-69 (161)
200 PRK11152 ilvM acetolactate syn 72.5 11 0.00024 31.0 5.7 51 483-536 10-64 (76)
201 cd04869 ACT_GcvR_2 ACT domains 72.1 22 0.00048 28.6 7.6 30 398-430 2-31 (81)
202 cd04872 ACT_1ZPV ACT domain pr 71.5 19 0.0004 29.9 7.1 32 397-431 3-34 (88)
203 PRK05007 PII uridylyl-transfer 71.2 1.5E+02 0.0033 35.6 17.2 140 393-537 699-875 (884)
204 PRK13010 purU formyltetrahydro 69.9 54 0.0012 34.0 11.5 33 396-431 10-42 (289)
205 cd04887 ACT_MalLac-Enz ACT_Mal 69.8 20 0.00043 28.3 6.7 56 406-468 7-67 (74)
206 cd04875 ACT_F4HF-DF N-terminal 68.9 21 0.00045 28.5 6.6 31 398-431 2-32 (74)
207 cd04908 ACT_Bt0572_1 N-termina 68.7 8 0.00017 30.2 4.0 26 405-430 8-33 (66)
208 cd04903 ACT_LSD C-terminal ACT 67.6 17 0.00036 27.8 5.7 51 484-534 7-61 (71)
209 cd04877 ACT_TyrR N-terminal AC 67.0 17 0.00038 29.0 5.8 55 406-467 8-63 (74)
210 cd04881 ACT_HSDH-Hom ACT_HSDH_ 66.8 46 0.001 25.8 8.3 56 406-468 8-69 (79)
211 cd04872 ACT_1ZPV ACT domain pr 66.6 22 0.00047 29.5 6.5 35 475-511 2-36 (88)
212 cd04893 ACT_GcvR_1 ACT domains 66.0 31 0.00067 28.0 7.2 32 397-431 3-34 (77)
213 PRK05092 PII uridylyl-transfer 65.9 1.9E+02 0.0041 35.0 16.7 124 394-522 731-891 (931)
214 cd04875 ACT_F4HF-DF N-terminal 65.7 18 0.00039 28.9 5.7 32 477-510 2-33 (74)
215 cd04869 ACT_GcvR_2 ACT domains 65.4 33 0.00071 27.6 7.3 33 477-511 2-34 (81)
216 cd04878 ACT_AHAS N-terminal AC 64.5 38 0.00082 25.8 7.3 53 406-466 8-66 (72)
217 COG4747 ACT domain-containing 64.3 18 0.00039 32.4 5.6 65 484-550 11-80 (142)
218 PRK01759 glnD PII uridylyl-tra 64.0 1.1E+02 0.0025 36.6 14.1 126 393-523 675-832 (854)
219 cd04895 ACT_ACR_1 ACT domain-c 63.2 70 0.0015 26.0 8.6 54 484-537 9-69 (72)
220 PRK03059 PII uridylyl-transfer 63.1 2.6E+02 0.0056 33.6 16.9 124 393-521 676-833 (856)
221 PRK08577 hypothetical protein; 63.0 20 0.00043 32.6 6.1 34 394-430 55-88 (136)
222 cd04886 ACT_ThrD-II-like C-ter 61.6 42 0.00091 25.6 7.0 51 484-534 6-66 (73)
223 cd04925 ACT_ACR_2 ACT domain-c 61.1 66 0.0014 25.8 8.2 45 476-522 2-48 (74)
224 cd02116 ACT ACT domains are co 60.8 27 0.00058 24.2 5.4 37 407-443 7-49 (60)
225 cd04905 ACT_CM-PDT C-terminal 59.5 55 0.0012 26.5 7.6 53 483-535 8-69 (80)
226 PRK03670 competence damage-ind 58.8 39 0.00084 34.3 7.8 70 204-301 20-89 (252)
227 COG2150 Predicted regulator of 58.8 49 0.0011 31.2 7.7 79 454-532 70-155 (167)
228 cd04879 ACT_3PGDH-like ACT_3PG 58.5 24 0.00052 26.8 5.1 25 406-430 7-31 (71)
229 cd04880 ACT_AAAH-PDT-like ACT 58.0 30 0.00065 27.6 5.7 25 407-431 8-32 (75)
230 cd04874 ACT_Af1403 N-terminal 57.8 45 0.00098 25.5 6.6 41 483-523 7-50 (72)
231 TIGR00655 PurU formyltetrahydr 57.6 1.2E+02 0.0027 31.2 11.4 64 397-463 2-73 (280)
232 PF13710 ACT_5: ACT domain; PD 57.4 17 0.00037 28.6 4.0 49 485-533 1-55 (63)
233 PF00994 MoCF_biosynth: Probab 57.1 47 0.001 30.2 7.5 69 203-300 16-84 (144)
234 PRK06027 purU formyltetrahydro 56.8 89 0.0019 32.3 10.3 34 395-431 6-39 (286)
235 PRK00275 glnD PII uridylyl-tra 56.7 2.2E+02 0.0047 34.5 14.8 125 394-523 703-863 (895)
236 cd04886 ACT_ThrD-II-like C-ter 55.8 38 0.00081 25.9 5.8 25 406-430 6-30 (73)
237 cd04905 ACT_CM-PDT C-terminal 55.6 60 0.0013 26.3 7.2 37 406-442 9-50 (80)
238 cd04874 ACT_Af1403 N-terminal 55.2 35 0.00076 26.1 5.5 25 406-430 8-32 (72)
239 cd04884 ACT_CBS C-terminal ACT 54.2 53 0.0011 25.9 6.5 28 483-510 6-33 (72)
240 cd04881 ACT_HSDH-Hom ACT_HSDH_ 53.7 66 0.0014 24.9 7.1 51 484-534 8-65 (79)
241 cd04887 ACT_MalLac-Enz ACT_Mal 53.5 64 0.0014 25.3 6.9 51 484-534 7-60 (74)
242 PF09413 DUF2007: Domain of un 53.4 36 0.00078 26.6 5.3 44 491-534 13-64 (67)
243 COG1058 CinA Predicted nucleot 53.1 56 0.0012 33.3 7.8 68 205-301 22-89 (255)
244 PRK11589 gcvR glycine cleavage 53.1 39 0.00085 32.8 6.5 60 473-536 7-68 (190)
245 cd04903 ACT_LSD C-terminal ACT 51.9 42 0.0009 25.5 5.5 25 406-430 7-31 (71)
246 cd04931 ACT_PAH ACT domain of 51.7 68 0.0015 27.2 7.0 59 478-536 16-82 (90)
247 PF13291 ACT_4: ACT domain; PD 50.3 55 0.0012 26.3 6.1 50 484-533 14-67 (80)
248 PRK13010 purU formyltetrahydro 50.2 33 0.00071 35.6 5.8 35 474-510 9-43 (289)
249 TIGR00655 PurU formyltetrahydr 50.1 38 0.00082 35.0 6.2 34 476-511 2-35 (280)
250 cd04878 ACT_AHAS N-terminal AC 49.9 65 0.0014 24.4 6.3 40 484-523 8-51 (72)
251 cd04879 ACT_3PGDH-like ACT_3PG 49.3 55 0.0012 24.7 5.8 49 484-532 7-59 (71)
252 cd04889 ACT_PDH-BS-like C-term 49.2 18 0.00038 27.1 2.8 26 405-430 5-30 (56)
253 cd04877 ACT_TyrR N-terminal AC 49.1 83 0.0018 25.0 6.9 44 484-528 8-51 (74)
254 cd04929 ACT_TPH ACT domain of 48.7 68 0.0015 26.1 6.3 52 484-535 8-66 (74)
255 cd04819 PA_2 PA_2: Protease-as 48.7 93 0.002 27.8 7.9 76 276-364 44-127 (127)
256 cd04880 ACT_AAAH-PDT-like ACT 48.5 49 0.0011 26.3 5.5 51 484-534 7-66 (75)
257 cd04900 ACT_UUR-like_1 ACT dom 48.4 1.1E+02 0.0024 24.2 7.6 23 484-506 9-31 (73)
258 cd00885 cinA Competence-damage 48.2 92 0.002 29.5 8.1 69 204-301 19-87 (170)
259 cd04882 ACT_Bt0572_2 C-termina 48.0 15 0.00033 27.9 2.3 26 405-430 6-31 (65)
260 cd04901 ACT_3PGDH C-terminal A 47.6 17 0.00037 28.1 2.6 51 484-534 7-59 (69)
261 cd04902 ACT_3PGDH-xct C-termin 46.5 41 0.00088 26.2 4.7 50 483-532 6-59 (73)
262 cd04904 ACT_AAAH ACT domain of 46.4 76 0.0016 25.5 6.3 51 484-534 8-65 (74)
263 PRK04374 PII uridylyl-transfer 46.3 5.6E+02 0.012 30.9 15.9 126 393-523 688-845 (869)
264 TIGR00177 molyb_syn molybdenum 46.3 1.1E+02 0.0023 28.0 8.0 66 204-298 27-92 (144)
265 cd04883 ACT_AcuB C-terminal AC 45.9 97 0.0021 24.0 6.8 26 405-430 8-33 (72)
266 TIGR00719 sda_beta L-serine de 43.8 1.3E+02 0.0027 29.6 8.6 24 407-430 157-180 (208)
267 PRK13011 formyltetrahydrofolat 42.9 99 0.0021 32.0 8.0 34 475-510 8-41 (286)
268 cd04897 ACT_ACR_3 ACT domain-c 42.5 1.9E+02 0.0041 23.7 8.8 31 396-429 2-32 (75)
269 cd04895 ACT_ACR_1 ACT domain-c 41.9 49 0.0011 26.9 4.4 31 396-429 2-32 (72)
270 PRK03673 hypothetical protein; 41.6 92 0.002 33.8 7.8 69 204-301 21-89 (396)
271 PRK01215 competence damage-ind 41.5 96 0.0021 31.7 7.6 70 203-301 22-91 (264)
272 PF13511 DUF4124: Domain of un 41.4 23 0.0005 27.1 2.4 28 292-319 4-33 (60)
273 cd04876 ACT_RelA-SpoT ACT dom 41.1 77 0.0017 23.1 5.4 24 407-430 7-30 (71)
274 COG0440 IlvH Acetolactate synt 40.9 36 0.00078 32.2 3.9 63 484-546 12-80 (163)
275 PRK06027 purU formyltetrahydro 40.3 99 0.0021 32.0 7.5 64 474-539 6-80 (286)
276 cd04871 ACT_PSP_2 ACT domains 39.9 24 0.00052 29.4 2.4 58 476-537 1-70 (84)
277 cd04884 ACT_CBS C-terminal ACT 39.6 45 0.00097 26.3 3.9 26 405-430 6-31 (72)
278 cd04896 ACT_ACR-like_3 ACT dom 39.1 1.9E+02 0.0041 23.7 7.5 30 397-429 2-31 (75)
279 cd04897 ACT_ACR_3 ACT domain-c 38.4 2.1E+02 0.0045 23.5 7.6 49 475-525 2-52 (75)
280 COG4492 PheB ACT domain-contai 37.4 1.7E+02 0.0036 27.0 7.4 62 475-536 71-135 (150)
281 PRK13581 D-3-phosphoglycerate 37.2 90 0.0019 35.2 7.2 85 347-431 385-485 (526)
282 smart00852 MoCF_biosynth Proba 36.8 1.5E+02 0.0033 26.5 7.4 69 203-300 17-85 (135)
283 cd04873 ACT_UUR-ACR-like ACT d 36.4 1.3E+02 0.0028 22.8 6.1 41 484-524 8-50 (70)
284 TIGR01327 PGDH D-3-phosphoglyc 36.3 83 0.0018 35.4 6.7 84 347-430 384-483 (525)
285 PRK08198 threonine dehydratase 35.1 1.5E+02 0.0032 32.0 8.2 45 482-526 333-384 (404)
286 cd05014 SIS_Kpsf KpsF-like pro 34.8 1.4E+02 0.0031 25.9 6.8 78 277-363 1-80 (128)
287 TIGR02667 moaB_proteo molybden 34.2 1.5E+02 0.0032 27.9 7.1 69 203-299 21-90 (163)
288 TIGR02726 phenyl_P_delta pheny 34.0 24 0.00053 33.5 1.7 48 304-365 9-58 (169)
289 cd04926 ACT_ACR_4 C-terminal 33.9 1.1E+02 0.0025 24.2 5.4 40 483-522 8-49 (72)
290 COG0440 IlvH Acetolactate synt 33.6 54 0.0012 31.1 3.9 37 407-443 13-55 (163)
291 cd04871 ACT_PSP_2 ACT domains 33.3 39 0.00084 28.1 2.7 31 398-430 2-32 (84)
292 COG3602 Uncharacterized protei 32.6 30 0.00066 30.7 1.9 46 388-433 63-108 (134)
293 cd00886 MogA_MoaB MogA_MoaB fa 32.5 1.7E+02 0.0037 26.9 7.2 66 205-299 21-88 (152)
294 cd00758 MoCF_BD MoCF_BD: molyb 32.2 2.1E+02 0.0046 25.6 7.6 66 204-298 19-84 (133)
295 cd04909 ACT_PDH-BS C-terminal 32.2 65 0.0014 24.9 3.7 26 405-430 8-33 (69)
296 cd04899 ACT_ACR-UUR-like_2 C-t 32.0 72 0.0016 24.6 3.9 30 397-429 2-31 (70)
297 PRK00549 competence damage-ind 31.9 1.8E+02 0.0039 31.7 8.2 69 204-301 20-88 (414)
298 cd04876 ACT_RelA-SpoT ACT dom 30.9 2.1E+02 0.0044 20.6 6.9 40 484-523 6-48 (71)
299 cd04896 ACT_ACR-like_3 ACT dom 30.8 2E+02 0.0043 23.6 6.3 38 484-522 8-50 (75)
300 COG2150 Predicted regulator of 30.5 2.1E+02 0.0045 27.2 7.1 36 407-442 104-145 (167)
301 PRK08577 hypothetical protein; 29.6 1.8E+02 0.0039 26.2 6.7 50 474-525 56-109 (136)
302 COG0645 Predicted kinase [Gene 29.5 99 0.0021 29.5 5.0 64 289-367 16-86 (170)
303 cd04902 ACT_3PGDH-xct C-termin 29.4 89 0.0019 24.2 4.1 25 406-430 7-31 (73)
304 cd04927 ACT_ACR-like_2 Second 29.0 2.3E+02 0.0051 22.8 6.6 26 484-509 8-35 (76)
305 cd04925 ACT_ACR_2 ACT domain-c 28.5 68 0.0015 25.7 3.3 30 397-429 2-31 (74)
306 cd04926 ACT_ACR_4 C-terminal 27.9 1.1E+02 0.0024 24.3 4.4 24 406-429 9-32 (72)
307 PRK08198 threonine dehydratase 27.3 1.6E+02 0.0035 31.7 6.9 39 390-431 322-360 (404)
308 cd04930 ACT_TH ACT domain of t 27.2 2.3E+02 0.0049 25.2 6.6 57 478-534 43-106 (115)
309 COG0462 PrsA Phosphoribosylpyr 26.9 6.1E+02 0.013 26.7 10.6 149 195-366 99-276 (314)
310 cd04885 ACT_ThrD-I Tandem C-te 26.9 2.9E+02 0.0063 21.5 6.6 42 483-525 5-49 (68)
311 COG0303 MoeA Molybdopterin bio 26.7 2.1E+02 0.0046 31.2 7.6 72 205-307 204-275 (404)
312 PRK11898 prephenate dehydratas 26.3 6.6E+02 0.014 25.8 10.9 113 320-441 121-245 (283)
313 cd04906 ACT_ThrD-I_1 First of 26.3 2.8E+02 0.006 22.8 6.7 51 482-534 7-64 (85)
314 COG3367 Uncharacterized conser 26.1 5.4E+02 0.012 27.3 10.0 114 299-437 67-191 (339)
315 cd04873 ACT_UUR-ACR-like ACT d 25.5 1.1E+02 0.0024 23.3 3.9 25 406-430 8-32 (70)
316 cd04904 ACT_AAAH ACT domain of 25.3 83 0.0018 25.2 3.2 25 407-431 9-33 (74)
317 TIGR00200 cinA_nterm competenc 25.2 3.1E+02 0.0067 30.0 8.5 68 205-301 21-88 (413)
318 cd04931 ACT_PAH ACT domain of 24.9 2.5E+02 0.0054 23.7 6.2 35 407-441 23-62 (90)
319 COG1707 ACT domain-containing 23.8 6E+02 0.013 24.3 8.9 112 407-532 11-136 (218)
320 PRK05788 cobalamin biosynthesi 23.8 7E+02 0.015 26.2 10.6 125 284-429 99-228 (315)
321 cd04899 ACT_ACR-UUR-like_2 C-t 23.0 3.5E+02 0.0075 20.6 6.8 30 477-508 3-32 (70)
322 cd04929 ACT_TPH ACT domain of 22.3 1.1E+02 0.0023 24.9 3.3 35 407-441 9-48 (74)
323 PRK06349 homoserine dehydrogen 21.6 1.7E+02 0.0037 31.9 5.8 41 484-524 356-399 (426)
324 cd04928 ACT_TyrKc Uncharacteri 21.4 3.8E+02 0.0082 21.5 6.3 43 484-526 9-54 (68)
325 PHA01735 hypothetical protein 20.3 3.1E+02 0.0068 22.2 5.3 31 196-227 24-56 (76)
326 COG2716 GcvR Glycine cleavage 20.3 4.6E+02 0.0099 25.2 7.4 104 393-506 3-122 (176)
327 PRK06349 homoserine dehydrogen 20.3 3.7E+02 0.0081 29.3 8.1 55 406-467 356-415 (426)
328 TIGR01127 ilvA_1Cterm threonin 20.2 4.1E+02 0.009 28.2 8.3 55 482-537 311-372 (380)
329 cd04900 ACT_UUR-like_1 ACT dom 20.1 1.4E+02 0.003 23.6 3.6 29 398-429 4-32 (73)
330 PRK10629 EnvZ/OmpR regulon mod 20.1 2.5E+02 0.0054 25.5 5.5 50 488-539 50-100 (127)
No 1
>KOG0456 consensus Aspartate kinase [Amino acid transport and metabolism]
Probab=100.00 E-value=1.5e-112 Score=857.18 Aligned_cols=550 Identities=70% Similarity=0.998 Sum_probs=519.8
Q ss_pred Cccccccccccccccccc---ccccccccccccccccccceecccCCCcccceeEeeecccceeeeccccccccccccCC
Q 008693 2 ANTMQFSSIIQKNSLHCQ---ALSWQRFAFAKCVSSSSRLCVSVRNSCGGRGGLRVSCEGARIDVIERKKSENLGVDESE 78 (557)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (557)
++++|++|+.+++..-.+ +..+++.+|+.-.+++.+.++ .++||++ ++|++|+..++...+++.+++...++ +
T Consensus 1 ~a~~~~~~~~~~~l~l~~~r~~~~~~~~~f~~~~~~~~~~~~--~~s~~~i-~~~~~~~~~r~~l~~~k~~e~~~s~g-~ 76 (559)
T KOG0456|consen 1 MASTQVYGVKTPRLALTSKRLEFSSKGVDFSTLKKSSLPIGR--GSSCRNI-SLRVSCEAVRVVLLERKNPETDPSNG-E 76 (559)
T ss_pred CCceeEEeecCCCcccccccccccccCccchhhccccccccC--Cccceec-eeeeeeeeeeEeeecccCcccCccCC-C
Confidence 468999999776555332 556778888887777765555 5667777 89999999999999999999866666 8
Q ss_pred CcceEEEEecccccCCHHHHHHHHHHHHcCCCCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHH
Q 008693 79 KQLTCVMKFGGSSLASAERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRT 158 (557)
Q Consensus 79 ~~~~~V~KFGGsSv~~~~~~~~va~iI~~~~~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~ 158 (557)
+..|+|+|||||||++++++..++..+..+++++++||+|||+++||.|+..++++..|+..+.+.+++++.|++.|++.
T Consensus 77 k~~~~V~KFGGsSV~s~~~~i~v~~l~~~~~~e~~~vV~SA~sk~Tna~~ta~~~~~~c~va~~~sie~l~iIke~Hi~t 156 (559)
T KOG0456|consen 77 KGLTCVMKFGGSSVGSAERMIEVAVLILYFPDERPVVVLSAMSKTTNALLTAGEKAVCCGVANVESIEELSIIKELHIRT 156 (559)
T ss_pred cceEEEEecCCccccccchhhhhhHHHHhcCCCCeEEEEEccccchhhhhhhhhheecccccCcchHHHHHHHHHHHHhh
Confidence 88999999999999999999999999998888999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCC
Q 008693 159 VDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTN 238 (557)
Q Consensus 159 ~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~ 238 (557)
+++|++++..+.++++.|+++|+|+++++|.++|++|+++||||++|+++|++||+..|+++..+|..++++++.++|.+
T Consensus 157 a~e~~~d~~v~~~~le~leq~Lk~i~mm~Elt~RTrD~lvs~GE~lS~rf~aA~lnd~G~kar~~D~~~I~~~~~d~~t~ 236 (559)
T KOG0456|consen 157 AHELIVDPAVIAKLLEGLEQLLKGIAMMKELTLRTRDYLVSFGECLSTRFFAAYLNDIGHKARQYDAFEIGFITTDDFTN 236 (559)
T ss_pred HHHhccCHHHHHHHHHHHHHHHHHHHHHHhcchhhhhHhhhhhhHHHHHHHHHHHHhcCccceeechhheeccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCC
Q 008693 239 ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPN 318 (557)
Q Consensus 239 a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~ 318 (557)
+++.+.+++.+.+.+...|...+.|||++||.|..++.|..+++||||||++|+.||.+||++++++|+|||||+|+|||
T Consensus 237 ~d~~~a~~~av~k~~~~~~aken~VPVvTGf~Gk~~~tg~lt~lGRG~sDl~At~i~~al~~~EiQVWKdVDGv~T~DP~ 316 (559)
T KOG0456|consen 237 DDILEATYPAVSKLLSGDWAKENAVPVVTGFLGKGWPTGALTTLGRGGSDLTATTIGKALGLDEIQVWKDVDGVLTCDPR 316 (559)
T ss_pred hhHHHHHHHHHHHhcccccccCCccceEeeccccCccccceecccCCchhhHHHHHHHHcCchhhhhhhhcCceEecCCc
Confidence 99999999888888888888888999999999988889999999999999999999999999999999999999999999
Q ss_pred CCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCCCCcceeeEEeeeccEEEE
Q 008693 319 IHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSIVLKRNVTML 398 (557)
Q Consensus 319 ~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~Vt~Is~~~nialI 398 (557)
++|.|+++|.+|++||.||+|||++|+||-+|+|+++.+|||||+|++||.+|||.|.+++++.+...|+|+.++|++++
T Consensus 317 ~~p~Ar~vp~lT~dEAaELaYfGaqVlHP~sM~~~~~~~IPvRvKN~~NP~~~GTvI~~d~~m~k~~~TsI~lK~nv~ml 396 (559)
T KOG0456|consen 317 IYPGARLVPYLTFDEAAELAYFGAQVLHPFSMRPAREGRIPVRVKNSYNPTAPGTVITPDRDMSKAGLTSIVLKRNVTML 396 (559)
T ss_pred cCCCccccCccCHHHHHHHHhhhhhhccccccchhhccCcceEeecCCCCCCCceEeccchhhhhccceEEEEeccEEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999988899999999999999
Q ss_pred EEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeecccceeEEE
Q 008693 399 DIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNLLQHRSIIS 478 (557)
Q Consensus 399 tI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~~~~~aiIs 478 (557)
+|.+++|+++.||++++|.+|+++||+||.+++||.+||++++++++|++++++.++++..++|++++.+++.++.++||
T Consensus 397 dI~Str~l~q~GFLAkvFti~ek~~isVDvvaTSEV~iSltL~~~~~~sreliq~~l~~a~eeL~ki~~vdll~~~sIiS 476 (559)
T KOG0456|consen 397 DIASTRMLGQHGFLAKVFTIFEKLGISVDVVATSEVSISLTLDPSKLDSRELIQGELDQAVEELEKIAVVDLLKGRSIIS 476 (559)
T ss_pred EecccchhhhhhHHHHHHHHHHHhCcEEEEEEeeeEEEEEecChhhhhhHHHHHhhHHHHHHHHHHhhhhhhhccchHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEccccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccC-ccccccccccCCCCCC
Q 008693 479 LIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFES-DLANLDCVCGSENNSS 555 (557)
Q Consensus 479 IVG~~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~~-~~~~~~~~~~~~~~~~ 555 (557)
+||+|.+..+++.++|..|+++||||.|||||+|++|||++|+++++++|+++||++||++ +..|+..++...++.+
T Consensus 477 LiGnvq~ss~i~~rmF~~l~e~giNvqMISQGAskvNIS~ivne~ea~k~v~~lH~~~~e~~~~~e~~~q~~~~~~~~ 554 (559)
T KOG0456|consen 477 LIGNVQNSSGILERMFCVLAENGINVQMISQGASKVNISCIVNEKEAEKCVQALHKAFFETLDLHEVPSQASMGVEKP 554 (559)
T ss_pred hhhhhhhhhHHHHHHHHHHHhcCcceeeeccccccceEEEEEChHHHHHHHHHHHHHHcCCCCccccccccccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999 8888888887776654
No 2
>PLN02551 aspartokinase
Probab=100.00 E-value=6.7e-104 Score=861.45 Aligned_cols=499 Identities=84% Similarity=1.207 Sum_probs=452.5
Q ss_pred cccCCCcccceeEeeecccceeeeccccccccccccCCCcceEEEEecccccCCHHHHHHHHHHHHcCCCCccEEEEcCC
Q 008693 41 SVRNSCGGRGGLRVSCEGARIDVIERKKSENLGVDESEKQLTCVMKFGGSSLASAERMREVAELILSFPNERPVIVLSAM 120 (557)
Q Consensus 41 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~V~KFGGsSv~~~~~~~~va~iI~~~~~~~~vvVVSA~ 120 (557)
+...++.+++.+++.|..+......+..++........+.+++|+|||||||+|+++|++|+++|....+.++|||||||
T Consensus 12 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~V~KFGGtSv~~~e~i~~v~~iI~~~~~~~~vVVvSA~ 91 (521)
T PLN02551 12 RSVGSSCRNIVLRVNCSAGRVEALVEAPSETRQGGGTEKQLTVVMKFGGSSVASAERMREVADLILSFPDERPVVVLSAM 91 (521)
T ss_pred ccccccchhHHHHhhhhhhhhHhhhhcccccccccccccCceEEEEECCCccCCHHHHHHHHHHHHhcCCCCEEEEEcCC
Confidence 33444444457888887777665656666666666777788899999999999999999999999987666799999999
Q ss_pred CcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhh
Q 008693 121 GKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSF 200 (557)
Q Consensus 121 gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~ 200 (557)
+|+||.|+++++.+..++..+.++...++.++++|.+++++|+.+...+..++++|+++++++.++++++++.+|+|+|+
T Consensus 92 ~~~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~h~~~~~~L~~~~~~~~~~~~~l~~ll~~i~~~~~~~~~~~d~ils~ 171 (521)
T PLN02551 92 GKTTNNLLLAGEKAVSCGVTNVSEIEELSAIRELHLRTADELGVDESVVEKLLDELEQLLKGIAMMKELTPRTRDYLVSF 171 (521)
T ss_pred CCchHHHHHHHHHHhhccccchhhHHHHHHHHHHHHHHHHHhhcchHHHHHHHHHHHHHHHhhhhhcccchHHHHHHHhH
Confidence 99999999998888766544456777899999999999999998888899999999999999999999999999999999
Q ss_pred chHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCcee
Q 008693 201 GECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAIT 280 (557)
Q Consensus 201 GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~t 280 (557)
||++|+.||+++|+++|+++.++|++++|++|+++|+++++.+.+++++.+.+...|.+.+.|||+|||+|.++++|++|
T Consensus 172 GE~lSa~lla~~L~~~Gi~a~~lda~~~gi~t~~~~~~a~i~~~~~~~l~~~l~~~~~~~~~v~Vv~GFig~~~~~G~~t 251 (521)
T PLN02551 172 GERMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWIDDPAVPVVTGFLGKGWKTGAIT 251 (521)
T ss_pred HHHHHHHHHHHHHHHCCCCcEEechHHcceEecCCCCccchhhhhHHHHHHHHHhhhccCCeEEEEcCccccCCCCCcEE
Confidence 99999999999999999999999999999999999999998877888888877665555678999999999982379999
Q ss_pred ecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCE
Q 008693 281 TLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPV 360 (557)
Q Consensus 281 tlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv 360 (557)
|||||||||||+++|++|+|++|+||||||||||+|||++|+|+++++|||+||.||+|+||+||||+|++||++++|||
T Consensus 252 tLGRGGSD~sA~~la~~L~A~~v~I~tDV~Gi~taDPr~v~~A~~l~~lsy~Ea~elA~~GakVlhp~ai~pa~~~~Ipi 331 (521)
T PLN02551 252 TLGRGGSDLTATTIGKALGLREIQVWKDVDGVLTCDPRIYPNAVPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPV 331 (521)
T ss_pred ecCCChHHHHHHHHHHHcCCCEEEEEeCCCceeCCCCCCCCCceEecccCHHHHHHHHhCCCcccCHHHHHHHHHCCceE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEecCCCCCCCCeeEecCCCCCcceeeEEeeeccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEe
Q 008693 361 RVKNSYNPNAPGTLIRRSRDMSKAVLTSIVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTL 440 (557)
Q Consensus 361 ~I~n~~~p~~~GT~I~~~~~~~~~~Vt~Is~~~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I 440 (557)
+|+|+|+|+++||+|++..++++..||+|+.++|+++|++.+.+|++.+||++++|+.|+++||+|+|+++|+.+|+|++
T Consensus 332 ~vknt~~p~~~GT~I~~~~~~~~~~v~~It~~~~v~li~i~~~~m~~~~g~~arvf~~l~~~~I~Vd~IssSe~sIs~~v 411 (521)
T PLN02551 332 RVKNSYNPTAPGTLITKTRDMSKAVLTSIVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSISLTL 411 (521)
T ss_pred EEEecCCCCCCCcEEecccccCCCcccceecCCCeEEEEEecCCCCCcccHHHHHHHHHHHcCCcEEEEeccCCEEEEEE
Confidence 99999999999999988765555679999999999999999999999999999999999999999999999999999999
Q ss_pred CCchhhhHHHHHHHHHHHHHHHhhhheeecccceeEEEEEccccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEE
Q 008693 441 DPSKLWSRELIQQELDHVVEELEKIAIVNLLQHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIV 520 (557)
Q Consensus 441 ~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~~~~~aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV 520 (557)
+.++.+..+.+++.++.++.+++++..+.+.+++++|++||+|+.++++++++|++|+++||||+||+||+|+++||++|
T Consensus 412 ~~~~~~~~~~i~~~l~~l~~el~~~~~V~v~~~vAiISvVG~~~~~~gvaariF~aLa~~gInV~mIsqgaSeinIS~vV 491 (521)
T PLN02551 412 DPSKLWSRELIQQELDHLVEELEKIAVVNLLQGRSIISLIGNVQRSSLILEKVFRVLRTNGVNVQMISQGASKVNISLIV 491 (521)
T ss_pred ehhHhhhhhhHHHHHHHHHHHhhcCCeEEEeCCEEEEEEEccCCCCccHHHHHHHHHHHCCCCeEEEEecCCCcEEEEEE
Confidence 99876554555566777777888777899999999999999987889999999999999999999999999999999999
Q ss_pred ecccHHHHHHHHHHHhccC
Q 008693 521 NDDEAEQCVRALHETFFES 539 (557)
Q Consensus 521 ~~~d~~kAv~~LH~~f~~~ 539 (557)
+++|.++|+++||++||..
T Consensus 492 ~~~d~~~Av~aLH~~Ff~~ 510 (521)
T PLN02551 492 NDDEAEQCVRALHSAFFEG 510 (521)
T ss_pred eHHHHHHHHHHHHHHHhcC
Confidence 9999999999999999986
No 3
>COG0527 LysC Aspartokinases [Amino acid transport and metabolism]
Probab=100.00 E-value=6.4e-93 Score=760.66 Aligned_cols=439 Identities=38% Similarity=0.617 Sum_probs=381.7
Q ss_pred cceEEEEecccccCCHHHHHHHHHHHHcCCC--CccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHH
Q 008693 80 QLTCVMKFGGSSLASAERMREVAELILSFPN--ERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHR 157 (557)
Q Consensus 80 ~~~~V~KFGGsSv~~~~~~~~va~iI~~~~~--~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~ 157 (557)
|.|+|+|||||||+|+++|++++++|.+..+ .++|||+|||||+||.|+++++.+..... ... .++|.+
T Consensus 1 m~~iV~KFGGTSva~~e~i~~va~iv~~~~~~g~~vVVVvSA~~~vTd~Lv~~a~~~~~~~~-----~~~----~~~~~~ 71 (447)
T COG0527 1 MRLIVQKFGGTSVADAERILRVADIVKEDSEEGVKVVVVVSAMGGVTDLLVALAEGAESGRD-----AVA----EQRHRD 71 (447)
T ss_pred CceEEEEeCCcccCCHHHHHHHHHHHHhhhhcCCcEEEEECCCCCchHHHHHHHhhcccccc-----hhH----HHHHHH
Confidence 4589999999999999999999999998643 67899999999999999999876543221 111 566777
Q ss_pred HHHHhCCCHH---HHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEec
Q 008693 158 TVDELGIDRS---IIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTD 234 (557)
Q Consensus 158 ~~~~l~~~~~---~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~ 234 (557)
.+.++..+.. .+.....+++..+.++..+++.+++.+|+++|+||++|+.||+++|+++|++|.+++++++++++++
T Consensus 72 ~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~D~ilS~GE~~Sa~lla~~L~~~Gv~A~~~~~~~~~i~t~~ 151 (447)
T COG0527 72 IASELILDPFIAARLAEVIAEFKKVLLGIALLGEVSPRERDELLSLGERLSAALLAAALNALGVDARSLDGRQAGIATDS 151 (447)
T ss_pred HHHHHhhcchhhhhHhhhHhhhhHHhhhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHhCCCceEEEchHHceeeecC
Confidence 7777765442 2344444447788888999999999999999999999999999999999999999999999999999
Q ss_pred CCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCcccc
Q 008693 235 DFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLT 314 (557)
Q Consensus 235 ~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~t 314 (557)
.|+++.+....+.+. +. .+++.+.||||+||+|.+ ++|++||||||||||||++||++|+|++|+||||||||||
T Consensus 152 ~~~~a~i~~~~~~~~---l~-~~~~~~~v~Vv~GF~G~~-~~G~~tTLGRGGSD~SA~~laa~l~Ad~~~I~TDVdGI~T 226 (447)
T COG0527 152 NHGNARILDEDSERR---LL-RLLEEGKVPVVAGFQGIN-EDGETTTLGRGGSDYSAAALAAALGADEVEIWTDVDGVYT 226 (447)
T ss_pred cccccccchhhhhhh---HH-HHhcCCcEEEecCceeec-CCCCEEEeCCCcHHHHHHHHHHHcCCCEEEEEECCCCCcc
Confidence 999999876665541 22 235678999999999999 5899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCCCCcceeeEEeeecc
Q 008693 315 CDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSIVLKRN 394 (557)
Q Consensus 315 aDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~Vt~Is~~~n 394 (557)
+|||+||+|++|++|||+||+||+++|||||||+|++||++++||++|+|||+|+++||+|..........+++|+..++
T Consensus 227 aDPRiVp~Ar~i~~isyeEa~ELA~~GAkVLHprav~pa~~~~Ip~~i~~t~~p~~~GTlI~~~~~~~~~~v~gIa~~~~ 306 (447)
T COG0527 227 ADPRIVPDARLLPEISYEEALELAYLGAKVLHPRAVEPAMRSGIPLRIKNTFNPDAPGTLITAETESDEPVVKGIALDDN 306 (447)
T ss_pred CCCCCCCcceEcCccCHHHHHHHHHCCchhcCHHHHHHHHhcCCcEEEEecCCCCCCceEEecCCcCCCCceEEEEeCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999986544468999999999
Q ss_pred EEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEcc--CceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeeccc
Q 008693 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATS--EVSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNLLQ 472 (557)
Q Consensus 395 ialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstS--e~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~~~ 472 (557)
+++|++.+..|.+.+||++++|..|+++||++++|.++ +.+++|+++.++.... .+.+.....+.. ..+.+.+
T Consensus 307 ~~~i~v~~~~~~~~~g~~a~vf~~l~~~~i~v~~I~q~~~~~~i~~~v~~~~~~~a---~~~l~~~~~~~~--~~v~~~~ 381 (447)
T COG0527 307 VALITVSGPGMNGMVGFAARVFGILAEAGINVDLITQSISEVSISFTVPESDAPRA---LRALLEEKLELL--AEVEVEE 381 (447)
T ss_pred eEEEEEEccCccccccHHHHHHHHHHHcCCcEEEEEeccCCCeEEEEEchhhHHHH---HHHHHHHHhhhc--ceEEeeC
Confidence 99999999999999999999999999999999999766 7889999998764321 122322222111 2688889
Q ss_pred ceeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccC
Q 008693 473 HRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFES 539 (557)
Q Consensus 473 ~~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~~ 539 (557)
++++|++||. |..++|+++++|++|++++|||.||+ +|+++|+|+|+++|.++|+++||++|+.+
T Consensus 382 ~~a~vsiVG~gm~~~~gvaa~~f~aL~~~~ini~~is--sSe~~Is~vV~~~~~~~av~~LH~~~~~~ 447 (447)
T COG0527 382 GLALVSIVGAGMRSNPGVAARIFQALAEENINIIMIS--SSEISISFVVDEKDAEKAVRALHEAFFLG 447 (447)
T ss_pred CeeEEEEEccccccCcCHHHHHHHHHHhCCCcEEEEE--cCCceEEEEEccHHHHHHHHHHHHHHhcC
Confidence 9999999997 88899999999999999999999999 59999999999999999999999999863
No 4
>PRK09084 aspartate kinase III; Validated
Probab=100.00 E-value=2e-88 Score=732.56 Aligned_cols=440 Identities=36% Similarity=0.549 Sum_probs=391.9
Q ss_pred eEEEEecccccCCHHHHHHHHHHHHcCCCCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHHHH
Q 008693 82 TCVMKFGGSSLASAERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVDE 161 (557)
Q Consensus 82 ~~V~KFGGsSv~~~~~~~~va~iI~~~~~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~~~ 161 (557)
|+|+|||||||+|++++++|+++|.+. +.+++||||||||+||.|+++++.+..+ .++...++.++++|..++++
T Consensus 1 m~V~KFGGtSv~~~e~i~~v~~ii~~~-~~~~vvVVSA~~~~Td~L~~~~~~~~~~----~~~~~~~~~i~~~h~~~~~~ 75 (448)
T PRK09084 1 LVVAKFGGTSVADFDAMNRSADIVLSN-PNTRLVVLSASAGVTNLLVALAEGAEPG----DERLALLDEIRQIQYAILDR 75 (448)
T ss_pred CEEEEECccCcCCHHHHHHHHHHHhcC-CCCEEEEEcCCCCchHHHHHHHHHHHcC----ccHHHHHHHHHHHHHHHHHH
Confidence 689999999999999999999999863 5678999999999999999998876532 35778899999999999999
Q ss_pred hCCCH---HHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCC
Q 008693 162 LGIDR---SIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTN 238 (557)
Q Consensus 162 l~~~~---~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~ 238 (557)
|..+. ..+.+.+++|+++++++.. +++++.+|+|+|+||++|+.+++++|+++|+++.++|++++ ++|+++|++
T Consensus 76 l~~~~~~~~~i~~~~~~l~~l~~~~~~--~~~~~~~d~i~s~GE~lSa~l~~~~L~~~Gi~a~~l~~~~~-i~t~~~~~~ 152 (448)
T PRK09084 76 LGDPNVVREEIERLLENITVLAEAASL--ATSPALTDELVSHGELMSTLLFVELLRERGVQAEWFDVRKV-MRTDDRFGR 152 (448)
T ss_pred hccchHHHHHHHHHHHHHHHHHHhhhh--cCChhhhhhhhhHHHHHHHHHHHHHHHhCCCCcEEEchHHe-EEecCCCCc
Confidence 97654 3588899999999998866 77889999999999999999999999999999999999998 899999998
Q ss_pred ceeeecc-hHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCC
Q 008693 239 ADILEAT-YPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDP 317 (557)
Q Consensus 239 a~i~~~~-~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP 317 (557)
+++.... ...+.+.+.+ +++.+ |||++||+|.+ .+|.+||||||||||+|+++|.+|+|+++++|||||||||+||
T Consensus 153 ~~~~~~~~~~~~~~~~~~-~~~~~-v~Vv~Gf~g~~-~~G~~ttLgRggSD~~a~~~a~~l~a~~~~i~tdv~Gi~t~dP 229 (448)
T PRK09084 153 AEPDVAALAELAQEQLLP-LLAEG-VVVTQGFIGSD-EKGRTTTLGRGGSDYSAALLAEALNASRVEIWTDVPGIYTTDP 229 (448)
T ss_pred ccccHHHHHHHHHHHHHH-hhcCC-cEEecCeeecC-CCCCEeecCCCchHHHHHHHHHHcCCCEEEEEECCCccccCCC
Confidence 8874432 2333333433 34556 99999999998 5999999999999999999999999999999999999999999
Q ss_pred CCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCCCCcceeeEEeeeccEEE
Q 008693 318 NIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSIVLKRNVTM 397 (557)
Q Consensus 318 ~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~Vt~Is~~~nial 397 (557)
|++|+|+++++|||+||.||+++|++|+||+|+.|++++|||++|+|+++|+.+||+|.+... ....|++|+.++|+++
T Consensus 230 ~~~~~a~~i~~is~~ea~ela~~Ga~vlh~~~~~~~~~~~i~i~i~~~~~~~~~GT~I~~~~~-~~~~v~~it~~~~i~l 308 (448)
T PRK09084 230 RIVPAAKRIDEISFEEAAEMATFGAKVLHPATLLPAVRSNIPVFVGSSKDPEAGGTWICNDTE-NPPLFRAIALRRNQTL 308 (448)
T ss_pred CCCCCCeEcccCCHHHHHHHHhCCCcccCHHHHHHHHHcCCcEEEEeCCCCCCCceEEecCCC-CCCeeEEEEeeCCEEE
Confidence 999999999999999999999999999999999999999999999999999999999987643 2347999999999999
Q ss_pred EEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchhhh--HHHHHHHHHHHHHHHhhhheeeccccee
Q 008693 398 LDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWS--RELIQQELDHVVEELEKIAIVNLLQHRS 475 (557)
Q Consensus 398 ItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~~~--~~~~~~~l~~~~~~l~~~~~i~~~~~~a 475 (557)
|++.+.+|.+.+||++++|+.|+++||+|+|+++|+.+|+|+++.++... ...+ ..+++.+++.+..+.+.++++
T Consensus 309 Itv~~~~~~~~~g~~a~if~~l~~~~I~Vd~I~sse~sIs~~i~~~~~~~~~~~~~---~~~l~~el~~~~~i~~~~~va 385 (448)
T PRK09084 309 LTLHSLNMLHARGFLAEVFGILARHKISVDLITTSEVSVSLTLDTTGSTSTGDTLL---TQALLTELSQLCRVEVEEGLA 385 (448)
T ss_pred EEEecCCCCccccHHHHHHHHHHHcCCeEEEEeccCcEEEEEEechhhhhhhhHHH---HHHHHHHHhcCCeEEEECCeE
Confidence 99999999999999999999999999999999999999999999876321 1111 234455666667788889999
Q ss_pred EEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008693 476 IISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 538 (557)
Q Consensus 476 iIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~ 538 (557)
+|++||. |...+|+++|+|++|++ +||.||+||+|+++||++|+++|.++|+++||++||+
T Consensus 386 ~IsvvG~gm~~~~gv~arif~aL~~--~nI~~I~qgsSe~sIS~vV~~~d~~~al~~LH~~f~~ 447 (448)
T PRK09084 386 LVALIGNNLSKACGVAKRVFGVLEP--FNIRMICYGASSHNLCFLVPESDAEQVVQALHQNLFE 447 (448)
T ss_pred EEEEECCCcccCcChHHHHHHHHHh--CCeEEEEEcCCCCcEEEEEcHHHHHHHHHHHHHHHhc
Confidence 9999997 77899999999999985 6999999999999999999999999999999999985
No 5
>PRK09034 aspartate kinase; Reviewed
Probab=100.00 E-value=2.1e-88 Score=733.98 Aligned_cols=440 Identities=32% Similarity=0.482 Sum_probs=390.8
Q ss_pred eEEEEecccccCCHHHHHHHHHHHHcCCCCccEEEEcCCCc-------CcHHHHHhhHHhhhcCCCcchhhHHHHHHHHH
Q 008693 82 TCVMKFGGSSLASAERMREVAELILSFPNERPVIVLSAMGK-------TTNKLLLAGEKAVSCGVTNISCIDELSFVKDL 154 (557)
Q Consensus 82 ~~V~KFGGsSv~~~~~~~~va~iI~~~~~~~~vvVVSA~gg-------~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~ 154 (557)
|+|+|||||||+|++++++|+++|.+. .++++||||||+| +||.|+++++.+.+. .++...++.++++
T Consensus 1 m~V~KFGGtSv~~~~~i~~v~~ii~~~-~~~~vvVVSA~~~~~~~~~~~Td~L~~~~~~~~~~----~~~~~~~~~~~~~ 75 (454)
T PRK09034 1 MKVVKFGGSSLASAEQFKKVLNIVKSD-PERKIVVVSAPGKRFKEDTKVTDLLILYAEAVLAG----EDYEDIFEAIIAR 75 (454)
T ss_pred CEEEEeCccccCCHHHHHHHHHHHhcc-CCCEEEEEcCCcCCCCCccChHHHHHHHHHHHhcC----CcHHHHHHHHHHH
Confidence 689999999999999999999999864 4578999999986 999999988776542 3577789999999
Q ss_pred HHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEec
Q 008693 155 HHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTD 234 (557)
Q Consensus 155 ~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~ 234 (557)
|..++++|+.+.+.++++.++|+++...+ .+.+++.+|+|+|+||++|+.+|+++|+++|+++.++|++++|++|++
T Consensus 76 ~~~~~~~L~~~~~~~~~~~~~l~~l~~~~---~~~~~~~~d~l~s~GE~~S~~l~a~~L~~~g~~a~~~~~~~~~~~t~~ 152 (454)
T PRK09034 76 YAEIAKELGLDADILEKIEEILEHLANLA---SRNPDRLLDAFKARGEDLNAKLIAAYLNYEGIPARYVDPKEAGIIVTD 152 (454)
T ss_pred HHHHHHHhccchHHHHHHHHHHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHHHHHHhCCCCcEEEchHHceEEecC
Confidence 99999999888777777777777776543 467889999999999999999999999999999999999999999999
Q ss_pred CCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCcccc
Q 008693 235 DFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLT 314 (557)
Q Consensus 235 ~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~t 314 (557)
+|+++.+...++..+.+. ...+.|||+|||+|.+ .+|++||||||||||||+++|++|+|+++++|||||||||
T Consensus 153 ~~~~a~i~~~~~~~~~~~-----~~~~~v~Vv~GFig~~-~~g~~ttlgRggSD~tA~~la~~l~A~~~~i~tdV~Gi~t 226 (454)
T PRK09034 153 EPGNAQVLPESYDNLKKL-----RDRDEKLVIPGFFGVT-KDGQIVTFSRGGSDITGAILARGVKADLYENFTDVDGIYA 226 (454)
T ss_pred CcCceeEcHhhHHHHHHH-----HhcCCEEEecCccccC-CCCCEEecCCCcHHHHHHHHHHHcCCCEEEEEecCCccCc
Confidence 999998866665554432 2356799999999999 5899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCCCC-cceeeEEeeec
Q 008693 315 CDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMS-KAVLTSIVLKR 393 (557)
Q Consensus 315 aDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~-~~~Vt~Is~~~ 393 (557)
+|||++|+|+++++|||+||.||+++|++||||+|++||+++|||++|+|+++|+++||+|....+.. +..|++|+.++
T Consensus 227 aDPr~v~~A~~l~~lsy~Ea~ela~~Gakvlhp~ai~~a~~~~Ipi~v~~~~~p~~~GT~I~~~~~~~~~~~Vk~It~~~ 306 (454)
T PRK09034 227 ANPRIVKNPKSIKEITYREMRELSYAGFSVFHDEALIPAYRGGIPINIKNTNNPEDPGTLIVPDRDNKNKNPITGIAGDK 306 (454)
T ss_pred CCCCCCCCCeECCccCHHHHHHHHhCCcccCCHHHHHHHHHcCCCEEEEcCCCCCCCccEEEeccccCccccceEEEecC
Confidence 99999999999999999999999999999999999999999999999999999999999998765332 24799999999
Q ss_pred cEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchhhhHHHHHHHHHHHHHHHhh---hheeec
Q 008693 394 NVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQELDHVVEELEK---IAIVNL 470 (557)
Q Consensus 394 nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~---~~~i~~ 470 (557)
|+++|++.+.+|.+.+|+++++|+.|+++||+|+|+++|+.+++|+++.++.... .+..+++++++ ...+..
T Consensus 307 ~i~~Itv~~~~~~~~~g~~a~if~~la~~~I~Vd~i~ss~~sis~~v~~~~~~~a-----~~~~l~~el~~~~~~~~I~~ 381 (454)
T PRK09034 307 GFTSIYISKYLMNREVGFGRKVLQILEDHGISYEHMPSGIDDLSIIIRERQLTPK-----KEDEILAEIKQELNPDELEI 381 (454)
T ss_pred CEEEEEEccCCCCCCccHHHHHHHHHHHcCCeEEEEcCCCcEEEEEEeHHHhhHH-----HHHHHHHHHHHhhCCceEEE
Confidence 9999999988899999999999999999999999999999999999998764321 01233344432 356888
Q ss_pred ccceeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccCc
Q 008693 471 LQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFESD 540 (557)
Q Consensus 471 ~~~~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~~~ 540 (557)
.+++++|+++|. |...+++++++|++|+++||||.||+|++|+.+|+|+|+++|.++|++.||++|+.++
T Consensus 382 ~~~va~VsivG~g~~~~~gv~arif~aL~~~~InV~mIsq~~Se~~Is~vV~~~d~~~av~~LH~~f~~~~ 452 (454)
T PRK09034 382 EHDLAIIMVVGEGMRQTVGVAAKITKALAEANINIQMINQGSSEISIMFGVKNEDAEKAVKAIYNAFFKEV 452 (454)
T ss_pred eCCEEEEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEEecCCcceEEEEEcHHHHHHHHHHHHHHHhccc
Confidence 899999999997 7788999999999999999999999999999999999999999999999999999753
No 6
>PRK06291 aspartate kinase; Provisional
Probab=100.00 E-value=1e-86 Score=723.67 Aligned_cols=450 Identities=39% Similarity=0.668 Sum_probs=402.8
Q ss_pred ceEEEEecccccCCHHHHHHHHHHHHcC--CCCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHH
Q 008693 81 LTCVMKFGGSSLASAERMREVAELILSF--PNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRT 158 (557)
Q Consensus 81 ~~~V~KFGGsSv~~~~~~~~va~iI~~~--~~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~ 158 (557)
+++|+|||||||+|++++++|+++|.+. .+.++|||||||+|+||.|+++++.+... ...+++.+.++.++++|..+
T Consensus 1 ~~~V~KFGGtSv~~~~~~~~v~~ii~~~~~~~~~~vvVvSA~~~~Td~L~~~~~~~~~~-~~~~~~~~~~~~i~~~~~~~ 79 (465)
T PRK06291 1 MRLVMKFGGTSVGDGERIRHVAKLVKRYRSEGNEVVVVVSAMTGVTDALLEIAEQALDV-RDIAKVKDFIADLRERHYKA 79 (465)
T ss_pred CcEEEEeCcccCCCHHHHHHHHHHHHHHHhcCCCEEEEEcCCCCCHHHHHHHHHHHHhc-cchhhHHHHHHHHHHHHHHH
Confidence 4689999999999999999999999864 34688999999999999999988765331 11245788899999999999
Q ss_pred HHHhCCCH-------HHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEE
Q 008693 159 VDELGIDR-------SIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFI 231 (557)
Q Consensus 159 ~~~l~~~~-------~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~ii 231 (557)
+++|..++ ..++..+++|+++++++..+++++++.+|+|+|+||++|+.||+++|+++|++++++++++++++
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~i~s~GE~~Sa~l~~~~L~~~Gi~a~~l~~~~~~i~ 159 (465)
T PRK06291 80 IEEAIKDPDIREEVSKTIDSRIEELEKALVGVSYLGELTPRSRDYILSFGERLSAPILSGALRDLGIKSVALTGGEAGII 159 (465)
T ss_pred HHHhhcChhhHHHHHHHHHHHHHHHHHHHHHHHHhccCChHHHHHHHhhhHHHHHHHHHHHHHhCCCCeEEEchHHCcEE
Confidence 99997543 24788899999999999999999999999999999999999999999999999999999999999
Q ss_pred EecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCc
Q 008693 232 TTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDG 311 (557)
Q Consensus 232 t~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdG 311 (557)
|+++|+++.+.+.++.++.+.+.. +++.+.|||++||+|.+ .+|.++||||||||++|+++|.+|+|+++++||||||
T Consensus 160 t~~~~~~~~~~~~~~~~~~~~~~~-ll~~~~vpVv~Gfig~~-~~g~~~tlgrggsD~~A~~~A~~l~a~~~~i~tdV~G 237 (465)
T PRK06291 160 TDSNFGNARPLPKTYERVKERLEP-LLKEGVIPVVTGFIGET-EEGIITTLGRGGSDYSAAIIGAALDADEIWIWTDVDG 237 (465)
T ss_pred ecCCCCceeechhhHHHHHHHHHH-HhhcCcEEEEeCcEEcC-CCCCEEEecCCChHHHHHHHHHhcCCCEEEEEECCCC
Confidence 999999888766677777766554 46788999999999998 5899999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCCCCcceeeEEee
Q 008693 312 VLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSIVL 391 (557)
Q Consensus 312 V~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~Vt~Is~ 391 (557)
|||+||+++|+|+++++|||+||.+|+++|++++||+|+.||+++|||++|+|+++|+++||+|.+...+.+..|++|+.
T Consensus 238 i~~~dP~~~~~a~~i~~l~~~ea~~l~~~G~~v~~~~a~~~~~~~~i~i~i~~~~~~~~~gt~i~~~~~~~~~~V~~It~ 317 (465)
T PRK06291 238 VMTTDPRIVPEARVIPKISYIEAMELSYFGAKVLHPRTIEPAMEKGIPVRVKNTFNPEFPGTLITSDSESSKRVVKAVTL 317 (465)
T ss_pred CCCCCCCCCCCCeEccccCHHHHHHHHhCCCcccCHHHHHHHHHcCCcEEEecCCCCCCCceEEEecccccCcccceEEe
Confidence 99999999999999999999999999999999999999999999999999999999999999998765444457999999
Q ss_pred eccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEE--ccCceeEEEeCCchhhhHHHHHHHHHHHHHHHhh--hhe
Q 008693 392 KRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVA--TSEVSLSLTLDPSKLWSRELIQQELDHVVEELEK--IAI 467 (557)
Q Consensus 392 ~~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Is--tSe~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~--~~~ 467 (557)
++++++|++.+.+|.+.+|+++++|+.|+++||+|+|++ +|+.+++|+++.++... .+..+.+++.. ...
T Consensus 318 ~~~valIsI~g~~m~~~~g~~arvf~~L~~~gI~V~mIsq~sse~sIsf~V~~~d~~~------av~~L~~~~~~~~~~~ 391 (465)
T PRK06291 318 IKNVALINISGAGMVGVPGTAARIFSALAEEGVNVIMISQGSSESNISLVVDEADLEK------ALKALRREFGEGLVRD 391 (465)
T ss_pred eCCEEEEEEeCCCCCCCccHHHHHHHHHHHCCCcEEEEEecCCCceEEEEEeHHHHHH------HHHHHHHHHHHhcCcc
Confidence 999999999999999999999999999999999999998 57899999999876432 12222222322 456
Q ss_pred eecccceeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccC
Q 008693 468 VNLLQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFES 539 (557)
Q Consensus 468 i~~~~~~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~~ 539 (557)
+++.+++++|+++|. |...+|+++|+|++|+++||||+||+||+|+++|+|+|+++|.++|+++||++|+..
T Consensus 392 i~~~~~~a~IsvvG~gm~~~~gv~~rif~aL~~~~I~v~~isqgsSe~~Is~vV~~~d~~~av~~Lh~~f~~~ 464 (465)
T PRK06291 392 VTFDKDVCVVAVVGAGMAGTPGVAGRIFSALGESGINIKMISQGSSEVNISFVVDEEDGERAVKVLHDEFILG 464 (465)
T ss_pred eEEeCCEEEEEEEcCCccCCcChHHHHHHHHHHCCCCEEEEEeccccCeEEEEEeHHHHHHHHHHHHHHhccC
Confidence 888999999999997 788999999999999999999999999999999999999999999999999999753
No 7
>PRK09181 aspartate kinase; Validated
Probab=100.00 E-value=1.3e-85 Score=711.25 Aligned_cols=434 Identities=28% Similarity=0.378 Sum_probs=362.2
Q ss_pred cceEEEEecccccCCHHHHHHHHH-HHHcCC----CCccEEEEcCCCcCcHHHHHhhHHh-------hhcCCCcchhhHH
Q 008693 80 QLTCVMKFGGSSLASAERMREVAE-LILSFP----NERPVIVLSAMGKTTNKLLLAGEKA-------VSCGVTNISCIDE 147 (557)
Q Consensus 80 ~~~~V~KFGGsSv~~~~~~~~va~-iI~~~~----~~~~vvVVSA~gg~Td~L~~~~~~a-------~~~~~~~~~~~~~ 147 (557)
|+.+|+||||||| +++++|.+ ++.... .++++||||||||+||.|+++++.+ ...+ ...++.+.
T Consensus 2 ~~~~V~KFGGtSv---~~~~~v~~~iv~~~~~~~~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~-~~~~~~~~ 77 (475)
T PRK09181 2 MMHTVEKIGGTSM---SAFDAVLDNIILRPRKGEDLYNRIFVVSAYGGVTDALLEHKKTGEPGVYALFAKA-NDEAWREA 77 (475)
T ss_pred CceEEEEECCCcH---HHHHHHHhheEeccccccCCCCeEEEEeCCCcchHHHHHhHhhcchhHHHHHHHh-cCccHHHH
Confidence 5579999999999 45666777 444321 2578999999999999999866411 1110 23467888
Q ss_pred HHHHHHHHHHHHHHhCCCH-------HH-------HHHHHHHHHHHHH-hhhhccCCCHHHHHHHHhhchHHHHHHHHHH
Q 008693 148 LSFVKDLHHRTVDELGIDR-------SI-------IATHLEELEQLLK-GIAMLKELTPRSRDYLVSFGECMSTRIFAAY 212 (557)
Q Consensus 148 l~~i~~~~~~~~~~l~~~~-------~~-------i~~~~~~l~~~l~-~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~ 212 (557)
++.++++|.+++++|..+. +. +.++|.++++++. ++.++++++++.+|+++|+||++|+.||+.+
T Consensus 78 l~~i~~~~~~i~~~L~~~~~~~~~~~~~i~~~~~~~~~~l~~l~~~l~~~~~~l~e~~~~~~D~l~s~GE~lSa~lla~~ 157 (475)
T PRK09181 78 LEAVEQRMLAINAELFADGLDLARADKFIRERIEEARACLIDLQRLCAYGHFSLDEHLLTVREMLASIGEAHSAFNTALL 157 (475)
T ss_pred HHHHHHHHHHHHHHHhhccchhHHHHHHHHHHHHHHHHHHHHHHHHHhcCcchhhccChhHhHHHhhHhHHHHHHHHHHH
Confidence 9999999999999997421 12 3667777777777 8888999999999999999999999999999
Q ss_pred HHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHH
Q 008693 213 LNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTAT 292 (557)
Q Consensus 213 L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa 292 (557)
|+++|++|.++|+..+ ..++ ... ..+++.+.+.+ |...+.|||+|||++ + .+|++||||||||||||+
T Consensus 158 L~~~Gi~a~~ld~~~~--~~~~------~~~-~~~~i~~~l~~-~~~~~~v~Vv~GF~~-~-~~G~itTLGRGGSDyTAa 225 (475)
T PRK09181 158 LQNRGVNARFVDLTGW--DDDD------PLT-LDERIKKAFKD-IDVTKELPIVTGYAK-C-KEGLMRTFDRGYSEMTFS 225 (475)
T ss_pred HHhCCCCeEEeccccc--cCCc------ccc-hHHHHHHHHhh-hccCCcEEEecCCcC-C-CCCCEEecCCChHHHHHH
Confidence 9999999999887543 1111 111 23444444432 123567999999975 5 479999999999999999
Q ss_pred HHHHHcCcCcEEEeeCCCccccCCCCCC--CCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCC
Q 008693 293 TIGKALGLQEIQVWKDVDGVLTCDPNIH--PHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNA 370 (557)
Q Consensus 293 ~lA~~L~A~~l~i~TDVdGV~taDP~~v--~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~ 370 (557)
++|++|+|++|+|||||+ |||+|||+| |+|++|++|||+||.||+|+|||||||+|++||+++|||++|+|+|+|++
T Consensus 226 ilAa~L~A~~~~IwTDV~-I~taDPriV~~~~A~~i~~lsy~Ea~ELA~~GAkVLHp~ti~pa~~~~Ipi~V~nt~~p~~ 304 (475)
T PRK09181 226 RIAVLTGADEAIIHKEYH-LSSADPKLVGEDKVVPIGRTNYDVADQLANLGMEAIHPKAAKGLRQAGIPLRIKNTFEPEH 304 (475)
T ss_pred HHHHHcCCCEEEEeCCCc-cccCCCCcCCCCCCeEcCccCHHHHHHHHHcCchhcCHHHHHHHHHcCCeEEEecCCCCCC
Confidence 999999999999999997 999999999 69999999999999999999999999999999999999999999999999
Q ss_pred CCeeEecCCCCCcceeeEEeeeccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchhhhHHH
Q 008693 371 PGTLIRRSRDMSKAVLTSIVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSREL 450 (557)
Q Consensus 371 ~GT~I~~~~~~~~~~Vt~Is~~~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~~~~~~ 450 (557)
+||+|.+...+....+++|+.++++++|++.+.+|.+.+||++++|+.|++++|+|+++++|+.++||+++.+ ..
T Consensus 305 ~GT~I~~~~~~~~~~ik~It~~~~~~~i~i~~~~~~~~~g~~~~if~~l~~~~i~v~~i~ss~~sis~~v~~~-~~---- 379 (475)
T PRK09181 305 PGTLITKDYVSEQPRVEIIAGSDKVFALEVFDQDMVGEDGYDLEILEILTRHKVSYISKATNANTITHYLWGS-LK---- 379 (475)
T ss_pred CCeEEecCcccccccceeEeccCCEEEEEEcCCCCCCcchHHHHHHHHHHHcCCeEEEEEecCcEEEEEEcCC-hH----
Confidence 9999987543344568999999999999999999999999999999999999999999999999999999876 11
Q ss_pred HHHHHHHHHHHHhh---hheeecccceeEEEEEccccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHH
Q 008693 451 IQQELDHVVEELEK---IAIVNLLQHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQ 527 (557)
Q Consensus 451 ~~~~l~~~~~~l~~---~~~i~~~~~~aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~k 527 (557)
.+++++++|++ ...++. +++++|++||..+..+|+++|+|++|+++||||+||+||+|+++||++|+++|.++
T Consensus 380 ---~~~~~~~~L~~~~~~~~i~~-~~~a~VsvVG~gm~~~gv~ak~f~aL~~~~Ini~~i~qg~se~~Is~vV~~~d~~~ 455 (475)
T PRK09181 380 ---TLKRVIAELEKRYPNAEVTV-RKVAIVSAIGSNIAVPGVLAKAVQALAEAGINVLALHQSMRQVNMQFVVDEDDYEK 455 (475)
T ss_pred ---HHHHHHHHHHHhcCCceEEE-CCceEEEEeCCCCCcccHHHHHHHHHHHCCCCeEEEEecCCcceEEEEEeHHHHHH
Confidence 12223333432 234664 89999999997335899999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhccC
Q 008693 528 CVRALHETFFES 539 (557)
Q Consensus 528 Av~~LH~~f~~~ 539 (557)
|+++||++||..
T Consensus 456 Av~~lH~~f~~~ 467 (475)
T PRK09181 456 AICALHEALVEN 467 (475)
T ss_pred HHHHHHHHHhcC
Confidence 999999999854
No 8
>PRK05925 aspartate kinase; Provisional
Probab=100.00 E-value=9.5e-84 Score=691.50 Aligned_cols=436 Identities=26% Similarity=0.388 Sum_probs=377.7
Q ss_pred cceEEEEecccccCCHHHHHHHHHHHHcCCCCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHH
Q 008693 80 QLTCVMKFGGSSLASAERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTV 159 (557)
Q Consensus 80 ~~~~V~KFGGsSv~~~~~~~~va~iI~~~~~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~ 159 (557)
|.|+|+|||||||+|++++++++++|... .+++||||||+|+||.|+++++.+. ......++.++++|..++
T Consensus 1 ~~~~V~KFGGtSv~~~e~i~~v~~ii~~~--~~~vVVvSA~~~~Td~L~~~~~~a~------~~~~~~~~~i~~~~~~~~ 72 (440)
T PRK05925 1 MAPLVYKFGGTSLGTAESIRRVCDIICKE--KPSFVVVSAVAGVTDLLEEFCRLSK------GKREALTEKIREKHEEIA 72 (440)
T ss_pred CCcEEEEECccccCCHHHHHHHHHHHhcC--CCEEEEECCCCCCHHHHHHHHHHhh------hhHHHHHHHHHHHHHHHH
Confidence 67899999999999999999999999863 5689999999999999999877542 224457889999999999
Q ss_pred HHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCc
Q 008693 160 DELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNA 239 (557)
Q Consensus 160 ~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a 239 (557)
++|..+.. +.+++++|++++. .++++++.+|+++|+||++|+.||+++|+++|+++.++|++++ ++|+++|+++
T Consensus 73 ~~l~~~~~-~~~~~~~L~~~~~----~~~~~~~~~d~i~s~GE~~Sa~l~a~~L~~~Gi~a~~ld~~~~-i~t~~~~~~a 146 (440)
T PRK05925 73 KELGIEFS-LSPWWERLEHFED----VEEISSEDQARILAIGEDISASLICAYCCTYVLPLEFLEARQV-ILTDDQYLRA 146 (440)
T ss_pred HHhhcchh-hhHHHHHHHHHHH----hCcCCchhhhhheehhHHHHHHHHHHHHHhCCCCeEEEcHHHh-EeecCCcccc
Confidence 99976432 4566677777664 4677889999999999999999999999999999999999998 8999999988
Q ss_pred eeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCC
Q 008693 240 DILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNI 319 (557)
Q Consensus 240 ~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~ 319 (557)
++. .+.+.+.+....++++.|||+|||+|.+ .+|+++|||||||||+|+++|.+|+|+++++|||||||||+|||+
T Consensus 147 ~~~---~~~~~~~~~~~~~~~~~v~Vv~GF~g~~-~~G~~ttLgrGgsD~~AallA~~l~Ad~~~i~TdVdGvytaDP~~ 222 (440)
T PRK05925 147 VPD---LALMQTAWHELALQEDAIYIMQGFIGAN-SSGKTTVLGRGGSDFSASLIAELCKAREVRIYTDVNGIYTMDPKI 222 (440)
T ss_pred ccC---HHHHHHHHHHhhccCCcEEEecCcceeC-CCCCEEEeccCcHHHHHHHHHHHcCCCEEEEEEcCCccCCCCcCC
Confidence 873 2333444443334566899999999999 589999999999999999999999999999999999999999999
Q ss_pred CCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCC--CCcceeeEEeeeccEEE
Q 008693 320 HPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRD--MSKAVLTSIVLKRNVTM 397 (557)
Q Consensus 320 v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~--~~~~~Vt~Is~~~nial 397 (557)
+|+|++|+++||+||.+|+++|++++||++++||+++|||++|+|+++|+++||+|.+..+ +....|++|+.++|+++
T Consensus 223 ~~~A~~i~~is~~ea~ela~~Ga~vl~~~~~~~a~~~~Ipi~I~~~~~p~~~GT~i~~~~~~~~~~~~ik~It~~~~~~~ 302 (440)
T PRK05925 223 IKDAQLIPELSFEEMQNLASFGAKVLHPPMLKPCVRAGIPIFVTSTFDVTKGGTWIYASDKEVSYEPRIKALSLKQNQAL 302 (440)
T ss_pred CCCCeEeeEECHHHHHHHHhCCCCcCCHHHHHHHHHCCCcEEEecCCCCCCCccEEecCCccccCCCceEEEEEeCCEEE
Confidence 9999999999999999999999999999999999999999999999999999999987532 23446999999999999
Q ss_pred EEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeecccceeEE
Q 008693 398 LDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNLLQHRSII 477 (557)
Q Consensus 398 ItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~~~~~aiI 477 (557)
+++.+. ....++++++|+.|+++||+++++++++.+++|+++.++... ..+..+..+++.+..+++.+++++|
T Consensus 303 i~v~~~--~~~~~~~~~if~~l~~~~I~vd~i~s~~~sis~~i~~~~~~~-----~~~~~l~~~l~~~~~i~~~~~~a~V 375 (440)
T PRK05925 303 WSVDYN--SLGLVRLEDVLGILRSLGIVPGLVMAQNLGVYFTIDDDDISE-----EYPQHLTDALSAFGTVSCEGPLALI 375 (440)
T ss_pred EEEecC--CcchhHHHHHHHHHHHcCCcEEEEeccCCEEEEEEechhccH-----HHHHHHHHHhcCCceEEEECCEEEE
Confidence 999753 235788999999999999999999877899999999765321 1233444556666778889999999
Q ss_pred EEEccccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccCccc
Q 008693 478 SLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFESDLA 542 (557)
Q Consensus 478 sIVG~~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~~~~~ 542 (557)
++||..+..+++++++|++|+++||||++++| |+.+|||+|+++|.++|+++||++||+++|+
T Consensus 376 svVG~gm~~~~v~~~~~~aL~~~~Ini~~i~~--s~~~is~vV~~~d~~~av~~LH~~f~~~~~~ 438 (440)
T PRK05925 376 TMIGAKLASWKVVRTFTEKLRGYQTPVFCWCQ--SDMALNLVVNEELAVAVTELLHNDYVKQKFS 438 (440)
T ss_pred EEeCCCcccccHHHHHHHHHhhCCCCEEEEEC--CCceEEEEEehHHHHHHHHHHHHHHhccccc
Confidence 99998333478999999999999999999998 6679999999999999999999999999886
No 9
>PRK09466 metL bifunctional aspartate kinase II/homoserine dehydrogenase II; Provisional
Probab=100.00 E-value=1e-82 Score=725.45 Aligned_cols=440 Identities=25% Similarity=0.362 Sum_probs=370.8
Q ss_pred CCCcceEEEEecccccCCHHHHHHHHHHHHcCCCCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHH
Q 008693 77 SEKQLTCVMKFGGSSLASAERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHH 156 (557)
Q Consensus 77 ~~~~~~~V~KFGGsSv~~~~~~~~va~iI~~~~~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~ 156 (557)
..+|.|+|+|||||||+|++++++|+++|....+.+++||||||+|+||.|+++++.+.. ....+.+.++.++++|.
T Consensus 7 ~~~M~~~V~KFGGtSv~~~e~i~~v~~iI~~~~~~~~vVVVSA~~~~Td~L~~~~~~~~~---~~~~~~~~l~~i~~~h~ 83 (810)
T PRK09466 7 AGAMGRQLHKFGGSSLADAKCYRRVAGILAEYSQPDDLVVVSAAGKTTNQLISWLKLSQT---DRLSAHQVQQTLRRYQQ 83 (810)
T ss_pred cccceeEEEEECccccCCHHHHHHHHHHHhhhccCCEEEEEcCCCCCHHHHHHHHHHhhc---CchhHHHHHHHHHHHHH
Confidence 367889999999999999999999999998765556899999999999999998876522 12345677899999999
Q ss_pred HHHHHhCCCHH------HHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEE
Q 008693 157 RTVDELGIDRS------IIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGF 230 (557)
Q Consensus 157 ~~~~~l~~~~~------~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~i 230 (557)
+++++|..+.. .+.+.+++|++++. ++++++.+|+|+|+||++|+.||+++|+++|+++.++|++++
T Consensus 84 ~~~~~L~~~~~~~~~~~~i~~~~~~l~~~l~-----~~~~~~~~d~ils~GE~~Sa~lla~~L~~~G~~a~~ld~~~~-- 156 (810)
T PRK09466 84 DLIEGLLPAEQARSLLSRLISDLERLAALLD-----GGINDAQYAEVVGHGEVWSARLMAALLNQQGLPAAWLDARSF-- 156 (810)
T ss_pred HHHHHhhcchhhhHHHHHHHHHHHHHHHHhh-----ccCCchhhhheecHHHHHHHHHHHHHHHhCCCCcEEEcHHHh--
Confidence 99999976432 25566666666665 478889999999999999999999999999999999999995
Q ss_pred EEecCCCCceee-ecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCC
Q 008693 231 ITTDDFTNADIL-EATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDV 309 (557)
Q Consensus 231 it~~~~~~a~i~-~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDV 309 (557)
++++.+.++++. ..+.+.+.+.+.+ ..+.+||++||+|.+ .+|++||||||||||||+++|++|+|++|+|||||
T Consensus 157 i~~~~~~~~~i~~~~~~~~l~~~~~~---~~~~v~Vv~GF~g~~-~~G~~ttLGRGGSD~tA~~la~~l~A~~v~i~tDV 232 (810)
T PRK09466 157 LRAERAAQPQVDEGLSYPLLQQLLAQ---HPGKRLVVTGFISRN-EAGETVLLGRNGSDYSATLIGALAGVERVTIWSDV 232 (810)
T ss_pred eecCCCCCcccchhhhHHHHHHHHhc---cCCeEEEeeCccccC-CCCCEEEcCCChHHHHHHHHHHHcCCCEEEEEeCC
Confidence 555555556652 3344444443321 134799999999999 58999999999999999999999999999999999
Q ss_pred CccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCCCCcceeeEE
Q 008693 310 DGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSI 389 (557)
Q Consensus 310 dGV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~Vt~I 389 (557)
|||||+|||++|+|++|++|||+||.||+++|||||||+|++||+++|||++|+|+|+|+++||+|..... ....+++|
T Consensus 233 ~Gi~taDPr~v~~A~~i~~isy~Ea~ela~~GakVlHp~ti~pa~~~~Ipi~V~ntf~p~~~GT~I~~~~~-~~~~v~~I 311 (810)
T PRK09466 233 AGVYSADPRKVKDACLLPLLRLDEASELARLAAPVLHARTLQPVSGSDIDLQLRCSYQPEQGSTRIERVLA-SGTGARIV 311 (810)
T ss_pred CccccCCcccCCCceEcccCCHHHHHHHHHcCccccCHHHHHHHHHcCCeEEEecCCCCCCCceEEecCcc-cccceeee
Confidence 99999999999999999999999999999999999999999999999999999999999999999986422 23358999
Q ss_pred eeeccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEc--cCceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhhe
Q 008693 390 VLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT--SEVSLSLTLDPSKLWSRELIQQELDHVVEELEKIAI 467 (557)
Q Consensus 390 s~~~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Ist--Se~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~ 467 (557)
+.++++++|++.+.++.+.+|+++++|+.|+++||+++++++ ++.+++|+++.++... +...++++.....
T Consensus 312 t~~~~v~~i~i~~~~~~g~~g~~~~if~~l~~~~I~v~~i~~~~s~~sis~~i~~~~~~~-------~~~~l~~~~~~~~ 384 (810)
T PRK09466 312 TSLDDVCLIELQVPASHDFKLAQKELDQLLKRAQLRPLAVGVHPDRQLLQLAYTSEVADS-------ALKLLDDAALPGE 384 (810)
T ss_pred eccCCEEEEEEecCCcCCcchHHHHHHHHHHHCCCeEEEEEecCCCcEEEEEEeHHHHHH-------HHHHHHhhcCCCc
Confidence 999999999999887788899999999999999999999963 4567899988553211 1122222223367
Q ss_pred eecccceeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccCc
Q 008693 468 VNLLQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFESD 540 (557)
Q Consensus 468 i~~~~~~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~~~ 540 (557)
+++.+++++|++||. |.+.+|+++++|++|++++|++ ++|+.|+++||++|+++|.++|+++||++||...
T Consensus 385 i~v~~~~a~VsvVG~gm~~~~gv~~~~f~aL~~~~I~i--i~~~~s~~sis~vV~~~d~~~av~~LH~~f~~~~ 456 (810)
T PRK09466 385 LKLREGLALVALVGAGVTRNPLHCHRFYQQLKDQPVEF--IWQSEDGLSLVAVLRQGPTESLIQGLHQSLFRAE 456 (810)
T ss_pred EEEeCCeEEEEEeCCCcccCccHHHHHHHHHHhCCCcE--EEEeCCCcEEEEEEehHHHHHHHHHHHHHHhCcC
Confidence 888899999999997 7789999999999999987776 5555699999999999999999999999999763
No 10
>PRK09436 thrA bifunctional aspartokinase I/homoserine dehydrogenase I; Provisional
Probab=100.00 E-value=2.4e-81 Score=718.85 Aligned_cols=445 Identities=32% Similarity=0.511 Sum_probs=388.4
Q ss_pred eEEEEecccccCCHHHHHHHHHHHHcCC-CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHHH
Q 008693 82 TCVMKFGGSSLASAERMREVAELILSFP-NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVD 160 (557)
Q Consensus 82 ~~V~KFGGsSv~~~~~~~~va~iI~~~~-~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~~ 160 (557)
|+|+|||||||++++++++++++|.+.. .+++|||||||+|+||.|+++++.+.+. +..+...++.++++|. +++
T Consensus 1 m~V~KFGGtSv~~~~~i~~v~~iI~~~~~~~~~vVVVSA~~~vTd~L~~~~~~~~~~---~~~~~~~~~~~~~~h~-~~~ 76 (819)
T PRK09436 1 MRVLKFGGTSVANAERFLRVADIIESNARQEQVAVVLSAPAKVTNHLVAMIEKAAKG---DDAYPEILDAERIFHE-LLD 76 (819)
T ss_pred CEEEEeCccccCCHHHHHHHHHHHHhhcccCCEEEEEcCCcCcHHHHHHHHHHHhcC---CchHHHHHHHHHHHHH-HHH
Confidence 6899999999999999999999998753 3678999999999999999998876542 2345667888888884 333
Q ss_pred Hh---CCC------HHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEE
Q 008693 161 EL---GID------RSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFI 231 (557)
Q Consensus 161 ~l---~~~------~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~ii 231 (557)
++ ... .+.+.+.|++|++++++++++++++++.+|+|+|+||++|+.||+++|+++|+++.++|++++ ++
T Consensus 77 ~l~~~~~~~~~~~~~~~i~~~~~~l~~~~~~~~~~~~~~~~~~d~i~s~GE~lSa~lla~~L~~~Gi~a~~ld~~~~-i~ 155 (819)
T PRK09436 77 GLAAALPGFDLAQLKAKVDQEFAQLKDILHGISLLGECPDSVNAAIISRGERLSIAIMAAVLEARGHDVTVIDPREL-LL 155 (819)
T ss_pred HHHhhccchhhHHHHHHHHHHHHHHHHHHHHHHhhccCChhhhhheeeHHHHHHHHHHHHHHHhCCCCeEEECHHHe-EE
Confidence 33 111 136888999999999999999999999999999999999999999999999999999999997 88
Q ss_pred EecCCCCceee-ecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCC
Q 008693 232 TTDDFTNADIL-EATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVD 310 (557)
Q Consensus 232 t~~~~~~a~i~-~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVd 310 (557)
|++.|+++.+. +...+.+++.+ .+.+.|||+|||+|.+ .+|+++||||||||++|+++|.+|+|+++++|||||
T Consensus 156 t~~~~~~~~~~~~~~~~~i~~~~----~~~~~v~Vv~Gfig~~-~~G~~ttlGRgGSD~~A~~~A~~l~A~~~~i~tdVd 230 (819)
T PRK09436 156 ADGHYLESTVDIAESTRRIAASF----IPADHVILMPGFTAGN-EKGELVTLGRNGSDYSAAILAACLDADCCEIWTDVD 230 (819)
T ss_pred ecCCCCCceechHhhHHHHHHHH----hcCCcEEEecCcccCC-CCCCEEEeCCCCchHHHHHHHHHcCCCEEEEEECCC
Confidence 88888888773 33444444332 3457899999999998 589999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCCCCcceeeEEe
Q 008693 311 GVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSIV 390 (557)
Q Consensus 311 GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~Vt~Is 390 (557)
||||+|||++|+|++|++|||+||.+|+++|++++||+|+.||+++|||++|+|+++|+.+||+|+.+.++....|++|+
T Consensus 231 Gvyt~DP~~~~~A~~i~~isy~ea~el~~~G~kvlhp~a~~~a~~~~Ipi~i~n~~~p~~~GT~I~~~~~~~~~~Vk~It 310 (819)
T PRK09436 231 GVYTADPRVVPDARLLKSLSYQEAMELSYFGAKVLHPRTIAPIAQFQIPCLIKNTFNPQAPGTLIGAESDEDSLPVKGIS 310 (819)
T ss_pred ceECCCCCCCCCCeEeeEecHHHHHHHHhcCCccchHHHHHHHHHCCceEEEccCCCCCCCceEEEecCcccccccceEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999876544445799999
Q ss_pred eeccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEE--ccCceeEEEeCCchhhhHHHHHHHHHHHH-HHHh--hh
Q 008693 391 LKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVA--TSEVSLSLTLDPSKLWSRELIQQELDHVV-EELE--KI 465 (557)
Q Consensus 391 ~~~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Is--tSe~sIS~~I~~~~~~~~~~~~~~l~~~~-~~l~--~~ 465 (557)
.++++++|++.+.+|.+.+|+++++|+.|+++||+++|++ +|+.+++|+++.++.... .+.+.+.+ .++. .+
T Consensus 311 ~~~dvalIsV~G~gm~~~~G~~arIf~~La~~gI~V~mIsqssSe~sIsf~V~~~d~~~a---v~~L~~~f~~el~~~~~ 387 (819)
T PRK09436 311 NLNNMAMFNVSGPGMKGMVGMASRVFAALSRAGISVVLITQSSSEYSISFCVPQSDAAKA---KRALEEEFALELKEGLL 387 (819)
T ss_pred EeCCEEEEEEEcCCCCCCcCHHHHHHHHHHHCCCcEEEEEcCCCCceEEEEEeHHHHHHH---HHHHHHHHHHHhccCCc
Confidence 9999999999999999999999999999999999999998 568999999998764321 11222211 1222 24
Q ss_pred heeecccceeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccC
Q 008693 466 AIVNLLQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFES 539 (557)
Q Consensus 466 ~~i~~~~~~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~~ 539 (557)
..+++.+++++|+++|. |...+++++|+|++|+++||||+||+||+|+++|||+|+++|.++|+++||++|+.+
T Consensus 388 ~~i~~~~~valIsvvG~gm~~~~gv~arif~aL~~~~InI~~IsqgsSe~~Is~vV~~~d~~~al~~LH~~f~~~ 462 (819)
T PRK09436 388 EPLEVEENLAIISVVGDGMRTHPGIAAKFFSALGRANINIVAIAQGSSERSISVVIDNDDATKALRACHQSFFLS 462 (819)
T ss_pred ceEEEeCCEEEEEEEccCcccCcCHHHHHHHHHHHCCCCEEEEEeccccceEEEEEcHHHHHHHHHHHHHHHhcc
Confidence 56888899999999997 788999999999999999999999999999999999999999999999999999976
No 11
>PRK08961 bifunctional aspartate kinase/diaminopimelate decarboxylase protein; Provisional
Probab=100.00 E-value=1.1e-79 Score=711.57 Aligned_cols=451 Identities=27% Similarity=0.465 Sum_probs=390.2
Q ss_pred CCCcceEEEEecccccCCHHHHHHHHHHHHcC--CCCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHH
Q 008693 77 SEKQLTCVMKFGGSSLASAERMREVAELILSF--PNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDL 154 (557)
Q Consensus 77 ~~~~~~~V~KFGGsSv~~~~~~~~va~iI~~~--~~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~ 154 (557)
+..|.|+|+|||||||+|++++++++++|.+. .+++++||||||+|+||+|+++++.+.+ .++.+.++.++++
T Consensus 4 ~~~~~~~V~KFGGtSv~~~~~~~~v~~ii~~~~~~~~~~vvVvSA~~~~Td~L~~~~~~~~~-----~~~~~~~~~i~~~ 78 (861)
T PRK08961 4 PSTDRWVVLKFGGTSVSRRHRWDTIAKIVRKRLAEGGRVLVVVSALSGVSNELEAIIAAAGA-----GDSASRVAAIRQR 78 (861)
T ss_pred CCCCCcEEEEECccccCCHHHHHHHHHHHHhhcccCCCEEEEEeCCCCchHHHHHHHHHHhc-----cCHHHHHHHHHHH
Confidence 45578999999999999999999999999864 2468899999999999999998765432 3567889999999
Q ss_pred HHHHHHHhCCCHH-HHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEe
Q 008693 155 HHRTVDELGIDRS-IIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITT 233 (557)
Q Consensus 155 ~~~~~~~l~~~~~-~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~ 233 (557)
|..++++|+.+.. .+.+.+++|+++++++..+++++++.+|+++|+||++|+.||+++|+++|+++.++|++++ ++++
T Consensus 79 ~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~i~s~GE~lSa~lla~~L~~~Gi~a~~ld~~~~-~~~~ 157 (861)
T PRK08961 79 HRELLAELGVDAEAVLAERLAALQRLLDGIRALTRASLRWQAEVLGQGELLSTTLGAAYLEASGLDMGWLDAREW-LTAL 157 (861)
T ss_pred HHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHhccCChhhhheEEEehHHHHHHHHHHHHHhCCCCcEEEcHHHh-Eeec
Confidence 9999999976543 6889999999999999999999999999999999999999999999999999999999998 5555
Q ss_pred cCC-C--Cceeeecch-HHHHHHHhhchhcCC-ceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeC
Q 008693 234 DDF-T--NADILEATY-PAVAKRLHGDWITDL-AIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKD 308 (557)
Q Consensus 234 ~~~-~--~a~i~~~~~-~~v~~~l~~~ll~~~-~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TD 308 (557)
+++ . ......... ....+.+.+.+.+.+ .|||++||+|.+ .+|++|||||||||++|+++|.+|+|+++++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~Vv~Gf~g~~-~~g~~ttLgrggsD~~A~~iA~~l~a~~~~i~td 236 (861)
T PRK08961 158 PQPNQSEWSQYLSVSCQWQSDPALRERFAAQPAQVLITQGFIARN-ADGGTALLGRGGSDTSAAYFAAKLGASRVEIWTD 236 (861)
T ss_pred CccccccccccccceecHhhHHHHHHHHhccCCeEEEeCCcceeC-CCCCEEEEeCCchHHHHHHHHHHcCCCEEEEEeC
Confidence 522 1 122211110 112222333333333 599999999999 5899999999999999999999999999999999
Q ss_pred CCccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCCCCcceeeE
Q 008693 309 VDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTS 388 (557)
Q Consensus 309 VdGV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~Vt~ 388 (557)
||||||+|||++|+|+++++|||+||.+|+++|++|+||+|++||+++|||++|+|+++|+.+||+|..+. +....|++
T Consensus 237 v~Gv~t~dP~~~~~a~~i~~ls~~e~~el~~~g~~v~~~~a~~~a~~~~i~i~v~~~~~~~~~gT~I~~~~-~~~~~v~~ 315 (861)
T PRK08961 237 VPGMFSANPKEVPDARLLTRLDYDEAQEIATTGAKVLHPRSIKPCRDAGIPMAILDTERPDLSGTSIDGDA-EPVPGVKA 315 (861)
T ss_pred CCccccCCCCCCCCceEecccCHHHHHHHHHCCCeEECHHHHHHHHHCCCCEEEEeCCCCCCCccEEeCCC-CCCCccee
Confidence 99999999999999999999999999999999999999999999999999999999999999999998754 33457999
Q ss_pred EeeeccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhhee
Q 008693 389 IVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIV 468 (557)
Q Consensus 389 Is~~~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i 468 (557)
|+.++|+++|++.+.+|.+.+||++++|+.|+++||+|+||++|+.++||+++..+.... ++.++.+..++..+..+
T Consensus 316 It~~~~v~lItv~~~~~~~~~g~~a~if~~la~~~I~Vd~I~sse~sis~~i~~~~~~~~---~~~~~~l~~~l~~~~~i 392 (861)
T PRK08961 316 ISRKNGIVLVSMETIGMWQQVGFLADVFTLFKKHGLSVDLISSSETNVTVSLDPSENLVN---TDVLAALSADLSQICRV 392 (861)
T ss_pred EEEECCEEEEEEecCCccccccHHHHHHHHHHHcCCeEEEEEcCCCEEEEEEccccccch---HHHHHHHHHHHhhcCcE
Confidence 999999999999999999999999999999999999999999999999999998653210 12244455566666778
Q ss_pred ecccceeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccCc
Q 008693 469 NLLQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFESD 540 (557)
Q Consensus 469 ~~~~~~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~~~ 540 (557)
.+.+++++||+||. |...+|+++++|++|++. +|.+++||+|+++||++|+++|.++|++.||++||..+
T Consensus 393 ~~~~~va~ISvVG~gm~~~~gv~arif~aL~~~--~I~~i~~gsSe~~Is~vV~~~d~~~av~~LH~~f~~~~ 463 (861)
T PRK08961 393 KIIVPCAAVSLVGRGMRSLLHKLGPAWATFGAE--RVHLISQASNDLNLTFVIDESDADGLLPRLHAELIESG 463 (861)
T ss_pred EEeCCeEEEEEeCCCcccCcChHHHHHHHHhhc--CeEEEECCCccccEEEEEeHHHHHHHHHHHHHHHhcCC
Confidence 88899999999997 788999999999999875 67889999999999999999999999999999999873
No 12
>TIGR00657 asp_kinases aspartate kinase. The Lys-sensitive enzyme of Bacillus subtilis resembles the E. coli form but is an alpha 2/beta 2 heterotetramer, where the beta subunit is translated from an in-phase alternative initiator at Met-246. This may be a feature of a number of closely related forms, including a paralog from B. subtilis.
Probab=100.00 E-value=2.4e-76 Score=639.71 Aligned_cols=434 Identities=36% Similarity=0.587 Sum_probs=370.5
Q ss_pred ceEEEEecccccCCHHHHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHH
Q 008693 81 LTCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRT 158 (557)
Q Consensus 81 ~~~V~KFGGsSv~~~~~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~ 158 (557)
+|+|+|||||||+|++++++++++|.... +.+++||||||+|+||.|+++++.+... ...+.++.++++|.++
T Consensus 1 ~~~V~KFGGssv~~~~~~~~v~~~i~~~~~~~~~~vvVvSA~~~~Td~L~~~~~~~~~~-----~~~~~~~~i~~~~~~~ 75 (441)
T TIGR00657 1 ALIVQKFGGTSVGNAERIRRVAKIVLKEKKKGNQVVVVVSAMAGVTDALVELAEQASPG-----PSKEFLEKIREKHIEI 75 (441)
T ss_pred CCEEEEeCcccCCCHHHHHHHHHHHHHHHhcCCCEEEEEcCCCCCHHHHHHHHHHHhcC-----CchHHHHHHHHHHHHH
Confidence 47899999999999999999999999742 4578999999999999999988766432 1256789999999999
Q ss_pred HHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCC
Q 008693 159 VDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTN 238 (557)
Q Consensus 159 ~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~ 238 (557)
+++|. +. ...+++++.++.+.. ...+++.+|+++|+||++|+.+++++|+++|++++++++.+.+++++++|++
T Consensus 76 ~~~l~-~~----~~~~~~~~~~~~~~~-~~~~~~~~d~ils~GE~~s~~l~~~~l~~~Gi~a~~l~~~~~~l~t~~~~~~ 149 (441)
T TIGR00657 76 LERLI-PQ----AIAEELKRLLDAELV-LEEKPREMDRILSFGERLSAALLSAALEELGVKAVSLLGGEAGILTDSNFGR 149 (441)
T ss_pred HHHhh-hH----HHHHHHHHHHHHHHh-hhcCcchHhheecHHHHHHHHHHHHHHHhCCCCCEEEEcCcceEEecCCCCc
Confidence 99997 32 233334444433321 1224678899999999999999999999999999999999999999998887
Q ss_pred ce-eeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCC
Q 008693 239 AD-ILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDP 317 (557)
Q Consensus 239 a~-i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP 317 (557)
+. +.+.+.+.+. .+++.+.|||++||+|.+ .+|+++++||||||++|+++|.+|+|+++++||||||||++||
T Consensus 150 ~~~~~~~~~~~l~-----~~l~~~~vpVv~G~~g~~-~~g~~~~lgrggsD~~A~~lA~~l~a~~l~~~tDV~Gv~~~DP 223 (441)
T TIGR00657 150 ARVIIEILTERLE-----PLLEEGIIPVVAGFQGAT-EKGETTTLGRGGSDYTAALLAAALKADECEIYTDVDGIYTTDP 223 (441)
T ss_pred eeecHhhhHHHHH-----HHHhcCCEEEEeCcEeeC-CCCCEeecCCCchHHHHHHHHHHcCCCEEEEEECCCCCCcCCC
Confidence 66 4344443332 245678899999999998 5899999999999999999999999999999999999999999
Q ss_pred CCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCC-CCcceeeEEeeeccEE
Q 008693 318 NIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRD-MSKAVLTSIVLKRNVT 396 (557)
Q Consensus 318 ~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~-~~~~~Vt~Is~~~nia 396 (557)
+++|+++++++|||+||.+|+++|++++||+|+.||++++||++|+|+++|+.+||+|.+..+ +.+..+++|+.+++++
T Consensus 224 ~~~~~a~~i~~is~~ea~el~~~G~~v~~~~a~~~~~~~~i~i~i~~~~~~~~~GT~I~~~~~~~~~~~i~~It~~~~v~ 303 (441)
T TIGR00657 224 RIVPDARRIDEISYEEMLELASFGAKVLHPRTLEPAMRAKIPIVVKSTFNPEAPGTLIVASTKEMEEPIVKGLSLDRNQA 303 (441)
T ss_pred CCCCCCeECCccCHHHHHHHHhcCCcccCHHHHHHHHHcCCeEEEecCCCCCCCceEEEeCCCccccCccceEEEeCCEE
Confidence 999999999999999999999999999999999999999999999999999999999987654 3445799999999999
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCceEEEEE--ccCceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeecccce
Q 008693 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVA--TSEVSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNLLQHR 474 (557)
Q Consensus 397 lItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Is--tSe~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~~~~~ 474 (557)
+|++.+.+|.+ +|+++++|+.|+++||++++++ +|+.+++|+++.++.... .+.+..+ .....+..+++.+++
T Consensus 304 ~Isv~g~~~~~-~g~la~if~~L~~~~I~I~~i~q~~se~sIs~~I~~~~~~~a---~~~L~~~-~~~~~~~~I~~~~~~ 378 (441)
T TIGR00657 304 RVTVSGLGMKG-PGFLARVFGALAEAGINVDLITQSSSETSISFTVDKEDADQA---KTLLKSE-LNLSALSSVEVEKGL 378 (441)
T ss_pred EEEEECCCCCC-ccHHHHHHHHHHHcCCeEEEEEecCCCceEEEEEEHHHHHHH---HHHHHHH-HHhcCcceEEEcCCe
Confidence 99999988888 9999999999999999999997 568899999998764321 1112211 112234568889999
Q ss_pred eEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008693 475 SIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 538 (557)
Q Consensus 475 aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~ 538 (557)
++|+++|. |.+.+++++++|++|+++||||.||++ |+.+|+|+|+++|.++|++.||++|++
T Consensus 379 a~VsvvG~~~~~~~g~~a~if~~La~~~Inv~~i~~--se~~Is~vV~~~d~~~a~~~Lh~~f~~ 441 (441)
T TIGR00657 379 AKVSLVGAGMKSAPGVASKIFEALAQNGINIEMISS--SEINISFVVDEKDAEKAVRLLHNALFE 441 (441)
T ss_pred EEEEEEcCCCCCCCchHHHHHHHHHHCCCCEEEEEe--cCCcEEEEEeHHHHHHHHHHHHHHhhC
Confidence 99999997 778899999999999999999999996 789999999999999999999999974
No 13
>PRK08841 aspartate kinase; Validated
Probab=100.00 E-value=1.1e-73 Score=607.10 Aligned_cols=378 Identities=30% Similarity=0.448 Sum_probs=329.9
Q ss_pred cceEEEEecccccCCHHHHHHHHHHHHcC--CCCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHH
Q 008693 80 QLTCVMKFGGSSLASAERMREVAELILSF--PNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHR 157 (557)
Q Consensus 80 ~~~~V~KFGGsSv~~~~~~~~va~iI~~~--~~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~ 157 (557)
|.|+|+|||||||+|++++++++++|... .+.+++||||||+|+||.|+..+...
T Consensus 1 m~~~V~KfGGtsv~~~~~i~~va~~I~~~~~~g~~vvvVvSa~~~~td~ll~~~~~~----------------------- 57 (392)
T PRK08841 1 MPLIVQKFGGTSVGSIERIQTVAEHIIKAKNDGNQVVVVVSAMAGETNRLLGLAKQV----------------------- 57 (392)
T ss_pred CCeEEEeECcccCCCHHHHHHHHHHHHHHHHCCCCEEEEECCCchHHHHHHHhhhhh-----------------------
Confidence 56899999999999999999999999864 34678999999999999998753210
Q ss_pred HHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCC
Q 008693 158 TVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFT 237 (557)
Q Consensus 158 ~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~ 237 (557)
.+..+++.+|+++|+||++|+.|++++|+++|+++++++++|.++++++.+.
T Consensus 58 ----------------------------~~~~~~~~~d~l~s~GE~~s~~lla~~L~~~Gi~a~~l~~~~~~i~t~~~~~ 109 (392)
T PRK08841 58 ----------------------------DSVPTARELDVLLSAGEQVSMALLAMTLNKLGYAARSLTGAQANIVTDNQHN 109 (392)
T ss_pred ----------------------------ccCCCHHHHHHHHHHHHHHHHHHHHHHHHhCCCCeEEEehhHcCEEecCCCC
Confidence 0112566789999999999999999999999999999999999899988888
Q ss_pred CceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCC
Q 008693 238 NADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDP 317 (557)
Q Consensus 238 ~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP 317 (557)
++++...+...+.+ +++.+.|||++||+|.+ ++|+++|||||||||+|+++|.+|+|+++++|||||||||+||
T Consensus 110 ~~~i~~~~~~~i~~-----ll~~~~vpVv~Gf~g~~-~~g~~ttlgrggsD~tAa~lA~~L~Ad~l~i~TDVdGVyt~DP 183 (392)
T PRK08841 110 DATIKHIDTSTITE-----LLEQDQIVIVAGFQGRN-ENGDITTLGRGGSDTTAVALAGALNADECQIFTDVDGVYTCDP 183 (392)
T ss_pred CceechhhHHHHHH-----HHhCCCEEEEeCCcccC-CCCCEEEeCCCChHHHHHHHHHHcCCCEEEEEeCCCCCCcCCC
Confidence 78776554443332 34677899999999999 5899999999999999999999999999999999999999999
Q ss_pred CCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCCCCcceeeEEeeeccEEE
Q 008693 318 NIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSIVLKRNVTM 397 (557)
Q Consensus 318 ~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~Vt~Is~~~nial 397 (557)
|++|+|+++++|||+||.||+++|++|+||+|++||+++|||++|+|+++| .+||+|.... ...+|++|+.++|+++
T Consensus 184 ~~v~~A~~i~~is~~ea~ela~~Ga~vlhp~ai~~a~~~~Ipi~i~n~~~~-~~GT~I~~~~--~~~~i~~i~~~~~~~~ 260 (392)
T PRK08841 184 RVVKNARKLDVIDFPSMEAMARKGAKVLHLPSVQHAWKHSVPLRVLSSFEV-GEGTLIKGEA--GTQAVCGIALQRDLAL 260 (392)
T ss_pred CCCCCceEcccccHHHHHHHHhcCccccCHHHHHHHHHCCCeEEEEecCCC-CCCeEEEecc--CCCcEEEEEEeCCeEE
Confidence 999999999999999999999999999999999999999999999999997 6799997642 3347999999999999
Q ss_pred EEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeecccceeEE
Q 008693 398 LDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNLLQHRSII 477 (557)
Q Consensus 398 ItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~~~~~aiI 477 (557)
|++.+ +.++++|+.|+++||+++++++++.+++|+++..++ +++...+ ...+...+++++|
T Consensus 261 i~v~~-------~~~~~i~~~l~~~~i~v~~i~~~~~~~~~~v~~~~~----------~~~~~~~--~~~i~~~~~~a~v 321 (392)
T PRK08841 261 IEVES-------ESLPSLTKQCQMLGIEVWNVIEEADRAQIVIKQDAC----------AKLKLVF--DDKIRNSESVSLL 321 (392)
T ss_pred EEecc-------chHHHHHHHHHHcCCCEEEEEecCCcEEEEECHHHH----------HHHHHhC--cccEEEeCCEEEE
Confidence 99975 246899999999999999999999999999986542 1111111 1246777899999
Q ss_pred EEEccccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccCc
Q 008693 478 SLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFESD 540 (557)
Q Consensus 478 sIVG~~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~~~ 540 (557)
++||.. .+|+++++|++|.+++||++++++ |+++|||+|+++|.++|+++||++|+..+
T Consensus 322 svVG~~--~~gv~~~~~~aL~~~~I~i~~i~~--s~~~is~vv~~~~~~~av~~lH~~f~~~~ 380 (392)
T PRK08841 322 TLVGLE--ANGMVEHACNLLAQNGIDVRQCST--EPQSSMLVLDPANVDRAANILHKTYVTSE 380 (392)
T ss_pred EEECCC--ChHHHHHHHHHHHhCCCCEEEEEC--CCcEEEEEEeHHHHHHHHHHHHHHHcCCc
Confidence 999973 389999999999999999999998 78999999999999999999999999874
No 14
>TIGR00656 asp_kin_monofn aspartate kinase, monofunctional class. The Lys-sensitive enzyme of Bacillus subtilis resembles the E. coli form but is an alpha 2/beta 2 heterotetramer, where the beta subunit is translated from an in-phase alternative initiator at Met-246. The protein slr0657 from Synechocystis PCC6803 is extended by a duplication of the C-terminal region corresponding to the beta chain. Incorporation of a second copy of the C-terminal domain may be quite common in this subgroup of aspartokinases.
Probab=100.00 E-value=6.4e-72 Score=598.58 Aligned_cols=394 Identities=36% Similarity=0.582 Sum_probs=343.5
Q ss_pred ceEEEEecccccCCHHHHHHHHHHHHcC--CCCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHH
Q 008693 81 LTCVMKFGGSSLASAERMREVAELILSF--PNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRT 158 (557)
Q Consensus 81 ~~~V~KFGGsSv~~~~~~~~va~iI~~~--~~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~ 158 (557)
+++|+|||||+|++++.+++++++|+.. .+.+++|||||++++||.|+++++...
T Consensus 1 ~~iViK~GGs~~~~~~~i~~~~~~i~~~~~~g~~~vvV~sg~~~~t~~l~~~~~~~~----------------------- 57 (401)
T TIGR00656 1 ELIVQKFGGTSVGSGERIKNAARIVLKEKKEGHKVVVVVSAMSGVTDALVEISEKAI----------------------- 57 (401)
T ss_pred CcEEEEECCcCcCCHHHHHHHHHHHHHHHHcCCCEEEEEeCCCCChHHHHHHHHHHh-----------------------
Confidence 4689999999999999999999999864 346889999999999999987643110
Q ss_pred HHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCC
Q 008693 159 VDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTN 238 (557)
Q Consensus 159 ~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~ 238 (557)
-...++..+|+++++||++|+.+++++|+++|+++.++++.+.+++|++++++
T Consensus 58 ---------------------------~~~~~~~~~~~i~~~Ge~~s~~~~~~~l~~~g~~a~~l~~~~~~~~t~~~~~~ 110 (401)
T TIGR00656 58 ---------------------------RDAITPRERDELVSHGERLSSALFSGALRDLGVKAIWLDGGEAGIITDDNFGN 110 (401)
T ss_pred ---------------------------ccCCChHHHHHHhhHHHHHHHHHHHHHHHhCCCceEEeccccceEEeCCCCCc
Confidence 01235677899999999999999999999999999999999999999999988
Q ss_pred ceeeecch-HHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCC
Q 008693 239 ADILEATY-PAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDP 317 (557)
Q Consensus 239 a~i~~~~~-~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP 317 (557)
+++.+... +.+. .+++.+.|||++||+|.+ .+|+++|+||||||++|+++|.+|+|+++++|||||||||+||
T Consensus 111 ~~~~~~~~~~~l~-----~~l~~~~vpVi~g~~~~~-~~g~~~~lgrg~sD~~A~~lA~~l~A~~l~i~tdV~Gv~~~DP 184 (401)
T TIGR00656 111 AKIDIIATEERLL-----PLLEEGIIVVVAGFQGAT-EKGYTTTLGRGGSDYTAALLAAALKADRVDIYTDVPGVYTTDP 184 (401)
T ss_pred eEeeecchHHHHH-----HHHhCCCEEEecCcceeC-CCCCEeecCCCcHHHHHHHHHHHcCCCEEEEEECCCCCCcCCC
Confidence 87765554 3333 235678999999999998 4899999999999999999999999999999999999999999
Q ss_pred CCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCCCCcceeeEEeeeccEEE
Q 008693 318 NIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSIVLKRNVTM 397 (557)
Q Consensus 318 ~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~Vt~Is~~~nial 397 (557)
+++|+|+++++|||+||.+|+++|++++||+|+.||++++||++|+|+++|+ +||+|.+..+ ..+.+++|+.++|+++
T Consensus 185 ~~~~~a~~i~~ls~~ea~~l~~~G~~v~~~~a~~~a~~~~i~i~i~~~~~~~-~gT~I~~~~~-~~~~v~~I~~~~~va~ 262 (401)
T TIGR00656 185 RVVEAAKRIDKISYEEALELATFGAKVLHPRTVEPAMRSGVPIEVRSSFDPE-EGTLITNSME-NPPLVKGIALRKNVTR 262 (401)
T ss_pred CCCCCcEECCccCHHHHHHHHHcCCcccCHHHHHHHHHCCCeEEEEECCCCC-CCeEEEeCcc-cCCceEEEEEECCEEE
Confidence 9999999999999999999999999999999999999999999999999998 8999987532 2236999999999999
Q ss_pred EEEEecCccchhhHHHHHHHHHHhCCceEEEEEc--cCceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeeccccee
Q 008693 398 LDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT--SEVSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNLLQHRS 475 (557)
Q Consensus 398 ItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Ist--Se~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~~~~~a 475 (557)
|++.+.+|.+.+|+++++|+.|++++|+++++++ |+.+++|+++.++... ..+.+.+..... ....+...++++
T Consensus 263 vsv~g~~~~~~~g~~~~if~~L~~~~I~i~~i~~~~s~~~Is~~V~~~d~~~---a~~~L~~~~~~~-~~~~i~~~~~~a 338 (401)
T TIGR00656 263 VTVHGLGMLGKRGFLARIFGALAERNINVDLISQTPSETSISLTVDETDADE---AVRALKDQSGAA-GLDRVEVEEGLA 338 (401)
T ss_pred EEEecCCCCCCccHHHHHHHHHHHcCCcEEEEEcCCCCceEEEEEeHHHHHH---HHHHHHHHHHhc-CCceEEEeCCeE
Confidence 9999999999999999999999999999999998 7899999998765321 111222221111 134577889999
Q ss_pred EEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008693 476 IISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 538 (557)
Q Consensus 476 iIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~ 538 (557)
+|++||. |.+.+|+++++|++|+++||||.+++ +|+.+++|+|+++|.++|+++||++||.
T Consensus 339 ~IsvVG~~~~~~~g~~a~i~~~L~~~gIni~~i~--~s~~~is~vv~~~d~~~av~~Lh~~f~~ 400 (401)
T TIGR00656 339 KVSIVGAGMVGAPGVASEIFSALEEKNINILMIG--SSETNISFLVDEKDAEKAVRKLHEVFEE 400 (401)
T ss_pred EEEEECCCcccCccHHHHHHHHHHHCCCcEEEEE--cCCCEEEEEEeHHHHHHHHHHHHHHHcc
Confidence 9999997 78899999999999999999999987 5899999999999999999999999985
No 15
>PRK08210 aspartate kinase I; Reviewed
Probab=100.00 E-value=2e-68 Score=571.82 Aligned_cols=388 Identities=31% Similarity=0.518 Sum_probs=333.4
Q ss_pred cceEEEEecccccCCHHHHHHHHHHHHcC--CCCccEEEEcCCCc-----CcHHHHHhhHHhhhcCCCcchhhHHHHHHH
Q 008693 80 QLTCVMKFGGSSLASAERMREVAELILSF--PNERPVIVLSAMGK-----TTNKLLLAGEKAVSCGVTNISCIDELSFVK 152 (557)
Q Consensus 80 ~~~~V~KFGGsSv~~~~~~~~va~iI~~~--~~~~~vvVVSA~gg-----~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~ 152 (557)
|.++|+|||||++.|++.++++++.|... .+.+++|||||||+ +|+.|+..+...
T Consensus 1 m~~iViK~GGs~l~~~~~~~~~~~~i~~~~~~g~~~vvV~sa~g~~G~~~~t~~l~~~~~~~------------------ 62 (403)
T PRK08210 1 MKIIVQKFGGTSVSTEERRKMAVNKIKKALKEGYKVVVVVSAMGRKGDPYATDTLLSLVGEE------------------ 62 (403)
T ss_pred CCeEEEeECCcccCCHHHHHHHHHHHHHHHHcCCCEEEEEeCCCCCCCCCccHHHHHHHHHh------------------
Confidence 56899999999999999999999998863 24578999999976 588776542210
Q ss_pred HHHHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEE
Q 008693 153 DLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFIT 232 (557)
Q Consensus 153 ~~~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit 232 (557)
....+++.+|.++++||.+|+.+++++|+++|+++.++++.+.+++|
T Consensus 63 ---------------------------------~~~~~~~~~~~l~~~Ge~~s~~~~~~~l~~~Gi~a~~l~~~~~~~~t 109 (403)
T PRK08210 63 ---------------------------------FSEISKREQDLLMSCGEIISSVVFSNMLNENGIKAVALTGGQAGIIT 109 (403)
T ss_pred ---------------------------------ccCCChHHHHHHHhHhHHHHHHHHHHHHHhCCCCeEEechHHccEEc
Confidence 01235667888999999999999999999999999999999988999
Q ss_pred ecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCcc
Q 008693 233 TDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGV 312 (557)
Q Consensus 233 ~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV 312 (557)
+++++++++...+.+.+.. +++.+.|||++||+|.+ .+|+++|+||||||++|+++|.+|+|+++++|||||||
T Consensus 110 ~~~~~~~~v~~~~~~~l~~-----~l~~~~vpVi~G~~~~~-~~g~~~~l~rg~sD~~A~~lA~~l~A~~l~i~tDV~GV 183 (403)
T PRK08210 110 DDNFTNAKIIEVNPDRILE-----ALEEGDVVVVAGFQGVT-ENGDITTLGRGGSDTTAAALGVALKAEYVDIYTDVDGI 183 (403)
T ss_pred cCCCCceeeehhhHHHHHH-----HHhcCCEEEeeCeeecC-CCCCEEEeCCCchHHHHHHHHHHcCCCEEEEEECCCCC
Confidence 9988877775555443332 34678899999999988 58999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCC------CCccee
Q 008693 313 LTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRD------MSKAVL 386 (557)
Q Consensus 313 ~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~------~~~~~V 386 (557)
|++|||++|++++|++|||+||.+|+++|++|+||+|++||+++|||++|+|+++| .+||+|.+..+ +....|
T Consensus 184 ~~~dP~~~~~a~~i~~ls~~ea~~l~~~G~~v~~~~a~~~~~~~~i~i~i~~~~~~-~~gT~I~~~~~~~~~~~~~~~~v 262 (403)
T PRK08210 184 MTADPRIVEDARLLDVVSYNEVFQMAYQGAKVIHPRAVEIAMQANIPLRIRSTYSD-SPGTLITSLGDAKGGIDVEERLI 262 (403)
T ss_pred CcCCCCcCCCCeECCccCHHHHHHHHHCCccccCHHHHHHHHHCCCeEEEEecCCC-cCCcEEEecCccccccccccCce
Confidence 99999999999999999999999999999999999999999999999999999985 46999987642 134579
Q ss_pred eEEeeeccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhh
Q 008693 387 TSIVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQELDHVVEELEKIA 466 (557)
Q Consensus 387 t~Is~~~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~ 466 (557)
++|+.++|+++|++.+..+ .+|+++++|+.|+++||+|++++++..+++|+++.++... +..+++++. .
T Consensus 263 ~~It~~~~i~~isv~~~~~--~~g~la~If~~L~~~~I~i~~i~~~~~~is~~v~~~~~~~-------a~~~l~~~~--~ 331 (403)
T PRK08210 263 TGIAHVSNVTQIKVKAKEN--AYDLQQEVFKALAEAGISVDFINIFPTEVVFTVSDEDSEK-------AKEILENLG--L 331 (403)
T ss_pred EEEEEcCCcEEEEEecCCC--cchHHHHHHHHHHHcCCeEEEEEecCceEEEEEcHHHHHH-------HHHHHHHhC--C
Confidence 9999999999999986543 4999999999999999999999988889999998755321 122223322 1
Q ss_pred eeecccceeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008693 467 IVNLLQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 538 (557)
Q Consensus 467 ~i~~~~~~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~ 538 (557)
.+.+.+++++|+++|. |.+.+|+++++|++|+++||||.++++ |+++++|+|+++|.++|+++||++|+.
T Consensus 332 ~v~~~~~~a~isvvG~~~~~~~g~~~~i~~aL~~~~I~i~~~~~--s~~~is~vv~~~~~~~a~~~Lh~~f~~ 402 (403)
T PRK08210 332 KPSVRENCAKVSIVGAGMAGVPGVMAKIVTALSEEGIEILQSAD--SHTTIWVLVKEEDMEKAVNALHDAFEL 402 (403)
T ss_pred cEEEeCCcEEEEEEcCCcCCCccHHHHHHHHHHhCCCCEEEEec--CCCEEEEEEcHHHHHHHHHHHHHHhcC
Confidence 4777889999999997 788999999999999999999988766 899999999999999999999999964
No 16
>PRK07431 aspartate kinase; Provisional
Probab=100.00 E-value=7.9e-68 Score=591.76 Aligned_cols=395 Identities=30% Similarity=0.482 Sum_probs=341.3
Q ss_pred cceEEEEecccccCCHHHHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHH
Q 008693 80 QLTCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHR 157 (557)
Q Consensus 80 ~~~~V~KFGGsSv~~~~~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~ 157 (557)
|.|+|+|||||||+|++.+++++++|.... +.+++||+||||++||+|++++...
T Consensus 1 m~~iViKfGGss~~~~~~i~~~a~~I~~~~~~g~~vvvV~sa~g~~t~~l~~~~~~~----------------------- 57 (587)
T PRK07431 1 MALIVQKFGGTSVGSVERIQAVAQRIARTKEAGNDVVVVVSAMGKTTDELVKLAKEI----------------------- 57 (587)
T ss_pred CCeEEEEECchhcCCHHHHHHHHHHHHHHHHCCCCEEEEECCCCchhHHHHHHHHHh-----------------------
Confidence 568999999999999999999999998642 4678999999999999997643210
Q ss_pred HHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCC
Q 008693 158 TVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFT 237 (557)
Q Consensus 158 ~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~ 237 (557)
.++.+.+.+|+++++||.+|+.+++.+|+++|+++++++++++++++++.++
T Consensus 58 ----------------------------t~~~~~~~~~~~ls~Ge~~s~~l~~~~l~~~gi~a~~l~~~~~~~~~~~~~~ 109 (587)
T PRK07431 58 ----------------------------SSNPPRREMDMLLSTGEQVSIALLSMALHELGQPAISLTGAQVGIVTESEHG 109 (587)
T ss_pred ----------------------------ccCCCHHHHHHHHHHhHHHHHHHHHHHHHHCCCCeEEechhHcCeEecCCCC
Confidence 1233566789999999999999999999999999999999999899988888
Q ss_pred CceeeecchHHHHHHHhhchhcCCceEEEcCCCcccC-CCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCC
Q 008693 238 NADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAW-RTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCD 316 (557)
Q Consensus 238 ~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~-~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taD 316 (557)
.+++...+.+.+.+ +++.+.|||++||+|.+. .+|+++|+||||||++|+++|.+|+|+++++||||||||++|
T Consensus 110 ~~~i~~~~~~~l~~-----~l~~g~vpVv~g~~g~~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~i~TDVdGVyt~D 184 (587)
T PRK07431 110 RARILEIKTDRIQR-----HLDAGKVVVVAGFQGISLSSNLEITTLGRGGSDTSAVALAAALGADACEIYTDVPGVLTTD 184 (587)
T ss_pred ceeeeeccHHHHHH-----HHhCCCeEEecCCcCCCCCCCCCEeecCCCchHHHHHHHHHHcCCCEEEEEeCCCccCcCC
Confidence 78877666654443 346789999999999752 238899999999999999999999999999999999999999
Q ss_pred CCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCCCC--------cceeeE
Q 008693 317 PNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMS--------KAVLTS 388 (557)
Q Consensus 317 P~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~--------~~~Vt~ 388 (557)
|+++|+|++|++|+|+||.+|+++|+++|||+|++|++++|||++|+|++ |+.+||+|.+..+.. ..++++
T Consensus 185 P~~~~~a~~i~~i~~~e~~el~~~G~~v~~~~a~~~~~~~~i~i~i~~~~-~~~~GT~i~~~~~~~~~~~~~~~~~~i~g 263 (587)
T PRK07431 185 PRLVPEAQLMDEISCDEMLELASLGASVLHPRAVEIARNYGVPLVVRSSW-SDAPGTLVTSPPPRPRSLGGLELGKPVDG 263 (587)
T ss_pred CCCCCCCeECCCcCHHHHHHHHhCCCceEhHHHHHHHHHcCCcEEEecCC-CCCCCeEEEeCCcccccccchhcccccce
Confidence 99999999999999999999999999999999999999999999999999 467899998764321 346899
Q ss_pred EeeeccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEcc-----CceeEEEeCCchhhhHHHHHHHHHHHHHHHh
Q 008693 389 IVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATS-----EVSLSLTLDPSKLWSRELIQQELDHVVEELE 463 (557)
Q Consensus 389 Is~~~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstS-----e~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~ 463 (557)
++..++++++++. ++.+.+||++++|+.|+++||+|+|++++ ..+++|+++.++.... .+.++.+..++.
T Consensus 264 i~~~~~~a~itl~--~~~~~~g~~a~if~~l~~~~I~v~~i~qs~~~~~~~~isf~i~~~d~~~~---~~~l~~l~~~~~ 338 (587)
T PRK07431 264 VELDEDQAKVALL--RVPDRPGIAAQLFEELAAQGVNVDLIIQSIHEGNSNDIAFTVAENELKKA---EAVAEAIAPALG 338 (587)
T ss_pred EEEecCceEEEEe--cCCCcccHHHHHHHHHHHcCCcEEEEEeccCCCCCccEEEEEeHHHHHHH---HHHHHHHHHHcC
Confidence 9999999999996 57889999999999999999999999853 2789999988764321 122333333333
Q ss_pred hhheeecccceeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccC
Q 008693 464 KIAIVNLLQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFES 539 (557)
Q Consensus 464 ~~~~i~~~~~~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~~ 539 (557)
. ..+++.+++++|+++|. |...+|+++|+|++|++++|||++|+ +|+++|||+|+++|.++|++.||++|+.+
T Consensus 339 ~-~~i~~~~~~a~IsvvG~gm~~~~gi~~ki~~aL~~~~I~i~~i~--sSe~~Is~vv~~~d~~~av~~Lh~~f~~~ 412 (587)
T PRK07431 339 G-AEVLVETNVAKLSISGAGMMGRPGIAAKMFDTLAEAGINIRMIS--TSEVKVSCVIDAEDGDKALRAVCEAFELE 412 (587)
T ss_pred C-CcEEEeCCeEEEEEECCCcccCccHHHHHHHHHHHCCCcEEEEE--cCCCEEEEEEcHHHHHHHHHHHHHHhccC
Confidence 2 56888899999999997 78899999999999999999999999 49999999999999999999999999766
No 17
>PRK06635 aspartate kinase; Reviewed
Probab=100.00 E-value=8e-67 Score=559.71 Aligned_cols=393 Identities=33% Similarity=0.540 Sum_probs=341.1
Q ss_pred cceEEEEecccccCCHHHHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHH
Q 008693 80 QLTCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHR 157 (557)
Q Consensus 80 ~~~~V~KFGGsSv~~~~~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~ 157 (557)
|+++|+|||||++.|++.++++++.|.... +.+++|||||++++||+|++..+...
T Consensus 1 m~~iViK~GGs~l~~~~~~~~~~~~i~~~~~~g~~~vvV~sg~~~~~~~l~~~~~~~~---------------------- 58 (404)
T PRK06635 1 MALIVQKFGGTSVGDVERIKRVAERVKAEVEAGHQVVVVVSAMGGTTDELLDLAKEVS---------------------- 58 (404)
T ss_pred CCeEEEeECCcccCCHHHHHHHHHHHHHHHHcCCCEEEEEeCCCCcHHHHHHHHHHhc----------------------
Confidence 568999999999999999999999998642 46789999999999999987532100
Q ss_pred HHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCC
Q 008693 158 TVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFT 237 (557)
Q Consensus 158 ~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~ 237 (557)
...++..+|+++++||++|+.+++.+|+++|++++++++++++++++++|+
T Consensus 59 -----------------------------~~~~~~~~~~~~~~Ge~~~~~~~~~~l~~~g~~a~~l~~~~~~~~~~~~~~ 109 (404)
T PRK06635 59 -----------------------------PLPDPRELDMLLSTGEQVSVALLAMALQSLGVKARSFTGWQAGIITDSAHG 109 (404)
T ss_pred -----------------------------cCCCHHHHHHHhhhhHHHHHHHHHHHHHhCCCCeEEeChhhCCEEecCCCC
Confidence 012456778999999999999999999999999999999999899988888
Q ss_pred CceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCC
Q 008693 238 NADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDP 317 (557)
Q Consensus 238 ~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP 317 (557)
++++...+.+.+.+ +++.+.|||++||+|.+ .+|.++|+||||||++|+++|.+|+|+++++||||||||++||
T Consensus 110 ~~~~~~~~~~~l~~-----~l~~~~ipVi~g~~~~~-~~g~~~~l~rg~sD~~A~~lA~~l~A~~l~~~tDV~Gv~~~dP 183 (404)
T PRK06635 110 KARITDIDPSRIRE-----ALDEGDVVVVAGFQGVD-EDGEITTLGRGGSDTTAVALAAALKADECEIYTDVDGVYTTDP 183 (404)
T ss_pred ceEeeecCHHHHHH-----HHhCCCEEEecCccEeC-CCCCEEecCCCChHHHHHHHHHHhCCCEEEEEEcCCCCCcCCC
Confidence 88876666554443 34578999999999998 5899999999999999999999999999999999999999999
Q ss_pred CCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCC--CCcceeeEEeeeccE
Q 008693 318 NIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRD--MSKAVLTSIVLKRNV 395 (557)
Q Consensus 318 ~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~--~~~~~Vt~Is~~~ni 395 (557)
|++|++++++++||+|+.+|+++|++++||+|++|+++++||++|+|+++| .+||+|..... +.+..+++|+..+++
T Consensus 184 ~~~~~a~~i~~i~~~e~~~l~~~g~~~~~~~a~~~~~~~~i~~~i~~~~~~-~~gT~i~~~~~~~~~~~~i~~I~~~~~v 262 (404)
T PRK06635 184 RIVPKARKLDKISYEEMLELASLGAKVLHPRSVEYAKKYNVPLRVRSSFSD-NPGTLITGEEEEIMEQPVVTGIAFDKDE 262 (404)
T ss_pred CCCCCceECCccCHHHHHHHHHcCCcccCHHHHHHHHHcCceEEEEcCCCC-CCCCEEeeCCccccccCceEEEEecCCe
Confidence 999999999999999999999999999999999999999999999999988 68999987643 344579999999999
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEcc-----CceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeec
Q 008693 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATS-----EVSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNL 470 (557)
Q Consensus 396 alItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstS-----e~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~ 470 (557)
++|++.+ |.+.+|+++++|+.|+++||++++++++ +.+++|+++.++... ..+.+++...++ .+..++.
T Consensus 263 ~~Isv~g--~~~~~g~l~~i~~~L~~~~I~i~~is~s~~~~~~~~is~~v~~~~~~~---a~~~L~~~~~~~-~~~~i~~ 336 (404)
T PRK06635 263 AKVTVVG--VPDKPGIAAQIFGALAEANINVDMIVQNVSEDGKTDITFTVPRDDLEK---ALELLEEVKDEI-GAESVTY 336 (404)
T ss_pred EEEEECC--CCCCccHHHHHHHHHHHcCCeEEEEEecCCCCCceeEEEEEcHHHHHH---HHHHHHHHHHHc-CcceEEE
Confidence 9999987 8889999999999999999999999886 477999998765422 112233211111 2355888
Q ss_pred ccceeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008693 471 LQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 538 (557)
Q Consensus 471 ~~~~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~ 538 (557)
.+++++|+++|. +...+|+++++|++|+++||||.++++ |+.+++|+|+++|.++|++.||++|+.
T Consensus 337 ~~~ia~isvvG~~~~~~~g~~a~i~~~La~~~Ini~~i~s--s~~~is~vv~~~d~~~a~~~Lh~~f~~ 403 (404)
T PRK06635 337 DDDIAKVSVVGVGMRSHPGVAAKMFEALAEEGINIQMIST--SEIKISVLIDEKYLELAVRALHEAFGL 403 (404)
T ss_pred cCCeEEEEEECCCCCCCchHHHHHHHHHHHCCCCEEEEEe--cCCeEEEEEcHHHHHHHHHHHHHHHCC
Confidence 899999999996 788899999999999999999999986 789999999999999999999999953
No 18
>cd04245 AAK_AKiii-YclM-BS AAK_AKiii-YclM-BS: Amino Acid Kinase Superfamily (AAK), AKiii-YclM-BS; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in Bacilli (Bacillus subtilis YclM) and Clostridia species. Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. In Bacillus subtilis (BS), YclM is reported to be a single polypeptide of 50 kD. The Bacillus subtilis 168 AKIII is induced by lysine and repressed by threonine, and it is synergistically inhibited by lysine and threonine.
Probab=100.00 E-value=2.5e-66 Score=528.10 Aligned_cols=281 Identities=35% Similarity=0.514 Sum_probs=249.8
Q ss_pred eEEEEecccccCCHHHHHHHHHHHHcCCCCccEEEEcCCC-------cCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHH
Q 008693 82 TCVMKFGGSSLASAERMREVAELILSFPNERPVIVLSAMG-------KTTNKLLLAGEKAVSCGVTNISCIDELSFVKDL 154 (557)
Q Consensus 82 ~~V~KFGGsSv~~~~~~~~va~iI~~~~~~~~vvVVSA~g-------g~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~ 154 (557)
|+|+|||||||+|++++++|+++|... .++++||||||+ |+||.|+++++.+.+. .++.+.++.++++
T Consensus 1 m~V~KFGGtSv~~~~~i~~v~~ii~~~-~~~~vvVvSA~~~~~~~~~~vTd~L~~~~~~~~~~----~~~~~~~~~i~~~ 75 (288)
T cd04245 1 MKVVKFGGSSLASAEQFQKVKAIVKAD-PERKIVVVSAPGKRFKDDTKVTDLLILYAEAVLAG----EDTESIFEAIVDR 75 (288)
T ss_pred CEEEEECcCccCCHHHHHHHHHHHHhc-CCCEEEEEcCCCCCCCchhhHHHHHHHHHHHHhcC----cchHHHHHHHHHH
Confidence 589999999999999999999999865 467899999998 5999999988766441 2456789999999
Q ss_pred HHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEec
Q 008693 155 HHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTD 234 (557)
Q Consensus 155 ~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~ 234 (557)
|.+++++|..+.+.+.+..+.++++.+. +...+++.+|+|+|+||++|+.+|+.+|+++|+++.++|++++|++|++
T Consensus 76 h~~~~~~L~~~~~~~~~i~~~~~~l~~~---~~~~~~~~~d~i~s~GE~lSa~ll~~~L~~~Gi~a~~ld~~~~~i~t~~ 152 (288)
T cd04245 76 YAEIADELGLPMSILEEIAEILENLANL---DYANPDYLLDALKARGEYLNAQLMAAYLNYQGIDARYVIPKDAGLVVTD 152 (288)
T ss_pred HHHHHHHhhhhhhHHHHHHHHHHHHHHh---hccCCHHHHHHHHHHhHHHHHHHHHHHHHHCCCCeEEEcHHHCceeecC
Confidence 9999999987766555555555555442 2356789999999999999999999999999999999999999999999
Q ss_pred CCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCcccc
Q 008693 235 DFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLT 314 (557)
Q Consensus 235 ~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~t 314 (557)
+|+++++...+.+++.+.+ +.+.|||++||+|.+ .+|++||||||||||||+++|.+|+|+++++|||||||||
T Consensus 153 ~~~~a~~~~~~~~~~~~~~-----~~~~v~Vv~Gf~g~~-~~G~~ttLgRggSD~tAal~A~~l~A~~v~i~tdVdGvyt 226 (288)
T cd04245 153 EPGNAQILPESYQKIKKLR-----DSDEKLVIPGFYGYS-KNGDIKTFSRGGSDITGAILARGFQADLYENFTDVDGIYA 226 (288)
T ss_pred CccccccchhhHHHHHHHH-----hCCCEEEEeCccccC-CCCCEEEcCCCchHHHHHHHHHHcCCCEEEEEeCCCceEC
Confidence 9999888666665554433 457899999999999 5899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEe
Q 008693 315 CDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (557)
Q Consensus 315 aDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (557)
+|||++|+|+++++|||+||.||+++|++||||+|+.||+++||||+|+|+++|+++||+|.
T Consensus 227 aDPr~v~~A~~i~~lsy~EA~ela~~GakVlhp~ai~~a~~~~Ipi~v~n~~~p~~~GT~I~ 288 (288)
T cd04245 227 ANPRIVANPKPISEMTYREMRELSYAGFSVFHDEALIPAIEAGIPINIKNTNHPEAPGTLIV 288 (288)
T ss_pred CCCCCCCCCeEeCccCHHHHHHHHHCCCcccCHHHHHHHHHCCCcEEEeeCCCCCCCCceeC
Confidence 99999999999999999999999999999999999999999999999999999999999984
No 19
>cd04258 AAK_AKiii-LysC-EC AAK_AKiii-LysC-EC: Amino Acid Kinase Superfamily (AAK), AKiii-LysC-EC: this CD includes the N-terminal catalytic aspartokinase (AK) domain of the lysine-sensitive aspartokinase isoenzyme AKIII. AKIII is a monofunctional class enzyme (LysC) found in some bacteria such as E. coli. Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. In E. coli, LysC is reported to be a homodimer of 50 kD subunits.
Probab=100.00 E-value=3.9e-66 Score=527.72 Aligned_cols=288 Identities=39% Similarity=0.559 Sum_probs=259.5
Q ss_pred eEEEEecccccCCHHHHHHHHHHHHcCCCCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHHHH
Q 008693 82 TCVMKFGGSSLASAERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVDE 161 (557)
Q Consensus 82 ~~V~KFGGsSv~~~~~~~~va~iI~~~~~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~~~ 161 (557)
|+|+|||||||+|++++++++++|... ++++|||||||+|+||.|+++++.+..+.. ..+...++.++++|.+++++
T Consensus 1 m~V~KFGGtSv~~~~~i~~v~~ii~~~-~~~~vVVVSA~~~vTd~L~~~~~~~~~~~~--~~~~~~l~~l~~~h~~~~~~ 77 (292)
T cd04258 1 MVVAKFGGTSVADYAAMLRCAAIVKSD-ASVRLVVVSASAGVTNLLVALADAAESGEE--IESIPQLHEIRAIHFAILNR 77 (292)
T ss_pred CEEEEECccccCCHHHHHHHHHHHhcc-CCCEEEEEeCCCCchHHHHHHHHHHhcCCc--chhhHHHHHHHHHHHHHHHH
Confidence 689999999999999999999999875 567899999999999999999887654321 23455799999999999999
Q ss_pred hCCCHH---HHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCC
Q 008693 162 LGIDRS---IIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTN 238 (557)
Q Consensus 162 l~~~~~---~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~ 238 (557)
|..+.+ .+...+++|+++++++.++++++++.+|+|+|+||++|+.+|+++|+++|+++.++|++++ ++|+++|++
T Consensus 78 L~~~~~~~~~i~~~~~~l~~~~~~~~~~~~~~~~~~d~i~s~GE~lSa~lla~~L~~~Gi~a~~ld~~~~-i~t~~~~~~ 156 (292)
T cd04258 78 LGAPEELRAKLEELLEELTQLAEGAALLGELSPASRDELLSFGERMSSLLFSEALREQGVPAEWFDVRTV-LRTDSRFGR 156 (292)
T ss_pred hhcchhHHHHHHHHHHHHHHHHhhhccccccChHhHhHhhhHHHHHHHHHHHHHHHhCCCCeEEEchHHe-EEecCCCcc
Confidence 987654 5888999999999999999999999999999999999999999999999999999999998 889999998
Q ss_pred ceeeecc-hHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCC
Q 008693 239 ADILEAT-YPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDP 317 (557)
Q Consensus 239 a~i~~~~-~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP 317 (557)
+++.... .+.+.+.+. .+ .++.|||+|||+|.+ .+|++|||||||||++|+++|.+|+|+++++|||||||||+||
T Consensus 157 a~~~~~~~~~~~~~~~~-~~-~~~~v~Vv~Gf~g~~-~~G~~ttLGrggsD~~a~~~a~~l~a~~~~i~tdv~Gv~~~dP 233 (292)
T cd04258 157 AAPDLNALAELAAKLLK-PL-LAGTVVVTQGFIGST-EKGRTTTLGRGGSDYSAALLAEALHAEELQIWTDVAGIYTTDP 233 (292)
T ss_pred ccccHHHHHHHHHHHHH-Hh-hcCCEEEECCccccC-CCCCEEecCCCchHHHHHHHHHHcCCCEEEEEECCCccCCCCC
Confidence 8875433 333443333 22 355899999999998 5899999999999999999999999999999999999999999
Q ss_pred CCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEe
Q 008693 318 NIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (557)
Q Consensus 318 ~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (557)
+++|+|+++++|||+||.||+++|++|+||+|+.|+++++|||+|+|+++|+++||+|+
T Consensus 234 ~~~~~a~~i~~isy~Ea~ela~~Gakvlhp~a~~~~~~~~ipi~i~~~~~p~~~GT~I~ 292 (292)
T cd04258 234 RICPAARAIKEISFAEAAEMATFGAKVLHPATLLPAIRKNIPVFVGSSKDPEAGGTLIT 292 (292)
T ss_pred CCCCCCeEeceeCHHHHHHHHHCCCcccCHHHHHHHHHcCCcEEEEeCCCCCCCCceeC
Confidence 99999999999999999999999999999999999999999999999999999999995
No 20
>cd04244 AAK_AK-LysC-like AAK_AK-LysC-like: Amino Acid Kinase Superfamily (AAK), AK-LysC-like; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the lysine-sensitive AK isoenzyme found in higher plants. The lysine-sensitive AK isoenzyme is a monofunctional protein. It is involved in the overall regulation of the aspartate pathway and can be synergistically inhibited by S-adenosylmethionine. Also included in this CD is an uncharacterized LysC-like AK found in Euryarchaeota and some bacteria. AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP.
Probab=100.00 E-value=1.1e-65 Score=527.66 Aligned_cols=290 Identities=55% Similarity=0.830 Sum_probs=265.2
Q ss_pred EEEEecccccCCHHHHHHHHHHHHcC-CCCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHHHH
Q 008693 83 CVMKFGGSSLASAERMREVAELILSF-PNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVDE 161 (557)
Q Consensus 83 ~V~KFGGsSv~~~~~~~~va~iI~~~-~~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~~~ 161 (557)
+|+|||||||+|++++++++++|.+. .+++++||||||+|+||.|+++++.+.... ..++...++.++++|.+++++
T Consensus 2 ~V~KFGGtSv~~~~~~~~v~~iI~~~~~~~~~vvVvSA~~~iTd~L~~~~~~~~~~~--~~~~~~~l~~i~~~h~~~~~~ 79 (298)
T cd04244 2 LVMKFGGTSVGSAERIRHVADLVGTYAEGHEVVVVVSAMGGVTDRLLLAAEAAVSGR--IAGVKDFIEILRLRHIKAAKE 79 (298)
T ss_pred EEEEECcccCCCHHHHHHHHHHHHHhhcCCCEEEEEeCCCCcHHHHHHHHHHHhcCC--chhHHHHHHHHHHHHHHHHHH
Confidence 69999999999999999999999974 346889999999999999999887664321 235677899999999999999
Q ss_pred hCCCH------HHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecC
Q 008693 162 LGIDR------SIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDD 235 (557)
Q Consensus 162 l~~~~------~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~ 235 (557)
|..+. +.+++++++|+++++++..+++++++.+|+|+|+||++|+.||+++|+++|++++++++++++++|+++
T Consensus 80 l~~~~~~~~~~~~i~~~~~~l~~~~~~~~~~~~~~~~~~d~i~s~GE~lSa~lla~~L~~~Gi~a~~l~~~~~~i~t~~~ 159 (298)
T cd04244 80 AISDEEIAEVESIIDSLLEELEKLLYGIAYLGELTPRSRDYIVSFGERLSAPIFSAALRSLGIKARALDGGEAGIITDDN 159 (298)
T ss_pred hhcchhhHHHHHHHHHHHHHHHHHHHHHHhhhcCCchHhhHhccHhHHHHHHHHHHHHHhCCCCeEEEcHHHcceeecCc
Confidence 98653 468899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccC
Q 008693 236 FTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTC 315 (557)
Q Consensus 236 ~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~ta 315 (557)
++++.+...+..++++.+.. +++.+.|||++||+|.+ .+|+++||||||||++|+++|.+|+|+++++||||||||++
T Consensus 160 ~~~a~~~~~~~~~i~~~l~~-ll~~~~vpVv~Gfig~~-~~g~~ttlgRggsD~~A~~~A~~l~a~~l~i~tdV~Gv~~~ 237 (298)
T cd04244 160 FGNARPLPATYERVRKRLLP-MLEDGKIPVVTGFIGAT-EDGAITTLGRGGSDYSATIIGAALDADEIWIWKDVDGVMTA 237 (298)
T ss_pred ccccccchhHHHHHHHHHHH-HhhcCCEEEEeCccccC-CCCCEEEecCCChHHHHHHHHHHcCCCEEEEEECCCCCCCC
Confidence 88877665566777776653 46778999999999998 58999999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEe
Q 008693 316 DPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (557)
Q Consensus 316 DP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (557)
||+++|+|+++++|||+||.+|+++|++|+||+|+.||+++|||++|+|+++|+++||+|+
T Consensus 238 dP~~~~~a~~i~~lsy~Ea~el~~~Ga~vlhp~ai~~a~~~~Ipi~i~n~~~p~~~GT~I~ 298 (298)
T cd04244 238 DPRIVPEARTIPRLSYAEAMELAYFGAKVLHPRTVEPAMEKGIPVRVKNTFNPEAPGTLIT 298 (298)
T ss_pred CCCCCCCCeEcCccCHHHHHHHHhCCCcccCHHHHHHHHHcCCcEEEeeCCCCCCCCCEeC
Confidence 9999999999999999999999999999999999999999999999999999999999995
No 21
>cd04257 AAK_AK-HSDH AAK_AK-HSDH: Amino Acid Kinase Superfamily (AAK), AK-HSDH; this CD includes the N-terminal catalytic domain of aspartokinase (AK) of the bifunctional enzyme AK - homoserine dehydrogenase (HSDH). These aspartokinases are found in bacteria (E. coli AKI-HSDHI, ThrA and E. coli AKII-HSDHII, MetL) and higher plants (Z. mays AK-HSDH). AK and HSDH are the first and third enzymes in the biosynthetic pathway of the aspartate family of amino acids. AK catalyzes the phosphorylation of Asp to P-aspartyl phosphate. HSDH catalyzes the NADPH-dependent conversion of Asp 3-semialdehyde to homoserine. ThrA and MetL are involved in threonine and methionine biosynthesis, respectively. In E. coli, ThrA is subject to allosteric regulation by the end product L-threonine and the native enzyme is reported to be tetrameric. As with bacteria, plant AK and HSDH are feedback inhibited by pathway end products. Maize AK-HSDH is a Thr-sensitive 180-kD enzyme. Arabidopsis AK-HSDH is an alanine-act
Probab=100.00 E-value=5.9e-65 Score=520.66 Aligned_cols=286 Identities=39% Similarity=0.619 Sum_probs=258.3
Q ss_pred eEEEEecccccCCHHHHHHHHHHHHcCC-CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHHH
Q 008693 82 TCVMKFGGSSLASAERMREVAELILSFP-NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVD 160 (557)
Q Consensus 82 ~~V~KFGGsSv~~~~~~~~va~iI~~~~-~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~~ 160 (557)
|+|+|||||||+|++++++++++|.... +.+++||||||+|+||.|+++++.+.+. +..+...++.++++|..+++
T Consensus 1 m~V~KFGGtSv~~~~~i~~v~~iI~~~~~~~~~vvVvSA~~gvTd~L~~~~~~~~~~---~~~~~~~l~~i~~~h~~~~~ 77 (294)
T cd04257 1 MKVLKFGGTSLANAERIRRVADIILNAAKQEQVAVVVSAPGKVTDLLLELAELASSG---DDAYEDILQELESKHLDLIT 77 (294)
T ss_pred CEEEEeCccccCCHHHHHHHHHHHHhhccCCCEEEEEcCCCCcHHHHHHHHHHHhcC---ChhHHHHHHHHHHHHHHHHH
Confidence 6899999999999999999999999753 4678999999999999999988866532 12356679999999999999
Q ss_pred HhCCCH------HHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEec
Q 008693 161 ELGIDR------SIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTD 234 (557)
Q Consensus 161 ~l~~~~------~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~ 234 (557)
+|..+. ..+++.+++|+++++++..+++++++.+|+|+|+||+||+.||+++|+++|+++.++|++++ ++|++
T Consensus 78 ~l~~~~~~~~~~~~i~~~~~~l~~~l~~~~~~~~~~~~~~d~ils~GE~lSa~lla~~L~~~Gi~a~~ld~~~~-i~t~~ 156 (294)
T cd04257 78 ELLSGDAAAELLSALGNDLEELKDLLEGIYLLGELPDSIRAKVLSFGERLSARLLSALLNQQGLDAAWIDAREL-IVTDG 156 (294)
T ss_pred HhhcchhhHHHHHHHHHHHHHHHHHHHHHHhhccCChhHhhhheeHHHHHHHHHHHHHHHhCCCCeEEEchHHe-eEecC
Confidence 997653 35888999999999999999999999999999999999999999999999999999999996 88998
Q ss_pred CCCCceeee-cchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccc
Q 008693 235 DFTNADILE-ATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVL 313 (557)
Q Consensus 235 ~~~~a~i~~-~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~ 313 (557)
+|+++.+.. .+.+.+++.+. ..+.|||++||+|.+ .+|++|||||||||++|+++|.+|+|+++++||||||||
T Consensus 157 ~~~~a~~~~~~~~~~l~~~~~----~~~~v~Vv~Gfig~~-~~G~~ttlGRGGSD~~A~~lA~~l~a~~l~i~tdVdGvy 231 (294)
T cd04257 157 GYLNAVVDIELSKERIKAWFS----SNGKVIVVTGFIASN-PQGETTTLGRNGSDYSAAILAALLDADQVEIWTDVDGVY 231 (294)
T ss_pred CCCceEechHhhHHHHHHHHh----cCCCEEEecCcccCC-CCCCEEECCCCchHHHHHHHHHHhCCCEEEEEeCCCccC
Confidence 999888753 33455544332 227899999999998 589999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEe
Q 008693 314 TCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (557)
Q Consensus 314 taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (557)
|+||+++|+|+++++|||+||.+|+++|++|+||+|+.||+++|||++|+|+++|+.+||+|+
T Consensus 232 t~DP~~~~~A~~i~~is~~ea~~l~~~Gakv~h~~~~~~a~~~~Ipi~i~~~~~p~~~GT~I~ 294 (294)
T cd04257 232 SADPRKVKDARLLPSLSYQEAMELSYFGAKVLHPKTIQPVAKKNIPILIKNTFNPEAPGTLIS 294 (294)
T ss_pred CCCCCCCCCCeEeceeCHHHHHHHHhCCCcccCHHHHHHHHHCCCCEEEeeCCCCCCCCCEeC
Confidence 999999999999999999999999999999999999999999999999999999999999995
No 22
>cd04243 AAK_AK-HSDH-like AAK_AK-HSDH-like: Amino Acid Kinase Superfamily (AAK), AK-HSDH-like; this family includes the N-terminal catalytic domain of aspartokinase (AK) of the bifunctional enzyme AK- homoserine dehydrogenase (HSDH). These aspartokinases are found in such bacteria as E. coli (AKI-HSDHI, ThrA and AKII-HSDHII, MetL) and in higher plants (Z. mays AK-HSDH). AK and HSDH are the first and third enzymes in the biosynthetic pathway of the aspartate family of amino acids. AK catalyzes the phosphorylation of Asp to P-aspartyl phosphate. HSDH catalyzes the NADPH-dependent conversion of Asp 3-semialdehyde to homoserine. ThrA and MetL are involved in threonine and methionine biosynthesis, respectively. In E. coli, ThrA is subject to allosteric regulation by the end product L-threonine and the native enzyme is reported to be tetrameric. As with bacteria, plant AK and HSDH are feedback inhibited by pathway end products. Maize AK-HSDH is a Thr-sensitive 180-kD enzyme. Arabidopsis AK-
Probab=100.00 E-value=1.8e-64 Score=516.86 Aligned_cols=285 Identities=40% Similarity=0.644 Sum_probs=256.6
Q ss_pred eEEEEecccccCCHHHHHHHHHHHHcCCCCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHHHH
Q 008693 82 TCVMKFGGSSLASAERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVDE 161 (557)
Q Consensus 82 ~~V~KFGGsSv~~~~~~~~va~iI~~~~~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~~~ 161 (557)
|+|+|||||||+|++++++++++|....+.+++||||||+|+||.|+++++.+.+.. ..+...++.++++|.+++++
T Consensus 1 m~V~KFGGtSv~~~~~i~~v~~iI~~~~~~~~vvVvSA~~gvTd~L~~~~~~a~~~~---~~~~~~l~~i~~~h~~~~~~ 77 (293)
T cd04243 1 MKVLKFGGTSVASAERIRRVADIIKSRASSPVLVVVSALGGVTNRLVALAELAASGD---DAQAIVLQEIRERHLDLIKE 77 (293)
T ss_pred CEEEEECccccCCHHHHHHHHHHHHHhcCCCEEEEEcCCCCcHHHHHHHHHHHhcCC---hhHHHHHHHHHHHHHHHHHH
Confidence 689999999999999999999999875456889999999999999999988765432 23444689999999999999
Q ss_pred hCCCHH------HHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecC
Q 008693 162 LGIDRS------IIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDD 235 (557)
Q Consensus 162 l~~~~~------~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~ 235 (557)
|..+.. .+..++++|+++++++.++++++++.+|+|+|+||+||+.||+++|+++|+++.++|++++ +++++.
T Consensus 78 L~~~~~~~~~~~~i~~~~~~l~~~l~~~~~~~~~s~~~~d~ils~GE~lSa~lla~~L~~~Gi~a~~ld~~~~-i~t~~~ 156 (293)
T cd04243 78 LLSGESAAELLAALDSLLERLKDLLEGIRLLGELSDKTRAEVLSFGELLSSRLMSAYLQEQGLPAAWLDAREL-LLTDDG 156 (293)
T ss_pred hhcchhhHHHHHHHHHHHHHHHHHHHhhhhhccCCchhhhHheeHHHHHHHHHHHHHHHhCCCCcEEEcHHHe-EEecCC
Confidence 987642 5888999999999999999999999999999999999999999999999999999999997 888888
Q ss_pred CCCceeeecc-hHHHHHHHhhchhcC-CceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccc
Q 008693 236 FTNADILEAT-YPAVAKRLHGDWITD-LAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVL 313 (557)
Q Consensus 236 ~~~a~i~~~~-~~~v~~~l~~~ll~~-~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~ 313 (557)
++++.+.... .+.++.. +.. +.|||++||+|.+ .+|++|||||||||++|+++|.+|+|+++++||||||||
T Consensus 157 ~~~~~~~~~~s~~~~~~~-----~~~~~~v~Vv~Gfig~~-~~G~~ttLGRggsD~~A~~~a~~l~a~~~~i~tdvdGiy 230 (293)
T cd04243 157 FLNAVVDLKLSKERLAQL-----LAEHGKVVVTQGFIASN-EDGETTTLGRGGSDYSAALLAALLDAEEVEIWTDVDGVY 230 (293)
T ss_pred CCcchhhhHHHHHHHHHH-----HhcCCCEEEecCccccC-CCCCEEEeCCCCcHHHHHHHHHHcCCCEEEEEeCCCccC
Confidence 8887764332 3333332 233 7899999999998 589999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEe
Q 008693 314 TCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (557)
Q Consensus 314 taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (557)
|+||+++|+|+++++|||+||.+|+++|++++||+|+.||+++|||++|+|+++|+.+||+|+
T Consensus 231 t~dP~~~~~a~~i~~ls~~ea~~l~~~Gakvl~p~ai~~a~~~~i~i~i~~~~~p~~~GT~I~ 293 (293)
T cd04243 231 TADPRKVPDARLLKELSYDEAMELAYFGAKVLHPRTIQPAIRKNIPIFIKNTFNPEAPGTLIS 293 (293)
T ss_pred CCCCCCCCCCeEeceeCHHHHHHHHhCCCcccCHHHHHHHHHCCCcEEEecCCCCCCCCCEeC
Confidence 999999999999999999999999999999999999999999999999999999999999995
No 23
>cd04259 AAK_AK-DapDC AAK_AK-DapDC: Amino Acid Kinase Superfamily (AAK), AK-DapDC; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the bifunctional enzyme AK - DAP decarboxylase (DapDC) found in some bacteria. Aspartokinase is the first enzyme in the aspartate metabolic pathway, catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. DapDC, which is the lysA gene product, catalyzes the decarboxylation of DAP to lysine.
Probab=100.00 E-value=1.9e-64 Score=516.79 Aligned_cols=284 Identities=34% Similarity=0.550 Sum_probs=253.1
Q ss_pred eEEEEecccccCCHHHHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHH
Q 008693 82 TCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTV 159 (557)
Q Consensus 82 ~~V~KFGGsSv~~~~~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~ 159 (557)
|+|+|||||||+|++++++++++|.... +++++||||||+|+||.|+++++.+.. ..+...++.+.++|.+++
T Consensus 1 ~~V~KFGGtSv~~~~~~~~v~~ii~~~~~~~~~~vVVVSA~~gvTd~L~~~~~~a~~-----~~~~~~l~~i~~~~~~~~ 75 (295)
T cd04259 1 WVVLKFGGTSVSSRARWDTIAKLAQKHLNTGGQPLIVCSALSGISNKLEALIDQALL-----DEHHSLFNAIQSRHLNLA 75 (295)
T ss_pred CEEEEeCccccCCHHHHHHHHHHHHHHhhcCCCEEEEEeCCCCCchHHHHHHHHHhc-----cChHHHHHHHHHHHHHHH
Confidence 6899999999999999999999998642 457899999999999999998876543 225667999999999999
Q ss_pred HHhCCCH-HHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCC
Q 008693 160 DELGIDR-SIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTN 238 (557)
Q Consensus 160 ~~l~~~~-~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~ 238 (557)
++|..+. ..+++.+++|+++++++.++++++++.+|+|+|+||++|+.||+++|+++|+++.++|++++ +++++++++
T Consensus 76 ~~L~~~~~~~i~~~~~~l~~~l~~~~~~~~~~~~~~d~i~s~GE~lSa~lla~~L~~~Gi~a~~ld~~~~-i~~~~~~~~ 154 (295)
T cd04259 76 EQLEVDADALLANDLAQLQRWLTGISLLKQASPRTRAEVLALGELMSTRLGAAYLEAQGLKVKWLDAREL-LTATPTLGG 154 (295)
T ss_pred HHhhhhhhhHHHHHHHHHHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHHHHHHHhCCCCeEEEcHHHh-eeecccccc
Confidence 9998654 36889999999999999999999999999999999999999999999999999999999998 777777754
Q ss_pred c-------eee-ecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCC
Q 008693 239 A-------DIL-EATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVD 310 (557)
Q Consensus 239 a-------~i~-~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVd 310 (557)
+ ++. +.+..++.+.+. ..+.|||+|||+|.+ .+|++|||||||||++|+++|.+|+|+++++|||||
T Consensus 155 ~~~~~~~a~v~~~~~~~~l~~~l~----~~~~v~Vv~GFig~~-~~G~~ttLGrggsD~tA~~lA~~l~A~~l~i~TdV~ 229 (295)
T cd04259 155 ETMNYLSARCESEYADALLQKRLA----DGAQLIITQGFIARN-AHGETVLLGRGGSDTSAAYFAAKLQAARCEIWTDVP 229 (295)
T ss_pred cccccccceehhhhhHHHHHHHHh----cCCceeEeCCceeeC-CCCCEEEECCCChHHHHHHHHHHcCCCEEEEEECCC
Confidence 3 331 223334443332 235799999999999 589999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEe
Q 008693 311 GVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (557)
Q Consensus 311 GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (557)
||||+||+.+|+|+++++|||+||.+|+++|++++||+|++||+++|||++|+|+++|+++||+|+
T Consensus 230 Gvyt~DP~~~~~a~~i~~ls~~ea~~l~~~Ga~v~h~~a~~~a~~~~ipi~i~~~~~p~~~GT~I~ 295 (295)
T cd04259 230 GLFTANPHEVPHARLLKRLDYDEAQEIATMGAKVLHPRCIPPARRANIPMVVRSTERPELSGTLIT 295 (295)
T ss_pred ccccCCCCCCCCCeEeceeCHHHHHHHHHcCCcccCHHHHHHHHHCCCCEEEEeCCCCCCCCcEeC
Confidence 999999999999999999999999999999999999999999999999999999999999999995
No 24
>cd04247 AAK_AK-Hom3 AAK_AK-Hom3: Amino Acid Kinase Superfamily (AAK), AK-Hom3; this CD includes the N-terminal catalytic domain of the aspartokinase HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae and other related AK domains. Aspartokinase, the first enzyme in the aspartate metabolic pathway, catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and in fungi, is responsible for the production of threonine, isoleucine and methionine. S. cerevisiae has a single aspartokinase isoenzyme type, which is regulated by feedback, allosteric inhibition by L-threonine. Recent studies show that the allosteric transition triggered by binding of threonine to AK involves a large change in the conformation of the native hexameric enzyme that is converted to an inactive one of different shape and substantially smaller hydrodynamic size.
Probab=100.00 E-value=2.1e-64 Score=517.21 Aligned_cols=288 Identities=32% Similarity=0.500 Sum_probs=246.1
Q ss_pred eEEEEecccccCCHHHHHHHHHHHHcC--CCCccEEEEcCCC------cCcHHHHHhhHHhhhcCCCcchhhHHHHHHHH
Q 008693 82 TCVMKFGGSSLASAERMREVAELILSF--PNERPVIVLSAMG------KTTNKLLLAGEKAVSCGVTNISCIDELSFVKD 153 (557)
Q Consensus 82 ~~V~KFGGsSv~~~~~~~~va~iI~~~--~~~~~vvVVSA~g------g~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~ 153 (557)
|+|+|||||||+|++ ++++++|... .+.+++||||||+ |+||.|+++++.+..+. ..++.+.++.+++
T Consensus 2 ~~V~KFGGtSv~~~~--~~v~~~i~~~~~~~~~~vVVvSA~~~~~~~~gvTd~L~~~~~~a~~~~--~~~~~~~l~~i~~ 77 (306)
T cd04247 2 WVVQKFGGTSVGKFP--DNIADDIVKAYLKGNKVAVVCSARSTGTKAEGTTNRLLQAADEALDAQ--EKAFHDIVEDIRS 77 (306)
T ss_pred CEEEEeCchhhccHH--HHHHHHHHhhhccCCceEEEEeccccCCCccChHHHHHHHHHHHHhhc--cccHHHHHHHHHH
Confidence 689999999999984 7999866642 2457899999998 99999999988764321 2467888999999
Q ss_pred HHHHHHHHhCCCH-------HHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccc
Q 008693 154 LHHRTVDELGIDR-------SIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAF 226 (557)
Q Consensus 154 ~~~~~~~~l~~~~-------~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~ 226 (557)
+|.+++++|..+. ..+++.+++|++++.++.++++++++.+|+|+|+||+||+.||+.+|+++|+++.++|++
T Consensus 78 ~h~~~~~~L~~~~~~~~~~~~~i~~~~~~l~~~l~~~~~l~~~~~~~~d~i~s~GE~lSa~l~a~~L~~~Gi~a~~ld~~ 157 (306)
T cd04247 78 DHLAAARKFIKNPELQAELEEEINKECELLRKYLEAAKILSEISPRTKDLVISTGEKLSCRFMAAVLRDRGVDAEYVDLS 157 (306)
T ss_pred HHHHHHHHhccChhhHHHHHHHHHHHHHHHHHHHHHHHhhhhcchHHHHHHhhHHHHHHHHHHHHHHHhCCCCeEEEcHH
Confidence 9999999997653 247788999999999999999999999999999999999999999999999999999999
Q ss_pred eeEEEEecCCCCceeeecchHHHHHHHhhchhc-CCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEE
Q 008693 227 DIGFITTDDFTNADILEATYPAVAKRLHGDWIT-DLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQV 305 (557)
Q Consensus 227 ~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~-~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i 305 (557)
++ +.++.. ...+.......+.+.+...+.+ .+.|||+|||+|.+ .+|++||||||||||+|+++|.+|+|+++++
T Consensus 158 ~~-i~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~v~Vv~GFig~~-~~G~~ttLGRgGsD~~A~~la~~l~a~~v~i 233 (306)
T cd04247 158 HI-VDLDFS--IEALDQTFYDELAQVLGEKITACENRVPVVTGFFGNV-PGGLLSQIGRGYTDLCAALCAVGLNADELQI 233 (306)
T ss_pred Hh-eecCCC--ccccccchhHHHHHHHHHHhhccCCceEEeeccEecC-CCCCeEEeCCCchHHHHHHHHHHcCCCEEEE
Confidence 96 444332 1111111112233333332222 46799999999998 5899999999999999999999999999999
Q ss_pred eeCCCccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEec
Q 008693 306 WKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRR 377 (557)
Q Consensus 306 ~TDVdGV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~ 377 (557)
|||||||||+||+++|+|++|++|||+||.||+++|++||||+|++||+++||||+|+|+|+|+++||+|.+
T Consensus 234 ~tdVdGvyt~DP~~~~~a~~i~~is~~ea~el~~~GakVlHp~ti~pa~~~~Ipi~i~nt~~P~~~GT~I~~ 305 (306)
T cd04247 234 WKEVDGIFTADPRKVPTARLLPSITPEEAAELTYYGSEVIHPFTMEQVIKARIPIRIKNVENPRGEGTVIYP 305 (306)
T ss_pred eecCCeeECCCCCCCCCCeEecccCHHHHHHHHhCcCcccCHHHHHHHHHcCCcEEEecCCCCCCCCcEEcC
Confidence 999999999999999999999999999999999999999999999999999999999999999999999975
No 25
>PRK08373 aspartate kinase; Validated
Probab=100.00 E-value=1.4e-60 Score=495.11 Aligned_cols=322 Identities=30% Similarity=0.466 Sum_probs=266.3
Q ss_pred ceEEEEecccccCCHHHHHHHHHHHHcC-CCCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHH
Q 008693 81 LTCVMKFGGSSLASAERMREVAELILSF-PNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTV 159 (557)
Q Consensus 81 ~~~V~KFGGsSv~~~~~~~~va~iI~~~-~~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~ 159 (557)
+|+|+|||||||++ ++++++++|... .+++++||||||+|+||.|+++++.+ ....++.++++|.+++
T Consensus 4 ~m~V~KFGGsSv~~--~~~~v~~ii~~~~~~~~vvVVVSA~~gvTd~L~~l~~~~---------~~~~l~~i~~~h~~~~ 72 (341)
T PRK08373 4 KMIVVKFGGSSVRY--DFEEALELVKYLSEENEVVVVVSALKGVTDKLLKLAETF---------DKEALEEIEEIHEEFA 72 (341)
T ss_pred CCEEEEECCcchHh--HHHHHHHHHHHHhcCCCEEEEecCCchHHHHHHHHHHHH---------hHHHHHHHHHHHHHHH
Confidence 57999999999998 599999999853 24678999999999999999987643 1456889999999999
Q ss_pred HHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCc
Q 008693 160 DELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNA 239 (557)
Q Consensus 160 ~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a 239 (557)
++|+.+.. .+.++|++.++.+..+ ++++.+|+|+|+||++|+.+++.+|+++|+++.+++++++ +.|++.|+++
T Consensus 73 ~~L~~~~~---~~~~~l~~~~~~~~~~--~~~~~~D~ils~GE~lSa~lla~~L~~~Gi~a~~l~~~~~-i~t~~~~~~a 146 (341)
T PRK08373 73 KRLGIDLE---ILSPYLKKLFNSRPDL--PSEALRDYILSFGERLSAVLFAEALENEGIKGKVVDPWEI-LEAKGSFGNA 146 (341)
T ss_pred HHhccchh---hHHHHHHHHHHHhhcc--CChHHHHHHHHHHHHHHHHHHHHHHHHCCCceEEEeHHHh-eeecCCccce
Confidence 99987643 3445566666543322 3578899999999999999999999999999999999998 8888889888
Q ss_pred eeeec-chHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCC
Q 008693 240 DILEA-TYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPN 318 (557)
Q Consensus 240 ~i~~~-~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~ 318 (557)
++... +...+ +.+. .+++.+.|||++||+| + .+|.++||||||||++|+++|.+|+|+++++|||||||||+||+
T Consensus 147 ~i~~~~s~~~~-~~l~-~~l~~g~VpVv~Gf~g-~-~~G~~ttLGRGGSD~tA~~lA~~L~A~~v~i~TDVdGVytaDP~ 222 (341)
T PRK08373 147 FIDIKKSKRNV-KILY-ELLERGRVPVVPGFIG-N-LNGFRATLGRGGSDYSAVALGVLLNAKAVLIMSDVEGIYTADPK 222 (341)
T ss_pred eechhhhhhhH-HHHH-HHHhCCcEEEEeCCcc-C-CCCeEEEcCCCchHHHHHHHHHHcCCCEEEEEECCCccCCCCCC
Confidence 87321 11112 2233 3457889999999999 7 58999999999999999999999999999999999999999999
Q ss_pred CCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCCCCcceeeEEeeeccEEEE
Q 008693 319 IHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSIVLKRNVTML 398 (557)
Q Consensus 319 ~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~Vt~Is~~~nialI 398 (557)
++|+|+++++|||+||.+|+++|++++||+|++||++ |||++|+|+|+| .+||+|++..+ ....++++ +.+|.+.|
T Consensus 223 ~v~~A~~i~~isy~Ea~ela~~Gakvlhp~ai~~a~~-~Ipi~v~~t~~~-~~GT~I~~~~~-~~~~~~~~-~~~~~~~i 298 (341)
T PRK08373 223 LVPSARLIPYLSYDEALIAAKLGMKALHWKAIEPVKG-KIPIIFGRTRDW-RMGTLVSNESS-GMPILVHK-VGEEHAEI 298 (341)
T ss_pred CCCCCeEcccCCHHHHHHHHHCcChhhhHHHHHHHHc-CCcEEEecCCCC-CCCcEEecCCC-CCceEEEE-ecCCEEEE
Confidence 9999999999999999999999999999999999999 999999999998 58999987543 33568888 89999999
Q ss_pred EEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCch
Q 008693 399 DIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSK 444 (557)
Q Consensus 399 tI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~ 444 (557)
++.+. ...+++ . .+.-++..+.+.+++++
T Consensus 299 ~~~~~--~~~~~~-------------~--~~~~~~~~~~~~~~~~~ 327 (341)
T PRK08373 299 LVVGV--EEEIGY-------------P--VYEEGEFWFKIKVPKEE 327 (341)
T ss_pred EEecc--CCCCCC-------------C--ceecCCceEEEecCHHH
Confidence 99852 222321 1 23445667777777654
No 26
>TIGR02078 AspKin_pair Pyrococcus aspartate kinase subunit, putative. This family consists of proteins restricted to and found as paralogous pairs (typically close together) in species of Pyrococcus, a hyperthermophilic archaeal genus. Members are always found close to other genes of threonine biosynthesis and appear to represent the Pyrococcal form of aspartate kinase. Alignment to aspartokinase III from E. coli shows that 300 N-terminal and 20 C-terminal amino acids are homologous, but the form in Pyrococcus lacks ~ 100 amino acids in between.
Probab=100.00 E-value=8.1e-58 Score=472.08 Aligned_cols=289 Identities=31% Similarity=0.470 Sum_probs=244.7
Q ss_pred eEEEEecccccCCHHHHHHHHHHHHcCC-CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHHH
Q 008693 82 TCVMKFGGSSLASAERMREVAELILSFP-NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVD 160 (557)
Q Consensus 82 ~~V~KFGGsSv~~~~~~~~va~iI~~~~-~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~~ 160 (557)
|+|+|||||||+++ +++++++|.... +.+++||||||+|+||.|+++++.+ ....++.++++|.++++
T Consensus 1 m~V~KFGGsSv~~~--~~~v~~ii~~~~~~~~~vVVVSA~~gvTd~L~~~~~~~---------~~~~l~~i~~~h~~~~~ 69 (327)
T TIGR02078 1 MIVVKFGGSSVRYA--FEEALELVKSLSEEKRVIVVVSALKGITDCLIRYANTF---------DKSAALEIEEIYEEFAK 69 (327)
T ss_pred CEEEEECCcchHHH--HHHHHHHHHHHhcCCCEEEEeCCCcchHHHHHHHHHHH---------HHHHHHHHHHHHHHHHH
Confidence 58999999999986 999999998643 4578999999999999999976421 13568899999999999
Q ss_pred HhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCce
Q 008693 161 ELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNAD 240 (557)
Q Consensus 161 ~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~ 240 (557)
+|+.+...+.+.++++.+. .. -+++..+|+|+|+||++|+.|++. |+++.+++++++ ++|++.|+++.
T Consensus 70 ~L~~~~~~~~~~l~~~~~~---~~---l~~~~~~d~I~s~GE~lSa~Lla~-----gi~a~~vd~~~~-i~t~~~~~~a~ 137 (327)
T TIGR02078 70 ELGVDLNILSPYLKELFNP---PD---LPKEALRDYILSLGERLSAVIFAE-----GINGKVVDPWDI-FFAKGDFGNAF 137 (327)
T ss_pred HhccchhhhHHHHHHHHhh---hc---cCChHHHHHHHHHHHHHHHHHHHc-----cCCcEEEcHHHH-hccCCcCCcee
Confidence 9998765555555555443 11 245678999999999999999986 899999999998 88888999888
Q ss_pred ee-ecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCC
Q 008693 241 IL-EATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNI 319 (557)
Q Consensus 241 i~-~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~ 319 (557)
+. +....+++. +. .+++.+.|||++||+| + .+|.++|+||||||++|+++|.+|+|+++++|||||||||+||++
T Consensus 138 ~~~~~~~~~~~~-l~-~~l~~g~IpVv~Gf~~-~-~~G~~ttlGRGgSD~~Aa~lA~~L~A~~v~i~TDVdGVytaDP~~ 213 (327)
T TIGR02078 138 IDIKKSKRNAKI-LY-EVLESGKIPVIPGFYG-N-LNGYRVTLGRGGSDYSAVALGVLLNSKLVAIMSDVEGIFTADPKL 213 (327)
T ss_pred echhhhHhhHHH-HH-HHHhCCcEEEEeCCcc-C-CCCeEEEcCCCChHHHHHHHHHhcCCCEEEEEECCCccCCCCCCc
Confidence 75 222222322 32 2356788999999999 7 489999999999999999999999999999999999999999999
Q ss_pred CCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCCCCcceeeEEeeecc-EEEE
Q 008693 320 HPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSIVLKRN-VTML 398 (557)
Q Consensus 320 v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~Vt~Is~~~n-ialI 398 (557)
+|+|++++++||+||.+++++|++++||+|++||+++|||++|+|+++|+ +||+|+...+. ...|+++++ +++|
T Consensus 214 v~~A~~i~~lsy~Ea~ela~~Gakvlhp~a~~~a~~~~Ipi~I~~t~~~~-~GT~I~~~~~~----~~~i~~~~~~i~~v 288 (327)
T TIGR02078 214 VPSARLIPYLSYEEIKIAAKLGMKALQWKAADLAKEYKIPVLFGRTRDWR-MGTLISNRSSG----MPLMVYKDGELLVV 288 (327)
T ss_pred CCCceEccccCHHHHHHHHHCCchhhHHHHHHHHHHCCCeEEEEeCCCcC-CCcEEecCCCC----CcEEEEccCcEEEE
Confidence 99999999999999999999999999999999999999999999999997 89999875432 445888999 9999
Q ss_pred EEEe
Q 008693 399 DIVS 402 (557)
Q Consensus 399 tI~~ 402 (557)
.+..
T Consensus 289 ~~~~ 292 (327)
T TIGR02078 289 NVRR 292 (327)
T ss_pred EEee
Confidence 9853
No 27
>cd04248 AAK_AK-Ectoine AAK_AK-Ectoine: Amino Acid Kinase Superfamily (AAK), AK-Ectoine; this CD includes the N-terminal catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway found in Methylomicrobium alcaliphilum, Vibrio cholerae, and other various halotolerant or halophilic bacteria. Bacteria exposed to hyperosmotic stress accumulate organic solutes called 'compatible solutes' of which ectoine, a heterocyclic amino acid, is one. Apart from its osmotic function, ectoine also exhibits a protective effect on proteins, nucleic acids and membranes against a variety of stress factors. de novo synthesis of ectoine starts with the phosphorylation of L-aspartate and shares its first two enzymatic steps with the biosynthesis of amino acids of the aspartate family: aspartokinase and L-aspartate-semialdehyde dehydrogenase. The M. alcaliphilum and the V. cholerae aspartokinases are encoded on the ectABCask operon.
Probab=100.00 E-value=5.1e-58 Score=464.30 Aligned_cols=279 Identities=27% Similarity=0.390 Sum_probs=224.2
Q ss_pred EEEEecccccCCHHHHHHHHHHHHcCCC--CccEEEEcCCCcCcHHHHHhhHHh---hhcC--CCcchhhHHHHHHHHHH
Q 008693 83 CVMKFGGSSLASAERMREVAELILSFPN--ERPVIVLSAMGKTTNKLLLAGEKA---VSCG--VTNISCIDELSFVKDLH 155 (557)
Q Consensus 83 ~V~KFGGsSv~~~~~~~~va~iI~~~~~--~~~vvVVSA~gg~Td~L~~~~~~a---~~~~--~~~~~~~~~l~~i~~~~ 155 (557)
.|+|||||||++.+.++. ++|..... ..+|+||||++|+||.|++.-+.. +... ..+..|.+.|+.++++|
T Consensus 2 ~V~K~GGTSms~~~~~~d--~i~~~~~~~~~~rv~VVSA~~gvT~~Lle~k~t~~~gv~~~~~~~~~~~~~al~~~~~~~ 79 (304)
T cd04248 2 TVEKIGGTSMSAFGAVLD--NIILKPDSDLYGRVFVVSAYSGVTNALLEHKKTGAPGIYQHFVDADEAWREALSALKQAM 79 (304)
T ss_pred ceeeecCcccccHHHHhh--hHhcCCcccCccEEEEEECCccchHHHHHhhhcCCcchhHHHhcCchHHHHHHHHHHHHH
Confidence 699999999999988888 66663222 358999999999999999731110 0000 12244788899999999
Q ss_pred HHHHHHhCCC------H-HHHHHHH-------HHHHHHH-HhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCce
Q 008693 156 HRTVDELGID------R-SIIATHL-------EELEQLL-KGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKA 220 (557)
Q Consensus 156 ~~~~~~l~~~------~-~~i~~~~-------~~l~~~l-~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a 220 (557)
.++..+|..+ . +++.+.+ .++.+++ .|+..+++++++.+|+|+|+||++|+.+++.+|+++|++|
T Consensus 80 ~~~~~~l~~~~~~~~~a~~~i~~r~~~~~~~l~~~~~~~~~g~~~l~e~~~~~rd~l~S~GE~~Sa~l~a~~L~~~Gi~A 159 (304)
T cd04248 80 LKINEAFADIGLDVEQADAFIGARIQDARACLHDLARLCSSGYFSLAEHLLAARELLASLGEAHSAFNTALLLQNRGVNA 159 (304)
T ss_pred HHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHhhCCHHHHHHHhhhCHHHHHHHHHHHHHHCCCCe
Confidence 8888777643 1 2344443 3344444 5778889999999999999999999999999999999999
Q ss_pred EEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCc
Q 008693 221 RQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGL 300 (557)
Q Consensus 221 ~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A 300 (557)
+++|...+ ...+.+. ....+.+.+.. +...+.|||+|||.+ + .+|+++|||||||||||+++|++|+|
T Consensus 160 ~~vD~~~~--~~~~~~t-------~~~~i~~~~~~-~~~~~~v~IvtGF~~-~-~~G~itTLGRGGSDyTAs~iAa~l~A 227 (304)
T cd04248 160 RFVDLSGW--RDSGDMT-------LDERISEAFRD-IDPRDELPIVTGYAK-C-AEGLMREFDRGYSEMTFSRIAVLTGA 227 (304)
T ss_pred EEECcccc--cccCCCC-------cHHHHHHHHHh-hccCCcEEEeCCccC-C-CCCCEEEcCCCcHHHHHHHHHHHcCC
Confidence 99887653 2112211 12344444432 233567999999954 5 48999999999999999999999999
Q ss_pred CcEEEeeCCCccccCCCCCC--CCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEe
Q 008693 301 QEIQVWKDVDGVLTCDPNIH--PHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (557)
Q Consensus 301 ~~l~i~TDVdGV~taDP~~v--~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (557)
++++|||||+ |||+|||+| |+|++|++|||+||.||+++|++||||+|++||+++||||+|+|+|+|+++||+|+
T Consensus 228 ~ev~I~TDV~-i~taDPriV~~~~A~~i~~lsY~EA~ELA~~GakvLHP~ai~pa~~~~IPi~Vkntf~P~~~GTlIt 304 (304)
T cd04248 228 SEAIIHKEFH-LSSADPKLVGEDKARPIGRTNYDVADQLANLGMEAIHPKAAKGLRQAGIPLRVKNTFEPDHPGTLIT 304 (304)
T ss_pred CEEEEECCCc-eecCCCCccCCCCceEeCccCHHHHHHHHHcChhhcCHHHHHHHHHcCCeEEEecCCCCCCCCceeC
Confidence 9999999996 999999999 68999999999999999999999999999999999999999999999999999995
No 28
>cd04261 AAK_AKii-LysC-BS AAK_AKii-LysC-BS: Amino Acid Kinase Superfamily (AAK), AKii; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, and related sequences. In B. subtilis 168, the regulation of the diaminopimelate (Dap)-lysine biosynthetic pathway involves dual control by Dap and lysine, effected through separate Dap- and lysine-sensitive aspartokinase isoenzymes. The B. subtilis 168 AKII is induced by methionine, and repressed and inhibited by lysine. Although Corynebacterium glutamicum is known to contain a single aspartokinase isoenzyme type, both the succinylase and dehydrogenase variant pathways of DAP-lysine synthesis operate simultaneously in this organism. In this organism and other various Gram-positive bacteria, the DAP-lysine pathway is feedback regulated by the concerted action of lysine and
Probab=100.00 E-value=3.8e-47 Score=379.99 Aligned_cols=237 Identities=38% Similarity=0.607 Sum_probs=211.0
Q ss_pred eEEEEecccccCCHHHHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHH
Q 008693 82 TCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTV 159 (557)
Q Consensus 82 ~~V~KFGGsSv~~~~~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~ 159 (557)
++|+||||+++.|++.++++++.|.... +.++++|+||+++.|++|++......
T Consensus 1 ~iViK~GGs~l~~~~~~~~~~~~i~~l~~~g~~~vvV~sg~g~~~~~l~~~~~~~~------------------------ 56 (239)
T cd04261 1 LIVQKFGGTSVASIERIKRVAERIKKRKKKGNQVVVVVSAMGGTTDELIELAKEIS------------------------ 56 (239)
T ss_pred CEEEEECCcccCCHHHHHHHHHHHHHHHHcCCCEEEEECCCCchhHHHHHHHHHhc------------------------
Confidence 4799999999999999999999998743 45789999999999999987532110
Q ss_pred HHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCc
Q 008693 160 DELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNA 239 (557)
Q Consensus 160 ~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a 239 (557)
+..+.+.+|.++++||++|+.+++++|+++|++++++++.++++++.++|+.+
T Consensus 57 ---------------------------~~~~~~~~~~i~a~Ge~~~~~l~~~~l~~~g~~a~~l~~~~~~l~~~~~~~~~ 109 (239)
T cd04261 57 ---------------------------PRPPARELDVLLSTGEQVSIALLAMALNRLGIKAISLTGWQAGILTDGHHGKA 109 (239)
T ss_pred ---------------------------cCCCHHHHHHHHHHHHHHHHHHHHHHHHhCCCCeEEechhhCCEEecCCCCcc
Confidence 12345677889999999999999999999999999999999989998888777
Q ss_pred eeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCC
Q 008693 240 DILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNI 319 (557)
Q Consensus 240 ~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~ 319 (557)
++...+.+.+.+ +++++.|||++||+|.+ .+|.++++|||++|++|+++|.+|+|+++++||||||||++||+.
T Consensus 110 ~i~~~~~~~l~~-----ll~~~~ipVi~G~~~~~-~~g~~~~l~rg~sD~~A~~lA~~l~A~~lii~tdV~GVy~~dP~~ 183 (239)
T cd04261 110 RIIDIDPDRIRE-----LLEEGDVVIVAGFQGIN-EDGDITTLGRGGSDTSAVALAAALGADRCEIYTDVDGVYTADPRI 183 (239)
T ss_pred eechhhHHHHHH-----HHHcCCeEEEcCccccC-CCCCEEecCCCChHHHHHHHHHHcCCCEEEEEeCCCCCCCCCCCC
Confidence 775555443332 35678999999999999 589999999999999999999999999999999999999999999
Q ss_pred CCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEe
Q 008693 320 HPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (557)
Q Consensus 320 v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (557)
+|+++++++|+|+|+.+|+++|++++||+|++||+++|||++|+|+++|+ +||+|+
T Consensus 184 ~~~a~~i~~i~~~ea~~l~~~G~~~~~~~a~~~~~~~~i~i~I~n~~~~~-~gt~i~ 239 (239)
T cd04261 184 VPKARKLDEISYDEMLEMASLGAKVLHPRSVELAKKYGVPLRVLSSFSEE-PGTLIT 239 (239)
T ss_pred CCCceEccccCHHHHHHHHhccccccCHHHHHHHHHcCCeEEEecCCCCC-CCcEeC
Confidence 99999999999999999999999999999999999999999999999999 999995
No 29
>cd04234 AAK_AK AAK_AK: Amino Acid Kinase Superfamily (AAK), Aspartokinase (AK); this CD includes the N-terminal catalytic domain of aspartokinase (4-L-aspartate-4-phosphotransferase;). AK is the first enzyme in the biosynthetic pathway of the aspartate family of amino acids (lysine, threonine, methionine, and isoleucine) and the bacterial cell wall component, meso-diaminopimelate. It also catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. One mechanism for the regulation of this pathway is by the production of several isoenzymes of aspartokinase with different repressors and allosteric inhibitors. Pairs of ACT domains are proposed to specifically bind amino acids leading to allosteric regulation of the enzyme. In Escherichia coli, three different aspartokinase isoenzymes are regulated specifically by lysine, methionine, and threonine. AK-HSDHI (ThrA) and AK-HSDHII (MetL) are bifunctional enzymes that consist of an N-terminal AK and a C-terminal homoserine dehyd
Probab=100.00 E-value=3.4e-47 Score=377.51 Aligned_cols=225 Identities=49% Similarity=0.860 Sum_probs=198.5
Q ss_pred eEEEEecccccCCHHHHHHHHHHHHcC-CCCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHHH
Q 008693 82 TCVMKFGGSSLASAERMREVAELILSF-PNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVD 160 (557)
Q Consensus 82 ~~V~KFGGsSv~~~~~~~~va~iI~~~-~~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~~ 160 (557)
|+|+|||||++++++.+++++++|... .+.++|||+||++++|+.|++.+
T Consensus 1 ~iViK~GGs~l~~~~~~~~~~~~i~~l~~g~~vvvV~Sg~~~~t~~l~~~~----------------------------- 51 (227)
T cd04234 1 MVVQKFGGTSVASAERIKRVADIIKAYEKGNRVVVVVSAMGGVTDLLIELA----------------------------- 51 (227)
T ss_pred CEEEEECccccCCHHHHHHHHHHHHHhhcCCCEEEEEcCCCcccHHHHHHH-----------------------------
Confidence 689999999999999999999999875 34678999999999999886520
Q ss_pred HhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCce
Q 008693 161 ELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNAD 240 (557)
Q Consensus 161 ~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~ 240 (557)
.++++||.+|+.+++++|+++|+++.++++.++.+.+++.+....
T Consensus 52 -----------------------------------~~~s~Ge~~~~~l~~~~l~~~Gi~a~~l~~~~~~~~~~~~~~~~~ 96 (227)
T cd04234 52 -----------------------------------LLLSFGERLSARLLAAALRDRGIKARSLDARQAGITTDDNHGAAR 96 (227)
T ss_pred -----------------------------------HHHHHHHHHHHHHHHHHHHHCCCCeEEeCHHHCCEEcCCccchhh
Confidence 578899999999999999999999999999998555544323233
Q ss_pred eeecchHHHHHHHhhchhcC-CceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCC
Q 008693 241 ILEATYPAVAKRLHGDWITD-LAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNI 319 (557)
Q Consensus 241 i~~~~~~~v~~~l~~~ll~~-~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~ 319 (557)
+.+.+...+. .+++. +.|||++||+|.+ ++|.++++||||||++|+++|.+|+|+++++|||||||||+||+.
T Consensus 97 ~~~~~~~~l~-----~~l~~~~~vpVv~g~i~~~-~~g~~~~l~rg~sD~~A~~lA~~l~A~~l~~~tdV~Gvy~~dP~~ 170 (227)
T cd04234 97 IIEISYERLK-----ELLAEIGKVPVVTGFIGRN-EDGEITTLGRGGSDYSAAALAAALGADEVEIWTDVDGIYTADPRI 170 (227)
T ss_pred HHHHHHHHHH-----HHHhhCCCEEEecCceecC-CCCCEEEeeCCCcHHHHHHHHHHhCCCEEEEEECCCccCCCCCCC
Confidence 3333333333 23566 8999999999998 589999999999999999999999999999999999999999999
Q ss_pred CCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEe
Q 008693 320 HPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (557)
Q Consensus 320 v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (557)
+|++++++++||+|+.+|+++|++++||+|+++|++++||++|+|+++|+.+||+|+
T Consensus 171 ~~~a~~i~~i~~~e~~~l~~~G~~~~~~~a~~~a~~~~i~i~i~~~~~~~~~gT~I~ 227 (227)
T cd04234 171 VPEARLIPEISYDEALELAYFGAKVLHPRAVEPARKANIPIRVKNTFNPEAPGTLIT 227 (227)
T ss_pred CCCceEcCcCCHHHHHHHHhCCccccCHHHHHHHHHcCCeEEEEeCCCCCCCCCEeC
Confidence 999999999999999999999999999999999999999999999999999999984
No 30
>cd04246 AAK_AK-DapG-like AAK_AK-DapG-like: Amino Acid Kinase Superfamily (AAK), AK-DapG-like; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the diaminopimelate-sensitive aspartokinase isoenzyme AKI (DapG), a monofunctional enzymes found in Bacilli (Bacillus subtilis 168), Clostridia, and Actinobacteria bacterial species, as well as, the catalytic AK domain of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis 168, the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, and related isoenzymes. In Bacillus subtilis, the regulation of the diaminopimelate-lysine biosynthetic pathway involves dual control by diaminopimelate and lysine, effected through separate diaminopimelate- and lysine-sensitive aspartokinase isoenzymes. The role of the AKI isoenzyme is most likely to provide a constant level of aspartyl-beta-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis and dipicolinate during sporulati
Probab=100.00 E-value=1.1e-46 Score=376.60 Aligned_cols=237 Identities=39% Similarity=0.627 Sum_probs=210.4
Q ss_pred eEEEEecccccCCHHHHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHH
Q 008693 82 TCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTV 159 (557)
Q Consensus 82 ~~V~KFGGsSv~~~~~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~ 159 (557)
|+|+||||+++.|++.++++++.|.... +.++++|+||+++.+++|++......
T Consensus 1 ~iViK~GGs~l~~~~~~~~~~~~i~~l~~~g~~~viV~sg~g~~~~~ll~~~~~~~------------------------ 56 (239)
T cd04246 1 IIVQKFGGTSVADIERIKRVAERIKKAVKKGYQVVVVVSAMGGTTDELIGLAKEVS------------------------ 56 (239)
T ss_pred CEEEEECccccCCHHHHHHHHHHHHHHHHcCCCEEEEECCCCchHHHHHHHHHHhc------------------------
Confidence 6899999999999999999999998753 46789999999999999987532100
Q ss_pred HHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCc
Q 008693 160 DELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNA 239 (557)
Q Consensus 160 ~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a 239 (557)
...+...+|.++++||.+|+.+++++|+++|++++++++.+.++++.++|+++
T Consensus 57 ---------------------------~~~~~~~~~~i~~~Ge~~~~~~~~~~l~~~g~~a~~l~~~~~~l~~~~~~~~~ 109 (239)
T cd04246 57 ---------------------------PRPSPRELDMLLSTGEQISAALLAMALNRLGIKAISLTGWQAGILTDDHHGNA 109 (239)
T ss_pred ---------------------------cCCCHHHHHHHHHHhHHHHHHHHHHHHHhCCCCeEEeccccCCEEecCCCCce
Confidence 01245667889999999999999999999999999999999888988888877
Q ss_pred eeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCC
Q 008693 240 DILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNI 319 (557)
Q Consensus 240 ~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~ 319 (557)
++...+...+.+ +++++.|||++||+|.+ .+|.++++|||++|++|+++|.+|+|+++++||||||||++||+.
T Consensus 110 ~~~~~~~~~l~~-----ll~~g~ipVi~g~~~~~-~~g~~~~l~~g~~D~~A~~lA~~l~A~~li~~tdV~GVy~~dP~~ 183 (239)
T cd04246 110 RIIDIDPKRILE-----ALEEGDVVVVAGFQGVN-EDGEITTLGRGGSDTTAVALAAALKADRCEIYTDVDGVYTADPRI 183 (239)
T ss_pred eechhhHHHHHH-----HHhcCCEEEEcCccccC-CCCCEEecCCCChHHHHHHHHHHcCCCEEEEEECCCCCCCCCCCC
Confidence 775555444332 35678999999999998 489999999999999999999999999999999999999999999
Q ss_pred CCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEe
Q 008693 320 HPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (557)
Q Consensus 320 v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (557)
+|+++++++|||+|+.+|+++|++++||+|++||+++|||++|+|+++|+ +||+|+
T Consensus 184 ~~~a~~i~~l~~~e~~~l~~~G~~~~~~~a~~~a~~~gi~i~i~~~~~~~-~gt~i~ 239 (239)
T cd04246 184 VPKARKLDVISYDEMLEMASLGAKVLHPRSVELAKKYNVPLRVRSSFSEN-PGTLIT 239 (239)
T ss_pred CCCCeEcccCCHHHHHHHHhCCCcccCHHHHHHHHHCCCeEEEecCCCCC-CCcEeC
Confidence 99999999999999999999999999999999999999999999999999 999995
No 31
>cd04260 AAK_AKi-DapG-BS AAK_AKi-DapG-BS: Amino Acid Kinase Superfamily (AAK), AKi-DapG; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the diaminopimelate-sensitive aspartokinase isoenzyme AKI (DapG), a monofunctional class enzyme found in Bacilli (Bacillus subtilis 168), Clostridia, and Actinobacteria bacterial species. In Bacillus subtilis, the regulation of the diaminopimelate-lysine biosynthetic pathway involves dual control by diaminopimelate and lysine, effected through separate diaminopimelate- and lysine-sensitive aspartokinase isoenzymes. AKI activity is invariant during the exponential and stationary phases of growth and is not altered by addition of amino acids to the growth medium. The role of this isoenzyme is most likely to provide a constant level of aspartyl-beta-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis and dipicolinate during sporulation. The B. subtilis AKI is tetrameric consisting of two alpha and two bet
Probab=100.00 E-value=2.9e-46 Score=374.65 Aligned_cols=237 Identities=34% Similarity=0.611 Sum_probs=207.0
Q ss_pred eEEEEecccccCCHHHHHHHHHHHHcCC--CCccEEEEcCCCcC-----cHHHHHhhHHhhhcCCCcchhhHHHHHHHHH
Q 008693 82 TCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKT-----TNKLLLAGEKAVSCGVTNISCIDELSFVKDL 154 (557)
Q Consensus 82 ~~V~KFGGsSv~~~~~~~~va~iI~~~~--~~~~vvVVSA~gg~-----Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~ 154 (557)
++|+|||||++.|++.++++++.|.... +.+++||+||||+. |+.|.....
T Consensus 1 ~~ViK~GGs~l~~~~~~~~~~~~I~~~~~~g~~~vvV~sa~g~~G~~~~~~~l~~~~~---------------------- 58 (244)
T cd04260 1 IIVQKFGGTSVSTKERREQVAKKVKQAVDEGYKPVVVVSAMGRKGDPYATDTLINLVY---------------------- 58 (244)
T ss_pred CEEEEECchhcCCHHHHHHHHHHHHHHHHCCCCeEEEEECCCCCCCchHHHHHHHHHH----------------------
Confidence 3799999999999999999999998753 35789999999773 554433210
Q ss_pred HHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEec
Q 008693 155 HHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTD 234 (557)
Q Consensus 155 ~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~ 234 (557)
..+ ...+++.+|.++++||.+++.+++++|+++|+++.++++.+.++++.+
T Consensus 59 ------~~~-----------------------~~~t~~~~~~~~~~Ge~~~~~~~~~~l~~~Gi~a~~l~~~~~~lit~~ 109 (244)
T cd04260 59 ------AEN-----------------------SDISPRELDLLMSCGEIISAVVLTSTLRAQGLKAVALTGAQAGILTDD 109 (244)
T ss_pred ------hhc-----------------------CCCCHHHHHHHHHHhHHHHHHHHHHHHHhCCCCeEEechHHcCEEecC
Confidence 000 123567789999999999999999999999999999999999999999
Q ss_pred CCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCcccc
Q 008693 235 DFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLT 314 (557)
Q Consensus 235 ~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~t 314 (557)
+++.+++...+.+.+.+ +++.+.|||++||+|.+ .+|++++++|||+|++|+++|.+|+|+++++||||||||+
T Consensus 110 ~~~~~~v~~~~~~~l~~-----ll~~g~VPVv~g~~~~~-~~g~~~~l~rg~sD~~A~~lA~~l~A~~l~~~tDV~GVy~ 183 (244)
T cd04260 110 NYSNAKIIKVNPKKILS-----ALKEGDVVVVAGFQGVT-EDGEVTTLGRGGSDTTAAALGAALNAEYVEIYTDVDGIMT 183 (244)
T ss_pred CCCceeeeccCHHHHHH-----HHhCCCEEEecCCcccC-CCCCEEEeCCCchHHHHHHHHHHcCCCEEEEEECCCcCCc
Confidence 88877766556554432 35678999999999998 4899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEe
Q 008693 315 CDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (557)
Q Consensus 315 aDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (557)
+||+.+|++++|++|||+|+.+|+++|++++||+|++++++++||++|+|+++|+ +||+|+
T Consensus 184 ~dP~~~~~a~~i~~i~~~e~~~l~~~g~~v~~~~a~~~~~~~~i~v~I~~~~~~~-~gt~i~ 244 (244)
T cd04260 184 ADPRVVPNARILDVVSYNEVFQMAHQGAKVIHPRAVEIAMQANIPIRIRSTMSEN-PGTLIT 244 (244)
T ss_pred CCCCCCCCCeEcccCCHHHHHHHHHcCchhcCHHHHHHHHHcCCeEEEecCCCCC-CCCEeC
Confidence 9999999999999999999999999999999999999999999999999999998 999995
No 32
>cd02115 AAK Amino Acid Kinases (AAK) superfamily, catalytic domain; present in such enzymes like N-acetylglutamate kinase (NAGK), carbamate kinase (CK), aspartokinase (AK), glutamate-5-kinase (G5K) and UMP kinase (UMPK). The AAK superfamily includes kinases that phosphorylate a variety of amino acid substrates. These kinases catalyze the formation of phosphoric anhydrides, generally with a carboxylate, and use ATP as the source of the phosphoryl group; are involved in amino acid biosynthesis. Some of these kinases control the process via allosteric feed-back inhibition.
Probab=100.00 E-value=1.6e-36 Score=303.81 Aligned_cols=237 Identities=40% Similarity=0.603 Sum_probs=199.0
Q ss_pred EEEecccccCCHHHHHHHHHHHHcC--CCCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHHHH
Q 008693 84 VMKFGGSSLASAERMREVAELILSF--PNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVDE 161 (557)
Q Consensus 84 V~KFGGsSv~~~~~~~~va~iI~~~--~~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~~~ 161 (557)
|+||||+++.+.+.++++++.|... .+.+.|+|+||+++.|+.+.+.....
T Consensus 1 ViKiGGs~l~~~~~~~~~~~~i~~l~~~~~~~viV~ggg~~~~~~~~~~~~~~--------------------------- 53 (248)
T cd02115 1 VIKFGGSSVSSEERLRNLARILVKLASEGGRVVVVHGAGPQITDELLAHGELL--------------------------- 53 (248)
T ss_pred CEeeCccccCCHHHHHHHHHHHHHHHhcCCCEEEEECCCCCcCHHHHHHHHhh---------------------------
Confidence 7899999999999999999999974 24578999999999999887643211
Q ss_pred hCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCC-ce
Q 008693 162 LGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTN-AD 240 (557)
Q Consensus 162 l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~-a~ 240 (557)
.+..+ ...+....+.++++||.+++.++.++|+++|+++.++++.++.+.+. +++. ..
T Consensus 54 ----------------~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~gi~a~~~~~~~~~~~~~-~~~~~g~ 112 (248)
T cd02115 54 ----------------GYARG----LRITDRETDALAAMGEGMSNLLIAAALEQHGIKAVPLDLTQAGFASP-NQGHVGK 112 (248)
T ss_pred ----------------hhhhc----cCCCHHHHHHHHHHHHHHHHHHHHHHHHhCCCCeEEEchHHcCeEeC-CCCCccc
Confidence 00000 13466778999999999999999999999999999999999865544 4433 44
Q ss_pred eeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCC
Q 008693 241 ILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIH 320 (557)
Q Consensus 241 i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v 320 (557)
+...+.+.+++. ++.+.|||++||.+.+. + +..+++|++||++|+.+|.+|+|+++++||||||||++||+++
T Consensus 113 ~~~~~~~~l~~~-----l~~~~ipVv~g~~~~~~-~-~~~~~~~~~sD~~A~~lA~~l~A~~li~~tdV~Gv~~~dP~~~ 185 (248)
T cd02115 113 ITKVSTDRLKSL-----LENGILPILSGFGGTDE-K-ETGTLGRGGSDSTAALLAAALKADRLVILTDVDGVYTADPRKV 185 (248)
T ss_pred ceeeCHHHHHHH-----HhCCcEEEecCeEeccC-C-ceeeecCCCHHHHHHHHHHHcCCCEEEEEecCCeeecCCCCcC
Confidence 555555555432 45789999999988763 4 6788999999999999999999999999999999999999999
Q ss_pred CCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCC--------CCCCCeeE
Q 008693 321 PHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYN--------PNAPGTLI 375 (557)
Q Consensus 321 ~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~--------p~~~GT~I 375 (557)
|++++|++|||+|+.+++++|+.++||+++.+++++++|++|.|+++ ++++||+|
T Consensus 186 ~~a~~i~~i~~~e~~~l~~~g~~~~k~~a~~~~~~~~~~v~I~~~~~~~~l~~~~~~~~GT~I 248 (248)
T cd02115 186 PDAKLLSELTYEEAAELAYAGAMVLKPKAADPAARAGIPVRIANTENPGALALFTPDGGGTLI 248 (248)
T ss_pred CcCeECCcCCHHHHHHHHHcCCCccCHHHHHHHHHcCCcEEEEeCCCcccccccCCCCCCCCC
Confidence 99999999999999999999999999999999999999999999988 56677765
No 33
>PRK12314 gamma-glutamyl kinase; Provisional
Probab=100.00 E-value=1.1e-31 Score=272.28 Aligned_cols=227 Identities=22% Similarity=0.311 Sum_probs=180.5
Q ss_pred CcceEEEEecccccC------CHHHHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHH
Q 008693 79 KQLTCVMKFGGSSLA------SAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSF 150 (557)
Q Consensus 79 ~~~~~V~KFGGsSv~------~~~~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~ 150 (557)
.|+++|+||||||+. +.++++++++.|.+.. +.++|+|+||+++.+..++....
T Consensus 8 ~~~~iViK~Ggs~l~~~~~~~~~~~i~~~~~~I~~~~~~g~~vvlV~Sga~~~g~~~l~~~~------------------ 69 (266)
T PRK12314 8 NAKRIVIKVGSSTLSYENGKINLERIEQLVFVISDLMNKGKEVILVSSGAIGAGLTKLKLDK------------------ 69 (266)
T ss_pred hCCEEEEEeCCCeeeCCCCCcCHHHHHHHHHHHHHHHHCCCeEEEEeeCcccccceeecccc------------------
Confidence 477899999999999 7899999999998642 34567788998888876653210
Q ss_pred HHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEE
Q 008693 151 VKDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGF 230 (557)
Q Consensus 151 i~~~~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~i 230 (557)
.......++.+++.||.++..++..+|+++|+++ +|+ +
T Consensus 70 ------------------------------------~~~~~~~~~a~aa~Gq~~l~~~~~~~~~~~g~~~-----~q~-l 107 (266)
T PRK12314 70 ------------------------------------RPTSLAEKQALAAVGQPELMSLYSKFFAEYGIVV-----AQI-L 107 (266)
T ss_pred ------------------------------------CCCCHHHHHHHHHHhHHHHHHHHHHHHHHcCCeE-----EEE-E
Confidence 0012234688999999999999999999999974 566 8
Q ss_pred EEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecC----CCcchhHHHHHHHHcCcCcEEEe
Q 008693 231 ITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLG----RGGSDLTATTIGKALGLQEIQVW 306 (557)
Q Consensus 231 it~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlg----RgGSD~tAa~lA~~L~A~~l~i~ 306 (557)
+|.++|.+.+.. .+..+.+. .+++.|.|||+.+ ++.+++.+ +|++|++|+++|.+|+|+.++||
T Consensus 108 lT~~~~~~~~~~----~~~~~~l~-~ll~~g~IPVv~~-------nd~v~~~~~~~~~~~~D~~Aa~lA~~l~Ad~liil 175 (266)
T PRK12314 108 LTRDDFDSPKSR----ANVKNTFE-SLLELGILPIVNE-------NDAVATDEIDTKFGDNDRLSAIVAKLVKADLLIIL 175 (266)
T ss_pred EecccccchHHH----HHHHHHHH-HHHHCCCEEEEcC-------CCCeeeccccceecchHHHHHHHHHHhCCCEEEEE
Confidence 888888766542 22233333 3567899999953 45565665 89999999999999999999999
Q ss_pred eCCCccccCCCCCCCCCccccccCH--HHHHHHHHc-------CCCcchHhHHHHHHhCCCCEEEecCCCCC--------
Q 008693 307 KDVDGVLTCDPNIHPHAKPVPYLTF--DEAAELAYF-------GAQVLHPQSMRPAREGDIPVRVKNSYNPN-------- 369 (557)
Q Consensus 307 TDVdGV~taDP~~v~~a~~i~~ls~--~Ea~eLa~~-------Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~-------- 369 (557)
|||||||++||+.+|+|++|++++| +|..+++.. |..+.|++++..|.++|+|++|.|+++|+
T Consensus 176 TDVdGVy~~dP~~~~~a~~i~~I~~~~~~~~~~~~~~~~~~~tGGM~~Kl~aa~~a~~~gv~v~I~~g~~~~~i~~~l~g 255 (266)
T PRK12314 176 SDIDGLYDKNPRINPDAKLRSEVTEITEEILALAGGAGSKFGTGGMVTKLKAAKFLMEAGIKMVLANGFNPSDILDFLEG 255 (266)
T ss_pred eCCCcccCCCCCCCCCCeEEEEecCCCHHHHHHhccCCCCcccCchHHHHHHHHHHHHCCCeEEEEcCCCchHHHHHHcC
Confidence 9999999999999999999999997 666666543 46778889999999999999999988874
Q ss_pred -CCCeeEec
Q 008693 370 -APGTLIRR 377 (557)
Q Consensus 370 -~~GT~I~~ 377 (557)
..||+|.+
T Consensus 256 ~~~GT~i~~ 264 (266)
T PRK12314 256 ESIGTLFAP 264 (266)
T ss_pred CCCceEEcc
Confidence 46888864
No 34
>PF00696 AA_kinase: Amino acid kinase family Match to Glutamate-5-kinases, C-terminal end of the alignment Match to Aspartate kinases; InterPro: IPR001048 This entry contains proteins with various specificities and includes the aspartate, glutamate and uridylate kinase families. In prokaryotes and plants the synthesis of the essential amino acids lysine and threonine is predominantly regulated by feed-back inhibition of aspartate kinase (AK) and dihydrodipicolinate synthase (DHPS). In Escherichia coli, thrA, metLM, and lysC encode aspartokinase isozymes that show feedback inhibition by threonine, methionine, and lysine, respectively []. The lysine-sensitive isoenzyme of aspartate kinase from spinach leaves has a subunit composition of 4 large and 4 small subunits []. In plants although the control of carbon fixation and nitrogen assimilation has been studied in detail, relatively little is known about the regulation of carbon and nitrogen flow into amino acids. The metabolic regulation of expression of an Arabidopsis thaliana aspartate kinase/homoserine dehydrogenase (AK/HSD) gene, which encodes two linked key enzymes in the biosynthetic pathway of aspartate family amino acids has been studied []. The conversion of aspartate into either the storage amino acid asparagine or aspartate family amino acids may be subject to a coordinated, reciprocal metabolic control, and this biochemical branch point is a part of a larger, coordinated regulatory mechanism of nitrogen and carbon storage and utilization.; GO: 0008652 cellular amino acid biosynthetic process; PDB: 2X2W_B 2WXB_B 1B7B_C 2J4L_F 2J4K_E 2J4J_F 2OGX_B 3QUO_A 3D40_A 3D41_A ....
Probab=99.98 E-value=1.2e-32 Score=275.01 Aligned_cols=233 Identities=35% Similarity=0.455 Sum_probs=179.3
Q ss_pred ceEEEEecccccCCH--HHHHHHHHHHHcCC-CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHH
Q 008693 81 LTCVMKFGGSSLASA--ERMREVAELILSFP-NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHR 157 (557)
Q Consensus 81 ~~~V~KFGGsSv~~~--~~~~~va~iI~~~~-~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~ 157 (557)
+++|+|||||++.+. + ++++++.|.... ...++||||++|+.+|.+++........ .. ..+|..
T Consensus 1 k~~ViK~GGs~l~~~~~~-~~~~~~~i~~l~~~g~~vvvV~g~g~~~~~~~~~~~~~~~~-------~~-----~~r~~~ 67 (242)
T PF00696_consen 1 KTIVIKLGGSSLTDKDEE-LRELADDIALLSQLGIKVVVVHGGGSFTDELLEKYGIEPKF-------VD-----GSRVTD 67 (242)
T ss_dssp SEEEEEE-HHGHSSHSHH-HHHHHHHHHHHHHTTSEEEEEESSHHHHHHHHHHCTHTTSE-------ET-----HHCHBH
T ss_pred CeEEEEECchhhCCchHH-HHHHHHHHHHHHhCCCeEEEEECChhhcCchHHhccCCccc-------ch-----hhhhhh
Confidence 478999999999998 7 999999998642 3466799999999999998763221110 00 011111
Q ss_pred HHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCC
Q 008693 158 TVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFT 237 (557)
Q Consensus 158 ~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~ 237 (557)
....+.. -.....+|.+ +...|.+++.|+.+++.++...+.+.|+.+...++.
T Consensus 68 ~~~~~~~----~~~~~~~l~~------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 120 (242)
T PF00696_consen 68 IETGLII----TMAAAAELNR------------DALLDEIVSAGERLGAHAVGLSLSDGGISAAKRDAR----------- 120 (242)
T ss_dssp HHHHHHH----HHHHHHHHHH------------HHHHHHHHHHHHHCTHHEEEHHHTGGTEEEEEEESS-----------
T ss_pred hhhhHHH----HHHHhhcccc------------chhHHHHHHhhhhhhHHHHhhhhhcccchhhhhhhh-----------
Confidence 1110000 0000111111 467788999999999999999999988877766543
Q ss_pred CceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCC
Q 008693 238 NADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDP 317 (557)
Q Consensus 238 ~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP 317 (557)
..+.+.+.+ +++++.|||++||.+.+ .+|++++++++++|++|+.+|.+|+|+++++||||||||++||
T Consensus 121 -----~~~~~~i~~-----~l~~~~ipVv~g~~~~~-~~g~~~~~~~~~sD~~A~~lA~~l~A~~li~~tdV~Gv~~~dP 189 (242)
T PF00696_consen 121 -----EVDKEAIRE-----LLEQGIIPVVSGFAGID-DDGEVTTLGNVSSDYIAALLAAALGADKLIFLTDVDGVYTADP 189 (242)
T ss_dssp -----EEHHHHHHH-----HHHTTSEEEEESEEEEE-TTSTEEEEEEETHHHHHHHHHHHTTCSEEEEEESSSSEBSSST
T ss_pred -----hhHHHHHHH-----HHHCCCEEEEeCCcccC-CCCCcccCCCCCHHHHHHHHHHHhCchhhhhhhhcCceeecCC
Confidence 112233333 34578999999999888 4899999999999999999999999999999999999999999
Q ss_pred CCCCCCccccccCHHHHHHHH------HcCCCcchHhHHHHHHhCCCCEEEec
Q 008693 318 NIHPHAKPVPYLTFDEAAELA------YFGAQVLHPQSMRPAREGDIPVRVKN 364 (557)
Q Consensus 318 ~~v~~a~~i~~ls~~Ea~eLa------~~Ga~vlhp~a~~~a~~~~Ipv~I~n 364 (557)
+.+|+++++++|||+|+.+|+ ++|++++||.|+++++++++|++|.|
T Consensus 190 ~~~~~~~~i~~l~~~e~~~l~~~~~~~~~gm~~k~~~a~~~~~~~~~~v~I~n 242 (242)
T PF00696_consen 190 RIVPDARLIPELSYDEAEELASKSGDVTGGMKPKHPAALEAAEEGGIPVHIIN 242 (242)
T ss_dssp TTSTTSEBESEEEHHHHHHHHHHTTSSTTTHHHHHHHHHHHHHHTTSEEEEEE
T ss_pred CCCCCCeeeeEeeHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHcCCCcEEEeC
Confidence 999999999999999999999 89999999999999999999999986
No 35
>cd04242 AAK_G5K_ProB AAK_G5K_ProB: Glutamate-5-kinase (G5K) catalyzes glutamate-dependent ATP cleavage; G5K transfers the terminal phosphoryl group of ATP to the gamma-carboxyl group of glutamate, in the first and controlling step of proline (and, in mammals, ornithine) biosynthesis. G5K is subject to feedback allosteric inhibition by proline or ornithine. In microorganisms and plants, proline plays an important role as an osmoprotectant and, in mammals, ornithine biosynthesis is crucial for proper ammonia detoxification, since a G5K mutation has been shown to cause human hyperammonaemia. Microbial G5K generally consists of two domains: a catalytic G5K domain and one PUA (pseudo uridine synthases and archaeosine-specific transglycosylases) domain, and some lack the PUA domain. G5K requires free Mg for activity, it is tetrameric, and it aggregates to higher forms in a proline-dependent way. G5K lacking the PUA domain remains tetrameric, active, and proline-inhibitable, but the Mg requir
Probab=99.97 E-value=1.5e-30 Score=262.19 Aligned_cols=215 Identities=23% Similarity=0.383 Sum_probs=170.1
Q ss_pred EEEEecccccCCHH------HHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHH
Q 008693 83 CVMKFGGSSLASAE------RMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDL 154 (557)
Q Consensus 83 ~V~KFGGsSv~~~~------~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~ 154 (557)
+|+|||||++.+.+ .++++++.|.+.. +.+.|+|+||+++.+...+..
T Consensus 2 iViK~GGs~i~~~~~~~~~~~i~~~~~~i~~~~~~~~~viiV~sg~~~~g~~~~~~------------------------ 57 (251)
T cd04242 2 IVVKVGSSLLTDEDGGLDLGRLASLVEQIAELRNQGKEVILVSSGAVAAGRQRLGL------------------------ 57 (251)
T ss_pred EEEEeCCCeeeCCCCCcCHHHHHHHHHHHHHHHHCCCeEEEEecCchhhChhhhcc------------------------
Confidence 79999999999876 9999999998643 345677888877766321110
Q ss_pred HHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEec
Q 008693 155 HHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTD 234 (557)
Q Consensus 155 ~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~ 234 (557)
.. +......++.++++||..+..+++.+|+++|+++ +++ ++|++
T Consensus 58 ----------~~--------------------~~~~~~~~~~~~~~Gq~~l~~~~~~~l~~~Gi~~-----~q~-l~t~~ 101 (251)
T cd04242 58 ----------EK--------------------RPKTLPEKQALAAVGQSLLMALYEQLFAQYGIKV-----AQI-LLTRD 101 (251)
T ss_pred ----------Cc--------------------CCCchhHHHHHHHHhHHHHHHHHHHHHHHcCCeE-----EEE-EEehh
Confidence 00 0001234578999999999999999999999996 344 67777
Q ss_pred CCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceee--cCCCcchhHHHHHHHHcCcCcEEEeeCCCcc
Q 008693 235 DFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITT--LGRGGSDLTATTIGKALGLQEIQVWKDVDGV 312 (557)
Q Consensus 235 ~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~tt--lgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV 312 (557)
+|.++.. +....+.+ ..+++.+.|||+.+ ++.+++ ++||++|++|+.+|.+|+|++++||||||||
T Consensus 102 ~~~~~~~----~~~~~~~i-~~ll~~g~iPVv~~-------~d~v~~~~~~~~~~D~~A~~lA~~l~Ad~liilTDVdGv 169 (251)
T cd04242 102 DFEDRKR----YLNARNTL-ETLLELGVIPIINE-------NDTVATEEIRFGDNDRLSALVAGLVNADLLILLSDVDGL 169 (251)
T ss_pred HhcchHH----HHHHHHHH-HHHHHCCCEEEEcC-------CCCeeeeccccCChHHHHHHHHHHcCCCEEEEecCcCEE
Confidence 7765542 12222223 34567889999954 345555 8999999999999999999999999999999
Q ss_pred ccCCCCCCCCCccccccC--HHHHHHHH-----HcCCCcchH--hHHHHHHhCCCCEEEecCCCCC
Q 008693 313 LTCDPNIHPHAKPVPYLT--FDEAAELA-----YFGAQVLHP--QSMRPAREGDIPVRVKNSYNPN 369 (557)
Q Consensus 313 ~taDP~~v~~a~~i~~ls--~~Ea~eLa-----~~Ga~vlhp--~a~~~a~~~~Ipv~I~n~~~p~ 369 (557)
|++||+.+|++++|++++ ++|+.+++ .+|..+||| +++..+.++|+|++|.|++.|+
T Consensus 170 y~~dP~~~~~a~~i~~i~~~~~e~~~~~~~~~~~~~tggm~~Kl~a~~~a~~~gi~v~I~~g~~~~ 235 (251)
T cd04242 170 YDKNPRENPDAKLIPEVEEITDEIEAMAGGSGSSVGTGGMRTKLKAARIATEAGIPVVIANGRKPD 235 (251)
T ss_pred EeCCCCCCCCCeEEEEecCChHHHHHHhcccCcCcccCCcHHHHHHHHHHHHCCCcEEEEcCCCCC
Confidence 999999999999999999 99999996 678999999 6889999999999999988874
No 36
>PRK14557 pyrH uridylate kinase; Provisional
Probab=99.97 E-value=1.3e-29 Score=253.84 Aligned_cols=219 Identities=24% Similarity=0.319 Sum_probs=169.4
Q ss_pred CcceEEEEecccccCC-------HHHHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHH
Q 008693 79 KQLTCVMKFGGSSLAS-------AERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELS 149 (557)
Q Consensus 79 ~~~~~V~KFGGsSv~~-------~~~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~ 149 (557)
+.+.+|+||||+++.+ .++++++++.|+... +.+++||||| | |.+.. +
T Consensus 3 ~~~riViKlGG~al~~~~~~~~~~~~i~~~a~~i~~~~~~g~~vvVVvGg-G---n~~rg--~----------------- 59 (247)
T PRK14557 3 PYKRVLIKLSGGALADQTGNSFNSKRLEHIANEILSIVDLGIEVSIVIGG-G---NIFRG--H----------------- 59 (247)
T ss_pred cccEEEEEeCceeECCCCCCCcCHHHHHHHHHHHHHHHHcCCeEEEEECC-c---HHHHH--H-----------------
Confidence 3567999999999988 789999999998642 3567888887 3 43321 0
Q ss_pred HHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeE
Q 008693 150 FVKDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIG 229 (557)
Q Consensus 150 ~i~~~~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~ 229 (557)
.++.++. +....|+++++||++|+.+++.+|++. ++++.+
T Consensus 60 --------~a~~~~~-------------------------~~~~~D~ig~~g~~lna~ll~~~l~~~-------~~~~~~ 99 (247)
T PRK14557 60 --------LAEEWGI-------------------------DRVEADNIGTLGTIINSLMLRGVLTSK-------TNKEVR 99 (247)
T ss_pred --------HHHhcCC-------------------------ChHHHHHHHHHHHHHHHHHHHHHHHhh-------hCCcee
Confidence 0111221 234569999999999999999999984 455666
Q ss_pred EEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEee-C
Q 008693 230 FITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWK-D 308 (557)
Q Consensus 230 iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~T-D 308 (557)
++|+..+.... .. ....++.+. ++++.|||++||+|.+ ..+ ||++|+++|.+++|+.+++|| |
T Consensus 100 i~t~~~~~~~~-~~----~~~~~~~~~-l~~g~VvV~~G~~g~~----~~s------tD~lAallA~~l~Ad~li~~ttd 163 (247)
T PRK14557 100 VMTSIPFNAVA-EP----YIRLRAVHH-LDNGYIVIFGGGNGQP----FVT------TDYPSVQRAIEMNSDAILVAKQG 163 (247)
T ss_pred EEecccccccc-ch----hhHHHHHHH-HhCCCEEEEECCcCCC----ccC------hHHHHHHHHHHhCCCEEEEecCC
Confidence 78776665221 11 111223333 4678899999998843 233 999999999999999999995 9
Q ss_pred CCccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCC---------CCCeeEecCC
Q 008693 309 VDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPN---------APGTLIRRSR 379 (557)
Q Consensus 309 VdGV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~---------~~GT~I~~~~ 379 (557)
||||||+||+.+|+|++|++++|+|+. +.+.++|||+|+++|.++|||++|.|..+|+ ..||+|.+..
T Consensus 164 VdGvY~~DP~~~~~Ak~i~~i~~~e~~---~~~~~~~~~~A~~~a~~~gi~v~I~ng~~~~~l~~~l~g~~~GT~i~~~~ 240 (247)
T PRK14557 164 VDGVFTSDPKHNKSAKMYRKLNYNDVV---RQNIQVMDQAALLLARDYNLPAHVFNFDEPGVMRRICLGEHVGTLINDDA 240 (247)
T ss_pred cCEeECCCCCCCCCCEEeeEEChhhhc---ccCHHHHHHHHHHHHHHCCCcEEEEeCCCChHHHHHHcCCCCcEEEecCc
Confidence 999999999999999999999999884 5688999999999999999999999998885 4799997643
No 37
>cd04239 AAK_UMPK-like AAK_UMPK-like: UMP kinase (UMPK)-like, the microbial/chloroplast uridine monophosphate kinase (uridylate kinase) enzyme that catalyzes UMP phosphorylation and plays a key role in pyrimidine nucleotide biosynthesis. Regulation of this process is via feed-back control and via gene repression of carbamoyl phosphate synthetase (the first enzyme of the pyrimidine biosynthesis pathway). The UMP kinases of E. coli (Ec) and Pyrococcus furiosus (Pf) are known to function as homohexamers, with GTP and UTP being allosteric effectors. Like other related enzymes (carbamate kinase, aspartokinase, and N-acetylglutamate kinase) the E. coli and most bacterial UMPKs have a conserved, N-terminal, lysine residue proposed to function in the catalysis of the phosphoryl group transfer, whereas most archaeal UMPKs appear to lack this residue and the Pyrococcus furiosus structure has an additional Mg ion bound to the ATP molecule which is proposed to function as the catalysis instead. Als
Probab=99.97 E-value=1e-29 Score=252.76 Aligned_cols=204 Identities=24% Similarity=0.331 Sum_probs=160.0
Q ss_pred EEEEecccccCC------HHHHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHH
Q 008693 83 CVMKFGGSSLAS------AERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDL 154 (557)
Q Consensus 83 ~V~KFGGsSv~~------~~~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~ 154 (557)
+|+|||||++.+ .+.++++++.|.+.. +.+.++|+|| |...+.....
T Consensus 2 iViKiGGs~l~~~~~~~~~~~i~~~a~~i~~~~~~g~~vvvV~gg-G~~a~~~~~~------------------------ 56 (229)
T cd04239 2 IVLKLSGEALAGEGGGIDPEVLKEIAREIKEVVDLGVEVAIVVGG-GNIARGYIAA------------------------ 56 (229)
T ss_pred EEEEECcceecCCCCCCCHHHHHHHHHHHHHHHHCCCEEEEEECC-ChHHhhHHHh------------------------
Confidence 699999999988 799999999998642 2455666665 4333322110
Q ss_pred HHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEec
Q 008693 155 HHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTD 234 (557)
Q Consensus 155 ~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~ 234 (557)
.+ ..++...|++.+.||++|+.+|+.+|+++|+++..+++.+++.++.
T Consensus 57 ------~~-------------------------~~~~~~~~~~~~~~~~l~~~l~~~~l~~~Gi~a~~~~~~~~~~~~~- 104 (229)
T cd04239 57 ------AR-------------------------GMPRATADYIGMLATVMNALALQDALEKLGVKTRVMSAIPMQGVAE- 104 (229)
T ss_pred ------hc-------------------------CCChhhHHHHHHHHHHHHHHHHHHHHHHcCCCEEEeCHHHHhhhhc-
Confidence 00 0122345788899999999999999999999999999887532211
Q ss_pred CCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCcccc
Q 008693 235 DFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLT 314 (557)
Q Consensus 235 ~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~t 314 (557)
..+.+. +. .+++.+.|||++||.|... +.||++|+.+|.+|+|+++++||||||||+
T Consensus 105 --------~~~~~~----l~-~~l~~g~ipVi~g~~g~~~----------~~sD~~A~~lA~~l~a~~li~~tdVdGvy~ 161 (229)
T cd04239 105 --------PYIRRR----AI-RHLEKGRIVIFGGGTGNPG----------FTTDTAAALRAEEIGADVLLKATNVDGVYD 161 (229)
T ss_pred --------cccHHH----HH-HHHhCCCEEEEeCccCCCC----------CCcHHHHHHHHHHcCCCEEEEEECCCcccC
Confidence 112222 22 2356889999999986431 239999999999999999999999999999
Q ss_pred CCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCC
Q 008693 315 CDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPN 369 (557)
Q Consensus 315 aDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~ 369 (557)
+||+.+|+|++|++++|+|+.+++. +++||.+++++.++++|++|.|+++|+
T Consensus 162 ~dP~~~~~a~~i~~i~~~e~~~~~~---~~~~~~a~~~~~~~~i~v~I~~g~~~~ 213 (229)
T cd04239 162 ADPKKNPDAKKYDRISYDELLKKGL---KVMDATALTLCRRNKIPIIVFNGLKPG 213 (229)
T ss_pred CCCCCCCCCeEEeEEcHHHHHHHhc---CCccHHHHHHHHHCCCeEEEECCCChh
Confidence 9999999999999999999999865 899999999999999999999998874
No 38
>PRK00358 pyrH uridylate kinase; Provisional
Probab=99.97 E-value=2.5e-29 Score=250.21 Aligned_cols=206 Identities=24% Similarity=0.346 Sum_probs=157.2
Q ss_pred ceEEEEecccccC-------CHHHHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHH
Q 008693 81 LTCVMKFGGSSLA-------SAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFV 151 (557)
Q Consensus 81 ~~~V~KFGGsSv~-------~~~~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i 151 (557)
+++|+|||||++. +.+.++++++.|.+.. +.++++|+|+ |......
T Consensus 1 ~~iViK~GGs~l~~~~~~~~~~~~i~~~~~~i~~~~~~g~~vvlV~gG-G~~a~~~------------------------ 55 (231)
T PRK00358 1 KRVLLKLSGEALAGEKGFGIDPEVLDRIAEEIKEVVELGVEVAIVVGG-GNIFRGY------------------------ 55 (231)
T ss_pred CeEEEEeccceecCCCCCCCCHHHHHHHHHHHHHHHHCCCeEEEEECC-CHHHHHH------------------------
Confidence 3589999999998 6789999999998743 2355666663 3221110
Q ss_pred HHHHHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEE
Q 008693 152 KDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFI 231 (557)
Q Consensus 152 ~~~~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~ii 231 (557)
... .++ .+....|++.+.++++|+.+|+.+|+++|+++..+++.+.+.+
T Consensus 56 ----~~~--~~~-------------------------~~~~~~~~~~~~~~~l~~~ll~~~l~~~Gi~a~~~~~~~~~~~ 104 (231)
T PRK00358 56 ----IGA--AAG-------------------------MDRATADYMGMLATVMNALALQDALERAGVDTRVQSAIPMPQV 104 (231)
T ss_pred ----HHh--hcC-------------------------CChhhHHHHHHHHHHHHHHHHHHHHHHcCCCeEEechhhcccc
Confidence 000 011 1223457788889999999999999999999987776554333
Q ss_pred EecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCc
Q 008693 232 TTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDG 311 (557)
Q Consensus 232 t~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdG 311 (557)
+. .+ .. +.+. .+++++.|||++||.+.+ + +.+|++|+.+|.+|+|+++++||||||
T Consensus 105 ~~-~~--------~~----~~~~-~~l~~g~vPVv~g~~~~~---~-------~ssD~~A~~lA~~l~A~~li~~tdVdG 160 (231)
T PRK00358 105 AE-PY--------IR----RRAI-RHLEKGRVVIFAAGTGNP---F-------FTTDTAAALRAEEIGADVLLKATNVDG 160 (231)
T ss_pred cC-cc--------cH----HHHH-HHHHCCCEEEEECCCCCC---C-------CCchHHHHHHHHHcCCCEEEEeeCcCc
Confidence 21 10 11 2233 345788999999875421 1 239999999999999999999999999
Q ss_pred cccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCC
Q 008693 312 VLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPN 369 (557)
Q Consensus 312 V~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~ 369 (557)
||++||+.+|+|++|++++|+|+.++ |++++||.++++|.++++|++|.|+++|+
T Consensus 161 Vy~~dP~~~~~a~~i~~i~~~e~~~~---g~~~~d~~a~~~a~~~~i~v~I~~g~~~~ 215 (231)
T PRK00358 161 VYDADPKKDPDAKKYDRLTYDEVLEK---GLKVMDATAISLARDNKIPIIVFNMNKPG 215 (231)
T ss_pred eEcCCCCCCCCCEEeeEecHHHHHHc---CCcchhHHHHHHHHHcCCcEEEECCCCch
Confidence 99999999999999999999998877 99999999999999999999999998875
No 39
>PRK14558 pyrH uridylate kinase; Provisional
Probab=99.96 E-value=8.3e-29 Score=246.49 Aligned_cols=153 Identities=21% Similarity=0.301 Sum_probs=126.6
Q ss_pred CHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCC
Q 008693 190 TPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGF 269 (557)
Q Consensus 190 ~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gf 269 (557)
++...|.++++||+||+.+++.+|.++|+++.++++ +.+..+ +...+.. .+. .+++.+.|||++||
T Consensus 61 ~~~~~d~ig~~~~~ln~~~~~~~l~~~gi~a~~~~~----~~~~~~-----~~~~~~~----~i~-~ll~~g~vpV~~G~ 126 (231)
T PRK14558 61 SPTRADQIGMLGTVINALYLKDIFEKSGLKAVIVSQ----IVNLPS-----VEPINYD----DIE-LYFRAGYIVIFAGG 126 (231)
T ss_pred ChHHHHHHHHHHHHHHHHHHHHHHHHcCCCeEEecc----ccccch-----hhhhhHH----HHH-HHHHCCCEEEEECC
Confidence 445678899999999999999999999999999885 222211 1111222 233 23567899999998
Q ss_pred CcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhH
Q 008693 270 LGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQS 349 (557)
Q Consensus 270 ig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a 349 (557)
.+.. . +.+|++|+++|.+|+|+++++||||||||++||+.+|+|+++++++|+|+.++ |++++||++
T Consensus 127 ~~~~----~------~~~D~~a~~lA~~l~a~~l~~~tdVdGvy~~dP~~~~~a~~i~~i~~~e~~~~---g~~~~d~~a 193 (231)
T PRK14558 127 TSNP----F------FTTDTAAALRAVEMKADILIKATKVDGIYDKDPKKFPDAKKIDHLTFSEAIKM---GLKVMDTEA 193 (231)
T ss_pred CCCC----C------CCcHHHHHHHHHHcCCCEEEEEecCCeeEccCCCCCCCCeEcccccHHHHHHc---CcccccHHH
Confidence 6522 1 23899999999999999999999999999999999999999999999999987 889999999
Q ss_pred HHHHHhCCCCEEEecCCCCC
Q 008693 350 MRPAREGDIPVRVKNSYNPN 369 (557)
Q Consensus 350 ~~~a~~~~Ipv~I~n~~~p~ 369 (557)
+++|+++|||++|.|+++|+
T Consensus 194 ~~~a~~~gi~v~I~ng~~~~ 213 (231)
T PRK14558 194 FSICKKYGITILVINFFEPG 213 (231)
T ss_pred HHHHHHCCCCEEEEeCCCCC
Confidence 99999999999999998874
No 40
>cd04254 AAK_UMPK-PyrH-Ec UMP kinase (UMPK)-Ec, the microbial/chloroplast uridine monophosphate kinase (uridylate kinase) enzyme that catalyzes UMP phosphorylation and plays a key role in pyrimidine nucleotide biosynthesis; regulation of this process is via feed-back control and via gene repression of carbamoyl phosphate synthetase (the first enzyme of the pyrimidine biosynthesis pathway). The UMP kinase of E. coli (Ec) is known to function as a homohexamer, with GTP and UTP being allosteric effectors. Like other related enzymes (carbamate kinase, aspartokinase, and N-acetylglutamate kinase) the E. coli and most bacterial and chloroplast UMPKs (this CD) have a conserved, N-terminal, lysine residue proposed to function in the catalysis of the phosphoryl group transfer, whereas most archaeal UMPKs appear to lack this residue and the Pyrococcus furiosus structure has an additional Mg ion bound to the ATP molecule which is proposed to function as the catalysis instead. Members of this CD be
Probab=99.96 E-value=3e-29 Score=249.66 Aligned_cols=206 Identities=23% Similarity=0.315 Sum_probs=159.8
Q ss_pred ceEEEEecccccC-------CHHHHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHH
Q 008693 81 LTCVMKFGGSSLA-------SAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFV 151 (557)
Q Consensus 81 ~~~V~KFGGsSv~-------~~~~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i 151 (557)
+++|+|||||++. +.+.++++++.|++.. +.++|+|+|| |..... .. +
T Consensus 1 ~~iViKlGGs~itdk~~~~~~~~~i~~~a~~i~~~~~~~~~~viVhGg-G~~~~~-~~----~----------------- 57 (231)
T cd04254 1 KRVLLKLSGEALAGENGFGIDPEVLNRIAREIKEVVDLGVEVAIVVGG-GNIFRG-AS----A----------------- 57 (231)
T ss_pred CeEEEEeCceEECCCCCCCCCHHHHHHHHHHHHHHHHCCCcEEEEECC-Cccccc-ch----h-----------------
Confidence 3689999999996 7899999999998643 3467788887 422100 00 0
Q ss_pred HHHHHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEE
Q 008693 152 KDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFI 231 (557)
Q Consensus 152 ~~~~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~ii 231 (557)
..++. .....|++.++||++|+.+++.+|+++|+++.++++.+.+.+
T Consensus 58 --------~~~~~-------------------------~~~~~d~~g~~~~~~n~~ll~~~L~~~Gv~a~~l~~~~~~~~ 104 (231)
T cd04254 58 --------AEAGM-------------------------DRATADYMGMLATVINALALQDALESLGVKTRVMSAIPMQGV 104 (231)
T ss_pred --------hhcCC-------------------------CchhhhHHHHHHHHHHHHHHHHHHHHcCCCeEEEcHHHhhhh
Confidence 00111 111246788899999999999999999999999999875222
Q ss_pred EecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCc
Q 008693 232 TTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDG 311 (557)
Q Consensus 232 t~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdG 311 (557)
+ ...+...+ . .+++++.|||++||.|.. .. .+|++|+++|.+|+|+++++||||||
T Consensus 105 ~---------~~~~~~~l----~-~~l~~g~ipV~~g~~G~~----~~------~~D~~a~~lA~~l~a~~l~~~tdVdG 160 (231)
T cd04254 105 A---------EPYIRRRA----I-RHLEKGRVVIFAGGTGNP----FF------TTDTAAALRAIEINADVILKATKVDG 160 (231)
T ss_pred h---------cccCHHHH----H-HHHHCCCEEEEECCcCCC----CC------CcHHHHHHHHHHcCCCEEEEEeCCCE
Confidence 1 11122222 2 235678899999987632 11 28999999999999999999999999
Q ss_pred cccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCC
Q 008693 312 VLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPN 369 (557)
Q Consensus 312 V~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~ 369 (557)
||++||+.+|+++++++++|+|+.+ .|++++||.++++|+++|||++|.|+++|+
T Consensus 161 vy~~dp~~~~~a~~i~~i~~~~~~~---~~~~~~d~~a~~~a~~~gi~~~I~~g~~~~ 215 (231)
T cd04254 161 VYDADPKKNPNAKRYDHLTYDEVLS---KGLKVMDATAFTLCRDNNLPIVVFNINEPG 215 (231)
T ss_pred EEecCCCCCCCcEEeeEecHHHHHh---cchhhhHHHHHHHHHHCCCeEEEEeCCCcc
Confidence 9999999999999999999999977 488999999999999999999999998875
No 41
>TIGR02075 pyrH_bact uridylate kinase. This protein, also called UMP kinase, converts UMP to UDP by adding a phosphate from ATP. It is the first step in pyrimidine biosynthesis. GTP is an allosteric activator. In a large fraction of all bacterial genomes, the gene tends to be located immediately downstream of elongation factor Ts and upstream of ribosome recycling factor. A related protein family, believed to be equivalent in function and found in the archaea and in spirochetes, is described by a separate model, TIGR02076.
Probab=99.96 E-value=6.6e-28 Score=240.32 Aligned_cols=213 Identities=24% Similarity=0.352 Sum_probs=162.4
Q ss_pred ceEEEEecccccC-------CHHHHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHH
Q 008693 81 LTCVMKFGGSSLA-------SAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFV 151 (557)
Q Consensus 81 ~~~V~KFGGsSv~-------~~~~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i 151 (557)
+++|+|||||++. +.+.++++++.|.+.. +.+.|+|+|| | +-+...
T Consensus 2 ~~iViKlGGs~i~~~~~~~~~~~~i~~~a~~i~~~~~~~~~vviV~G~-G---s~~~~~--------------------- 56 (233)
T TIGR02075 2 KRVLLKLSGEALAGESGFGIDPDRLNRIANEIKELVKMGIEVGIVIGG-G---NIFRGV--------------------- 56 (233)
T ss_pred CEEEEEeChhhcCCCCCCCCCHHHHHHHHHHHHHHHhCCCeEEEEECC-C---HHHHHH---------------------
Confidence 3689999999998 5788999999998643 2355666666 3 222111
Q ss_pred HHHHHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEE
Q 008693 152 KDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFI 231 (557)
Q Consensus 152 ~~~~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~ii 231 (557)
. ++.++. +....|++.++++++++.+|+.+|+++|+++..+++.+.+ .
T Consensus 57 ----~--a~~~~~-------------------------~~~~~d~~g~~~~~l~~~l~~~~L~~~Gi~a~~l~~~~~~-~ 104 (233)
T TIGR02075 57 ----S--AKELGI-------------------------DRVTADYMGMLATVINGLALRDALEKLGVKTRVLSAISMP-Q 104 (233)
T ss_pred ----H--HHhcCC-------------------------CCccHHHHHHHHHHHHHHHHHHHHHhCCCCcEEeccccCC-C
Confidence 0 111211 1112478889999999999999999999999999987753 1
Q ss_pred EecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeC-CC
Q 008693 232 TTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKD-VD 310 (557)
Q Consensus 232 t~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TD-Vd 310 (557)
+...| ..+ .+.+ +++++.|||++||.|.. .. .+|++|+++|..|+|+.+++||| ||
T Consensus 105 ~~~~~--------~~~----~i~~-ll~~g~VpV~~g~~g~~----~~------s~D~~a~~lA~~l~a~~li~~td~Vd 161 (233)
T TIGR02075 105 ICESY--------IRR----KAIK-HLEKGKVVIFSGGTGNP----FF------TTDTAAALRAIEINADVILKGTNGVD 161 (233)
T ss_pred Ccccc--------CHH----HHHH-HHHCCCEEEEECCCCCC----CC------CchHHHHHHHHHcCCCEEEEeecccC
Confidence 11111 112 2322 45778899999987642 11 28999999999999999999999 99
Q ss_pred ccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCC---------CCCeeEe
Q 008693 311 GVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPN---------APGTLIR 376 (557)
Q Consensus 311 GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~---------~~GT~I~ 376 (557)
|||++||+.+|+++++++++|+|+.++ |++++||.++++|+++|||++|.|+++|+ ..||+|+
T Consensus 162 Gvy~~dp~~~~~a~~i~~i~~~e~~~~---~~~~~d~~~~~~a~~~~i~v~i~~g~~~~~l~~~l~g~~~GT~i~ 233 (233)
T TIGR02075 162 GVYTADPKKNKDAKKYETITYNEALKK---NLKVMDLTAFALARDNNLPIVVFNIDEPGALKKVILGKGIGTLVS 233 (233)
T ss_pred eEEcCCCCCCCCCeECcEecHHHHHhc---CHHHHHHHHHHHHHHCCCeEEEEeCCCcchHHHHHCCCCCCEEeC
Confidence 999999999999999999999998765 88999999999999999999999988774 3577663
No 42
>cd04253 AAK_UMPK-PyrH-Pf AAK_UMPK-PyrH-Pf: UMP kinase (UMPK)-Pf, the mostly archaeal uridine monophosphate kinase (uridylate kinase) enzymes that catalyze UMP phosphorylation and play a key role in pyrimidine nucleotide biosynthesis; regulation of this process is via feed-back control and via gene repression of carbamoyl phosphate synthetase (the first enzyme of the pyrimidine biosynthesis pathway). The UMP kinase of Pyrococcus furiosus (Pf) is known to function as a homohexamer, with GTP and UTP being allosteric effectors. Like other related enzymes (carbamate kinase, aspartokinase, and N-acetylglutamate kinase) the E. coli and most bacterial UMPKs have a conserved, N-terminal, lysine residue proposed to function in the catalysis of the phosphoryl group transfer, whereas most archaeal UMPKs (this CD) appear to lack this residue and the Pyrococcus furiosus structure has an additional Mg ion bound to the ATP molecule which is proposed to function as the catalysis instead. Members of thi
Probab=99.95 E-value=5.7e-27 Score=231.79 Aligned_cols=195 Identities=22% Similarity=0.299 Sum_probs=155.0
Q ss_pred EEEEecccccCC---HHHHHHHHHHHHcCCCCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHH
Q 008693 83 CVMKFGGSSLAS---AERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTV 159 (557)
Q Consensus 83 ~V~KFGGsSv~~---~~~~~~va~iI~~~~~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~ 159 (557)
+|+|||||++.+ .+.++++++.|++..+.+++++|+++|..++.+.+..+
T Consensus 2 iViKlGGs~l~~~~~~~~i~~~~~~i~~~~~~~~iiiV~GgG~~a~~~~~~~~--------------------------- 54 (221)
T cd04253 2 IVISLGGSVLAPEKDADFIKEYANVLRKISDGHKVAVVVGGGRLAREYISVAR--------------------------- 54 (221)
T ss_pred EEEEeccceeCCCCChHHHHHHHHHHHHHhCCCEEEEEECCCHHHHHHHHHHH---------------------------
Confidence 699999999998 69999999999875434456667777877776654321
Q ss_pred HHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCc
Q 008693 160 DELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNA 239 (557)
Q Consensus 160 ~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a 239 (557)
+++. +....|++...++++|+.+++.+|. .|++++.++
T Consensus 55 -~~~~-------------------------~~~~~d~~g~~~~~ln~~~~~~~l~-~~~~~~~~~--------------- 92 (221)
T cd04253 55 -KLGA-------------------------SEAFLDEIGIMATRLNARLLIAALG-DAYPPVPTS--------------- 92 (221)
T ss_pred -HcCC-------------------------CHHHHHHhcCHHHHHHHHHHHHHHh-cCCCcCCCC---------------
Confidence 1111 2234578888899999999998887 777654432
Q ss_pred eeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCC
Q 008693 240 DILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNI 319 (557)
Q Consensus 240 ~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~ 319 (557)
...+.+ +++.+.|||++||++ |. + +|++|+++|.+|+|+.+++||||||||++||+.
T Consensus 93 ------~~~~~~-----~l~~g~vpv~~G~~~-----~~-s------~D~~a~~lA~~l~a~~li~~tdVdGVy~~dP~~ 149 (221)
T cd04253 93 ------YEEALE-----AMFTGKIVVMGGTEP-----GQ-S------TDAVAALLAERLGADLLINATNVDGVYSKDPRK 149 (221)
T ss_pred ------HHHHHH-----HHHcCCeEEEECCCC-----CC-c------cHHHHHHHHHHcCCCEEEEEeCCCeeECCCCCC
Confidence 111221 245778999999863 22 2 799999999999999999999999999999999
Q ss_pred CCCCccccccCHHHHHHHHHc-----CC-CcchHhHHHHHHhCCCCEEEecCCCCC
Q 008693 320 HPHAKPVPYLTFDEAAELAYF-----GA-QVLHPQSMRPAREGDIPVRVKNSYNPN 369 (557)
Q Consensus 320 v~~a~~i~~ls~~Ea~eLa~~-----Ga-~vlhp~a~~~a~~~~Ipv~I~n~~~p~ 369 (557)
.|+|++|++++++|+.+++.. |. .++|+.+++++.++++|++|.|+.+|+
T Consensus 150 ~~~a~~i~~i~~~e~~~~~~~~~~~~g~~~~~d~~a~~~~~~~gi~~~I~~g~~p~ 205 (221)
T cd04253 150 DPDAKKFDRLSADELIDIVGKSSWKAGSNEPFDPLAAKIIERSGIKTIVVDGRDPE 205 (221)
T ss_pred CCCCeEeeEeCHHHHHHHccCCCcCCCCCcchHHHHHHHHHHCCCeEEEECCCCcc
Confidence 999999999999999999876 55 689999999999999999999988774
No 43
>PRK13402 gamma-glutamyl kinase; Provisional
Probab=99.95 E-value=1.3e-26 Score=244.13 Aligned_cols=227 Identities=19% Similarity=0.319 Sum_probs=173.7
Q ss_pred CCcceEEEEecccccCC------HHHHHHHHHHHHcCC--CCccEEEEcCC--CcCcHHHHHhhHHhhhcCCCcchhhHH
Q 008693 78 EKQLTCVMKFGGSSLAS------AERMREVAELILSFP--NERPVIVLSAM--GKTTNKLLLAGEKAVSCGVTNISCIDE 147 (557)
Q Consensus 78 ~~~~~~V~KFGGsSv~~------~~~~~~va~iI~~~~--~~~~vvVVSA~--gg~Td~L~~~~~~a~~~~~~~~~~~~~ 147 (557)
+.+.++|+||||+++.+ .+.+.++++.|.... +.++|+|+|++ .|. +.|
T Consensus 3 ~~~kriVIKiGgs~L~~~~~~l~~~~i~~la~~I~~l~~~G~~vvlVsSGava~G~-~~l-------------------- 61 (368)
T PRK13402 3 SNWKRIVVKVGSSLLTPHHQGCSSHYLLGLVQQIVYLKDQGHQVVLVSSGAVAAGY-HKL-------------------- 61 (368)
T ss_pred CCCcEEEEEEchhhccCCCCCcCHHHHHHHHHHHHHHHHCCCEEEEEeCChhhcCc-ccc--------------------
Confidence 34678999999999985 489999999998643 34567777764 222 111
Q ss_pred HHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccce
Q 008693 148 LSFVKDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFD 227 (557)
Q Consensus 148 l~~i~~~~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~ 227 (557)
+. . .......++.+.+.|+..+..++..+|+++|+++. |
T Consensus 62 ---------------~~---------------~------~~~~~~~~qalaavGq~~l~~~~~~~f~~~g~~~a-----q 100 (368)
T PRK13402 62 ---------------GF---------------I------DRPSVPEKQAMAAAGQGLLMATWSKLFLSHGFPAA-----Q 100 (368)
T ss_pred ---------------CC---------------C------CCCCccHHHHHHHhhHHHHHHHHHHHHHHCCCeEE-----E
Confidence 00 0 00012345788899999999999999999999983 3
Q ss_pred eEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceee--cCCCcchhHHHHHHHHcCcCcEEE
Q 008693 228 IGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITT--LGRGGSDLTATTIGKALGLQEIQV 305 (557)
Q Consensus 228 ~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~tt--lgRgGSD~tAa~lA~~L~A~~l~i 305 (557)
+ ++|.+++.+.+ .+.+++..+. .+++.+.|||+.. ++.+++ +++|++|++|+++|.+|+|+.+++
T Consensus 101 v-LlT~~d~~~~~----~y~n~~~~l~-~LL~~g~IPIine-------nD~v~~~el~~GdnD~lAa~vA~~l~Ad~Lii 167 (368)
T PRK13402 101 L-LLTHGDLRDRE----RYINIRNTIN-VLLERGILPIINE-------NDAVTTDRLKVGDNDNLSAMVAALADADTLII 167 (368)
T ss_pred E-EEecchhhhHH----HHHHHHHHHH-HHHHCCcEEEEeC-------CCcEeecccccCChHHHHHHHHHHhCCCEEEE
Confidence 3 56766654322 2334455454 3568899999943 233444 889999999999999999999999
Q ss_pred eeCCCccccCCCCCCCCCccccccCH--HHHHHHH-----HcCCCcchH--hHHHHHHhCCCCEEEecCCCCC-------
Q 008693 306 WKDVDGVLTCDPNIHPHAKPVPYLTF--DEAAELA-----YFGAQVLHP--QSMRPAREGDIPVRVKNSYNPN------- 369 (557)
Q Consensus 306 ~TDVdGV~taDP~~v~~a~~i~~ls~--~Ea~eLa-----~~Ga~vlhp--~a~~~a~~~~Ipv~I~n~~~p~------- 369 (557)
||||||||++||+..|+|++|+++++ +|+.+++ .+|...|+| .++..|.++|+|++|.|..+|+
T Consensus 168 lTDVdGvy~~dP~~~p~a~~I~~I~~i~~e~~~l~~~~~s~~gtGGM~~Kl~Aa~~a~~~gi~v~I~~g~~~~~l~~~l~ 247 (368)
T PRK13402 168 LSDIDGLYDQNPRTNPDAKLIKQVTEINAEIYAMAGGAGSNVGTGGMRTKIQAAKIAMSHGIETFIGNGFTADIFNQLLK 247 (368)
T ss_pred EecCCeEEeCCCCCCCCCEEEEEeccCcHHHHHHhcccccCcCcCCchHHHHHHHHHHHcCCcEEEEcCCCchHHHHHhc
Confidence 99999999999999999999999997 7888876 468899999 5899999999999999998873
Q ss_pred --CCCeeEecCC
Q 008693 370 --APGTLIRRSR 379 (557)
Q Consensus 370 --~~GT~I~~~~ 379 (557)
..||+|.+..
T Consensus 248 g~~~GT~i~~~~ 259 (368)
T PRK13402 248 GQNPGTYFTPEE 259 (368)
T ss_pred CCCCceEEecCC
Confidence 4699997643
No 44
>TIGR02076 pyrH_arch uridylate kinase, putative. This family consists of the archaeal and spirochete proteins most closely related to bacterial uridylate kinases (TIGR02075), an enzyme involved in pyrimidine biosynthesis. Members are likely, but not known, to be functionally equivalent to their bacterial counterparts. However, substantial sequence differences suggest that regulatory mechanisms may be different; the bacterial form is allosterically regulated by GTP.
Probab=99.94 E-value=2.7e-26 Score=226.88 Aligned_cols=196 Identities=23% Similarity=0.247 Sum_probs=152.2
Q ss_pred EEEEecccccCC---HHHHHHHHHHHHcCCCCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHH
Q 008693 83 CVMKFGGSSLAS---AERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTV 159 (557)
Q Consensus 83 ~V~KFGGsSv~~---~~~~~~va~iI~~~~~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~ 159 (557)
+|+|||||++.+ .+.++++++.|++..+.+++++|+++|..++.+++.+
T Consensus 1 iViKlGGs~l~~~~~~~~i~~i~~~i~~~~~~~~viiV~ggG~~a~~~~~~~---------------------------- 52 (221)
T TIGR02076 1 IVISLGGSVLSPEIDAEFIKEFANILRKLSDEHKVGVVVGGGKTARRYIGVA---------------------------- 52 (221)
T ss_pred CEEEechhhcCCCCCHHHHHHHHHHHHHHHhCCeEEEEECCcHHHHHHHHHH----------------------------
Confidence 489999999988 6999999999987543345666666666555444321
Q ss_pred HHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCc
Q 008693 160 DELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNA 239 (557)
Q Consensus 160 ~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a 239 (557)
++++. +....|++...++++|+.++...|+..+++++..+..+
T Consensus 53 ~~~~~-------------------------~~~~~~~~g~~~~~ln~~~l~~ll~~~~~~~~~~~~~~------------ 95 (221)
T TIGR02076 53 RELGA-------------------------SETFLDEIGIDATRLNAMLLIAALGDDAYPKVPENFEE------------ 95 (221)
T ss_pred HHcCC-------------------------CHHHHHHhhhHHHHHHHHHHHHHHHhcCCCCcCCCHHH------------
Confidence 11221 23355788888999999999999988888765443211
Q ss_pred eeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCC
Q 008693 240 DILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNI 319 (557)
Q Consensus 240 ~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~ 319 (557)
..+ .+..+.+||++||++ |. .+|++|+++|.+|+|+.+++||||||||++||+.
T Consensus 96 ---------~~~-----~l~~g~ipv~~G~~~-----~~-------s~D~~A~~lA~~l~A~~li~ltdVdGvy~~dP~~ 149 (221)
T TIGR02076 96 ---------ALE-----AMSLGKIVVMGGTHP-----GH-------TTDAVAALLAEFSKADLLINATNVDGVYDKDPKK 149 (221)
T ss_pred ---------HHH-----HHHcCCEEEEcCCCC-----CC-------CcHHHHHHHHHHcCCCEEEEEeCCCcccCCCCCC
Confidence 111 135678999999862 32 2799999999999999999999999999999999
Q ss_pred CCCCccccccCHHHHHHHHH---cCC---CcchHhHHHHHHhCCCCEEEecCCCCC
Q 008693 320 HPHAKPVPYLTFDEAAELAY---FGA---QVLHPQSMRPAREGDIPVRVKNSYNPN 369 (557)
Q Consensus 320 v~~a~~i~~ls~~Ea~eLa~---~Ga---~vlhp~a~~~a~~~~Ipv~I~n~~~p~ 369 (557)
+|+|++|++++++|+.+++. +|. .++|+.+++++.+.++|++|.|..+|+
T Consensus 150 ~~~a~~i~~i~~~e~~~~~~~~~~~~g~~~~~~~~a~~~~~~~~i~v~I~~g~~~~ 205 (221)
T TIGR02076 150 DPDAKKFDKLTPEELVEIVGSSSVKAGSNEVVDPLAAKIIERSKIRTIVVNGRDPE 205 (221)
T ss_pred CCCCeEeeEECHHHHHHHhcCCCccCCCCceeHHHHHHHHHHCCCcEEEECCCCcc
Confidence 99999999999999999987 333 378999999999999999999988774
No 45
>cd04249 AAK_NAGK-NC AAK_NAGK-NC: N-Acetyl-L-glutamate kinase - noncyclic (NAGK-NC) catalyzes the phosphorylation of the gamma-COOH group of N-acetyl-L-glutamate (NAG) by ATP in the second step of microbial arginine biosynthesis using the acetylated, noncyclic route of ornithine biosynthesis. There are two variants of this pathway. In one, typified by the pathway in Escherichia coli, glutamate is acetylated by acetyl-CoA and acetylornithine is deacylated hydrolytically. In this pathway, feedback inhibition by arginine occurs at the initial acetylation of glutamate and not at the phosphorylation of NAG by NAGK. Homodimeric NAGK-NC are members of the Amino Acid Kinase Superfamily (AAK).
Probab=99.94 E-value=4e-26 Score=230.07 Aligned_cols=224 Identities=18% Similarity=0.286 Sum_probs=172.8
Q ss_pred EEEEecccccCCHHHHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHHH
Q 008693 83 CVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVD 160 (557)
Q Consensus 83 ~V~KFGGsSv~~~~~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~~ 160 (557)
.|+|||||++.+++.++++++.|.... ...++|+||++|+.+|.|++....
T Consensus 1 ~ViK~GGs~l~~~~~~~~~~~~i~~~~~~~~~~iVlVhGgg~~~~~~~~~~g~--------------------------- 53 (252)
T cd04249 1 LVIKLGGALLETEAALEQLFSALSEYQQQHNRQLVIVHGGGCVVDELLKKLNF--------------------------- 53 (252)
T ss_pred CEEEEChHHhcChhhHHHHHHHHHHHHHhCCCCEEEECCCCHHHHHHHHHcCC---------------------------
Confidence 489999999999989999999998642 346889999999999998864221
Q ss_pred HhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHh-hchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCC-
Q 008693 161 ELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVS-FGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTN- 238 (557)
Q Consensus 161 ~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s-~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~- 238 (557)
.. ++.++++. .+....+.+.. +++++|..++++++ ++|++++++++.+.++++.++++.
T Consensus 54 ----~~-----------~~~~g~rv---t~~~~l~~~~~~~~~~~n~~lv~~l~-~~Gv~a~~l~~~~~~~~~~~~~~~~ 114 (252)
T cd04249 54 ----PS-----------EKKNGLRV---TPKEQIPYITGALAGTANKQLMAQAI-KAGLKPVGLSLADGGMTAVTQLDPE 114 (252)
T ss_pred ----CC-----------EEECCEec---CCHHHHHHHHHHHcCcccHHHHHHHH-hCCCCceeeeccCCCEEEEEEcCCC
Confidence 00 01112221 24455566544 47899999888765 899999999999998998875542
Q ss_pred ----ceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCcccc
Q 008693 239 ----ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLT 314 (557)
Q Consensus 239 ----a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~t 314 (557)
+++.+.+.+.++. +++.+.|||++| +|.+ .+|++++++ +|++|+.+|.+|+|+ +++||||||||+
T Consensus 115 ~~~~G~v~~i~~~~l~~-----ll~~g~ipVi~~-~g~~-~~g~~~~~~---~D~~A~~lA~~l~A~-~i~ltdv~Gv~~ 183 (252)
T cd04249 115 LGAVGKATANDPSLLND-----LLKAGFLPIISS-IGAD-DQGQLMNVN---ADQAATAIAQLLNAD-LVLLSDVSGVLD 183 (252)
T ss_pred CCcccceEEEcHHHHHH-----HHHCCCEEEECC-CEEC-CCCCEeeec---HHHHHHHHHHHcCCC-EEEEeCCcccCC
Confidence 4555555554443 356789999997 6888 479999998 999999999999999 789999999999
Q ss_pred CCCCCCCCCccccccCHHHHHHHHHcCC-----CcchHhHHHHHHhCCCCEEEecCCCCC
Q 008693 315 CDPNIHPHAKPVPYLTFDEAAELAYFGA-----QVLHPQSMRPAREGDIPVRVKNSYNPN 369 (557)
Q Consensus 315 aDP~~v~~a~~i~~ls~~Ea~eLa~~Ga-----~vlhp~a~~~a~~~~Ipv~I~n~~~p~ 369 (557)
.|| +++++++++|+.++...|. ...++.|++.+.+.+++++|.|...|+
T Consensus 184 ~~~------~~i~~i~~~e~~~~~~~g~~~gGm~~kl~~a~~~~~~~~~~v~I~~g~~~~ 237 (252)
T cd04249 184 ADK------QLISELNAKQAAELIEQGVITDGMIVKVNAALDAAQSLRRGIDIASWQYPE 237 (252)
T ss_pred CCC------cCccccCHHHHHHHHhcCCCcCCcHHHHHHHHHHHHhCCCeEEEEeCCCcc
Confidence 876 5799999999999987543 455667888888888999999877663
No 46
>cd04250 AAK_NAGK-C AAK_NAGK-C: N-Acetyl-L-glutamate kinase - cyclic (NAGK-C) catalyzes the phosphorylation of the gamma-COOH group of N-acetyl-L-glutamate (NAG) by ATP in the second step of arginine biosynthesis found in some bacteria and photosynthetic organisms using the non-acetylated, cyclic route of ornithine biosynthesis. In this pathway, glutamate is first N-acetylated and then phosphorylated by NAGK to give phosphoryl NAG, which is converted to NAG-ornithine. There are two variants of this pathway. In one, typified by the pathway in Thermotoga maritima and Pseudomonas aeruginosa, the acetyl group is recycled by reversible transacetylation from acetylornithine to glutamate. The phosphorylation of NAG by NAGK is feedback inhibited by arginine. In photosynthetic organisms, NAGK is the target of the nitrogen-signaling protein PII. Hexameric formation of NAGK domains appears to be essential to both arginine inhibition and NAGK-PII complex formation. NAGK-C are members of the Amino A
Probab=99.94 E-value=3.3e-26 Score=234.00 Aligned_cols=230 Identities=21% Similarity=0.300 Sum_probs=171.6
Q ss_pred ceEEEEecccccCCHHHHHHHHHHHHcC--CCCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHH
Q 008693 81 LTCVMKFGGSSLASAERMREVAELILSF--PNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRT 158 (557)
Q Consensus 81 ~~~V~KFGGsSv~~~~~~~~va~iI~~~--~~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~ 158 (557)
.++|+|||||++.+++.++.+++.|... .+.++|+|++|++.+++.|.+.+...
T Consensus 15 ~~~ViKlGGs~i~~~~~~~~~~~~i~~l~~~g~~~ViVhG~g~~~~~~l~~~g~~~------------------------ 70 (279)
T cd04250 15 KTVVIKYGGNAMKDEELKESFARDIVLLKYVGINPVVVHGGGPEINEMLKKLGIES------------------------ 70 (279)
T ss_pred CEEEEEEChHHhcCccHHHHHHHHHHHHHHCCCCEEEEcCCcHHHHHHHHHCCCCC------------------------
Confidence 5799999999999998888888888743 23467888888776766665432110
Q ss_pred HHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCC
Q 008693 159 VDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTN 238 (557)
Q Consensus 159 ~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~ 238 (557)
.+.++++.+.+.+.+..+++++ | ++|..+ ++.|++.|++++++++.+.++++.+.++.
T Consensus 71 -------------------~~~~g~r~t~~~~~~~~~~~~~-g-~ln~~l-~~~L~~~Gv~a~~l~~~~~~~~~~~~~~~ 128 (279)
T cd04250 71 -------------------EFVNGLRVTDEETMEIVEMVLV-G-KVNKEI-VSLINRAGGKAVGLSGKDGNLIKAKKKDA 128 (279)
T ss_pred -------------------EeECCeecCCHHHHHHHHHHHc-C-chHHHH-HHHHHHcCCCcceeecCCCCEEEEEECcc
Confidence 0111222222212223345555 7 689886 77899999999999999998999877652
Q ss_pred ------------ceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEe
Q 008693 239 ------------ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVW 306 (557)
Q Consensus 239 ------------a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~ 306 (557)
+++...+...++ .+++.+.|||++| ++.+ ..|++++++ +|.+|+.+|.+|+|+++++|
T Consensus 129 ~~~~~~~~~~~~g~i~~i~~~~i~-----~ll~~g~IPVi~~-~~~~-~~g~~~~~~---~D~~A~~lA~~l~A~~li~l 198 (279)
T cd04250 129 TVIEEIIDLGFVGEVTEVNPELLE-----TLLEAGYIPVIAP-VGVG-EDGETYNIN---ADTAAGAIAAALKAEKLILL 198 (279)
T ss_pred cccCCCcccCcccceEEEcHHHHH-----HHHHCCCeEEEcC-CccC-CCCcEEEeC---HHHHHHHHHHHhCCCEEEEE
Confidence 345455554443 3456789999999 6877 478888887 99999999999999999999
Q ss_pred eCCCccccCCCCCCCCCccccccCHHHHHHHHHcC--CCcchHh--HHHHHHhCCCC-EEEecCCCCC
Q 008693 307 KDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFG--AQVLHPQ--SMRPAREGDIP-VRVKNSYNPN 369 (557)
Q Consensus 307 TDVdGV~taDP~~v~~a~~i~~ls~~Ea~eLa~~G--a~vlhp~--a~~~a~~~~Ip-v~I~n~~~p~ 369 (557)
|||||||++||+ ++++|++++++|+.+++..| ...|.++ ++..+.+.|++ ++|.|..+|+
T Consensus 199 tdv~Gv~~~~p~---~~~~i~~i~~~e~~~l~~~~~~tGgm~~Kl~~a~~a~~~g~~~v~I~~g~~~~ 263 (279)
T cd04250 199 TDVAGVLDDPND---PGSLISEISLKEAEELIADGIISGGMIPKVEACIEALEGGVKAAHIIDGRVPH 263 (279)
T ss_pred ECCcccccCCCC---CccccccCCHHHHHHHHHcCCCCCchHHHHHHHHHHHHhCCCEEEEeCCCCCc
Confidence 999999999984 58999999999999998653 3577776 55666777886 9999887764
No 47
>PRK00942 acetylglutamate kinase; Provisional
Probab=99.93 E-value=1.3e-25 Score=230.19 Aligned_cols=237 Identities=22% Similarity=0.316 Sum_probs=174.3
Q ss_pred cceEEEEecccccCCHHHHHHHHHHHHcCC-CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHH
Q 008693 80 QLTCVMKFGGSSLASAERMREVAELILSFP-NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRT 158 (557)
Q Consensus 80 ~~~~V~KFGGsSv~~~~~~~~va~iI~~~~-~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~ 158 (557)
+.++|+||||+++.+.+.+..+++.|.... ...++||||++|+.++.+++....
T Consensus 23 ~~~iViK~GGs~l~~~~~~~~l~~~i~~l~~~g~~vVlVhGgg~~~~~~~~~~g~------------------------- 77 (283)
T PRK00942 23 GKTIVIKYGGNAMTDEELKEAFARDIVLLKQVGINPVVVHGGGPQIDELLKKLGI------------------------- 77 (283)
T ss_pred CCeEEEEEChHHhcCcchHHHHHHHHHHHHHCCCCEEEEeCChHHHHHHHHHCCC-------------------------
Confidence 457999999999999999999998887532 233468899999999988763110
Q ss_pred HHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCC--
Q 008693 159 VDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDF-- 236 (557)
Q Consensus 159 ~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~-- 236 (557)
.. ++.++++.+.+.+....+++++ | ++|..++ ++|+++|+++.++++.+.++++.+++
T Consensus 78 ------~~-----------~~~~g~~~t~~~~l~~~~~a~~-G-~l~~~i~-~~L~~~Gv~a~~l~~~~~~~~ta~~~~~ 137 (283)
T PRK00942 78 ------ES-----------EFVNGLRVTDAETMEVVEMVLA-G-KVNKELV-SLINKHGGKAVGLSGKDGGLITAKKLEE 137 (283)
T ss_pred ------Cc-----------EeeCCEecCCHHHHHHHHHHHc-C-chHHHHH-HHHHhCCCCccceeeccCCEEEEEECCC
Confidence 00 0011222211111122345555 7 7888766 78999999999999999999998765
Q ss_pred ----C-CceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCc
Q 008693 237 ----T-NADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDG 311 (557)
Q Consensus 237 ----~-~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdG 311 (557)
+ .+++...+...+++ +++.|.|||+++ +|.+ .+|++++++ +|++|+.+|.+|+|+++++||||||
T Consensus 138 ~~~~~~~g~i~~i~~~~l~~-----ll~~g~vpVv~~-~~~~-~~g~~~~l~---~D~~A~~lA~~l~A~~li~~tdv~G 207 (283)
T PRK00942 138 DEDLGFVGEVTPVNPALLEA-----LLEAGYIPVISP-IGVG-EDGETYNIN---ADTAAGAIAAALGAEKLILLTDVPG 207 (283)
T ss_pred CCCCccccceEEECHHHHHH-----HHHCCCEEEEcC-cEEC-CCCcEEEEC---HHHHHHHHHHHcCCCEEEEEECCcc
Confidence 2 14455555544433 356789999997 6888 479999997 9999999999999999999999999
Q ss_pred cccCCCCCCCCCccccccCHHHHHHHHHcCC--CcchHh--HHHHHHhCCC-CEEEecCCCCC----------CCCeeEe
Q 008693 312 VLTCDPNIHPHAKPVPYLTFDEAAELAYFGA--QVLHPQ--SMRPAREGDI-PVRVKNSYNPN----------APGTLIR 376 (557)
Q Consensus 312 V~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga--~vlhp~--a~~~a~~~~I-pv~I~n~~~p~----------~~GT~I~ 376 (557)
||++ +++++++++++|+.+++..|. ..|.|+ ++..+.++|+ +++|.|..+|+ +.||+|.
T Consensus 208 v~~~------~~~~i~~i~~~e~~~~~~~~~~tggm~~Kl~~a~~~~~~gv~~v~I~~g~~~~~ll~~~~~~~~~GT~i~ 281 (283)
T PRK00942 208 VLDD------KGQLISELTASEAEELIEDGVITGGMIPKVEAALDAARGGVRSVHIIDGRVPHALLLELFTDEGIGTMIV 281 (283)
T ss_pred cccC------CCcccccCCHHHHHHHHHcCCCCCchHHHHHHHHHHHHhCCCEEEEeCCCCCchHHHHHhcCCCcceEEe
Confidence 9986 488999999999999987642 456665 5555667787 59999876664 3688886
Q ss_pred c
Q 008693 377 R 377 (557)
Q Consensus 377 ~ 377 (557)
+
T Consensus 282 ~ 282 (283)
T PRK00942 282 P 282 (283)
T ss_pred c
Confidence 5
No 48
>PRK05429 gamma-glutamyl kinase; Provisional
Probab=99.93 E-value=2.4e-25 Score=235.94 Aligned_cols=229 Identities=23% Similarity=0.374 Sum_probs=168.6
Q ss_pred CcceEEEEecccccCC------HHHHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHH
Q 008693 79 KQLTCVMKFGGSSLAS------AERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSF 150 (557)
Q Consensus 79 ~~~~~V~KFGGsSv~~------~~~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~ 150 (557)
.|+++|+|||||++.+ .+.++++++.|.+.. +.++|+|+|++ +. .+..
T Consensus 7 ~~~~iVIKiGGs~l~~~~~~l~~~~i~~la~~I~~l~~~g~~vViV~sGa--i~-----~g~~----------------- 62 (372)
T PRK05429 7 DARRIVVKVGSSLLTGGGGGLDRARIAELARQIAALRAAGHEVVLVSSGA--VA-----AGRE----------------- 62 (372)
T ss_pred hCCEEEEEeChhhccCCCCCcCHHHHHHHHHHHHHHHHCCCeEEEEcccH--hh-----hhHh-----------------
Confidence 3678999999999986 789999999998753 23555666542 11 1100
Q ss_pred HHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEE
Q 008693 151 VKDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGF 230 (557)
Q Consensus 151 i~~~~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~i 230 (557)
.++... +......++.+.+.||...+.++..+|+++|+++..+ +
T Consensus 63 ----------~l~l~~--------------------~~~~~~~~qa~aavGq~~L~~~~~~~l~~~gi~~~qi------l 106 (372)
T PRK05429 63 ----------RLGLPE--------------------RPKTLAEKQAAAAVGQSRLMQAYEELFARYGITVAQI------L 106 (372)
T ss_pred ----------hcCCCC--------------------CCCchHHHHHHHHHhHHHHHHHHHHHHHHCCCCEEEE------E
Confidence 011110 0012234578889999999999999999999996542 4
Q ss_pred EEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCce--eecCCCcchhHHHHHHHHcCcCcEEEeeC
Q 008693 231 ITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAI--TTLGRGGSDLTATTIGKALGLQEIQVWKD 308 (557)
Q Consensus 231 it~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~--ttlgRgGSD~tAa~lA~~L~A~~l~i~TD 308 (557)
+|.+++.+.. .+-+... +...+++.+.|||+.+ ++.+ ..+++|++|++|+++|.+|+|+.++||||
T Consensus 107 ~t~~d~~~~~----~~ln~~~-~i~~Ll~~g~IPVi~~-------nd~v~~~~l~~gd~D~~Aa~lA~~l~Ad~LiilTD 174 (372)
T PRK05429 107 LTRDDLEDRE----RYLNARN-TLRTLLELGVVPIINE-------NDTVATDEIKFGDNDTLSALVANLVEADLLILLTD 174 (372)
T ss_pred eehhHhhhhh----HhhhHHH-HHHHHHHCCCEEEEcC-------CCccceecccccChHHHHHHHHHHcCCCEEEEecC
Confidence 6665553211 1111122 2334567889999963 1222 23688999999999999999999999999
Q ss_pred CCccccCCCCCCCCCccccccCH--HHHHHHHH-----cCCCcchH--hHHHHHHhCCCCEEEecCCCCC---------C
Q 008693 309 VDGVLTCDPNIHPHAKPVPYLTF--DEAAELAY-----FGAQVLHP--QSMRPAREGDIPVRVKNSYNPN---------A 370 (557)
Q Consensus 309 VdGV~taDP~~v~~a~~i~~ls~--~Ea~eLa~-----~Ga~vlhp--~a~~~a~~~~Ipv~I~n~~~p~---------~ 370 (557)
|||||++||+.+|++++|+++++ +|+.+++. +|...|+| +++..+.++|+|++|.|+.+|+ .
T Consensus 175 VdGVy~~dP~~~p~a~~I~~i~~~~~e~~~~~~~~~~~~gtGGM~~Kl~aa~~a~~~Gi~v~I~~g~~~~~l~~~l~g~~ 254 (372)
T PRK05429 175 VDGLYTADPRKNPDAKLIPEVEEITDELEAMAGGAGSGLGTGGMATKLEAARIATRAGIPVVIASGREPDVLLRLLAGEA 254 (372)
T ss_pred CCeeEcCCCCCCCCceEEEEeccCCHHHHHHhcCCCCCcCcCCcHHHHHHHHHHHHCCCeEEEEcCCCccHHHHHhcCCC
Confidence 99999999999999999999998 68888863 67889999 5889999999999999988774 4
Q ss_pred CCeeEecCC
Q 008693 371 PGTLIRRSR 379 (557)
Q Consensus 371 ~GT~I~~~~ 379 (557)
.||+|.+..
T Consensus 255 ~GT~i~~~~ 263 (372)
T PRK05429 255 VGTLFLPQE 263 (372)
T ss_pred CCEEEeeCC
Confidence 699998653
No 49
>TIGR00761 argB acetylglutamate kinase. This model describes N-acetylglutamate kinases (ArgB) of many prokaryotes and the N-acetylglutamate kinase domains of multifunctional proteins from yeasts. This enzyme is the second step in the "acetylated" ornithine biosynthesis pathway. A related group of enzymes representing the first step of the pathway contain a homologous domain and are excluded from this model.
Probab=99.93 E-value=1.6e-25 Score=222.80 Aligned_cols=215 Identities=19% Similarity=0.268 Sum_probs=160.2
Q ss_pred eEEEEecccccCCHHHHHHHHHHHHcCC-CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHHH
Q 008693 82 TCVMKFGGSSLASAERMREVAELILSFP-NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVD 160 (557)
Q Consensus 82 ~~V~KFGGsSv~~~~~~~~va~iI~~~~-~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~~ 160 (557)
++|+|||||++.++ ++++++.|.... ...++|+||++|+.+|.+++......
T Consensus 1 ~~ViK~GGs~l~~~--~~~~~~~i~~l~~~g~~~VlVhggg~~~~~~~~~~~~~~------------------------- 53 (231)
T TIGR00761 1 TIVIKIGGAAISDL--LEAFASDIAFLRAVGIKPVIVHGGGPEINELLEALGIPP------------------------- 53 (231)
T ss_pred CEEEEEChHHHhcc--HHHHHHHHHHHHHcCCCEEEEcCCcHHHHHHHHHcCCCC-------------------------
Confidence 47999999999987 889999888542 23346788999999998876422100
Q ss_pred HhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHH-HhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCC--
Q 008693 161 ELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYL-VSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFT-- 237 (557)
Q Consensus 161 ~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i-~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~-- 237 (557)
++.++++ ..++...+.+ .++++++|..+++ .|+++|++++++++.+.+++|.+.+.
T Consensus 54 -----------------~~~~g~r---~t~~~~~~~~~~~~~g~~~~~i~~-~L~~~G~~a~~l~~~~~~~it~~~~~~~ 112 (231)
T TIGR00761 54 -----------------EFKNGLR---VTDKETLEVVEMVLIGQVNKELVA-LLNKHGINAIGLTGGDGQLFTARSLDKE 112 (231)
T ss_pred -----------------EecCCCc---cCCHHHHHHHHHHHhcchHHHHHH-HHHhCCCCcccccCCCCCEEEEEECCCc
Confidence 0011111 1122333222 2335588988776 89999999999999998889876543
Q ss_pred ----CceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccc
Q 008693 238 ----NADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVL 313 (557)
Q Consensus 238 ----~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~ 313 (557)
.+++...+.+.+++ +++.+.|||++| +|.+ .+|++++++ +|++|+.+|.+|+|++++|||||||||
T Consensus 113 ~~~~~g~i~~i~~~~i~~-----~l~~g~IPVi~~-~~~~-~~g~~~~l~---sD~~A~~lA~~l~A~~li~ltdv~Gv~ 182 (231)
T TIGR00761 113 DLGYVGEIKKVNKALLEA-----LLKAGYIPVISS-LALT-AEGQALNVN---ADTAAGALAAALGAEKLVLLTDVPGIL 182 (231)
T ss_pred cCCcccceEEEcHHHHHH-----HHHCCCeEEECC-CccC-CCCcEEEeC---HHHHHHHHHHHcCCCEEEEEECCCCee
Confidence 23455555554443 356788999999 5877 479999997 999999999999999999999999999
Q ss_pred cCCCCCCCCCccccccCHHHHHHHHHcC--CCcchHh--HHHHHHhCCCC
Q 008693 314 TCDPNIHPHAKPVPYLTFDEAAELAYFG--AQVLHPQ--SMRPAREGDIP 359 (557)
Q Consensus 314 taDP~~v~~a~~i~~ls~~Ea~eLa~~G--a~vlhp~--a~~~a~~~~Ip 359 (557)
++||+ ++|++|+++|+.++++.| ...|.|| ++..+.++|++
T Consensus 183 ~~d~~-----~~i~~i~~~e~~~l~~~~~~tggm~~Kl~~a~~a~~~gv~ 227 (231)
T TIGR00761 183 NGDGQ-----SLISEIPLEEIEQLIEQGIITGGMIPKVNAALEALRGGVK 227 (231)
T ss_pred cCCCC-----eeccccCHHHHHHHHHcCCCCCchHHHHHHHHHHHHcCCC
Confidence 99984 689999999999999876 4678886 66666778876
No 50
>cd04238 AAK_NAGK-like AAK_NAGK-like: N-Acetyl-L-glutamate kinase (NAGK)-like . Included in this CD are the Escherichia coli and Pseudomonas aeruginosa type NAGKs which catalyze the phosphorylation of N-acetyl-L-glutamate (NAG) by ATP in the second step of arginine biosynthesis found in bacteria and photosynthetic organisms using either the acetylated, noncyclic (NC), or non-acetylated, cyclic (C) route of ornithine biosynthesis. Also included in this CD is a distinct group of uncharacterized (UC) bacterial and archeal NAGKs. Members of this CD belong to the Amino Acid Kinase Superfamily (AAK).
Probab=99.92 E-value=9.2e-25 Score=220.67 Aligned_cols=223 Identities=22% Similarity=0.298 Sum_probs=164.7
Q ss_pred EEEEecccccCCHHHHHHHHHHHHcCC-CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHHHH
Q 008693 83 CVMKFGGSSLASAERMREVAELILSFP-NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVDE 161 (557)
Q Consensus 83 ~V~KFGGsSv~~~~~~~~va~iI~~~~-~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~~~ 161 (557)
+|+||||+++.+++.++++++.|.... ...++|||+++|+.+|.+++......+
T Consensus 1 ~ViKlGGs~l~~~~~~~~~~~~i~~l~~~g~~~VlVhG~g~~~~~~~~~~~~~~~------------------------- 55 (256)
T cd04238 1 VVIKYGGSAMKDEELKEAFADDIVLLKQVGINPVIVHGGGPEINELLKRLGIESE------------------------- 55 (256)
T ss_pred CEEEEChHHhcCccHHHHHHHHHHHHHHCCCCEEEECCCcHHHHHHHHHCCCCCE-------------------------
Confidence 489999999999999999999887532 233466779999999998864321100
Q ss_pred hCCCHHHHHHHHHHHHHHHHhhhhccCCCHHH---HHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCC--
Q 008693 162 LGIDRSIIATHLEELEQLLKGIAMLKELTPRS---RDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDF-- 236 (557)
Q Consensus 162 l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~---~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~-- 236 (557)
+.+++ +..+++. .++.++ | ++|..+ .++|+++|++++++++.+.++++++.+
T Consensus 56 -----------------~~~~~---r~t~~~~l~~~~~a~~-g-~ln~~i-~~~L~~~Gv~a~~l~~~~~~~~~~~~~~~ 112 (256)
T cd04238 56 -----------------FVNGL---RVTDKETMEIVEMVLA-G-KVNKEL-VSLLNRAGGKAVGLSGKDGGLIKAEKKEE 112 (256)
T ss_pred -----------------eECCe---ecCCHHHHHHHHHHHc-C-chHHHH-HHHHHhCCCCCCCcccccCCEEEEEECCC
Confidence 00011 1112222 234444 7 889986 778999999999999999889988653
Q ss_pred -----C-CceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCC
Q 008693 237 -----T-NADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVD 310 (557)
Q Consensus 237 -----~-~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVd 310 (557)
+ .+++...+.+.+.. +++.+.|||++| ++.+ .+|++++++ +|++|+.+|.+|+|+++++|||||
T Consensus 113 ~~~~~~~~g~i~~i~~~~l~~-----ll~~g~ipVv~~-~~~~-~~g~~~~~~---~D~~A~~lA~~l~a~~li~ltdv~ 182 (256)
T cd04238 113 KDIDLGFVGEVTEVNPELLET-----LLEAGYIPVIAP-IAVD-EDGETYNVN---ADTAAGAIAAALKAEKLILLTDVP 182 (256)
T ss_pred CCCCcccccceEEECHHHHHH-----HHHCCCEEEECC-cEEC-CCCcEEEEC---HHHHHHHHHHHcCCCEEEEEeCCc
Confidence 1 14555555554443 356789999998 6877 479999997 999999999999999999999999
Q ss_pred ccccCCCCCCCCCccccccCHHHHHHHHHcC--CCcchHh--HHHHHHhCCC-CEEEecCCCCC
Q 008693 311 GVLTCDPNIHPHAKPVPYLTFDEAAELAYFG--AQVLHPQ--SMRPAREGDI-PVRVKNSYNPN 369 (557)
Q Consensus 311 GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~G--a~vlhp~--a~~~a~~~~I-pv~I~n~~~p~ 369 (557)
|||++ +++++++++++|+.++...+ ...|.|+ ++..+.+.++ +++|.|...|+
T Consensus 183 Gv~~~------~~~~i~~i~~~e~~~~~~~~~~~ggm~~Kl~~a~~~~~~g~~~v~I~~g~~~~ 240 (256)
T cd04238 183 GVLDD------PGSLISELTPKEAEELIEDGVISGGMIPKVEAALEALEGGVRKVHIIDGRVPH 240 (256)
T ss_pred cccCC------CCCccccCCHHHHHHHHHcCCCCCChHHHHHHHHHHHHhCCCEEEEeCCCCCc
Confidence 99987 27899999999999998633 2566665 4555566666 59999877663
No 51
>PLN02418 delta-1-pyrroline-5-carboxylate synthase
Probab=99.92 E-value=2.3e-24 Score=245.17 Aligned_cols=239 Identities=18% Similarity=0.267 Sum_probs=177.1
Q ss_pred CcceEEEEecccccCCHH------HHHHHHHHHHcC--CCCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHH
Q 008693 79 KQLTCVMKFGGSSLASAE------RMREVAELILSF--PNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSF 150 (557)
Q Consensus 79 ~~~~~V~KFGGsSv~~~~------~~~~va~iI~~~--~~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~ 150 (557)
.|+++|+|||||||.+.+ +|++++++|.+. .+.++|+|+||+.+.|+.++...+..
T Consensus 14 ~~~~iViK~G~ssl~~~~~~~~~~~i~~l~~~i~~l~~~g~~vvlVsSga~~~g~~~l~~~~~~---------------- 77 (718)
T PLN02418 14 DVKRVVIKVGTAVVTRDDGRLALGRLGALCEQIKELNSDGYEVILVSSGAVGVGRQRLRYRRLV---------------- 77 (718)
T ss_pred hCCEEEEEeCCCeecCCCCCccHHHHHHHHHHHHHHHHCCCEEEEEecchHHHHHHHHhhhhhh----------------
Confidence 467899999999999988 999999999853 34568999999999999988753311
Q ss_pred HHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEE
Q 008693 151 VKDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGF 230 (557)
Q Consensus 151 i~~~~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~i 230 (557)
+++..+ + .+......+..++|+||.+++.+++.+|+++|++ ++|+ +
T Consensus 78 ---------~~~~~~-----------------~--~~~~~~~~~qa~aa~Gq~~l~~~~~~~f~~~g~~-----~~qi-l 123 (718)
T PLN02418 78 ---------NSSFAD-----------------L--QKPQMELDGKACAAVGQSELMALYDTLFSQLDVT-----ASQL-L 123 (718)
T ss_pred ---------hccccc-----------------C--CCCcchHHHHHHHHhhHHHHHHHHHHHHHHcCCe-----EEEE-E
Confidence 000000 0 0000111223789999999999999999999994 5666 7
Q ss_pred EEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCC---------CcchhHHHHHHHHcCcC
Q 008693 231 ITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGR---------GGSDLTATTIGKALGLQ 301 (557)
Q Consensus 231 it~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgR---------gGSD~tAa~lA~~L~A~ 301 (557)
+|+++|.+.+. +.+..+.+. .+++.+.|||+.| ++.+++..+ +++|++|+++|.+++|+
T Consensus 124 lT~~~~~~~~~----~~~~~~~l~-~ll~~g~iPVv~~-------nd~v~~~~~~~~~~~~~~~d~D~~A~~lA~~l~Ad 191 (718)
T PLN02418 124 VTDSDFRDPDF----RKQLSETVE-SLLDLRVIPIFNE-------NDAVSTRRAPYEDSSGIFWDNDSLAALLALELKAD 191 (718)
T ss_pred ecHhHhcchhH----hHhHHHHHH-HHHHCCCEEEEcC-------CCCccccccccccccCeecCcHHHHHHHHHHcCCC
Confidence 88888876543 223334444 3567889999955 344444422 26999999999999999
Q ss_pred cEEEeeCCCccccCCCCCCCCCccccccCHHHHHH-HHH-----cCCCcchHh--HHHHHHhCCCCEEEecCCCCC----
Q 008693 302 EIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAE-LAY-----FGAQVLHPQ--SMRPAREGDIPVRVKNSYNPN---- 369 (557)
Q Consensus 302 ~l~i~TDVdGV~taDP~~v~~a~~i~~ls~~Ea~e-La~-----~Ga~vlhp~--a~~~a~~~~Ipv~I~n~~~p~---- 369 (557)
.++|||||||||++||+ .|++++|++++..+... +.. .|...|.|| ++..+.++|+|++|.|...|+
T Consensus 192 ~li~~TdVdGvy~~~p~-~~~a~~i~~i~~~~~~~~i~~~~~s~~~tGGM~~Kl~Aa~~a~~~Gi~v~I~~g~~~~~l~~ 270 (718)
T PLN02418 192 LLILLSDVEGLYTGPPS-DPSSKLIHTYIKEKHQDEITFGEKSRVGRGGMTAKVKAAVNAASAGIPVVITSGYALDNIRK 270 (718)
T ss_pred EEEEeecCCeeecCCCC-CCCceEcceecccchhhhhhcccccccCCCCcHHHHHHHHHHHHCCCcEEEeCCCCcchHHH
Confidence 99999999999999998 59999999998765433 222 246688885 888999999999999987774
Q ss_pred -----CCCeeEecCCC
Q 008693 370 -----APGTLIRRSRD 380 (557)
Q Consensus 370 -----~~GT~I~~~~~ 380 (557)
..||+|.+...
T Consensus 271 ~l~g~~~GT~i~~~~~ 286 (718)
T PLN02418 271 VLRGERVGTLFHQDAH 286 (718)
T ss_pred HhcCCCCceEeccccc
Confidence 47999987543
No 52
>TIGR01027 proB glutamate 5-kinase. Bacterial ProB proteins hit the full length of this model, but the ProB-like domain of delta 1-pyrroline-5-carboxylate synthetase does not hit the C-terminal 100 residues of this model. The noise cutoff is set low enough to hit delta 1-pyrroline-5-carboxylate synthetase and other partial matches to this family.
Probab=99.92 E-value=3.4e-24 Score=226.29 Aligned_cols=225 Identities=22% Similarity=0.383 Sum_probs=164.4
Q ss_pred eEEEEecccccCCHH------HHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHH
Q 008693 82 TCVMKFGGSSLASAE------RMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKD 153 (557)
Q Consensus 82 ~~V~KFGGsSv~~~~------~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~ 153 (557)
.+|+|||||++.+.+ .++++++.|.+.. +.++|+|+|++ ... +..
T Consensus 2 riVIKiGgs~l~~~~~~~~~~~i~~la~~I~~l~~~g~~vvlV~sG~--~~~-----g~~-------------------- 54 (363)
T TIGR01027 2 RIVVKVGSSSLTGSSGSLDRSHIAELVEQVAALHAAGHEVVIVSSGA--IAA-----GFE-------------------- 54 (363)
T ss_pred eEEEEeccceEeCCCCCcCHHHHHHHHHHHHHHHHCCCeEEEEeCcH--Hhc-----Ccc--------------------
Confidence 589999999999754 4899999988643 23455666533 210 000
Q ss_pred HHHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEe
Q 008693 154 LHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITT 233 (557)
Q Consensus 154 ~~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~ 233 (557)
.++... +......++.+.+.|+..+..++...|.++|+++ .++ ++|.
T Consensus 55 -------~lg~~~--------------------~~~~l~~~qa~aa~Gq~~l~~~~~~~l~~~Gi~~-----aqi-llt~ 101 (363)
T TIGR01027 55 -------ALGLPE--------------------RPKTLAEKQALAAVGQVRLMQLYEQLFSQYGIKV-----AQI-LLTR 101 (363)
T ss_pred -------ccCCCC--------------------CccchHHHHHHHHhChHHHHHHHHHHHHHcCCeE-----EEE-EEec
Confidence 011110 0111234577899999999999999999999986 333 6777
Q ss_pred cCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCce--eecCCCcchhHHHHHHHHcCcCcEEEeeCCCc
Q 008693 234 DDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAI--TTLGRGGSDLTATTIGKALGLQEIQVWKDVDG 311 (557)
Q Consensus 234 ~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~--ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdG 311 (557)
++|.+.. .+.+....+. .+++.+.|||+.- ++.+ +.+++|++|++|+++|.+|+|+.++|||||||
T Consensus 102 ~d~~~~~----~~lna~~~i~-~Ll~~g~iPVi~e-------nd~v~~~~l~~gd~D~lAa~lA~~l~Ad~liilTDVdG 169 (363)
T TIGR01027 102 ADFSDRE----RYLNARNTLE-ALLELGVVPIINE-------NDTVATEEIKFGDNDTLSALVAILVGADLLVLLTDVDG 169 (363)
T ss_pred cchhhHH----HHHHHHHHHH-HHHhCCCEEEEeC-------CCceeeeecCcCChHHHHHHHHHHcCCCEEEEEeCCCc
Confidence 7665422 1222223333 4567889999952 2222 45788999999999999999999999999999
Q ss_pred cccCCCCCCCCCccccccCHH--HHHHHH-----HcCCCcchHh--HHHHHHhCCCCEEEecCCCCC---------CCCe
Q 008693 312 VLTCDPNIHPHAKPVPYLTFD--EAAELA-----YFGAQVLHPQ--SMRPAREGDIPVRVKNSYNPN---------APGT 373 (557)
Q Consensus 312 V~taDP~~v~~a~~i~~ls~~--Ea~eLa-----~~Ga~vlhp~--a~~~a~~~~Ipv~I~n~~~p~---------~~GT 373 (557)
||++||+..|+|++|+++++. +..+++ .+|...|+|| ++..|.++|+|++|.|..+|+ ..||
T Consensus 170 Vy~~dP~~~p~A~~I~~i~~~~~~~~~i~~~~~~~~gtGGM~~Kl~Aa~~a~~~gi~v~I~~g~~~~~l~~~l~g~~~GT 249 (363)
T TIGR01027 170 LYDADPRTNPDAKLIPVVEEITDLLLGVAGDSGSSVGTGGMRTKLQAADLATRAGVPVIIASGSKPEKIADALEGAPVGT 249 (363)
T ss_pred ccCCCCCCCCCCeEEEEeccCcHHHHHhhcCCCcCcCcCCchHHHHHHHHHHHCCCeEEEEeCCCccHHHHHhcCCCCcE
Confidence 999999999999999999974 555665 4788899998 889999999999999998874 3599
Q ss_pred eEecC
Q 008693 374 LIRRS 378 (557)
Q Consensus 374 ~I~~~ 378 (557)
+|.+.
T Consensus 250 ~i~~~ 254 (363)
T TIGR01027 250 LFHAQ 254 (363)
T ss_pred EEeeC
Confidence 99764
No 53
>COG0528 PyrH Uridylate kinase [Nucleotide transport and metabolism]
Probab=99.92 E-value=6.6e-24 Score=205.94 Aligned_cols=207 Identities=24% Similarity=0.369 Sum_probs=162.2
Q ss_pred ceEEEEecccccCC-------HHHHHHHHHHHHcCCC-CccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHH
Q 008693 81 LTCVMKFGGSSLAS-------AERMREVAELILSFPN-ERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVK 152 (557)
Q Consensus 81 ~~~V~KFGGsSv~~-------~~~~~~va~iI~~~~~-~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~ 152 (557)
+.+|.|+||+.+.. ++.++++++.|++..+ +..|.||-++|.+-.......
T Consensus 6 ~rillkLsGe~l~g~~~~gid~~~i~~~a~~i~~~~~~g~eV~iVvGGGni~Rg~~~~~--------------------- 64 (238)
T COG0528 6 MRILLKLSGEALAGEQGFGIDPEVLDRIANEIKELVDLGVEVAVVVGGGNIARGYIGAA--------------------- 64 (238)
T ss_pred EEEEEEeecceecCCCCCCCCHHHHHHHHHHHHHHHhcCcEEEEEECCCHHHHhHHHHH---------------------
Confidence 55899999999975 5899999999988643 345555556666644332210
Q ss_pred HHHHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEE
Q 008693 153 DLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFIT 232 (557)
Q Consensus 153 ~~~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit 232 (557)
.|. +....|++..++.++|+.+|...|++.|++++.+++...+.+.
T Consensus 65 ---------~g~-------------------------~r~~~D~mGmlaTvmNal~L~~aL~~~~~~~~v~sai~~~~~~ 110 (238)
T COG0528 65 ---------AGM-------------------------DRVTADYMGMLATVMNALALQDALERLGVDTRVQSAIAMPQVA 110 (238)
T ss_pred ---------cCC-------------------------chhhhhHHHHHHHHHHHHHHHHHHHhcCCcceecccccCcccc
Confidence 011 3446699999999999999999999999999999876542111
Q ss_pred ecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeC-CCc
Q 008693 233 TDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKD-VDG 311 (557)
Q Consensus 233 ~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TD-VdG 311 (557)
. ++..++..++ ++++.|+|++|..|.. |.+ +|++|+++|..++||-++.-|+ |||
T Consensus 111 -e------------~~~~~~A~~~-l~~grVvIf~gGtg~P---~fT-------TDt~AALrA~ei~ad~ll~atn~VDG 166 (238)
T COG0528 111 -E------------PYSRREAIRH-LEKGRVVIFGGGTGNP---GFT-------TDTAAALRAEEIEADVLLKATNKVDG 166 (238)
T ss_pred -C------------ccCHHHHHHH-HHcCCEEEEeCCCCCC---CCc-------hHHHHHHHHHHhCCcEEEEeccCCCc
Confidence 1 1112223333 4678999999865532 555 8999999999999999999995 999
Q ss_pred cccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCC
Q 008693 312 VLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPN 369 (557)
Q Consensus 312 V~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~ 369 (557)
||++||+++|+|+++++|||+|+.++ +.+||+|-|+..+++++||++|.|.++|.
T Consensus 167 VY~~DPkk~pdA~~~~~Lty~e~l~~---~l~vmD~tA~~l~~~~~i~i~Vfn~~~~~ 221 (238)
T COG0528 167 VYDADPKKDPDAKKYDTLTYDEVLKI---GLKVMDPTAFSLARDNGIPIIVFNINKPG 221 (238)
T ss_pred eeCCCCCCCCCceecccCCHHHHHHh---cCeeecHHHHHHHHHcCCcEEEEeCCCCc
Confidence 99999999999999999999999988 57999999999999999999999977764
No 54
>PRK14058 acetylglutamate/acetylaminoadipate kinase; Provisional
Probab=99.92 E-value=9.3e-24 Score=214.70 Aligned_cols=174 Identities=18% Similarity=0.247 Sum_probs=139.7
Q ss_pred CCHHHHHHH-HhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecC----------------CCC-ceeeecchHHHH
Q 008693 189 LTPRSRDYL-VSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDD----------------FTN-ADILEATYPAVA 250 (557)
Q Consensus 189 ~~~~~~d~i-~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~----------------~~~-a~i~~~~~~~v~ 250 (557)
.+++..+.+ .++| ++|..+++ +|+++|++|+++++.+.++++.+. ++. +++...+.+.++
T Consensus 66 t~~~~l~~~~~a~~-~ln~~lv~-~L~~~Gv~a~~l~~~~~~l~~~~~~~~~~~~~~g~~~~~d~g~~g~v~~v~~~~i~ 143 (268)
T PRK14058 66 TDRETLEVFIMAMA-LINKQLVE-RLQSLGVNAVGLSGLDGGLLEGKRKKAVRVVEEGKKKIIRGDYTGKIEEVNTDLLK 143 (268)
T ss_pred CCHHHHHHHHHHHH-HHHHHHHH-HHHhCCCCccccCcccCCEEEEEEecccccccCCcceeccCCceeEEEEECHHHHH
Confidence 356666664 6888 99999886 899999999999999988876431 111 455555555444
Q ss_pred HHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCccccccC
Q 008693 251 KRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLT 330 (557)
Q Consensus 251 ~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~i~~ls 330 (557)
. +++.+.|||++|+ +.+ .+|+.++++ +|++|+.+|.+|+|++++|||||||||++||+ +++++++++
T Consensus 144 ~-----ll~~g~iPVi~~~-~~~-~~g~~~~i~---~D~~A~~lA~~l~A~~li~ltdv~Gv~~~~p~---~~~~i~~i~ 210 (268)
T PRK14058 144 L-----LLKAGYLPVVAPP-ALS-EEGEPLNVD---GDRAAAAIAGALKAEALVLLSDVPGLLRDPPD---EGSLIERIT 210 (268)
T ss_pred H-----HHHCCCEEEEeCc-eEC-CCCcEEecC---HHHHHHHHHHHcCCCEEEEEeCChhhccCCCC---CCcCccCcC
Confidence 3 3567899999996 555 478888886 99999999999999999999999999999994 588999999
Q ss_pred HHHHHHHHHcCCCcchHh--HHHHHHhCCC-CEEEecCCCCC-------CCCeeEec
Q 008693 331 FDEAAELAYFGAQVLHPQ--SMRPAREGDI-PVRVKNSYNPN-------APGTLIRR 377 (557)
Q Consensus 331 ~~Ea~eLa~~Ga~vlhp~--a~~~a~~~~I-pv~I~n~~~p~-------~~GT~I~~ 377 (557)
++|+.++..+....|.|| ++..+.++|+ +++|.|..+|+ +.||+|.+
T Consensus 211 ~~e~~~l~~~~tGgM~~Kl~aa~~a~~~Gv~~v~I~~g~~~~~l~~~l~G~GT~I~~ 267 (268)
T PRK14058 211 PEEAEELSKAAGGGMKKKVLMAAEAVEGGVGRVIIADANVDDPISAALAGEGTVIVN 267 (268)
T ss_pred HHHHHHHhhccCCccHHHHHHHHHHHHcCCCEEEEEcCCCcchHHHHhCCCceEEec
Confidence 999999987777788887 6667778899 79999887774 35999865
No 55
>PRK14556 pyrH uridylate kinase; Provisional
Probab=99.91 E-value=1.2e-23 Score=209.15 Aligned_cols=214 Identities=21% Similarity=0.295 Sum_probs=163.6
Q ss_pred ceEEEEecccccCC-------HHHHHHHHHHHHcCCC--CccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHH
Q 008693 81 LTCVMKFGGSSLAS-------AERMREVAELILSFPN--ERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFV 151 (557)
Q Consensus 81 ~~~V~KFGGsSv~~-------~~~~~~va~iI~~~~~--~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i 151 (557)
+.+|.|.+|..+.. ++.++++++.|++..+ .+..||| +.|.+-.-.
T Consensus 16 ~rvllKlsGe~l~~~~~~~~d~~~~~~~a~~i~~~~~~g~~i~iVv-GGGni~Rg~------------------------ 70 (249)
T PRK14556 16 KRILLKLSGESLSADQGFGINVESAQPIINQIKTLTNFGVELALVV-GGGNILRGG------------------------ 70 (249)
T ss_pred CEEEEEEehhhCcCCCCCCcCHHHHHHHHHHHHHHHhCCcEEEEEE-CCCHHHhCc------------------------
Confidence 46899999999974 4789999999987543 4555666 445443210
Q ss_pred HHHHHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEE
Q 008693 152 KDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFI 231 (557)
Q Consensus 152 ~~~~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~ii 231 (557)
...++ ...+....|++..++.++|+.+|..+|++.|++++.+++-..
T Consensus 71 -------~~~~~-----------------------~~~~r~~~D~~GmlaT~iNal~l~~~l~~~~~~~~v~sa~~~--- 117 (249)
T PRK14556 71 -------RANFG-----------------------NKIRRATADSMGMIATMINALALRDMLISEGVDAEVFSAKGV--- 117 (249)
T ss_pred -------hhhcc-----------------------CCCchhhhhHHHHHHHHHHHHHHHHHHHHcCCCeEEeecccc---
Confidence 00000 012345679999999999999999999999999999987432
Q ss_pred EecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCc
Q 008693 232 TTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDG 311 (557)
Q Consensus 232 t~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdG 311 (557)
..+ +++. ++++ ..+. +++|.|+|++|+.|.. ..+ +|++|+++|..++|+.+++||||||
T Consensus 118 --~~~--~e~~--~~~~----~~~~-l~~g~vvi~~gg~G~p----~~S------tD~lAallA~~l~Ad~Lii~TdVDG 176 (249)
T PRK14556 118 --DGL--LKVA--SAHE----FNQE-LAKGRVLIFAGGTGNP----FVT------TDTTASLRAVEIGADALLKATTVNG 176 (249)
T ss_pred --CcC--CCCC--CHHH----HHHH-HhCCCEEEEECCCCCC----cCC------cHHHHHHHHHHcCCCEEEEEeCCCc
Confidence 111 2221 2332 3332 4678899989987742 233 8999999999999999999999999
Q ss_pred cccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCC---------CCCeeEe
Q 008693 312 VLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPN---------APGTLIR 376 (557)
Q Consensus 312 V~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~---------~~GT~I~ 376 (557)
||++||+++|+|+++++++|+|+.+. +.+++++.++++|+++|||++|.|..+|+ ..||+|.
T Consensus 177 VYd~DP~~~p~A~~i~~I~~~e~~~~---~l~vmd~~A~~~a~~~gIpi~I~ng~~~~~L~~~l~Ge~~GT~i~ 247 (249)
T PRK14556 177 VYDKDPNKYSDAKRFDKVTFSEVVSK---ELNVMDLGAFTQCRDFGIPIYVFDLTQPNALVDAVLDSKYGTWVT 247 (249)
T ss_pred cCCCCCCCCCCceEeeEEchhhhccc---chHhHHHHHHHHHHHCCCcEEEECCCCchHHHHHHcCCCCceEEE
Confidence 99999999999999999999998774 66899999999999999999999988874 4688774
No 56
>cd04241 AAK_FomA-like AAK_FomA-like: This CD includes a fosfomycin biosynthetic gene product, FomA, and similar proteins found in a wide range of organisms. Together, the fomA and fomB genes in the fosfomycin biosynthetic gene cluster of Streptomyces wedmorensis confer high-level fosfomycin resistance. FomA and FomB proteins converted fosfomycin to fosfomycin monophosphate and fosfomycin diphosphate in the presence of ATP and a magnesium ion, indicating that FomA and FomB catalyzed phosphorylations of fosfomycin and fosfomycin monophosphate, respectively. FomA and related sequences in this CD are members of the Amino Acid Kinase Superfamily (AAK).
Probab=99.89 E-value=5.9e-22 Score=199.73 Aligned_cols=148 Identities=21% Similarity=0.260 Sum_probs=118.1
Q ss_pred HHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeec
Q 008693 203 CMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTL 282 (557)
Q Consensus 203 ~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttl 282 (557)
+++.. +.++|.++|+++.++++.++ +.+. ..++...+.+.+.+ +++.+.|||++|+.+.+ .+|.+.++
T Consensus 80 ~ln~~-~~~~l~~~g~~a~~l~~~~~-~~~~----~g~~~~~~~~~l~~-----ll~~g~iPVi~~~~~~~-~~~~~~~~ 147 (252)
T cd04241 80 ELNSI-VVDALLEAGVPAVSVPPSSF-FVTE----NGRIVSFDLEVIKE-----LLDRGFVPVLHGDVVLD-EGGGITIL 147 (252)
T ss_pred HHHHH-HHHHHHHCCCCeEEEChHHe-EEec----CCeeeeecHHHHHH-----HHhCCCEEEEcCCeEec-CCCCeEEe
Confidence 66764 56679999999999999986 3332 23444444443332 35788999999988777 36777777
Q ss_pred CCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCccccccCHHHHHHHHHc-------CCCcchHh--HHHHH
Q 008693 283 GRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYF-------GAQVLHPQ--SMRPA 353 (557)
Q Consensus 283 gRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~i~~ls~~Ea~eLa~~-------Ga~vlhp~--a~~~a 353 (557)
+ +|++|+.+|.+|+|+++++||||||||++|| |+++++++++++|+.++... ....|.|| ++..+
T Consensus 148 ~---~D~~A~~lA~~l~A~~li~ltdv~Gv~~~~P---~~~~~i~~i~~~~~~~~~~~~~~~~~~~tGGm~~Kl~aa~~a 221 (252)
T cd04241 148 S---GDDIVVELAKALKPERVIFLTDVDGVYDKPP---PDAKLIPEIDVGSLEDILAALGSAGTDVTGGMAGKIEELLEL 221 (252)
T ss_pred C---hHHHHHHHHHHcCCCEEEEEeCCCeeECCCC---CCCeEcceeCccchHHHHHhcCcCCccccCCHHHHHHHHHHH
Confidence 6 9999999999999999999999999999999 89999999999998888652 33567776 66777
Q ss_pred HhCCCCEEEecCCCC
Q 008693 354 REGDIPVRVKNSYNP 368 (557)
Q Consensus 354 ~~~~Ipv~I~n~~~p 368 (557)
.++|++++|.|..+|
T Consensus 222 ~~~Gv~v~I~~g~~~ 236 (252)
T cd04241 222 ARRGIEVYIFNGDKP 236 (252)
T ss_pred HhcCCeEEEEeCCCH
Confidence 789999999988766
No 57
>PLN02512 acetylglutamate kinase
Probab=99.89 E-value=8.9e-22 Score=203.86 Aligned_cols=227 Identities=20% Similarity=0.292 Sum_probs=159.6
Q ss_pred ceEEEEecccccCCHHHHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHH
Q 008693 81 LTCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRT 158 (557)
Q Consensus 81 ~~~V~KFGGsSv~~~~~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~ 158 (557)
.++|.||||+++.+.+..+.+.+.|.... +.++|+| .++|...+.+++.
T Consensus 48 ~tiVIKlGGs~i~d~~~~~~~~~di~~l~~~g~~iVlV-HGgG~~i~~~~~~---------------------------- 98 (309)
T PLN02512 48 KTVVVKYGGAAMKDPELKAGVIRDLVLLSCVGLRPVLV-HGGGPEINSWLKK---------------------------- 98 (309)
T ss_pred CeEEEEECCeeccChhHHHHHHHHHHHHHHCCCCEEEE-ECCcHHHHHHHHH----------------------------
Confidence 56999999999998776666666665322 2344545 4555555554431
Q ss_pred HHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHH-h-hchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCC
Q 008693 159 VDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLV-S-FGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDF 236 (557)
Q Consensus 159 ~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~-s-~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~ 236 (557)
++.++ ++.+|++.+ ++...+.+. . .| .+|..+. ++|+++|++++++++.+.++++.+.+
T Consensus 99 ---~gi~~-----------~~~~G~rvT---~~~~lei~~~~l~g-~ln~~lv-~~L~~~Gv~av~l~g~d~~~i~a~~~ 159 (309)
T PLN02512 99 ---VGIEP-----------QFKNGLRVT---DAETMEVVEMVLVG-KVNKSLV-SLINKAGGTAVGLSGKDGRLLRARPS 159 (309)
T ss_pred ---cCCCC-----------cCCCCCcCC---CHHHHHHHHHHHhh-HHHHHHH-HHHHHcCCCeEEeehhhCCEEEEEEc
Confidence 11111 112233222 333333331 1 24 6677755 57999999999999999889988765
Q ss_pred CC-------ceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCC
Q 008693 237 TN-------ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDV 309 (557)
Q Consensus 237 ~~-------a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDV 309 (557)
.+ .++...+.+.++ .+++.+.|||++|+ +.+ .+|+.++++ +|.+|+.+|.+|+|+++++||||
T Consensus 160 ~~~~~~~~~G~i~~v~~~~i~-----~lL~~g~IPVi~~~-~~d-~~g~~~~i~---~D~~A~~lA~~L~Ad~li~lTdV 229 (309)
T PLN02512 160 PNSADLGFVGEVTRVDPTVLR-----PLVDDGHIPVIATV-AAD-EDGQAYNIN---ADTAAGEIAAALGAEKLILLTDV 229 (309)
T ss_pred CcCccccccceeeecCHHHHH-----HHHhCCCEEEEeCc-eEC-CCCCEeccC---HHHHHHHHHHHcCCCEEEEEeCC
Confidence 32 344455555443 34578899999995 777 478888886 99999999999999999999999
Q ss_pred CccccCCCCCCCCCccccccCHHHHHHHHHcC--CCcchHh--HHHHHHhCCCC-EEEecCCCC
Q 008693 310 DGVLTCDPNIHPHAKPVPYLTFDEAAELAYFG--AQVLHPQ--SMRPAREGDIP-VRVKNSYNP 368 (557)
Q Consensus 310 dGV~taDP~~v~~a~~i~~ls~~Ea~eLa~~G--a~vlhp~--a~~~a~~~~Ip-v~I~n~~~p 368 (557)
||||++|| +++++|++++++|+.++...| ...|.|| ++..+.+.|++ ++|.|...|
T Consensus 230 ~GV~~~~~---~~~~lI~~i~~~e~~~l~~~~~vtGGM~~Kl~aa~~a~~~Gv~~v~I~~g~~~ 290 (309)
T PLN02512 230 AGVLEDKD---DPGSLVKELDIKGVRKLIADGKIAGGMIPKVECCVRSLAQGVKTAHIIDGRVP 290 (309)
T ss_pred cceeCCCC---CCcCCCcccCHHHHHHHHhCCCCCCcHHHHHHHHHHHHHcCCCEEEEecCCCC
Confidence 99999875 358999999999999998543 3678887 45556678996 899887665
No 58
>COG0548 ArgB Acetylglutamate kinase [Amino acid transport and metabolism]
Probab=99.88 E-value=3.4e-22 Score=199.47 Aligned_cols=230 Identities=23% Similarity=0.336 Sum_probs=173.7
Q ss_pred cceEEEEecccccCCHHHHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHH
Q 008693 80 QLTCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHR 157 (557)
Q Consensus 80 ~~~~V~KFGGsSv~~~~~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~ 157 (557)
+.+.|.|+||+.|.+.+.+..+++.|..+. +.++|||+ +.|..-|++++.
T Consensus 2 ~k~~VIK~GG~~~~~~~l~~~~~~di~lL~~~G~~~VvVH-Gggp~I~~~l~~--------------------------- 53 (265)
T COG0548 2 GKTIVIKLGGSAMEDENLLEAFASDIALLKSVGIRPVVVH-GGGPQIDEMLAK--------------------------- 53 (265)
T ss_pred CceEEEEECceeecCchHHHHHHHHHHHHHHCCCcEEEEe-CCchHHHHHHHH---------------------------
Confidence 467999999999999998999999876543 45775555 445544444331
Q ss_pred HHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCC
Q 008693 158 TVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFT 237 (557)
Q Consensus 158 ~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~ 237 (557)
++.++ ++.+|++++.+.+.....++ ++-.+|..|.+ .|+..|.+++.+++.|.++++.....
T Consensus 54 ----~gie~-----------~f~~glRvTd~~tlevv~mv--l~G~vNk~iva-~l~~~g~~avGlsg~Dg~li~A~~~~ 115 (265)
T COG0548 54 ----LGIEP-----------EFVKGLRVTDAETLEVVEMV--LGGTVNKEIVA-RLSKHGGQAVGLSGVDGNLVTAKKLD 115 (265)
T ss_pred ----cCCCC-----------eeeCCEEcCCHHHHHHHHHH--HHHHHHHHHHH-HHHHhCCcceeeeecCCCEEEEEEcc
Confidence 22222 24556655544444443444 34477888665 69999999999999998899876432
Q ss_pred C---------ceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeC
Q 008693 238 N---------ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKD 308 (557)
Q Consensus 238 ~---------a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TD 308 (557)
. .++.+++++.+ ..+++++.|||+++ +|.+ .+|++.|++ +|++|+.+|.+|+|++++++||
T Consensus 116 ~~~~id~g~vG~i~~Vn~~~i-----~~ll~~~~IpViap-ia~~-~~G~~~Nvn---aD~~A~~iA~aLkAekLi~ltd 185 (265)
T COG0548 116 VDDGVDLGYVGEIRKVNPELI-----ERLLDNGAIPVIAP-IAVD-EDGETLNVN---ADTAAGALAAALKAEKLILLTD 185 (265)
T ss_pred cccccccceeeeEEEECHHHH-----HHHHhCCCceEEec-ceEC-CCCcEEeeC---HHHHHHHHHHHcCCCeEEEEeC
Confidence 2 34555665533 34467889999999 7888 589999999 9999999999999999999999
Q ss_pred CCccccCCCCCCCCCccccccCHHHHHHHHHcC--CCcchHh--HHHHHHhCCC-CEEEecCCCCC
Q 008693 309 VDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFG--AQVLHPQ--SMRPAREGDI-PVRVKNSYNPN 369 (557)
Q Consensus 309 VdGV~taDP~~v~~a~~i~~ls~~Ea~eLa~~G--a~vlhp~--a~~~a~~~~I-pv~I~n~~~p~ 369 (557)
|+|||+.+|+ .+.+++++.+|+.+|...| ...|.|+ +..-|.+.|+ +++|.|...|.
T Consensus 186 v~Gvl~~~~~----~s~i~~~~~~~~~~li~~~~i~~GMi~Kv~~a~~A~~~Gv~~v~ii~g~~~~ 247 (265)
T COG0548 186 VPGVLDDKGD----PSLISELDAEEAEELIEQGIITGGMIPKVEAALEALESGVRRVHIISGRVPH 247 (265)
T ss_pred CcccccCCCC----ceeeccCCHHHHHHHHhcCCccCccHHHHHHHHHHHHhCCCeEEEecCCCcc
Confidence 9999998875 2789999999999999987 4678886 7778889999 59998877664
No 59
>CHL00202 argB acetylglutamate kinase; Provisional
Probab=99.87 E-value=1.4e-21 Score=200.28 Aligned_cols=235 Identities=17% Similarity=0.249 Sum_probs=165.9
Q ss_pred ceEEEEecccccCCHHHHHHHHHHHHcCC-CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHH
Q 008693 81 LTCVMKFGGSSLASAERMREVAELILSFP-NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTV 159 (557)
Q Consensus 81 ~~~V~KFGGsSv~~~~~~~~va~iI~~~~-~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~ 159 (557)
.+.|.|+||+.+.+....+.+++.|.... ...++|+|++.|..-+.+++.
T Consensus 24 ~~~VIk~gG~~~~~~~l~~~~~~di~~l~~~g~~~VlVHGgg~~i~~~~~~----------------------------- 74 (284)
T CHL00202 24 RIMVIKYGGAAMKNLILKADIIKDILFLSCIGLKIVVVHGGGPEINFWLKQ----------------------------- 74 (284)
T ss_pred CeEEEEEChHHhcCcchHHHHHHHHHHHHHCCCcEEEEeCCcHHHHHHHHH-----------------------------
Confidence 57999999999988666667777776542 233455556656544444331
Q ss_pred HHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHh-hchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCC--
Q 008693 160 DELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVS-FGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDF-- 236 (557)
Q Consensus 160 ~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s-~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~-- 236 (557)
++.++ ++++|++.+ ++.+.+.+.. +--.++..++ ++|++.|++++++++.+.++++...+
T Consensus 75 --~g~~~-----------~~~~G~rvT---~~~~l~~~~~~l~g~ln~~lv-~~L~~~Gv~av~l~~~d~~~i~a~~~~~ 137 (284)
T CHL00202 75 --LNISP-----------KFWNGIRVT---DKVTMEIVEMVLAGKVNKDLV-GSINANGGKAVGLCGKDANLIVARASDK 137 (284)
T ss_pred --CCCCC-----------EeECCcccC---CHHHHHHHHHHHhhHHHHHHH-HHHHhCCCCeeeeeeccCCEEEEEeCCC
Confidence 12111 123444433 3444443321 2226788765 56899999999999999888886543
Q ss_pred ---CC-ceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCcc
Q 008693 237 ---TN-ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGV 312 (557)
Q Consensus 237 ---~~-a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV 312 (557)
+. .++...+.+.++. +++.+.|||++|+ +.+ ..|++++++ +|++|+.+|.+|+|++++||||||||
T Consensus 138 ~d~~~~G~i~~v~~~~i~~-----ll~~g~iPVi~~~-~~~-~~g~~~ni~---~D~~A~~lA~~l~Ad~li~lTdv~Gv 207 (284)
T CHL00202 138 KDLGLVGEIQQVDPQLIDM-----LLEKNYIPVIASV-AAD-HDGQTYNIN---ADVVAGEIAAKLNAEKLILLTDTPGI 207 (284)
T ss_pred cccccceeEEecCHHHHHH-----HHHCCCEEEECCC-ccC-CCCcEEecC---HHHHHHHHHHHhCCCEEEEEeCChhh
Confidence 22 4455555554443 4567899999995 777 479999997 99999999999999999999999999
Q ss_pred ccC--CCCCCCCCccccccCHHHHHHHHHcC--CCcchHh--HHHHHHhCCCC-EEEecCCCCC----------CCCeeE
Q 008693 313 LTC--DPNIHPHAKPVPYLTFDEAAELAYFG--AQVLHPQ--SMRPAREGDIP-VRVKNSYNPN----------APGTLI 375 (557)
Q Consensus 313 ~ta--DP~~v~~a~~i~~ls~~Ea~eLa~~G--a~vlhp~--a~~~a~~~~Ip-v~I~n~~~p~----------~~GT~I 375 (557)
|++ || .+++++++++|+.++...| ...|.|| +...+.++|++ ++|.|..+|+ +.||+|
T Consensus 208 ~~~~~d~-----~~~i~~i~~~e~~~l~~~g~~tGGM~~Kl~aa~~a~~~Gv~~v~I~~g~~~~~ll~el~~~~g~GT~i 282 (284)
T CHL00202 208 LADINDP-----NSLISTLNIKEARNLASTGIISGGMIPKVNCCIRALAQGVEAAHIIDGKEKHALLLEILTEKGIGSML 282 (284)
T ss_pred cCCCCCC-----CCccccccHHHHHHHHhcCCCCCCHHHHHHHHHHHHHcCCCEEEEeCCCCCChHHHHHhcCCCCceEE
Confidence 984 44 3799999999999998764 3578887 55667788987 7898877764 357877
Q ss_pred e
Q 008693 376 R 376 (557)
Q Consensus 376 ~ 376 (557)
.
T Consensus 283 ~ 283 (284)
T CHL00202 283 V 283 (284)
T ss_pred e
Confidence 4
No 60
>cd04255 AAK_UMPK-MosAB AAK_UMPK-MosAB: This CD includes the alpha and beta subunits of the Mo storage protein (MosA and MosB) which are related to uridine monophosphate kinase (UMPK) enzymes that catalyze the phosphorylation of UMP by ATP, yielding UDP, and playing a key role in pyrimidine nucleotide biosynthesis. The Mo storage protein from the nitrogen-fixing bacterium, Azotobacter vinelandii, is characterized as an alpha4-beta4 octamer containing a polynuclear molybdenum-oxide cluster which is ATP-dependent to bind Mo and pH-dependent to release Mo. These and related bacterial sequences in this CD are members of the Amino Acid Kinase Superfamily (AAK).
Probab=99.86 E-value=2.4e-20 Score=188.54 Aligned_cols=207 Identities=20% Similarity=0.270 Sum_probs=143.0
Q ss_pred cceEEEEecccccCC--HHHHHHHHHHHHcCCCCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHH
Q 008693 80 QLTCVMKFGGSSLAS--AERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHR 157 (557)
Q Consensus 80 ~~~~V~KFGGsSv~~--~~~~~~va~iI~~~~~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~ 157 (557)
+.++|.|+|||.+.+ .+.++++++.|++..+...+++|++.|....... .
T Consensus 30 ~~~~ViKiGGSvitdk~~~~i~~la~~i~~~~~~~~vilV~GGG~~~r~~~----------------------------~ 81 (262)
T cd04255 30 PDLNVVKIGGQSIIDRGAEAVLPLVEEIVALRPEHKLLILTGGGTRARHVY----------------------------S 81 (262)
T ss_pred CCcEEEEeccceecCCcHHHHHHHHHHHHHHhCCCcEEEEECCHHHHHHHH----------------------------H
Confidence 356999999999954 5789999999987654445555554443221111 0
Q ss_pred HHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCC
Q 008693 158 TVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFT 237 (557)
Q Consensus 158 ~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~ 237 (557)
....++. +....|++...-..+|+.++...|...|+++. +..
T Consensus 82 ~~~~~g~-------------------------~~~~~~~~~~aa~~ln~lv~~~~l~~~g~~~i----------~~~--- 123 (262)
T cd04255 82 IGLDLGM-------------------------PTGVLAKLGASVSEQNAEMLATLLAKHGGSKV----------GHG--- 123 (262)
T ss_pred HHHHcCC-------------------------CchHHHHHHHHHHHHHHHHHHHHHHHcCCCcc----------ccc---
Confidence 1111222 22234445444457888877777888888652 111
Q ss_pred CceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCc------chhHHHHHHHHcCcCcEEEeeCCCc
Q 008693 238 NADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGG------SDLTATTIGKALGLQEIQVWKDVDG 311 (557)
Q Consensus 238 ~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgG------SD~tAa~lA~~L~A~~l~i~TDVdG 311 (557)
+... +. .+++.+.|||+.|+.+.+ ..++++|+| +|++|+++|.+|+|+.+++||||||
T Consensus 124 -------~~~~----l~-~lL~~g~vPVi~g~~~~~----~~~i~~~~g~~~~~~~D~~Aa~lA~~l~ad~li~~TdVdG 187 (262)
T cd04255 124 -------DLLQ----LP-TFLKAGRAPVISGMPPYG----LWEHPAEEGRIPPHRTDVGAFLLAEVIGARNLIFVKDEDG 187 (262)
T ss_pred -------cHHH----HH-HHHHCCCeEEEeCCcCCC----eeeecCCCccCCCCCcHHHHHHHHHHhCCCEEEEEeccCe
Confidence 1112 22 235788999999997643 345667666 9999999999999999999999999
Q ss_pred cccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCC--CCEEEecCCCCC
Q 008693 312 VLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGD--IPVRVKNSYNPN 369 (557)
Q Consensus 312 V~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~--Ipv~I~n~~~p~ 369 (557)
||++||+.+|+|++|++++++|+.++.. +..++...+...++..+ +|++|.|..+|+
T Consensus 188 Vy~~dP~~~~~a~~i~~i~~~~~~~~~~-~~~~~~~~~~~~l~aa~~~~~v~I~~g~~~~ 246 (262)
T cd04255 188 LYTADPKKNKKAEFIPEISAAELLKKDL-DDLVLERPVLDLLQNARHVKEVQIVNGLVPG 246 (262)
T ss_pred eECCCCCCCCCCeEccEeCHHHHHHHhc-CCCCCcHHHHHHHHHhCCCCcEEEEeCCCCC
Confidence 9999999999999999999999888752 23356666555555333 699999987774
No 61
>cd04251 AAK_NAGK-UC AAK_NAGK-UC: N-Acetyl-L-glutamate kinase - uncharacterized (NAGK-UC). This domain is similar to Escherichia coli and Pseudomonas aeruginosa NAGKs which catalyze the phosphorylation of the gamma-COOH group of N-acetyl-L-glutamate (NAG) by ATP in the second step of microbial arginine biosynthesis. These uncharacterized domain sequences are found in some bacteria (Deinococci and Chloroflexi) and archea and belong to the Amino Acid Kinase Superfamily (AAK).
Probab=99.85 E-value=4.7e-20 Score=186.49 Aligned_cols=221 Identities=19% Similarity=0.282 Sum_probs=159.3
Q ss_pred EEEEecccccCCHHHHHHHHHHHHcCCCCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHHHHh
Q 008693 83 CVMKFGGSSLASAERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVDEL 162 (557)
Q Consensus 83 ~V~KFGGsSv~~~~~~~~va~iI~~~~~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~~~l 162 (557)
+|.||||+.+.+. +++++.|... +. ++|+|+++|...+.+++..
T Consensus 1 ~VIKlGGs~l~~~---~~~~~~i~~l-g~-~~VlVHGgg~~i~~~~~~~------------------------------- 44 (257)
T cd04251 1 IVVKIGGSVVSDL---DKVIDDIANF-GE-RLIVVHGGGNYVNEYLKRL------------------------------- 44 (257)
T ss_pred CEEEEChHHhhCh---HHHHHHHHHc-CC-CEEEECCCHHHHHHHHHHc-------------------------------
Confidence 4899999999864 5677777765 33 4777788887666655421
Q ss_pred CCCHHHHHHHHHHHHHHH---HhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCC---
Q 008693 163 GIDRSIIATHLEELEQLL---KGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDF--- 236 (557)
Q Consensus 163 ~~~~~~i~~~~~~l~~~l---~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~--- 236 (557)
+++. +++ +|+. .+-.+++..+.+....+.+|..+++ .|+++|++++.+++.+.++++.+.+
T Consensus 45 gi~~-----------~~~~~~~G~~-~Rvt~~~~l~~~~~a~~~ln~~iv~-~L~~~Gi~a~~l~~~~~~~~~~~~~~~~ 111 (257)
T cd04251 45 GVEP-----------KFVTSPSGIR-SRYTDKETLEVFVMVMGLINKKIVA-RLHSLGVKAVGLTGLDGRLLEAKRKEIV 111 (257)
T ss_pred CCCc-----------EEEeCCCCCc-cccCCHHHHHHHHHHHHHHHHHHHH-HHHhCCCCceecccccCCEEEEEEeecc
Confidence 1111 001 0100 0123456666665444899999766 8999999999999999877765533
Q ss_pred -----C---------CceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCc
Q 008693 237 -----T---------NADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQE 302 (557)
Q Consensus 237 -----~---------~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~ 302 (557)
+ .+++...+.+.++. +++++.|||+++| +.+ .+|++++++ +|++|+.+|.+|+|++
T Consensus 112 ~~~~~~~~~~~d~~~~G~v~~v~~~~i~~-----ll~~g~vpVi~~~-~~~-~~G~~~~i~---~D~~A~~lA~~L~A~~ 181 (257)
T cd04251 112 RVNERGRKMIIRGGYTGKVEKVNSDLIEA-----LLDAGYLPVVSPV-AYS-EEGEPLNVD---GDRAAAAIAAALKAER 181 (257)
T ss_pred cccccCcccccCCcceEEEEEEcHHHHHH-----HHhCCCeEEEeCc-EEC-CCCcEEecC---HHHHHHHHHHHcCCCE
Confidence 1 02444455554433 3578899999986 445 379999997 9999999999999999
Q ss_pred EEEeeCCCccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHh--HHHHHHhCCC-CEEEecCCCCC
Q 008693 303 IQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQ--SMRPAREGDI-PVRVKNSYNPN 369 (557)
Q Consensus 303 l~i~TDVdGV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~--a~~~a~~~~I-pv~I~n~~~p~ 369 (557)
+++||||||||++ ++++++++++|+.++...-...|.|+ ++..+.++|+ .++|.|...|+
T Consensus 182 li~~tdv~Gv~~~-------~~~i~~i~~~e~~~l~~~~~ggm~~Kl~aa~~a~~~gv~~v~i~~g~~~~ 244 (257)
T cd04251 182 LILLTDVEGLYLD-------GRVIERITVSDAESLLEKAGGGMKRKLLAAAEAVEGGVREVVIGDARADS 244 (257)
T ss_pred EEEEeCChhheeC-------CcccCccCHHHHHHHHhhCCCchHHHHHHHHHHHHcCCCEEEEecCCCcc
Confidence 9999999999973 78999999999999986555667775 6777778888 58888877764
No 62
>cd04256 AAK_P5CS_ProBA AAK_P5CS_ProBA: Glutamate-5-kinase (G5K) domain of the bifunctional delta 1-pyrroline-5-carboxylate synthetase (P5CS), composed of an N-terminal G5K (ProB) and a C-terminal glutamyl 5- phosphate reductase (G5PR, ProA), the first and second enzyme catalyzing proline (and, in mammals, ornithine) biosynthesis. G5K transfers the terminal phosphoryl group of ATP to the gamma-carboxyl group of glutamate, and is subject to feedback allosteric inhibition by proline or ornithine. In plants, proline plays an important role as an osmoprotectant and, in mammals, ornithine biosynthesis is crucial for proper ammonia detoxification, since a G5K mutation has been shown to cause human hyperammonaemia.
Probab=99.82 E-value=6.2e-19 Score=180.39 Aligned_cols=169 Identities=16% Similarity=0.227 Sum_probs=128.1
Q ss_pred HHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCccc
Q 008693 194 RDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKA 273 (557)
Q Consensus 194 ~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~ 273 (557)
+..+.+.|+..-..+....|..+|+++ .|+ ++|.++|.+.+. +.+..+.+. .+++.+.|||+.|+=...
T Consensus 94 ~qa~aa~gq~~L~~~y~~~f~~~~~~~-----~q~-llt~~d~~~~~~----~~~~~~~l~-~lL~~g~iPVi~~nD~v~ 162 (284)
T cd04256 94 GRACAAVGQSGLMALYEAMFTQYGITV-----AQV-LVTKPDFYDEQT----RRNLNGTLE-ELLRLNIIPIINTNDAVS 162 (284)
T ss_pred HHHHHHcccHHHHHHHHHHHHHcCCcH-----HHe-eeeccccccHHH----HHHHHHHHH-HHHHCCCEEEEeCCCccc
Confidence 456788999999999999999999875 666 888888876553 223344443 456889999998632211
Q ss_pred C-----CCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCccccccCHHHHHHHHH-----cCCC
Q 008693 274 W-----RTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAY-----FGAQ 343 (557)
Q Consensus 274 ~-----~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~i~~ls~~Ea~eLa~-----~Ga~ 343 (557)
. .+|+.. .--+++|+.|+.+|.+++|+.++++|||||||++||+ .|++++|++++.+|..++++ .|..
T Consensus 163 ~~~~~~~~~~~~-~~i~d~D~lAa~lA~~l~Ad~Li~lTDVdGVy~~dP~-~~~a~~I~~i~~~~~~~~~~~~~s~~gtG 240 (284)
T cd04256 163 PPPEPDEDLQGV-ISIKDNDSLAARLAVELKADLLILLSDVDGLYDGPPG-SDDAKLIHTFYPGDQQSITFGTKSRVGTG 240 (284)
T ss_pred cccccccccccc-ccccChHHHHHHHHHHcCCCEEEEEeCCCeeecCCCC-CCCCeEcccccHhHHHHhhcccccCcccC
Confidence 0 011111 1124699999999999999999999999999999997 59999999999988776643 2567
Q ss_pred cchHh--HHHHHHhCCCCEEEecCCCCC---------CCCeeE
Q 008693 344 VLHPQ--SMRPAREGDIPVRVKNSYNPN---------APGTLI 375 (557)
Q Consensus 344 vlhp~--a~~~a~~~~Ipv~I~n~~~p~---------~~GT~I 375 (557)
.|.|| ++..+.++|++++|.|..+|+ ..||+|
T Consensus 241 GM~~Kl~Aa~~a~~~Gi~v~I~~G~~~~~i~~~l~G~~~GT~~ 283 (284)
T cd04256 241 GMEAKVKAALWALQGGTSVVITNGMAGDVITKILEGKKVGTFF 283 (284)
T ss_pred CcHHHHHHHHHHHHCCCeEEEEcCCCccHHHHHHcCCCCCEEe
Confidence 89886 888899999999999987774 357766
No 63
>TIGR01092 P5CS delta l-pyrroline-5-carboxylate synthetase. This protein contains a glutamate 5-kinase (ProB, EC 2.7.2.11) region followed by a gamma-glutamyl phosphate reductase (ProA, EC 1.2.1.41) region.
Probab=99.82 E-value=2.6e-19 Score=204.31 Aligned_cols=236 Identities=17% Similarity=0.282 Sum_probs=162.2
Q ss_pred cceEEEEecccccCCHH------HHHHHHHHHHcC--CCCccEEEEc---CCCcCcHHHHHhhHHhhhcCCCcchhhHHH
Q 008693 80 QLTCVMKFGGSSLASAE------RMREVAELILSF--PNERPVIVLS---AMGKTTNKLLLAGEKAVSCGVTNISCIDEL 148 (557)
Q Consensus 80 ~~~~V~KFGGsSv~~~~------~~~~va~iI~~~--~~~~~vvVVS---A~gg~Td~L~~~~~~a~~~~~~~~~~~~~l 148 (557)
.+.+|.|||||++.+.+ .+.++++.|... .+.+.|+|+| |+|..+..+.+..... .
T Consensus 7 ~~~iViKiGss~lt~~~~~~~~~~l~~l~~~i~~l~~~g~~vilVsSGA~a~G~~~~~~~~~~~~~----~--------- 73 (715)
T TIGR01092 7 VKRIVVKVGTAVVTRGDGRLALGRLGSICEQLSELNSDGREVILVTSGAVAFGRQRLRHRILVNSS----F--------- 73 (715)
T ss_pred CCEEEEEeCcceeECCCCCCCHHHHHHHHHHHHHHHHCCCEEEEEccchHHhchHHhccchhcccc----c---------
Confidence 46799999999998765 899999998863 2456677788 6666655443211000 0
Q ss_pred HHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEecccee
Q 008693 149 SFVKDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDI 228 (557)
Q Consensus 149 ~~i~~~~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~ 228 (557)
. ...+..+...+..+.+.|+..-..+....|..+++. +.|+
T Consensus 74 ----------------~------------------~~~~~~~~~~~qa~aa~gq~~L~~~y~~~f~~~~i~-----~aQ~ 114 (715)
T TIGR01092 74 ----------------A------------------DLQKPQPELDGKACAAVGQSGLMALYETMFTQLDIT-----AAQI 114 (715)
T ss_pred ----------------c------------------ccCCCCchHHHHHHHHHHHHHHHHHHHHHHHHcCCe-----eEEE
Confidence 0 000011122233345556554455555566666665 4666
Q ss_pred EEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCc---------chhHHHHHHHHcC
Q 008693 229 GFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGG---------SDLTATTIGKALG 299 (557)
Q Consensus 229 ~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgG---------SD~tAa~lA~~L~ 299 (557)
++|.++|.+.+. +.+..+.+. .+++.|.|||+.+ |+.+++.+++| +|++|+++|.+|+
T Consensus 115 -Llt~~d~~~~~~----~~~~~~~l~-~lL~~g~iPVin~-------nD~V~~~~~~~~~~~g~~~d~D~lAa~lA~~l~ 181 (715)
T TIGR01092 115 -LVTDLDFRDEQF----RRQLNETVH-ELLRMNVVPVVNE-------NDAVSTRAAPYSDSQGIFWDNDSLAALLALELK 181 (715)
T ss_pred -EechhhcccHHH----HHHHHHHHH-HHHHCCCEEEEcC-------CCcccccccccccccceecchHHHHHHHHHHcC
Confidence 888888776543 223333343 4568899999964 45566666654 6999999999999
Q ss_pred cCcEEEeeCCCccccCCCCCCCCCccccccCHHHHH-HHHH-----cCCCcchH--hHHHHHHhCCCCEEEecCCCCC--
Q 008693 300 LQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAA-ELAY-----FGAQVLHP--QSMRPAREGDIPVRVKNSYNPN-- 369 (557)
Q Consensus 300 A~~l~i~TDVdGV~taDP~~v~~a~~i~~ls~~Ea~-eLa~-----~Ga~vlhp--~a~~~a~~~~Ipv~I~n~~~p~-- 369 (557)
|+.+++||||||||++||+ .|++++|++++..+.. ++++ .+...|.| +++..+.++|+|++|.|+.+|+
T Consensus 182 Ad~LiilTDVdGVy~~dP~-~~~a~~I~~i~~~~~~~~i~~~~~~~~~tGGM~~Kl~aa~~a~~~gi~v~I~~g~~~~~l 260 (715)
T TIGR01092 182 ADLLILLSDVEGLYDGPPS-DDDSKLIDTFYKEKHQGEITFGTKSRLGRGGMTAKVKAAVWAAYGGTPVIIASGTAPKNI 260 (715)
T ss_pred CCEEEEEeCCCeeeCCCCC-CCCCeEeeeecccchhhhhccCcccccCCCCchHHHHHHHHHHHCCCeEEEeCCCCcchH
Confidence 9999999999999999997 5999999999876554 3322 23567777 5888999999999999987773
Q ss_pred -------CCCeeEecCCCC
Q 008693 370 -------APGTLIRRSRDM 381 (557)
Q Consensus 370 -------~~GT~I~~~~~~ 381 (557)
..||+|.+...|
T Consensus 261 ~~~l~g~~~GT~~~~~~~~ 279 (715)
T TIGR01092 261 TKVVEGKKVGTLFHEDAHL 279 (715)
T ss_pred HHHhcCCCCceEecccchh
Confidence 469999776544
No 64
>PTZ00489 glutamate 5-kinase; Provisional
Probab=99.77 E-value=2.9e-17 Score=166.15 Aligned_cols=169 Identities=17% Similarity=0.234 Sum_probs=121.1
Q ss_pred HHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCccc
Q 008693 194 RDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKA 273 (557)
Q Consensus 194 ~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~ 273 (557)
+..+.+.|...-..++...|.++|+++. |+ ++|..++.+.. .+.+..+.+. .+++.+.|||+.|.-. .
T Consensus 72 ~qa~aaiGq~~L~~~y~~~f~~~~~~~a-----qi-Llt~~d~~~~~----~~~n~~~~l~-~lL~~g~VPIinend~-~ 139 (264)
T PTZ00489 72 KQALASMGQPLLMHMYYTELQKHGILCA-----QM-LLAAYDLDSRK----RTINAHNTIE-VLISHKVIPIINENDA-T 139 (264)
T ss_pred HHHHHHhCHHHHHHHHHHHHHhCCCeEE-----Ee-eeeccccccch----hhHHHHHHHH-HHHHCCCEEEECCCCC-c
Confidence 3456677886677778889999999873 33 45555554321 1222333343 3567899999987311 1
Q ss_pred CCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCcc---ccccCHHHHHHHH----HcCCCcch
Q 008693 274 WRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKP---VPYLTFDEAAELA----YFGAQVLH 346 (557)
Q Consensus 274 ~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~---i~~ls~~Ea~eLa----~~Ga~vlh 346 (557)
..++.. -|++|..|+++|.+++|+.++++|||||||++||+..|+|++ ++++++++..... ..|...|.
T Consensus 140 -~~~e~~---~gdnD~lAa~lA~~l~Ad~LiilTDVdGVy~~dP~~~~~A~~~~~i~~i~~~~~~~~~~~~~~~~tGGM~ 215 (264)
T PTZ00489 140 -ALHELV---FGDNDRLSALVAHHFKADLLVILSDIDGYYTENPRTSTDAKIRSVVHELSPDDLVAEATPNNRFATGGIV 215 (264)
T ss_pred -ccceeE---eCChHHHHHHHHHHhCCCEEEEeeccCeeEcCCCCCCCccceeeeeccCCHHHHHHhcCcCCCcccCChH
Confidence 112322 346999999999999999999999999999999999999998 7889988774432 23456777
Q ss_pred Hh--HHHHHHhCCCCEEEecCCCCC-----------CCCeeEecC
Q 008693 347 PQ--SMRPAREGDIPVRVKNSYNPN-----------APGTLIRRS 378 (557)
Q Consensus 347 p~--a~~~a~~~~Ipv~I~n~~~p~-----------~~GT~I~~~ 378 (557)
+| ++..+.++|++++|.|..+|+ ..||+|.+.
T Consensus 216 ~Kl~aa~~a~~~Gi~v~I~~g~~~~~i~~~l~g~~~~~GT~~~~~ 260 (264)
T PTZ00489 216 TKLQAAQFLLERGGKMYLSSGFHLEKARDFLIGGSHEIGTLFYPR 260 (264)
T ss_pred HHHHHHHHHHHCCCCEEEEeCCCchHHHHHHcCCCCCCceEEeec
Confidence 65 888999999999999887763 258888653
No 65
>COG0263 ProB Glutamate 5-kinase [Amino acid transport and metabolism]
Probab=99.75 E-value=8e-17 Score=164.54 Aligned_cols=230 Identities=21% Similarity=0.391 Sum_probs=171.6
Q ss_pred CcceEEEEecccccCC------HHHHHHHHHHHHcCC-CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHH
Q 008693 79 KQLTCVMKFGGSSLAS------AERMREVAELILSFP-NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFV 151 (557)
Q Consensus 79 ~~~~~V~KFGGsSv~~------~~~~~~va~iI~~~~-~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i 151 (557)
..+.+|.|+|-|++.+ .+.+..+++.|.... ..+.||+||.++ +. ++.
T Consensus 5 ~~~riVvKiGSs~Lt~~~g~l~~~~l~~l~~~ia~L~~~G~eVilVSSGA-ia-----aG~------------------- 59 (369)
T COG0263 5 SARRIVVKIGSSSLTDGTGGLDRSKLEELVRQVAALHKAGHEVVLVSSGA-IA-----AGR------------------- 59 (369)
T ss_pred cceEEEEEECcceeeCCCCCcCHHHHHHHHHHHHHHHhCCCEEEEEccch-hh-----hCh-------------------
Confidence 3466999999999985 467777777776643 345566666322 21 110
Q ss_pred HHHHHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEE
Q 008693 152 KDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFI 231 (557)
Q Consensus 152 ~~~~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~ii 231 (557)
..|+.+. +...-...+.+.+.|+..-+......|..+|++. .|+ ++
T Consensus 60 --------~~Lg~~~--------------------rp~~l~~kQA~AAVGQ~~Lm~~y~~~f~~~g~~v-----~Qi-LL 105 (369)
T COG0263 60 --------TRLGLPK--------------------RPKTLAEKQAAAAVGQVRLMQLYEELFARYGIKV-----GQI-LL 105 (369)
T ss_pred --------hhcCCCC--------------------CCcchHHHHHHHHhCHHHHHHHHHHHHHhcCCee-----eEE-Ee
Confidence 1122221 1222345677889999999999999999999985 455 78
Q ss_pred EecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceee--cCCCcchhHHHHHHHHcCcCcEEEeeCC
Q 008693 232 TTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITT--LGRGGSDLTATTIGKALGLQEIQVWKDV 309 (557)
Q Consensus 232 t~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~tt--lgRgGSD~tAa~lA~~L~A~~l~i~TDV 309 (557)
|.+++.+.+ .+.+.+..|.. |++.|.|||| |+ |..+.+ +--|.+|..++++|...+||.++++||+
T Consensus 106 Tr~D~~~r~----ry~Nar~Tl~~-Ll~~gvVPII------NE-NDtva~~EikfGDND~LsA~VA~lv~ADlLvlLsDi 173 (369)
T COG0263 106 TRDDFSDRR----RYLNARNTLSA-LLELGVVPII------NE-NDTVATEEIKFGDNDTLSALVAILVGADLLVLLSDI 173 (369)
T ss_pred ehhhhhhHH----HHHHHHHHHHH-HHHCCceeee------cC-CCceeeeeeeecCCchHHHHHHHHhCCCEEEEEEcc
Confidence 877765432 45566666664 5788999999 63 665544 5578999999999999999999999999
Q ss_pred CccccCCCCCCCCCccccccCH--HHHHHHHH-----cCCCcchHh--HHHHHHhCCCCEEEecCCCCC---------CC
Q 008693 310 DGVLTCDPNIHPHAKPVPYLTF--DEAAELAY-----FGAQVLHPQ--SMRPAREGDIPVRVKNSYNPN---------AP 371 (557)
Q Consensus 310 dGV~taDP~~v~~a~~i~~ls~--~Ea~eLa~-----~Ga~vlhp~--a~~~a~~~~Ipv~I~n~~~p~---------~~ 371 (557)
||+||+|||..|+|++|++++- .|...++- +|...|.-| |.+.|.++|+|+.|.++.+|+ ..
T Consensus 174 DGLyd~nPr~~pdAk~i~~V~~it~ei~~~aggsgs~~GTGGM~TKl~AA~iA~~aG~~~iI~~g~~~~~i~~~~~~~~~ 253 (369)
T COG0263 174 DGLYDANPRTNPDAKLIPEVEEITPEIEAMAGGSGSELGTGGMRTKLEAAKIATRAGVPVIIASGSKPDVILDALEGEAV 253 (369)
T ss_pred CcccCCCCCCCCCCeeehhhcccCHHHHHHhcCCCCCCCcccHHHHHHHHHHHHHcCCcEEEecCCCcchHHHHHhCCCC
Confidence 9999999999999999999873 47777765 456677765 899999999999999999985 47
Q ss_pred CeeEecCC
Q 008693 372 GTLIRRSR 379 (557)
Q Consensus 372 GT~I~~~~ 379 (557)
||++.+..
T Consensus 254 GT~F~~~~ 261 (369)
T COG0263 254 GTLFEPQA 261 (369)
T ss_pred ccEEecCC
Confidence 99998653
No 66
>TIGR01890 N-Ac-Glu-synth amino-acid N-acetyltransferase. This model represents a clade of amino-acid N-acetyltransferases acting mainly on glutamate in the first step of the "acetylated" ornithine biosynthesis pathway. For this reason it is also called N-acetylglutamate synthase. The enzyme may also act on aspartate.
Probab=99.73 E-value=1.3e-16 Score=172.76 Aligned_cols=234 Identities=15% Similarity=0.168 Sum_probs=158.6
Q ss_pred ceEEEEecccccCCHHHHHHHHHHHHcCCC-CccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHH
Q 008693 81 LTCVMKFGGSSLASAERMREVAELILSFPN-ERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTV 159 (557)
Q Consensus 81 ~~~V~KFGGsSv~~~~~~~~va~iI~~~~~-~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~ 159 (557)
.+.|.|+||+.+.++ .+..+++.|..... ..++|+|++.|..-+++++
T Consensus 18 ~~~ViK~GG~~~~~~-~~~~~~~~i~~l~~~g~~~vlVHGgg~~i~~~~~------------------------------ 66 (429)
T TIGR01890 18 KTFVVGLGGELVEGG-NLGNIVADIALLHSLGVRLVLVHGARPQIERILA------------------------------ 66 (429)
T ss_pred CEEEEEEChhhccCc-cHHHHHHHHHHHHHCCCcEEEEcCCCHHHHHHHH------------------------------
Confidence 579999999999875 34677777765432 3345666666655444433
Q ss_pred HHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceE-----EeccceeEEEEec
Q 008693 160 DELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKAR-----QYDAFDIGFITTD 234 (557)
Q Consensus 160 ~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~-----~l~~~~~~iit~~ 234 (557)
.+++++ ++++|++++.+.+.....++ .| .+|..|.+ .|++. +++. .+++.|.++++..
T Consensus 67 -~~g~~~-----------~~~~G~RvT~~~~l~~~~~~--~g-~vn~~l~~-~l~~~-~~~~~~~~~~l~~~dg~~~~a~ 129 (429)
T TIGR01890 67 -ARGRTP-----------HYHRGLRVTDEASLEQAQQA--AG-TLRLAIEA-RLSMS-LSNTPMAGSRLPVVSGNFVTAR 129 (429)
T ss_pred -HcCCCc-----------eeeCCcccCCHHHHHHHHHH--hC-hHHHHHHH-HHHhc-CCcccccccCceEccceEEEEE
Confidence 122222 34556655543333333332 45 67877655 46655 4443 3666666676643
Q ss_pred C--------CCC-ceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEE
Q 008693 235 D--------FTN-ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQV 305 (557)
Q Consensus 235 ~--------~~~-a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i 305 (557)
. ++. .++..++.+.++. +++.+.+||+++ +|.+ .+|+.++++ +|..|+.||.+|+|+++++
T Consensus 130 ~~~~~~~~~~g~~G~v~~v~~~~l~~-----ll~~g~ipvi~p-i~~~-~~g~~~nvn---aD~~A~~lA~al~a~kli~ 199 (429)
T TIGR01890 130 PIGVIEGVDYEHTGVIRKIDTEGIRR-----QLDAGSIVLLSP-LGHS-PTGETFNLD---MEDVATSVAISLKADKLIY 199 (429)
T ss_pred ECCCCcCccccccceEEEEcHHHHHH-----HHHCCCeEEECC-cccC-CCCCEEEeC---HHHHHHHHHHHcCCCEEEE
Confidence 2 222 4566666665543 456789999998 6877 489999999 9999999999999999999
Q ss_pred eeCCCccccCCCCCCCCCccccccCHHHHHHHHHcCCCc-chHh--HHHHHHhCCC-CEEEecCCCCC----------CC
Q 008693 306 WKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQV-LHPQ--SMRPAREGDI-PVRVKNSYNPN----------AP 371 (557)
Q Consensus 306 ~TDVdGV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~v-lhp~--a~~~a~~~~I-pv~I~n~~~p~----------~~ 371 (557)
+|||||||+. +.++|++|+.+|+.++......- +-|+ ++.-|.+.|+ +++|.|...|+ +.
T Consensus 200 ltdv~Gv~~~------~g~~i~~i~~~~~~~l~~~~~~~~~~~kl~~a~~a~~~gv~~v~i~~g~~~~~l~~el~~~~g~ 273 (429)
T TIGR01890 200 FTLSPGISDP------DGTLAAELSPQEVESLAERLGSETTRRLLSAAVKACRGGVHRSHIVSYAEDGSLLQELFTRDGI 273 (429)
T ss_pred EeCCCcccCC------CCCCcccCCHHHHHHHHHhccCCCcHHHHHHHHHHHHcCCCeEEEECCCCCcHHHHHHhcCCCC
Confidence 9999999963 36799999999999987542223 4676 5566678886 58998876553 47
Q ss_pred CeeEecC
Q 008693 372 GTLIRRS 378 (557)
Q Consensus 372 GT~I~~~ 378 (557)
||.|..+
T Consensus 274 GT~i~~d 280 (429)
T TIGR01890 274 GTSISKE 280 (429)
T ss_pred cceEecc
Confidence 9999764
No 67
>cd04237 AAK_NAGS-ABP AAK_NAGS-ABP: N-acetylglutamate (NAG) kinase-like domain of the NAG Synthase (NAGS) of the arginine-biosynthesis pathway (ABP) found in gamma- and beta-proteobacteria and higher plant chloroplasts. Domain architecture of these NAGS consisted of an N-terminal NAG kinase-like (ArgB) domain (this CD) and a C-terminal NAG synthase, acetyltransferase (ArgA) domain. Both bacterial and plant sequences in this CD have a conserved N-terminal extension; a similar sequence in the NAG kinases of the cyclic arginine-biosynthesis pathway has been implicated in feedback inhibition sensing. Plant sequences also have an N-terminal chloroplast transit peptide and an insert (approx. 70 residues) in the C-terminal region of ArgB. Members of this CD belong to the Amino Acid Kinase Superfamily (AAK).
Probab=99.71 E-value=3.4e-16 Score=160.22 Aligned_cols=223 Identities=18% Similarity=0.241 Sum_probs=146.3
Q ss_pred ceEEEEecccccCCHHHHHHHHHHHHcCCC-CccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHH
Q 008693 81 LTCVMKFGGSSLASAERMREVAELILSFPN-ERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTV 159 (557)
Q Consensus 81 ~~~V~KFGGsSv~~~~~~~~va~iI~~~~~-~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~ 159 (557)
+++|.|+||+.+.+. .++++++.|....+ ..++|+|++.|..-+++++.
T Consensus 19 ~~~VIKlGG~ai~~~-~l~~~~~~ia~l~~~g~~~ViVHGggp~i~~~~~~----------------------------- 68 (280)
T cd04237 19 KTFVIAFGGEAVAHP-NFDNIVHDIALLHSLGIRLVLVHGARPQIDQRLAE----------------------------- 68 (280)
T ss_pred CEEEEEEChHHhcCc-hHHHHHHHHHHHHHCCCcEEEEeCCCHHHHHHHHH-----------------------------
Confidence 579999999999874 45677776665432 33444555555544443321
Q ss_pred HHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHH-HhhchHHHHHHHHHHHHHcCCceEEec-----cceeEEEEe
Q 008693 160 DELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYL-VSFGECMSTRIFAAYLNKIGVKARQYD-----AFDIGFITT 233 (557)
Q Consensus 160 ~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i-~s~GE~lsa~ll~~~L~~~Gi~a~~l~-----~~~~~iit~ 233 (557)
++.++ ++++|++.+ ++...+.+ .++|+ ++..+ .+.|+. |++++.+. +.+..++..
T Consensus 69 --~gi~~-----------~~~~G~RvT---~~~~l~~~~~~~g~-v~~~l-~~~l~~-~~~a~~~~~~~~~~~~~~~v~~ 129 (280)
T cd04237 69 --RGLEP-----------RYHRGLRIT---DAAALECVKEAAGA-VRLEI-EALLSM-GLPNSPMAGARIRVVSGNFVTA 129 (280)
T ss_pred --cCCCc-----------cccCCcCcC---CHHHHHHHHHHHHH-HHHHH-HHHHHh-hccccCcCCCceEEecCeEEEE
Confidence 11111 233444333 33343333 23464 47764 455655 88877443 223223333
Q ss_pred cCCC---------CceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEE
Q 008693 234 DDFT---------NADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQ 304 (557)
Q Consensus 234 ~~~~---------~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~ 304 (557)
...+ ..++...+.+.++ .+++.+.+||+++ +|.+ .+|+.++++ +|..|+.||.+|+|++++
T Consensus 130 ~~~~~~~~~~~g~~G~v~~v~~~~i~-----~lL~~g~ipv~~~-~g~~-~~g~~lnvn---aD~~A~~LA~~L~a~klv 199 (280)
T cd04237 130 RPLGVVDGVDFGHTGEVRRIDADAIR-----RQLDQGSIVLLSP-LGYS-PTGEVFNLS---MEDVATAVAIALKADKLI 199 (280)
T ss_pred EECCcccCceEeeeccEEEEcHHHHH-----HHHHCCCEEEECC-ceEC-CCCCEEeeC---HHHHHHHHHHHcCCCEEE
Confidence 2211 1334444544443 3457888999988 6777 479999888 999999999999999999
Q ss_pred EeeCCCccccCCCCCCCCCccccccCHHHHHHHHHcCC---CcchHh--HHHHHHhCCC-CEEEecCCCC
Q 008693 305 VWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGA---QVLHPQ--SMRPAREGDI-PVRVKNSYNP 368 (557)
Q Consensus 305 i~TDVdGV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga---~vlhp~--a~~~a~~~~I-pv~I~n~~~p 368 (557)
|.|||||||++ +.+++++++.+|+.++...|. ..|.|| ++..+.+.|+ +++|.+...|
T Consensus 200 ~ltdv~GV~~~------~~~~i~~i~~~e~~~l~~~~~~~~ggM~~Kv~~a~~a~~~Gv~~v~I~~~~~~ 263 (280)
T cd04237 200 FLTDGPGLLDD------DGELIRELTAQEAEALLETGALLTNDTARLLQAAIEACRGGVPRVHLISYAED 263 (280)
T ss_pred EEeCCCcccCC------CCCccccCCHHHHHHHHHcCCCCCCCHHHHHHHHHHHHHcCCCEEEEeCCCCC
Confidence 99999999973 368999999999999988764 678887 5666677899 6999987666
No 68
>cd04236 AAK_NAGS-Urea AAK_NAGS-Urea: N-acetylglutamate (NAG) kinase-like domain of the NAG Synthase (NAGS) of the urea cycle found in animals. Ureogenic NAGS is a mitochondrial enzyme catalyzing the formation of NAG from acetylcoenzyme A and L-glutamate; NAG is an essential allosteric activator of carbamylphosphate synthase I, the first and rate limiting enzyme of the urea cycle. Ureogenic NAGS activity is dependent on the concentration of glutamate (substrate) and arginine (activator). Domain architecture of ureogenic NAGS consists of an N-terminal NAG kinase-like (ArgB) domain (this CD) and a C-terminal DUF619 domain. Members of this CD belong to the protein superfamily, the Amino Acid Kinase Family (AAKF).
Probab=99.70 E-value=8.9e-16 Score=155.54 Aligned_cols=207 Identities=11% Similarity=0.088 Sum_probs=151.7
Q ss_pred CCcceEEEEecccccCCHHHHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHH
Q 008693 78 EKQLTCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLH 155 (557)
Q Consensus 78 ~~~~~~V~KFGGsSv~~~~~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~ 155 (557)
..++..|.|+||+.+.+++.+..++..+.-.. +-++|+|+.+...++..|. . .
T Consensus 33 ~~~~f~VIK~GG~~~~~~~~~~~l~~dla~L~~lGl~~VlVHGggp~i~~~l~---~----~------------------ 87 (271)
T cd04236 33 DWPAFAVLEVDHSVFRSLEMVQSLSFGLAFLQRMDMKLLVVMGLSAPDGTNMS---D----L------------------ 87 (271)
T ss_pred CCCCEEEEEEChhhhcCchhHHHHHHHHHHHHHCCCeEEEEeCCChHHhhhhc---C----C------------------
Confidence 55688999999999999999999999887643 4577777765443433221 0 0
Q ss_pred HHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEec-
Q 008693 156 HRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTD- 234 (557)
Q Consensus 156 ~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~- 234 (557)
......+++. ..|..| ...|+..|++++.+.+.. ++++..
T Consensus 88 ----------------------------------~~~~~~~v~~---~~n~~L-v~~L~~~G~~A~gl~g~~-~~i~a~~ 128 (271)
T cd04236 88 ----------------------------------ELQAARSRLV---KDCKTL-VEALQANSAAAHPLFSGE-SVLQAEE 128 (271)
T ss_pred ----------------------------------cchheehhHH---HHHHHH-HHHHHhCCCCeeeecCcc-ceEEEEE
Confidence 0001122222 456654 456899999999999874 466543
Q ss_pred --CCCC-ceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCc
Q 008693 235 --DFTN-ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDG 311 (557)
Q Consensus 235 --~~~~-a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdG 311 (557)
+++. +++..++.+.++. +++.|.|||+++ +|.+ .+|++.+++ +|..|+.+|.+|+|++++++||++|
T Consensus 129 ~~d~g~vG~V~~Vd~~~I~~-----lL~~g~IPVisp-lg~~-~~G~~~NiN---aD~~A~~lA~aL~A~KLIfltd~~G 198 (271)
T cd04236 129 PEPGASKGPSVSVDTELLQW-----CLGSGHIPLVCP-IGET-SSGRSVSLD---SSEVTTAIAKALQPIKVIFLNRSGG 198 (271)
T ss_pred cccCCccceEEEECHHHHHH-----HHhCCCeEEECC-ceEC-CCCCEEEEC---HHHHHHHHHHHcCCCEEEEEeCCcc
Confidence 2222 4566666665543 457899999999 7888 489999999 9999999999999999999999999
Q ss_pred cccCCCCCCCCCccccccCH-HHHHHHHHcCC--Ccc---hHh--HHHHHHhCCCCEEEec
Q 008693 312 VLTCDPNIHPHAKPVPYLTF-DEAAELAYFGA--QVL---HPQ--SMRPAREGDIPVRVKN 364 (557)
Q Consensus 312 V~taDP~~v~~a~~i~~ls~-~Ea~eLa~~Ga--~vl---hp~--a~~~a~~~~Ipv~I~n 364 (557)
||+. +.+++++|+. +|..+|...|. ..| -|+ ++.-+...++.++|.+
T Consensus 199 V~~~------~g~lI~~l~~~~e~~~li~~g~i~gGm~~ki~ki~~~l~~l~~g~sv~I~~ 253 (271)
T cd04236 199 LRDQ------KHKVLPQVHLPADLPSLSDAEWLSETEQNRIQDIATLLNALPSMSSAVITS 253 (271)
T ss_pred eECC------CCCCccccCcHHHHHHHHhCCEEcCCeeechHHHHHHHHhcccCCeEEEeC
Confidence 9973 2678999995 99999988754 345 454 6667788999999987
No 69
>PRK07431 aspartate kinase; Provisional
Probab=99.69 E-value=5.8e-16 Score=174.02 Aligned_cols=146 Identities=25% Similarity=0.401 Sum_probs=124.3
Q ss_pred CcceeeEEeeeccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEcc-------CceeEEEeCCchhhhHHHHHHH
Q 008693 382 SKAVLTSIVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATS-------EVSLSLTLDPSKLWSRELIQQE 454 (557)
Q Consensus 382 ~~~~Vt~Is~~~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstS-------e~sIS~~I~~~~~~~~~~~~~~ 454 (557)
++..+++|+.++|+++|++. ++.+.+|+++++|+.|+++||+++|++++ ..+++|+++.++....
T Consensus 426 ~~~~v~gIa~~~~~~~i~l~--~~~~~~g~~a~if~~l~~~~i~id~i~~~~~~~~~~~~~isf~v~~~~~~~~------ 497 (587)
T PRK07431 426 DEPEVRGVALDRNQAQLAIR--NVPDRPGMAASIFGALAEANISVDMIVQSQRCRSDGTRDISFTVPKEDREAA------ 497 (587)
T ss_pred CCCcEEEEEccCCEEEEEEC--CCCCCccHHHHHHHHHHHcCCeEEEEEecCCCCCCCceeEEEEEcHHHHHHH------
Confidence 34579999999999999996 58889999999999999999999999874 3679999998764321
Q ss_pred HHHHHHHHhh---hheeecccceeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHH
Q 008693 455 LDHVVEELEK---IAIVNLLQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVR 530 (557)
Q Consensus 455 l~~~~~~l~~---~~~i~~~~~~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~ 530 (557)
..+++++.+ ...+.+.+++++||+||. |...+|+++|+|++|+++||+++++++ |+++|+++|+++|.++|++
T Consensus 498 -~~~l~~l~~~~~~~~i~~~~~va~VSvVG~gm~~~~gv~~ri~~aL~~~~I~v~~i~~--S~~~Is~vV~~~~~~~av~ 574 (587)
T PRK07431 498 -QKVLRELAKQLPGAEVEDGPAIAKVSIVGAGMPGTPGVAARMFRALADAGINIEMIAT--SEIRTSCVVAEDDGVKALQ 574 (587)
T ss_pred -HHHHHHHHHhcCCceEEEeCCeEEEEEECCCccCCcCHHHHHHHHHHHCCCcEEEeec--cceEEEEEEeHHHHHHHHH
Confidence 222333331 245777899999999997 778999999999999999999999986 9999999999999999999
Q ss_pred HHHHHhcc
Q 008693 531 ALHETFFE 538 (557)
Q Consensus 531 ~LH~~f~~ 538 (557)
+||++|..
T Consensus 575 ~Lh~~f~~ 582 (587)
T PRK07431 575 AVHQAFGL 582 (587)
T ss_pred HHHHHhcc
Confidence 99999953
No 70
>PRK12353 putative amino acid kinase; Reviewed
Probab=99.67 E-value=1.7e-15 Score=157.17 Aligned_cols=122 Identities=13% Similarity=0.118 Sum_probs=88.4
Q ss_pred HhhchhcCCceEEEcCCC--cccCCCCceeecC-CCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCcccccc
Q 008693 253 LHGDWITDLAIPIVTGFL--GKAWRTCAITTLG-RGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYL 329 (557)
Q Consensus 253 l~~~ll~~~~vpVv~Gfi--g~~~~~G~~ttlg-RgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~i~~l 329 (557)
..+.+++.+.|||++|.- +....++.+.+.. -+.+|..|+.+|.+|+|+.++++|||||||++||+ |++++|+++
T Consensus 177 ~i~~lL~~g~IpV~~g~gg~Pi~~~~~~~~~~~~~~d~D~lAa~lA~~l~Ad~Li~lTdvdGVy~~~~~--~~a~~i~~i 254 (314)
T PRK12353 177 AIKTLVDAGQVVIAAGGGGIPVIREGGGLKGVEAVIDKDFASAKLAELVDADLLIILTAVDKVYINFGK--PNQKKLDEV 254 (314)
T ss_pred HHHHHHHCCCEEEEcCCCCCCEEEeCCceeeeeEecCHHHHHHHHHHHhCCCEEEEEeCCccccCCCCC--CCCeECcCc
Confidence 333456889999999762 2211233332211 24589999999999999999999999999997663 899999999
Q ss_pred CHHHHHHHHH---cCCCcchHh---HHHHH-HhCCCCEEEecCCCC-----CCCCeeEe
Q 008693 330 TFDEAAELAY---FGAQVLHPQ---SMRPA-REGDIPVRVKNSYNP-----NAPGTLIR 376 (557)
Q Consensus 330 s~~Ea~eLa~---~Ga~vlhp~---a~~~a-~~~~Ipv~I~n~~~p-----~~~GT~I~ 376 (557)
+++|+.++.. .+...|.|| |++.+ .+.+++++|.|..+. ...||+|.
T Consensus 255 ~~~e~~~~~~~~~~~tGGM~~Kl~aA~~a~~~~~g~~v~I~~~~~i~~~l~g~~GT~i~ 313 (314)
T PRK12353 255 TVSEAEKYIEEGQFAPGSMLPKVEAAISFVESRPGRKAIITSLEKAKEALEGKAGTVIV 313 (314)
T ss_pred CHHHHHHHHhcCCcCCCCcHHHHHHHHHHHHHcCCCEEEECCchHHHHHhCCCCCeEec
Confidence 9999999874 345678886 44555 578999999873211 12688874
No 71
>PRK05279 N-acetylglutamate synthase; Validated
Probab=99.67 E-value=1.6e-15 Score=164.85 Aligned_cols=234 Identities=19% Similarity=0.233 Sum_probs=152.9
Q ss_pred ceEEEEecccccCCHHHHHHHHHHHHcCCC-CccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHH
Q 008693 81 LTCVMKFGGSSLASAERMREVAELILSFPN-ERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTV 159 (557)
Q Consensus 81 ~~~V~KFGGsSv~~~~~~~~va~iI~~~~~-~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~ 159 (557)
+++|.|+||+.+.+.+ ++++++.|....+ ..++|+|++.|..-+++++.
T Consensus 26 ~~~VIk~GG~~l~~~~-~~~~~~~i~~l~~~g~~~VlVHGgg~~i~~~~~~----------------------------- 75 (441)
T PRK05279 26 KTFVIMLGGEAIAHGN-FSNIVHDIALLHSLGIRLVLVHGARPQIEEQLAA----------------------------- 75 (441)
T ss_pred CEEEEEECchhccChh-HHHHHHHHHHHHHCCCeEEEECCCCHHHHHHHHH-----------------------------
Confidence 5799999999998753 5677777765432 33455555555544444321
Q ss_pred HHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEecccee-----EEEEec
Q 008693 160 DELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDI-----GFITTD 234 (557)
Q Consensus 160 ~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~-----~iit~~ 234 (557)
++..+ ++.+|++.+.+.+.....++ .| .++..+ .+.|+ .|++++.+.+..+ .++...
T Consensus 76 --~g~~~-----------~~~~G~RvT~~~~l~~~~~~--~g-~v~~~l-~~~l~-~g~~a~~~~~~~~~~~~~~~~~~~ 137 (441)
T PRK05279 76 --RGIEP-----------RYHKGLRVTDAAALECVKQA--AG-ELRLDI-EARLS-MGLPNTPMAGAHIRVVSGNFVTAR 137 (441)
T ss_pred --cCCCc-----------eecCCcccCCHHHHHHHHHH--HH-HHHHHH-HHHHh-ccCCCCcccCCcceEeeccEEEEE
Confidence 12221 23445544433222222333 46 778775 45565 4998877544332 222222
Q ss_pred C--------CCC-ceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEE
Q 008693 235 D--------FTN-ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQV 305 (557)
Q Consensus 235 ~--------~~~-a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i 305 (557)
. ++. .++...+.+.++ .+++.|.|||+++ +|.+ .+|++.+++ +|..|+.||.+|+|+++++
T Consensus 138 ~~~~~~~~~~g~~G~v~~v~~~~i~-----~ll~~g~ipV~~~-i~~~-~~g~~~ni~---~D~~a~~lA~~l~a~~lv~ 207 (441)
T PRK05279 138 PLGVDDGVDYQHTGEVRRIDAEAIR-----RQLDSGAIVLLSP-LGYS-PTGESFNLT---MEEVATQVAIALKADKLIF 207 (441)
T ss_pred ECCCCCCccccceeeEEEEeHHHHH-----HHHHCCCeEEECC-ceEC-CCCCEEEEC---HHHHHHHHHHHcCCCEEEE
Confidence 1 221 334444444443 3457889999976 6777 479998888 9999999999999999999
Q ss_pred eeCCCccccCCCCCCCCCccccccCHHHHHHHHH---cC--CCcchHh--HHHHHHhCCC-CEEEecCCCCC--------
Q 008693 306 WKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAY---FG--AQVLHPQ--SMRPAREGDI-PVRVKNSYNPN-------- 369 (557)
Q Consensus 306 ~TDVdGV~taDP~~v~~a~~i~~ls~~Ea~eLa~---~G--a~vlhp~--a~~~a~~~~I-pv~I~n~~~p~-------- 369 (557)
+|||||||++ ++++|++++.+|+.++.. .| ...|-|| ++.-+.++|+ +++|.+...|+
T Consensus 208 ltdv~GV~~~------~~~~i~~i~~~~~~~~~~~~~~~~~~ggM~~Kv~~a~~~~~~gv~~v~i~~~~~~~~l~~~l~~ 281 (441)
T PRK05279 208 FTESQGVLDE------DGELIRELSPNEAQALLEALEDGDYNSGTARFLRAAVKACRGGVRRSHLISYAEDGALLQELFT 281 (441)
T ss_pred EECCCCccCC------CCchhhhCCHHHHHHHHhhhhcCCCCccHHHHHHHHHHHHHcCCCEEEEecCCCCcHHHHHHhc
Confidence 9999999953 478999999999999876 33 2567787 4455567799 69998876663
Q ss_pred --CCCeeEecC
Q 008693 370 --APGTLIRRS 378 (557)
Q Consensus 370 --~~GT~I~~~ 378 (557)
+.||.|...
T Consensus 282 ~~g~GT~i~~~ 292 (441)
T PRK05279 282 RDGIGTMIVME 292 (441)
T ss_pred CCCCceEEecC
Confidence 479999764
No 72
>cd04252 AAK_NAGK-fArgBP AAK_NAGK-fArgBP: N-Acetyl-L-glutamate kinase (NAGK) of the fungal arginine-biosynthetic pathway (fArgBP). The nuclear-encoded, mitochondrial polyprotein precursor with an N-terminal NAGK (ArgB) domain (this CD), a central DUF619 domain, and a C-terminal reductase domain (ArgC, N-Acetylglutamate Phosphate Reductase, NAGPR). The precursor is cleaved in the mitochondria into two distinct enzymes (NAGK-DUF619 and NAGPR). Native molecular weights of these proteins indicate that the kinase is an octamer whereas the reductase is a dimer. This CD also includes some gamma-proteobacteria (Xanthomonas and Xylella) NAG kinases with an N-terminal NAGK (ArgB) domain (this CD) and a C-terminal DUF619 domain. The DUF619 domain is described as a putative distant homolog of the acetyltransferase, ArgA, predicted to function in NAG synthase association in fungi. Eukaryotic sequences have an N-terminal mitochondrial transit peptide. Members of this NAG kinase domain CD belong to th
Probab=99.66 E-value=2.9e-15 Score=150.87 Aligned_cols=212 Identities=18% Similarity=0.282 Sum_probs=142.8
Q ss_pred EEEecccccCCHHHHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHHHHH
Q 008693 84 VMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVDE 161 (557)
Q Consensus 84 V~KFGGsSv~~~~~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~~~~ 161 (557)
|.|+||+.+.+. ++++++.|.... +.++ |+|++.|..-+.+++.
T Consensus 2 ViKiGG~~~~~~--l~~~~~di~~l~~~g~~~-VlVHGgg~~i~~~~~~------------------------------- 47 (248)
T cd04252 2 VIKVGGAIIEDD--LDELAASLSFLQHVGLYP-IVVHGAGPQLNEELEA------------------------------- 47 (248)
T ss_pred EEEEChhhhhcc--HHHHHHHHHHHHHCCCcE-EEEeCCCHHHHHHHHH-------------------------------
Confidence 899999999874 677877777543 3355 5555555544444331
Q ss_pred hCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHH-HhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEec-----C
Q 008693 162 LGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYL-VSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTD-----D 235 (557)
Q Consensus 162 l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i-~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~-----~ 235 (557)
++..+ ++.+|++.+ ++...+.+ .+++ .+|..++++ |+++|++++.+.+. +++.. +
T Consensus 48 ~gi~~-----------~~~~g~RvT---~~~~l~~v~~al~-~vn~~iv~~-l~~~g~~a~~l~~~---~~~a~~~~~~d 108 (248)
T cd04252 48 AGVEP-----------EYVDGLRVT---DPETLAVARKVFL-EENLKLVEA-LERNGARARPITSG---VFEAEYLDKDK 108 (248)
T ss_pred cCCCc-----------EeeCCcccC---CHHHHHHHHHHHH-HHHHHHHHH-HHhCCCCcccccCc---eEEEEECcCcc
Confidence 22221 123343333 34444443 3456 788886654 89999999999874 33332 3
Q ss_pred CCC-ceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCcccc
Q 008693 236 FTN-ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLT 314 (557)
Q Consensus 236 ~~~-a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~t 314 (557)
|+. .++...+.+.++. +++.+.|||++| +|.+ .+|++.+++ +|..|+.+|.+|+|+++++.|||||||+
T Consensus 109 ~g~~G~v~~i~~~~i~~-----~L~~g~IPVi~p-~~~~-~~g~~~nvn---aD~~A~~lA~aL~a~kli~ltdv~GV~~ 178 (248)
T cd04252 109 YGLVGKITGVNKAPIEA-----AIRAGYLPILTS-LAET-PSGQLLNVN---ADVAAGELARVLEPLKIVFLNETGGLLD 178 (248)
T ss_pred CCccCceeeECHHHHHH-----HHHCCCeEEECC-ceEC-CCCCEEEEC---HHHHHHHHHHHcCCCeEEEEECCcccCC
Confidence 332 4555566655543 357899999998 6777 479999998 9999999999999999999999999996
Q ss_pred CCCCCCCCCccccccCH-HHHHHHHHcCC--CcchHh--HHHHHHhC---CCCEEEec
Q 008693 315 CDPNIHPHAKPVPYLTF-DEAAELAYFGA--QVLHPQ--SMRPAREG---DIPVRVKN 364 (557)
Q Consensus 315 aDP~~v~~a~~i~~ls~-~Ea~eLa~~Ga--~vlhp~--a~~~a~~~---~Ipv~I~n 364 (557)
. +.+++++++. +++.++...|. ..|.|| ++..+.+. ...++|.+
T Consensus 179 ~------~g~~i~~i~~~~~~~~l~~~~~vtgGM~~Kl~~~~~~~~~~~~~~~v~i~~ 230 (248)
T cd04252 179 G------TGKKISAINLDEEYDDLMKQPWVKYGTKLKIKEIKELLDTLPRSSSVSITS 230 (248)
T ss_pred C------CCCcccccCHHHHHHHHHHcCCcCCchHHHHHHHHHHHHhCCCceEEEEEC
Confidence 4 3678999997 57778876542 456666 44455554 34577765
No 73
>PLN02825 amino-acid N-acetyltransferase
Probab=99.62 E-value=1.3e-14 Score=158.70 Aligned_cols=196 Identities=15% Similarity=0.188 Sum_probs=136.3
Q ss_pred ceEEEEecccccCCHHHHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHHHHHHHHHHHH
Q 008693 81 LTCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRT 158 (557)
Q Consensus 81 ~~~V~KFGGsSv~~~~~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~~~~~ 158 (557)
.+.|.||||+.+.++ .+..++..|.... +.++|+|+ +.+..-|++++.
T Consensus 18 ktfVIk~gG~~l~~~-~~~~l~~DialL~~lGi~~VlVH-GggpqI~~~l~~---------------------------- 67 (515)
T PLN02825 18 STFVVVISGEVVAGP-HLDNILQDISLLHGLGIKFVLVP-GTHVQIDKLLAE---------------------------- 67 (515)
T ss_pred CEEEEEECchhhcCc-hHHHHHHHHHHHHHCCCCEEEEc-CCCHHHHHHHHH----------------------------
Confidence 579999999999887 6888888887542 34555555 444444444431
Q ss_pred HHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHH--------HHHHcCCce----EEeccc
Q 008693 159 VDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAA--------YLNKIGVKA----RQYDAF 226 (557)
Q Consensus 159 ~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~--------~L~~~Gi~a----~~l~~~ 226 (557)
+++++ ++.+|++++. +.+.+.+....-.++..+.+. .|++.|+++ ..+++.
T Consensus 68 ---~gi~~-----------~f~~G~RVTd---~~~L~~~~~~~G~v~~~i~a~Ls~~~~v~~l~~~G~~a~~~~~gl~~~ 130 (515)
T PLN02825 68 ---RGREP-----------KYVGAYRITD---SAALQASMEAAGKIRVMIEAKLSPGPSIPNLRRHGDNSRWHEVGVSVA 130 (515)
T ss_pred ---cCCCc-----------eeeCCcccCC---HHHHHHHHHHHHHHHHHHHHhhccccchhHHHhcCCCCccccCceEec
Confidence 11111 2334444443 233332222222556665554 489999999 788887
Q ss_pred eeEEEEecC--------CCC-ceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHH
Q 008693 227 DIGFITTDD--------FTN-ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKA 297 (557)
Q Consensus 227 ~~~iit~~~--------~~~-a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~ 297 (557)
+..+++... |+. +++..++.+.++. +++.|.|||+++ +|.+ .+|++.|++ +|..|+.+|.+
T Consensus 131 ~Gn~v~a~~~gv~dgvD~g~vG~V~~Vd~~~i~~-----~L~~g~Ipvisp-lg~s-~~Ge~~Nin---aD~vA~avA~a 200 (515)
T PLN02825 131 SGNFLAAKRRGVVNGVDFGATGEVKKIDVSRIKE-----RLDSNCIVLLSN-LGYS-SSGEVLNCN---TYEVATACALA 200 (515)
T ss_pred cCcEEEEEECCCCcCccccceeeEEEEcHHHHHH-----HHhCCCeEEECC-ceEC-CCCCEEeeC---HHHHHHHHHHH
Confidence 777887753 332 4566667665543 357899999999 7888 589999999 99999999999
Q ss_pred cCcCcEEEeeCCCccccCCCCCCCCCccccccCHHHHHHHHHc
Q 008693 298 LGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYF 340 (557)
Q Consensus 298 L~A~~l~i~TDVdGV~taDP~~v~~a~~i~~ls~~Ea~eLa~~ 340 (557)
|+|++++++||++ +++. +.+++++|+.+|+.+|...
T Consensus 201 L~A~KLI~ltd~~-~~~~------~g~li~~l~~~e~~~li~~ 236 (515)
T PLN02825 201 IGADKLICIVDGP-ILDE------NGRLIRFMTLEEADMLIRK 236 (515)
T ss_pred cCCCeEEEEeCcc-eecC------CCCCcCcCCHHHHHHHHHh
Confidence 9999999999977 5543 3578999999999998754
No 74
>cd04240 AAK_UC AAK_UC: Uncharacterized (UC) amino acid kinase-like proteins found mainly in archaea and a few bacteria. Sequences in this CD are members of the Amino Acid Kinase (AAK) superfamily.
Probab=99.61 E-value=1.7e-14 Score=141.04 Aligned_cols=135 Identities=18% Similarity=0.163 Sum_probs=96.5
Q ss_pred CHHHHHHHHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCC
Q 008693 190 TPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGF 269 (557)
Q Consensus 190 ~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gf 269 (557)
+....|++......+|+.+|+..+...+. .+...+... +..+.+||+.++
T Consensus 50 ~~~~ad~mgilat~~na~~l~~~~~~~~~-------------------------~~~~~~~~~-----~~~g~ipV~~P~ 99 (203)
T cd04240 50 SDAAAHWMAILAMEQYGYLLADLEPRLVA-------------------------RTLAELTDV-----LERGKIAILLPY 99 (203)
T ss_pred ChHHHHHHHHHHHHHHHHHHhccCCcccc-------------------------CCHHHHHHH-----HHCCCcEEEeCc
Confidence 45566888887888888876532211110 011223222 356789999875
Q ss_pred Cc---ccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCccccccCHHHHHHHHHcCCCcch
Q 008693 270 LG---KAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLH 346 (557)
Q Consensus 270 ig---~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlh 346 (557)
-- .+ ..++..++. +|..|+.+|..|+|+.+++.|||||||++| ++++++++++|+.+ ..+++
T Consensus 100 ~~~~~~~-~~~~~~~~t---tD~lAa~lA~~l~A~~Li~ltdVdGVy~~d------a~~i~~i~~~e~~~-----~~~id 164 (203)
T cd04240 100 RLLLDTD-PLPHSWEVT---SDSIAAWLAKKLGAKRLVIVTDVDGIYEKD------GKLVNEIAAAELLG-----ETSVD 164 (203)
T ss_pred hhhcccC-CCCcccccC---HHHHHHHHHHHcCCCEEEEEeCCccccCCC------CcCccccCHHHhCC-----CCeeh
Confidence 21 12 123444444 999999999999999999999999999865 89999999988753 56778
Q ss_pred HhHHHHHHhCCCCEEEecCCCCC
Q 008693 347 PQSMRPAREGDIPVRVKNSYNPN 369 (557)
Q Consensus 347 p~a~~~a~~~~Ipv~I~n~~~p~ 369 (557)
+-+.+.+.++++|++|.|..+|+
T Consensus 165 ~~~~~~~~~~gi~v~I~~g~~~~ 187 (203)
T cd04240 165 PAFPRLLTKYGIRCYVVNGDDPE 187 (203)
T ss_pred hhHHHHHHhCCCeEEEECCCCcc
Confidence 76777889999999999988774
No 75
>PRK12352 putative carbamate kinase; Reviewed
Probab=99.61 E-value=1e-14 Score=150.75 Aligned_cols=240 Identities=16% Similarity=0.155 Sum_probs=144.9
Q ss_pred ceEEEEecccccCCH----------HHHHHHHHHHHcCC--CCccEEEEcCCCcCcHHHHHhhHHhhhcCCCcchhhHHH
Q 008693 81 LTCVMKFGGSSLASA----------ERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDEL 148 (557)
Q Consensus 81 ~~~V~KFGGsSv~~~----------~~~~~va~iI~~~~--~~~~vvVVSA~gg~Td~L~~~~~~a~~~~~~~~~~~~~l 148 (557)
+.+|.||||..+.+. +.++++++.|.... +.++|+|+.+...+.+.|.+.....
T Consensus 3 k~iVI~lGGnAl~~~~~~~~~~~~~~~~~~~a~dia~l~~~G~~lVivHG~GPqI~~~l~~~~~~~-------------- 68 (316)
T PRK12352 3 ELVVVAIGGNSIIKDNASQSIEHQAEAVKAVADTVLEMLASDYDIVLTHGNGPQVGLDLRRAEIAH-------------- 68 (316)
T ss_pred cEEEEEEChHHhcCCCCCcchhhHHHHHHHHHHHHHHHHHCCCeEEEEeCCCHHHHHHHHHcCccc--------------
Confidence 479999999999761 46677777776643 4566666655555655554422100
Q ss_pred HHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHHcCCce-------E
Q 008693 149 SFVKDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKA-------R 221 (557)
Q Consensus 149 ~~i~~~~~~~~~~l~~~~~~i~~~~~~l~~~l~~v~~~~~~~~~~~d~i~s~GE~lsa~ll~~~L~~~Gi~a-------~ 221 (557)
++ ++++.+... ..........|-.+++.|. ..|...|.++ +
T Consensus 69 -----------------------------~~-~g~rvt~~~-~~v~~~~g~i~~~i~~~L~-~~l~~~g~~~~~~vvt~v 116 (316)
T PRK12352 69 -----------------------------ER-EGLPLTPLA-NCVADTQGGIGYLIQQALN-NRLARHGEKKAVTVVTQV 116 (316)
T ss_pred -----------------------------cc-CCCCCCCHH-HHHHHHHHHHHHHHHHHHH-HHHHhcCCCCeeEEEEEE
Confidence 01 122211110 1111223345667777754 5688777664 6
Q ss_pred EeccceeEEEEecC--------------------CCC----ce-----------eeecchHHHHHHHhhchhcCCceEEE
Q 008693 222 QYDAFDIGFITTDD--------------------FTN----AD-----------ILEATYPAVAKRLHGDWITDLAIPIV 266 (557)
Q Consensus 222 ~l~~~~~~iit~~~--------------------~~~----a~-----------i~~~~~~~v~~~l~~~ll~~~~vpVv 266 (557)
.+++.|..++...+ ++. .+ +..++.+ +++.+++++.|+|.
T Consensus 117 ~vs~~D~~f~~~~kpiG~~y~~~~a~~~~~~~~~~~~~~d~g~G~rrvv~sp~pv~~V~~~-----~I~~ll~~g~iVi~ 191 (316)
T PRK12352 117 EVDKNDPGFAHPTKPIGAFFSESQRDELQKANPDWRFVEDAGRGYRRVVASPEPKRIVEAP-----AIKALIQQGFVVIG 191 (316)
T ss_pred EECCCCccccCCcccccCcccHHHHHHHhhhcCCceEeecCCCCeEEecCCCCCceEEcHH-----HHHHHHHCCCEEEe
Confidence 66766665542211 000 00 2223333 44445678889555
Q ss_pred cCC----CcccCCCCc----eeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCccccccCHHHHHHHH
Q 008693 267 TGF----LGKAWRTCA----ITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELA 338 (557)
Q Consensus 267 ~Gf----ig~~~~~G~----~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~i~~ls~~Ea~eLa 338 (557)
+|. ++.+ ..|+ ..+++ .|+.|+.+|.+|+|++++|+|||+|||.++|+ |+++++++++.+|+.++.
T Consensus 192 ~ggggiPv~~~-~~g~~~n~~~nIn---aD~aAa~iA~aL~AdkLI~LTDV~GV~~d~~~--~~~~li~~lt~~e~~~li 265 (316)
T PRK12352 192 AGGGGIPVVRT-DAGDYQSVDAVID---KDLSTALLAREIHADILVITTGVEKVCIHFGK--PQQQALDRVDIATMTRYM 265 (316)
T ss_pred cCCCCCCEEeC-CCCCccCceeeec---HHHHHHHHHHHhCCCEEEEEeCchhhccCCCC--CCcccccccCHHHHHHHH
Confidence 411 1222 1233 33455 89999999999999999999999999988765 678899999999999998
Q ss_pred HcC---CCcchHh---HHHHHHhCCCCEEEecCCCC-----CCCCeeEec
Q 008693 339 YFG---AQVLHPQ---SMRPAREGDIPVRVKNSYNP-----NAPGTLIRR 377 (557)
Q Consensus 339 ~~G---a~vlhp~---a~~~a~~~~Ipv~I~n~~~p-----~~~GT~I~~ 377 (557)
..| ...|-|| |++.+.+...+++|.+.... ...||+|.+
T Consensus 266 ~~g~i~~GgM~pKl~aA~~al~~Gv~~v~I~~~~~i~~al~g~~GT~I~~ 315 (316)
T PRK12352 266 QEGHFPPGSMLPKIIASLTFLEQGGKEVIITTPECLPAALRGETGTHIIK 315 (316)
T ss_pred hcCCcCCCCCHHHHHHHHHHHHhCCCeEEEcchHHHHHHHcCCCCeEEEe
Confidence 754 3568886 44555555557998862210 126888864
No 76
>TIGR00746 arcC carbamate kinase. The seed alignment for this model includes experimentally confirmed examples from a set of phylogenetically distinct species. In a neighbor-joining tree constructed from an alignment of candidate carbamate kinases and several acetylglutamate kinases, the latter group forms a clear outgroup which roots the tree of carbamate kinase-like proteins. This analysis suggests that in E. coli, the ArcC paralog YqeA may be a second isozyme, while the paralog YahI branches as an outlier and is less likely to be an authentic carbamate kinase. The homolog from Mycoplasma pneumoniae likewise branches outside the set containing known carbamate kinases and also scores below the trusted cutoff.
Probab=99.58 E-value=6.8e-14 Score=144.44 Aligned_cols=118 Identities=18% Similarity=0.229 Sum_probs=85.7
Q ss_pred hchhcCCceEEEcCCCc--c-cCCCCceeec-CCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCccccccC
Q 008693 255 GDWITDLAIPIVTGFLG--K-AWRTCAITTL-GRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLT 330 (557)
Q Consensus 255 ~~ll~~~~vpVv~Gfig--~-~~~~G~~ttl-gRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~i~~ls 330 (557)
+.+++.|.++|.+|.-| . + .+|.+.+. --+..|..|+++|.+|+||.++++|||||||+++ ..|+++++++++
T Consensus 176 ~~LL~~G~iVI~~ggggiPvi~-e~~~~~g~e~~id~D~lAa~lA~~l~AD~LIiLTDVdGVy~~~--~~p~a~~i~~it 252 (310)
T TIGR00746 176 KTLVENGVIVISSGGGGVPVVL-EGAELKGVEAVIDKDLASEKLAEEVNADILVILTDVDAVYINY--GKPDEKALREVT 252 (310)
T ss_pred HHHHHCCCEEEeCCCCCcCEEe-cCCeEEeeEecCCHHHHHHHHHHHhCCCEEEEEeCCCceeCCC--CCCCCcCCcCcC
Confidence 34567887767665433 2 2 24443211 0245999999999999999999999999999964 248899999999
Q ss_pred HHHHHHHHH---cCCCcchHh---HHHHHHhCCCCEEEecCCC------CCCCCeeEe
Q 008693 331 FDEAAELAY---FGAQVLHPQ---SMRPAREGDIPVRVKNSYN------PNAPGTLIR 376 (557)
Q Consensus 331 ~~Ea~eLa~---~Ga~vlhp~---a~~~a~~~~Ipv~I~n~~~------p~~~GT~I~ 376 (557)
++|+.++.. ++...|.|| |++.+.+.+++++|.|..+ .+ .||+|.
T Consensus 253 ~~e~~~~~~~g~~~tGgM~~Kl~AA~~~~~~g~~~v~I~~~~~i~~~l~G~-~GT~I~ 309 (310)
T TIGR00746 253 VEELEDYYKAGHFAAGSMGPKVEAAIEFVESGGKRAIITSLENAVEALEGK-AGTRVT 309 (310)
T ss_pred HHHHHHHHhcCCcCCCCcHHHHHHHHHHHHhCCCeEEEechHHHHHHHCCC-CCcEEe
Confidence 999999974 455778775 4466777788999976221 22 688885
No 77
>cd04235 AAK_CK AAK_CK: Carbamate kinase (CK) catalyzes both the ATP-phosphorylation of carbamate and carbamoyl phosphate (CP) utilization with the production of ATP from ADP and CP. Both CK (this CD) and nonhomologous CP synthetase synthesize carbamoyl phosphate, an essential precursor of arginine and pyrimidine bases, in the presence of ATP, bicarbonate, and ammonia. CK is a homodimer of 33 kDa subunits and is a member of the Amino Acid Kinase Superfamily (AAK).
Probab=99.54 E-value=1.9e-13 Score=140.49 Aligned_cols=120 Identities=18% Similarity=0.238 Sum_probs=89.0
Q ss_pred hhchhcCCceEEEcCCCcccC--CCCceeecC-CCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCccccccC
Q 008693 254 HGDWITDLAIPIVTGFLGKAW--RTCAITTLG-RGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLT 330 (557)
Q Consensus 254 ~~~ll~~~~vpVv~Gfig~~~--~~G~~ttlg-RgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~i~~ls 330 (557)
.+.|++++.|||+.|--|... .+|...+.. -...|++|+++|..|+|+.++++|||||||+++| .|++++|+++|
T Consensus 174 I~~Ll~~g~IpI~~GggGiPv~~~~~~~~gveaVid~D~~AallA~~l~Ad~LiilTdVdGVy~~~~--~pda~~i~~Is 251 (308)
T cd04235 174 IKTLVDNGVIVIAAGGGGIPVVREGGGLKGVEAVIDKDLASALLAEEINADLLVILTDVDNVYINFG--KPNQKALEQVT 251 (308)
T ss_pred HHHHHHCCCEEEEECCCccCEEEcCCceeeeeeccCccHHHHHHHHHcCCCEEEEEecCCeEECCCC--CCCCeEcCCcC
Confidence 334568899999997532211 123322211 1346999999999999999999999999999665 38999999999
Q ss_pred HHHHHHHHH---cCCCcchHh---HHHHHHhCCCCEEEecCCCC-----CCCCeeE
Q 008693 331 FDEAAELAY---FGAQVLHPQ---SMRPAREGDIPVRVKNSYNP-----NAPGTLI 375 (557)
Q Consensus 331 ~~Ea~eLa~---~Ga~vlhp~---a~~~a~~~~Ipv~I~n~~~p-----~~~GT~I 375 (557)
++|+.++.. ++...|+|| +++.+.+.+.+++|.+..+. ...||+|
T Consensus 252 ~~e~~~l~~~g~~~tGGM~pKv~aA~~~a~~gg~~v~I~~~~~i~~aL~G~~GT~I 307 (308)
T cd04235 252 VEELEKYIEEGQFAPGSMGPKVEAAIRFVESGGKKAIITSLENAEAALEGKAGTVI 307 (308)
T ss_pred HHHHHHHHhcCccccCCcHHHHHHHHHHHHhCCCeEEECCHHHHHHHHCCCCCeEE
Confidence 999999985 567789999 77788877889999763220 1257776
No 78
>PRK12686 carbamate kinase; Reviewed
Probab=99.46 E-value=2.4e-12 Score=132.60 Aligned_cols=122 Identities=13% Similarity=0.144 Sum_probs=87.1
Q ss_pred HhhchhcCCceEEEcCCCc--ccCCCCceeecC-CCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCcccccc
Q 008693 253 LHGDWITDLAIPIVTGFLG--KAWRTCAITTLG-RGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYL 329 (557)
Q Consensus 253 l~~~ll~~~~vpVv~Gfig--~~~~~G~~ttlg-RgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~i~~l 329 (557)
..+.|++.+.|||.+|--| .-..+|...... -+..|..|+.||.+|+|+.++|+|||||||+ ||+ .|++++|+++
T Consensus 175 ~I~~Ll~~G~IpI~~GgggIPVv~~~~~~~gv~avid~D~~Aa~LA~~L~Ad~LIiLTDVdGVy~-~~~-~p~ak~I~~I 252 (312)
T PRK12686 175 TIRTLVDGGNIVIACGGGGIPVIRDDNTLKGVEAVIDKDFASEKLAEQIDADLLIILTGVENVFI-NFN-KPNQQKLDDI 252 (312)
T ss_pred HHHHHHHCCCEEEEeCCCCCCeEecCCcEEeeecccCccHHHHHHHHHcCCCEEEEEeCchhhcc-CCC-CCCCeECCcc
Confidence 3344568899999887522 211245444332 3458999999999999999999999999999 455 3889999999
Q ss_pred CHHHHHHHHHc---CCCcchHh---HHHHHHh-CCCCEEEecCCCC-----CCCCeeEe
Q 008693 330 TFDEAAELAYF---GAQVLHPQ---SMRPARE-GDIPVRVKNSYNP-----NAPGTLIR 376 (557)
Q Consensus 330 s~~Ea~eLa~~---Ga~vlhp~---a~~~a~~-~~Ipv~I~n~~~p-----~~~GT~I~ 376 (557)
+++|+.++... +...|-|| |+..+.+ .+.+++|.+..+. ...||+|.
T Consensus 253 ~~~e~~~li~~g~~~tGGM~pKveAA~~av~~g~g~~viI~~~~~i~~aL~G~~GT~I~ 311 (312)
T PRK12686 253 TVAEAKQYIAEGQFAPGSMLPKVEAAIDFVESGEGKKAIITSLEQAKEALAGNAGTHIT 311 (312)
T ss_pred CHHHHHHHhhCCCccCCCcHHHHHHHHHHHHhCCCCEEEEeCchHHHHHhCCCCCeEEe
Confidence 99999999753 45678887 3444443 3678888863221 12688874
No 79
>cd04918 ACT_AK1-AT_2 ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1). This CD includes the second of two ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1), which can be synergistically inhibited by S-adenosylmethionine (SAM). This isoenzyme is found in higher plants, Arabidopsis thaliana (AT) and Zea mays, and also in Chlorophyta. In its inactive state, Arabidopsis AK1 binds the effectors lysine and SAM (two molecules each) at the interface of two ACT1 domain subunits. The second ACT domain (ACT2), this CD, does not interact with an effector. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.44 E-value=3e-13 Score=107.98 Aligned_cols=64 Identities=84% Similarity=1.138 Sum_probs=61.2
Q ss_pred eEEEEEccccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008693 475 SIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 538 (557)
Q Consensus 475 aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~ 538 (557)
++|++||.++..+++++++|++|+++||++.||+||+|+++++++|+++|.++|++.||++||+
T Consensus 2 a~VsvVG~~~~~~~~~~~i~~aL~~~~I~v~~i~~g~s~~sis~~v~~~~~~~av~~Lh~~f~~ 65 (65)
T cd04918 2 SIISLIGNVQRSSLILERAFHVLYTKGVNVQMISQGASKVNISLIVNDSEAEGCVQALHKSFFE 65 (65)
T ss_pred cEEEEECCCCCCccHHHHHHHHHHHCCCCEEEEEecCccceEEEEEeHHHHHHHHHHHHHHHhC
Confidence 7899999977778999999999999999999999999999999999999999999999999974
No 80
>cd04915 ACT_AK-Ectoine_2 ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway found in Methylomicrobium alcaliphilum, Vibrio cholerae, and various other halotolerant or halophilic bacteria. Bacteria exposed to hyperosmotic stress accumulate organic solutes called 'compatible solutes' of which ectoine, a heterocyclic amino acid, is one. Apart from its osmotic function, ectoine also exhibits a protective effect on proteins, nucleic acids and membranes against a variety of stress factors. de novo synthesis of ectoine starts with the phosphorylation of L-aspartate and shares its first two enzymatic steps with the biosynthesis of amino acids of the aspartate family: aspartokinas
Probab=99.44 E-value=4e-13 Score=107.66 Aligned_cols=64 Identities=23% Similarity=0.511 Sum_probs=61.2
Q ss_pred eeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008693 474 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 538 (557)
Q Consensus 474 ~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~ 538 (557)
+++|++||. | ..+++++++|++|+++||+++||+||+|+++||++|+++|.++|++.||++||+
T Consensus 2 ~a~VsvVG~gm-~~~gv~~ki~~~L~~~~I~v~~i~~~~s~~~is~~V~~~~~~~av~~Lh~~f~~ 66 (66)
T cd04915 2 VAIVSVIGRDL-STPGVLARGLAALAEAGIEPIAAHQSMRNVDVQFVVDRDDYDNAIKALHAALVE 66 (66)
T ss_pred EEEEEEECCCC-CcchHHHHHHHHHHHCCCCEEEEEecCCeeEEEEEEEHHHHHHHHHHHHHHHhC
Confidence 689999997 6 589999999999999999999999999999999999999999999999999985
No 81
>COG1608 Predicted archaeal kinase [General function prediction only]
Probab=99.41 E-value=2.4e-11 Score=118.70 Aligned_cols=156 Identities=20% Similarity=0.189 Sum_probs=106.6
Q ss_pred HHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeec
Q 008693 203 CMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTL 282 (557)
Q Consensus 203 ~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttl 282 (557)
.++.. ++..|.+.|++++...|... .+. +.++.......+.+ +++.+.|||+.|-+-.+..+| ...+
T Consensus 81 ~L~~~-V~~~l~~~Gv~av~~~P~s~--~~~----~gr~~~~~l~~i~~-----~l~~gfvPvl~GDVv~d~~~g-~~Ii 147 (252)
T COG1608 81 ELNSI-VVDALLDAGVRAVSVVPISF--STF----NGRILYTYLEAIKD-----ALEKGFVPVLYGDVVPDDDNG-YEII 147 (252)
T ss_pred HHHHH-HHHHHHhcCCccccccCcce--eec----CCceeechHHHHHH-----HHHcCCEeeeecceEEcCCCc-eEEE
Confidence 44554 56678899999987666553 221 12332211222322 357889999999876653223 3344
Q ss_pred CCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCccccccCHHHHHHHHHcC-CC---cch--HhHHHHHHhC
Q 008693 283 GRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFG-AQ---VLH--PQSMRPAREG 356 (557)
Q Consensus 283 gRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~i~~ls~~Ea~eLa~~G-a~---vlh--p~a~~~a~~~ 356 (557)
. .|-.+..||..|+++++.+.|||||||+.||..+|+++.++++... ..+...+ .. .|- -+++..+.+.
T Consensus 148 S---GDdIv~~LA~~l~pd~v~f~tdVdGVy~~~p~~~p~~~~l~~i~~~--~~~~gs~~~DVTGGi~~Kl~~~~~~~~~ 222 (252)
T COG1608 148 S---GDDIVLHLAKELKPDRVIFLTDVDGVYDRDPGKVPDARLLSEIEGR--VALGGSGGTDVTGGIAKKLEALLEIARY 222 (252)
T ss_pred e---ccHHHHHHHHHhCCCEEEEEecCCceecCCCCcCccccchhhhhhh--hhhcCcCcccchhhHHHHHHHHHHHHhc
Confidence 4 6999999999999999999999999999999999999998887654 2222112 11 222 3466666777
Q ss_pred CCCEEEecCCCCC---------CCCeeEe
Q 008693 357 DIPVRVKNSYNPN---------APGTLIR 376 (557)
Q Consensus 357 ~Ipv~I~n~~~p~---------~~GT~I~ 376 (557)
+-++++.|...|+ ..||+|.
T Consensus 223 ~~~vyi~ng~~~~ni~~~l~G~~vGT~I~ 251 (252)
T COG1608 223 GKEVYIFNGNKPENIYRALRGENVGTRID 251 (252)
T ss_pred CceEEEECCCCHHHHHHHhcCCCCceEec
Confidence 8889999988774 5788885
No 82
>PRK04531 acetylglutamate kinase; Provisional
Probab=99.40 E-value=3e-12 Score=136.71 Aligned_cols=109 Identities=21% Similarity=0.345 Sum_probs=79.5
Q ss_pred hcCCceEEEcCCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCccccccCH-HHHHH
Q 008693 258 ITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTF-DEAAE 336 (557)
Q Consensus 258 l~~~~vpVv~Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~i~~ls~-~Ea~e 336 (557)
++.|.|||+++ +|.+ .+|++.+++ +|..|+.+|.+|+|++++++|||+|||+.| .+++++|+. +|...
T Consensus 126 L~~g~IPVlsp-lg~~-~~G~~~Nvn---aD~vA~~LA~aL~a~KLIfltdv~GV~d~~------g~~i~~i~~~~e~~~ 194 (398)
T PRK04531 126 LRAGSIPVIAS-LGET-PSGQILNIN---ADVAANELVSALQPYKIIFLTGTGGLLDAD------GKLISSINLSTEYDH 194 (398)
T ss_pred HHCCCEEEEeC-cEEC-CCCcEEEEC---HHHHHHHHHHHcCCCEEEEEECCCCccCCC------CCCcccCCHHHHHHH
Confidence 46889999988 5776 479999998 999999999999999999999999999743 678999996 57777
Q ss_pred HHHcCC--CcchHh--HHHHHHhCCCC-EEEecCCCC----------CCCCeeEecC
Q 008693 337 LAYFGA--QVLHPQ--SMRPAREGDIP-VRVKNSYNP----------NAPGTLIRRS 378 (557)
Q Consensus 337 La~~Ga--~vlhp~--a~~~a~~~~Ip-v~I~n~~~p----------~~~GT~I~~~ 378 (557)
|...|. ..|.|+ ++.-|.+ ++| +++.....| ++.||+|...
T Consensus 195 l~~~~~vtgGM~~KL~~a~~al~-~~~~~~~V~i~~~~~Ll~eLft~~G~GT~I~~g 250 (398)
T PRK04531 195 LMQQPWINGGMKLKLEQIKELLD-RLPLESSVSITSPSDLAKELFTHKGSGTLVRRG 250 (398)
T ss_pred HHhcCCCCccHHHHHHHHHHHHh-CCCcEEEEEecCCCHHHHHHccCCCCCeEEecC
Confidence 765432 456665 3444443 343 333222223 2479999764
No 83
>PRK12454 carbamate kinase-like carbamoyl phosphate synthetase; Reviewed
Probab=99.38 E-value=4e-11 Score=123.38 Aligned_cols=119 Identities=19% Similarity=0.207 Sum_probs=86.7
Q ss_pred hchhcCCceEEEcCCCc---ccCCCCceeecC-CCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCccccccC
Q 008693 255 GDWITDLAIPIVTGFLG---KAWRTCAITTLG-RGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLT 330 (557)
Q Consensus 255 ~~ll~~~~vpVv~Gfig---~~~~~G~~ttlg-RgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~i~~ls 330 (557)
+.+++++.|||++|.-| .+ .+|++.++. -...|.+|+.+|.+|+|+.++|+|||||||++ |+ .|++++|++++
T Consensus 179 ~~LLe~G~IvI~~GgGGiPV~~-~~g~~~gveaViD~D~aAa~LA~~L~AD~LIiLTdVdGVy~~-~~-~p~~~~i~~It 255 (313)
T PRK12454 179 KALVENGFIVIASGGGGIPVIE-EDGELKGVEAVIDKDLASELLAEELNADIFIILTDVEKVYLN-YG-KPDQKPLDKVT 255 (313)
T ss_pred HHHHHCCCEEEEeCCCccceEc-CCCcEEeeeeecCccHHHHHHHHHcCCCEEEEEeCCceeeCC-CC-CCCCeEccccC
Confidence 34567899999997532 23 245554432 13479999999999999999999999999986 43 47899999999
Q ss_pred HHHHHHHHHc---CCCcchHh---HHHHHHhCCCCEEEecCCCC-----CCCCeeEe
Q 008693 331 FDEAAELAYF---GAQVLHPQ---SMRPAREGDIPVRVKNSYNP-----NAPGTLIR 376 (557)
Q Consensus 331 ~~Ea~eLa~~---Ga~vlhp~---a~~~a~~~~Ipv~I~n~~~p-----~~~GT~I~ 376 (557)
++|+.++... +..-|-|| |++.+.+.+.+++|.+..+. ...||+|.
T Consensus 256 ~~e~~~~i~~g~~~~GgM~pKv~AA~~~v~~gg~~a~I~~~~~i~~aL~G~~GT~I~ 312 (313)
T PRK12454 256 VEEAKKYYEEGHFKAGSMGPKILAAIRFVENGGKRAIIASLEKAVEALEGKTGTRII 312 (313)
T ss_pred HHHHHHHHhcCCcCCCChHHHHHHHHHHHHcCCCeEEECchHHHHHHHCCCCCeEeC
Confidence 9999998753 34568886 44556666778988753221 12688885
No 84
>PRK12354 carbamate kinase; Reviewed
Probab=99.37 E-value=9e-12 Score=127.79 Aligned_cols=123 Identities=20% Similarity=0.142 Sum_probs=88.2
Q ss_pred HhhchhcCCceEEEcCCCcccC---CCCceeecC-CCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCccccc
Q 008693 253 LHGDWITDLAIPIVTGFLGKAW---RTCAITTLG-RGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPY 328 (557)
Q Consensus 253 l~~~ll~~~~vpVv~Gfig~~~---~~G~~ttlg-RgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~i~~ 328 (557)
..+.|++.+.|||.+|.=|... .+|...... -.+.|.+|+.||.+|+|+.++|+|||||||++++ .|++++|++
T Consensus 167 ~I~~Ll~~g~ivIa~GGGGIPV~~~~~~~~~gv~aViD~D~~Aa~LA~~l~Ad~LiiLTdVdGVy~~~~--~p~~k~i~~ 244 (307)
T PRK12354 167 PIRWLLEKGHLVICAGGGGIPVVYDADGKLHGVEAVIDKDLAAALLAEQLDADLLLILTDVDAVYLDWG--KPTQRAIAQ 244 (307)
T ss_pred HHHHHHHCCCEEEEeCCCccCeEecCCCceeeeeecCCccHHHHHHHHHcCCCEEEEEeCCcceecCCC--CCCCeECCC
Confidence 3334567889888875433321 113222221 2468999999999999999999999999999754 378999999
Q ss_pred cCHHHHHHHHHcCCCcchHh---HHHHHHhCCCCEEEecCCCC-----CCCCeeEecC
Q 008693 329 LTFDEAAELAYFGAQVLHPQ---SMRPAREGDIPVRVKNSYNP-----NAPGTLIRRS 378 (557)
Q Consensus 329 ls~~Ea~eLa~~Ga~vlhp~---a~~~a~~~~Ipv~I~n~~~p-----~~~GT~I~~~ 378 (557)
++++|+.++ .++..-|-|| |++.+.+.+.+++|.+..+. ...||+|.+.
T Consensus 245 it~~e~~~~-~f~~GgM~pKV~AA~~~~~~gg~~viI~~~~~l~~al~G~~GT~I~~~ 301 (307)
T PRK12354 245 ATPDELREL-GFAAGSMGPKVEAACEFVRATGKIAGIGSLEDIQAILAGEAGTRISPE 301 (307)
T ss_pred CCHHHHHhh-CCCcCChHHHHHHHHHHHHhCCCEEEECCHHHHHHHHCCCCceEEecC
Confidence 999999998 6777889997 44556666768888642210 1269999764
No 85
>cd04937 ACT_AKi-DapG-BS_2 ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI. This CD includes the C-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) strain 168), Clostridia, and Actinobacteria bacterial species. In B. subtilis, the regulation of the diaminopimelate-lysine biosynthetic pathway involves dual control by diaminopimelate and lysine, effected through separate diaminopimelate- and lysine-sensitive AK isoenzymes. AKI activity is invariant during the exponential and stationary phases of growth and is not altered by addition of amino acids to the growth medium. The role of this isoenzyme is most likely to provide a constant level of aspartyl-beta-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis and dipicolinate during sporulation. The BS AKI is tetrameric consisting of two alpha and two beta subunits; th
Probab=99.26 E-value=1.7e-11 Score=97.51 Aligned_cols=63 Identities=25% Similarity=0.479 Sum_probs=59.2
Q ss_pred eeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008693 474 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 538 (557)
Q Consensus 474 ~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~ 538 (557)
+++|+++|. |...+|+++|+|++|+++||++.++++ |+++|+++|+++|.++|+++||++|+.
T Consensus 1 ~~~isvvG~~~~~~~gi~~~if~aL~~~~I~v~~~~~--Se~~is~~v~~~~~~~av~~Lh~~f~~ 64 (64)
T cd04937 1 CAKVTIIGSRIRGVPGVMAKIVGALSKEGIEILQTAD--SHTTISCLVSEDDVKEAVNALHEAFEL 64 (64)
T ss_pred CeEEEEECCCccCCcCHHHHHHHHHHHCCCCEEEEEc--CccEEEEEEcHHHHHHHHHHHHHHhcC
Confidence 478999997 788999999999999999999999887 899999999999999999999999963
No 86
>cd04919 ACT_AK-Hom3_2 ACT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae, and other related ACT domains. AK is the first enzyme in the aspartate metabolic pathway, catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and in fungi, is responsible for the production of threonine, isoleucine and methionine. S. cerevisiae has a single AK, which is regulated by feedback, allosteric inhibition by L-threonine. Recent studies shown that the allosteric transition triggered by binding of threonine to AK involves a large change in the conformation of the native hexameric enzyme that is converted to an inactive one of different shape and substantially smaller hydrodynamic size. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.26 E-value=2.1e-11 Score=96.93 Aligned_cols=65 Identities=32% Similarity=0.589 Sum_probs=61.8
Q ss_pred eeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008693 474 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 538 (557)
Q Consensus 474 ~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~ 538 (557)
+++|+++|. +...+++.+++|+.|+++||++.||+|++|+.+++|++++++.+++++.||++||+
T Consensus 1 ~~~isvvg~~~~~~~~~~~~if~~L~~~~I~v~~i~q~~s~~~isf~v~~~~~~~a~~~lh~~~~~ 66 (66)
T cd04919 1 LAILSLVGKHMKNMIGIAGRMFTTLADHRINIEMISQGASEINISCVIDEKDAVKALNIIHTNLLE 66 (66)
T ss_pred CeEEEEECCCCCCCcCHHHHHHHHHHHCCCCEEEEEecCccceEEEEEeHHHHHHHHHHHHHHHhC
Confidence 479999997 77889999999999999999999999999999999999999999999999999985
No 87
>cd04920 ACT_AKiii-DAPDC_2 ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC). This CD includes the second of two ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC) bacterial protein. Aspartokinase (AK) is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The lysA gene encodes the enzyme DAPDC, a pyridoxal-5'-phosphate (PLP)-dependent enzyme which catalyzes the final step in the lysine biosynthetic pathway converting meso-diaminopimelic acid (DAP) to l-lysine. Tandem ACT domains are positioned centrally with the AK catalytic domain N-terminal and the DAPDC domains C-terminal. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.26 E-value=1.6e-11 Score=97.52 Aligned_cols=62 Identities=27% Similarity=0.501 Sum_probs=57.0
Q ss_pred eEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008693 475 SIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 538 (557)
Q Consensus 475 aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~ 538 (557)
++||+||. |...+++++++|++|.+. +|.+++||+|+++||++|+++|.++|+++||++||+
T Consensus 1 a~VsvVG~g~~~~~gv~~~~~~~L~~~--~i~~i~~~~s~~~is~vv~~~d~~~av~~LH~~f~~ 63 (63)
T cd04920 1 AAVSLVGRGIRSLLHKLGPALEVFGKK--PVHLVSQAANDLNLTFVVDEDQADGLCARLHFQLIE 63 (63)
T ss_pred CEEEEECCCcccCccHHHHHHHHHhcC--CceEEEEeCCCCeEEEEEeHHHHHHHHHHHHHHHhC
Confidence 58999997 778999999999999865 677789999999999999999999999999999985
No 88
>cd04917 ACT_AKiii-LysC-EC_2 ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in bacteria (Escherichia coli (EC) LysC). Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The E. coli AKIII (LysC) binds two feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. The second ACT domain (ACT2), this CD, is not involved in the binding of heterotrophic effectors. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.24 E-value=2.5e-11 Score=96.35 Aligned_cols=63 Identities=32% Similarity=0.657 Sum_probs=59.0
Q ss_pred eeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008693 474 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 538 (557)
Q Consensus 474 ~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~ 538 (557)
+++|+++|. +...+++++++|++|+ +++|.+++||+|+++++|+|+++|.++|++.||++||.
T Consensus 1 ~alIsvvG~~~~~~~~v~~~i~~~L~--~i~i~~i~~~~s~~~is~~V~~~~~~~a~~~Lh~~f~~ 64 (64)
T cd04917 1 LALVALIGNDISETAGVEKRIFDALE--DINVRMICYGASNHNLCFLVKEEDKDEVVQRLHSRLFE 64 (64)
T ss_pred CeEEEEECCCccCCcCHHHHHHHHHH--hCCeEEEEEecCccEEEEEEeHHHHHHHHHHHHHHHhC
Confidence 489999997 7788999999999996 58999999999999999999999999999999999984
No 89
>cd04922 ACT_AKi-HSDH-ThrA_2 ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). This CD includes the second of two ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). The ACT domains are positioned between the N-terminal catalytic domain of AK and the C-terminal HSDH domain found in bacteria (Escherichia coli (EC) ThrA) and higher plants (Zea mays AK-HSDH). AK and HSDH are the first and third enzymes in the biosynthetic pathway of the aspartate family of amino acids. AK catalyzes the phosphorylation of Asp to P-aspartyl phosphate. HSDH catalyzes the NADPH-dependent conversion of Asp 3-semialdehyde to homoserine. HSDH is the first committed reaction in the branch of the pathway that leads to Thr and Met. In E. coli, ThrA is subject to allosteric regulation by the end product L-threonine and the native enzyme is reported to be tetrameric. As with bacteria, plant AK and HSDH are feedback inhibited by pathwa
Probab=99.22 E-value=4.2e-11 Score=94.98 Aligned_cols=65 Identities=35% Similarity=0.651 Sum_probs=61.5
Q ss_pred eeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008693 474 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 538 (557)
Q Consensus 474 ~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~ 538 (557)
+++|+++|. +...+++.+++|+.|+++||++.|++|+.|+.+++|+|++++.++++++||++||+
T Consensus 1 ~~~isvvg~~~~~~~~~~~~i~~~l~~~~I~v~~i~~~~s~~~is~~v~~~~~~~~~~~lh~~~~~ 66 (66)
T cd04922 1 LSILALVGDGMAGTPGVAATFFSALAKANVNIRAIAQGSSERNISAVIDEDDATKALRAVHERFFL 66 (66)
T ss_pred CeEEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEEecCcccEEEEEEeHHHHHHHHHHHHHHHhC
Confidence 478999997 77889999999999999999999999998999999999999999999999999984
No 90
>PRK09411 carbamate kinase; Reviewed
Probab=99.21 E-value=7.1e-10 Score=113.08 Aligned_cols=117 Identities=17% Similarity=0.174 Sum_probs=85.3
Q ss_pred hhchhcCCceEEEcCC--CcccC-CCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCccccccC
Q 008693 254 HGDWITDLAIPIVTGF--LGKAW-RTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLT 330 (557)
Q Consensus 254 ~~~ll~~~~vpVv~Gf--ig~~~-~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~i~~ls 330 (557)
.+.|++++.|||.+|. ++... .+|...++. .|.+|+.||.+|+|+.++|+|||||||+.++ .|++++|++++
T Consensus 169 I~~Ll~~G~IVI~~gGGGIPV~~~~~G~e~vID---kD~~Aa~LA~~L~Ad~LIiLTDVdGV~~n~~--~p~~~~I~~it 243 (297)
T PRK09411 169 IELLLKEGHVVICSGGGGVPVTEDGAGSEAVID---KDLAAALLAEQINADGLVILTDADAVYENWG--TPQQRAIRHAT 243 (297)
T ss_pred HHHHHHCCCEEEecCCCCCCeEEcCCCeEEecC---HHHHHHHHHHHhCCCEEEEEeCchhhccCCC--CCCCcCCCCcC
Confidence 3345678889888743 22211 234444454 8999999999999999999999999998653 57889999999
Q ss_pred HHHHHHHHHcCCCcchHh---HHHHHHhCCCCEEEecCCCC-----CCCCeeEe
Q 008693 331 FDEAAELAYFGAQVLHPQ---SMRPAREGDIPVRVKNSYNP-----NAPGTLIR 376 (557)
Q Consensus 331 ~~Ea~eLa~~Ga~vlhp~---a~~~a~~~~Ipv~I~n~~~p-----~~~GT~I~ 376 (557)
.+|+.++.. ....|.|| |++.+...+.+++|.+..+. ...||+|.
T Consensus 244 ~~e~~~~~~-~~GgM~pKVeAA~~~v~~~g~~a~I~~l~~~~~~l~G~~GT~I~ 296 (297)
T PRK09411 244 PDELAPFAK-ADGAMGPKVTAVSGYVRSRGKPAWIGALSRIEETLAGEAGTCIS 296 (297)
T ss_pred HHHHHHhcc-CCCCcHHHHHHHHHHHHhCCCeEEECChhHHHHHHCCCCCeEEe
Confidence 999987765 44568887 45667777889999753221 12588874
No 91
>KOG1154 consensus Gamma-glutamyl kinase [Amino acid transport and metabolism]
Probab=99.19 E-value=2.4e-10 Score=110.76 Aligned_cols=157 Identities=15% Similarity=0.267 Sum_probs=111.3
Q ss_pred HHhhchHHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCC
Q 008693 197 LVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRT 276 (557)
Q Consensus 197 i~s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~ 276 (557)
+.+.|..=-..+.-..|.++|+.. .|+ ++|..++.+. ..+.++...+.+ |+..+.|||+-- |
T Consensus 92 ~AAvGQ~~Lmalye~lF~Qy~~~i-----AQv-LvT~~Di~d~----~~r~Nl~~Ti~e-LL~m~viPIvNe-------N 153 (285)
T KOG1154|consen 92 CAAVGQSGLMALYETLFTQYGITI-----AQV-LVTRNDILDE----QQRKNLQNTISE-LLSMNVIPIVNE-------N 153 (285)
T ss_pred HHHhCcchHHHHHHHHHHHhccch-----hee-eecCcchhhH----HHHHHHHHHHHH-HHhCCceeeecC-------C
Confidence 445554444456677789999975 444 6776655432 345666666654 567899999932 3
Q ss_pred Ccee--ecCCCc---chhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCccccccCHHHHH-H-----HHHcCCCcc
Q 008693 277 CAIT--TLGRGG---SDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAA-E-----LAYFGAQVL 345 (557)
Q Consensus 277 G~~t--tlgRgG---SD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~i~~ls~~Ea~-e-----La~~Ga~vl 345 (557)
..+. -..+|. +|..|+++|..++||-++++|||||+||..|. -..+++++..+..+.. . -+..|...|
T Consensus 154 Davs~~~~~~~D~~dNDsLsA~laaei~ADlLilLsDVdglYt~PPd-~~~~~li~~~~~~~~~v~~tfG~~SkvGtGGM 232 (285)
T KOG1154|consen 154 DAVSPREIPFGDSSDNDSLAAILAAEIKADLLILLSDVDGLYTGPPD-ADPSKLIHTFSPGDPQVSTTFGSKSKVGTGGM 232 (285)
T ss_pred CccCCcccccCCCCcccHHHHHHHHHhccCEEEEEecccccccCCCC-CCcceeeeeeccCCCCCccccCccCccCcCcc
Confidence 3322 234555 89999999999999999999999999995544 3457778877766554 2 334466678
Q ss_pred hHh--HHHHHHhCCCCEEEecCCCCCCCC
Q 008693 346 HPQ--SMRPAREGDIPVRVKNSYNPNAPG 372 (557)
Q Consensus 346 hp~--a~~~a~~~~Ipv~I~n~~~p~~~G 372 (557)
..| |...|...|+++.|.|+..|+..+
T Consensus 233 ~tKv~AA~~A~~~Gv~viI~~g~~p~~I~ 261 (285)
T KOG1154|consen 233 ETKVKAAVNALNAGVSVIITNGDAPENIT 261 (285)
T ss_pred hhhHHHHHHHhcCCceEEEeCCCChHHHH
Confidence 765 788999999999999999997543
No 92
>cd04916 ACT_AKiii-YclM-BS_2 ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) YclM) and Clostridia species. Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. B. subtilis YclM is reported to be a single polypeptide of 50 kD. AKIII from B. subtilis strain 168 is induced by lysine and repressed by threonine and it is synergistically inhibited by lysine and threonine. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.12 E-value=2.6e-10 Score=90.43 Aligned_cols=65 Identities=29% Similarity=0.614 Sum_probs=61.2
Q ss_pred eeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008693 474 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 538 (557)
Q Consensus 474 ~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~ 538 (557)
+++|+++|. +...+++.+++|+.|++.||++.|++|+.++.+++|+|+++|.+++++.||++||.
T Consensus 1 ~~lisivg~~~~~~~~~~~~i~~~L~~~~i~v~~i~~~~s~~~isf~v~~~d~~~~~~~lh~~~~~ 66 (66)
T cd04916 1 LALIMVVGEGMKNTVGVSARATAALAKAGINIRMINQGSSEISIMIGVHNEDADKAVKAIYEEFFN 66 (66)
T ss_pred CeEEEEEcCCCCCCccHHHHHHHHHHHCCCCEEEEEecCcccEEEEEEeHHHHHHHHHHHHHHHhC
Confidence 478999997 77889999999999999999999999998999999999999999999999999984
No 93
>cd04924 ACT_AK-Arch_2 ACT domains of a monofunctional aspartokinase found mostly in Archaea species (ACT_AK-Arch_2). Included in this CD is the second of two ACT domains of a monofunctional aspartokinase found mostly in Archaea species (ACT_AK-Arch_2). The first or N-terminal ACT domain of these proteins cluster with the ThrA-like ACT 1 domains (ACT_AKi-HSDH-ThrA-like_1) which includes the threonine-sensitive archaeal Methanococcus jannaschii aspartokinase ACT 1 domain. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.03 E-value=9.9e-10 Score=86.94 Aligned_cols=64 Identities=33% Similarity=0.620 Sum_probs=60.3
Q ss_pred eeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhc
Q 008693 474 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFF 537 (557)
Q Consensus 474 ~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~ 537 (557)
+++|+++|. +...+++.+++|+.|+++||++.|++|+.++.+++|+++++|.+++++.||++|.
T Consensus 1 ~~~isivg~~~~~~~~~~~~i~~~L~~~~I~v~~i~q~~s~~~isf~i~~~~~~~~~~~Lh~~~~ 65 (66)
T cd04924 1 VAVVAVVGSGMRGTPGVAGRVFGALGKAGINVIMISQGSSEYNISFVVAEDDGWAAVKAVHDEFG 65 (66)
T ss_pred CeEEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEEecCccceEEEEEeHHHHHHHHHHHHHHhc
Confidence 479999997 7778999999999999999999999999899999999999999999999999984
No 94
>PF13840 ACT_7: ACT domain ; PDB: 3S1T_A 1ZHV_A 3AB4_K 3AB2_O 2DTJ_A 3AAW_A 2RE1_B 3MAH_A 1ZVP_D.
Probab=98.98 E-value=1.8e-09 Score=86.26 Aligned_cols=62 Identities=34% Similarity=0.580 Sum_probs=56.4
Q ss_pred cccceeEEEEEcc-ccc-cchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHH
Q 008693 470 LLQHRSIISLIGN-VQR-SSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHE 534 (557)
Q Consensus 470 ~~~~~aiIsIVG~-~~~-~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~ 534 (557)
..+++++|+++|. +.. .+|+++++|++|+++||||++++ |+.+++++|+++|.++|+++||+
T Consensus 2 ~~~~~~~i~v~g~g~~~~~~Gv~a~i~~~La~~~I~i~~is---S~~~~~ilV~~~~~~~A~~~L~~ 65 (65)
T PF13840_consen 2 IEEDWAKISVVGPGLRFDVPGVAAKIFSALAEAGINIFMIS---SEISISILVKEEDLEKAVEALHE 65 (65)
T ss_dssp EESEEEEEEEEEECGTTTSHHHHHHHHHHHHHTTS-ECEEE---ESSEEEEEEEGGGHHHHHHHHHH
T ss_pred ccCCEEEEEEEccccCCCcccHHHHHHHHHHHCCCCEEEEE---EeeeEEEEEeHHHHHHHHHHhcC
Confidence 3578999999997 644 89999999999999999999998 79999999999999999999996
No 95
>cd04933 ACT_AK1-AT_1 ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1). This CD includes the first of two ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1), which can be synergistically inhibited by S-adenosylmethionine. This isoenzyme is found in higher plants, Arabidopsis thaliana (AT) and Zea mays, and also in Chlorophyta. Like the Escherichia coli AKIII (LysC), Arabidopsis AK1 binds two feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. A loop in common is involved in the binding of both Lys and S-adenosylmethionine providing an explanation for the synergistic inhibition by these effectors. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.92 E-value=5.4e-09 Score=86.47 Aligned_cols=75 Identities=92% Similarity=1.237 Sum_probs=65.9
Q ss_pred EEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhheee
Q 008693 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIVN 469 (557)
Q Consensus 395 ialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~ 469 (557)
+++|++.+.++.+.+|+++++|+.|+++||++|||++++.++||+++.++.+....+.++++.+.+++++.+.++
T Consensus 1 ~~~i~i~~~~~~~~~g~~a~IF~~La~~~InVDmI~qs~~sISftV~~sd~~~~~~~~~~l~~~~~~~~~~~~~~ 75 (78)
T cd04933 1 VTMLDITSTRMLGQYGFLAKVFSIFETLGISVDVVATSEVSISLTLDPSKLWSRELIQQELDHVVEELEKDAVVN 75 (78)
T ss_pred CEEEEEEcCCCCCccCHHHHHHHHHHHcCCcEEEEEecCCEEEEEEEhhhhhhhhhHHHHHHHHHHHHHHcCeEE
Confidence 368999999999999999999999999999999999999999999999887655566667888888898877554
No 96
>COG2054 Uncharacterized archaeal kinase related to aspartokinases, uridylate kinases [General function prediction only]
Probab=98.85 E-value=1.1e-07 Score=89.14 Aligned_cols=88 Identities=27% Similarity=0.332 Sum_probs=75.9
Q ss_pred CCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHh
Q 008693 276 TCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPARE 355 (557)
Q Consensus 276 ~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~ 355 (557)
+.++| ||..+..+|+.++|.++++.|||||||+.+|+ ++++++|+..|..+ |-..++|-+=..+.+
T Consensus 113 SW~VT------SDsis~~Ia~~~~~~~vv~aTDVdGI~~~~~~----~kLv~eI~A~dl~~----~~t~vD~~~P~Ll~k 178 (212)
T COG2054 113 SWEVT------SDSISVWIAAKAGATEVVKATDVDGIYEEDPK----GKLVREIRASDLKT----GETSVDPYLPKLLVK 178 (212)
T ss_pred ceeec------ccHHHHHHHHHcCCcEEEEEecCCcccccCCc----chhhhhhhHhhccc----CcccccchhhHHHHH
Confidence 34677 99999999999999999999999999999875 58999988776654 778999999999999
Q ss_pred CCCCEEEecCCCCC----------CCCeeEec
Q 008693 356 GDIPVRVKNSYNPN----------APGTLIRR 377 (557)
Q Consensus 356 ~~Ipv~I~n~~~p~----------~~GT~I~~ 377 (557)
.++.++|.|..+|+ .+||+|.+
T Consensus 179 ~~m~~~Vvng~~pervi~~lrGk~~v~T~Ivg 210 (212)
T COG2054 179 YKMNCRVVNGKEPERVILALRGKEVVGTLIVG 210 (212)
T ss_pred cCCceEEECCCCHHHHHHHHhccccceEEEeC
Confidence 99999999999885 26677654
No 97
>cd04921 ACT_AKi-HSDH-ThrA-like_1 ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). This CD includes the first of two ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). The ACT domains are positioned between the N-terminal catalytic domain of AK and the C-terminal HSDH domain found in bacteria (Escherichia coli (EC) ThrA) and higher plants (Zea mays AK-HSDH). AK and HSDH are the first and third enzymes in the biosynthetic pathway of the aspartate family of amino acids. AK catalyzes the phosphorylation of Asp to P-aspartyl phosphate. HSDH catalyzes the NADPH-dependent conversion of Asp 3-semialdehyde to homoserine. HSDH is the first committed reaction in the branch of the pathway that leads to Thr and Met. In E. coli, ThrA is subject to allosteric regulation by the end product L-threonine and the native enzyme is reported to be tetrameric. As with bacteria, plant AK and HSDH are feedback inhibited by pat
Probab=98.76 E-value=3e-08 Score=81.84 Aligned_cols=66 Identities=32% Similarity=0.526 Sum_probs=61.6
Q ss_pred eeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccC
Q 008693 474 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFES 539 (557)
Q Consensus 474 ~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~~ 539 (557)
+++|+++|. +...+++.+++|+.|++++|++.|++|++++.+++|+++.++.+++++.||++|+.+
T Consensus 1 ~~~I~vvg~~~~~~~~~~~~i~~~L~~~~I~v~~i~~~~~~~~isf~v~~~d~~~~~~~l~~~~~~~ 67 (80)
T cd04921 1 VALINIEGTGMVGVPGIAARIFSALARAGINVILISQASSEHSISFVVDESDADKALEALEEEFALE 67 (80)
T ss_pred CEEEEEEcCCCCCCccHHHHHHHHHHHCCCcEEEEEecCCcceEEEEEeHHHHHHHHHHHHHHHHhh
Confidence 478999996 778899999999999999999999999999999999999999999999999999754
No 98
>cd04923 ACT_AK-LysC-DapG-like_2 ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168 and related domains. This CD includes the C-terminal of the two ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, as well as, the second and fourth, of four, ACT domains present in cyanobacteria AK. Also included are the C-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase isoenzyme AKI found in Bacilli (B. subtilis strain 168), Clostridia, and Actinobacteria bacterial species. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.75 E-value=3.7e-08 Score=76.93 Aligned_cols=61 Identities=39% Similarity=0.707 Sum_probs=56.6
Q ss_pred eEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhc
Q 008693 475 SIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFF 537 (557)
Q Consensus 475 aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~ 537 (557)
++|+++|. +...+++++++|+.|++++|++.++++ ++.+++|+|+++|.+++++.||++|+
T Consensus 1 ~~v~v~g~~~~~~~~~~~~i~~~L~~~~i~v~~i~~--s~~~is~~v~~~~~~~~~~~l~~~l~ 62 (63)
T cd04923 1 AKVSIVGAGMRSHPGVAAKMFKALAEAGINIEMIST--SEIKISCLVDEDDAEKAVRALHEAFE 62 (63)
T ss_pred CEEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEEc--cCCeEEEEEeHHHHHHHHHHHHHHhc
Confidence 47899996 777899999999999999999999987 68999999999999999999999996
No 99
>cd04892 ACT_AK-like_2 ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). This CD includes the second of two ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). The exception in this group, is the inclusion of the first ACT domain of the bifunctional aspartokinase - homoserine dehydrogenase-like enzyme group (ACT_AKi-HSDH-ThrA-like_1) which includes the monofunctional, threonine-sensitive, aspartokinase found in Methanococcus jannaschii and other related archaeal species. AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. AK is the first enzyme in the pathway of the biosynthesis of the aspartate family of amino acids (lysine, threonine, methionine, and isoleucine) and the bacterial cell wall component, meso-diaminopimelate. One mechanism for the regulation of this pathway is by the production of several isoenzymes of AK with different repressors an
Probab=98.75 E-value=3.9e-08 Score=76.58 Aligned_cols=64 Identities=41% Similarity=0.776 Sum_probs=59.3
Q ss_pred eEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008693 475 SIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 538 (557)
Q Consensus 475 aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~ 538 (557)
++|+++|. +...+++.+++|+.|++.+|++.+++|+.++.+++|++++++.+++++.||++|+.
T Consensus 1 ~~i~i~g~~~~~~~~~~~~i~~~l~~~~i~v~~i~~~~~~~~i~~~v~~~~~~~~~~~l~~~~~~ 65 (65)
T cd04892 1 ALVSVVGAGMRGTPGVAARIFSALAEAGINIIMISQGSSEVNISFVVDEDDADKAVKALHEEFFL 65 (65)
T ss_pred CEEEEECCCCCCCccHHHHHHHHHHHCCCcEEEEEcCCCceeEEEEEeHHHHHHHHHHHHHHHhC
Confidence 57999997 77889999999999999999999999987789999999999999999999999973
No 100
>cd04936 ACT_AKii-LysC-BS-like_2 ACT domains of the lysine-sensitive, aspartokinase (AK) isoenzyme AKII of Bacillus subtilis (BS) strain 168 and related domains. This CD includes the C-terminal of the two ACT domains of the lysine-sensitive, aspartokinase (AK) isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, and related sequences. In B. subtilis strain 168, the regulation of the diaminopimelate (Dap)-lysine biosynthetic pathway involves dual control by Dap and lysine, effected through separate Dap- and lysine-sensitive AK isoenzymes. The B. subtilis strain 168 AKII is induced by methionine and repressed and inhibited by lysine. Although C. glutamicum is known to contain a single AK, both the succinylase and dehydrogenase variant pathways of DAP-lysine synthesis operate simultaneously in this organism. In corynebacteria and other various Gram-positive bacteria, the DAP-lysine pathway is feedback regu
Probab=98.73 E-value=4.3e-08 Score=76.54 Aligned_cols=61 Identities=38% Similarity=0.693 Sum_probs=56.4
Q ss_pred eEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhc
Q 008693 475 SIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFF 537 (557)
Q Consensus 475 aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~ 537 (557)
++|+++|. +...+++.+++|+.|++.+|++.++++ ++.+++|+|+++|.+++++.||++|+
T Consensus 1 ~~i~v~g~~~~~~~~~~~~i~~~L~~~~i~v~~i~~--s~~~is~~v~~~d~~~~~~~l~~~~~ 62 (63)
T cd04936 1 AKVSIVGAGMRSHPGVAAKMFEALAEAGINIEMIST--SEIKISCLIDEDDAEKAVRALHEAFE 62 (63)
T ss_pred CEEEEECCCCCCCccHHHHHHHHHHHCCCcEEEEEc--cCceEEEEEeHHHHHHHHHHHHHHhc
Confidence 47899997 777899999999999999999999987 67999999999999999999999996
No 101
>cd04934 ACT_AK-Hom3_1 CT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae, and other related ACT domains. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae, and other related ACT domains. AK is the first enzyme in the aspartate metabolic pathway, catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and in fungi, is responsible for the production of threonine, isoleucine and methionine. S. cerevisiae has a single AK, which is regulated by feedback, allosteric inhibition by L-threonine. Recent studies shown that the allosteric transition triggered by binding of threonine to AK involves a large change in the conformation of the native hexameric enzyme that is converted to an inactive one of different shape and substantially smaller hydro
Probab=98.71 E-value=5.7e-08 Score=79.43 Aligned_cols=71 Identities=31% Similarity=0.543 Sum_probs=59.9
Q ss_pred EEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeec
Q 008693 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNL 470 (557)
Q Consensus 395 ialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~ 470 (557)
++.|++.+.+|.+.+|+++++|+.|+++||++||+++++.+++|+++.+++.. +.++.++++|++++.+++
T Consensus 1 ~~~I~i~~~~m~~~~g~~~~If~~la~~~I~vd~I~~s~~~isftv~~~~~~~-----~~l~~l~~el~~~~~v~~ 71 (73)
T cd04934 1 ILVINIHSNKKSLSHGFLARIFAILDKYRLSVDLISTSEVHVSMALHMENAED-----TNLDAAVKDLQKLGTVDI 71 (73)
T ss_pred CEEEEEEcccCccccCHHHHHHHHHHHcCCcEEEEEeCCCEEEEEEehhhcCh-----HHHHHHHHHHHHheEEEe
Confidence 46789999999999999999999999999999999999999999999875421 145677788888776654
No 102
>cd04932 ACT_AKiii-LysC-EC_1 ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in bacteria (Escherichia coli (EC) LysC). Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The E. coli AKIII (LysC) binds two feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.71 E-value=6.8e-08 Score=79.42 Aligned_cols=72 Identities=42% Similarity=0.556 Sum_probs=59.2
Q ss_pred EEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchhhhHHHHHHHHH-HHHHHHhhhheeec
Q 008693 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQELD-HVVEELEKIAIVNL 470 (557)
Q Consensus 395 ialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~~~~~~~~~~l~-~~~~~l~~~~~i~~ 470 (557)
+++|++.+.++.+.+|+++++|+.|+++||+++||++++.++||+++.++.... +++. .++.+|++++.+++
T Consensus 1 ~~~ItI~~~~~~~~~g~~~~IF~~La~~~I~VDmI~~s~~~iSftv~~~d~~~~----~~~~~~l~~~l~~~~~v~~ 73 (75)
T cd04932 1 QTLVTLKSPNMLHAQGFLAKVFGILAKHNISVDLITTSEISVALTLDNTGSTSD----QLLTQALLKELSQICDVKV 73 (75)
T ss_pred CEEEEEecCCCCCCcCHHHHHHHHHHHcCCcEEEEeecCCEEEEEEeccccchh----HHHHHHHHHHHHhccEEEe
Confidence 468899888899999999999999999999999999999999999998764321 2344 56677887776654
No 103
>cd04935 ACT_AKiii-DAPDC_1 ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC) bacterial protein. This CD includes the first of two ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC) bacterial protein. Aspartokinase (AK) is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The lysA gene encodes the enzyme DAPDC, a pyridoxal-5'-phosphate (PLP)-dependent enzyme which catalyzes the final step in the lysine biosynthetic pathway converting meso-diaminopimelic acid (DAP) to l-lysine. Tandem ACT domains are positioned centrally with the AK catalytic domain N-terminal and the DAPDC domains C-terminal. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.63 E-value=1.6e-07 Score=77.28 Aligned_cols=73 Identities=34% Similarity=0.597 Sum_probs=59.6
Q ss_pred EEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeec
Q 008693 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNL 470 (557)
Q Consensus 395 ialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~ 470 (557)
+++|++.+.+|.+.+|+++++|+.|+++||++||+++++.+++|+++.++.+... +.++.+.++|++++.+++
T Consensus 1 ~~~i~i~~~~~~~~~g~~~~IF~~La~~~I~vDmI~~s~~~isftv~~~~~~~~~---~~~~~l~~el~~~~~v~~ 73 (75)
T cd04935 1 IRLVSMETLGMWQQVGFLADVFAPFKKHGVSVDLVSTSETNVTVSLDPDPNGLDP---DVLDALLDDLNQICRVKI 73 (75)
T ss_pred CEEEEEEcCCCCCccCHHHHHHHHHHHcCCcEEEEEeCCCEEEEEEeCcccccch---HHHHHHHHHHHhceEEEE
Confidence 4689999999999999999999999999999999999999999999987631111 145667778887666653
No 104
>TIGR00656 asp_kin_monofn aspartate kinase, monofunctional class. The Lys-sensitive enzyme of Bacillus subtilis resembles the E. coli form but is an alpha 2/beta 2 heterotetramer, where the beta subunit is translated from an in-phase alternative initiator at Met-246. The protein slr0657 from Synechocystis PCC6803 is extended by a duplication of the C-terminal region corresponding to the beta chain. Incorporation of a second copy of the C-terminal domain may be quite common in this subgroup of aspartokinases.
Probab=98.52 E-value=5.1e-07 Score=97.28 Aligned_cols=114 Identities=21% Similarity=0.292 Sum_probs=89.7
Q ss_pred HHHHHHHHHHhCCceEEEEEccCceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeecccceeEEEEEcc-ccccchH
Q 008693 411 FLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNLLQHRSIISLIGN-VQRSSLI 489 (557)
Q Consensus 411 ~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~~~~~aiIsIVG~-~~~~~~v 489 (557)
+..+.+....+++|++....+....-.-.|.... ..-..+..++..+++++|+++|. |.+.+|+
T Consensus 212 ~~~~a~~~a~~~~i~i~i~~~~~~~~gT~I~~~~---------------~~~~~v~~I~~~~~va~vsv~g~~~~~~~g~ 276 (401)
T TIGR00656 212 LHPRTVEPAMRSGVPIEVRSSFDPEEGTLITNSM---------------ENPPLVKGIALRKNVTRVTVHGLGMLGKRGF 276 (401)
T ss_pred cCHHHHHHHHHCCCeEEEEECCCCCCCeEEEeCc---------------ccCCceEEEEEECCEEEEEEecCCCCCCccH
Confidence 3466778888999999888654322112221110 01113566888899999999996 8888999
Q ss_pred HHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccC
Q 008693 490 LEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFES 539 (557)
Q Consensus 490 ~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~~ 539 (557)
++++|+.|++++|++.+++|++|+.+++|+|+++|.+++++.||+.|...
T Consensus 277 ~~~if~~L~~~~I~i~~i~~~~s~~~Is~~V~~~d~~~a~~~L~~~~~~~ 326 (401)
T TIGR00656 277 LARIFGALAERNINVDLISQTPSETSISLTVDETDADEAVRALKDQSGAA 326 (401)
T ss_pred HHHHHHHHHHcCCcEEEEEcCCCCceEEEEEeHHHHHHHHHHHHHHHHhc
Confidence 99999999999999999999999999999999999999999999998443
No 105
>PRK06291 aspartate kinase; Provisional
Probab=98.47 E-value=8.7e-07 Score=97.31 Aligned_cols=112 Identities=29% Similarity=0.407 Sum_probs=89.1
Q ss_pred HHHHHHHHHhCCceEEEEEccCc--eeEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeecccceeEEEEEcc-ccccch
Q 008693 412 LAKVFSTFEDLGISVDVVATSEV--SLSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNLLQHRSIISLIGN-VQRSSL 488 (557)
Q Consensus 412 la~If~~L~~~gI~Vd~IstSe~--sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~~~~~aiIsIVG~-~~~~~~ 488 (557)
..+.+....++||++....+.+. .-++..+.... .. ..+..|+..+++++|+++|. |...++
T Consensus 272 ~~~a~~~~~~~~i~i~i~~~~~~~~~gt~i~~~~~~--------------~~-~~V~~It~~~~valIsI~g~~m~~~~g 336 (465)
T PRK06291 272 HPRTIEPAMEKGIPVRVKNTFNPEFPGTLITSDSES--------------SK-RVVKAVTLIKNVALINISGAGMVGVPG 336 (465)
T ss_pred CHHHHHHHHHcCCcEEEecCCCCCCCceEEEecccc--------------cC-cccceEEeeCCEEEEEEeCCCCCCCcc
Confidence 35567778889999888765332 12222221110 00 23567888999999999997 778899
Q ss_pred HHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008693 489 ILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 538 (557)
Q Consensus 489 v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~ 538 (557)
+++++|++|+++||+|.||+|++|+.+++|+|++++.+++++.||++|..
T Consensus 337 ~~arvf~~L~~~gI~V~mIsq~sse~sIsf~V~~~d~~~av~~L~~~~~~ 386 (465)
T PRK06291 337 TAARIFSALAEEGVNVIMISQGSSESNISLVVDEADLEKALKALRREFGE 386 (465)
T ss_pred HHHHHHHHHHHCCCcEEEEEecCCCceEEEEEeHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999975
No 106
>cd04868 ACT_AK-like ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). This CD includes each of two ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). Typically, AK consists of two ACT domains in a tandem repeat, but the second ACT domain is inserted within the first, resulting in, what is normally the terminal beta strand of ACT2, formed from a region N-terminal of ACT1. AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. Aspartokinase is the first enzyme in the pathway of the biosynthesis of the aspartate family of amino acids (lysine, threonine, methionine, and isoleucine) and the bacterial cell wall component, meso-diaminopimelate. One mechanism for the regulation of this pathway is by the production of several isoenzymes of aspartokinase with different repressors and allosteric inhibitors. Pairs of ACT domains are proposed to specifically bind am
Probab=98.46 E-value=5e-07 Score=68.80 Aligned_cols=59 Identities=39% Similarity=0.646 Sum_probs=54.4
Q ss_pred eEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHH
Q 008693 475 SIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALH 533 (557)
Q Consensus 475 aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH 533 (557)
++|+++|. +...+++.+++|+.|++++|++.+++|+.++.+++|+++.++.+++++.||
T Consensus 1 ~~i~v~g~~~~~~~~~~~~i~~~l~~~~i~i~~i~~~~~~~~~s~~v~~~~~~~~~~~lh 60 (60)
T cd04868 1 AKVSIVGVGMRGTPGVAAKIFSALAEAGINVDMISQSESEVNISFTVDESDLEKAVKALH 60 (60)
T ss_pred CEEEEECCCCCCCCCHHHHHHHHHHHCCCcEEEEEcCCCcEEEEEEEeHHHHHHHHHHhC
Confidence 47899997 667899999999999999999999999887899999999999999999987
No 107
>cd04912 ACT_AKiii-LysC-EC-like_1 ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in bacteria (Escherichia coli (EC) LysC) and plants, (Zea mays Ask1, Ask2, and Arabidopsis thaliana AK1). Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. Like the A. thaliana AK1 (AK1-AT), the E. coli AKIII (LysC) has two bound feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. The lysine-sensitive plant isoenzyme is synergistically inhibited by S-adenosylmethionine. A homolog of this group appears to be the Saccharomyces cerevisiae AK (Hom3) which clusters with this group as well. Members of this CD
Probab=98.44 E-value=9.8e-07 Score=72.37 Aligned_cols=73 Identities=55% Similarity=0.788 Sum_probs=59.1
Q ss_pred EEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeec
Q 008693 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNL 470 (557)
Q Consensus 395 ialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~ 470 (557)
+++|++.+.++.+.+|+++++|+.|+++||+++++++|+.+++|+++.++.... +..++.+.++|++++.+++
T Consensus 1 ~~~Vsi~g~~l~~~~g~~~~if~~L~~~~I~v~~i~~s~~~is~~v~~~~~~~~---~~~~~~~~~~l~~~~~~~~ 73 (75)
T cd04912 1 ITLLNIKSNRMLGAHGFLAKVFEIFAKHGLSVDLISTSEVSVSLTLDPTKNLSD---QLLLDALVKDLSQIGDVEV 73 (75)
T ss_pred CEEEEEEcCCCCCCccHHHHHHHHHHHcCCeEEEEEcCCcEEEEEEEchhhccc---hHHHHHHHHHHHhCCEEEE
Confidence 468999999999999999999999999999999999999999999998764221 1245667777877555543
No 108
>COG0549 ArcC Carbamate kinase [Amino acid transport and metabolism]
Probab=98.38 E-value=3.4e-05 Score=77.72 Aligned_cols=120 Identities=18% Similarity=0.221 Sum_probs=86.5
Q ss_pred HHhhchhcCCceEEEcCCCcccC-CCCc-e----eecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCcc
Q 008693 252 RLHGDWITDLAIPIVTGFLGKAW-RTCA-I----TTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKP 325 (557)
Q Consensus 252 ~l~~~ll~~~~vpVv~Gfig~~~-~~G~-~----ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~ 325 (557)
..++.|+++|.++|..|.=|... +++. . ..+. -|+++++||..++||.++|+||||+||-.=-+ |+-+.
T Consensus 175 ~~Ik~L~~~g~vVI~~GGGGIPVv~~~~~~~GVeAVID---KDlasalLA~~i~AD~liILTdVd~Vy~n~gk--p~q~~ 249 (312)
T COG0549 175 EAIKALLESGHVVIAAGGGGIPVVEEGAGLQGVEAVID---KDLASALLAEQIDADLLIILTDVDAVYVNFGK--PNQQA 249 (312)
T ss_pred HHHHHHHhCCCEEEEeCCCCcceEecCCCcceeeEEEc---cHHHHHHHHHHhcCCEEEEEeccchheecCCC--ccchh
Confidence 34455678888888876422211 0111 0 0111 49999999999999999999999999986433 67899
Q ss_pred ccccCHHHHHHHHHc---CCCcchHh---HHHHHHhCCCCEEEecCCCC-----CCCCeeEe
Q 008693 326 VPYLTFDEAAELAYF---GAQVLHPQ---SMRPAREGDIPVRVKNSYNP-----NAPGTLIR 376 (557)
Q Consensus 326 i~~ls~~Ea~eLa~~---Ga~vlhp~---a~~~a~~~~Ipv~I~n~~~p-----~~~GT~I~ 376 (557)
|++++.+|+.+.... ...-|-|| |+..+...|-+..|.+-.+- ...||.|.
T Consensus 250 L~~v~~~e~~~yl~eg~Fa~GSM~PKVeAai~Fv~~~gk~A~ItsLe~~~~~l~g~~GT~I~ 311 (312)
T COG0549 250 LDRVTVDEMEKYLAEGQFAAGSMGPKVEAAISFVENTGKPAIITSLENAEAALEGKAGTVIV 311 (312)
T ss_pred hcccCHHHHHHHHhcCCCCCCCccHHHHHHHHHHHcCCCceEECcHHHHHHHhccCCCcEec
Confidence 999999999888764 45688898 77888888888888764332 24688875
No 109
>PRK09436 thrA bifunctional aspartokinase I/homoserine dehydrogenase I; Provisional
Probab=98.35 E-value=2.2e-06 Score=100.03 Aligned_cols=111 Identities=22% Similarity=0.305 Sum_probs=88.2
Q ss_pred HHHHHHHHHhCCceEEEEEccCc-e-eEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeecccceeEEEEEcc-ccccch
Q 008693 412 LAKVFSTFEDLGISVDVVATSEV-S-LSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNLLQHRSIISLIGN-VQRSSL 488 (557)
Q Consensus 412 la~If~~L~~~gI~Vd~IstSe~-s-IS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~~~~~aiIsIVG~-~~~~~~ 488 (557)
..+.+....++||++....+.+. . -++...... .+-..+..|+..+++++|+++|. |...++
T Consensus 266 hp~a~~~a~~~~Ipi~i~n~~~p~~~GT~I~~~~~---------------~~~~~Vk~It~~~dvalIsV~G~gm~~~~G 330 (819)
T PRK09436 266 HPRTIAPIAQFQIPCLIKNTFNPQAPGTLIGAESD---------------EDSLPVKGISNLNNMAMFNVSGPGMKGMVG 330 (819)
T ss_pred hHHHHHHHHHCCceEEEccCCCCCCCceEEEecCc---------------ccccccceEEEeCCEEEEEEEcCCCCCCcC
Confidence 45667778889999988765332 1 222221110 00123567888899999999997 788999
Q ss_pred HHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhc
Q 008693 489 ILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFF 537 (557)
Q Consensus 489 v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~ 537 (557)
+++++|+.|+++||+|.||+|++|+.+|+|+|++++.+++++.||++|.
T Consensus 331 ~~arIf~~La~~gI~V~mIsqssSe~sIsf~V~~~d~~~av~~L~~~f~ 379 (819)
T PRK09436 331 MASRVFAALSRAGISVVLITQSSSEYSISFCVPQSDAAKAKRALEEEFA 379 (819)
T ss_pred HHHHHHHHHHHCCCcEEEEEcCCCCceEEEEEeHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999999999985
No 110
>cd04890 ACT_AK-like_1 ACT domains found C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). This CD includes the first of two ACT domains found C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and is the first enzyme in the pathway of the biosynthesis of the aspartate family of amino acids, lysine, threonine, methionine, and isoleucine. This CD, includes the first ACT domain of the Escherichia coli (EC) isoenzyme, AKIII (LysC) and the Arabidopsis isoenzyme, asparate kinase 1, both enzymes monofunctional and involved in lysine synthesis, as well as the the first ACT domain of Bacillus subtilis (BS) isoenzyme, AKIII (YclM), and of the Saccharomyces cerevisiae AK (Hom3). Also included are the first ACT domains of the Methylomicrobium alcaliphilum AK, the first enzyme of the ectoine biosynthetic pathway. Members of this CD bel
Probab=98.34 E-value=1.6e-06 Score=67.97 Aligned_cols=49 Identities=47% Similarity=0.692 Sum_probs=45.6
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchh
Q 008693 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKL 445 (557)
Q Consensus 397 lItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~ 445 (557)
.|++.+.+|.+.+|+.+++|+.|++++|+++++++++.+++|+++.++.
T Consensus 2 ~i~i~~~~m~~~~~~~~~if~~l~~~~i~v~~i~t~~~~is~~v~~~~~ 50 (62)
T cd04890 2 AIEIFDQLMNGEVGFLRKIFEILEKHGISVDLIPTSENSVTLYLDDSLL 50 (62)
T ss_pred EEEEeccccCcccCHHHHHHHHHHHcCCeEEEEecCCCEEEEEEehhhh
Confidence 5788999999999999999999999999999999999999999998653
No 111
>cd04937 ACT_AKi-DapG-BS_2 ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI. This CD includes the C-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) strain 168), Clostridia, and Actinobacteria bacterial species. In B. subtilis, the regulation of the diaminopimelate-lysine biosynthetic pathway involves dual control by diaminopimelate and lysine, effected through separate diaminopimelate- and lysine-sensitive AK isoenzymes. AKI activity is invariant during the exponential and stationary phases of growth and is not altered by addition of amino acids to the growth medium. The role of this isoenzyme is most likely to provide a constant level of aspartyl-beta-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis and dipicolinate during sporulation. The BS AKI is tetrameric consisting of two alpha and two beta subunits; th
Probab=98.22 E-value=4.4e-06 Score=66.26 Aligned_cols=51 Identities=22% Similarity=0.380 Sum_probs=47.5
Q ss_pred EEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchh
Q 008693 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKL 445 (557)
Q Consensus 395 ialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~ 445 (557)
+++|++.|.+|...+|+++++|+.|++.||++.++++|+.+++|+++.++.
T Consensus 1 ~~~isvvG~~~~~~~gi~~~if~aL~~~~I~v~~~~~Se~~is~~v~~~~~ 51 (64)
T cd04937 1 CAKVTIIGSRIRGVPGVMAKIVGALSKEGIEILQTADSHTTISCLVSEDDV 51 (64)
T ss_pred CeEEEEECCCccCCcCHHHHHHHHHHHCCCCEEEEEcCccEEEEEEcHHHH
Confidence 367999999999999999999999999999999999999999999998763
No 112
>cd04912 ACT_AKiii-LysC-EC-like_1 ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in bacteria (Escherichia coli (EC) LysC) and plants, (Zea mays Ask1, Ask2, and Arabidopsis thaliana AK1). Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. Like the A. thaliana AK1 (AK1-AT), the E. coli AKIII (LysC) has two bound feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. The lysine-sensitive plant isoenzyme is synergistically inhibited by S-adenosylmethionine. A homolog of this group appears to be the Saccharomyces cerevisiae AK (Hom3) which clusters with this group as well. Members of this CD
Probab=98.18 E-value=8.8e-06 Score=66.72 Aligned_cols=63 Identities=22% Similarity=0.416 Sum_probs=54.4
Q ss_pred eeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccH---HHHHHHHHHHhcc
Q 008693 474 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEA---EQCVRALHETFFE 538 (557)
Q Consensus 474 ~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~---~kAv~~LH~~f~~ 538 (557)
+++|+++|. +...+++++++|++|+++||++.++++ |+.+++|+|++++. +..++.|-++|-.
T Consensus 1 ~~~Vsi~g~~l~~~~g~~~~if~~L~~~~I~v~~i~~--s~~~is~~v~~~~~~~~~~~~~~~~~~l~~ 67 (75)
T cd04912 1 ITLLNIKSNRMLGAHGFLAKVFEIFAKHGLSVDLIST--SEVSVSLTLDPTKNLSDQLLLDALVKDLSQ 67 (75)
T ss_pred CEEEEEEcCCCCCCccHHHHHHHHHHHcCCeEEEEEc--CCcEEEEEEEchhhccchHHHHHHHHHHHh
Confidence 478999997 778899999999999999999999987 78999999999986 5577777766655
No 113
>PF13840 ACT_7: ACT domain ; PDB: 3S1T_A 1ZHV_A 3AB4_K 3AB2_O 2DTJ_A 3AAW_A 2RE1_B 3MAH_A 1ZVP_D.
Probab=98.08 E-value=1.6e-05 Score=63.44 Aligned_cols=54 Identities=24% Similarity=0.438 Sum_probs=48.5
Q ss_pred eeccEEEEEEEecCccc-hhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchh
Q 008693 391 LKRNVTMLDIVSTRMLG-QYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKL 445 (557)
Q Consensus 391 ~~~nialItI~~~~m~~-~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~ 445 (557)
..++++.|++.+.+|.. .+|+++++|+.|+++||++.+++ |+.++++.|+++++
T Consensus 2 ~~~~~~~i~v~g~g~~~~~~Gv~a~i~~~La~~~I~i~~is-S~~~~~ilV~~~~~ 56 (65)
T PF13840_consen 2 IEEDWAKISVVGPGLRFDVPGVAAKIFSALAEAGINIFMIS-SEISISILVKEEDL 56 (65)
T ss_dssp EESEEEEEEEEEECGTTTSHHHHHHHHHHHHHTTS-ECEEE-ESSEEEEEEEGGGH
T ss_pred ccCCEEEEEEEccccCCCcccHHHHHHHHHHHCCCCEEEEE-EeeeEEEEEeHHHH
Confidence 35789999999998866 99999999999999999999999 99999999998874
No 114
>cd04891 ACT_AK-LysC-DapG-like_1 ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII and related proteins. This CD includes the N-terminal of the two ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, as well as, the first and third, of four, ACT domains present in cyanobacteria AK. Also included are the N-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase isoenzyme AKI found in Bacilli (Bacillus subtilis strain 168), Clostridia, and Actinobacteria bacterial species. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.07 E-value=1.6e-05 Score=61.03 Aligned_cols=57 Identities=28% Similarity=0.461 Sum_probs=50.1
Q ss_pred eEEEEEccccccchHHHHHHHHHHhCCCcEEEEEecCCc---eEEEEEEecccHHHHHHHH
Q 008693 475 SIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASK---VNISLIVNDDEAEQCVRAL 532 (557)
Q Consensus 475 aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~IsqgsSe---~sIs~vV~~~d~~kAv~~L 532 (557)
++|+++|. .+.+++++++|+.|.+++|++.+++|+.+. .+++|.++++|.+++++.|
T Consensus 1 ~~v~v~~~-~~~~~~~~~i~~~L~~~~i~i~~i~~~~~~~~~~~is~~v~~~~~~~~~~~l 60 (61)
T cd04891 1 AQVTIKGV-PDKPGVAAKIFSALAEAGINVDMIVQSVSRGGTTDISFTVPKSDLEKALAIL 60 (61)
T ss_pred CEEEEecC-CCCCcHHHHHHHHHHHcCCcEEEEEEcCCCCCcEEEEEEEeHHHHHHHHHHh
Confidence 36788884 566899999999999999999999998766 8899999999999998875
No 115
>cd04913 ACT_AKii-LysC-BS-like_1 ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168 and related proteins. This CD includes the N-terminal of the two ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, and related sequences. In B. subtilis 168, the regulation of the diaminopimelate (Dap)-lysine biosynthetic pathway involves dual control by Dap and lysine, effected through separate Dap- and lysine-sensitive aspartokinase isoenzymes. The B. subtilis 168 AKII is induced by methionine and repressed and inhibited by lysine. Although Corynebacterium glutamicum is known to contain a single aspartokinase, both the succinylase and dehydrogenase variant pathways of DAP-lysine synthesis operate simultaneously in this organism. In corynebacteria and other various Gram-positive bacteria, the DAP-lysine pathway is fee
Probab=98.05 E-value=1.6e-05 Score=63.81 Aligned_cols=61 Identities=26% Similarity=0.363 Sum_probs=53.5
Q ss_pred eEEEEEccccccchHHHHHHHHHHhCCCcEEEEEecCC---ceEEEEEEecccHHHHHHHHHHHh
Q 008693 475 SIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGAS---KVNISLIVNDDEAEQCVRALHETF 536 (557)
Q Consensus 475 aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~IsqgsS---e~sIs~vV~~~d~~kAv~~LH~~f 536 (557)
++|+++|. .+.+++++++|+.|+++||++.+++|+.+ +.+++|+++++|.+++++.||+..
T Consensus 2 ~~v~v~~~-~~~~g~~~~i~~~L~~~~I~i~~i~~~~~~~~~~~is~~v~~~d~~~~~~~l~~~~ 65 (75)
T cd04913 2 AKITLRGV-PDKPGVAAKIFGALAEANINVDMIVQNVSRDGTTDISFTVPKSDLKKALAVLEKLK 65 (75)
T ss_pred eEEEECCC-CCCCcHHHHHHHHHHHcCCeEEEEEeCCCCCCcEEEEEEecHHHHHHHHHHHHHHH
Confidence 67888884 55689999999999999999999999765 357999999999999999999954
No 116
>cd04933 ACT_AK1-AT_1 ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1). This CD includes the first of two ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1), which can be synergistically inhibited by S-adenosylmethionine. This isoenzyme is found in higher plants, Arabidopsis thaliana (AT) and Zea mays, and also in Chlorophyta. Like the Escherichia coli AKIII (LysC), Arabidopsis AK1 binds two feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. A loop in common is involved in the binding of both Lys and S-adenosylmethionine providing an explanation for the synergistic inhibition by these effectors. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.03 E-value=2.5e-05 Score=64.73 Aligned_cols=64 Identities=19% Similarity=0.317 Sum_probs=54.5
Q ss_pred eeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHH------HHHHHHHHHhccC
Q 008693 474 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAE------QCVRALHETFFES 539 (557)
Q Consensus 474 ~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~------kAv~~LH~~f~~~ 539 (557)
+++|+|.+. +...+|+++++|+.|+++||+|.||+| ++.+++|.|++++.. .+++.|-++|-..
T Consensus 1 ~~~i~i~~~~~~~~~g~~a~IF~~La~~~InVDmI~q--s~~sISftV~~sd~~~~~~~~~~l~~~~~~~~~~ 71 (78)
T cd04933 1 VTMLDITSTRMLGQYGFLAKVFSIFETLGISVDVVAT--SEVSISLTLDPSKLWSRELIQQELDHVVEELEKD 71 (78)
T ss_pred CEEEEEEcCCCCCccCHHHHHHHHHHHcCCcEEEEEe--cCCEEEEEEEhhhhhhhhhHHHHHHHHHHHHHHc
Confidence 368899997 777899999999999999999999998 679999999999984 5777777766543
No 117
>cd04919 ACT_AK-Hom3_2 ACT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae, and other related ACT domains. AK is the first enzyme in the aspartate metabolic pathway, catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and in fungi, is responsible for the production of threonine, isoleucine and methionine. S. cerevisiae has a single AK, which is regulated by feedback, allosteric inhibition by L-threonine. Recent studies shown that the allosteric transition triggered by binding of threonine to AK involves a large change in the conformation of the native hexameric enzyme that is converted to an inactive one of different shape and substantially smaller hydrodynamic size. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.01 E-value=2e-05 Score=62.31 Aligned_cols=50 Identities=24% Similarity=0.541 Sum_probs=45.6
Q ss_pred EEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEc--cCceeEEEeCCch
Q 008693 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT--SEVSLSLTLDPSK 444 (557)
Q Consensus 395 ialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Ist--Se~sIS~~I~~~~ 444 (557)
+++|++.|.++.+.+++.+++|+.|++.||+++++++ ++.+++|+++.++
T Consensus 1 ~~~isvvg~~~~~~~~~~~~if~~L~~~~I~v~~i~q~~s~~~isf~v~~~~ 52 (66)
T cd04919 1 LAILSLVGKHMKNMIGIAGRMFTTLADHRINIEMISQGASEINISCVIDEKD 52 (66)
T ss_pred CeEEEEECCCCCCCcCHHHHHHHHHHHCCCCEEEEEecCccceEEEEEeHHH
Confidence 4689999999999999999999999999999999975 7889999998865
No 118
>COG0527 LysC Aspartokinases [Amino acid transport and metabolism]
Probab=98.00 E-value=3.9e-05 Score=83.54 Aligned_cols=114 Identities=23% Similarity=0.326 Sum_probs=93.7
Q ss_pred HHHHHHHHHHhCCceEEEEEccCce--eEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeecccceeEEEEEcc-ccccc
Q 008693 411 FLAKVFSTFEDLGISVDVVATSEVS--LSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNLLQHRSIISLIGN-VQRSS 487 (557)
Q Consensus 411 ~la~If~~L~~~gI~Vd~IstSe~s--IS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~~~~~aiIsIVG~-~~~~~ 487 (557)
+..+.++...+++|++..-++.+.. =|+....... .. ..+..|+..++.++|++.|. |...+
T Consensus 257 LHprav~pa~~~~Ip~~i~~t~~p~~~GTlI~~~~~~--------------~~-~~v~gIa~~~~~~~i~v~~~~~~~~~ 321 (447)
T COG0527 257 LHPRAVEPAMRSGIPLRIKNTFNPDAPGTLITAETES--------------DE-PVVKGIALDDNVALITVSGPGMNGMV 321 (447)
T ss_pred cCHHHHHHHHhcCCcEEEEecCCCCCCceEEecCCcC--------------CC-CceEEEEeCCCeEEEEEEccCccccc
Confidence 4577888899999999888765544 3444433210 00 23457888899999999997 77788
Q ss_pred hHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccC
Q 008693 488 LILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFES 539 (557)
Q Consensus 488 ~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~~ 539 (557)
|+++++|..|+++||++.+|.|+.++.+++|.+++++.+++.+.||+++...
T Consensus 322 g~~a~vf~~l~~~~i~v~~I~q~~~~~~i~~~v~~~~~~~a~~~l~~~~~~~ 373 (447)
T COG0527 322 GFAARVFGILAEAGINVDLITQSISEVSISFTVPESDAPRALRALLEEKLEL 373 (447)
T ss_pred cHHHHHHHHHHHcCCcEEEEEeccCCCeEEEEEchhhHHHHHHHHHHHHhhh
Confidence 9999999999999999999999999999999999999999999999999855
No 119
>cd04890 ACT_AK-like_1 ACT domains found C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). This CD includes the first of two ACT domains found C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and is the first enzyme in the pathway of the biosynthesis of the aspartate family of amino acids, lysine, threonine, methionine, and isoleucine. This CD, includes the first ACT domain of the Escherichia coli (EC) isoenzyme, AKIII (LysC) and the Arabidopsis isoenzyme, asparate kinase 1, both enzymes monofunctional and involved in lysine synthesis, as well as the the first ACT domain of Bacillus subtilis (BS) isoenzyme, AKIII (YclM), and of the Saccharomyces cerevisiae AK (Hom3). Also included are the first ACT domains of the Methylomicrobium alcaliphilum AK, the first enzyme of the ectoine biosynthetic pathway. Members of this CD bel
Probab=97.97 E-value=3.2e-05 Score=60.61 Aligned_cols=59 Identities=20% Similarity=0.412 Sum_probs=52.5
Q ss_pred EEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHh
Q 008693 476 IISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETF 536 (557)
Q Consensus 476 iIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f 536 (557)
.|++.|. |...+++.+++|+.|++++|++.+|++ ++.+++|+++.++.++.++.|-+++
T Consensus 2 ~i~i~~~~m~~~~~~~~~if~~l~~~~i~v~~i~t--~~~~is~~v~~~~~~~~~~~l~~~l 61 (62)
T cd04890 2 AIEIFDQLMNGEVGFLRKIFEILEKHGISVDLIPT--SENSVTLYLDDSLLPKKLKRLLAEL 61 (62)
T ss_pred EEEEeccccCcccCHHHHHHHHHHHcCCeEEEEec--CCCEEEEEEehhhhhHHHHHHHHhh
Confidence 5788886 777899999999999999999999998 6799999999999888888877654
No 120
>cd04922 ACT_AKi-HSDH-ThrA_2 ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). This CD includes the second of two ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). The ACT domains are positioned between the N-terminal catalytic domain of AK and the C-terminal HSDH domain found in bacteria (Escherichia coli (EC) ThrA) and higher plants (Zea mays AK-HSDH). AK and HSDH are the first and third enzymes in the biosynthetic pathway of the aspartate family of amino acids. AK catalyzes the phosphorylation of Asp to P-aspartyl phosphate. HSDH catalyzes the NADPH-dependent conversion of Asp 3-semialdehyde to homoserine. HSDH is the first committed reaction in the branch of the pathway that leads to Thr and Met. In E. coli, ThrA is subject to allosteric regulation by the end product L-threonine and the native enzyme is reported to be tetrameric. As with bacteria, plant AK and HSDH are feedback inhibited by pathwa
Probab=97.95 E-value=3e-05 Score=61.06 Aligned_cols=51 Identities=25% Similarity=0.452 Sum_probs=45.8
Q ss_pred EEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEc--cCceeEEEeCCchh
Q 008693 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT--SEVSLSLTLDPSKL 445 (557)
Q Consensus 395 ialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Ist--Se~sIS~~I~~~~~ 445 (557)
+++|++.|.++.+.+++.+++|+.|+++||+++++++ ++.+++|++++++.
T Consensus 1 ~~~isvvg~~~~~~~~~~~~i~~~l~~~~I~v~~i~~~~s~~~is~~v~~~~~ 53 (66)
T cd04922 1 LSILALVGDGMAGTPGVAATFFSALAKANVNIRAIAQGSSERNISAVIDEDDA 53 (66)
T ss_pred CeEEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEEecCcccEEEEEEeHHHH
Confidence 4689999999999999999999999999999999974 78899999988653
No 121
>cd04934 ACT_AK-Hom3_1 CT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae, and other related ACT domains. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae, and other related ACT domains. AK is the first enzyme in the aspartate metabolic pathway, catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and in fungi, is responsible for the production of threonine, isoleucine and methionine. S. cerevisiae has a single AK, which is regulated by feedback, allosteric inhibition by L-threonine. Recent studies shown that the allosteric transition triggered by binding of threonine to AK involves a large change in the conformation of the native hexameric enzyme that is converted to an inactive one of different shape and substantially smaller hydro
Probab=97.92 E-value=4.2e-05 Score=62.55 Aligned_cols=62 Identities=24% Similarity=0.362 Sum_probs=53.9
Q ss_pred eEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHH-HHHHHHHHhcc
Q 008693 475 SIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQ-CVRALHETFFE 538 (557)
Q Consensus 475 aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~k-Av~~LH~~f~~ 538 (557)
++|.+.+. |...+|+++++|+.|+++||++.||+| ++.+++|.++.++.+. .++.|.++|-.
T Consensus 2 ~~I~i~~~~m~~~~g~~~~If~~la~~~I~vd~I~~--s~~~isftv~~~~~~~~~l~~l~~el~~ 65 (73)
T cd04934 2 LVINIHSNKKSLSHGFLARIFAILDKYRLSVDLIST--SEVHVSMALHMENAEDTNLDAAVKDLQK 65 (73)
T ss_pred EEEEEEcccCccccCHHHHHHHHHHHcCCcEEEEEe--CCCEEEEEEehhhcChHHHHHHHHHHHH
Confidence 67889997 778899999999999999999999998 6699999999987655 78888777754
No 122
>cd04911 ACT_AKiii-YclM-BS_1 ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) YclM) and Clostridia species. Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. Bacillus subtilis YclM is reported to be a single polypeptide of 50 kD. AKIII from Bacillus subtilis strain 168 is induced by lysine and repressed by threonine and it is synergistically inhibited by lysine and threonine. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=97.89 E-value=2.8e-05 Score=63.85 Aligned_cols=64 Identities=22% Similarity=0.314 Sum_probs=52.3
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchhhhHHHHHHHHHHHHHHHhh
Q 008693 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQELDHVVEELEK 464 (557)
Q Consensus 396 alItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~ 464 (557)
+.|++....|....||..|++++|+++||++++++++.+++|++++.+++... .++.+++++++
T Consensus 2 ~~I~i~K~~Mn~evGF~rk~L~I~E~~~is~Eh~PSGID~~Siii~~~~~~~~-----~~~~i~~~i~~ 65 (76)
T cd04911 2 CSIYISKYLMNREVGFGRKLLSILEDNGISYEHMPSGIDDISIIIRDNQLTDE-----KEQKILAEIKE 65 (76)
T ss_pred ceEehhHhhccchhcHHHHHHHHHHHcCCCEeeecCCCccEEEEEEccccchh-----hHHHHHHHHHH
Confidence 45677788899999999999999999999999999999999999998865421 24455555554
No 123
>cd04932 ACT_AKiii-LysC-EC_1 ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in bacteria (Escherichia coli (EC) LysC). Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The E. coli AKIII (LysC) binds two feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=97.87 E-value=6.7e-05 Score=61.64 Aligned_cols=61 Identities=20% Similarity=0.422 Sum_probs=49.9
Q ss_pred eEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHH--HHHH-HHHHHhc
Q 008693 475 SIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAE--QCVR-ALHETFF 537 (557)
Q Consensus 475 aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~--kAv~-~LH~~f~ 537 (557)
++|++.|. +...+|+++++|+.|+++||+|.||+| ++.+++|.|+.++.. ++++ .|-.+|-
T Consensus 2 ~~ItI~~~~~~~~~g~~~~IF~~La~~~I~VDmI~~--s~~~iSftv~~~d~~~~~~~~~~l~~~l~ 66 (75)
T cd04932 2 TLVTLKSPNMLHAQGFLAKVFGILAKHNISVDLITT--SEISVALTLDNTGSTSDQLLTQALLKELS 66 (75)
T ss_pred EEEEEecCCCCCCcCHHHHHHHHHHHcCCcEEEEee--cCCEEEEEEeccccchhHHHHHHHHHHHH
Confidence 67889776 677899999999999999999999998 669999999999843 3554 5555543
No 124
>PRK06635 aspartate kinase; Reviewed
Probab=97.85 E-value=3.7e-05 Score=82.97 Aligned_cols=111 Identities=17% Similarity=0.279 Sum_probs=85.6
Q ss_pred HHHHHHHHHHhCCceEEEEEcc-CceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeecccceeEEEEEccccccchH
Q 008693 411 FLAKVFSTFEDLGISVDVVATS-EVSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNLLQHRSIISLIGNVQRSSLI 489 (557)
Q Consensus 411 ~la~If~~L~~~gI~Vd~IstS-e~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~~~~~aiIsIVG~~~~~~~v 489 (557)
+..+.++.+.+.||++....+. ....++....... ..+ -.....+...+++++|+++| +.+.+|+
T Consensus 211 ~~~~a~~~~~~~~i~~~i~~~~~~~~gT~i~~~~~~--------~~~-----~~~i~~I~~~~~v~~Isv~g-~~~~~g~ 276 (404)
T PRK06635 211 LHPRSVEYAKKYNVPLRVRSSFSDNPGTLITGEEEE--------IME-----QPVVTGIAFDKDEAKVTVVG-VPDKPGI 276 (404)
T ss_pred cCHHHHHHHHHcCceEEEEcCCCCCCCCEEeeCCcc--------ccc-----cCceEEEEecCCeEEEEECC-CCCCccH
Confidence 4466788899999999877542 2334444332110 000 01235677889999999999 8888999
Q ss_pred HHHHHHHHHhCCCcEEEEEecCCc---eEEEEEEecccHHHHHHHHHHH
Q 008693 490 LEKAFRVLRRSGVNVQMISQGASK---VNISLIVNDDEAEQCVRALHET 535 (557)
Q Consensus 490 ~~rif~~L~~~gInI~~IsqgsSe---~sIs~vV~~~d~~kAv~~LH~~ 535 (557)
++++|++|++.||+|.+++|+.++ .+++|+|++++.+++++.||+.
T Consensus 277 l~~i~~~L~~~~I~i~~is~s~~~~~~~~is~~v~~~~~~~a~~~L~~~ 325 (404)
T PRK06635 277 AAQIFGALAEANINVDMIVQNVSEDGKTDITFTVPRDDLEKALELLEEV 325 (404)
T ss_pred HHHHHHHHHHcCCeEEEEEecCCCCCceeEEEEEcHHHHHHHHHHHHHH
Confidence 999999999999999999998766 8999999999999999999993
No 125
>cd04924 ACT_AK-Arch_2 ACT domains of a monofunctional aspartokinase found mostly in Archaea species (ACT_AK-Arch_2). Included in this CD is the second of two ACT domains of a monofunctional aspartokinase found mostly in Archaea species (ACT_AK-Arch_2). The first or N-terminal ACT domain of these proteins cluster with the ThrA-like ACT 1 domains (ACT_AKi-HSDH-ThrA-like_1) which includes the threonine-sensitive archaeal Methanococcus jannaschii aspartokinase ACT 1 domain. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=97.74 E-value=0.00011 Score=57.80 Aligned_cols=51 Identities=25% Similarity=0.444 Sum_probs=45.5
Q ss_pred EEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEc--cCceeEEEeCCchh
Q 008693 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT--SEVSLSLTLDPSKL 445 (557)
Q Consensus 395 ialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Ist--Se~sIS~~I~~~~~ 445 (557)
+++|++.|.++.+.+++.+++|+.|++.||+++|+++ ++.+++|+++.++.
T Consensus 1 ~~~isivg~~~~~~~~~~~~i~~~L~~~~I~v~~i~q~~s~~~isf~i~~~~~ 53 (66)
T cd04924 1 VAVVAVVGSGMRGTPGVAGRVFGALGKAGINVIMISQGSSEYNISFVVAEDDG 53 (66)
T ss_pred CeEEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEEecCccceEEEEEeHHHH
Confidence 4689999999999999999999999999999999974 67889999988664
No 126
>cd04936 ACT_AKii-LysC-BS-like_2 ACT domains of the lysine-sensitive, aspartokinase (AK) isoenzyme AKII of Bacillus subtilis (BS) strain 168 and related domains. This CD includes the C-terminal of the two ACT domains of the lysine-sensitive, aspartokinase (AK) isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, and related sequences. In B. subtilis strain 168, the regulation of the diaminopimelate (Dap)-lysine biosynthetic pathway involves dual control by Dap and lysine, effected through separate Dap- and lysine-sensitive AK isoenzymes. The B. subtilis strain 168 AKII is induced by methionine and repressed and inhibited by lysine. Although C. glutamicum is known to contain a single AK, both the succinylase and dehydrogenase variant pathways of DAP-lysine synthesis operate simultaneously in this organism. In corynebacteria and other various Gram-positive bacteria, the DAP-lysine pathway is feedback regu
Probab=97.73 E-value=0.00011 Score=57.09 Aligned_cols=49 Identities=29% Similarity=0.521 Sum_probs=44.8
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchh
Q 008693 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKL 445 (557)
Q Consensus 397 lItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~ 445 (557)
+|++.+.++.+.+++.+++|+.|++.+|+++++++++.+++|+++.++.
T Consensus 2 ~i~v~g~~~~~~~~~~~~i~~~L~~~~i~v~~i~~s~~~is~~v~~~d~ 50 (63)
T cd04936 2 KVSIVGAGMRSHPGVAAKMFEALAEAGINIEMISTSEIKISCLIDEDDA 50 (63)
T ss_pred EEEEECCCCCCCccHHHHHHHHHHHCCCcEEEEEccCceEEEEEeHHHH
Confidence 5788888888899999999999999999999999889999999998764
No 127
>cd04923 ACT_AK-LysC-DapG-like_2 ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168 and related domains. This CD includes the C-terminal of the two ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, as well as, the second and fourth, of four, ACT domains present in cyanobacteria AK. Also included are the C-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase isoenzyme AKI found in Bacilli (B. subtilis strain 168), Clostridia, and Actinobacteria bacterial species. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=97.71 E-value=0.00012 Score=56.76 Aligned_cols=49 Identities=29% Similarity=0.514 Sum_probs=44.8
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchh
Q 008693 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKL 445 (557)
Q Consensus 397 lItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~ 445 (557)
+|++.+.++.+.+++.+++|+.|++++|+++++++++.+++|+++.++.
T Consensus 2 ~v~v~g~~~~~~~~~~~~i~~~L~~~~i~v~~i~~s~~~is~~v~~~~~ 50 (63)
T cd04923 2 KVSIVGAGMRSHPGVAAKMFKALAEAGINIEMISTSEIKISCLVDEDDA 50 (63)
T ss_pred EEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEEccCCeEEEEEeHHHH
Confidence 5788888888889999999999999999999999999999999998764
No 128
>cd04915 ACT_AK-Ectoine_2 ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway found in Methylomicrobium alcaliphilum, Vibrio cholerae, and various other halotolerant or halophilic bacteria. Bacteria exposed to hyperosmotic stress accumulate organic solutes called 'compatible solutes' of which ectoine, a heterocyclic amino acid, is one. Apart from its osmotic function, ectoine also exhibits a protective effect on proteins, nucleic acids and membranes against a variety of stress factors. de novo synthesis of ectoine starts with the phosphorylation of L-aspartate and shares its first two enzymatic steps with the biosynthesis of amino acids of the aspartate family: aspartokinas
Probab=97.71 E-value=0.00015 Score=57.96 Aligned_cols=50 Identities=16% Similarity=0.348 Sum_probs=44.4
Q ss_pred EEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEc--cCceeEEEeCCchh
Q 008693 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT--SEVSLSLTLDPSKL 445 (557)
Q Consensus 395 ialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Ist--Se~sIS~~I~~~~~ 445 (557)
+++|++.|.+|. .+|+.+++|+.|.+.||++.|+++ |+.++||.+++++.
T Consensus 2 ~a~VsvVG~gm~-~~gv~~ki~~~L~~~~I~v~~i~~~~s~~~is~~V~~~~~ 53 (66)
T cd04915 2 VAIVSVIGRDLS-TPGVLARGLAALAEAGIEPIAAHQSMRNVDVQFVVDRDDY 53 (66)
T ss_pred EEEEEEECCCCC-cchHHHHHHHHHHHCCCCEEEEEecCCeeEEEEEEEHHHH
Confidence 678999999994 899999999999999999999987 55899999988663
No 129
>cd04918 ACT_AK1-AT_2 ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1). This CD includes the second of two ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1), which can be synergistically inhibited by S-adenosylmethionine (SAM). This isoenzyme is found in higher plants, Arabidopsis thaliana (AT) and Zea mays, and also in Chlorophyta. In its inactive state, Arabidopsis AK1 binds the effectors lysine and SAM (two molecules each) at the interface of two ACT1 domain subunits. The second ACT domain (ACT2), this CD, does not interact with an effector. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=97.71 E-value=0.00012 Score=58.17 Aligned_cols=49 Identities=18% Similarity=0.421 Sum_probs=43.7
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCceEEEEE--ccCceeEEEeCCchh
Q 008693 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVA--TSEVSLSLTLDPSKL 445 (557)
Q Consensus 396 alItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Is--tSe~sIS~~I~~~~~ 445 (557)
++|++.|. +...+|+++++|++|++.||++.|++ +|+.+++|.+++++.
T Consensus 2 a~VsvVG~-~~~~~~~~~~i~~aL~~~~I~v~~i~~g~s~~sis~~v~~~~~ 52 (65)
T cd04918 2 SIISLIGN-VQRSSLILERAFHVLYTKGVNVQMISQGASKVNISLIVNDSEA 52 (65)
T ss_pred cEEEEECC-CCCCccHHHHHHHHHHHCCCCEEEEEecCccceEEEEEeHHHH
Confidence 57889998 77789999999999999999999998 788999999998763
No 130
>cd04935 ACT_AKiii-DAPDC_1 ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC) bacterial protein. This CD includes the first of two ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC) bacterial protein. Aspartokinase (AK) is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The lysA gene encodes the enzyme DAPDC, a pyridoxal-5'-phosphate (PLP)-dependent enzyme which catalyzes the final step in the lysine biosynthetic pathway converting meso-diaminopimelic acid (DAP) to l-lysine. Tandem ACT domains are positioned centrally with the AK catalytic domain N-terminal and the DAPDC domains C-terminal. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=97.68 E-value=0.00021 Score=58.68 Aligned_cols=61 Identities=20% Similarity=0.373 Sum_probs=51.1
Q ss_pred eEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEeccc--HHH-HHHHHHHHhc
Q 008693 475 SIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDE--AEQ-CVRALHETFF 537 (557)
Q Consensus 475 aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d--~~k-Av~~LH~~f~ 537 (557)
++|++.+. +...+++++++|+.|+++||++.||+| ++.+++|.++.++ ... .++.|-+++-
T Consensus 2 ~~i~i~~~~~~~~~g~~~~IF~~La~~~I~vDmI~~--s~~~isftv~~~~~~~~~~~~~~l~~el~ 66 (75)
T cd04935 2 RLVSMETLGMWQQVGFLADVFAPFKKHGVSVDLVST--SETNVTVSLDPDPNGLDPDVLDALLDDLN 66 (75)
T ss_pred EEEEEEcCCCCCccCHHHHHHHHHHHcCCcEEEEEe--CCCEEEEEEeCcccccchHHHHHHHHHHH
Confidence 67889997 777899999999999999999999998 6699999999998 233 6666666654
No 131
>cd04916 ACT_AKiii-YclM-BS_2 ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) YclM) and Clostridia species. Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. B. subtilis YclM is reported to be a single polypeptide of 50 kD. AKIII from B. subtilis strain 168 is induced by lysine and repressed by threonine and it is synergistically inhibited by lysine and threonine. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=97.67 E-value=0.00017 Score=56.74 Aligned_cols=51 Identities=18% Similarity=0.371 Sum_probs=45.5
Q ss_pred EEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEc--cCceeEEEeCCchh
Q 008693 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT--SEVSLSLTLDPSKL 445 (557)
Q Consensus 395 ialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Ist--Se~sIS~~I~~~~~ 445 (557)
+++|++.|.++...+++.+++|+.|++.||+++++++ ++.+++|+++.++.
T Consensus 1 ~~lisivg~~~~~~~~~~~~i~~~L~~~~i~v~~i~~~~s~~~isf~v~~~d~ 53 (66)
T cd04916 1 LALIMVVGEGMKNTVGVSARATAALAKAGINIRMINQGSSEISIMIGVHNEDA 53 (66)
T ss_pred CeEEEEEcCCCCCCccHHHHHHHHHHHCCCCEEEEEecCcccEEEEEEeHHHH
Confidence 4689999999999999999999999999999999975 67889999998764
No 132
>TIGR00657 asp_kinases aspartate kinase. The Lys-sensitive enzyme of Bacillus subtilis resembles the E. coli form but is an alpha 2/beta 2 heterotetramer, where the beta subunit is translated from an in-phase alternative initiator at Met-246. This may be a feature of a number of closely related forms, including a paralog from B. subtilis.
Probab=97.66 E-value=0.00012 Score=80.12 Aligned_cols=108 Identities=21% Similarity=0.298 Sum_probs=81.8
Q ss_pred HHHHHHHHHhCCceEEEEEccCce--eEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeecccceeEEEEEcc-ccccch
Q 008693 412 LAKVFSTFEDLGISVDVVATSEVS--LSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNLLQHRSIISLIGN-VQRSSL 488 (557)
Q Consensus 412 la~If~~L~~~gI~Vd~IstSe~s--IS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~~~~~aiIsIVG~-~~~~~~ 488 (557)
..+.+..+.+++|++....+.... -+...+.... .+-..+..++..+++++|++.|. +.. +|
T Consensus 252 ~~~a~~~~~~~~i~i~i~~~~~~~~~GT~I~~~~~~--------------~~~~~i~~It~~~~v~~Isv~g~~~~~-~g 316 (441)
T TIGR00657 252 HPRTLEPAMRAKIPIVVKSTFNPEAPGTLIVASTKE--------------MEEPIVKGLSLDRNQARVTVSGLGMKG-PG 316 (441)
T ss_pred CHHHHHHHHHcCCeEEEecCCCCCCCceEEEeCCCc--------------cccCccceEEEeCCEEEEEEECCCCCC-cc
Confidence 356677888899998887643211 2222211110 00012567888899999999997 555 99
Q ss_pred HHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHH
Q 008693 489 ILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHE 534 (557)
Q Consensus 489 v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~ 534 (557)
+++++|+.|+++||+|.+|+|++|+.+|+|+|++++.+++++.|..
T Consensus 317 ~la~if~~L~~~~I~I~~i~q~~se~sIs~~I~~~~~~~a~~~L~~ 362 (441)
T TIGR00657 317 FLARVFGALAEAGINVDLITQSSSETSISFTVDKEDADQAKTLLKS 362 (441)
T ss_pred HHHHHHHHHHHcCCeEEEEEecCCCceEEEEEEHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999888744
No 133
>cd04868 ACT_AK-like ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). This CD includes each of two ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). Typically, AK consists of two ACT domains in a tandem repeat, but the second ACT domain is inserted within the first, resulting in, what is normally the terminal beta strand of ACT2, formed from a region N-terminal of ACT1. AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. Aspartokinase is the first enzyme in the pathway of the biosynthesis of the aspartate family of amino acids (lysine, threonine, methionine, and isoleucine) and the bacterial cell wall component, meso-diaminopimelate. One mechanism for the regulation of this pathway is by the production of several isoenzymes of aspartokinase with different repressors and allosteric inhibitors. Pairs of ACT domains are proposed to specifically bind am
Probab=97.57 E-value=0.00024 Score=53.78 Aligned_cols=48 Identities=42% Similarity=0.657 Sum_probs=42.8
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccC--ceeEEEeCCch
Q 008693 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSE--VSLSLTLDPSK 444 (557)
Q Consensus 397 lItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe--~sIS~~I~~~~ 444 (557)
+|++.+.+|.+.+++.+++|+.|++++|++++++++. .+++|+++.++
T Consensus 2 ~i~v~g~~~~~~~~~~~~i~~~l~~~~i~i~~i~~~~~~~~~s~~v~~~~ 51 (60)
T cd04868 2 KVSIVGVGMRGTPGVAAKIFSALAEAGINVDMISQSESEVNISFTVDESD 51 (60)
T ss_pred EEEEECCCCCCCCCHHHHHHHHHHHCCCcEEEEEcCCCcEEEEEEEeHHH
Confidence 5788888888889999999999999999999999876 78999998754
No 134
>cd04920 ACT_AKiii-DAPDC_2 ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC). This CD includes the second of two ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC) bacterial protein. Aspartokinase (AK) is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The lysA gene encodes the enzyme DAPDC, a pyridoxal-5'-phosphate (PLP)-dependent enzyme which catalyzes the final step in the lysine biosynthetic pathway converting meso-diaminopimelic acid (DAP) to l-lysine. Tandem ACT domains are positioned centrally with the AK catalytic domain N-terminal and the DAPDC domains C-terminal. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=97.56 E-value=0.00025 Score=56.06 Aligned_cols=50 Identities=12% Similarity=0.229 Sum_probs=45.7
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchh
Q 008693 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKL 445 (557)
Q Consensus 396 alItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~ 445 (557)
++|++.|.+|...+|+++++|+.|++.+|++.+..+|+.++||.++.++.
T Consensus 1 a~VsvVG~g~~~~~gv~~~~~~~L~~~~i~~i~~~~s~~~is~vv~~~d~ 50 (63)
T cd04920 1 AAVSLVGRGIRSLLHKLGPALEVFGKKPVHLVSQAANDLNLTFVVDEDQA 50 (63)
T ss_pred CEEEEECCCcccCccHHHHHHHHHhcCCceEEEEeCCCCeEEEEEeHHHH
Confidence 46899999999999999999999999999998889999999999998763
No 135
>cd04892 ACT_AK-like_2 ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). This CD includes the second of two ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). The exception in this group, is the inclusion of the first ACT domain of the bifunctional aspartokinase - homoserine dehydrogenase-like enzyme group (ACT_AKi-HSDH-ThrA-like_1) which includes the monofunctional, threonine-sensitive, aspartokinase found in Methanococcus jannaschii and other related archaeal species. AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. AK is the first enzyme in the pathway of the biosynthesis of the aspartate family of amino acids (lysine, threonine, methionine, and isoleucine) and the bacterial cell wall component, meso-diaminopimelate. One mechanism for the regulation of this pathway is by the production of several isoenzymes of AK with different repressors an
Probab=97.41 E-value=0.00053 Score=52.89 Aligned_cols=50 Identities=26% Similarity=0.551 Sum_probs=43.7
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEcc--CceeEEEeCCchh
Q 008693 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATS--EVSLSLTLDPSKL 445 (557)
Q Consensus 396 alItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstS--e~sIS~~I~~~~~ 445 (557)
++|++.+.++.+.+++.+++|+.|++++|++++++++ +.+++|+++.++.
T Consensus 1 ~~i~i~g~~~~~~~~~~~~i~~~l~~~~i~v~~i~~~~~~~~i~~~v~~~~~ 52 (65)
T cd04892 1 ALVSVVGAGMRGTPGVAARIFSALAEAGINIIMISQGSSEVNISFVVDEDDA 52 (65)
T ss_pred CEEEEECCCCCCCccHHHHHHHHHHHCCCcEEEEEcCCCceeEEEEEeHHHH
Confidence 3688888889899999999999999999999999874 4889999988653
No 136
>PRK09181 aspartate kinase; Validated
Probab=97.35 E-value=0.0013 Score=72.40 Aligned_cols=111 Identities=12% Similarity=0.110 Sum_probs=83.9
Q ss_pred HHHHHHHHHHhCCceEEEEEccCc--eeEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeecccceeEEEEEcc-ccccc
Q 008693 411 FLAKVFSTFEDLGISVDVVATSEV--SLSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNLLQHRSIISLIGN-VQRSS 487 (557)
Q Consensus 411 ~la~If~~L~~~gI~Vd~IstSe~--sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~~~~~aiIsIVG~-~~~~~ 487 (557)
+..+.++...+++|++..-++... .=++..+... ..-..+..|+..+++++|++.|. |...+
T Consensus 279 LHp~ti~pa~~~~Ipi~V~nt~~p~~~GT~I~~~~~---------------~~~~~ik~It~~~~~~~i~i~~~~~~~~~ 343 (475)
T PRK09181 279 IHPKAAKGLRQAGIPLRIKNTFEPEHPGTLITKDYV---------------SEQPRVEIIAGSDKVFALEVFDQDMVGED 343 (475)
T ss_pred cCHHHHHHHHHcCCeEEEecCCCCCCCCeEEecCcc---------------cccccceeEeccCCEEEEEEcCCCCCCcc
Confidence 456778889999999988765432 2222222110 00112456788889999999996 77889
Q ss_pred hHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecc-c-HHHHHHHHHHHhcc
Q 008693 488 LILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDD-E-AEQCVRALHETFFE 538 (557)
Q Consensus 488 ~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~-d-~~kAv~~LH~~f~~ 538 (557)
|+++++|+.|++.+|+|.++++ |+.+++|+|+.+ + .+++++.|+++|-.
T Consensus 344 g~~~~if~~l~~~~i~v~~i~s--s~~sis~~v~~~~~~~~~~~~~L~~~~~~ 394 (475)
T PRK09181 344 GYDLEILEILTRHKVSYISKAT--NANTITHYLWGSLKTLKRVIAELEKRYPN 394 (475)
T ss_pred hHHHHHHHHHHHcCCeEEEEEe--cCcEEEEEEcCChHHHHHHHHHHHHhcCC
Confidence 9999999999999999999987 689999999988 3 67889999988854
No 137
>cd04921 ACT_AKi-HSDH-ThrA-like_1 ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). This CD includes the first of two ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). The ACT domains are positioned between the N-terminal catalytic domain of AK and the C-terminal HSDH domain found in bacteria (Escherichia coli (EC) ThrA) and higher plants (Zea mays AK-HSDH). AK and HSDH are the first and third enzymes in the biosynthetic pathway of the aspartate family of amino acids. AK catalyzes the phosphorylation of Asp to P-aspartyl phosphate. HSDH catalyzes the NADPH-dependent conversion of Asp 3-semialdehyde to homoserine. HSDH is the first committed reaction in the branch of the pathway that leads to Thr and Met. In E. coli, ThrA is subject to allosteric regulation by the end product L-threonine and the native enzyme is reported to be tetrameric. As with bacteria, plant AK and HSDH are feedback inhibited by pat
Probab=97.29 E-value=0.00091 Score=54.90 Aligned_cols=51 Identities=35% Similarity=0.565 Sum_probs=45.0
Q ss_pred EEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEc--cCceeEEEeCCchh
Q 008693 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT--SEVSLSLTLDPSKL 445 (557)
Q Consensus 395 ialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Ist--Se~sIS~~I~~~~~ 445 (557)
+++|++.+.++.+.+++.+++|+.|++.+|+++|+++ ++.+++|+++.++.
T Consensus 1 ~~~I~vvg~~~~~~~~~~~~i~~~L~~~~I~v~~i~~~~~~~~isf~v~~~d~ 53 (80)
T cd04921 1 VALINIEGTGMVGVPGIAARIFSALARAGINVILISQASSEHSISFVVDESDA 53 (80)
T ss_pred CEEEEEEcCCCCCCccHHHHHHHHHHHCCCcEEEEEecCCcceEEEEEeHHHH
Confidence 4788999989999999999999999999999999974 56789999988764
No 138
>PRK09034 aspartate kinase; Reviewed
Probab=97.25 E-value=0.00083 Score=73.74 Aligned_cols=97 Identities=14% Similarity=0.258 Sum_probs=71.7
Q ss_pred HhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCCCC-------------cceeeEEeeeccEEEEEEEecCccchhhHHH
Q 008693 347 PQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMS-------------KAVLTSIVLKRNVTMLDIVSTRMLGQYGFLA 413 (557)
Q Consensus 347 p~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~-------------~~~Vt~Is~~~nialItI~~~~m~~~~g~la 413 (557)
.+-+..+.++||++...++.. .. =++..+..+.. ...+.+|+..+++++|++.|.+|.+.+|+++
T Consensus 326 a~if~~la~~~I~Vd~i~ss~-~s-is~~v~~~~~~~a~~~~l~~el~~~~~~~~I~~~~~va~VsivG~g~~~~~gv~a 403 (454)
T PRK09034 326 RKVLQILEDHGISYEHMPSGI-DD-LSIIIRERQLTPKKEDEILAEIKQELNPDELEIEHDLAIIMVVGEGMRQTVGVAA 403 (454)
T ss_pred HHHHHHHHHcCCeEEEEcCCC-cE-EEEEEeHHHhhHHHHHHHHHHHHHhhCCceEEEeCCEEEEEEECCCCCCCccHHH
Confidence 355778888999877663211 01 11121211110 1124689999999999999999999999999
Q ss_pred HHHHHHHhCCceEEEEE--ccCceeEEEeCCchh
Q 008693 414 KVFSTFEDLGISVDVVA--TSEVSLSLTLDPSKL 445 (557)
Q Consensus 414 ~If~~L~~~gI~Vd~Is--tSe~sIS~~I~~~~~ 445 (557)
++|+.|+++||+|+|++ +|+.+++|+++.++.
T Consensus 404 rif~aL~~~~InV~mIsq~~Se~~Is~vV~~~d~ 437 (454)
T PRK09034 404 KITKALAEANINIQMINQGSSEISIMFGVKNEDA 437 (454)
T ss_pred HHHHHHHHCCCCEEEEEecCCcceEEEEEcHHHH
Confidence 99999999999999998 578999999998763
No 139
>cd04917 ACT_AKiii-LysC-EC_2 ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in bacteria (Escherichia coli (EC) LysC). Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The E. coli AKIII (LysC) binds two feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. The second ACT domain (ACT2), this CD, is not involved in the binding of heterotrophic effectors. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=97.17 E-value=0.0016 Score=51.35 Aligned_cols=48 Identities=17% Similarity=0.427 Sum_probs=40.8
Q ss_pred EEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEE--ccCceeEEEeCCch
Q 008693 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVA--TSEVSLSLTLDPSK 444 (557)
Q Consensus 395 ialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Is--tSe~sIS~~I~~~~ 444 (557)
+++|++.|.+|.+.++..+++|+.|++ +++.+++ +|+.+++|.++.++
T Consensus 1 ~alIsvvG~~~~~~~~v~~~i~~~L~~--i~i~~i~~~~s~~~is~~V~~~~ 50 (64)
T cd04917 1 LALVALIGNDISETAGVEKRIFDALED--INVRMICYGASNHNLCFLVKEED 50 (64)
T ss_pred CeEEEEECCCccCCcCHHHHHHHHHHh--CCeEEEEEecCccEEEEEEeHHH
Confidence 478999999999999999999999976 5555554 77889999998876
No 140
>PLN02551 aspartokinase
Probab=97.16 E-value=0.0026 Score=70.82 Aligned_cols=100 Identities=15% Similarity=0.239 Sum_probs=75.1
Q ss_pred HHHHHHHHHHhCCceEEEEEccCc--eeEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeecccceeEEEEEcc-ccccc
Q 008693 411 FLAKVFSTFEDLGISVDVVATSEV--SLSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNLLQHRSIISLIGN-VQRSS 487 (557)
Q Consensus 411 ~la~If~~L~~~gI~Vd~IstSe~--sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~~~~~aiIsIVG~-~~~~~ 487 (557)
+..+.++...+++|++..-++... .-++.....+. . -..+..|+..+|+++|++.|. |...+
T Consensus 316 lhp~ai~pa~~~~Ipi~vknt~~p~~~GT~I~~~~~~--------------~-~~~v~~It~~~~v~li~i~~~~m~~~~ 380 (521)
T PLN02551 316 LHPQSMRPAREGDIPVRVKNSYNPTAPGTLITKTRDM--------------S-KAVLTSIVLKRNVTMLDIVSTRMLGQY 380 (521)
T ss_pred cCHHHHHHHHHCCceEEEEecCCCCCCCcEEeccccc--------------C-CCcccceecCCCeEEEEEecCCCCCcc
Confidence 346777888899999888765322 12222221110 0 012556888899999999996 77889
Q ss_pred hHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHH
Q 008693 488 LILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQ 527 (557)
Q Consensus 488 ~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~k 527 (557)
|+++++|+.|+++||+|.||+| |+.+|+|.++.++..+
T Consensus 381 g~~arvf~~l~~~~I~Vd~Iss--Se~sIs~~v~~~~~~~ 418 (521)
T PLN02551 381 GFLAKVFSTFEDLGISVDVVAT--SEVSISLTLDPSKLWS 418 (521)
T ss_pred cHHHHHHHHHHHcCCcEEEEec--cCCEEEEEEehhHhhh
Confidence 9999999999999999999987 7899999999998755
No 141
>cd04910 ACT_AK-Ectoine_1 ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway found in Methylomicrobium alcaliphilum, Vibrio cholerae, and various other halotolerant or halophilic bacteria. Bacteria exposed to hyperosmotic stress accumulate organic solutes called 'compatible solutes' of which ectoine, a heterocyclic amino acid, is one. Apart from its osmotic function, ectoine also exhibits a protective effect on proteins, nucleic acids and membranes against a variety of stress factors. de novo synthesis of ectoine starts with the phosphorylation of L-aspartate and shares its first two enzymatic steps with the biosynthesis of amino acids of the aspartate family: aspartokinase
Probab=97.12 E-value=0.0027 Score=51.55 Aligned_cols=61 Identities=18% Similarity=0.364 Sum_probs=50.5
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchhhhHHHHHHHHHHHHHHHhh
Q 008693 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQELDHVVEELEK 464 (557)
Q Consensus 396 alItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~ 464 (557)
..|.+.+.+|.|.+|+.+++|+.|+++++++.+..++..+|+.++..+. ..++++..+|++
T Consensus 2 ~alevfdqdMvG~~g~d~~i~~~l~~~~v~ii~K~~nANtit~yl~~~~--------k~~~r~~~~Le~ 62 (71)
T cd04910 2 FALEVFDQDMVGEVGYDLEILELLQRFKVSIIAKDTNANTITHYLAGSL--------KTIKRLTEDLEN 62 (71)
T ss_pred eEEEEeCCCccCChhHHHHHHHHHHHcCCeEEEEecCCCeEEEEEEcCH--------HHHHHHHHHHHH
Confidence 4578999999999999999999999999999999999999999997653 124555555543
No 142
>cd04914 ACT_AKi-DapG-BS_1 ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI. This CD includes the N-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) strain 168), Clostridia, and Actinobacteria, bacterial species. In B. subtilis, the regulation of the diaminopimelate-lysine biosynthetic pathway involves dual control by diaminopimelate and lysine, effected through separate diaminopimelate- and lysine-sensitive aspartokinase isoenzymes. AKI activity is invariant during the exponential and stationary phases of growth and is not altered by addition of amino acids to the growth medium. The role of this isoenzyme is most likely to provide a constant level of aspartyl-beta-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis and dipicolinate during sporulation. The B. subtilis AKI is tetrameric consisting of two alpha and
Probab=97.08 E-value=0.0018 Score=51.92 Aligned_cols=48 Identities=23% Similarity=0.362 Sum_probs=39.2
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCchh
Q 008693 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKL 445 (557)
Q Consensus 396 alItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~~ 445 (557)
+.+++.+ ....+|+++++|+.|+++||+++||+.+..+++|+++.++.
T Consensus 2 ~~vtv~~--~~~~~~~~a~if~~La~~~InvDmI~~~~~~isFtv~~~d~ 49 (67)
T cd04914 2 TQIKVKA--KDNENDLQQRVFKALANAGISVDLINVSPEEVIFTVDGEVA 49 (67)
T ss_pred eEEEEec--CCCCccHHHHHHHHHHHcCCcEEEEEecCCCEEEEEchhhH
Confidence 4567775 34568999999999999999999997554479999998764
No 143
>cd04914 ACT_AKi-DapG-BS_1 ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI. This CD includes the N-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) strain 168), Clostridia, and Actinobacteria, bacterial species. In B. subtilis, the regulation of the diaminopimelate-lysine biosynthetic pathway involves dual control by diaminopimelate and lysine, effected through separate diaminopimelate- and lysine-sensitive aspartokinase isoenzymes. AKI activity is invariant during the exponential and stationary phases of growth and is not altered by addition of amino acids to the growth medium. The role of this isoenzyme is most likely to provide a constant level of aspartyl-beta-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis and dipicolinate during sporulation. The B. subtilis AKI is tetrameric consisting of two alpha and
Probab=97.04 E-value=0.0031 Score=50.50 Aligned_cols=56 Identities=20% Similarity=0.402 Sum_probs=45.4
Q ss_pred eEEEEEccccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHH
Q 008693 475 SIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALH 533 (557)
Q Consensus 475 aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH 533 (557)
+.|++.|.- ..+++++++|+.|+++||+|.||++. ++ +++|.++..|.+++.+.|-
T Consensus 2 ~~vtv~~~~-~~~~~~a~if~~La~~~InvDmI~~~-~~-~isFtv~~~d~~~~~~il~ 57 (67)
T cd04914 2 TQIKVKAKD-NENDLQQRVFKALANAGISVDLINVS-PE-EVIFTVDGEVAEKAVDILE 57 (67)
T ss_pred eEEEEecCC-CCccHHHHHHHHHHHcCCcEEEEEec-CC-CEEEEEchhhHHHHHHHHH
Confidence 567777742 34789999999999999999999875 33 7999999999999865543
No 144
>PRK09466 metL bifunctional aspartate kinase II/homoserine dehydrogenase II; Provisional
Probab=97.01 E-value=0.0032 Score=73.65 Aligned_cols=110 Identities=12% Similarity=0.120 Sum_probs=84.2
Q ss_pred HHHHHHHHHHhCCceEEEEEccCce--eEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeecccceeEEEEEcc-ccccc
Q 008693 411 FLAKVFSTFEDLGISVDVVATSEVS--LSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNLLQHRSIISLIGN-VQRSS 487 (557)
Q Consensus 411 ~la~If~~L~~~gI~Vd~IstSe~s--IS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~~~~~aiIsIVG~-~~~~~ 487 (557)
+..+.++...+++|++..-++.... =++...... .-.....|+..+++++|++.|. +...+
T Consensus 268 lHp~ti~pa~~~~Ipi~V~ntf~p~~~GT~I~~~~~----------------~~~~v~~It~~~~v~~i~i~~~~~~g~~ 331 (810)
T PRK09466 268 LHARTLQPVSGSDIDLQLRCSYQPEQGSTRIERVLA----------------SGTGARIVTSLDDVCLIELQVPASHDFK 331 (810)
T ss_pred cCHHHHHHHHHcCCeEEEecCCCCCCCceEEecCcc----------------cccceeeeeccCCEEEEEEecCCcCCcc
Confidence 3467788889999998877654321 222222110 0011345677789999999986 66778
Q ss_pred hHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHh
Q 008693 488 LILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETF 536 (557)
Q Consensus 488 ~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f 536 (557)
++++++|+.|++++|++.+|+|++++.+++|.++.++.+++.+.|++..
T Consensus 332 g~~~~if~~l~~~~I~v~~i~~~~s~~sis~~i~~~~~~~~~~~l~~~~ 380 (810)
T PRK09466 332 LAQKELDQLLKRAQLRPLAVGVHPDRQLLQLAYTSEVADSALKLLDDAA 380 (810)
T ss_pred hHHHHHHHHHHHCCCeEEEEEecCCCcEEEEEEeHHHHHHHHHHHHhhc
Confidence 9999999999999999999999999999999999999999999998864
No 145
>PRK09084 aspartate kinase III; Validated
Probab=96.94 E-value=0.002 Score=70.63 Aligned_cols=106 Identities=15% Similarity=0.223 Sum_probs=75.8
Q ss_pred HHHHHHHHhCCceEEEEEccCc--eeEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeecccceeEEEEEcc-ccccchH
Q 008693 413 AKVFSTFEDLGISVDVVATSEV--SLSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNLLQHRSIISLIGN-VQRSSLI 489 (557)
Q Consensus 413 a~If~~L~~~gI~Vd~IstSe~--sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~~~~~aiIsIVG~-~~~~~~v 489 (557)
.+.+....+.+|++....+.+. .-++..+... .-..+..|+..+++++|++-|. |...+|+
T Consensus 259 ~~~~~~~~~~~i~i~i~~~~~~~~~GT~I~~~~~----------------~~~~v~~it~~~~i~lItv~~~~~~~~~g~ 322 (448)
T PRK09084 259 PATLLPAVRSNIPVFVGSSKDPEAGGTWICNDTE----------------NPPLFRAIALRRNQTLLTLHSLNMLHARGF 322 (448)
T ss_pred HHHHHHHHHcCCcEEEEeCCCCCCCceEEecCCC----------------CCCeeEEEEeeCCEEEEEEecCCCCccccH
Confidence 4556667788888887764321 1222222110 0013557888899999999996 7778999
Q ss_pred HHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccH-HHHHHHHHHHh
Q 008693 490 LEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEA-EQCVRALHETF 536 (557)
Q Consensus 490 ~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~-~kAv~~LH~~f 536 (557)
++++|+.|++++|+|.||+| |+.+|+|.|++++. .++...+++++
T Consensus 323 ~a~if~~l~~~~I~Vd~I~s--se~sIs~~i~~~~~~~~~~~~~~~~l 368 (448)
T PRK09084 323 LAEVFGILARHKISVDLITT--SEVSVSLTLDTTGSTSTGDTLLTQAL 368 (448)
T ss_pred HHHHHHHHHHcCCeEEEEec--cCcEEEEEEechhhhhhhhHHHHHHH
Confidence 99999999999999999997 78999999999984 34444444444
No 146
>COG4747 ACT domain-containing protein [General function prediction only]
Probab=96.90 E-value=0.035 Score=49.01 Aligned_cols=113 Identities=20% Similarity=0.294 Sum_probs=81.8
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEE---ccCcee-EEEeCCchhhhHHHHHHHHHHHHHHHhhhheeecccceeEEEEEc
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVA---TSEVSL-SLTLDPSKLWSRELIQQELDHVVEELEKIAIVNLLQHRSIISLIG 481 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~Is---tSe~sI-S~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~~~~~aiIsIVG 481 (557)
.+.||=++.+.+.|.++|||+...+ +++..| .+.++..+. ..+. |+. ...+ +..-.+++
T Consensus 11 ENk~GRL~~~~~~L~eagINiRA~tiAdt~dFGIiRmvV~~~d~---------A~~~---Lee-~gF~----Vr~~dVla 73 (142)
T COG4747 11 ENKPGRLASVANKLKEAGINIRAFTIADTGDFGIIRMVVDRPDE---------AHSV---LEE-AGFT----VRETDVLA 73 (142)
T ss_pred cCCcchHHHHHHHHHHcCCceEEEEeccccCcceEEEEcCChHH---------HHHH---HHH-CCcE----EEeeeEEE
Confidence 4678989999999999999999876 566654 677776642 1222 222 1121 12334566
Q ss_pred -cccccchHHHHHHHHHHhCCCcEEEEEec-CCceEEEEEEecccHHHHHHHHHHH
Q 008693 482 -NVQRSSLILEKAFRVLRRSGVNVQMISQG-ASKVNISLIVNDDEAEQCVRALHET 535 (557)
Q Consensus 482 -~~~~~~~v~~rif~~L~~~gInI~~Isqg-sSe~sIs~vV~~~d~~kAv~~LH~~ 535 (557)
+|.+.||-+.++..+|..++||+.-|..- .....-.++++-+|.+++.++|.+.
T Consensus 74 VEmeD~PG~l~~I~~vl~d~diNldYiYAFv~ek~KAlli~r~ed~d~~~~aLed~ 129 (142)
T COG4747 74 VEMEDVPGGLSRIAEVLGDADINLDYIYAFVTEKQKALLIVRVEDIDRAIKALEDA 129 (142)
T ss_pred EEecCCCCcHHHHHHHHhhcCcCceeeeeeeecCceEEEEEEhhHHHHHHHHHHHc
Confidence 48889999999999999999998643221 1346677889999999999999876
No 147
>PRK05925 aspartate kinase; Provisional
Probab=96.88 E-value=0.0078 Score=65.79 Aligned_cols=96 Identities=9% Similarity=0.149 Sum_probs=70.9
Q ss_pred HhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCCCCc----------ceeeEEeeeccEEEEEEEecCccchhhHHHHHH
Q 008693 347 PQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSK----------AVLTSIVLKRNVTMLDIVSTRMLGQYGFLAKVF 416 (557)
Q Consensus 347 p~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~----------~~Vt~Is~~~nialItI~~~~m~~~~g~la~If 416 (557)
.+-+..+.++||++.+.++.. ... ++..+..+... ..+..|...+++++|++.|.+|.+ +++.+++|
T Consensus 316 ~~if~~l~~~~I~vd~i~s~~-~si-s~~i~~~~~~~~~~~~l~~~l~~~~~i~~~~~~a~VsvVG~gm~~-~~v~~~~~ 392 (440)
T PRK05925 316 EDVLGILRSLGIVPGLVMAQN-LGV-YFTIDDDDISEEYPQHLTDALSAFGTVSCEGPLALITMIGAKLAS-WKVVRTFT 392 (440)
T ss_pred HHHHHHHHHcCCcEEEEeccC-CEE-EEEEechhccHHHHHHHHHHhcCCceEEEECCEEEEEEeCCCccc-ccHHHHHH
Confidence 467888999999985543321 111 11122111100 123467888999999999999987 78999999
Q ss_pred HHHHhCCceEEEEEccCceeEEEeCCchh
Q 008693 417 STFEDLGISVDVVATSEVSLSLTLDPSKL 445 (557)
Q Consensus 417 ~~L~~~gI~Vd~IstSe~sIS~~I~~~~~ 445 (557)
+.|++.||++.++++|+.++||+|+.++.
T Consensus 393 ~aL~~~~Ini~~i~~s~~~is~vV~~~d~ 421 (440)
T PRK05925 393 EKLRGYQTPVFCWCQSDMALNLVVNEELA 421 (440)
T ss_pred HHHhhCCCCEEEEECCCceEEEEEehHHH
Confidence 99999999999999999999999998763
No 148
>PRK08210 aspartate kinase I; Reviewed
Probab=96.76 E-value=0.0042 Score=67.17 Aligned_cols=99 Identities=20% Similarity=0.301 Sum_probs=74.8
Q ss_pred cchHhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCCCCc--ce---e-eEEeeeccEEEEEEEecCccchhhHHHHHHH
Q 008693 344 VLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSK--AV---L-TSIVLKRNVTMLDIVSTRMLGQYGFLAKVFS 417 (557)
Q Consensus 344 vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~--~~---V-t~Is~~~nialItI~~~~m~~~~g~la~If~ 417 (557)
.+..+-+..+.++||++....... + .+++.....+..+ .. . ..+...+++++|++.|.+|.+.+|+++++|+
T Consensus 284 g~la~If~~L~~~~I~i~~i~~~~-~-~is~~v~~~~~~~a~~~l~~~~~~v~~~~~~a~isvvG~~~~~~~g~~~~i~~ 361 (403)
T PRK08210 284 DLQQEVFKALAEAGISVDFINIFP-T-EVVFTVSDEDSEKAKEILENLGLKPSVRENCAKVSIVGAGMAGVPGVMAKIVT 361 (403)
T ss_pred hHHHHHHHHHHHcCCeEEEEEecC-c-eEEEEEcHHHHHHHHHHHHHhCCcEEEeCCcEEEEEEcCCcCCCccHHHHHHH
Confidence 344556788899999988765442 2 3444433221110 00 0 1467789999999999999999999999999
Q ss_pred HHHhCCceEEEEEccCceeEEEeCCch
Q 008693 418 TFEDLGISVDVVATSEVSLSLTLDPSK 444 (557)
Q Consensus 418 ~L~~~gI~Vd~IstSe~sIS~~I~~~~ 444 (557)
.|++.||++.++++|+.+++|+++.++
T Consensus 362 aL~~~~I~i~~~~~s~~~is~vv~~~~ 388 (403)
T PRK08210 362 ALSEEGIEILQSADSHTTIWVLVKEED 388 (403)
T ss_pred HHHhCCCCEEEEecCCCEEEEEEcHHH
Confidence 999999999999999999999999876
No 149
>cd04891 ACT_AK-LysC-DapG-like_1 ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII and related proteins. This CD includes the N-terminal of the two ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, as well as, the first and third, of four, ACT domains present in cyanobacteria AK. Also included are the N-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase isoenzyme AKI found in Bacilli (Bacillus subtilis strain 168), Clostridia, and Actinobacteria bacterial species. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=96.64 E-value=0.006 Score=46.36 Aligned_cols=46 Identities=30% Similarity=0.484 Sum_probs=37.7
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccC-----ceeEEEeCCch
Q 008693 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSE-----VSLSLTLDPSK 444 (557)
Q Consensus 397 lItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe-----~sIS~~I~~~~ 444 (557)
+|++.+ +.+.+|+++++|+.|.++||++++++++. .+++|++++++
T Consensus 2 ~v~v~~--~~~~~~~~~~i~~~L~~~~i~i~~i~~~~~~~~~~~is~~v~~~~ 52 (61)
T cd04891 2 QVTIKG--VPDKPGVAAKIFSALAEAGINVDMIVQSVSRGGTTDISFTVPKSD 52 (61)
T ss_pred EEEEec--CCCCCcHHHHHHHHHHHcCCcEEEEEEcCCCCCcEEEEEEEeHHH
Confidence 466654 56789999999999999999999998643 66889998765
No 150
>PRK08961 bifunctional aspartate kinase/diaminopimelate decarboxylase protein; Provisional
Probab=96.63 E-value=0.0094 Score=70.60 Aligned_cols=107 Identities=16% Similarity=0.272 Sum_probs=80.0
Q ss_pred HHHHHHHHhCCceEEEEEccCce--eEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeecccceeEEEEEcc-ccccchH
Q 008693 413 AKVFSTFEDLGISVDVVATSEVS--LSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNLLQHRSIISLIGN-VQRSSLI 489 (557)
Q Consensus 413 a~If~~L~~~gI~Vd~IstSe~s--IS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~~~~~aiIsIVG~-~~~~~~v 489 (557)
.+.++...+.||++...++.... =++..... ..-..+..|+..+|+++|++-|. |...+++
T Consensus 275 ~~a~~~a~~~~i~i~v~~~~~~~~~gT~I~~~~----------------~~~~~v~~It~~~~v~lItv~~~~~~~~~g~ 338 (861)
T PRK08961 275 PRSIKPCRDAGIPMAILDTERPDLSGTSIDGDA----------------EPVPGVKAISRKNGIVLVSMETIGMWQQVGF 338 (861)
T ss_pred HHHHHHHHHCCCCEEEEeCCCCCCCccEEeCCC----------------CCCCcceeEEEECCEEEEEEecCCccccccH
Confidence 45667778899998887653221 12222111 00123567888999999999996 7788999
Q ss_pred HHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccH---HHHHHHHHHHhc
Q 008693 490 LEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEA---EQCVRALHETFF 537 (557)
Q Consensus 490 ~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~---~kAv~~LH~~f~ 537 (557)
++++|+.|++++|+|.||++ |+.++++.+++.+. +++++.|.++|-
T Consensus 339 ~a~if~~la~~~I~Vd~I~s--se~sis~~i~~~~~~~~~~~~~~l~~~l~ 387 (861)
T PRK08961 339 LADVFTLFKKHGLSVDLISS--SETNVTVSLDPSENLVNTDVLAALSADLS 387 (861)
T ss_pred HHHHHHHHHHcCCeEEEEEc--CCCEEEEEEccccccchHHHHHHHHHHHh
Confidence 99999999999999999987 78999999999885 367777777764
No 151
>KOG2436 consensus Acetylglutamate kinase/acetylglutamate synthase [Amino acid transport and metabolism]
Probab=96.62 E-value=0.0072 Score=65.40 Aligned_cols=123 Identities=16% Similarity=0.228 Sum_probs=82.2
Q ss_pred hhchHHHHHHHHHHHHHcCCceEEeccceeE--EEEec--------CCCC-ceeeecchHHHHHHHhhchhcCCceEEEc
Q 008693 199 SFGECMSTRIFAAYLNKIGVKARQYDAFDIG--FITTD--------DFTN-ADILEATYPAVAKRLHGDWITDLAIPIVT 267 (557)
Q Consensus 199 s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~--iit~~--------~~~~-a~i~~~~~~~v~~~l~~~ll~~~~vpVv~ 267 (557)
-+||.--. ++ ..|++.|-.++..+....- +++.+ +|+. .++...+.++++ ++++.|.+|+++
T Consensus 170 ~~~E~n~~-lv-~nL~~~g~~ar~~s~g~~v~~~f~a~~~~v~d~~~y~~~gei~~vd~d~i~-----~l~~~G~mp~L~ 242 (520)
T KOG2436|consen 170 VSLEANLN-LV-INLSQLGTRARPSSSGVRVGNFFPADRNGVLDGEDYGLVGEIKKVDVDRIR-----HLLDAGSMPLLR 242 (520)
T ss_pred chhhhhhH-HH-HHHHHhhceeccccccccccceeecccccccccceeeeecccceechhhhh-----hhhhCCCchheh
Confidence 34665333 34 4588999888887765321 23333 2222 233344555443 345788999998
Q ss_pred CCCcccCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCCCCccccccCHHHHHHHHH
Q 008693 268 GFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAY 339 (557)
Q Consensus 268 Gfig~~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~~a~~i~~ls~~Ea~eLa~ 339 (557)
- .+.+ ..|+++|.+ +|..|..+|.+|+++++++.+|+.=+...+ .+.++.++-+|...+..
T Consensus 243 s-la~T-aSGqvlnvN---a~~~a~elA~~L~~~kli~l~d~g~~l~e~------ge~~S~l~l~~e~~~l~ 303 (520)
T KOG2436|consen 243 S-LAAT-ASGQVLNVN---ADEVAGELALALGPDKLILLMDKGRILKEN------GEDISSLILQEEDAGLR 303 (520)
T ss_pred h-hccc-CccceEEee---HHHHhhHHHhccCcceeEEecccccccccC------cccccccccchhHhhhh
Confidence 8 5777 489999999 999999999999999999999972243333 45567777776666654
No 152
>PRK08841 aspartate kinase; Validated
Probab=96.53 E-value=0.0083 Score=64.67 Aligned_cols=94 Identities=18% Similarity=0.220 Sum_probs=68.0
Q ss_pred HhHHHHHHhCCCCEEEecCCCCCCCCeeEecCCCCC---cceeeEEeeeccEEEEEEEecCccchhhHHHHHHHHHHhCC
Q 008693 347 PQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMS---KAVLTSIVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLG 423 (557)
Q Consensus 347 p~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~---~~~Vt~Is~~~nialItI~~~~m~~~~g~la~If~~L~~~g 423 (557)
++.+..+.+++|++....... ..=+++.+..+.. ......+...+++++|++.|.+ .+|+.+++|+.|.+++
T Consensus 269 ~~i~~~l~~~~i~v~~i~~~~--~~~~~~v~~~~~~~~~~~~~~~i~~~~~~a~vsvVG~~---~~gv~~~~~~aL~~~~ 343 (392)
T PRK08841 269 PSLTKQCQMLGIEVWNVIEEA--DRAQIVIKQDACAKLKLVFDDKIRNSESVSLLTLVGLE---ANGMVEHACNLLAQNG 343 (392)
T ss_pred HHHHHHHHHcCCCEEEEEecC--CcEEEEECHHHHHHHHHhCcccEEEeCCEEEEEEECCC---ChHHHHHHHHHHHhCC
Confidence 455677888999977665321 1112222222111 1112347778999999999975 4999999999999999
Q ss_pred ceEEEEEccCceeEEEeCCchh
Q 008693 424 ISVDVVATSEVSLSLTLDPSKL 445 (557)
Q Consensus 424 I~Vd~IstSe~sIS~~I~~~~~ 445 (557)
|++.++++|+.+|+|.++.++.
T Consensus 344 I~i~~i~~s~~~is~vv~~~~~ 365 (392)
T PRK08841 344 IDVRQCSTEPQSSMLVLDPANV 365 (392)
T ss_pred CCEEEEECCCcEEEEEEeHHHH
Confidence 9999999999999999998764
No 153
>cd04910 ACT_AK-Ectoine_1 ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway found in Methylomicrobium alcaliphilum, Vibrio cholerae, and various other halotolerant or halophilic bacteria. Bacteria exposed to hyperosmotic stress accumulate organic solutes called 'compatible solutes' of which ectoine, a heterocyclic amino acid, is one. Apart from its osmotic function, ectoine also exhibits a protective effect on proteins, nucleic acids and membranes against a variety of stress factors. de novo synthesis of ectoine starts with the phosphorylation of L-aspartate and shares its first two enzymatic steps with the biosynthesis of amino acids of the aspartate family: aspartokinase
Probab=96.33 E-value=0.017 Score=46.87 Aligned_cols=63 Identities=11% Similarity=0.090 Sum_probs=55.0
Q ss_pred EEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008693 476 IISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 538 (557)
Q Consensus 476 iIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~f~~ 538 (557)
.|-+-+. |...+|+..++|+.|+++++++.+..+.+..+++++..+.+..+++++.|.+.|-.
T Consensus 3 alevfdqdMvG~~g~d~~i~~~l~~~~v~ii~K~~nANtit~yl~~~~k~~~r~~~~Le~~~p~ 66 (71)
T cd04910 3 ALEVFDQDMVGEVGYDLEILELLQRFKVSIIAKDTNANTITHYLAGSLKTIKRLTEDLENRFPN 66 (71)
T ss_pred EEEEeCCCccCChhHHHHHHHHHHHcCCeEEEEecCCCeEEEEEEcCHHHHHHHHHHHHHhCcc
Confidence 4567775 77788999999999999999999999988888888888888999999999998854
No 154
>COG3603 Uncharacterized conserved protein [Function unknown]
Probab=96.24 E-value=0.019 Score=50.70 Aligned_cols=67 Identities=21% Similarity=0.326 Sum_probs=58.2
Q ss_pred heeecccceeEEEEEccc-cccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHH
Q 008693 466 AIVNLLQHRSIISLIGNV-QRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHET 535 (557)
Q Consensus 466 ~~i~~~~~~aiIsIVG~~-~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~ 535 (557)
..|....+-+.+.+-|.. -.-+|+++.+.+.|+++||.|..+|+-..++ ++|+++|.++|+++|.++
T Consensus 55 ~~V~~~~GW~~lk~~gpf~FgltGilasV~~pLsd~gigIFavStydtDh---iLVr~~dLekAv~~L~ea 122 (128)
T COG3603 55 DVVQIEKGWSCLKFEGPFDFGLTGILASVSQPLSDNGIGIFAVSTYDTDH---ILVREEDLEKAVKALEEA 122 (128)
T ss_pred cceEecCCeEEEEEeccccCCcchhhhhhhhhHhhCCccEEEEEeccCce---EEEehhhHHHHHHHHHHc
Confidence 346667788899999974 5678999999999999999999999977666 799999999999999875
No 155
>cd04913 ACT_AKii-LysC-BS-like_1 ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168 and related proteins. This CD includes the N-terminal of the two ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, and related sequences. In B. subtilis 168, the regulation of the diaminopimelate (Dap)-lysine biosynthetic pathway involves dual control by Dap and lysine, effected through separate Dap- and lysine-sensitive aspartokinase isoenzymes. The B. subtilis 168 AKII is induced by methionine and repressed and inhibited by lysine. Although Corynebacterium glutamicum is known to contain a single aspartokinase, both the succinylase and dehydrogenase variant pathways of DAP-lysine synthesis operate simultaneously in this organism. In corynebacteria and other various Gram-positive bacteria, the DAP-lysine pathway is fee
Probab=96.20 E-value=0.016 Score=46.01 Aligned_cols=48 Identities=23% Similarity=0.438 Sum_probs=38.7
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEcc-----CceeEEEeCCchh
Q 008693 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATS-----EVSLSLTLDPSKL 445 (557)
Q Consensus 396 alItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstS-----e~sIS~~I~~~~~ 445 (557)
++|++.+ +.+.+|+++++|+.|+++||+++++.++ ..+++|+++.++.
T Consensus 2 ~~v~v~~--~~~~~g~~~~i~~~L~~~~I~i~~i~~~~~~~~~~~is~~v~~~d~ 54 (75)
T cd04913 2 AKITLRG--VPDKPGVAAKIFGALAEANINVDMIVQNVSRDGTTDISFTVPKSDL 54 (75)
T ss_pred eEEEECC--CCCCCcHHHHHHHHHHHcCCeEEEEEeCCCCCCcEEEEEEecHHHH
Confidence 5677754 5678999999999999999999999764 2368899987653
No 156
>PF01842 ACT: ACT domain; InterPro: IPR002912 The ACT domain is found in a variety of contexts and is proposed to be a conserved regulatory binding fold. ACT domains are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. The archetypical ACT domain is the C-terminal regulatory domain of 3-phosphoglycerate dehydrogenase (3PGDH), which folds with a ferredoxin-like topology. A pair of ACT domains form an eight-stranded antiparallel sheet with two molecules of allosteric inhibitor serine bound in the interface. Biochemical exploration of a few other proteins containing ACT domains supports the suggestions that these domains contain the archetypical ACT structure [].; GO: 0016597 amino acid binding, 0008152 metabolic process; PDB: 3L76_B 2F06_B 3NRB_C 1Y7P_C 2QMX_A 2DT9_A 2ZHO_D 3K5P_A 3TVI_K 3C1M_C ....
Probab=95.96 E-value=0.019 Score=44.61 Aligned_cols=54 Identities=28% Similarity=0.424 Sum_probs=44.7
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCCc-----eEEEEEEecccHHHHHHHHHHHh
Q 008693 483 VQRSSLILEKAFRVLRRSGVNVQMISQGASK-----VNISLIVNDDEAEQCVRALHETF 536 (557)
Q Consensus 483 ~~~~~~v~~rif~~L~~~gInI~~IsqgsSe-----~sIs~vV~~~d~~kAv~~LH~~f 536 (557)
+.+.||+++++++.|+++|+||..+.+..+. ..+.+..++.+.+++++.|++.+
T Consensus 7 ~~drpG~l~~v~~~la~~~inI~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 65 (66)
T PF01842_consen 7 VPDRPGILADVTEILADHGINIDSISQSSDKDGVGIVFIVIVVDEEDLEKLLEELEALP 65 (66)
T ss_dssp EETSTTHHHHHHHHHHHTTEEEEEEEEEEESSTTEEEEEEEEEEGHGHHHHHHHHHHHT
T ss_pred cCCCCCHHHHHHHHHHHcCCCHHHeEEEecCCCceEEEEEEECCCCCHHHHHHHHHccc
Confidence 4578999999999999999999998887664 44666677788889999998753
No 157
>PRK11589 gcvR glycine cleavage system transcriptional repressor; Provisional
Probab=95.20 E-value=0.58 Score=45.42 Aligned_cols=141 Identities=13% Similarity=0.180 Sum_probs=85.2
Q ss_pred ccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEc----cCceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhhee
Q 008693 393 RNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT----SEVSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIV 468 (557)
Q Consensus 393 ~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Ist----Se~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i 468 (557)
.+..+||+.|. ++||+.+++.+.|.++|.||.-+.+ ++++..+.+..... ....++..|..+.+++.-...+
T Consensus 6 ~~~lviTviG~---DrpGIVa~vs~~l~~~g~NI~ds~~t~lgg~Fa~i~lvs~~~~-~~~~le~~L~~l~~~~~L~i~v 81 (190)
T PRK11589 6 QHYLVITALGA---DRPGIVNTITRHVSSCGCNIEDSRLAMLGEEFTFIMLLSGSWN-AITLIESTLPLKGAELDLLIVM 81 (190)
T ss_pred ccEEEEEEEcC---CCChHHHHHHHHHHHcCCCeeehhhHhhCCceEEEEEEeCChh-HHHHHHHHHHhhhhhcCeEEEE
Confidence 35567888874 6899999999999999999987754 36666677754321 1222333333332221100011
Q ss_pred ---ec--ccc---eeEEEEEccccccchHHHHHHHHHHhCCCcEEEEEecC-----Cc-----eEEEEEEecc----cHH
Q 008693 469 ---NL--LQH---RSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA-----SK-----VNISLIVNDD----EAE 526 (557)
Q Consensus 469 ---~~--~~~---~aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~Isqgs-----Se-----~sIs~vV~~~----d~~ 526 (557)
.. ... -..|+++| .+.||+..++.+.|++.||||.-+++.. ++ ..+.+-++.. +..
T Consensus 82 ~~~~~~~~~~~~~~~~v~v~G--~DrPGIV~~vT~~la~~~iNI~~L~T~~~~a~~~~~~lf~~~~~v~lP~~~~~~~L~ 159 (190)
T PRK11589 82 KRTTARPRPAMPATVWVQVEV--ADSPHLIERFTALFDSHHMNIAELVSRTQPAEGERPAQLHIQITAHSPASQDAANIE 159 (190)
T ss_pred EeccccccccCCceEEEEEEE--CCCCCHHHHHHHHHHHcCCChhheEEeeecCCCCCcccEEEEEEEEcCCCCCHHHHH
Confidence 10 011 14677777 4789999999999999999998655432 11 2334444443 344
Q ss_pred HHHHHHHHHhccC
Q 008693 527 QCVRALHETFFES 539 (557)
Q Consensus 527 kAv~~LH~~f~~~ 539 (557)
.+++.|-+++..+
T Consensus 160 ~~l~~l~~eL~vd 172 (190)
T PRK11589 160 QAFKALCTELNAQ 172 (190)
T ss_pred HHHHHHHHHhCce
Confidence 5566666666554
No 158
>cd04888 ACT_PheB-BS C-terminal ACT domain of a small (~147 a.a.) putative phenylalanine biosynthetic pathway protein described in Bacillus subtilis (BS) PheB (PheB-BS) and related domains. This CD includes the C-terminal ACT domain of a small (~147 a.a.) putative phenylalanine biosynthetic pathway protein described in Bacillus subtilis (BS) PheB (PheB-BS) and other related ACT domains. In B. subtilis, the upstream gene of pheB, pheA encodes prephenate dehydratase (PDT). The presumed product of the pheB gene is chorismate mutase (CM). The deduced product of the B. subtilis pheB gene, however, has no significant homology to the CM portion of the bifunctional CM-PDT of Escherichia coli. The presence of an ACT domain lends support to the prediction that these proteins function as a phenylalanine-binding regulatory protein. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=94.52 E-value=0.32 Score=39.03 Aligned_cols=56 Identities=23% Similarity=0.379 Sum_probs=41.3
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEEcc---C--ceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhhe
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVATS---E--VSLSLTLDPSKLWSRELIQQELDHVVEELEKIAI 467 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~IstS---e--~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~ 467 (557)
.+++|.++++++.|++.|++++++.++ + ..++|+++.++.. ..++.+++.|+++..
T Consensus 8 ~d~~g~l~~I~~~la~~~inI~~i~~~~~~~~~~~i~~~v~v~~~~------~~l~~l~~~L~~i~~ 68 (76)
T cd04888 8 EHRPGVLSKVLNTIAQVRGNVLTINQNIPIHGRANVTISIDTSTMN------GDIDELLEELREIDG 68 (76)
T ss_pred cCCCchHHHHHHHHHHcCCCEEEEEeCCCCCCeEEEEEEEEcCchH------HHHHHHHHHHhcCCC
Confidence 467999999999999999999999752 2 4578888765531 246677777776443
No 159
>COG3830 ACT domain-containing protein [Signal transduction mechanisms]
Probab=94.26 E-value=0.1 Score=44.08 Aligned_cols=63 Identities=27% Similarity=0.354 Sum_probs=50.4
Q ss_pred eeEEEEEccccccchHHHHHHHHHHhCCCcEEEEEecC--CceEEEEEEecccHHHHHHHHHHHhcc
Q 008693 474 RSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA--SKVNISLIVNDDEAEQCVRALHETFFE 538 (557)
Q Consensus 474 ~aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~Isqgs--Se~sIs~vV~~~d~~kAv~~LH~~f~~ 538 (557)
.++|+++| ++.+|+.+.++.+|+++|+||+=|+|.- .--++.++|+-.........+.++|-.
T Consensus 3 ~avITV~G--kDr~GIva~is~vLAe~~vNIldisQtvm~~~ftm~~lV~~~~~~~d~~~lr~~l~~ 67 (90)
T COG3830 3 RAVITVIG--KDRVGIVAAVSRVLAEHGVNILDISQTVMDGFFTMIMLVDISKEVVDFAALRDELAA 67 (90)
T ss_pred eEEEEEEc--CCCCchhHHHHHHHHHcCCcEEEHHHHHHhhhceeeeEEcCChHhccHHHHHHHHHH
Confidence 57899999 4679999999999999999999999865 345677788887777666677766643
No 160
>cd04888 ACT_PheB-BS C-terminal ACT domain of a small (~147 a.a.) putative phenylalanine biosynthetic pathway protein described in Bacillus subtilis (BS) PheB (PheB-BS) and related domains. This CD includes the C-terminal ACT domain of a small (~147 a.a.) putative phenylalanine biosynthetic pathway protein described in Bacillus subtilis (BS) PheB (PheB-BS) and other related ACT domains. In B. subtilis, the upstream gene of pheB, pheA encodes prephenate dehydratase (PDT). The presumed product of the pheB gene is chorismate mutase (CM). The deduced product of the B. subtilis pheB gene, however, has no significant homology to the CM portion of the bifunctional CM-PDT of Escherichia coli. The presence of an ACT domain lends support to the prediction that these proteins function as a phenylalanine-binding regulatory protein. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=93.92 E-value=0.33 Score=38.92 Aligned_cols=55 Identities=18% Similarity=0.285 Sum_probs=45.1
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecC---CceEEEEEEecccHHHHHHHHHHHhcc
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGA---SKVNISLIVNDDEAEQCVRALHETFFE 538 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~Isqgs---Se~sIs~vV~~~d~~kAv~~LH~~f~~ 538 (557)
.+.+|.++++++.|++.|+||.++++.. ....++|.++..+.+..++.|.+.+-.
T Consensus 8 ~d~~g~l~~I~~~la~~~inI~~i~~~~~~~~~~~i~~~v~v~~~~~~l~~l~~~L~~ 65 (76)
T cd04888 8 EHRPGVLSKVLNTIAQVRGNVLTINQNIPIHGRANVTISIDTSTMNGDIDELLEELRE 65 (76)
T ss_pred cCCCchHHHHHHHHHHcCCCEEEEEeCCCCCCeEEEEEEEEcCchHHHHHHHHHHHhc
Confidence 4568999999999999999999998843 235689999999988788888777653
No 161
>PF01842 ACT: ACT domain; InterPro: IPR002912 The ACT domain is found in a variety of contexts and is proposed to be a conserved regulatory binding fold. ACT domains are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. The archetypical ACT domain is the C-terminal regulatory domain of 3-phosphoglycerate dehydrogenase (3PGDH), which folds with a ferredoxin-like topology. A pair of ACT domains form an eight-stranded antiparallel sheet with two molecules of allosteric inhibitor serine bound in the interface. Biochemical exploration of a few other proteins containing ACT domains supports the suggestions that these domains contain the archetypical ACT structure [].; GO: 0016597 amino acid binding, 0008152 metabolic process; PDB: 3L76_B 2F06_B 3NRB_C 1Y7P_C 2QMX_A 2DT9_A 2ZHO_D 3K5P_A 3TVI_K 3C1M_C ....
Probab=93.10 E-value=0.46 Score=36.66 Aligned_cols=27 Identities=30% Similarity=0.500 Sum_probs=24.4
Q ss_pred ccchhhHHHHHHHHHHhCCceEEEEEc
Q 008693 405 MLGQYGFLAKVFSTFEDLGISVDVVAT 431 (557)
Q Consensus 405 m~~~~g~la~If~~L~~~gI~Vd~Ist 431 (557)
+.++||.++++++.|+++|+||..+.+
T Consensus 7 ~~drpG~l~~v~~~la~~~inI~~~~~ 33 (66)
T PF01842_consen 7 VPDRPGILADVTEILADHGINIDSISQ 33 (66)
T ss_dssp EETSTTHHHHHHHHHHHTTEEEEEEEE
T ss_pred cCCCCCHHHHHHHHHHHcCCCHHHeEE
Confidence 457899999999999999999999864
No 162
>PRK04435 hypothetical protein; Provisional
Probab=92.45 E-value=0.86 Score=42.37 Aligned_cols=63 Identities=19% Similarity=0.444 Sum_probs=44.2
Q ss_pred EEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEcc---C--ceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhh
Q 008693 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATS---E--VSLSLTLDPSKLWSRELIQQELDHVVEELEKIA 466 (557)
Q Consensus 395 ialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstS---e--~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~ 466 (557)
.+.+.+. +.+.+|.++++++.|++.|+||+.+.++ + .+++|+++-++.. ..++.+++.|+.+.
T Consensus 69 ~vtL~i~---l~Dr~GlLs~Il~~IA~~~aNIltI~q~i~~~g~a~vs~tVevs~~~------~~L~~Li~~L~~i~ 136 (147)
T PRK04435 69 IITLSLL---LEDRSGTLSKVLNVIAEAGGNILTINQSIPLQGRANVTISIDTSSME------GDIDELLEKLRNLD 136 (147)
T ss_pred EEEEEEE---EecCCCHHHHHHHHHHHcCCCeEEEEEEcCCCCEEEEEEEEEeCChH------HHHHHHHHHHHcCC
Confidence 3344554 3468999999999999999999999753 1 4577777665431 24667777777643
No 163
>cd04911 ACT_AKiii-YclM-BS_1 ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) YclM) and Clostridia species. Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. Bacillus subtilis YclM is reported to be a single polypeptide of 50 kD. AKIII from Bacillus subtilis strain 168 is induced by lysine and repressed by threonine and it is synergistically inhibited by lysine and threonine. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=92.33 E-value=0.46 Score=39.14 Aligned_cols=60 Identities=17% Similarity=0.310 Sum_probs=45.4
Q ss_pred EEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHH-----HHHHHHHHHhcc
Q 008693 477 ISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAE-----QCVRALHETFFE 538 (557)
Q Consensus 477 IsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~-----kAv~~LH~~f~~ 538 (557)
|.+.-. |....|+..|+++.|++.||++..+.+ +.-++|+++++++.. +.++.|++++..
T Consensus 4 I~i~K~~Mn~evGF~rk~L~I~E~~~is~Eh~PS--GID~~Siii~~~~~~~~~~~~i~~~i~~~~~p 69 (76)
T cd04911 4 IYISKYLMNREVGFGRKLLSILEDNGISYEHMPS--GIDDISIIIRDNQLTDEKEQKILAEIKEELHP 69 (76)
T ss_pred EehhHhhccchhcHHHHHHHHHHHcCCCEeeecC--CCccEEEEEEccccchhhHHHHHHHHHHhcCC
Confidence 333344 556689999999999999999999987 567789999999544 456666666544
No 164
>KOG0456 consensus Aspartate kinase [Amino acid transport and metabolism]
Probab=92.11 E-value=0.37 Score=50.94 Aligned_cols=70 Identities=17% Similarity=0.373 Sum_probs=59.5
Q ss_pred heeecccceeEEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHH--HHH-HHHHHHhc
Q 008693 466 AIVNLLQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAE--QCV-RALHETFF 537 (557)
Q Consensus 466 ~~i~~~~~~aiIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~--kAv-~~LH~~f~ 537 (557)
..|...+|+.++-|-.+ |....|+++++|..|.+.||.|..|++ ||.+||+-.+.++.. +.+ +.||+.+.
T Consensus 385 TsI~lK~nv~mldI~Str~l~q~GFLAkvFti~ek~~isVDvvaT--SEV~iSltL~~~~~~sreliq~~l~~a~e 458 (559)
T KOG0456|consen 385 TSIVLKRNVTMLDIASTRMLGQHGFLAKVFTIFEKLGISVDVVAT--SEVSISLTLDPSKLDSRELIQGELDQAVE 458 (559)
T ss_pred eEEEEeccEEEEEecccchhhhhhHHHHHHHHHHHhCcEEEEEEe--eeEEEEEecChhhhhhHHHHHhhHHHHHH
Confidence 45777889999999997 888899999999999999999999998 899999999887665 334 66666654
No 165
>cd04908 ACT_Bt0572_1 N-terminal ACT domain of a novel protein composed almost entirely of two tandem ACT domains. Included in this CD is the N-terminal ACT domain of a novel protein composed almost entirely of two tandem ACT domains as seen in the uncharacterized structure (pdb 2F06) of the Bt0572 protein from Bacteroides thetaiotaomicron and related ACT domains. These tandem ACT domain proteins belong to the superfamily of ACT regulatory domains.
Probab=91.68 E-value=0.52 Score=37.16 Aligned_cols=53 Identities=17% Similarity=0.219 Sum_probs=39.7
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHH
Q 008693 483 VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHET 535 (557)
Q Consensus 483 ~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~LH~~ 535 (557)
+.+.||.++++.+.|+++|+||.-+.....+....+.+..++.+++.+.|-+.
T Consensus 8 v~d~pG~La~v~~~l~~~~inI~~i~~~~~~~~~~~rl~~~~~~~~~~~L~~~ 60 (66)
T cd04908 8 LENKPGRLAAVTEILSEAGINIRALSIADTSEFGILRLIVSDPDKAKEALKEA 60 (66)
T ss_pred EcCCCChHHHHHHHHHHCCCCEEEEEEEecCCCCEEEEEECCHHHHHHHHHHC
Confidence 56789999999999999999997544333322466666778878888888654
No 166
>PRK06737 acetolactate synthase 1 regulatory subunit; Validated
Probab=90.83 E-value=0.74 Score=37.95 Aligned_cols=52 Identities=19% Similarity=0.270 Sum_probs=38.7
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEEccC------ceeEEEeCCchhhhHHHHHHHHHHHHHHHhhh
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLDPSKLWSRELIQQELDHVVEELEKI 465 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~IstSe------~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~ 465 (557)
.+.||+++|+...|.+.|+||+.++.++ ..+++++..++ +.++++.+.|+++
T Consensus 10 ~n~pGVL~Ri~~lf~rRgfNI~Sl~vg~te~~~~sriti~~~~~~--------~~i~qi~kQL~KL 67 (76)
T PRK06737 10 HNDPSVLLRISGIFARRGYYISSLNLNERDTSGVSEMKLTAVCTE--------NEATLLVSQLKKL 67 (76)
T ss_pred ecCCCHHHHHHHHHhccCcceEEEEecccCCCCeeEEEEEEECCH--------HHHHHHHHHHhCC
Confidence 3689999999999999999999997442 34667765443 2456677777764
No 167
>PRK13562 acetolactate synthase 1 regulatory subunit; Provisional
Probab=90.41 E-value=0.83 Score=38.35 Aligned_cols=52 Identities=17% Similarity=0.354 Sum_probs=39.1
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEEccC------ceeEEEeC-CchhhhHHHHHHHHHHHHHHHhhh
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLD-PSKLWSRELIQQELDHVVEELEKI 465 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~IstSe------~sIS~~I~-~~~~~~~~~~~~~l~~~~~~l~~~ 465 (557)
.+.||+++|+-..|.+.|+||+.++.++ .+++++++ .++ ..++++.+.|+++
T Consensus 10 eN~~GVL~Rit~lFsRRg~NI~SLtvg~Te~~~iSRmtivv~~~d~--------~~ieqI~kQL~Kl 68 (84)
T PRK13562 10 ADQVSTLNRITSAFVRLQYNIDTLHVTHSEQPGISNMEIQVDIQDD--------TSLHILIKKLKQQ 68 (84)
T ss_pred ECCCCHHHHHHHHHhccCcCeeeEEecccCCCCceEEEEEEeCCCH--------HHHHHHHHHHhCC
Confidence 3689999999999999999999997543 35778886 443 2356666677763
No 168
>cd02116 ACT ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme. Members of this CD belong to the superfamily of ACT regulatory domains. Pairs of ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme. The ACT domain has been detected in a number of diverse proteins; some of these proteins are involved in amino acid and purine biosynthesis, phenylalanine hydroxylation, regulation of bacterial metabolism and transcription, and many remain to be characterized. ACT domain-containing enzymes involved in amino acid and purine synthesis are in many cases allosteric enzymes with complex regulation enforced by the binding of ligands. The ACT domain is commonly involved in the binding of a small regulatory molecule, such as the amino acids L-Ser and L-Phe in the case of D-3-phosphoglycerate dehydrogenase and the bifunctional chorismate mutase-p
Probab=90.02 E-value=1 Score=32.09 Aligned_cols=49 Identities=31% Similarity=0.509 Sum_probs=38.1
Q ss_pred ccchHHHHHHHHHHhCCCcEEEEEecCC----ceEEEEEEecc-cHHHHHHHHH
Q 008693 485 RSSLILEKAFRVLRRSGVNVQMISQGAS----KVNISLIVNDD-EAEQCVRALH 533 (557)
Q Consensus 485 ~~~~v~~rif~~L~~~gInI~~IsqgsS----e~sIs~vV~~~-d~~kAv~~LH 533 (557)
+.++.+.++++.|++.++++..+.+... ...+++.++.. +.+++++.|+
T Consensus 7 ~~~~~l~~i~~~l~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 60 (60)
T cd02116 7 DRPGLLAKVLSVLAEAGINITSIEQRTSGDGGEADIFIVVDGDGDLEKLLEALE 60 (60)
T ss_pred CCCchHHHHHHHHHHCCCcEEEEEeEEcCCCCeEEEEEEEechHHHHHHHHHhC
Confidence 3578999999999999999999877543 36688888887 6666666553
No 169
>PRK11152 ilvM acetolactate synthase 2 regulatory subunit; Provisional
Probab=88.63 E-value=1.3 Score=36.44 Aligned_cols=51 Identities=18% Similarity=0.313 Sum_probs=38.7
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEEccC------ceeEEEeCCchhhhHHHHHHHHHHHHHHHhhh
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLDPSKLWSRELIQQELDHVVEELEKI 465 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~IstSe------~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~ 465 (557)
.+.||.++|+...|++.|+||+.++.++ ..+++++..+ +.++.+.+.|+++
T Consensus 11 ~n~pGVL~Ri~~lf~rRGfnI~sl~v~~t~~~~~sriti~v~~~---------~~i~ql~kQL~KL 67 (76)
T PRK11152 11 RFRPEVLERVLRVVRHRGFQVCSMNMTQNTDAQNINIELTVASE---------RPIDLLSSQLNKL 67 (76)
T ss_pred ECCccHHHHHHHHHhcCCeeeeeEEeeecCCCCEEEEEEEECCC---------chHHHHHHHHhcC
Confidence 3689999999999999999999997432 4678888632 2456666777764
No 170
>COG3830 ACT domain-containing protein [Signal transduction mechanisms]
Probab=88.21 E-value=2.2 Score=36.23 Aligned_cols=47 Identities=13% Similarity=0.295 Sum_probs=36.8
Q ss_pred cEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEcc----CceeEEEeCCc
Q 008693 394 NVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATS----EVSLSLTLDPS 443 (557)
Q Consensus 394 nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstS----e~sIS~~I~~~ 443 (557)
..++||+.|. ++||+.+.++..|+++|+||.-++++ -.+.-+.++-+
T Consensus 2 ~~avITV~Gk---Dr~GIva~is~vLAe~~vNIldisQtvm~~~ftm~~lV~~~ 52 (90)
T COG3830 2 MRAVITVIGK---DRVGIVAAVSRVLAEHGVNILDISQTVMDGFFTMIMLVDIS 52 (90)
T ss_pred ceEEEEEEcC---CCCchhHHHHHHHHHcCCcEEEHHHHHHhhhceeeeEEcCC
Confidence 4578899874 68999999999999999999999865 24455555543
No 171
>PRK11895 ilvH acetolactate synthase 3 regulatory subunit; Reviewed
Probab=88.01 E-value=11 Score=35.57 Aligned_cols=91 Identities=12% Similarity=0.252 Sum_probs=56.6
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEEcc--C----ceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhhe---ee-------
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVATS--E----VSLSLTLDPSKLWSRELIQQELDHVVEELEKIAI---VN------- 469 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~IstS--e----~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~---i~------- 469 (557)
.+.||.++++...|+++|+||+.++.+ + ..+++.++.++ +.++++.+.|+++-. +.
T Consensus 10 eN~pGvL~rI~~lf~rrg~NI~Sl~v~~te~~~~sriti~V~~~~--------~~i~qi~kQl~KLidV~~V~~~~~~~~ 81 (161)
T PRK11895 10 ENEPGVLSRVAGLFSRRGYNIESLTVGPTEDPGLSRMTIVTSGDE--------QVIEQITKQLNKLIDVLKVVDLTEEAH 81 (161)
T ss_pred cCCCcHHHHHHHHHHhCCCcEEEEEeeecCCCCEEEEEEEEECCH--------HHHHHHHHHHhccccEEEEEecCCcch
Confidence 478999999999999999999987532 2 23667776543 235555566665321 11
Q ss_pred cccceeEEEEEccccccchHHHHHHHHHHhCCCcEEEEE
Q 008693 470 LLQHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMIS 508 (557)
Q Consensus 470 ~~~~~aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~Is 508 (557)
+...++++-+...-.. -..+++...-.+-+|.-++
T Consensus 82 v~rEl~LiKv~~~~~~----r~~i~~i~~~f~a~ivdv~ 116 (161)
T PRK11895 82 VERELALVKVRASGEN----RAEILRLADIFRAKIVDVT 116 (161)
T ss_pred hheEEEEEEEECCccc----HHHHHHHHHHhCCEEEEec
Confidence 2234677777664322 2355555555566766553
No 172
>cd04889 ACT_PDH-BS-like C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH) enzyme that catalyzes the formation of 4-hydroxyphenylpyruvate from prephenate. Included in this CD is the C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH) enzyme that catalyzes the formation of 4-hydroxyphenylpyruvate from prephenate, found in Bacillus subtilis (BS) and other Firmicutes, Deinococci, and Bacteroidetes. PDH is the first enzyme in the aromatic amino acid pathway specific for the biosynthesis of tyrosine. This enzyme is feedback inhibited by tyrosine in B. subtilis and other microorganisms. Both phenylalanine and tryptophan have been shown to be inhibitors of this activity in B. subtilis. Bifunctional chorismate mutase-PDH (TyrA) enzymes such as those seen in Escherichia coli do not contain an ACT domain. Also included in this CD is the N-terminal ACT domain of a novel protein composed almost entirely of two tandem A
Probab=87.67 E-value=1.9 Score=32.52 Aligned_cols=50 Identities=20% Similarity=0.226 Sum_probs=35.2
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCCc-eEEEEEEecccHHHHHHHH
Q 008693 483 VQRSSLILEKAFRVLRRSGVNVQMISQGASK-VNISLIVNDDEAEQCVRAL 532 (557)
Q Consensus 483 ~~~~~~v~~rif~~L~~~gInI~~IsqgsSe-~sIs~vV~~~d~~kAv~~L 532 (557)
+.+.||.++++.+.|.++|+||..+.....+ ..-.+.+.-++.++|.+.|
T Consensus 5 ~~d~~G~l~~i~~~l~~~~inI~~~~~~~~~~~~~~~~~~v~~~~~a~~~l 55 (56)
T cd04889 5 VENKPGRLAEVTEILAEAGINIKAISIAETRGEFGILRLIFSDPERAKEVL 55 (56)
T ss_pred eCCCCChHHHHHHHHHHcCCCEeeEEEEEccCCcEEEEEEECCHHHHHHHh
Confidence 4567999999999999999999654433322 2334445555588887765
No 173
>PF13740 ACT_6: ACT domain; PDB: 1ZPV_A 3P96_A 1U8S_A.
Probab=87.54 E-value=2.3 Score=34.66 Aligned_cols=58 Identities=19% Similarity=0.344 Sum_probs=38.3
Q ss_pred eEEEEEccccccchHHHHHHHHHHhCCCcEEEEEecC--CceEEEEEEecccHHHHHHHHHHHh
Q 008693 475 SIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA--SKVNISLIVNDDEAEQCVRALHETF 536 (557)
Q Consensus 475 aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~Isqgs--Se~sIs~vV~~~d~~kAv~~LH~~f 536 (557)
.+|+++| .+.||+.+.++++|++.|.||.-+.|.. ..-++.+.|+-. +.....|.++|
T Consensus 3 ~vItv~G--~DrpGiv~~v~~~l~~~g~ni~d~~~~~~~~~f~~~~~v~~~--~~~~~~l~~~L 62 (76)
T PF13740_consen 3 LVITVVG--PDRPGIVAAVTGVLAEHGCNIEDSRQAVLGGRFTLIMLVSIP--EDSLERLESAL 62 (76)
T ss_dssp EEEEEEE--E--TTHHHHHHHHHHCTT-EEEEEEEEEETTEEEEEEEEEES--HHHHHHHHHHH
T ss_pred EEEEEEe--cCCCcHHHHHHHHHHHCCCcEEEEEEEEEcCeEEEEEEEEeC--cccHHHHHHHH
Confidence 4688888 4679999999999999999998766654 444555555555 33444555444
No 174
>TIGR00119 acolac_sm acetolactate synthase, small subunit. acetohydroxyacid synthase is a synonym.
Probab=87.06 E-value=14 Score=34.78 Aligned_cols=91 Identities=13% Similarity=0.251 Sum_probs=55.6
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEEcc--C----ceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhhe---ee-------
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVATS--E----VSLSLTLDPSKLWSRELIQQELDHVVEELEKIAI---VN------- 469 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~IstS--e----~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~---i~------- 469 (557)
.+.||.++++...|++.|+||+.+..+ + ..+++.++.++ +.++++.+.|+++-. +.
T Consensus 9 en~pGvL~rI~~lf~rrg~NI~Sl~v~~t~~~~~sriti~V~~d~--------~~i~qi~kQl~Kli~V~~V~~~~~~~~ 80 (157)
T TIGR00119 9 ENEPGVLSRVAGLFTRRGFNIESLTVGPTEDPDLSRMTIVVVGDD--------KVLEQITKQLNKLVDVIKVSDLTESAI 80 (157)
T ss_pred cCCCcHHHHHHHHHHhCCceEEEEEEeecCCCCEEEEEEEEECCH--------HHHHHHHHHHhcCccEEEEEecCCCcc
Confidence 468999999999999999999987532 2 23677776532 234555556665321 11
Q ss_pred cccceeEEEEEccccccchHHHHHHHHHHhCCCcEEEEE
Q 008693 470 LLQHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMIS 508 (557)
Q Consensus 470 ~~~~~aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~Is 508 (557)
+...++++-+...... -..+++...-.+-+|.-++
T Consensus 81 v~rEl~LiKv~~~~~~----r~~i~~i~~~f~a~ivdv~ 115 (157)
T TIGR00119 81 VERELCLVKVSAPGEG----RDEIIRLTNIFRGRIVDVS 115 (157)
T ss_pred eeeEEEEEEEECCccC----HHHHHHHHHHhCCEEEEec
Confidence 2234577777664222 2355555555556665553
No 175
>PRK08178 acetolactate synthase 1 regulatory subunit; Reviewed
Probab=86.26 E-value=2 Score=36.99 Aligned_cols=51 Identities=18% Similarity=0.344 Sum_probs=37.9
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEEccC------ceeEEEeCCchhhhHHHHHHHHHHHHHHHhhh
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLDPSKLWSRELIQQELDHVVEELEKI 465 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~IstSe------~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~ 465 (557)
.+.||+++++...|++.|+||+.++.++ ..+++++.. + +.++++.+.|+++
T Consensus 16 ~N~pGVL~RIaglFsRRgyNIeSLtvg~te~~~iSRmtivv~~-~--------~~i~Qi~kQL~KL 72 (96)
T PRK08178 16 RNHPGVMSHVCGLFARRAFNVEGILCLPIQDGDKSRIWLLVND-D--------QRLEQMISQIEKL 72 (96)
T ss_pred ECCcCHHHHHHHHHhcCCcCeeeEEEeecCCCCceEEEEEEcC-c--------hHHHHHHHHHhCC
Confidence 3689999999999999999999996432 456777763 2 2356667777764
No 176
>PRK13562 acetolactate synthase 1 regulatory subunit; Provisional
Probab=86.08 E-value=4.1 Score=34.22 Aligned_cols=52 Identities=15% Similarity=0.257 Sum_probs=40.3
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCCce----EEEEEEe-cccH--HHHHHHHHHH
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGASKV----NISLIVN-DDEA--EQCVRALHET 535 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~IsqgsSe~----sIs~vV~-~~d~--~kAv~~LH~~ 535 (557)
.+.||++.|+...+.+.|+||..++.|.++. .++++++ .++. ++..+.|++-
T Consensus 10 eN~~GVL~Rit~lFsRRg~NI~SLtvg~Te~~~iSRmtivv~~~d~~~ieqI~kQL~Kl 68 (84)
T PRK13562 10 ADQVSTLNRITSAFVRLQYNIDTLHVTHSEQPGISNMEIQVDIQDDTSLHILIKKLKQQ 68 (84)
T ss_pred ECCCCHHHHHHHHHhccCcCeeeEEecccCCCCceEEEEEEeCCCHHHHHHHHHHHhCC
Confidence 4679999999999999999999999998765 6888887 4432 3555555543
No 177
>cd04870 ACT_PSP_1 CT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). The ACT_PSP_1 CD includes the first of the two ACT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). PSPs belong to the L-2-haloacid dehalogenase-like protein superfamily. PSP is involved in serine metabolism; serine is synthesized from phosphoglycerate through sequential reactions catalyzed by 3-phosphoglycerate dehydrogenase (SerA), 3-phosphoserine aminotransferase (SerC), and SerB. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=85.85 E-value=2.9 Score=33.82 Aligned_cols=31 Identities=10% Similarity=0.239 Sum_probs=26.2
Q ss_pred EEEEecCccchhhHHHHHHHHHHhCCceEEEEEc
Q 008693 398 LDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT 431 (557)
Q Consensus 398 ItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Ist 431 (557)
+++.|. ++||+.+++.+.|+++|+||.-+++
T Consensus 2 vtv~G~---DrpGiv~~vt~~la~~~~nI~dl~~ 32 (75)
T cd04870 2 ITVTGP---DRPGLTSALTEVLAAHGVRILDVGQ 32 (75)
T ss_pred EEEEcC---CCCCHHHHHHHHHHHCCCCEEeccc
Confidence 566663 6899999999999999999988753
No 178
>PRK04435 hypothetical protein; Provisional
Probab=85.17 E-value=4.9 Score=37.31 Aligned_cols=55 Identities=22% Similarity=0.347 Sum_probs=42.9
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCC---ceEEEEEEecccHHHHHHHHHHHhc
Q 008693 483 VQRSSLILEKAFRVLRRSGVNVQMISQGAS---KVNISLIVNDDEAEQCVRALHETFF 537 (557)
Q Consensus 483 ~~~~~~v~~rif~~L~~~gInI~~IsqgsS---e~sIs~vV~~~d~~kAv~~LH~~f~ 537 (557)
+.+.+|+++++++.+++.|+||..|+|... ..++++-++..+.+..++.|=+.+-
T Consensus 76 l~Dr~GlLs~Il~~IA~~~aNIltI~q~i~~~g~a~vs~tVevs~~~~~L~~Li~~L~ 133 (147)
T PRK04435 76 LEDRSGTLSKVLNVIAEAGGNILTINQSIPLQGRANVTISIDTSSMEGDIDELLEKLR 133 (147)
T ss_pred EecCCCHHHHHHHHHHHcCCCeEEEEEEcCCCCEEEEEEEEEeCChHHHHHHHHHHHH
Confidence 445689999999999999999999998542 2458888888888766666665554
No 179
>PF13710 ACT_5: ACT domain; PDB: 2FGC_A 2PC6_A 2F1F_B.
Probab=83.85 E-value=2.1 Score=33.75 Aligned_cols=51 Identities=20% Similarity=0.501 Sum_probs=35.9
Q ss_pred chhhHHHHHHHHHHhCCceEEEEEccC------ceeEEEeCCchhhhHHHHHHHHHHHHHHHhhh
Q 008693 407 GQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLDPSKLWSRELIQQELDHVVEELEKI 465 (557)
Q Consensus 407 ~~~g~la~If~~L~~~gI~Vd~IstSe------~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~ 465 (557)
+.||.+.|+...|.+.|++++.++.+. ..++++++.++ +.++.+.+.|+++
T Consensus 1 n~~GvL~Ri~~vf~rRg~nI~sl~v~~~~~~~~~riti~v~~~~--------~~i~~l~~Ql~Kl 57 (63)
T PF13710_consen 1 NQPGVLNRITGVFRRRGFNIESLSVGPTEDPGISRITIVVSGDD--------REIEQLVKQLEKL 57 (63)
T ss_dssp SSTTHHHHHHHHHHTTT-EECEEEEEE-SSTTEEEEEEEEES-C--------CHHHHHHHHHHCS
T ss_pred CCcHHHHHHHHHHhcCCeEEeeEEeeecCCCCEEEEEEEEeeCc--------hhHHHHHHHHhcc
Confidence 368999999999999999999986332 45677776633 1355566667764
No 180
>COG4492 PheB ACT domain-containing protein [General function prediction only]
Probab=83.79 E-value=8.7 Score=34.97 Aligned_cols=65 Identities=20% Similarity=0.470 Sum_probs=48.3
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEEcc-----CceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhheeecccceeEEEEE
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVATS-----EVSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIVNLLQHRSIISLI 480 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~IstS-----e~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i~~~~~~aiIsIV 480 (557)
..+.|.++++++.+++.++||.-|.|+ -.++++.++.+.. +..++.++.++.+ .++++.|-++
T Consensus 80 edr~G~LS~vLd~iA~~~~nvLTI~Q~ipl~g~Anvtlsi~~ssm------~~~V~~ii~kl~k------~e~V~kVeiv 147 (150)
T COG4492 80 EDRVGILSDVLDVIAREEINVLTIHQTIPLQGRANVTLSIDTSSM------EKDVDKIIEKLRK------VEGVEKVEIV 147 (150)
T ss_pred hhhhhhHHHHHHHHHHhCCcEEEEecccccCceeeEEEEEEchhh------hhhHHHHHHHHhc------ccceeEEEEe
Confidence 468999999999999999999999765 3567777776532 2356777777776 3456677777
Q ss_pred cc
Q 008693 481 GN 482 (557)
Q Consensus 481 G~ 482 (557)
|.
T Consensus 148 gs 149 (150)
T COG4492 148 GS 149 (150)
T ss_pred ec
Confidence 73
No 181
>CHL00100 ilvH acetohydroxyacid synthase small subunit
Probab=82.46 E-value=6.4 Score=37.71 Aligned_cols=57 Identities=23% Similarity=0.407 Sum_probs=41.9
Q ss_pred EEEEccccccchHHHHHHHHHHhCCCcEEEEEecC----CceEEEEEEeccc--HHHHHHHHHHH
Q 008693 477 ISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA----SKVNISLIVNDDE--AEQCVRALHET 535 (557)
Q Consensus 477 IsIVG~~~~~~~v~~rif~~L~~~gInI~~Isqgs----Se~sIs~vV~~~d--~~kAv~~LH~~ 535 (557)
+++++ .+.||++.|+...|++.|+||..++.+. ....++++++.++ .++..+.|++-
T Consensus 5 isvlv--~n~PGVL~RIt~lFsrRg~NIesLsv~~t~~~~~sr~TIvv~~~~~~ieqL~kQL~KL 67 (174)
T CHL00100 5 LSVLV--EDESGVLTRIAGLFARRGFNIESLAVGPAEQKGISRITMVVPGDDRTIEQLTKQLYKL 67 (174)
T ss_pred EEEEE--eCcCCHHHHHHHHHHhCCCCeeEEEeeEcCCCCccEEEEEEECCHHHHHHHHHHHHHH
Confidence 45555 4689999999999999999999988765 4446889999863 34444444443
No 182
>CHL00100 ilvH acetohydroxyacid synthase small subunit
Probab=82.37 E-value=20 Score=34.30 Aligned_cols=97 Identities=14% Similarity=0.185 Sum_probs=56.2
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEEcc------CceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhhee----eccccee
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVATS------EVSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIV----NLLQHRS 475 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~IstS------e~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i----~~~~~~a 475 (557)
.++||+++++...|++.|+||+.++++ ...++++++.++-. -+.+...|+++.+.++- ..+ .+...++
T Consensus 10 ~n~PGVL~RIt~lFsrRg~NIesLsv~~t~~~~~sr~TIvv~~~~~~-ieqL~kQL~KLidVl~V-~~~~~~~~v~rEl~ 87 (174)
T CHL00100 10 EDESGVLTRIAGLFARRGFNIESLAVGPAEQKGISRITMVVPGDDRT-IEQLTKQLYKLVNILKV-QDITNIPCVERELM 87 (174)
T ss_pred eCcCCHHHHHHHHHHhCCCCeeEEEeeEcCCCCccEEEEEEECCHHH-HHHHHHHHHHHhHhhEE-EecCCccceeeEEE
Confidence 368999999999999999999998743 24577888765321 22333344444443321 111 1234567
Q ss_pred EEEEEccccccchHHHHHHHHHHhCCCcEEEEE
Q 008693 476 IISLIGNVQRSSLILEKAFRVLRRSGVNVQMIS 508 (557)
Q Consensus 476 iIsIVG~~~~~~~v~~rif~~L~~~gInI~~Is 508 (557)
++-+.....+. ..+++...-.+-+|.-++
T Consensus 88 LiKv~~~~~~r----~ei~~~~~~f~a~ivdv~ 116 (174)
T CHL00100 88 LIKINVNSQTR----PEILEIAQIFRAKVVDLS 116 (174)
T ss_pred EEEEecCCcCH----HHHHHHHHHhCCEEEEec
Confidence 77776643222 234444444455665554
No 183
>cd04882 ACT_Bt0572_2 C-terminal ACT domain of a novel protein composed of just two ACT domains. Included in this CD is the C-terminal ACT domain of a novel protein composed of just two ACT domains, as seen in the yet uncharacterized structure (pdb 2F06) of the Bt0572 protein from Bacteroides thetaiotaomicron and related proteins. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=81.61 E-value=4.3 Score=31.07 Aligned_cols=53 Identities=21% Similarity=0.332 Sum_probs=36.3
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCCc--eEEEEEEecccHHHHHHHHHHH
Q 008693 483 VQRSSLILEKAFRVLRRSGVNVQMISQGASK--VNISLIVNDDEAEQCVRALHET 535 (557)
Q Consensus 483 ~~~~~~v~~rif~~L~~~gInI~~IsqgsSe--~sIs~vV~~~d~~kAv~~LH~~ 535 (557)
+.+.||.++++.+.|+++|+||..+.+.... ....+.+.-++.+++.+.|.+.
T Consensus 6 ~~d~pG~L~~i~~~l~~~~~nI~~i~~~~~~~~~~~~v~~~ve~~~~~~~~L~~~ 60 (65)
T cd04882 6 VPDKPGGLHEILQILSEEGINIEYMYAFVEKKGGKALLIFRTEDIEKAIEVLQER 60 (65)
T ss_pred eCCCCcHHHHHHHHHHHCCCChhheEEEccCCCCeEEEEEEeCCHHHHHHHHHHC
Confidence 4578999999999999999999866543222 2233445545577777766543
No 184
>PRK13011 formyltetrahydrofolate deformylase; Reviewed
Probab=80.84 E-value=44 Score=34.54 Aligned_cols=84 Identities=7% Similarity=0.113 Sum_probs=50.8
Q ss_pred EEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEcc------CceeEEEeC-CchhhhHHHHHHHHHHHHHHHhhhhe
Q 008693 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATS------EVSLSLTLD-PSKLWSRELIQQELDHVVEELEKIAI 467 (557)
Q Consensus 395 ialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstS------e~sIS~~I~-~~~~~~~~~~~~~l~~~~~~l~~~~~ 467 (557)
-..+++.+. ++||+.+++.+.|++.|+||.-+++. .....+.++ +.. .....++++|..+-+++.-...
T Consensus 7 ~~vitv~G~---DrpGIVa~VT~~La~~~vNI~dls~~~~~~~~~F~m~~~~~~p~~-~~~~~L~~~L~~l~~~l~l~i~ 82 (286)
T PRK13011 7 TFVLTLSCP---SAAGIVAAVTGFLAEHGCYITELHSFDDRLSGRFFMRVEFHSEEG-LDEDALRAGFAPIAARFGMQWE 82 (286)
T ss_pred eEEEEEEeC---CCCCHHHHHHHHHHhCCCCEEEeeeeecCCCCeEEEEEEEecCCC-CCHHHHHHHHHHHHHHhCcEEE
Confidence 345788764 68999999999999999999988763 122333332 111 1234456667666666553233
Q ss_pred eecccceeEEEEEcc
Q 008693 468 VNLLQHRSIISLIGN 482 (557)
Q Consensus 468 i~~~~~~aiIsIVG~ 482 (557)
+......-.|.+.|.
T Consensus 83 i~~~~~~~ri~vl~S 97 (286)
T PRK13011 83 LHDPAARPKVLIMVS 97 (286)
T ss_pred EeecccCceEEEEEc
Confidence 333333335666654
No 185
>PF13740 ACT_6: ACT domain; PDB: 1ZPV_A 3P96_A 1U8S_A.
Probab=80.48 E-value=12 Score=30.29 Aligned_cols=44 Identities=14% Similarity=0.289 Sum_probs=30.4
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEc----cCceeEEEeCC
Q 008693 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT----SEVSLSLTLDP 442 (557)
Q Consensus 396 alItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Ist----Se~sIS~~I~~ 442 (557)
.+|++.|. ++||++++++..|+++|.|+.-+.+ ...+..+.++-
T Consensus 3 ~vItv~G~---DrpGiv~~v~~~l~~~g~ni~d~~~~~~~~~f~~~~~v~~ 50 (76)
T PF13740_consen 3 LVITVVGP---DRPGIVAAVTGVLAEHGCNIEDSRQAVLGGRFTLIMLVSI 50 (76)
T ss_dssp EEEEEEEE-----TTHHHHHHHHHHCTT-EEEEEEEEEETTEEEEEEEEEE
T ss_pred EEEEEEec---CCCcHHHHHHHHHHHCCCcEEEEEEEEEcCeEEEEEEEEe
Confidence 46788874 6899999999999999999987753 23444555543
No 186
>PRK06737 acetolactate synthase 1 regulatory subunit; Validated
Probab=79.38 E-value=4.1 Score=33.60 Aligned_cols=40 Identities=10% Similarity=0.186 Sum_probs=32.4
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCCce----EEEEEEecc
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGASKV----NISLIVNDD 523 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~IsqgsSe~----sIs~vV~~~ 523 (557)
.+.||++.|+...+++.|+||..++.|.++. .+++++..+
T Consensus 10 ~n~pGVL~Ri~~lf~rRgfNI~Sl~vg~te~~~~sriti~~~~~ 53 (76)
T PRK06737 10 HNDPSVLLRISGIFARRGYYISSLNLNERDTSGVSEMKLTAVCT 53 (76)
T ss_pred ecCCCHHHHHHHHHhccCcceEEEEecccCCCCeeEEEEEEECC
Confidence 4679999999999999999999999886553 356665544
No 187
>COG3603 Uncharacterized conserved protein [Function unknown]
Probab=78.68 E-value=10 Score=33.89 Aligned_cols=58 Identities=19% Similarity=0.258 Sum_probs=45.6
Q ss_pred eeEEeeeccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccCceeEEEeCCch
Q 008693 386 LTSIVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSK 444 (557)
Q Consensus 386 Vt~Is~~~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe~sIS~~I~~~~ 444 (557)
...|...++-..+++++.--.+..|+++.+.+.|+++||.|..+++....- +.+.+++
T Consensus 54 p~~V~~~~GW~~lk~~gpf~FgltGilasV~~pLsd~gigIFavStydtDh-iLVr~~d 111 (128)
T COG3603 54 PDVVQIEKGWSCLKFEGPFDFGLTGILASVSQPLSDNGIGIFAVSTYDTDH-ILVREED 111 (128)
T ss_pred CcceEecCCeEEEEEeccccCCcchhhhhhhhhHhhCCccEEEEEeccCce-EEEehhh
Confidence 345677888899999986666889999999999999999999998765544 3444443
No 188
>PF13291 ACT_4: ACT domain; PDB: 2KO1_B 3IBW_A.
Probab=78.68 E-value=8.9 Score=31.12 Aligned_cols=62 Identities=23% Similarity=0.433 Sum_probs=39.9
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccC------ceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhhee
Q 008693 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIV 468 (557)
Q Consensus 397 lItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe------~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i 468 (557)
.|.+.. .+++|.++++.+.+++.|++|..+.... ..+.|.+.-.+. +.|+.+++.|+++..|
T Consensus 8 ~l~i~~---~dr~GlL~dI~~~i~~~~~nI~~i~~~~~~~~~~~~~~l~v~V~d~-------~~L~~ii~~L~~i~~V 75 (80)
T PF13291_consen 8 RLRIEA---EDRPGLLADITSVISENGVNIRSINARTNKDDGTARITLTVEVKDL-------EHLNQIIRKLRQIPGV 75 (80)
T ss_dssp EEEEEE---E--TTHHHHHHHHHHCSSSEEEEEEEEE--ETTEEEEEEEEEESSH-------HHHHHHHHHHCTSTTE
T ss_pred EEEEEE---EcCCCHHHHHHHHHHHCCCCeEEEEeEEeccCCEEEEEEEEEECCH-------HHHHHHHHHHHCCCCe
Confidence 345553 4689999999999999999999885321 234444433331 3577888888775444
No 189
>PRK00194 hypothetical protein; Validated
Probab=77.86 E-value=4.4 Score=33.80 Aligned_cols=35 Identities=34% Similarity=0.381 Sum_probs=29.6
Q ss_pred eEEEEEccccccchHHHHHHHHHHhCCCcEEEEEecC
Q 008693 475 SIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA 511 (557)
Q Consensus 475 aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~Isqgs 511 (557)
.++++.| .+.||+++++.+.|+++|+||.-+++..
T Consensus 4 ~~ltv~g--~DrpGiva~vt~~la~~g~nI~~~~~~~ 38 (90)
T PRK00194 4 AIITVIG--KDKVGIIAGVSTVLAELNVNILDISQTI 38 (90)
T ss_pred EEEEEEc--CCCCCHHHHHHHHHHHcCCCEEehhhHh
Confidence 4677777 3579999999999999999999988754
No 190
>cd04883 ACT_AcuB C-terminal ACT domain of the Bacillus subtilis acetoin utilization protein, AcuB. This CD includes the C-terminal ACT domain of the Bacillus subtilis acetoin utilization protein, AcuB. AcuB is putatively involved in the anaerobic catabolism of acetoin, and related proteins. Studies report the induction of AcuB by nitrate respiration and also by fermentation. Since acetoin can be secreted and later serve as a source of carbon, it has been proposed that, during anaerobic growth when other carbon sources are exhausted, the induction of the AcuB protein results in acetoin catabolism. AcuB-like proteins have two N-terminal tandem CBS domains and a single C-terminal ACT domain. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=77.53 E-value=11 Score=29.64 Aligned_cols=54 Identities=15% Similarity=0.123 Sum_probs=40.0
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCC----ceEEEEEEecccHHHHHHHHHHHh
Q 008693 483 VQRSSLILEKAFRVLRRSGVNVQMISQGAS----KVNISLIVNDDEAEQCVRALHETF 536 (557)
Q Consensus 483 ~~~~~~v~~rif~~L~~~gInI~~IsqgsS----e~sIs~vV~~~d~~kAv~~LH~~f 536 (557)
+.+.||.+.++.+.|+++|+||.-+..... ...+.+-++..+.+++.+.|-+.-
T Consensus 8 ~~d~pG~l~~i~~~l~~~~inI~~i~~~~~~~~~~~~v~i~v~~~~~~~~~~~L~~~G 65 (72)
T cd04883 8 VPDRPGQLADIAAIFKDRGVNIVSVLVYPSKEEDNKILVFRVQTMNPRPIIEDLRRAG 65 (72)
T ss_pred ECCCCCHHHHHHHHHHHcCCCEEEEEEeccCCCCeEEEEEEEecCCHHHHHHHHHHCC
Confidence 567889999999999999999987654322 333666677677778888776653
No 191
>cd04870 ACT_PSP_1 CT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). The ACT_PSP_1 CD includes the first of the two ACT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). PSPs belong to the L-2-haloacid dehalogenase-like protein superfamily. PSP is involved in serine metabolism; serine is synthesized from phosphoglycerate through sequential reactions catalyzed by 3-phosphoglycerate dehydrogenase (SerA), 3-phosphoserine aminotransferase (SerC), and SerB. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=77.29 E-value=7.7 Score=31.29 Aligned_cols=44 Identities=18% Similarity=0.330 Sum_probs=32.1
Q ss_pred EEEEccccccchHHHHHHHHHHhCCCcEEEEEecC--CceEEEEEEec
Q 008693 477 ISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA--SKVNISLIVND 522 (557)
Q Consensus 477 IsIVG~~~~~~~v~~rif~~L~~~gInI~~Isqgs--Se~sIs~vV~~ 522 (557)
|+++| .+.||+.+++.+.|++.|+||.-++|.. ....+.+.++-
T Consensus 2 vtv~G--~DrpGiv~~vt~~la~~~~nI~dl~~~~~~~~f~~~~~v~~ 47 (75)
T cd04870 2 ITVTG--PDRPGLTSALTEVLAAHGVRILDVGQAVIHGRLSLGILVQI 47 (75)
T ss_pred EEEEc--CCCCCHHHHHHHHHHHCCCCEEecccEEEcCeeEEEEEEEc
Confidence 56777 4679999999999999999999775533 22344455543
No 192
>PRK03381 PII uridylyl-transferase; Provisional
Probab=76.42 E-value=89 Score=37.00 Aligned_cols=138 Identities=17% Similarity=0.253 Sum_probs=83.4
Q ss_pred ccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEE--EccC--ceeEEEeCCch-h-hhHHHHHHHHHHHHHH-----
Q 008693 393 RNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV--ATSE--VSLSLTLDPSK-L-WSRELIQQELDHVVEE----- 461 (557)
Q Consensus 393 ~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~I--stSe--~sIS~~I~~~~-~-~~~~~~~~~l~~~~~~----- 461 (557)
.+.+.|+|.+ .++||..+++...|...|.||.-. .+.. .--+|.|...+ . ...+.+++.+.+.+..
T Consensus 597 ~~~~~V~V~~---~DrpGLfa~i~~vL~~~glnI~dA~i~t~dg~~ld~F~V~~~~~~~~~~~~l~~~L~~~L~~~~~~~ 673 (774)
T PRK03381 597 PHMVEVTVVA---PDRRGLLSKAAGVLALHRLRVRSASVRSHDGVAVLEFVVSPRFGSPPDAALLRQDLRRALDGDLDVL 673 (774)
T ss_pred CCeEEEEEEe---cCCccHHHHHHHHHHHCCCeEEEeEEEecCCEEEEEEEEECCCCCcchHHHHHHHHHHHHcCCCchh
Confidence 3667778875 468999999999999999998754 2211 12345554321 1 1123344444443321
Q ss_pred --Hhhhh---------------eeecc----cceeEEEEEccccccchHHHHHHHHHHhCCCcEEE--EEecCCceEEEE
Q 008693 462 --LEKIA---------------IVNLL----QHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQM--ISQGASKVNISL 518 (557)
Q Consensus 462 --l~~~~---------------~i~~~----~~~aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~--IsqgsSe~sIs~ 518 (557)
+.+.. .+... .+.++|.|.+ .+.||+++++..+|...|+||.. |++.....-=+|
T Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~t~i~V~a--~DrpGLla~Ia~~L~~~~lnI~~AkI~T~g~~a~D~F 751 (774)
T PRK03381 674 ARLAAREAAAAAVPVRRPAAPPRVLWLDGASPDATVLEVRA--ADRPGLLARLARALERAGVDVRWARVATLGADVVDVF 751 (774)
T ss_pred hhhhcccccccccccccCCCCcEEEEEECCCCCeEEEEEEe--CCchhHHHHHHHHHHHCCCeEEEEEEeecCCeEEEEE
Confidence 00000 11111 2357777777 46899999999999999999986 665544455567
Q ss_pred EEecccH----HHHHHHHHHHh
Q 008693 519 IVNDDEA----EQCVRALHETF 536 (557)
Q Consensus 519 vV~~~d~----~kAv~~LH~~f 536 (557)
.|...+. +. .+.|.+++
T Consensus 752 ~V~d~~g~~~~~~-~~~l~~~L 772 (774)
T PRK03381 752 YVTGAAGGPLADA-RAAVEQAV 772 (774)
T ss_pred EEECCCCCcCchH-HHHHHHHh
Confidence 7765542 23 55665554
No 193
>TIGR01693 UTase_glnD [Protein-PII] uridylyltransferase. This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family.
Probab=75.25 E-value=81 Score=37.70 Aligned_cols=125 Identities=22% Similarity=0.225 Sum_probs=74.8
Q ss_pred ccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEE--EccCcee---EEEeCCch---hh---hHHHHHHHHHHHHHH
Q 008693 393 RNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV--ATSEVSL---SLTLDPSK---LW---SRELIQQELDHVVEE 461 (557)
Q Consensus 393 ~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~I--stSe~sI---S~~I~~~~---~~---~~~~~~~~l~~~~~~ 461 (557)
.+.+.|.|.. .++||.++++...|+..|++|... .++.... +|.|...+ .. ..+.+++.+...+..
T Consensus 666 ~~~t~i~V~~---~DrpgLla~i~~~L~~~~l~I~~A~I~tt~~g~~lD~F~V~~~~g~~~~~~~~~~~i~~~L~~~L~~ 742 (850)
T TIGR01693 666 SGGTEVFIYA---PDQPGLFAKVAGALAMLSLSVHDAQVNTTKDGVALDTFVVQDLFGSPPAAERVFQELLQGLVDVLAG 742 (850)
T ss_pred CCeEEEEEEe---CCCCcHHHHHHHHHHHCCCeEEEEEEEEecCCEEEEEEEEECCCCCCCCcHHHHHHHHHHHHHHHcC
Confidence 4667778775 468999999999999999998764 3232221 45553321 11 122333444443322
Q ss_pred Hhh--------------h------heeecc----cceeEEEEEccccccchHHHHHHHHHHhCCCcEEE--EEecCCceE
Q 008693 462 LEK--------------I------AIVNLL----QHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQM--ISQGASKVN 515 (557)
Q Consensus 462 l~~--------------~------~~i~~~----~~~aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~--IsqgsSe~s 515 (557)
... . ..|.+. ++.++|.|+| .+.||++.++.++|.+.|++|.. |++-....-
T Consensus 743 ~~~~~~~~~~~~~~~~~~~~~~~~~~V~~d~~~s~~~t~~~v~~--~DrpGll~~i~~~l~~~~~~i~~a~i~t~~~~~~ 820 (850)
T TIGR01693 743 LAKDPDTISARRARRRRLQHFAVPPRVTILNTASRKATIMEVRA--LDRPGLLARVGRTLEELGLSIQSAKITTFGEKAE 820 (850)
T ss_pred CCccccccccccCCcccccCCCCCCeEEEccCCCCCeEEEEEEE--CCccHHHHHHHHHHHHCCCeEEEEEEEecCccce
Confidence 100 0 123332 2457777777 46799999999999999999986 444332233
Q ss_pred EEEEEec
Q 008693 516 ISLIVND 522 (557)
Q Consensus 516 Is~vV~~ 522 (557)
=.|+|..
T Consensus 821 d~F~v~~ 827 (850)
T TIGR01693 821 DVFYVTD 827 (850)
T ss_pred eEEEEEC
Confidence 3455543
No 194
>PRK08178 acetolactate synthase 1 regulatory subunit; Reviewed
Probab=74.26 E-value=8.8 Score=33.11 Aligned_cols=51 Identities=24% Similarity=0.293 Sum_probs=36.6
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCCce----EEEEEEecc-cHHHHHHHHHH
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGASKV----NISLIVNDD-EAEQCVRALHE 534 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~IsqgsSe~----sIs~vV~~~-d~~kAv~~LH~ 534 (557)
.+.||++.|+...+++.|+||..++.|.++. .+++++.++ ..++.++.|++
T Consensus 16 ~N~pGVL~RIaglFsRRgyNIeSLtvg~te~~~iSRmtivv~~~~~i~Qi~kQL~K 71 (96)
T PRK08178 16 RNHPGVMSHVCGLFARRAFNVEGILCLPIQDGDKSRIWLLVNDDQRLEQMISQIEK 71 (96)
T ss_pred ECCcCHHHHHHHHHhcCCcCeeeEEEeecCCCCceEEEEEEcCchHHHHHHHHHhC
Confidence 4679999999999999999999998777543 477777632 22344444443
No 195
>cd04909 ACT_PDH-BS C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH). The C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH) enzyme that catalyzes the formation of 4-hydroxyphenylpyruvate from prephenate, found in Bacillus subtilis (BS) and other Firmicutes, Deinococci, and Bacteroidetes. PDH is the first enzyme in the aromatic amino acid pathway specific for the biosynthesis of tyrosine. This enzyme is feedback-inhibited by tyrosine in B. subtilis and other microorganisms. Both phenylalanine and tryptophan have been shown to be inhibitors of this activity in B. subtilis. Bifunctional chorismate mutase-PDH (TyrA) enzymes such as those seen in Escherichia coli do not contain an ACT domain. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=73.99 E-value=9.7 Score=29.77 Aligned_cols=52 Identities=13% Similarity=0.229 Sum_probs=35.8
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCC----ceEEEEEEec-ccHHHHHHHHHH
Q 008693 483 VQRSSLILEKAFRVLRRSGVNVQMISQGAS----KVNISLIVND-DEAEQCVRALHE 534 (557)
Q Consensus 483 ~~~~~~v~~rif~~L~~~gInI~~IsqgsS----e~sIs~vV~~-~d~~kAv~~LH~ 534 (557)
+.+.||.++++.+.|+++|+||..+.+... ...+.+.++. ++.+++.+.|.+
T Consensus 8 ~~d~~G~L~~l~~~l~~~~i~i~~~~~~~~~~~~~~~~~i~v~~~~~~~~~~~~L~~ 64 (69)
T cd04909 8 VPDEPGVIAEVTQILGDAGISIKNIEILEIREGIGGILRISFKTQEDRERAKEILKE 64 (69)
T ss_pred cCCCCCHHHHHHHHHHHcCCCceeeEeEEeecCCcEEEEEEECCHHHHHHHHHHHHH
Confidence 567899999999999999999986544322 3345566652 356666666654
No 196
>TIGR00119 acolac_sm acetolactate synthase, small subunit. acetohydroxyacid synthase is a synonym.
Probab=73.78 E-value=10 Score=35.77 Aligned_cols=53 Identities=15% Similarity=0.421 Sum_probs=39.8
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCCc----eEEEEEEecccHHHHHHHHHHHhc
Q 008693 483 VQRSSLILEKAFRVLRRSGVNVQMISQGASK----VNISLIVNDDEAEQCVRALHETFF 537 (557)
Q Consensus 483 ~~~~~~v~~rif~~L~~~gInI~~IsqgsSe----~sIs~vV~~~d~~kAv~~LH~~f~ 537 (557)
..+.||+++++...+++.|+||..++.+.++ ..+++.++.+ +++++.|.+.+.
T Consensus 8 ven~pGvL~rI~~lf~rrg~NI~Sl~v~~t~~~~~sriti~V~~d--~~~i~qi~kQl~ 64 (157)
T TIGR00119 8 VENEPGVLSRVAGLFTRRGFNIESLTVGPTEDPDLSRMTIVVVGD--DKVLEQITKQLN 64 (157)
T ss_pred EcCCCcHHHHHHHHHHhCCceEEEEEEeecCCCCEEEEEEEEECC--HHHHHHHHHHHh
Confidence 3568999999999999999999987776554 2377778763 556666666654
No 197
>PRK00194 hypothetical protein; Validated
Probab=73.60 E-value=15 Score=30.58 Aligned_cols=33 Identities=12% Similarity=0.409 Sum_probs=27.8
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEc
Q 008693 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT 431 (557)
Q Consensus 396 alItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Ist 431 (557)
..+++.+. ++||.++++.+.|+++|+||.-+.+
T Consensus 4 ~~ltv~g~---DrpGiva~vt~~la~~g~nI~~~~~ 36 (90)
T PRK00194 4 AIITVIGK---DKVGIIAGVSTVLAELNVNILDISQ 36 (90)
T ss_pred EEEEEEcC---CCCCHHHHHHHHHHHcCCCEEehhh
Confidence 45677764 5899999999999999999998864
No 198
>cd04893 ACT_GcvR_1 ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. This CD includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. The glycine cleavage enzyme system in Escherichia coli provides one-carbon units for cellular methylation reactions. This enzyme system, encoded by the gcvTHP operon and lpd gene, catalyzes the cleavage of glycine into CO2 + NH3 and transfers a one-carbon unit to tetrahydrofolate, producing 5,10-methylenetetrahydrofolate. The gcvTHP operon is activated by the GcvA protein in response to glycine and repressed by a GcvA/GcvR interaction in the absence of glycine. It has been proposed that the co-activator glycine acts through a mechanism of de-repression by binding to GcvR and preventing GcvR from interacting with GcvA to block GcvA's activator function. Evidence also suggests that GcvR int
Probab=72.61 E-value=12 Score=30.34 Aligned_cols=34 Identities=26% Similarity=0.338 Sum_probs=28.4
Q ss_pred EEEEEccccccchHHHHHHHHHHhCCCcEEEEEecC
Q 008693 476 IISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA 511 (557)
Q Consensus 476 iIsIVG~~~~~~~v~~rif~~L~~~gInI~~Isqgs 511 (557)
+|++.| .+.||+.+++.+.|+++|.||.-++|-.
T Consensus 3 iltv~g--~Dr~GiVa~vs~~la~~g~nI~d~~q~~ 36 (77)
T cd04893 3 VISALG--TDRPGILNELTRAVSESGCNILDSRMAI 36 (77)
T ss_pred EEEEEe--CCCChHHHHHHHHHHHcCCCEEEceeeE
Confidence 567777 4678999999999999999999877643
No 199
>PRK11895 ilvH acetolactate synthase 3 regulatory subunit; Reviewed
Probab=72.50 E-value=9.4 Score=36.11 Aligned_cols=55 Identities=18% Similarity=0.384 Sum_probs=41.4
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCCc----eEEEEEEecc--cHHHHHHHHHHHhc
Q 008693 483 VQRSSLILEKAFRVLRRSGVNVQMISQGASK----VNISLIVNDD--EAEQCVRALHETFF 537 (557)
Q Consensus 483 ~~~~~~v~~rif~~L~~~gInI~~IsqgsSe----~sIs~vV~~~--d~~kAv~~LH~~f~ 537 (557)
..+.||+++++...+++.|+||..++.+.++ ..+++.++.+ ..++..+.|++-..
T Consensus 9 veN~pGvL~rI~~lf~rrg~NI~Sl~v~~te~~~~sriti~V~~~~~~i~qi~kQl~KLid 69 (161)
T PRK11895 9 VENEPGVLSRVAGLFSRRGYNIESLTVGPTEDPGLSRMTIVTSGDEQVIEQITKQLNKLID 69 (161)
T ss_pred EcCCCcHHHHHHHHHHhCCCcEEEEEeeecCCCCEEEEEEEEECCHHHHHHHHHHHhcccc
Confidence 4578999999999999999999987777654 2377888753 35566666666543
No 200
>PRK11152 ilvM acetolactate synthase 2 regulatory subunit; Provisional
Probab=72.47 E-value=11 Score=31.03 Aligned_cols=51 Identities=25% Similarity=0.414 Sum_probs=37.8
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCCc----eEEEEEEecccHHHHHHHHHHHh
Q 008693 483 VQRSSLILEKAFRVLRRSGVNVQMISQGASK----VNISLIVNDDEAEQCVRALHETF 536 (557)
Q Consensus 483 ~~~~~~v~~rif~~L~~~gInI~~IsqgsSe----~sIs~vV~~~d~~kAv~~LH~~f 536 (557)
..+.||++.|+...+++.|.||..++-|..+ ..|++++.. ++.+..|-+.+
T Consensus 10 v~n~pGVL~Ri~~lf~rRGfnI~sl~v~~t~~~~~sriti~v~~---~~~i~ql~kQL 64 (76)
T PRK11152 10 ARFRPEVLERVLRVVRHRGFQVCSMNMTQNTDAQNINIELTVAS---ERPIDLLSSQL 64 (76)
T ss_pred EECCccHHHHHHHHHhcCCeeeeeEEeeecCCCCEEEEEEEECC---CchHHHHHHHH
Confidence 3578999999999999999999998887732 457788852 44444444444
No 201
>cd04869 ACT_GcvR_2 ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. This CD includes the second of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. The glycine cleavage enzyme system in Escherichia coli provides one-carbon units for cellular methylation reactions. This enzyme system, encoded by the gcvTHP operon and lpd gene, catalyzes the cleavage of glycine into CO2 + NH3 and transfers a one-carbon unit to tetrahydrofolate, producing 5,10-methylenetetrahydrofolate. The gcvTHP operon is activated by the GcvA protein in response to glycine and repressed by a GcvA/GcvR interaction in the absence of glycine. It has been proposed that the co-activator glycine acts through a mechanism of de-repression by binding to GcvR and preventing GcvR from interacting with GcvA to block GcvA's activator function. Evidence also suggests that GcvR in
Probab=72.06 E-value=22 Score=28.62 Aligned_cols=30 Identities=13% Similarity=0.309 Sum_probs=25.0
Q ss_pred EEEEecCccchhhHHHHHHHHHHhCCceEEEEE
Q 008693 398 LDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVA 430 (557)
Q Consensus 398 ItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Is 430 (557)
+++.+ ..+||.++++.+.|+++|++|.-+.
T Consensus 2 l~v~g---~D~~Giv~~it~~l~~~~~nI~~~~ 31 (81)
T cd04869 2 VEVVG---NDRPGIVHEVTQFLAQRNINIEDLS 31 (81)
T ss_pred EEEEe---CCCCCHHHHHHHHHHHcCCCeEEeE
Confidence 45554 3589999999999999999998875
No 202
>cd04872 ACT_1ZPV ACT domain proteins similar to the yet uncharacterized Streptococcus pneumoniae ACT domain protein. This CD, ACT_1ZPV, includes those single ACT domain proteins similar to the yet uncharacterized Streptococcus pneumoniae ACT domain protein (pdb structure 1ZPV). Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=71.48 E-value=19 Score=29.93 Aligned_cols=32 Identities=16% Similarity=0.377 Sum_probs=27.0
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCceEEEEEc
Q 008693 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT 431 (557)
Q Consensus 397 lItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Ist 431 (557)
++++.+ .++||.++++.+.|+++|+||.-+.+
T Consensus 3 vl~i~g---~D~pGiva~vt~~la~~g~nI~~~~~ 34 (88)
T cd04872 3 VITVVG---KDRVGIVAGVSTKLAELNVNILDISQ 34 (88)
T ss_pred EEEEEc---CCCCCHHHHHHHHHHHcCCCEEechh
Confidence 466665 36899999999999999999998864
No 203
>PRK05007 PII uridylyl-transferase; Provisional
Probab=71.24 E-value=1.5e+02 Score=35.64 Aligned_cols=140 Identities=19% Similarity=0.240 Sum_probs=81.8
Q ss_pred ccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEE--EccCcee---EEEeCCch---hh--hHHHHHHHHHHHHHHH
Q 008693 393 RNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV--ATSEVSL---SLTLDPSK---LW--SRELIQQELDHVVEEL 462 (557)
Q Consensus 393 ~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~I--stSe~sI---S~~I~~~~---~~--~~~~~~~~l~~~~~~l 462 (557)
.+.+.|.|.. .++||+++++...|+..|++|... .++.... +|.|.+.+ .. ..+.+++.|.+.+..-
T Consensus 699 ~~~t~V~V~a---~DrpGLfa~Ia~~La~~~L~I~~A~I~T~~dg~alD~F~V~d~~g~~~~~~~~~~I~~~L~~aL~~~ 775 (884)
T PRK05007 699 RGGTEIFIWS---PDRPYLFAAVCAELDRRNLSVHDAQIFTSRDGMAMDTFIVLEPDGSPLSQDRHQVIRKALEQALTQS 775 (884)
T ss_pred CCeEEEEEEe---cCCcCHHHHHHHHHHHCCCEEEEEEEEEcCCCeEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHcCC
Confidence 3567778775 468999999999999999998764 3433322 36653322 11 1122333343333111
Q ss_pred h-h----------------hheeeccc----ceeEEEEEccccccchHHHHHHHHHHhCCCcEEE--EEecCCceEEEEE
Q 008693 463 E-K----------------IAIVNLLQ----HRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQM--ISQGASKVNISLI 519 (557)
Q Consensus 463 ~-~----------------~~~i~~~~----~~aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~--IsqgsSe~sIs~v 519 (557)
. . -..|.+.+ +.++|.|.. .+.||++.++.++|.+.|++|.. |++-....-=+|+
T Consensus 776 ~~~~~~~~~~~~~~~~~~~~~~V~~d~~~s~~~TvlEV~a--~DRpGLL~~I~~~l~~~~l~I~~AkI~T~gera~DvFy 853 (884)
T PRK05007 776 SPQPPKPRRLPAKLRHFNVPTEVSFLPTHTDRRSYMELIA--LDQPGLLARVGKIFADLGISLHGARITTIGERVEDLFI 853 (884)
T ss_pred CCCcccccccccccCCCCCCCEEEEccCCCCCeEEEEEEe--CCchHHHHHHHHHHHHCCcEEEEEEEeccCceEEEEEE
Confidence 0 0 01233332 345666655 56799999999999999999986 6665444444566
Q ss_pred EecccH----HHHHHHHHHHhc
Q 008693 520 VNDDEA----EQCVRALHETFF 537 (557)
Q Consensus 520 V~~~d~----~kAv~~LH~~f~ 537 (557)
|...+. ++..+.|.+.+.
T Consensus 854 V~~~~g~~l~~~~~~~l~~~L~ 875 (884)
T PRK05007 854 LATADRRALNEELQQELRQRLT 875 (884)
T ss_pred EEcCCCCcCCHHHHHHHHHHHH
Confidence 644331 233444444443
No 204
>PRK13010 purU formyltetrahydrofolate deformylase; Reviewed
Probab=69.92 E-value=54 Score=33.96 Aligned_cols=33 Identities=15% Similarity=0.190 Sum_probs=28.7
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEc
Q 008693 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT 431 (557)
Q Consensus 396 alItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Ist 431 (557)
.+|++.+ .+++|+.+++.+.|+++|+||.-+++
T Consensus 10 ~iitv~G---~Dr~GIVA~Vs~~Lae~g~NI~disq 42 (289)
T PRK13010 10 YVLTLAC---PSAPGIVAAVSGFLAEKGCYIVELTQ 42 (289)
T ss_pred EEEEEEC---CCCCCcHHHHHHHHHHCCCCEEeccc
Confidence 4578876 46899999999999999999998876
No 205
>cd04887 ACT_MalLac-Enz ACT_MalLac-Enz CD includes the N-terminal ACT domain of putative NAD-dependent malic enzyme 1, Bacillus subtilis YqkI and related domains. The ACT_MalLac-Enz CD includes the N-terminal ACT domain of putative NAD-dependent malic enzyme 1, Bacillus subtilis YqkI, a malolactic enzyme (MalLac-Enz) which converts malate to lactate, and other related ACT domains. The yqkJ product is predicted to convert malate directly to lactate, as opposed to related malic enzymes that convert malate to pyruvate. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=69.82 E-value=20 Score=28.26 Aligned_cols=56 Identities=14% Similarity=0.258 Sum_probs=36.8
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEEcc-----CceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhhee
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVATS-----EVSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIV 468 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~IstS-----e~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i 468 (557)
.+.||.++++.+.+++.|+++.-+... ...+.|.+.-.+. +.++.+++.|+.+..|
T Consensus 7 ~d~~g~L~~i~~~i~~~~~nI~~v~~~~~~~~~~~~~~~vev~~~-------~~l~~i~~~L~~i~gV 67 (74)
T cd04887 7 PNRPGMLGRVTTAIGEAGGDIGAIDLVEQGRDYTVRDITVDAPSE-------EHAETIVAAVRALPEV 67 (74)
T ss_pred CCCCchHHHHHHHHHHcCCcEEEEEEEEecCCEEEEEEEEEcCCH-------HHHHHHHHHHhcCCCe
Confidence 468999999999999999999876422 1224455543331 2356666767665444
No 206
>cd04875 ACT_F4HF-DF N-terminal ACT domain of formyltetrahydrofolate deformylase (F4HF-DF; formyltetrahydrofolate hydrolase). This CD includes the N-terminal ACT domain of formyltetrahydrofolate deformylase (F4HF-DF; formyltetrahydrofolate hydrolase) which catalyzes the hydrolysis of 10-formyltetrahydrofolate (formyl-FH4) to FH4 and formate. Formyl-FH4 hydrolase generates the formate that is used by purT-encoded 5'-phosphoribosylglycinamide transformylase for step three of de novo purine nucleotide synthesis. Formyl-FH4 hydrolase, a hexamer which is activated by methionine and inhibited by glycine, is proposed to regulate the balance FH4 and C1-FH4 in response to changing growth conditions. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=68.90 E-value=21 Score=28.49 Aligned_cols=31 Identities=16% Similarity=0.164 Sum_probs=26.1
Q ss_pred EEEEecCccchhhHHHHHHHHHHhCCceEEEEEc
Q 008693 398 LDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT 431 (557)
Q Consensus 398 ItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Ist 431 (557)
|++.+ .++||.++++.+.|+++|++|.-+.+
T Consensus 2 i~v~g---~D~~Giv~~it~~l~~~g~nI~~~~~ 32 (74)
T cd04875 2 LTLSC---PDRPGIVAAVSGFLAEHGGNIVESDQ 32 (74)
T ss_pred EEEEc---CCCCCHHHHHHHHHHHcCCCEEeeee
Confidence 55665 46899999999999999999998854
No 207
>cd04908 ACT_Bt0572_1 N-terminal ACT domain of a novel protein composed almost entirely of two tandem ACT domains. Included in this CD is the N-terminal ACT domain of a novel protein composed almost entirely of two tandem ACT domains as seen in the uncharacterized structure (pdb 2F06) of the Bt0572 protein from Bacteroides thetaiotaomicron and related ACT domains. These tandem ACT domain proteins belong to the superfamily of ACT regulatory domains.
Probab=68.71 E-value=8 Score=30.24 Aligned_cols=26 Identities=23% Similarity=0.386 Sum_probs=23.0
Q ss_pred ccchhhHHHHHHHHHHhCCceEEEEE
Q 008693 405 MLGQYGFLAKVFSTFEDLGISVDVVA 430 (557)
Q Consensus 405 m~~~~g~la~If~~L~~~gI~Vd~Is 430 (557)
+.+.||.++++.+.|.++|+||+.+.
T Consensus 8 v~d~pG~La~v~~~l~~~~inI~~i~ 33 (66)
T cd04908 8 LENKPGRLAAVTEILSEAGINIRALS 33 (66)
T ss_pred EcCCCChHHHHHHHHHHCCCCEEEEE
Confidence 45789999999999999999998664
No 208
>cd04903 ACT_LSD C-terminal ACT domain of the L-serine dehydratase (LSD), iron-sulfur-dependent, beta subunit. The C-terminal ACT domain of the L-serine dehydratase (LSD), iron-sulfur-dependent, beta subunit, found in various bacterial anaerobes such as Clostridium, Bacillis, and Treponema species. These enzymes catalyze the deamination of L-serine, producing pyruvate and ammonia. Unlike the eukaryotic L-serine dehydratase, which requires the pyridoxal-5'-phosphate (PLP) cofactor, the prokaryotic L-serine dehydratase contains an [4Fe-4S] cluster instead of a PLP active site. The LSD alpha and beta subunits of the 'clostridial' enzyme are encoded by the sdhA and sdhB genes. The single subunit bacterial homologs of L-serine dehydratase (LSD1, LSD2, TdcG) present in Escherichia coli, and other enterobacterials, lack the ACT domain described here. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=67.59 E-value=17 Score=27.81 Aligned_cols=51 Identities=12% Similarity=0.228 Sum_probs=36.0
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecC----CceEEEEEEecccHHHHHHHHHH
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGA----SKVNISLIVNDDEAEQCVRALHE 534 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~Isqgs----Se~sIs~vV~~~d~~kAv~~LH~ 534 (557)
.+.+|+++++.+.|+++|+++..+.+.. ....+.+.++..+.+++++.|.+
T Consensus 7 ~d~~g~l~~i~~~l~~~~~~I~~~~~~~~~~~~~~~i~i~v~~~~~~~~i~~l~~ 61 (71)
T cd04903 7 KDKPGAIAKVTSVLADHEINIAFMRVSRKEKGDQALMVIEVDQPIDEEVIEEIKK 61 (71)
T ss_pred CCCCChHHHHHHHHHHcCcCeeeeEEEeccCCCeEEEEEEeCCCCCHHHHHHHHc
Confidence 4678999999999999999998775433 12235566666666666666653
No 209
>cd04877 ACT_TyrR N-terminal ACT domain of the TyrR protein. ACT_TyrR: N-terminal ACT domain of the TyrR protein. The TyrR protein of Escherichia coli controls the expression of a group of transcription units (TyrR regulon) whose gene products are involved in the biosynthesis or transport of the aromatic amino acids. Binding to specific DNA sequences known as TyrR boxes, the TyrR protein can either activate or repress transcription at different sigma70 promoters. Its regulatory activity occurs in response to intracellular levels of tyrosine, phenylalanine and tryptophan. The TyrR protein consists of an N-terminal region important for transcription activation with an ATP-independent aromatic amino acid binding site (contained within the ACT domain) and is involved in dimerization; a central region with an ATP binding site, an ATP-dependent aromatic amino acid binding site and is involved in hexamerization; and a helix turn helix DNA binding C-terminal region. In solution, in the absence
Probab=67.04 E-value=17 Score=29.03 Aligned_cols=55 Identities=13% Similarity=0.250 Sum_probs=37.3
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEEccC-ceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhhe
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVATSE-VSLSLTLDPSKLWSRELIQQELDHVVEELEKIAI 467 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~IstSe-~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~ 467 (557)
.+++|.++++...+++.|+++..+.... ..+.+.+.-.+. ..++.+++.|.++..
T Consensus 8 ~dr~Gll~dI~~~i~~~~~nI~~~~~~~~~~i~l~i~v~~~-------~~L~~li~~L~~i~g 63 (74)
T cd04877 8 EDRLGITQEVLDLLVEHNIDLRGIEIDPKGRIYLNFPTIEF-------EKLQTLMPEIRRIDG 63 (74)
T ss_pred EccchHHHHHHHHHHHCCCceEEEEEecCCeEEEEeEecCH-------HHHHHHHHHHhCCCC
Confidence 3589999999999999999999886433 224444443321 246777777776443
No 210
>cd04881 ACT_HSDH-Hom ACT_HSDH_Hom CD includes the C-terminal ACT domain of the NAD(P)H-dependent, homoserine dehydrogenase (HSDH) and related domains. The ACT_HSDH_Hom CD includes the C-terminal ACT domain of the NAD(P)H-dependent, homoserine dehydrogenase (HSDH) encoded by the hom gene of Bacillus subtilis and other related sequences. HSDH reduces aspartate semi-aldehyde to the amino acid homoserine, one that is required for the biosynthesis of Met, Thr, and Ile from Asp. Neither the enzyme nor the aspartate pathway is found in the animal kingdom. This mostly bacterial HSDH group has a C-terminal ACT domain and is believed to be involved in enzyme regulation. A C-terminal deletion in the Corynebacterium glutamicum HSDH abolished allosteric inhibition by L-threonine. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=66.82 E-value=46 Score=25.80 Aligned_cols=56 Identities=23% Similarity=0.405 Sum_probs=37.0
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEEccC------ceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhhee
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIV 468 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~IstSe------~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i 468 (557)
.+.+|.++++.+.|+++|+++.-+.+.. ..+.+.+...+ ...++.+++.|+++..+
T Consensus 8 ~d~~g~l~~i~~~l~~~~i~I~~~~~~~~~~~~~~~~~i~~~~~~-------~~~l~~~i~~L~~~~~V 69 (79)
T cd04881 8 KDKPGVLAKITGILAEHGISIESVIQKEADGGETAPVVIVTHETS-------EAALNAALAEIEALDAV 69 (79)
T ss_pred CCCCcHHHHHHHHHHHcCCCeEEEEEcccCCCCceeEEEEEccCC-------HHHHHHHHHHHHcCccc
Confidence 4678999999999999999998875321 23555554433 12456666667664433
No 211
>cd04872 ACT_1ZPV ACT domain proteins similar to the yet uncharacterized Streptococcus pneumoniae ACT domain protein. This CD, ACT_1ZPV, includes those single ACT domain proteins similar to the yet uncharacterized Streptococcus pneumoniae ACT domain protein (pdb structure 1ZPV). Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=66.56 E-value=22 Score=29.54 Aligned_cols=35 Identities=26% Similarity=0.303 Sum_probs=29.4
Q ss_pred eEEEEEccccccchHHHHHHHHHHhCCCcEEEEEecC
Q 008693 475 SIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA 511 (557)
Q Consensus 475 aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~Isqgs 511 (557)
.+|++.| .+.||+.+++.+.|++.|+||.-++|..
T Consensus 2 ~vl~i~g--~D~pGiva~vt~~la~~g~nI~~~~~~~ 36 (88)
T cd04872 2 AVITVVG--KDRVGIVAGVSTKLAELNVNILDISQTI 36 (88)
T ss_pred EEEEEEc--CCCCCHHHHHHHHHHHcCCCEEechhHh
Confidence 3567777 3579999999999999999999988765
No 212
>cd04893 ACT_GcvR_1 ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. This CD includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. The glycine cleavage enzyme system in Escherichia coli provides one-carbon units for cellular methylation reactions. This enzyme system, encoded by the gcvTHP operon and lpd gene, catalyzes the cleavage of glycine into CO2 + NH3 and transfers a one-carbon unit to tetrahydrofolate, producing 5,10-methylenetetrahydrofolate. The gcvTHP operon is activated by the GcvA protein in response to glycine and repressed by a GcvA/GcvR interaction in the absence of glycine. It has been proposed that the co-activator glycine acts through a mechanism of de-repression by binding to GcvR and preventing GcvR from interacting with GcvA to block GcvA's activator function. Evidence also suggests that GcvR int
Probab=65.99 E-value=31 Score=27.98 Aligned_cols=32 Identities=9% Similarity=0.182 Sum_probs=27.0
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCceEEEEEc
Q 008693 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT 431 (557)
Q Consensus 397 lItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Ist 431 (557)
++++.+ .++||+.+++.+.|+++|.||.-+.+
T Consensus 3 iltv~g---~Dr~GiVa~vs~~la~~g~nI~d~~q 34 (77)
T cd04893 3 VISALG---TDRPGILNELTRAVSESGCNILDSRM 34 (77)
T ss_pred EEEEEe---CCCChHHHHHHHHHHHcCCCEEEcee
Confidence 467776 46899999999999999999987754
No 213
>PRK05092 PII uridylyl-transferase; Provisional
Probab=65.89 E-value=1.9e+02 Score=35.03 Aligned_cols=124 Identities=13% Similarity=0.198 Sum_probs=73.4
Q ss_pred cEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEE--Ec--cCcee-EEEeCCchh------hhHHHHHHHHHHHHHH-
Q 008693 394 NVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV--AT--SEVSL-SLTLDPSKL------WSRELIQQELDHVVEE- 461 (557)
Q Consensus 394 nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~I--st--Se~sI-S~~I~~~~~------~~~~~~~~~l~~~~~~- 461 (557)
+.+.|+|.+. +++|.++++...|+..|.||.-. .+ ....+ +|.|...+- .....+++.|...+..
T Consensus 731 ~~t~v~I~~~---Dr~GLfa~i~~~L~~~glnI~~A~I~t~~dg~alD~F~V~~~~g~~~~~~~~~~~l~~~L~~~l~~~ 807 (931)
T PRK05092 731 GVTEVTVLAA---DHPGLFSRIAGACAAAGANIVDARIFTTTDGRALDTFWIQDAFGRDEDEPRRLARLAKAIEDALSGE 807 (931)
T ss_pred CeEEEEEEeC---CCCcHHHHHHHHHHHCCCcEEEEEEEEecCCeEEEEEEEECCCCCCCCCHHHHHHHHHHHHHHHcCC
Confidence 5677888764 68999999999999999998754 23 23333 366632111 1122333444443310
Q ss_pred H--hh-h-----h-----------eeec----ccceeEEEEEccccccchHHHHHHHHHHhCCCcEEE--EEecCCceEE
Q 008693 462 L--EK-I-----A-----------IVNL----LQHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQM--ISQGASKVNI 516 (557)
Q Consensus 462 l--~~-~-----~-----------~i~~----~~~~aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~--IsqgsSe~sI 516 (557)
. .. . . .|.+ ..+.+.|.|++ .+.||++.++..+|.+.|++|.. |++.....-=
T Consensus 808 ~~~~~~~~~r~~~~~~~~~~~~~~~V~~~~~~s~~~t~i~I~~--~DrpGLl~~I~~~l~~~gl~I~~A~I~T~~~~~~D 885 (931)
T PRK05092 808 VRLPEALAKRTKPKKRARAFHVPPRVTIDNEASNRFTVIEVNG--RDRPGLLYDLTRALSDLNLNIASAHIATYGERAVD 885 (931)
T ss_pred CCCccccccccCccccccCCCCCCEEEEeeCCCCCeEEEEEEE--CCcCcHHHHHHHHHHHCCceEEEEEEEEcCCEEEE
Confidence 0 00 0 0 0111 12446666666 46899999999999999999985 5554333334
Q ss_pred EEEEec
Q 008693 517 SLIVND 522 (557)
Q Consensus 517 s~vV~~ 522 (557)
.|.|..
T Consensus 886 ~F~v~d 891 (931)
T PRK05092 886 VFYVTD 891 (931)
T ss_pred EEEEeC
Confidence 566644
No 214
>cd04875 ACT_F4HF-DF N-terminal ACT domain of formyltetrahydrofolate deformylase (F4HF-DF; formyltetrahydrofolate hydrolase). This CD includes the N-terminal ACT domain of formyltetrahydrofolate deformylase (F4HF-DF; formyltetrahydrofolate hydrolase) which catalyzes the hydrolysis of 10-formyltetrahydrofolate (formyl-FH4) to FH4 and formate. Formyl-FH4 hydrolase generates the formate that is used by purT-encoded 5'-phosphoribosylglycinamide transformylase for step three of de novo purine nucleotide synthesis. Formyl-FH4 hydrolase, a hexamer which is activated by methionine and inhibited by glycine, is proposed to regulate the balance FH4 and C1-FH4 in response to changing growth conditions. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=65.66 E-value=18 Score=28.86 Aligned_cols=32 Identities=19% Similarity=0.087 Sum_probs=27.3
Q ss_pred EEEEccccccchHHHHHHHHHHhCCCcEEEEEec
Q 008693 477 ISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQG 510 (557)
Q Consensus 477 IsIVG~~~~~~~v~~rif~~L~~~gInI~~Isqg 510 (557)
|++.| .+.||+.+++.+.|++.|+||.-+++-
T Consensus 2 i~v~g--~D~~Giv~~it~~l~~~g~nI~~~~~~ 33 (74)
T cd04875 2 LTLSC--PDRPGIVAAVSGFLAEHGGNIVESDQF 33 (74)
T ss_pred EEEEc--CCCCCHHHHHHHHHHHcCCCEEeeeee
Confidence 56666 467899999999999999999988775
No 215
>cd04869 ACT_GcvR_2 ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. This CD includes the second of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. The glycine cleavage enzyme system in Escherichia coli provides one-carbon units for cellular methylation reactions. This enzyme system, encoded by the gcvTHP operon and lpd gene, catalyzes the cleavage of glycine into CO2 + NH3 and transfers a one-carbon unit to tetrahydrofolate, producing 5,10-methylenetetrahydrofolate. The gcvTHP operon is activated by the GcvA protein in response to glycine and repressed by a GcvA/GcvR interaction in the absence of glycine. It has been proposed that the co-activator glycine acts through a mechanism of de-repression by binding to GcvR and preventing GcvR from interacting with GcvA to block GcvA's activator function. Evidence also suggests that GcvR in
Probab=65.43 E-value=33 Score=27.58 Aligned_cols=33 Identities=15% Similarity=0.370 Sum_probs=26.9
Q ss_pred EEEEccccccchHHHHHHHHHHhCCCcEEEEEecC
Q 008693 477 ISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA 511 (557)
Q Consensus 477 IsIVG~~~~~~~v~~rif~~L~~~gInI~~Isqgs 511 (557)
|++.| .+.||+.+++.+.|++.|+||.-+++-.
T Consensus 2 l~v~g--~D~~Giv~~it~~l~~~~~nI~~~~~~~ 34 (81)
T cd04869 2 VEVVG--NDRPGIVHEVTQFLAQRNINIEDLSTET 34 (81)
T ss_pred EEEEe--CCCCCHHHHHHHHHHHcCCCeEEeEeee
Confidence 45555 3578999999999999999999887743
No 216
>cd04878 ACT_AHAS N-terminal ACT domain of the Escherichia coli IlvH-like regulatory subunit of acetohydroxyacid synthase (AHAS). ACT_AHAS: N-terminal ACT domain of the Escherichia coli IlvH-like regulatory subunit of acetohydroxyacid synthase (AHAS). AHAS catalyses the first common step in the biosynthesis of the three branched-chain amino acids. The first step involves the condensation of either pyruvate or 2-ketobutyrate with the two-carbon hydroxyethyl fragment derived from another pyruvate molecule, covalently bound to the coenzyme thiamine diphosphate. Bacterial AHASs generally consist of regulatory and catalytic subunits. The effector (valine) binding sites are proposed to be located in two symmetrically related positions in the interface between a pair of N-terminal ACT domains with the C-terminal domain of IlvH contacting the catalytic dimer. Plants Arabidopsis and Oryza have tandem IlvH subunits; both the first and second ACT domain sequences are present in this CD. Members of
Probab=64.51 E-value=38 Score=25.77 Aligned_cols=53 Identities=13% Similarity=0.370 Sum_probs=35.4
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEEccC------ceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhh
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLDPSKLWSRELIQQELDHVVEELEKIA 466 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~IstSe------~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~ 466 (557)
.+.+|.++++...|+++++++..+.+.. ..+.|.++... . .++.++.+|.++.
T Consensus 8 ~d~~g~l~~i~~~l~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~-------~~~~l~~~l~~~~ 66 (72)
T cd04878 8 ENEPGVLNRISGLFARRGFNIESLTVGPTEDPGISRITIVVEGDD-D-------VIEQIVKQLNKLV 66 (72)
T ss_pred cCCCcHHHHHHHHHHhCCCCEEEEEeeecCCCCeEEEEEEEECCH-H-------HHHHHHHHHhCCc
Confidence 4678999999999999999999875432 23556655422 1 2455666666543
No 217
>COG4747 ACT domain-containing protein [General function prediction only]
Probab=64.27 E-value=18 Score=32.39 Aligned_cols=65 Identities=15% Similarity=0.242 Sum_probs=44.8
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecC-Cc-eEEEEEEecccHHHHHHHHHHHhcc---CccccccccccC
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGA-SK-VNISLIVNDDEAEQCVRALHETFFE---SDLANLDCVCGS 550 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~Isqgs-Se-~sIs~vV~~~d~~kAv~~LH~~f~~---~~~~~~~~~~~~ 550 (557)
.+.||-++.+.+.|.++||||+..+-.- ++ --|-.+|++. +.|-++||++=|. ++....+.++.+
T Consensus 11 ENk~GRL~~~~~~L~eagINiRA~tiAdt~dFGIiRmvV~~~--d~A~~~Lee~gF~Vr~~dVlaVEmeD~P 80 (142)
T COG4747 11 ENKPGRLASVANKLKEAGINIRAFTIADTGDFGIIRMVVDRP--DEAHSVLEEAGFTVRETDVLAVEMEDVP 80 (142)
T ss_pred cCCcchHHHHHHHHHHcCCceEEEEeccccCcceEEEEcCCh--HHHHHHHHHCCcEEEeeeEEEEEecCCC
Confidence 4678899999999999999999855432 22 2366777766 5688899988653 244444444443
No 218
>PRK01759 glnD PII uridylyl-transferase; Provisional
Probab=64.04 E-value=1.1e+02 Score=36.55 Aligned_cols=126 Identities=21% Similarity=0.205 Sum_probs=75.2
Q ss_pred ccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEE--Ecc--Ccee-EEEeCCch---hh--hHHHHHHHHHHHHHHH
Q 008693 393 RNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV--ATS--EVSL-SLTLDPSK---LW--SRELIQQELDHVVEEL 462 (557)
Q Consensus 393 ~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~I--stS--e~sI-S~~I~~~~---~~--~~~~~~~~l~~~~~~l 462 (557)
.+.+.|.|.. .++||.++++...|+..|++|..- .++ +.-+ +|.|.+.+ .. ..+.+++.|...+..-
T Consensus 675 ~~~t~V~V~~---~DrpGLfa~Ia~~L~~~~L~I~~A~I~T~~~g~alD~F~V~d~~g~~~~~~~~~~l~~~L~~aL~~~ 751 (854)
T PRK01759 675 RGGTEIFIYC---QDQANLFLKVVSTIGAKKLSIHDAQIITSQDGYVLDSFIVTELNGKLLEFDRRRQLEQALTKALNTN 751 (854)
T ss_pred CCeEEEEEEe---cCCccHHHHHHHHHHHCCCeEEEEEEEEccCCEEEEEEEEeCCCCCCCCHHHHHHHHHHHHHHHcCC
Confidence 3566777775 468999999999999999999763 332 2222 45553221 11 1122333333333210
Q ss_pred h---h-------------hheeeccc----ceeEEEEEccccccchHHHHHHHHHHhCCCcEEE--EEecCCceEEEEEE
Q 008693 463 E---K-------------IAIVNLLQ----HRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQM--ISQGASKVNISLIV 520 (557)
Q Consensus 463 ~---~-------------~~~i~~~~----~~aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~--IsqgsSe~sIs~vV 520 (557)
. . -..|.+.+ +.++|.|.. .+.||++.++.++|.+.|++|.. |++-....-=.|+|
T Consensus 752 ~~~~~~~~~~~~~~~~~~~~~V~~dn~~s~~~T~iev~a--~DrpGLL~~I~~~l~~~~l~i~~AkI~T~gerv~D~Fyv 829 (854)
T PRK01759 752 KLKKLNLEENHKLQHFHVKTEVRFLNEEKQEQTEMELFA--LDRAGLLAQVSQVFSELNLNLLNAKITTIGEKAEDFFIL 829 (854)
T ss_pred CCcchhccccccccCCCCCCEEEEccCCCCCeEEEEEEe--CCchHHHHHHHHHHHHCCCEEEEEEEcccCceEEEEEEE
Confidence 0 0 01233332 345555554 56799999999999999999996 66654444445666
Q ss_pred ecc
Q 008693 521 NDD 523 (557)
Q Consensus 521 ~~~ 523 (557)
...
T Consensus 830 ~~~ 832 (854)
T PRK01759 830 TNQ 832 (854)
T ss_pred ECC
Confidence 543
No 219
>cd04895 ACT_ACR_1 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the N-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=63.16 E-value=70 Score=26.00 Aligned_cols=54 Identities=19% Similarity=0.163 Sum_probs=39.9
Q ss_pred cccchHHHHHHHHHHhCCCcEEE--EEecCCceEEEEEEecccH-----HHHHHHHHHHhc
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQM--ISQGASKVNISLIVNDDEA-----EQCVRALHETFF 537 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~--IsqgsSe~sIs~vV~~~d~-----~kAv~~LH~~f~ 537 (557)
.+.||++.++.++|.+.|++|.. |++-....-=.|+|...+. ++..+.|.+++.
T Consensus 9 ~DRpGLL~~i~~~l~~~gl~I~~AkIsT~Gerv~DvFyV~d~~g~kl~d~~~~~~l~~~L~ 69 (72)
T cd04895 9 ARKPGILLEAVQVLTDLDLCITKAYISSDGGWFMDVFHVTDQLGNKLTDDSLIAYIEKSLG 69 (72)
T ss_pred CCcCCHHHHHHHHHHHCCcEEEEEEEeecCCeEEEEEEEECCCCCCCCCHHHHHHHHHHhc
Confidence 46799999999999999999986 6665555555677765542 355667766654
No 220
>PRK03059 PII uridylyl-transferase; Provisional
Probab=63.08 E-value=2.6e+02 Score=33.60 Aligned_cols=124 Identities=19% Similarity=0.230 Sum_probs=72.5
Q ss_pred ccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEE--EccCcee---EEEeCCc-hh-h---hHHHHHHHHHHHHHH-
Q 008693 393 RNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV--ATSEVSL---SLTLDPS-KL-W---SRELIQQELDHVVEE- 461 (557)
Q Consensus 393 ~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~I--stSe~sI---S~~I~~~-~~-~---~~~~~~~~l~~~~~~- 461 (557)
.+.+-|.|.. .++||..+++...|+.+|+||.-. .++.... +|.|.+. .. . ..+.+++.+.+.+..
T Consensus 676 ~~~~~v~i~~---~d~~gLFa~i~g~l~~~~l~I~~A~i~t~~~g~~ld~f~V~~~~~~~~~~~~~~~i~~~l~~~l~~~ 752 (856)
T PRK03059 676 GEGLQVMVYT---PDQPDLFARICGYFDRAGFSILDARVHTTRHGYALDTFQVLDPEEDVHYRDIINLVEHELAERLAEQ 752 (856)
T ss_pred CCeEEEEEEe---cCCCcHHHHHHHHHHHCCCceeeeEEEEcCCCeEEEEEEEeCCCCCCChHHHHHHHHHHHHHHHcCC
Confidence 3566677774 468999999999999999998643 2332222 4555221 11 1 122233333333211
Q ss_pred --Hh----h--------h---heeecc----cceeEEEEEccccccchHHHHHHHHHHhCCCcEEE--EEecCCceEEEE
Q 008693 462 --LE----K--------I---AIVNLL----QHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQM--ISQGASKVNISL 518 (557)
Q Consensus 462 --l~----~--------~---~~i~~~----~~~aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~--IsqgsSe~sIs~ 518 (557)
+. + . ..+.+. .+.+.|.|++. +.||+++++..+|+..|++|.. |++-....-=+|
T Consensus 753 ~~~~~~~~~~~~~~~~~~~~~~~V~~~~~~~~~~T~i~V~a~--DrpGLLa~Ia~~L~~~~l~I~~AkI~T~~~~v~DvF 830 (856)
T PRK03059 753 APLPEPSKGRLSRQVKHFPITPRVDLRPDERGQYYILSVSAN--DRPGLLYAIARVLAEHRVSVHTAKINTLGERVEDTF 830 (856)
T ss_pred CCcchhhcccccccccCCCCCceEEEEEcCCCCEEEEEEEeC--CcchHHHHHHHHHHHCCCeEEEEEEeecCCEEEEEE
Confidence 00 0 0 012221 24566666663 6899999999999999999996 665433333456
Q ss_pred EEe
Q 008693 519 IVN 521 (557)
Q Consensus 519 vV~ 521 (557)
.|.
T Consensus 831 ~V~ 833 (856)
T PRK03059 831 LID 833 (856)
T ss_pred EEc
Confidence 664
No 221
>PRK08577 hypothetical protein; Provisional
Probab=63.00 E-value=20 Score=32.56 Aligned_cols=34 Identities=18% Similarity=0.349 Sum_probs=27.6
Q ss_pred cEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEE
Q 008693 394 NVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVA 430 (557)
Q Consensus 394 nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Is 430 (557)
+.+.+.+.. .+.+|.++++.+.|+++++++..+.
T Consensus 55 ~~~~I~V~~---~Dr~GvLa~I~~~l~~~~inI~~i~ 88 (136)
T PRK08577 55 KLVEIELVV---EDRPGVLAKITGLLAEHGVDILATE 88 (136)
T ss_pred cEEEEEEEE---cCCCCHHHHHHHHHHHCCCCEEEEE
Confidence 456667764 4689999999999999999998664
No 222
>cd04886 ACT_ThrD-II-like C-terminal ACT domain of biodegradative (catabolic) threonine dehydratase II (ThrD-II) and other related ACT domains. This CD includes the C-terminal ACT domain of biodegradative (catabolic) threonine dehydratase II (ThrD-II) and other related ACT domains. The Escherichia coli tdcB gene product, ThrD-II, anaerobically catalyzes the pyridoxal phosphate-dependent dehydration of L-threonine and L-serine to ammonia and to alpha-ketobutyrate and pyruvate, respectively. Tetrameric ThrD-II is subject to allosteric activation by AMP, inhibition by alpha-keto acids, and catabolite inactivation by several metabolites of glycolysis and the citric acid cycle. Also included in this CD are N-terminal ACT domains present in smaller (~170 a.a.) archaeal proteins of unknown function. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=61.60 E-value=42 Score=25.59 Aligned_cols=51 Identities=24% Similarity=0.361 Sum_probs=33.7
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCC-------ceEEEEEEeccc---HHHHHHHHHH
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGAS-------KVNISLIVNDDE---AEQCVRALHE 534 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~IsqgsS-------e~sIs~vV~~~d---~~kAv~~LH~ 534 (557)
.+.||.++++.+.++++|++|..+.+... ...+.+-+.-.+ .+..++.|.+
T Consensus 6 ~d~~G~L~~i~~~i~~~~~nI~~i~~~~~~~~~~~~~~~~~i~v~~~~~~~l~~l~~~l~~ 66 (73)
T cd04886 6 PDRPGQLAKLLAVIAEAGANIIEVSHDRAFKTLPLGEVEVELTLETRGAEHIEEIIAALRE 66 (73)
T ss_pred CCCCChHHHHHHHHHHcCCCEEEEEEEeccCCCCCceEEEEEEEEeCCHHHHHHHHHHHHH
Confidence 46799999999999999999987665432 233444454444 3355555544
No 223
>cd04925 ACT_ACR_2 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=61.05 E-value=66 Score=25.80 Aligned_cols=45 Identities=24% Similarity=0.283 Sum_probs=32.9
Q ss_pred EEEEEccccccchHHHHHHHHHHhCCCcEEE--EEecCCceEEEEEEec
Q 008693 476 IISLIGNVQRSSLILEKAFRVLRRSGVNVQM--ISQGASKVNISLIVND 522 (557)
Q Consensus 476 iIsIVG~~~~~~~v~~rif~~L~~~gInI~~--IsqgsSe~sIs~vV~~ 522 (557)
+|.+.|. +.||+++++..+|++.|+||.. |.+-....--+|.|.+
T Consensus 2 ~~~v~~~--Dr~gLl~~i~~~l~~~~lnI~~A~i~t~~~~~~d~f~V~d 48 (74)
T cd04925 2 AIELTGT--DRPGLLSEVFAVLADLHCNVVEARAWTHNGRLACVIYVRD 48 (74)
T ss_pred EEEEEEC--CCCCHHHHHHHHHHHCCCcEEEEEEEEECCEEEEEEEEEc
Confidence 4566664 6799999999999999999985 4443344556666654
No 224
>cd02116 ACT ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme. Members of this CD belong to the superfamily of ACT regulatory domains. Pairs of ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme. The ACT domain has been detected in a number of diverse proteins; some of these proteins are involved in amino acid and purine biosynthesis, phenylalanine hydroxylation, regulation of bacterial metabolism and transcription, and many remain to be characterized. ACT domain-containing enzymes involved in amino acid and purine synthesis are in many cases allosteric enzymes with complex regulation enforced by the binding of ligands. The ACT domain is commonly involved in the binding of a small regulatory molecule, such as the amino acids L-Ser and L-Phe in the case of D-3-phosphoglycerate dehydrogenase and the bifunctional chorismate mutase-p
Probab=60.77 E-value=27 Score=24.21 Aligned_cols=37 Identities=24% Similarity=0.478 Sum_probs=28.5
Q ss_pred chhhHHHHHHHHHHhCCceEEEEEccC------ceeEEEeCCc
Q 008693 407 GQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLDPS 443 (557)
Q Consensus 407 ~~~g~la~If~~L~~~gI~Vd~IstSe------~sIS~~I~~~ 443 (557)
+.+|.++++++.|++.++++..+.++. ..+++.++..
T Consensus 7 ~~~~~l~~i~~~l~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 49 (60)
T cd02116 7 DRPGLLAKVLSVLAEAGINITSIEQRTSGDGGEADIFIVVDGD 49 (60)
T ss_pred CCCchHHHHHHHHHHCCCcEEEEEeEEcCCCCeEEEEEEEech
Confidence 468899999999999999999886432 3466666554
No 225
>cd04905 ACT_CM-PDT C-terminal ACT domain of the bifunctional chorismate mutase-prephenate dehydratase (CM-PDT) enzyme and the prephenate dehydratase (PDT) enzyme. The C-terminal ACT domain of the bifunctional chorismate mutase-prephenate dehydratase (CM-PDT) enzyme and the prephenate dehydratase (PDT) enzyme, found in plants, fungi, bacteria, and archaea. The P-protein of E. coli (CM-PDT, PheA) catalyzes the conversion of chorismate to prephenate and then the decarboxylation and dehydration to form phenylpyruvate. These are the first two steps in the biosynthesis of L-Phe and L-Tyr via the shikimate pathway in microorganisms and plants. The E. coli P-protein (CM-PDT) has three domains with an N-terminal domain with chorismate mutase activity, a middle domain with prephenate dehydratase activity, and an ACT regulatory C-terminal domain. The prephenate dehydratase enzyme has a PDT and ACT domain. The ACT domain is essential to bring about the negative allosteric regulation by L-Phe bindi
Probab=59.51 E-value=55 Score=26.48 Aligned_cols=53 Identities=13% Similarity=0.222 Sum_probs=36.2
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCC---ceEEEEEEecc------cHHHHHHHHHHH
Q 008693 483 VQRSSLILEKAFRVLRRSGVNVQMISQGAS---KVNISLIVNDD------EAEQCVRALHET 535 (557)
Q Consensus 483 ~~~~~~v~~rif~~L~~~gInI~~IsqgsS---e~sIs~vV~~~------d~~kAv~~LH~~ 535 (557)
+.+.+|.++++.+.++++|||+..|..-.. ...+.|.|+-+ +.+++++.|.+.
T Consensus 8 ~~d~~G~L~~il~~f~~~~ini~~i~s~p~~~~~~~~~f~vd~~~~~~~~~~~~~l~~l~~~ 69 (80)
T cd04905 8 LPNKPGALYDVLGVFAERGINLTKIESRPSKGGLWEYVFFIDFEGHIEDPNVAEALEELKRL 69 (80)
T ss_pred ECCCCCHHHHHHHHHHHCCcCEEEEEEEEcCCCCceEEEEEEEECCCCCHHHHHHHHHHHHh
Confidence 345789999999999999999987644332 33456666533 345667666653
No 226
>PRK03670 competence damage-inducible protein A; Provisional
Probab=58.78 E-value=39 Score=34.34 Aligned_cols=70 Identities=17% Similarity=0.233 Sum_probs=45.5
Q ss_pred HHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecC
Q 008693 204 MSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLG 283 (557)
Q Consensus 204 lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlg 283 (557)
-|+..++..|.+.|++..... ++.+ +.+.+.+.+...+.....+.|++|.+|.+.
T Consensus 20 tN~~~la~~L~~~G~~v~~~~-----iV~D-----------d~~~I~~~l~~a~~~~~DlVIttGGlGpt~--------- 74 (252)
T PRK03670 20 SNSAFIAQKLTEKGYWVRRIT-----TVGD-----------DVEEIKSVVLEILSRKPEVLVISGGLGPTH--------- 74 (252)
T ss_pred hhHHHHHHHHHHCCCEEEEEE-----EcCC-----------CHHHHHHHHHHHhhCCCCEEEECCCccCCC---------
Confidence 466778899999998864432 2322 234455555432222347889999777552
Q ss_pred CCcchhHHHHHHHHcCcC
Q 008693 284 RGGSDLTATTIGKALGLQ 301 (557)
Q Consensus 284 RgGSD~tAa~lA~~L~A~ 301 (557)
-|.|.-.+|.+++-+
T Consensus 75 ---dD~T~eava~a~g~~ 89 (252)
T PRK03670 75 ---DDVTMLAVAEALGRE 89 (252)
T ss_pred ---CCchHHHHHHHhCCC
Confidence 688899999999843
No 227
>COG2150 Predicted regulator of amino acid metabolism, contains ACT domain [General function prediction only]
Probab=58.76 E-value=49 Score=31.22 Aligned_cols=79 Identities=19% Similarity=0.291 Sum_probs=52.1
Q ss_pred HHHHHHHHHhhh---heeecccceeEEEEEccccccchHHHHHHHHHHhCCCcEEEEEecC----CceEEEEEEecccHH
Q 008693 454 ELDHVVEELEKI---AIVNLLQHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA----SKVNISLIVNDDEAE 526 (557)
Q Consensus 454 ~l~~~~~~l~~~---~~i~~~~~~aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~Isqgs----Se~sIs~vV~~~d~~ 526 (557)
+|..+++.++.. ..+...-+..+|.+.=.-...||+++.+++.+++.||+|+.+-... .+..+.++.+..--.
T Consensus 70 ~L~~if~nl~P~a~l~~vA~~lG~gViei~~~~~~~pgi~A~V~~~iak~gi~Irqi~~~dpe~~~e~~l~IVte~~iP~ 149 (167)
T COG2150 70 ELRRIFENLEPVASLADVAPLLGLGVIEIYPEDARYPGILAGVASLIAKRGISIRQIISEDPELQEEPKLTIVTERPIPG 149 (167)
T ss_pred HHHHHHHhccchhhHHHHHHhcCCeEEEEEeccCCCccHHHHHHHHHHHcCceEEEEecCCcccCCCceEEEEEeccCCH
Confidence 355555555442 3344444667777777666789999999999999999999854322 344577777766555
Q ss_pred HHHHHH
Q 008693 527 QCVRAL 532 (557)
Q Consensus 527 kAv~~L 532 (557)
+.+..|
T Consensus 150 ~li~el 155 (167)
T COG2150 150 DLIDEL 155 (167)
T ss_pred HHHHHH
Confidence 555444
No 228
>cd04879 ACT_3PGDH-like ACT_3PGDH-like CD includes the C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH). ACT_3PGDH-like: The ACT_3PGDH-like CD includes the C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH), with or without an extended C-terminal (xct) region found in various bacteria, archaea, fungi, and plants. 3PGDH is an enzyme that belongs to the D-isomer specific, 2-hydroxyacid dehydrogenase family and catalyzes the oxidation of D-3-phosphoglycerate to 3- phosphohydroxypyruvate, which is the first step in the biosynthesis of L-serine, using NAD+ as the oxidizing agent. In bacteria, 3PGDH is feedback controlled by the end product L-serine in an allosteric manner. In the Escherichia coli homotetrameric enzyme, the interface at adjacent ACT (regulatory) domains couples to create an extended beta-sheet. Each regulatory interface forms two serine-binding sites. The mechanism by which serine transmits inhibition to the active
Probab=58.51 E-value=24 Score=26.79 Aligned_cols=25 Identities=20% Similarity=0.315 Sum_probs=22.1
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEE
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVA 430 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~Is 430 (557)
.+.+|.++++.+.|+++|+++..+.
T Consensus 7 ~d~~g~l~~i~~~l~~~~~nI~~~~ 31 (71)
T cd04879 7 KDVPGVIGKVGTILGEHGINIAAMQ 31 (71)
T ss_pred cCCCCHHHHHHHHHHhcCCCeeeEE
Confidence 4678999999999999999998774
No 229
>cd04880 ACT_AAAH-PDT-like ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH). ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH): Phenylalanine hydroxylases (PAH), tyrosine hydroxylases (TH) and tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. This family of enzymes shares a common catalytic mechanism, in which dioxygen is used by an active site containing a single, reduced iron atom to hydroxylate an unactivated aromatic substrate, concomitant with a two-electron oxidation of tetrahydropterin (BH4) cofactor to its quinonoid dihydropterin form. Eukaryotic AAAHs have an N-terminal ACT (regulatory) domain, a middle catalytic domain and a C-terminal domain which is responsible for the oligomeric state of the enzyme forming a domain-swapped tetrameric coiled-coil. The PAH, TH, and TPH enzymes contain highly conserved catalytic domains but distinct N-terminal ACT domains and differ in their mech
Probab=58.01 E-value=30 Score=27.57 Aligned_cols=25 Identities=28% Similarity=0.515 Sum_probs=22.6
Q ss_pred chhhHHHHHHHHHHhCCceEEEEEc
Q 008693 407 GQYGFLAKVFSTFEDLGISVDVVAT 431 (557)
Q Consensus 407 ~~~g~la~If~~L~~~gI~Vd~Ist 431 (557)
+.||.++++++.|+++|+|+..|.+
T Consensus 8 d~pG~L~~vL~~f~~~~vni~~I~S 32 (75)
T cd04880 8 NKPGALAKALKVFAERGINLTKIES 32 (75)
T ss_pred CcCCHHHHHHHHHHHCCCCEEEEEe
Confidence 5799999999999999999999853
No 230
>cd04874 ACT_Af1403 N-terminal ACT domain of the yet uncharacterized, small (~133 a.a.), putative amino acid binding protein, Af1403, and related domains. This CD includes the N-terminal ACT domain of the yet uncharacterized, small (~133 a.a.), putative amino acid binding protein, Af1403, from Archaeoglobus fulgidus and other related archeal ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=57.79 E-value=45 Score=25.45 Aligned_cols=41 Identities=17% Similarity=0.158 Sum_probs=29.2
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCC---ceEEEEEEecc
Q 008693 483 VQRSSLILEKAFRVLRRSGVNVQMISQGAS---KVNISLIVNDD 523 (557)
Q Consensus 483 ~~~~~~v~~rif~~L~~~gInI~~IsqgsS---e~sIs~vV~~~ 523 (557)
+.+.+|.++++.+.|+++++++..+.+... ...+.+.++..
T Consensus 7 ~~d~~g~l~~i~~~l~~~~~~i~~~~~~~~~~~~~~~~i~~~~~ 50 (72)
T cd04874 7 AEDKPGVLRDLTGVIAEHGGNITYTQQFIEREGKARIYMELEGV 50 (72)
T ss_pred eCCCCChHHHHHHHHHhCCCCEEEEEEeccCCCeEEEEEEEecc
Confidence 346789999999999999999986655432 23355555554
No 231
>TIGR00655 PurU formyltetrahydrofolate deformylase. This model describes formyltetrahydrofolate deformylases. The enzyme is a homohexamer. Sequences from a related enzyme formyl tetrahydrofolate-specific enzyme, phosphoribosylglycinamide formyltransferase, serve as an outgroup for phylogenetic analysis. Putative members of this family, scoring below the trusted cutoff, include a sequence from Rhodobacter capsulatus that lacks an otherwise conserved C-terminal region.
Probab=57.61 E-value=1.2e+02 Score=31.16 Aligned_cols=64 Identities=11% Similarity=0.178 Sum_probs=40.0
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccC------ceeEEEeCCchh-hhHHHHHHHHHH-HHHHHh
Q 008693 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLDPSKL-WSRELIQQELDH-VVEELE 463 (557)
Q Consensus 397 lItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe------~sIS~~I~~~~~-~~~~~~~~~l~~-~~~~l~ 463 (557)
.|++.+ .+++|+.+++.+.|+++|+||.-+++.. ....+.++-+.. ...+.++++++. +-+++.
T Consensus 2 ~itv~g---~D~~GIVA~Vt~~La~~g~NI~d~sq~~~~~~~~F~mr~~v~~~~~~~~~~~l~~~l~~~~~~~~~ 73 (280)
T TIGR00655 2 ILLVSC---PDQKGLVAAISTFIAKHGANIISNDQHTDPETGRFFMRVEFQLEGFRLEESSLLAAFKSALAEKFE 73 (280)
T ss_pred EEEEEC---CCCCChHHHHHHHHHHCCCCEEeeeEEEcCCCCeEEEEEEEEeCCCCCCHHHHHHHHHHHHHHHhC
Confidence 356665 4689999999999999999999887542 122233332221 233445555666 544444
No 232
>PF13710 ACT_5: ACT domain; PDB: 2FGC_A 2PC6_A 2F1F_B.
Probab=57.39 E-value=17 Score=28.56 Aligned_cols=49 Identities=31% Similarity=0.526 Sum_probs=33.5
Q ss_pred ccchHHHHHHHHHHhCCCcEEEEEecC----CceEEEEEEeccc--HHHHHHHHH
Q 008693 485 RSSLILEKAFRVLRRSGVNVQMISQGA----SKVNISLIVNDDE--AEQCVRALH 533 (557)
Q Consensus 485 ~~~~v~~rif~~L~~~gInI~~Isqgs----Se~sIs~vV~~~d--~~kAv~~LH 533 (557)
+.||++.|+...+.+.|+||..++-+. .-..+++.++.++ .++..+.|+
T Consensus 1 n~~GvL~Ri~~vf~rRg~nI~sl~v~~~~~~~~~riti~v~~~~~~i~~l~~Ql~ 55 (63)
T PF13710_consen 1 NQPGVLNRITGVFRRRGFNIESLSVGPTEDPGISRITIVVSGDDREIEQLVKQLE 55 (63)
T ss_dssp SSTTHHHHHHHHHHTTT-EECEEEEEE-SSTTEEEEEEEEES-CCHHHHHHHHHH
T ss_pred CCcHHHHHHHHHHhcCCeEEeeEEeeecCCCCEEEEEEEEeeCchhHHHHHHHHh
Confidence 368999999999999999999877655 3345777777743 334444443
No 233
>PF00994 MoCF_biosynth: Probable molybdopterin binding domain; InterPro: IPR001453 Eukaryotic and prokaryotic molybdoenzymes require a molybdopterin cofactor (MoCF) for their activity. The biosynthesis of this cofactor involves a complex multistep enzymatic pathway. One of the eukaryotic proteins involved in this pathway is the Drosophila protein cinnamon [] which is highly similar to gephyrin, a rat microtubule-associated protein which was thought to anchor the glycine receptor to subsynaptic microtubules. Cinnamon and gephyrin are evolutionary related, in their N-terminal half, to the Escherichia coli MoCF biosynthesis proteins mog/chlG and moaB/chlA2 and, in their C-terminal half, to E. coli moeA/chlE.; GO: 0006777 Mo-molybdopterin cofactor biosynthetic process; PDB: 3TCR_B 1O8O_B 1O8Q_G 1EAV_D 1O8N_C 1UUX_A 1UUY_A 2G2C_A 2G4R_C 3K6A_F ....
Probab=57.08 E-value=47 Score=30.18 Aligned_cols=69 Identities=22% Similarity=0.302 Sum_probs=46.8
Q ss_pred HHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeec
Q 008693 203 CMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTL 282 (557)
Q Consensus 203 ~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttl 282 (557)
--|+..++++|++.|+...... ++- .+.+.+.+.+.. ++++.++.|++|..|.+.
T Consensus 16 d~n~~~l~~~l~~~G~~v~~~~-----~v~-----------Dd~~~i~~~l~~-~~~~~D~VittGG~g~~~-------- 70 (144)
T PF00994_consen 16 DSNGPFLAALLEELGIEVIRYG-----IVP-----------DDPDAIKEALRR-ALDRADLVITTGGTGPGP-------- 70 (144)
T ss_dssp BHHHHHHHHHHHHTTEEEEEEE-----EEE-----------SSHHHHHHHHHH-HHHTTSEEEEESSSSSST--------
T ss_pred EhHHHHHHHHHHHcCCeeeEEE-----EEC-----------CCHHHHHHHHHh-hhccCCEEEEcCCcCccc--------
Confidence 4577888999999998654432 332 234556666643 345668889988666441
Q ss_pred CCCcchhHHHHHHHHcCc
Q 008693 283 GRGGSDLTATTIGKALGL 300 (557)
Q Consensus 283 gRgGSD~tAa~lA~~L~A 300 (557)
.|++.-.++.+.+-
T Consensus 71 ----~D~t~~a~~~~~~~ 84 (144)
T PF00994_consen 71 ----DDVTPEALAEAGGR 84 (144)
T ss_dssp ----TCHHHHHHHHHSSE
T ss_pred ----CCcccHHHHHhcCc
Confidence 78889888888764
No 234
>PRK06027 purU formyltetrahydrofolate deformylase; Reviewed
Probab=56.78 E-value=89 Score=32.29 Aligned_cols=34 Identities=15% Similarity=0.130 Sum_probs=28.5
Q ss_pred EEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEc
Q 008693 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT 431 (557)
Q Consensus 395 ialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Ist 431 (557)
...+++.+. ++||+.+++.+.|++.|+||.-+++
T Consensus 6 ~~vitv~G~---DrpGIVa~Vt~~La~~g~NI~d~s~ 39 (286)
T PRK06027 6 RYVLTLSCP---DRPGIVAAVSNFLYEHGGNIVDADQ 39 (286)
T ss_pred eEEEEEECC---CCCcHHHHHHHHHHHCCCCEEEcee
Confidence 356788864 6899999999999999999987754
No 235
>PRK00275 glnD PII uridylyl-transferase; Provisional
Probab=56.67 E-value=2.2e+02 Score=34.46 Aligned_cols=125 Identities=16% Similarity=0.231 Sum_probs=73.0
Q ss_pred cEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEE--EccCc--ee-EEEeCCch-h--h----hHHHHHHHHHHHHHH
Q 008693 394 NVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV--ATSEV--SL-SLTLDPSK-L--W----SRELIQQELDHVVEE 461 (557)
Q Consensus 394 nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~I--stSe~--sI-S~~I~~~~-~--~----~~~~~~~~l~~~~~~ 461 (557)
+.+.|.|.. .++||..+++...|+..|+||.-- .++.. .+ +|.|...+ . . ..+.+++.|.+.+..
T Consensus 703 ~~t~V~V~~---~DrpgLFa~i~g~L~~~~lnI~~A~I~Tt~dg~alD~F~V~d~~g~~~~~~~~r~~~i~~~L~~~L~~ 779 (895)
T PRK00275 703 GGTQIFIYA---PDQHDFFAATVAAMDQLNLNIHDARIITSSSQFTLDTYIVLDDDGEPIGDNPARIEQIREGLTEALRN 779 (895)
T ss_pred CeEEEEEEe---CCCCcHHHHHHHHHHHCCCeEEEEEEEEcCCCeEEEEEEEeCCCCCCccchHHHHHHHHHHHHHHHcC
Confidence 566777775 468999999999999999998652 23322 22 45553211 0 0 112233334333210
Q ss_pred -------Hhhh-----------heeec----ccceeEEEEEccccccchHHHHHHHHHHhCCCcEEE--EEecCCceEEE
Q 008693 462 -------LEKI-----------AIVNL----LQHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQM--ISQGASKVNIS 517 (557)
Q Consensus 462 -------l~~~-----------~~i~~----~~~~aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~--IsqgsSe~sIs 517 (557)
+... -.|.+ ..+.+.|.|.+ .+.||+++++..+|.+.|++|.. |++.....-=+
T Consensus 780 ~~~~~~~~~~~~~~~~~~~~~~~~V~i~~~~~~~~T~i~V~a--~DrpGLLa~I~~~L~~~~l~I~~AkI~T~g~~v~D~ 857 (895)
T PRK00275 780 PDDYPTIIQRRVPRQLKHFAFPTQVTISNDAQRPVTVLEIIA--PDRPGLLARIGRIFLEFDLSLQNAKIATLGERVEDV 857 (895)
T ss_pred CCccchhhhhhhhhhccCCCCCCEEEEEECCCCCeEEEEEEE--CCCCCHHHHHHHHHHHCCCEEEEeEEEecCCEEEEE
Confidence 0000 01111 12456666666 36799999999999999999985 55543334445
Q ss_pred EEEecc
Q 008693 518 LIVNDD 523 (557)
Q Consensus 518 ~vV~~~ 523 (557)
|+|.+.
T Consensus 858 F~V~d~ 863 (895)
T PRK00275 858 FFITDA 863 (895)
T ss_pred EEEECC
Confidence 666543
No 236
>cd04886 ACT_ThrD-II-like C-terminal ACT domain of biodegradative (catabolic) threonine dehydratase II (ThrD-II) and other related ACT domains. This CD includes the C-terminal ACT domain of biodegradative (catabolic) threonine dehydratase II (ThrD-II) and other related ACT domains. The Escherichia coli tdcB gene product, ThrD-II, anaerobically catalyzes the pyridoxal phosphate-dependent dehydration of L-threonine and L-serine to ammonia and to alpha-ketobutyrate and pyruvate, respectively. Tetrameric ThrD-II is subject to allosteric activation by AMP, inhibition by alpha-keto acids, and catabolite inactivation by several metabolites of glycolysis and the citric acid cycle. Also included in this CD are N-terminal ACT domains present in smaller (~170 a.a.) archaeal proteins of unknown function. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=55.79 E-value=38 Score=25.88 Aligned_cols=25 Identities=24% Similarity=0.345 Sum_probs=22.1
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEE
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVA 430 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~Is 430 (557)
.+.||.++++++.|+++|+++.-+.
T Consensus 6 ~d~~G~L~~i~~~i~~~~~nI~~i~ 30 (73)
T cd04886 6 PDRPGQLAKLLAVIAEAGANIIEVS 30 (73)
T ss_pred CCCCChHHHHHHHHHHcCCCEEEEE
Confidence 4689999999999999999998664
No 237
>cd04905 ACT_CM-PDT C-terminal ACT domain of the bifunctional chorismate mutase-prephenate dehydratase (CM-PDT) enzyme and the prephenate dehydratase (PDT) enzyme. The C-terminal ACT domain of the bifunctional chorismate mutase-prephenate dehydratase (CM-PDT) enzyme and the prephenate dehydratase (PDT) enzyme, found in plants, fungi, bacteria, and archaea. The P-protein of E. coli (CM-PDT, PheA) catalyzes the conversion of chorismate to prephenate and then the decarboxylation and dehydration to form phenylpyruvate. These are the first two steps in the biosynthesis of L-Phe and L-Tyr via the shikimate pathway in microorganisms and plants. The E. coli P-protein (CM-PDT) has three domains with an N-terminal domain with chorismate mutase activity, a middle domain with prephenate dehydratase activity, and an ACT regulatory C-terminal domain. The prephenate dehydratase enzyme has a PDT and ACT domain. The ACT domain is essential to bring about the negative allosteric regulation by L-Phe bindi
Probab=55.56 E-value=60 Score=26.26 Aligned_cols=37 Identities=19% Similarity=0.269 Sum_probs=27.4
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEEcc-----CceeEEEeCC
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVATS-----EVSLSLTLDP 442 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~IstS-----e~sIS~~I~~ 442 (557)
.+.||.++++++.|+++|||+..+.+. ...+.|.++-
T Consensus 9 ~d~~G~L~~il~~f~~~~ini~~i~s~p~~~~~~~~~f~vd~ 50 (80)
T cd04905 9 PNKPGALYDVLGVFAERGINLTKIESRPSKGGLWEYVFFIDF 50 (80)
T ss_pred CCCCCHHHHHHHHHHHCCcCEEEEEEEEcCCCCceEEEEEEE
Confidence 357999999999999999999877422 2335666643
No 238
>cd04874 ACT_Af1403 N-terminal ACT domain of the yet uncharacterized, small (~133 a.a.), putative amino acid binding protein, Af1403, and related domains. This CD includes the N-terminal ACT domain of the yet uncharacterized, small (~133 a.a.), putative amino acid binding protein, Af1403, from Archaeoglobus fulgidus and other related archeal ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=55.19 E-value=35 Score=26.10 Aligned_cols=25 Identities=12% Similarity=0.174 Sum_probs=22.0
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEE
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVA 430 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~Is 430 (557)
.+.+|.++++.+.|+++++++.-+.
T Consensus 8 ~d~~g~l~~i~~~l~~~~~~i~~~~ 32 (72)
T cd04874 8 EDKPGVLRDLTGVIAEHGGNITYTQ 32 (72)
T ss_pred CCCCChHHHHHHHHHhCCCCEEEEE
Confidence 4689999999999999999998664
No 239
>cd04884 ACT_CBS C-terminal ACT domain of the cystathionine beta-synthase (CBS) domain protein found in Thermotoga maritima, Tm0935, and delta proteobacteria. This CD includes the C-terminal ACT domain of the cystathionine beta-synthase (CBS) domain protein found in Thermotoga maritima, Tm0935, and delta proteobacteria. This protein has two N-terminal tandem CBS domains and a single C-terminal ACT domain. The CBS domain is found in a wide range of proteins, often in tandem arrangements and together with a variety of other functional domains. It has been proposed that the CBS domain may play a regulatory role, although its exact function is unknown. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=54.19 E-value=53 Score=25.90 Aligned_cols=28 Identities=14% Similarity=0.151 Sum_probs=24.2
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEec
Q 008693 483 VQRSSLILEKAFRVLRRSGVNVQMISQG 510 (557)
Q Consensus 483 ~~~~~~v~~rif~~L~~~gInI~~Isqg 510 (557)
+.+.||.++++.+.++++|+||..+.+.
T Consensus 6 ~~d~pG~L~~l~~~i~~~g~nI~~i~~~ 33 (72)
T cd04884 6 LEDKPGTLKPVVDTLREFNARIISILTA 33 (72)
T ss_pred ecCCCccHHHHHHHHHHCCCeEEEEEec
Confidence 4678999999999999999999876554
No 240
>cd04881 ACT_HSDH-Hom ACT_HSDH_Hom CD includes the C-terminal ACT domain of the NAD(P)H-dependent, homoserine dehydrogenase (HSDH) and related domains. The ACT_HSDH_Hom CD includes the C-terminal ACT domain of the NAD(P)H-dependent, homoserine dehydrogenase (HSDH) encoded by the hom gene of Bacillus subtilis and other related sequences. HSDH reduces aspartate semi-aldehyde to the amino acid homoserine, one that is required for the biosynthesis of Met, Thr, and Ile from Asp. Neither the enzyme nor the aspartate pathway is found in the animal kingdom. This mostly bacterial HSDH group has a C-terminal ACT domain and is believed to be involved in enzyme regulation. A C-terminal deletion in the Corynebacterium glutamicum HSDH abolished allosteric inhibition by L-threonine. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=53.72 E-value=66 Score=24.88 Aligned_cols=51 Identities=10% Similarity=0.290 Sum_probs=34.3
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCC----ceEEEEEEeccc---HHHHHHHHHH
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGAS----KVNISLIVNDDE---AEQCVRALHE 534 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~IsqgsS----e~sIs~vV~~~d---~~kAv~~LH~ 534 (557)
.+.+|.++++.+.|++.|+++.-+.+... ...+.+.+...+ .+++++.|.+
T Consensus 8 ~d~~g~l~~i~~~l~~~~i~I~~~~~~~~~~~~~~~~~i~~~~~~~~~l~~~i~~L~~ 65 (79)
T cd04881 8 KDKPGVLAKITGILAEHGISIESVIQKEADGGETAPVVIVTHETSEAALNAALAEIEA 65 (79)
T ss_pred CCCCcHHHHHHHHHHHcCCCeEEEEEcccCCCCceeEEEEEccCCHHHHHHHHHHHHc
Confidence 45688999999999999999998765332 233556555444 3445555543
No 241
>cd04887 ACT_MalLac-Enz ACT_MalLac-Enz CD includes the N-terminal ACT domain of putative NAD-dependent malic enzyme 1, Bacillus subtilis YqkI and related domains. The ACT_MalLac-Enz CD includes the N-terminal ACT domain of putative NAD-dependent malic enzyme 1, Bacillus subtilis YqkI, a malolactic enzyme (MalLac-Enz) which converts malate to lactate, and other related ACT domains. The yqkJ product is predicted to convert malate directly to lactate, as opposed to related malic enzymes that convert malate to pyruvate. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=53.46 E-value=64 Score=25.29 Aligned_cols=51 Identities=10% Similarity=0.111 Sum_probs=37.2
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecC---CceEEEEEEecccHHHHHHHHHH
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGA---SKVNISLIVNDDEAEQCVRALHE 534 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~Isqgs---Se~sIs~vV~~~d~~kAv~~LH~ 534 (557)
.+.||.++++.+++++.|+||.-+.... ....+.+.+.-.+.+.+-+.++.
T Consensus 7 ~d~~g~L~~i~~~i~~~~~nI~~v~~~~~~~~~~~~~~~vev~~~~~l~~i~~~ 60 (74)
T cd04887 7 PNRPGMLGRVTTAIGEAGGDIGAIDLVEQGRDYTVRDITVDAPSEEHAETIVAA 60 (74)
T ss_pred CCCCchHHHHHHHHHHcCCcEEEEEEEEecCCEEEEEEEEEcCCHHHHHHHHHH
Confidence 4678999999999999999998766533 23336667777777766655554
No 242
>PF09413 DUF2007: Domain of unknown function (DUF2007); InterPro: IPR018551 This is a family of proteins with unknown function. ; PDB: 2HFV_A.
Probab=53.44 E-value=36 Score=26.61 Aligned_cols=44 Identities=18% Similarity=0.266 Sum_probs=25.4
Q ss_pred HHHHHHHHhCCCcEEEEEecCCce--------EEEEEEecccHHHHHHHHHH
Q 008693 491 EKAFRVLRRSGVNVQMISQGASKV--------NISLIVNDDEAEQCVRALHE 534 (557)
Q Consensus 491 ~rif~~L~~~gInI~~IsqgsSe~--------sIs~vV~~~d~~kAv~~LH~ 534 (557)
.-+-+.|.++||+...-....+.. .+.+.|+++|.++|.+.|++
T Consensus 13 ~~i~~~L~~~gI~~~v~~~~~~~~~g~~g~~~~~~v~V~~~d~~~A~~il~~ 64 (67)
T PF09413_consen 13 ELIKGLLEENGIPAFVKNEHMSGYAGEPGTGGQVEVYVPEEDYERAREILEE 64 (67)
T ss_dssp HHHHHHHHHTT--EE--S----SS---S--SSSEEEEEEGGGHHHHHHHHHH
T ss_pred HHHHHHHHhCCCcEEEECCccchhhcccCccCceEEEECHHHHHHHHHHHHH
Confidence 344455666666655432221111 17899999999999999985
No 243
>COG1058 CinA Predicted nucleotide-utilizing enzyme related to molybdopterin-biosynthesis enzyme MoeA [General function prediction only]
Probab=53.12 E-value=56 Score=33.29 Aligned_cols=68 Identities=28% Similarity=0.382 Sum_probs=46.8
Q ss_pred HHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCC
Q 008693 205 STRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGR 284 (557)
Q Consensus 205 sa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgR 284 (557)
|+.-|+..|.++|++..... .+ +| +.+.+.+.+... .+..++.|++|.+|-+.
T Consensus 22 Na~~la~~L~~~G~~v~~~~-----~V--gD---------~~~~I~~~l~~a-~~r~D~vI~tGGLGPT~---------- 74 (255)
T COG1058 22 NAAFLADELTELGVDLARIT-----TV--GD---------NPDRIVEALREA-SERADVVITTGGLGPTH---------- 74 (255)
T ss_pred hHHHHHHHHHhcCceEEEEE-----ec--CC---------CHHHHHHHHHHH-HhCCCEEEECCCcCCCc----------
Confidence 66778999999999865543 11 11 234455555433 34567999999888552
Q ss_pred CcchhHHHHHHHHcCcC
Q 008693 285 GGSDLTATTIGKALGLQ 301 (557)
Q Consensus 285 gGSD~tAa~lA~~L~A~ 301 (557)
-|.|+=.+|.+||-+
T Consensus 75 --DDiT~e~vAka~g~~ 89 (255)
T COG1058 75 --DDLTAEAVAKALGRP 89 (255)
T ss_pred --cHhHHHHHHHHhCCC
Confidence 688899999999954
No 244
>PRK11589 gcvR glycine cleavage system transcriptional repressor; Provisional
Probab=53.06 E-value=39 Score=32.81 Aligned_cols=60 Identities=13% Similarity=0.264 Sum_probs=42.5
Q ss_pred ceeEEEEEccccccchHHHHHHHHHHhCCCcEEEEEecC--CceEEEEEEecccHHHHHHHHHHHh
Q 008693 473 HRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA--SKVNISLIVNDDEAEQCVRALHETF 536 (557)
Q Consensus 473 ~~aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~Isqgs--Se~sIs~vV~~~d~~kAv~~LH~~f 536 (557)
...+|+++| .+.||+.+++.+.|+++|.||.-.++.- .+-.+.++|.... ..+..|...|
T Consensus 7 ~~lviTviG--~DrpGIVa~vs~~l~~~g~NI~ds~~t~lgg~Fa~i~lvs~~~--~~~~~le~~L 68 (190)
T PRK11589 7 HYLVITALG--ADRPGIVNTITRHVSSCGCNIEDSRLAMLGEEFTFIMLLSGSW--NAITLIESTL 68 (190)
T ss_pred cEEEEEEEc--CCCChHHHHHHHHHHHcCCCeeehhhHhhCCceEEEEEEeCCh--hHHHHHHHHH
Confidence 457899999 4679999999999999999998766643 3445666675443 2444444444
No 245
>cd04903 ACT_LSD C-terminal ACT domain of the L-serine dehydratase (LSD), iron-sulfur-dependent, beta subunit. The C-terminal ACT domain of the L-serine dehydratase (LSD), iron-sulfur-dependent, beta subunit, found in various bacterial anaerobes such as Clostridium, Bacillis, and Treponema species. These enzymes catalyze the deamination of L-serine, producing pyruvate and ammonia. Unlike the eukaryotic L-serine dehydratase, which requires the pyridoxal-5'-phosphate (PLP) cofactor, the prokaryotic L-serine dehydratase contains an [4Fe-4S] cluster instead of a PLP active site. The LSD alpha and beta subunits of the 'clostridial' enzyme are encoded by the sdhA and sdhB genes. The single subunit bacterial homologs of L-serine dehydratase (LSD1, LSD2, TdcG) present in Escherichia coli, and other enterobacterials, lack the ACT domain described here. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=51.86 E-value=42 Score=25.51 Aligned_cols=25 Identities=28% Similarity=0.339 Sum_probs=22.0
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEE
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVA 430 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~Is 430 (557)
.+++|.++++.+.|+++|+++..+.
T Consensus 7 ~d~~g~l~~i~~~l~~~~~~I~~~~ 31 (71)
T cd04903 7 KDKPGAIAKVTSVLADHEINIAFMR 31 (71)
T ss_pred CCCCChHHHHHHHHHHcCcCeeeeE
Confidence 3688999999999999999998774
No 246
>cd04931 ACT_PAH ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, phenylalanine hydroxylases (PAH). ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, phenylalanine hydroxylases (PAH). PAH catalyzes the hydroxylation of L-Phe to L-Tyr, the first step in the catabolic degradation of L-Phe. In PAH, an autoregulatory sequence, N-terminal of the ACT domain, extends across the catalytic domain active site and regulates the enzyme by intrasteric regulation. It appears that the activation by L-Phe induces a conformational change that converts the enzyme to a high-affinity and high-activity state. Modulation of activity is achieved through inhibition by BH4 and activation by phosphorylation of serine residues of the autoregulatory region. The molecular basis for the cooperative activation process is not fully understood yet. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=51.75 E-value=68 Score=27.21 Aligned_cols=59 Identities=22% Similarity=0.384 Sum_probs=40.1
Q ss_pred EEEccccccchHHHHHHHHHHhCCCcEEEEEecCCceE---EEEEEecc-----cHHHHHHHHHHHh
Q 008693 478 SLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASKVN---ISLIVNDD-----EAEQCVRALHETF 536 (557)
Q Consensus 478 sIVG~~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~s---Is~vV~~~-----d~~kAv~~LH~~f 536 (557)
+++=.+.+.||.+.++++.++++|||+.-|..-++... ..|+|+-+ ...++++.|.+.+
T Consensus 16 slif~l~~~pGsL~~vL~~Fa~~~INLt~IeSRP~~~~~~~Y~FfVDieg~~~~~~~~~l~~L~~~~ 82 (90)
T cd04931 16 SLIFSLKEEVGALAKVLRLFEEKDINLTHIESRPSRLNKDEYEFFINLDKKSAPALDPIIKSLRNDI 82 (90)
T ss_pred EEEEEcCCCCcHHHHHHHHHHHCCCCEEEEEeccCCCCCceEEEEEEEEcCCCHHHHHHHHHHHHHh
Confidence 33333345689999999999999999998876554322 45666633 3456777777644
No 247
>PF13291 ACT_4: ACT domain; PDB: 2KO1_B 3IBW_A.
Probab=50.31 E-value=55 Score=26.33 Aligned_cols=50 Identities=20% Similarity=0.327 Sum_probs=34.9
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCC----ceEEEEEEecccHHHHHHHHH
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGAS----KVNISLIVNDDEAEQCVRALH 533 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~IsqgsS----e~sIs~vV~~~d~~kAv~~LH 533 (557)
.+.+|+++.+.+++++.|+||..+..... ...+.+-+.-.|.+..-+.++
T Consensus 14 ~dr~GlL~dI~~~i~~~~~nI~~i~~~~~~~~~~~~~~l~v~V~d~~~L~~ii~ 67 (80)
T PF13291_consen 14 EDRPGLLADITSVISENGVNIRSINARTNKDDGTARITLTVEVKDLEHLNQIIR 67 (80)
T ss_dssp E--TTHHHHHHHHHHCSSSEEEEEEEEE--ETTEEEEEEEEEESSHHHHHHHHH
T ss_pred EcCCCHHHHHHHHHHHCCCCeEEEEeEEeccCCEEEEEEEEEECCHHHHHHHHH
Confidence 46789999999999999999998776553 224666666667665554444
No 248
>PRK13010 purU formyltetrahydrofolate deformylase; Reviewed
Probab=50.23 E-value=33 Score=35.59 Aligned_cols=35 Identities=14% Similarity=0.150 Sum_probs=30.8
Q ss_pred eeEEEEEccccccchHHHHHHHHHHhCCCcEEEEEec
Q 008693 474 RSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQG 510 (557)
Q Consensus 474 ~aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~Isqg 510 (557)
..+|+++| .+.+|+.+++.+.|+++|+||.-++|-
T Consensus 9 ~~iitv~G--~Dr~GIVA~Vs~~Lae~g~NI~disq~ 43 (289)
T PRK13010 9 SYVLTLAC--PSAPGIVAAVSGFLAEKGCYIVELTQF 43 (289)
T ss_pred CEEEEEEC--CCCCCcHHHHHHHHHHCCCCEEecccc
Confidence 35789988 467899999999999999999999983
No 249
>TIGR00655 PurU formyltetrahydrofolate deformylase. This model describes formyltetrahydrofolate deformylases. The enzyme is a homohexamer. Sequences from a related enzyme formyl tetrahydrofolate-specific enzyme, phosphoribosylglycinamide formyltransferase, serve as an outgroup for phylogenetic analysis. Putative members of this family, scoring below the trusted cutoff, include a sequence from Rhodobacter capsulatus that lacks an otherwise conserved C-terminal region.
Probab=50.05 E-value=38 Score=34.96 Aligned_cols=34 Identities=12% Similarity=0.132 Sum_probs=29.5
Q ss_pred EEEEEccccccchHHHHHHHHHHhCCCcEEEEEecC
Q 008693 476 IISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA 511 (557)
Q Consensus 476 iIsIVG~~~~~~~v~~rif~~L~~~gInI~~Isqgs 511 (557)
+|+++| .+.+|+.+++.+.|+++|+||.-++|--
T Consensus 2 ~itv~g--~D~~GIVA~Vt~~La~~g~NI~d~sq~~ 35 (280)
T TIGR00655 2 ILLVSC--PDQKGLVAAISTFIAKHGANIISNDQHT 35 (280)
T ss_pred EEEEEC--CCCCChHHHHHHHHHHCCCCEEeeeEEE
Confidence 567777 4678999999999999999999998864
No 250
>cd04878 ACT_AHAS N-terminal ACT domain of the Escherichia coli IlvH-like regulatory subunit of acetohydroxyacid synthase (AHAS). ACT_AHAS: N-terminal ACT domain of the Escherichia coli IlvH-like regulatory subunit of acetohydroxyacid synthase (AHAS). AHAS catalyses the first common step in the biosynthesis of the three branched-chain amino acids. The first step involves the condensation of either pyruvate or 2-ketobutyrate with the two-carbon hydroxyethyl fragment derived from another pyruvate molecule, covalently bound to the coenzyme thiamine diphosphate. Bacterial AHASs generally consist of regulatory and catalytic subunits. The effector (valine) binding sites are proposed to be located in two symmetrically related positions in the interface between a pair of N-terminal ACT domains with the C-terminal domain of IlvH contacting the catalytic dimer. Plants Arabidopsis and Oryza have tandem IlvH subunits; both the first and second ACT domain sequences are present in this CD. Members of
Probab=49.87 E-value=65 Score=24.41 Aligned_cols=40 Identities=20% Similarity=0.458 Sum_probs=29.8
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCC----ceEEEEEEecc
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGAS----KVNISLIVNDD 523 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~IsqgsS----e~sIs~vV~~~ 523 (557)
.+.+|++.++.+.|++.++++..+.+... ...+.+.++..
T Consensus 8 ~d~~g~l~~i~~~l~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 51 (72)
T cd04878 8 ENEPGVLNRISGLFARRGFNIESLTVGPTEDPGISRITIVVEGD 51 (72)
T ss_pred cCCCcHHHHHHHHHHhCCCCEEEEEeeecCCCCeEEEEEEEECC
Confidence 46789999999999999999998776432 23366666653
No 251
>cd04879 ACT_3PGDH-like ACT_3PGDH-like CD includes the C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH). ACT_3PGDH-like: The ACT_3PGDH-like CD includes the C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH), with or without an extended C-terminal (xct) region found in various bacteria, archaea, fungi, and plants. 3PGDH is an enzyme that belongs to the D-isomer specific, 2-hydroxyacid dehydrogenase family and catalyzes the oxidation of D-3-phosphoglycerate to 3- phosphohydroxypyruvate, which is the first step in the biosynthesis of L-serine, using NAD+ as the oxidizing agent. In bacteria, 3PGDH is feedback controlled by the end product L-serine in an allosteric manner. In the Escherichia coli homotetrameric enzyme, the interface at adjacent ACT (regulatory) domains couples to create an extended beta-sheet. Each regulatory interface forms two serine-binding sites. The mechanism by which serine transmits inhibition to the active
Probab=49.28 E-value=55 Score=24.68 Aligned_cols=49 Identities=18% Similarity=0.288 Sum_probs=31.7
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCC----ceEEEEEEecccHHHHHHHH
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGAS----KVNISLIVNDDEAEQCVRAL 532 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~IsqgsS----e~sIs~vV~~~d~~kAv~~L 532 (557)
.+.+|.++++.+.|++.|+||..+..... ...+.+-++....++.++.|
T Consensus 7 ~d~~g~l~~i~~~l~~~~~nI~~~~~~~~~~~~~~~~~~~v~~~~~~~l~~~l 59 (71)
T cd04879 7 KDVPGVIGKVGTILGEHGINIAAMQVGRKEKGGIAYMVLDVDSPVPEEVLEEL 59 (71)
T ss_pred cCCCCHHHHHHHHHHhcCCCeeeEEEeccCCCCEEEEEEEcCCCCCHHHHHHH
Confidence 45789999999999999999986654432 22244555444433444444
No 252
>cd04889 ACT_PDH-BS-like C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH) enzyme that catalyzes the formation of 4-hydroxyphenylpyruvate from prephenate. Included in this CD is the C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH) enzyme that catalyzes the formation of 4-hydroxyphenylpyruvate from prephenate, found in Bacillus subtilis (BS) and other Firmicutes, Deinococci, and Bacteroidetes. PDH is the first enzyme in the aromatic amino acid pathway specific for the biosynthesis of tyrosine. This enzyme is feedback inhibited by tyrosine in B. subtilis and other microorganisms. Both phenylalanine and tryptophan have been shown to be inhibitors of this activity in B. subtilis. Bifunctional chorismate mutase-PDH (TyrA) enzymes such as those seen in Escherichia coli do not contain an ACT domain. Also included in this CD is the N-terminal ACT domain of a novel protein composed almost entirely of two tandem A
Probab=49.25 E-value=18 Score=27.08 Aligned_cols=26 Identities=23% Similarity=0.415 Sum_probs=22.9
Q ss_pred ccchhhHHHHHHHHHHhCCceEEEEE
Q 008693 405 MLGQYGFLAKVFSTFEDLGISVDVVA 430 (557)
Q Consensus 405 m~~~~g~la~If~~L~~~gI~Vd~Is 430 (557)
+.+.||.++++++.|.++|+|+..+.
T Consensus 5 ~~d~~G~l~~i~~~l~~~~inI~~~~ 30 (56)
T cd04889 5 VENKPGRLAEVTEILAEAGINIKAIS 30 (56)
T ss_pred eCCCCChHHHHHHHHHHcCCCEeeEE
Confidence 45789999999999999999998764
No 253
>cd04877 ACT_TyrR N-terminal ACT domain of the TyrR protein. ACT_TyrR: N-terminal ACT domain of the TyrR protein. The TyrR protein of Escherichia coli controls the expression of a group of transcription units (TyrR regulon) whose gene products are involved in the biosynthesis or transport of the aromatic amino acids. Binding to specific DNA sequences known as TyrR boxes, the TyrR protein can either activate or repress transcription at different sigma70 promoters. Its regulatory activity occurs in response to intracellular levels of tyrosine, phenylalanine and tryptophan. The TyrR protein consists of an N-terminal region important for transcription activation with an ATP-independent aromatic amino acid binding site (contained within the ACT domain) and is involved in dimerization; a central region with an ATP binding site, an ATP-dependent aromatic amino acid binding site and is involved in hexamerization; and a helix turn helix DNA binding C-terminal region. In solution, in the absence
Probab=49.14 E-value=83 Score=25.00 Aligned_cols=44 Identities=16% Similarity=0.116 Sum_probs=32.8
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHH
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQC 528 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kA 528 (557)
.+.+|+++.+.+.+++.++|+..+...+. ..+.+-+.-.+....
T Consensus 8 ~dr~Gll~dI~~~i~~~~~nI~~~~~~~~-~~i~l~i~v~~~~~L 51 (74)
T cd04877 8 EDRLGITQEVLDLLVEHNIDLRGIEIDPK-GRIYLNFPTIEFEKL 51 (74)
T ss_pred EccchHHHHHHHHHHHCCCceEEEEEecC-CeEEEEeEecCHHHH
Confidence 35689999999999999999999887553 225555665666553
No 254
>cd04929 ACT_TPH ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. TPH catalyses the hydroxylation of L-Trp to 5-hydroxytryptophan, the rate limiting step in the biosynthesis of 5-hydroxytryptamine (serotonin) and the first reaction in the synthesis of melatonin. Very little is known about the role of the ACT domain in TPH, which appears to be regulated by phosphorylation but not by its substrate or cofactor. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=48.72 E-value=68 Score=26.05 Aligned_cols=52 Identities=23% Similarity=0.313 Sum_probs=36.3
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCCceE---EEEEEec----ccHHHHHHHHHHH
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGASKVN---ISLIVND----DEAEQCVRALHET 535 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~IsqgsSe~s---Is~vV~~----~d~~kAv~~LH~~ 535 (557)
.+.||-+.++++.++.+|||+.-|..-++... -.|+|+- ++..++++.|++.
T Consensus 8 ~~~~g~L~~iL~~f~~~~inl~~IeSRP~~~~~~~y~F~id~e~~~~~i~~~l~~l~~~ 66 (74)
T cd04929 8 KNEVGGLAKALKLFQELGINVVHIESRKSKRRSSEFEIFVDCECDQRRLDELVQLLKRE 66 (74)
T ss_pred CCCCcHHHHHHHHHHHCCCCEEEEEeccCCCCCceEEEEEEEEcCHHHHHHHHHHHHHh
Confidence 45689999999999999999998876554333 3455553 3455666666553
No 255
>cd04819 PA_2 PA_2: Protease-associated (PA) domain subgroup 2. A subgroup of PA-domain containing proteins. The PA domain is an insert domain in a diverse fraction of proteases. The significance of the PA domain to many of the proteins in which it is inserted is undetermined. It may be a protein-protein interaction domain. At peptidase active sites, the PA domain may participate in substrate binding and/or promoting conformational changes, which influence the stability and accessibility of the site to substrate. Proteins in this group contain a C-terminal RING-finger domain. Proteins into which the PA domain is inserted include the following: i) various signal peptide peptidases: such as hSPPL2a and 2b, ii) various E3 ubiquitin ligases similar to human GRAIL (gene related to anergy in lymphocytes) protein, iii) various proteins containing a RING finger motif such as Arabidopsis ReMembR-H2 protein, iv) EDEM3 (ER-degradation-enhancing mannosidase-like 3 protein), v) various plant vacuola
Probab=48.67 E-value=93 Score=27.84 Aligned_cols=76 Identities=20% Similarity=0.219 Sum_probs=45.5
Q ss_pred CCceeecCCCcc--h-hHHHHHHHHcCcCcEEEeeCCCccccCCCCC-----CCCCccccccCHHHHHHHHHcCCCcchH
Q 008693 276 TCAITTLGRGGS--D-LTATTIGKALGLQEIQVWKDVDGVLTCDPNI-----HPHAKPVPYLTFDEAAELAYFGAQVLHP 347 (557)
Q Consensus 276 ~G~~ttlgRgGS--D-~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~-----v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp 347 (557)
.|.+..+.||+. + .--+..|...||.-++++.+.+|.+..-|.. .+..-+.=.||.+++..|..
T Consensus 44 ~GkIvlv~~g~~~~~~~~k~~~A~~~GA~avi~~~~~~g~~~~~~~~~~~~~~~~~IP~v~Is~edg~~L~~-------- 115 (127)
T cd04819 44 EGKIAVVKRDDPDVDRKEKYAKAVAAGAAAFVVVNTVPGVLPATGDEGTEDGPPSPIPAASVSGEDGLRLAR-------- 115 (127)
T ss_pred CCeEEEEEcCCCchhHHHHHHHHHHCCCEEEEEEeCCCCcCcccccccccCCCCCCCCEEEEeHHHHHHHHH--------
Confidence 466666666654 2 2357789999999999999999865311110 01122233566777777743
Q ss_pred hHHHHHHhCCCCEEEec
Q 008693 348 QSMRPAREGDIPVRVKN 364 (557)
Q Consensus 348 ~a~~~a~~~~Ipv~I~n 364 (557)
+++.|-++.+|+
T Consensus 116 -----~l~~g~~~~~~~ 127 (127)
T cd04819 116 -----VAERNDTLVLRV 127 (127)
T ss_pred -----HHhcCCceEeeC
Confidence 234466666653
No 256
>cd04880 ACT_AAAH-PDT-like ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH). ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH): Phenylalanine hydroxylases (PAH), tyrosine hydroxylases (TH) and tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. This family of enzymes shares a common catalytic mechanism, in which dioxygen is used by an active site containing a single, reduced iron atom to hydroxylate an unactivated aromatic substrate, concomitant with a two-electron oxidation of tetrahydropterin (BH4) cofactor to its quinonoid dihydropterin form. Eukaryotic AAAHs have an N-terminal ACT (regulatory) domain, a middle catalytic domain and a C-terminal domain which is responsible for the oligomeric state of the enzyme forming a domain-swapped tetrameric coiled-coil. The PAH, TH, and TPH enzymes contain highly conserved catalytic domains but distinct N-terminal ACT domains and differ in their mech
Probab=48.47 E-value=49 Score=26.30 Aligned_cols=51 Identities=20% Similarity=0.342 Sum_probs=34.7
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCC---ceEEEEEEecc------cHHHHHHHHHH
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGAS---KVNISLIVNDD------EAEQCVRALHE 534 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~IsqgsS---e~sIs~vV~~~------d~~kAv~~LH~ 534 (557)
.+.||.++++++.++++|+|+..|..-.. .....|+|+-+ +.+++++.|.+
T Consensus 7 ~d~pG~L~~vL~~f~~~~vni~~I~Srp~~~~~~~~~f~id~~~~~~~~~~~~~l~~l~~ 66 (75)
T cd04880 7 KNKPGALAKALKVFAERGINLTKIESRPSRKGLWEYEFFVDFEGHIDDPDVKEALEELKR 66 (75)
T ss_pred CCcCCHHHHHHHHHHHCCCCEEEEEeeecCCCCceEEEEEEEECCCCCHHHHHHHHHHHH
Confidence 45789999999999999999999854322 22345555433 24456666654
No 257
>cd04900 ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains. This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=48.37 E-value=1.1e+02 Score=24.20 Aligned_cols=23 Identities=13% Similarity=0.185 Sum_probs=21.2
Q ss_pred cccchHHHHHHHHHHhCCCcEEE
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQM 506 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~ 506 (557)
.+.||++.++..+|+..|++|..
T Consensus 9 ~Dr~gLl~~i~~~l~~~~l~I~~ 31 (73)
T cd04900 9 PDRPGLFARIAGALDQLGLNILD 31 (73)
T ss_pred cCCCCHHHHHHHHHHHCCCCeEE
Confidence 36899999999999999999986
No 258
>cd00885 cinA Competence-damaged protein. CinA is the first gene in the competence- inducible (cin) operon and is thought to be specifically required at some stage in the process of transformation. This domain is closely related to a domain, found in a variety of proteins involved in biosynthesis of molybdopterin cofactor, where the domain is presumed to bind molybdopterin.
Probab=48.25 E-value=92 Score=29.51 Aligned_cols=69 Identities=25% Similarity=0.341 Sum_probs=45.6
Q ss_pred HHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecC
Q 008693 204 MSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLG 283 (557)
Q Consensus 204 lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlg 283 (557)
-|+..++..|++.|++..... ++. | +.+.+.+.+.. +.+...+.|++|..|.+
T Consensus 19 ~n~~~l~~~L~~~G~~v~~~~-----~v~-D----------d~~~I~~~l~~-~~~~~dlVIttGG~G~t---------- 71 (170)
T cd00885 19 TNAAFLAKELAELGIEVYRVT-----VVG-D----------DEDRIAEALRR-ASERADLVITTGGLGPT---------- 71 (170)
T ss_pred hHHHHHHHHHHHCCCEEEEEE-----EeC-C----------CHHHHHHHHHH-HHhCCCEEEECCCCCCC----------
Confidence 466778889999998764421 232 2 23445555543 34456788998866644
Q ss_pred CCcchhHHHHHHHHcCcC
Q 008693 284 RGGSDLTATTIGKALGLQ 301 (557)
Q Consensus 284 RgGSD~tAa~lA~~L~A~ 301 (557)
.-|.|--.++.+++-+
T Consensus 72 --~~D~t~ea~~~~~~~~ 87 (170)
T cd00885 72 --HDDLTREAVAKAFGRP 87 (170)
T ss_pred --CCChHHHHHHHHhCCC
Confidence 2788999999999853
No 259
>cd04882 ACT_Bt0572_2 C-terminal ACT domain of a novel protein composed of just two ACT domains. Included in this CD is the C-terminal ACT domain of a novel protein composed of just two ACT domains, as seen in the yet uncharacterized structure (pdb 2F06) of the Bt0572 protein from Bacteroides thetaiotaomicron and related proteins. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=47.96 E-value=15 Score=27.89 Aligned_cols=26 Identities=15% Similarity=0.335 Sum_probs=22.7
Q ss_pred ccchhhHHHHHHHHHHhCCceEEEEE
Q 008693 405 MLGQYGFLAKVFSTFEDLGISVDVVA 430 (557)
Q Consensus 405 m~~~~g~la~If~~L~~~gI~Vd~Is 430 (557)
+.++||.++++++.|+++|+||..+.
T Consensus 6 ~~d~pG~L~~i~~~l~~~~~nI~~i~ 31 (65)
T cd04882 6 VPDKPGGLHEILQILSEEGINIEYMY 31 (65)
T ss_pred eCCCCcHHHHHHHHHHHCCCChhheE
Confidence 34689999999999999999998664
No 260
>cd04901 ACT_3PGDH C-terminal ACT (regulatory) domain of D-3-Phosphoglycerate Dehydrogenase (3PGDH) found in fungi and bacteria. The C-terminal ACT (regulatory) domain of D-3-Phosphoglycerate Dehydrogenase (3PGDH) found in fungi and bacteria. 3PGDH is an enzyme that belongs to the D-isomer specific, 2-hydroxyacid dehydrogenase family and catalyzes the oxidation of D-3-phosphoglycerate to 3- phosphohydroxypyruvate, which is the first step in the biosynthesis of L-serine, using NAD+ as the oxidizing agent. In Escherichia coli, the SerA 3PGDH is feedback-controlled by the end product L-serine in an allosteric manner. In the homotetrameric enzyme, the interface at adjacent ACT (regulatory) domains couples to create an extended beta-sheet. Each regulatory interface forms two serine-binding sites. The mechanism by which serine transmits inhibition to the active site is postulated to involve the tethering of the regulatory domains together to create a rigid quaternary structure with a solvent-
Probab=47.57 E-value=17 Score=28.15 Aligned_cols=51 Identities=12% Similarity=0.170 Sum_probs=36.0
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCC--ceEEEEEEecccHHHHHHHHHH
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGAS--KVNISLIVNDDEAEQCVRALHE 534 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~IsqgsS--e~sIs~vV~~~d~~kAv~~LH~ 534 (557)
.+.+|+++++.+.+++.|+|+..+...+. ...+.+-++..+.+..++.|.+
T Consensus 7 ~d~~g~l~~i~~~l~~~~~nI~~~~~~~~~~~a~~~~~~~~~~l~~li~~l~~ 59 (69)
T cd04901 7 KNVPGVLGQINTILAEHNINIAAQYLQTRGEIGYVVIDIDSEVSEELLEALRA 59 (69)
T ss_pred cCCCcHHHHHHHHHHHcCCCHHHHhccCCCCEEEEEEEcCCCCCHHHHHHHHc
Confidence 46789999999999999999976555432 2234455666666666666654
No 261
>cd04902 ACT_3PGDH-xct C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH). The C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH), with an extended C-terminal (xct) region from bacteria, archaea, fungi, and plants. 3PGDH is an enzyme that belongs to the D-isomer specific, 2-hydroxyacid dehydrogenase family and catalyzes the oxidation of D-3-phosphoglycerate to 3- phosphohydroxypyruvate, which is the first step in the biosynthesis of L-serine, using NAD+ as the oxidizing agent. In bacteria, 3PGDH is feedback-controlled by the end product L-serine in an allosteric manner. Some 3PGDH enzymes have an additional domain formed by an extended C-terminal region. This additional domain introduces significant asymmetry to the homotetramer. Adjacent ACT (regulatory) domains interact, creating two serine-binding sites, however, this asymmetric arrangement results in the formation of two different and distinct domain interfaces between iden
Probab=46.45 E-value=41 Score=26.15 Aligned_cols=50 Identities=14% Similarity=0.272 Sum_probs=31.1
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEE--ec--CCceEEEEEEecccHHHHHHHH
Q 008693 483 VQRSSLILEKAFRVLRRSGVNVQMIS--QG--ASKVNISLIVNDDEAEQCVRAL 532 (557)
Q Consensus 483 ~~~~~~v~~rif~~L~~~gInI~~Is--qg--sSe~sIs~vV~~~d~~kAv~~L 532 (557)
+.+.+|.++++.+.|+++|+||..+. .. .....+.+-++.......++.|
T Consensus 6 ~~d~~G~l~~i~~~l~~~~inI~~~~~~~~~~~~~~~~~i~v~~~~~~~~~~~l 59 (73)
T cd04902 6 NTDRPGVIGKVGTILGEAGINIAGMQVGRDEPGGEALMVLSVDEPVPDEVLEEL 59 (73)
T ss_pred eCCCCCHHHHHHHHHHHcCcChhheEeeccCCCCEEEEEEEeCCCCCHHHHHHH
Confidence 35678999999999999999996432 21 1233344555554433444443
No 262
>cd04904 ACT_AAAH ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH). ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH): Phenylalanine hydroxylases (PAH), tyrosine hydroxylases (TH) and tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. This family of enzymes shares a common catalytic mechanism, in which dioxygen is used by an active site containing a single, reduced iron atom to hydroxylate an unactivated aromatic substrate, concomitant with a two-electron oxidation of tetrahydropterin (BH4) cofactor to its quinonoid dihydropterin form. PAH catalyzes the hydroxylation of L-Phe to L-Tyr, the first step in the catabolic degradation of L-Phe; TH catalyses the hydroxylation of L-Tyr to 3,4-dihydroxyphenylalanine, the rate limiting step in the biosynthesis of catecholamines; and TPH catalyses the hydroxylation of L-Trp to 5-hydroxytryptophan, the rate limiting step in the biosynthesis of 5-hydroxy
Probab=46.36 E-value=76 Score=25.47 Aligned_cols=51 Identities=22% Similarity=0.382 Sum_probs=35.2
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCCceE---EEEEEecc----cHHHHHHHHHH
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGASKVN---ISLIVNDD----EAEQCVRALHE 534 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~IsqgsSe~s---Is~vV~~~----d~~kAv~~LH~ 534 (557)
.+.||-+.++++.++.+|||+.-|..-++... -.|+|+-+ +.+++++.|.+
T Consensus 8 ~~~pG~L~~vL~~f~~~~iNlt~IeSRP~~~~~~~y~Ffvd~~~~~~~~~~~l~~L~~ 65 (74)
T cd04904 8 KEEVGALARALKLFEEFGVNLTHIESRPSRRNGSEYEFFVDCEVDRGDLDQLISSLRR 65 (74)
T ss_pred CCCCcHHHHHHHHHHHCCCcEEEEECCCCCCCCceEEEEEEEEcChHHHHHHHHHHHH
Confidence 45689999999999999999998865444332 34555432 34556666654
No 263
>PRK04374 PII uridylyl-transferase; Provisional
Probab=46.29 E-value=5.6e+02 Score=30.93 Aligned_cols=126 Identities=17% Similarity=0.241 Sum_probs=75.6
Q ss_pred ccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEE--EccCce--e-EEEeCCchh---hhHHHHHHHHHHHHHH-Hh
Q 008693 393 RNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV--ATSEVS--L-SLTLDPSKL---WSRELIQQELDHVVEE-LE 463 (557)
Q Consensus 393 ~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~I--stSe~s--I-S~~I~~~~~---~~~~~~~~~l~~~~~~-l~ 463 (557)
.+.+-|.|.. .+++|..+++...|+.+|+||.-. .++... + +|.|.+.+- .....+++.+.+.+.. ..
T Consensus 688 ~~~~~v~v~~---~d~~gLFa~i~g~l~~~~lnI~~A~i~t~~~g~~ld~f~V~~~~~~~~~~~~~i~~~l~~~l~~~~~ 764 (869)
T PRK04374 688 NDALEVFVYS---PDRDGLFAAIVATLDRKGYGIHRARVLDAPHDAIFDVFEVLPQDTYADGDPQRLAAALRQVLAGDLQ 764 (869)
T ss_pred CCeEEEEEEe---CCCccHHHHHHHHHHHCCCeEEEEEEEEcCCCEEEEEEEEeCCCCCChHHHHHHHHHHHHHHcCCCC
Confidence 4566777774 468999999999999999998643 332222 2 444433211 1122244444443321 10
Q ss_pred -----hh------------heeecc----cceeEEEEEccccccchHHHHHHHHHHhCCCcEEE--EEecCCceEEEEEE
Q 008693 464 -----KI------------AIVNLL----QHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQM--ISQGASKVNISLIV 520 (557)
Q Consensus 464 -----~~------------~~i~~~----~~~aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~--IsqgsSe~sIs~vV 520 (557)
+- ..|.+. .+.+.|.|+. .+.||+++++..+|+..|++|.. |++-....-=+|.|
T Consensus 765 ~~~~~~~~~~~~~~~~~~~~~V~~~~~~~~~~t~leI~a--~DrpGLLa~Ia~~l~~~~l~I~~AkI~T~g~~a~D~F~V 842 (869)
T PRK04374 765 KVRPARRAVPRQLRHFRFAPRVEFSESAGGRRTRISLVA--PDRPGLLADVAHVLRMQHLRVHDARIATFGERAEDQFQI 842 (869)
T ss_pred ccccccccCcccccCCCCCCeEEEeecCCCCeEEEEEEe--CCcCcHHHHHHHHHHHCCCeEEEeEEEecCCEEEEEEEE
Confidence 00 012222 2456666666 35799999999999999999996 66654444446666
Q ss_pred ecc
Q 008693 521 NDD 523 (557)
Q Consensus 521 ~~~ 523 (557)
...
T Consensus 843 ~d~ 845 (869)
T PRK04374 843 TDE 845 (869)
T ss_pred ECC
Confidence 543
No 264
>TIGR00177 molyb_syn molybdenum cofactor synthesis domain. The Drosophila protein cinnamon, the Arabidopsis protein cnx1, and rat protein gephyrin each have one domain like MoeA and one like MoaB and Mog. These domains are, however, distantly related to each other, as captured by this model. Gephyrin is unusual in that it seems to be a tubulin-binding neuroprotein involved in the clustering of both blycine receptors and GABA receptors, rather than a protein of molybdenum cofactor biosynthesis.
Probab=46.25 E-value=1.1e+02 Score=28.03 Aligned_cols=66 Identities=15% Similarity=0.230 Sum_probs=42.3
Q ss_pred HHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecC
Q 008693 204 MSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLG 283 (557)
Q Consensus 204 lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlg 283 (557)
-|..++.+.|++.|++...+. ++.+ +.+.+.+.+.+ +.+..++.|++|-.|.+
T Consensus 27 ~n~~~l~~~l~~~G~~v~~~~-----~v~D-----------d~~~i~~~l~~-~~~~~DliIttGG~g~g---------- 79 (144)
T TIGR00177 27 SNGPLLAALLEEAGFNVSRLG-----IVPD-----------DPEEIREILRK-AVDEADVVLTTGGTGVG---------- 79 (144)
T ss_pred CcHHHHHHHHHHCCCeEEEEe-----ecCC-----------CHHHHHHHHHH-HHhCCCEEEECCCCCCC----------
Confidence 356678888999998765432 3322 23445555543 34456788998855433
Q ss_pred CCcchhHHHHHHHHc
Q 008693 284 RGGSDLTATTIGKAL 298 (557)
Q Consensus 284 RgGSD~tAa~lA~~L 298 (557)
.-|++..+++.+.
T Consensus 80 --~~D~t~~ai~~~g 92 (144)
T TIGR00177 80 --PRDVTPEALEELG 92 (144)
T ss_pred --CCccHHHHHHHhC
Confidence 2689999999876
No 265
>cd04883 ACT_AcuB C-terminal ACT domain of the Bacillus subtilis acetoin utilization protein, AcuB. This CD includes the C-terminal ACT domain of the Bacillus subtilis acetoin utilization protein, AcuB. AcuB is putatively involved in the anaerobic catabolism of acetoin, and related proteins. Studies report the induction of AcuB by nitrate respiration and also by fermentation. Since acetoin can be secreted and later serve as a source of carbon, it has been proposed that, during anaerobic growth when other carbon sources are exhausted, the induction of the AcuB protein results in acetoin catabolism. AcuB-like proteins have two N-terminal tandem CBS domains and a single C-terminal ACT domain. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=45.93 E-value=97 Score=23.99 Aligned_cols=26 Identities=27% Similarity=0.420 Sum_probs=22.9
Q ss_pred ccchhhHHHHHHHHHHhCCceEEEEE
Q 008693 405 MLGQYGFLAKVFSTFEDLGISVDVVA 430 (557)
Q Consensus 405 m~~~~g~la~If~~L~~~gI~Vd~Is 430 (557)
+.+.||.++++.+.|+++|+++..+.
T Consensus 8 ~~d~pG~l~~i~~~l~~~~inI~~i~ 33 (72)
T cd04883 8 VPDRPGQLADIAAIFKDRGVNIVSVL 33 (72)
T ss_pred ECCCCCHHHHHHHHHHHcCCCEEEEE
Confidence 45789999999999999999998764
No 266
>TIGR00719 sda_beta L-serine dehydratase, iron-sulfur-dependent, beta subunit. This family of enzymes is not homologous to the pyridoxal phosphate-dependent threonine deaminases and eukaryotic serine deaminases.
Probab=43.80 E-value=1.3e+02 Score=29.56 Aligned_cols=24 Identities=17% Similarity=0.414 Sum_probs=22.0
Q ss_pred chhhHHHHHHHHHHhCCceEEEEE
Q 008693 407 GQYGFLAKVFSTFEDLGISVDVVA 430 (557)
Q Consensus 407 ~~~g~la~If~~L~~~gI~Vd~Is 430 (557)
++||++.++-+.|.+++|||..+.
T Consensus 157 D~PG~Ig~vg~~Lg~~~iNIa~m~ 180 (208)
T TIGR00719 157 DKFGTIAGVANLLAGFEINIEHLE 180 (208)
T ss_pred CCCChHHHHHHHHHhCCccEEEEE
Confidence 589999999999999999998775
No 267
>PRK13011 formyltetrahydrofolate deformylase; Reviewed
Probab=42.95 E-value=99 Score=31.99 Aligned_cols=34 Identities=12% Similarity=0.121 Sum_probs=30.0
Q ss_pred eEEEEEccccccchHHHHHHHHHHhCCCcEEEEEec
Q 008693 475 SIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQG 510 (557)
Q Consensus 475 aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~Isqg 510 (557)
..|+++| .+.||+.+++.+.|++.|+||.-++|.
T Consensus 8 ~vitv~G--~DrpGIVa~VT~~La~~~vNI~dls~~ 41 (286)
T PRK13011 8 FVLTLSC--PSAAGIVAAVTGFLAEHGCYITELHSF 41 (286)
T ss_pred EEEEEEe--CCCCCHHHHHHHHHHhCCCCEEEeeee
Confidence 5688888 467999999999999999999998883
No 268
>cd04897 ACT_ACR_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=42.49 E-value=1.9e+02 Score=23.70 Aligned_cols=31 Identities=16% Similarity=0.184 Sum_probs=26.3
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCceEEEE
Q 008693 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV 429 (557)
Q Consensus 396 alItI~~~~m~~~~g~la~If~~L~~~gI~Vd~I 429 (557)
++|.|.. .++||.+.++...|.+.|++|..-
T Consensus 2 TvveV~~---~DRpGLL~~i~~~l~~~~l~I~~A 32 (75)
T cd04897 2 SVVTVQC---RDRPKLLFDVVCTLTDMDYVVFHA 32 (75)
T ss_pred EEEEEEe---CCcCcHHHHHHHHHHhCCeEEEEE
Confidence 4667765 478999999999999999999875
No 269
>cd04895 ACT_ACR_1 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the N-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=41.87 E-value=49 Score=26.94 Aligned_cols=31 Identities=19% Similarity=0.359 Sum_probs=26.0
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCceEEEE
Q 008693 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV 429 (557)
Q Consensus 396 alItI~~~~m~~~~g~la~If~~L~~~gI~Vd~I 429 (557)
++|.|.. .++||.+.++...|.+.|++|..-
T Consensus 2 Tviev~a---~DRpGLL~~i~~~l~~~gl~I~~A 32 (72)
T cd04895 2 TLVKVDS---ARKPGILLEAVQVLTDLDLCITKA 32 (72)
T ss_pred EEEEEEE---CCcCCHHHHHHHHHHHCCcEEEEE
Confidence 4566664 478999999999999999999875
No 270
>PRK03673 hypothetical protein; Provisional
Probab=41.58 E-value=92 Score=33.84 Aligned_cols=69 Identities=20% Similarity=0.238 Sum_probs=47.0
Q ss_pred HHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecC
Q 008693 204 MSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLG 283 (557)
Q Consensus 204 lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlg 283 (557)
-|+..++..|++.|++..... .+.| +.+.+.+.+... ++..++.|++|.+|-+.
T Consensus 21 tN~~~la~~L~~~G~~v~~~~-----~v~D-----------~~~~i~~~l~~a-~~~~DlVI~tGGlGpt~--------- 74 (396)
T PRK03673 21 TNAAWLADFFFHQGLPLSRRN-----TVGD-----------NLDALVAILRER-SQHADVLIVNGGLGPTS--------- 74 (396)
T ss_pred hHHHHHHHHHHHCCCEEEEEE-----EcCC-----------CHHHHHHHHHHH-hccCCEEEEcCCCCCCC---------
Confidence 477788999999999864432 2222 234455555543 45567889999776441
Q ss_pred CCcchhHHHHHHHHcCcC
Q 008693 284 RGGSDLTATTIGKALGLQ 301 (557)
Q Consensus 284 RgGSD~tAa~lA~~L~A~ 301 (557)
-|+|.-.+|.++|-.
T Consensus 75 ---dD~t~~avA~a~g~~ 89 (396)
T PRK03673 75 ---DDLSALAAATAAGEG 89 (396)
T ss_pred ---cccHHHHHHHHcCCC
Confidence 688999999999953
No 271
>PRK01215 competence damage-inducible protein A; Provisional
Probab=41.52 E-value=96 Score=31.67 Aligned_cols=70 Identities=21% Similarity=0.333 Sum_probs=46.9
Q ss_pred HHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeec
Q 008693 203 CMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTL 282 (557)
Q Consensus 203 ~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttl 282 (557)
--|+..++..|++.|++..... ++.+ +.+.+.+.+... ++..++.|++|.+|.+.
T Consensus 22 dtn~~~l~~~L~~~G~~v~~~~-----~v~D-----------d~~~I~~~l~~a-~~~~DlVIttGG~g~t~-------- 76 (264)
T PRK01215 22 NTNASWIARRLTYLGYTVRRIT-----VVMD-----------DIEEIVSAFREA-IDRADVVVSTGGLGPTY-------- 76 (264)
T ss_pred EhhHHHHHHHHHHCCCeEEEEE-----EeCC-----------CHHHHHHHHHHH-hcCCCEEEEeCCCcCCh--------
Confidence 3467788899999999864432 2322 234455555543 45567889988666442
Q ss_pred CCCcchhHHHHHHHHcCcC
Q 008693 283 GRGGSDLTATTIGKALGLQ 301 (557)
Q Consensus 283 gRgGSD~tAa~lA~~L~A~ 301 (557)
-|+|.-.++.+++-+
T Consensus 77 ----dD~t~eaia~~~g~~ 91 (264)
T PRK01215 77 ----DDKTNEGFAKALGVE 91 (264)
T ss_pred ----hhhHHHHHHHHhCCC
Confidence 799999999999853
No 272
>PF13511 DUF4124: Domain of unknown function (DUF4124)
Probab=41.35 E-value=23 Score=27.13 Aligned_cols=28 Identities=18% Similarity=0.324 Sum_probs=21.0
Q ss_pred HHHHHHcCcCcEEEeeCCCc--cccCCCCC
Q 008693 292 TTIGKALGLQEIQVWKDVDG--VLTCDPNI 319 (557)
Q Consensus 292 a~lA~~L~A~~l~i~TDVdG--V~taDP~~ 319 (557)
.+++....+..+.-|+|-+| +|++.|.-
T Consensus 4 l~l~~~a~aa~vYk~~D~~G~v~ysd~P~~ 33 (60)
T PF13511_consen 4 LLLAASAAAAEVYKWVDENGVVHYSDTPPP 33 (60)
T ss_pred HHHhHHHhhccEEEEECCCCCEEECccCCC
Confidence 34455555679999999999 68888763
No 273
>cd04876 ACT_RelA-SpoT ACT domain found C-terminal of the RelA/SpoT domains. ACT_RelA-SpoT: the ACT domain found C-terminal of the RelA/SpoT domains. Enzymes of the Rel/Spo family enable bacteria to survive prolonged periods of nutrient limitation by controlling guanosine-3'-diphosphate-5'-(tri)diphosphate ((p)ppGpp) production and subsequent rRNA repression (stringent response). Both the synthesis of (p)ppGpp from ATP and GDP(GTP), and its hydrolysis to GDP(GTP) and pyrophosphate, are catalyzed by Rel/Spo proteins. In Escherichia coli and its close relatives, the metabolism of (p)ppGpp is governed by two homologous proteins, RelA and SpoT. The RelA protein catalyzes (p)ppGpp synthesis in a reaction requiring its binding to ribosomes bearing codon-specified uncharged tRNA. The major role of the SpoT protein is the breakdown of (p)ppGpp by a manganese-dependent (p)ppGpp pyrophosphohydrolase activity. Although the stringent response appears to be tightly regulated by these two enzymes i
Probab=41.06 E-value=77 Score=23.10 Aligned_cols=24 Identities=21% Similarity=0.311 Sum_probs=21.1
Q ss_pred chhhHHHHHHHHHHhCCceEEEEE
Q 008693 407 GQYGFLAKVFSTFEDLGISVDVVA 430 (557)
Q Consensus 407 ~~~g~la~If~~L~~~gI~Vd~Is 430 (557)
+.+|.++++.+.|.++++++.-+.
T Consensus 7 ~~~~~l~~i~~~l~~~~~~i~~~~ 30 (71)
T cd04876 7 DRPGLLADITTVIAEEKINILSVN 30 (71)
T ss_pred ccCcHHHHHHHHHHhCCCCEEEEE
Confidence 578899999999999999998764
No 274
>COG0440 IlvH Acetolactate synthase, small (regulatory) subunit [Amino acid transport and metabolism]
Probab=40.88 E-value=36 Score=32.24 Aligned_cols=63 Identities=17% Similarity=0.361 Sum_probs=48.1
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCCce----EEEEEEec--ccHHHHHHHHHHHhccCccccccc
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGASKV----NISLIVND--DEAEQCVRALHETFFESDLANLDC 546 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~IsqgsSe~----sIs~vV~~--~d~~kAv~~LH~~f~~~~~~~~~~ 546 (557)
.+.||++.|+...+++-|.||..++-+.++. .+++++.. ...++..+.||+-.--.+..++..
T Consensus 12 ~ne~GvLsRv~glfsrRG~NIeSltv~~tE~~~~SRiTivv~g~~~~~EQi~kQL~kLidV~kV~d~~~ 80 (163)
T COG0440 12 ENEPGVLSRVTGLFSRRGYNIESLTVGPTETPGLSRITIVVSGDEQVLEQIIKQLNKLIDVLKVLDLTS 80 (163)
T ss_pred ECCCCeeehhhHHHHhcCcccceEEEEecCCCCceEEEEEEcCCcchHHHHHHHHHhhccceeEEEcCC
Confidence 4678999999999999999999988776553 47788887 337888888888765545554443
No 275
>PRK06027 purU formyltetrahydrofolate deformylase; Reviewed
Probab=40.30 E-value=99 Score=31.95 Aligned_cols=64 Identities=17% Similarity=0.134 Sum_probs=43.2
Q ss_pred eeEEEEEccccccchHHHHHHHHHHhCCCcEEEEEecC----CceEEEEEEec-------ccHHHHHHHHHHHhccC
Q 008693 474 RSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA----SKVNISLIVND-------DEAEQCVRALHETFFES 539 (557)
Q Consensus 474 ~aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~Isqgs----Se~sIs~vV~~-------~d~~kAv~~LH~~f~~~ 539 (557)
..+|+++| .+.||+.+++.+.|++.|+||.-+++.. ..-.+.+.++- ++.+++++.|-+++-..
T Consensus 6 ~~vitv~G--~DrpGIVa~Vt~~La~~g~NI~d~s~~~~~~~g~F~m~i~v~~~~~~~~~~~L~~~L~~l~~~l~l~ 80 (286)
T PRK06027 6 RYVLTLSC--PDRPGIVAAVSNFLYEHGGNIVDADQFVDPETGRFFMRVEFEGDGLIFNLETLRADFAALAEEFEMD 80 (286)
T ss_pred eEEEEEEC--CCCCcHHHHHHHHHHHCCCCEEEceeEEcCCCCeEEEEEEEEeCCCCCCHHHHHHHHHHHHHHhCCE
Confidence 35788888 4679999999999999999999877643 12233334443 23456666666665543
No 276
>cd04871 ACT_PSP_2 ACT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). The ACT_PSP_2 CD includes the second of the two ACT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). PSPs belong to the L-2-haloacid dehalogenase-like protein superfamily. PSP is involved in serine metabolism; serine is synthesized from phosphoglycerate through sequential reactions catalyzed by 3-phosphoglycerate dehydrogenase (SerA), 3-phosphoserine aminotransferase (SerC), and SerB. Members of this CD belong to the superfamily of ACT regulatory domains
Probab=39.91 E-value=24 Score=29.35 Aligned_cols=58 Identities=22% Similarity=0.399 Sum_probs=38.2
Q ss_pred EEEEEcc-ccccchHHHHHHHHHHhCCCcEEEEEecCC-----------ceEEEEEEecccHHHHHHHHHHHhc
Q 008693 476 IISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGAS-----------KVNISLIVNDDEAEQCVRALHETFF 537 (557)
Q Consensus 476 iIsIVG~-~~~~~~v~~rif~~L~~~gInI~~IsqgsS-----------e~sIs~vV~~~d~~kAv~~LH~~f~ 537 (557)
+|+++|. + +.+.++++.+.|+++|+||.-|++=+. ...+.|-++..+ .....|.++|.
T Consensus 1 ivtvlg~~~--~a~~ia~Vs~~lA~~~~NI~~I~~l~~~~~~~~~~~~~~~~~e~~v~~~~--~~~~~lr~~L~ 70 (84)
T cd04871 1 IVTLLGRPL--TAEQLAAVTRVVADQGLNIDRIRRLSGRVPLEEQDDSPKACVEFSVRGQP--ADLEALRAALL 70 (84)
T ss_pred CEEEEcCcC--CHHHHHHHHHHHHHcCCCHHHHHHhhccccccccCCCCcEEEEEEEeCCC--CCHHHHHHHHH
Confidence 4788885 3 568999999999999999987766321 224556666443 23444555444
No 277
>cd04884 ACT_CBS C-terminal ACT domain of the cystathionine beta-synthase (CBS) domain protein found in Thermotoga maritima, Tm0935, and delta proteobacteria. This CD includes the C-terminal ACT domain of the cystathionine beta-synthase (CBS) domain protein found in Thermotoga maritima, Tm0935, and delta proteobacteria. This protein has two N-terminal tandem CBS domains and a single C-terminal ACT domain. The CBS domain is found in a wide range of proteins, often in tandem arrangements and together with a variety of other functional domains. It has been proposed that the CBS domain may play a regulatory role, although its exact function is unknown. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=39.58 E-value=45 Score=26.31 Aligned_cols=26 Identities=15% Similarity=0.247 Sum_probs=23.0
Q ss_pred ccchhhHHHHHHHHHHhCCceEEEEE
Q 008693 405 MLGQYGFLAKVFSTFEDLGISVDVVA 430 (557)
Q Consensus 405 m~~~~g~la~If~~L~~~gI~Vd~Is 430 (557)
+.+.||.++++.+.|+++|+||..+.
T Consensus 6 ~~d~pG~L~~l~~~i~~~g~nI~~i~ 31 (72)
T cd04884 6 LEDKPGTLKPVVDTLREFNARIISIL 31 (72)
T ss_pred ecCCCccHHHHHHHHHHCCCeEEEEE
Confidence 45789999999999999999998664
No 278
>cd04896 ACT_ACR-like_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=39.06 E-value=1.9e+02 Score=23.70 Aligned_cols=30 Identities=27% Similarity=0.401 Sum_probs=24.8
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCceEEEE
Q 008693 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV 429 (557)
Q Consensus 397 lItI~~~~m~~~~g~la~If~~L~~~gI~Vd~I 429 (557)
++.|.. .++||.++++...|.+.|++|...
T Consensus 2 vlev~a---~DRpGLL~~i~~~l~~~~l~i~~A 31 (75)
T cd04896 2 LLQIRC---VDQKGLLYDILRTSKDCNIQISYG 31 (75)
T ss_pred EEEEEe---CCcccHHHHHHHHHHHCCeEEEEE
Confidence 345553 478999999999999999999875
No 279
>cd04897 ACT_ACR_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=38.39 E-value=2.1e+02 Score=23.50 Aligned_cols=49 Identities=10% Similarity=0.134 Sum_probs=35.6
Q ss_pred eEEEEEccccccchHHHHHHHHHHhCCCcEEE--EEecCCceEEEEEEecccH
Q 008693 475 SIISLIGNVQRSSLILEKAFRVLRRSGVNVQM--ISQGASKVNISLIVNDDEA 525 (557)
Q Consensus 475 aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~--IsqgsSe~sIs~vV~~~d~ 525 (557)
++|.|.+ .+.||.+.++..+|.+.|++|.. |++-....-=.|.|...+.
T Consensus 2 TvveV~~--~DRpGLL~~i~~~l~~~~l~I~~A~I~T~gera~D~FyV~d~~g 52 (75)
T cd04897 2 SVVTVQC--RDRPKLLFDVVCTLTDMDYVVFHATIDTDGDDAHQEYYIRHKDG 52 (75)
T ss_pred EEEEEEe--CCcCcHHHHHHHHHHhCCeEEEEEEEeecCceEEEEEEEEcCCC
Confidence 3445544 56899999999999999999986 6665555555677755543
No 280
>COG4492 PheB ACT domain-containing protein [General function prediction only]
Probab=37.45 E-value=1.7e+02 Score=26.95 Aligned_cols=62 Identities=26% Similarity=0.370 Sum_probs=44.6
Q ss_pred eEEEEEccccccchHHHHHHHHHHhCCCcEEEEEecC---CceEEEEEEecccHHHHHHHHHHHh
Q 008693 475 SIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA---SKVNISLIVNDDEAEQCVRALHETF 536 (557)
Q Consensus 475 aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~Isqgs---Se~sIs~vV~~~d~~kAv~~LH~~f 536 (557)
-++++.=.+....|.++++++++++.++||+-|.|.- ...++++.++.+-.+.-+..|-+.+
T Consensus 71 ri~TL~l~ledr~G~LS~vLd~iA~~~~nvLTI~Q~ipl~g~Anvtlsi~~ssm~~~V~~ii~kl 135 (150)
T COG4492 71 RIITLSLSLEDRVGILSDVLDVIAREEINVLTIHQTIPLQGRANVTLSIDTSSMEKDVDKIIEKL 135 (150)
T ss_pred eEEEEEEEEhhhhhhHHHHHHHHHHhCCcEEEEecccccCceeeEEEEEEchhhhhhHHHHHHHH
Confidence 3455555567788999999999999999999999853 3445677777665555555554444
No 281
>PRK13581 D-3-phosphoglycerate dehydrogenase; Provisional
Probab=37.18 E-value=90 Score=35.15 Aligned_cols=85 Identities=16% Similarity=0.195 Sum_probs=50.7
Q ss_pred HhHHHHHHhCCCCEEEecCC-CCCCCCeeEec-CCCCCcceeeEEeeecc-EEEEEEEe-------cC------ccchhh
Q 008693 347 PQSMRPAREGDIPVRVKNSY-NPNAPGTLIRR-SRDMSKAVLTSIVLKRN-VTMLDIVS-------TR------MLGQYG 410 (557)
Q Consensus 347 p~a~~~a~~~~Ipv~I~n~~-~p~~~GT~I~~-~~~~~~~~Vt~Is~~~n-ialItI~~-------~~------m~~~~g 410 (557)
+.|...|++.||.+...... .+.+|.|.-.. ..+.....+.|.+.-.+ +-++.|.+ .+ ..+.||
T Consensus 385 ~nA~~iA~e~GI~~~~~~~~~~~~hpNtv~i~l~~~~~~~~v~G~s~ggg~~~I~~ing~~v~~~~~~~~li~~~~D~pG 464 (526)
T PRK13581 385 VNAPLLAKERGIEVEESKSEESPDYSNLITVTVTTDDGERSVAGTVFGDGEPRIVEIDGYRVDAKPEGHMLIIRNRDRPG 464 (526)
T ss_pred cCHHHHHHHcCCEEEEEEecCCCCCCCEEEEEEEeCCeEEEEEEEEecCCceEEEEECCEEEEeeCCceEEEEEeCCcCC
Confidence 45888999999998765432 33466664332 11111223444443222 23333322 11 136899
Q ss_pred HHHHHHHHHHhCCceEEEEEc
Q 008693 411 FLAKVFSTFEDLGISVDVVAT 431 (557)
Q Consensus 411 ~la~If~~L~~~gI~Vd~Ist 431 (557)
.++++-+.|.+++|||..+..
T Consensus 465 ~I~~v~~~L~~~~iNIa~m~~ 485 (526)
T PRK13581 465 VIGKVGTLLGEAGINIAGMQL 485 (526)
T ss_pred hhHHHHHHHhhcCCCchhcEe
Confidence 999999999999999987753
No 282
>smart00852 MoCF_biosynth Probable molybdopterin binding domain. This domain is found a variety of proteins involved in biosynthesis of molybdopterin cofactor. The domain is presumed to bind molybdopterin. The structure of this domain is known, and it forms an alpha/beta structure. In the known structure of Gephyrin this domain mediates trimerisation.
Probab=36.84 E-value=1.5e+02 Score=26.47 Aligned_cols=69 Identities=23% Similarity=0.365 Sum_probs=44.3
Q ss_pred HHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeec
Q 008693 203 CMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTL 282 (557)
Q Consensus 203 ~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttl 282 (557)
.-|..++++.|++.|....... ++. | +.+.+.+.+.. +.+..++.|++|-.|.+
T Consensus 17 d~~~~~l~~~l~~~G~~~~~~~-----~v~-D----------d~~~I~~~l~~-~~~~~dliittGG~g~g--------- 70 (135)
T smart00852 17 DSNGPALAELLTELGIEVTRYV-----IVP-D----------DKEAIKEALRE-ALERADLVITTGGTGPG--------- 70 (135)
T ss_pred cCcHHHHHHHHHHCCCeEEEEE-----EeC-C----------CHHHHHHHHHH-HHhCCCEEEEcCCCCCC---------
Confidence 4466788889999998754432 232 1 23445555543 34456788888855533
Q ss_pred CCCcchhHHHHHHHHcCc
Q 008693 283 GRGGSDLTATTIGKALGL 300 (557)
Q Consensus 283 gRgGSD~tAa~lA~~L~A 300 (557)
-.|++-..++.+++.
T Consensus 71 ---~~D~t~~~l~~~~~~ 85 (135)
T smart00852 71 ---PDDVTPEAVAEALGK 85 (135)
T ss_pred ---CCcCcHHHHHHHhCC
Confidence 268888889888763
No 283
>cd04873 ACT_UUR-ACR-like ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD. This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted t
Probab=36.36 E-value=1.3e+02 Score=22.83 Aligned_cols=41 Identities=20% Similarity=0.234 Sum_probs=29.3
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecC--CceEEEEEEeccc
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGA--SKVNISLIVNDDE 524 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~Isqgs--Se~sIs~vV~~~d 524 (557)
.+.+|+++++...|.+.|++|..+.... ......|.+...+
T Consensus 8 ~d~~g~l~~i~~~l~~~~~~I~~~~~~~~~~~~~~~~~v~~~~ 50 (70)
T cd04873 8 PDRPGLLADITRVLADLGLNIHDARISTTGERALDVFYVTDSD 50 (70)
T ss_pred CCCCCHHHHHHHHHHHCCCeEEEEEEeecCCEEEEEEEEECCC
Confidence 4678999999999999999997644332 2444566665544
No 284
>TIGR01327 PGDH D-3-phosphoglycerate dehydrogenase. This model represents a long form of D-3-phosphoglycerate dehydrogenase, the serA gene of one pathway of serine biosynthesis. Shorter forms, scoring between trusted and noise cutoff, include SerA from E. coli.
Probab=36.32 E-value=83 Score=35.41 Aligned_cols=84 Identities=19% Similarity=0.232 Sum_probs=50.9
Q ss_pred HhHHHHHHhCCCCEEEecCC-CCCCCCeeEec-CCCCCcceeeEEeeec-cEEEEEEEecC-------------ccchhh
Q 008693 347 PQSMRPAREGDIPVRVKNSY-NPNAPGTLIRR-SRDMSKAVLTSIVLKR-NVTMLDIVSTR-------------MLGQYG 410 (557)
Q Consensus 347 p~a~~~a~~~~Ipv~I~n~~-~p~~~GT~I~~-~~~~~~~~Vt~Is~~~-nialItI~~~~-------------m~~~~g 410 (557)
+.|...|++.||.+...... .+.+|.|.-.. ..+.....+.|.+.-. .+-++.|.+.. ..++||
T Consensus 384 ~nA~~iA~e~GI~v~~~~~~~~~~hpNtv~i~l~~~~~~~~v~G~s~gGg~~~I~~ing~~v~~~~~~~~li~~~~D~pG 463 (525)
T TIGR01327 384 VNAPAVAKERGITVEESKSESSPDYKNYLSVTVTGDSGTVSVAGTVFGGFSPRIVEIDGFHVDLEPEGIMLIILHLDKPG 463 (525)
T ss_pred cCHHHHHHHcCCEEEEEEccCCCCCCCEEEEEEEeCCcEEEEEEEEecCCcEEEEEECCEEEEEecCccEEEEEecCcCC
Confidence 45889999999998665433 33467664322 1111222355555433 23333333211 135799
Q ss_pred HHHHHHHHHHhCCceEEEEE
Q 008693 411 FLAKVFSTFEDLGISVDVVA 430 (557)
Q Consensus 411 ~la~If~~L~~~gI~Vd~Is 430 (557)
+++++.+.|.+++|||-.+.
T Consensus 464 ~I~~v~~~L~~~~iNIa~m~ 483 (525)
T TIGR01327 464 VIGKVGTLLGTAGINIASMQ 483 (525)
T ss_pred cchHHHhHHhhcCCChHHcE
Confidence 99999999999999997664
No 285
>PRK08198 threonine dehydratase; Provisional
Probab=35.11 E-value=1.5e+02 Score=32.03 Aligned_cols=45 Identities=18% Similarity=0.285 Sum_probs=36.3
Q ss_pred cccccchHHHHHHHHHHhCCCcEEEEEecC-------CceEEEEEEecccHH
Q 008693 482 NVQRSSLILEKAFRVLRRSGVNVQMISQGA-------SKVNISLIVNDDEAE 526 (557)
Q Consensus 482 ~~~~~~~v~~rif~~L~~~gInI~~Isqgs-------Se~sIs~vV~~~d~~ 526 (557)
.+.+.||.++++++.+++.|.||.-|.|.- ....+++.++-.+.+
T Consensus 333 ~l~D~PG~L~~ll~~i~~~g~NI~~i~~~~~~~~~~~~~~~v~v~ie~~~~~ 384 (404)
T PRK08198 333 RLPDRPGQLAKLLSIIAELGANVIDVDHDRFSPDLRLGEVEVELTLETRGPE 384 (404)
T ss_pred EeCCCCCHHHHHHHHHhhCCCceEEEEEEEccCCCCCceEEEEEEEEeCCHH
Confidence 567889999999999999999999888852 346678888876644
No 286
>cd05014 SIS_Kpsf KpsF-like protein. KpsF is an arabinose-5-phosphate isomerase which contains SIS (Sugar ISomerase) domains. SIS domains are found in many phosphosugar isomerases and phosphosugar binding proteins. KpsF catalyzes the reversible reaction of ribulose 5-phosphate to arabinose 5-phosphate. This is the second step in the CMP-Kdo biosynthesis pathway.
Probab=34.84 E-value=1.4e+02 Score=25.94 Aligned_cols=78 Identities=13% Similarity=0.083 Sum_probs=42.3
Q ss_pred CceeecCCCcchhHHHHHHHHcCc--CcEEEeeCCCccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHH
Q 008693 277 CAITTLGRGGSDLTATTIGKALGL--QEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAR 354 (557)
Q Consensus 277 G~~ttlgRgGSD~tAa~lA~~L~A--~~l~i~TDVdGV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~ 354 (557)
|.+..+|+|+|...|-.++..|.. ..+..+.|...++. ++........+=-+| +.|..----++++.|+
T Consensus 1 ~~I~i~G~G~S~~~a~~~~~~l~~~g~~~~~~~~~~~~~~-~~~~~~~~d~vi~iS--------~sG~t~~~~~~~~~a~ 71 (128)
T cd05014 1 GKVVVTGVGKSGHIARKIAATLSSTGTPAFFLHPTEALHG-DLGMVTPGDVVIAIS--------NSGETDELLNLLPHLK 71 (128)
T ss_pred CeEEEEeCcHhHHHHHHHHHHhhcCCCceEEcccchhhcc-ccCcCCCCCEEEEEe--------CCCCCHHHHHHHHHHH
Confidence 457788999999999999988852 23444444332221 111111111111122 2222222234588899
Q ss_pred hCCCCEEEe
Q 008693 355 EGDIPVRVK 363 (557)
Q Consensus 355 ~~~Ipv~I~ 363 (557)
+.|+|+...
T Consensus 72 ~~g~~vi~i 80 (128)
T cd05014 72 RRGAPIIAI 80 (128)
T ss_pred HCCCeEEEE
Confidence 999996654
No 287
>TIGR02667 moaB_proteo molybdenum cofactor biosynthesis protein B, proteobacterial. This model represents the MoaB protein molybdopterin biosynthesis regions in Proteobacteria. This crystallized but incompletely characterized protein is thought to be involved in, though not required for, early steps in molybdopterin biosynthesis. It may bind a molybdopterin precursor. A distinctive conserved motif PCN near the C-terminus helps distinguish this clade from other homologs, including sets of proteins designated MogA.
Probab=34.18 E-value=1.5e+02 Score=27.91 Aligned_cols=69 Identities=14% Similarity=0.201 Sum_probs=43.4
Q ss_pred HHHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhch-hcCCceEEEcCCCcccCCCCceee
Q 008693 203 CMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDW-ITDLAIPIVTGFLGKAWRTCAITT 281 (557)
Q Consensus 203 ~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~l-l~~~~vpVv~Gfig~~~~~G~~tt 281 (557)
--|...++++|++.|++...+ +++.+ +.+.+.+.+.+.+ ....++.|++|..|.+
T Consensus 21 d~n~~~l~~~L~~~G~~v~~~-----~iv~D-----------d~~~i~~~l~~~~~~~~~DlVIttGGtg~g-------- 76 (163)
T TIGR02667 21 DTSGQYLVERLTEAGHRLADR-----AIVKD-----------DIYQIRAQVSAWIADPDVQVILITGGTGFT-------- 76 (163)
T ss_pred CCcHHHHHHHHHHCCCeEEEE-----EEcCC-----------CHHHHHHHHHHHHhcCCCCEEEECCCcCCC--------
Confidence 446677888899999875443 23432 2344555555422 1345788998865543
Q ss_pred cCCCcchhHHHHHHHHcC
Q 008693 282 LGRGGSDLTATTIGKALG 299 (557)
Q Consensus 282 lgRgGSD~tAa~lA~~L~ 299 (557)
--|++.-+++..++
T Consensus 77 ----~~D~t~eal~~l~~ 90 (163)
T TIGR02667 77 ----GRDVTPEALEPLFD 90 (163)
T ss_pred ----CCCCcHHHHHHHHC
Confidence 26888888887765
No 288
>TIGR02726 phenyl_P_delta phenylphosphate carboxylase, delta subunit. Members of this protein family are the alpha subunit of phenylphosphate carboxylase. Phenol (methyl-benzene) is converted to phenylphosphate, then para-carboxylated by this four-subunit enzyme, with the release of phosphate, to 4-hydroxybenzoate. The enzyme contains neither biotin nor thiamin pyrophosphate. This delta subunit belongs to HAD family hydrolases.
Probab=34.00 E-value=24 Score=33.47 Aligned_cols=48 Identities=23% Similarity=0.144 Sum_probs=27.8
Q ss_pred EEeeCCCccccCCCCCCC--CCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecC
Q 008693 304 QVWKDVDGVLTCDPNIHP--HAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNS 365 (557)
Q Consensus 304 ~i~TDVdGV~taDP~~v~--~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~ 365 (557)
.+.+|+|||+|.+ +++- .....+..+. -. --++..+++.|+++.|.+.
T Consensus 9 ~~v~d~dGv~tdg-~~~~~~~g~~~~~~~~--~D-----------~~~~~~L~~~Gi~laIiT~ 58 (169)
T TIGR02726 9 LVILDVDGVMTDG-RIVINDEGIESRNFDI--KD-----------GMGVIVLQLCGIDVAIITS 58 (169)
T ss_pred EEEEeCceeeECC-eEEEcCCCcEEEEEec--ch-----------HHHHHHHHHCCCEEEEEEC
Confidence 3567999999954 3322 2222222222 11 2246777889999887653
No 289
>cd04926 ACT_ACR_4 C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=33.92 E-value=1.1e+02 Score=24.22 Aligned_cols=40 Identities=25% Similarity=0.307 Sum_probs=28.1
Q ss_pred ccccchHHHHHHHHHHhCCCcEEE--EEecCCceEEEEEEec
Q 008693 483 VQRSSLILEKAFRVLRRSGVNVQM--ISQGASKVNISLIVND 522 (557)
Q Consensus 483 ~~~~~~v~~rif~~L~~~gInI~~--IsqgsSe~sIs~vV~~ 522 (557)
+.+.+|+++++..+|++.|+||.. +.+.....-.+|.|..
T Consensus 8 ~~D~~Gll~~i~~~l~~~~lnI~sa~i~t~~~~~~d~f~v~~ 49 (72)
T cd04926 8 TEDRVGLLSDVTRVFRENGLTVTRAEISTQGDMAVNVFYVTD 49 (72)
T ss_pred ECCccCHHHHHHHHHHHCCcEEEEEEEecCCCeEEEEEEEEC
Confidence 346799999999999999999974 3332223345666643
No 290
>COG0440 IlvH Acetolactate synthase, small (regulatory) subunit [Amino acid transport and metabolism]
Probab=33.63 E-value=54 Score=31.07 Aligned_cols=37 Identities=14% Similarity=0.337 Sum_probs=30.1
Q ss_pred chhhHHHHHHHHHHhCCceEEEEEcc------CceeEEEeCCc
Q 008693 407 GQYGFLAKVFSTFEDLGISVDVVATS------EVSLSLTLDPS 443 (557)
Q Consensus 407 ~~~g~la~If~~L~~~gI~Vd~IstS------e~sIS~~I~~~ 443 (557)
+.||.++++...|++.|+|++.++.. ...+++.+..+
T Consensus 13 ne~GvLsRv~glfsrRG~NIeSltv~~tE~~~~SRiTivv~g~ 55 (163)
T COG0440 13 NEPGVLSRVTGLFSRRGYNIESLTVGPTETPGLSRITIVVSGD 55 (163)
T ss_pred CCCCeeehhhHHHHhcCcccceEEEEecCCCCceEEEEEEcCC
Confidence 68999999999999999999998632 35677777763
No 291
>cd04871 ACT_PSP_2 ACT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). The ACT_PSP_2 CD includes the second of the two ACT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). PSPs belong to the L-2-haloacid dehalogenase-like protein superfamily. PSP is involved in serine metabolism; serine is synthesized from phosphoglycerate through sequential reactions catalyzed by 3-phosphoglycerate dehydrogenase (SerA), 3-phosphoserine aminotransferase (SerC), and SerB. Members of this CD belong to the superfamily of ACT regulatory domains
Probab=33.32 E-value=39 Score=28.09 Aligned_cols=31 Identities=19% Similarity=0.342 Sum_probs=24.6
Q ss_pred EEEEecCccchhhHHHHHHHHHHhCCceEEEEE
Q 008693 398 LDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVA 430 (557)
Q Consensus 398 ItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Is 430 (557)
||+-|..+ ..+.++++-+.|+++|+||+-+.
T Consensus 2 vtvlg~~~--~a~~ia~Vs~~lA~~~~NI~~I~ 32 (84)
T cd04871 2 VTLLGRPL--TAEQLAAVTRVVADQGLNIDRIR 32 (84)
T ss_pred EEEEcCcC--CHHHHHHHHHHHHHcCCCHHHHH
Confidence 45655432 67899999999999999998774
No 292
>COG3602 Uncharacterized protein conserved in bacteria [Function unknown]
Probab=32.57 E-value=30 Score=30.69 Aligned_cols=46 Identities=20% Similarity=0.273 Sum_probs=34.8
Q ss_pred EEeeeccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccC
Q 008693 388 SIVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSE 433 (557)
Q Consensus 388 ~Is~~~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe 433 (557)
|..+.--+.+|++.-..-+...|+.+.+-..|+++||+..+++-.-
T Consensus 63 Gl~~~~~~~lITL~VhSsLeaVGltAA~ataLa~aGis~Nvvaayy 108 (134)
T COG3602 63 GLSYSAVCRLITLNVHSSLEAVGLTAAFATALAEAGISCNVVAAYY 108 (134)
T ss_pred CCCccceeeeEEeehhhhhhhhhHHHHHHHHHHHcCcccchhhhhh
Confidence 4444555677776654456789999999999999999999886543
No 293
>cd00886 MogA_MoaB MogA_MoaB family. Members of this family are involved in biosynthesis of the molybdenum cofactor (MoCF) an essential cofactor of a diverse group of redox enzymes. MoCF biosynthesis is an evolutionarily conserved pathway present in eubacteria, archaea, and eukaryotes. MoCF contains a tricyclic pyranopterin, termed molybdopterin (MPT). MogA, together with MoeA, is responsible for the metal incorporation into MPT, the third step in MoCF biosynthesis. The plant homolog Cnx1 is a MoeA-MogA fusion protein. The mammalian homolog gephyrin is a MogA-MoeA fusion protein, that plays a critical role in postsynaptic anchoring of inhibitory glycine receptors and major GABAa receptor subtypes. In contrast, MoaB shows high similarity to MogA, but little is known about its physiological role. All well studied members of this family form highly stable trimers.
Probab=32.49 E-value=1.7e+02 Score=26.89 Aligned_cols=66 Identities=18% Similarity=0.203 Sum_probs=42.0
Q ss_pred HHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhc--CCceEEEcCCCcccCCCCceeec
Q 008693 205 STRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWIT--DLAIPIVTGFLGKAWRTCAITTL 282 (557)
Q Consensus 205 sa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~--~~~vpVv~Gfig~~~~~G~~ttl 282 (557)
|..+++++|++.|.+.... +++.+ +.+.+.+.+... .+ ..++.|++|-.+.+
T Consensus 21 n~~~l~~~l~~~G~~v~~~-----~~v~D-----------d~~~i~~~l~~~-~~~~~~DlVittGG~s~g--------- 74 (152)
T cd00886 21 SGPALVELLEEAGHEVVAY-----EIVPD-----------DKDEIREALIEW-ADEDGVDLILTTGGTGLA--------- 74 (152)
T ss_pred hHHHHHHHHHHcCCeeeeE-----EEcCC-----------CHHHHHHHHHHH-HhcCCCCEEEECCCcCCC---------
Confidence 5667888999999865432 23322 234455555432 34 55788998865543
Q ss_pred CCCcchhHHHHHHHHcC
Q 008693 283 GRGGSDLTATTIGKALG 299 (557)
Q Consensus 283 gRgGSD~tAa~lA~~L~ 299 (557)
.-|++...++..++
T Consensus 75 ---~~D~t~~al~~~~~ 88 (152)
T cd00886 75 ---PRDVTPEATRPLLD 88 (152)
T ss_pred ---CCcCcHHHHHHHhC
Confidence 16888888888874
No 294
>cd00758 MoCF_BD MoCF_BD: molybdenum cofactor (MoCF) binding domain (BD). This domain is found a variety of proteins involved in biosynthesis of molybdopterin cofactor, like MoaB, MogA, and MoeA. The domain is presumed to bind molybdopterin.
Probab=32.20 E-value=2.1e+02 Score=25.55 Aligned_cols=66 Identities=14% Similarity=0.174 Sum_probs=42.1
Q ss_pred HHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecC
Q 008693 204 MSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLG 283 (557)
Q Consensus 204 lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlg 283 (557)
-|..++.+.|++.|.+..... ++.+ +...+.+.+.+. +++.++.|++|-.|.+
T Consensus 19 ~n~~~l~~~l~~~G~~v~~~~-----~v~D-----------d~~~i~~~i~~~-~~~~DlvittGG~g~g---------- 71 (133)
T cd00758 19 TNGPALEALLEDLGCEVIYAG-----VVPD-----------DADSIRAALIEA-SREADLVLTTGGTGVG---------- 71 (133)
T ss_pred chHHHHHHHHHHCCCEEEEee-----ecCC-----------CHHHHHHHHHHH-HhcCCEEEECCCCCCC----------
Confidence 467788888999997654321 2221 234455555543 4456788998866543
Q ss_pred CCcchhHHHHHHHHc
Q 008693 284 RGGSDLTATTIGKAL 298 (557)
Q Consensus 284 RgGSD~tAa~lA~~L 298 (557)
--|++.-.++.+.
T Consensus 72 --~~D~t~~ai~~~g 84 (133)
T cd00758 72 --RRDVTPEALAELG 84 (133)
T ss_pred --CCcchHHHHHHhc
Confidence 2788888888765
No 295
>cd04909 ACT_PDH-BS C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH). The C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH) enzyme that catalyzes the formation of 4-hydroxyphenylpyruvate from prephenate, found in Bacillus subtilis (BS) and other Firmicutes, Deinococci, and Bacteroidetes. PDH is the first enzyme in the aromatic amino acid pathway specific for the biosynthesis of tyrosine. This enzyme is feedback-inhibited by tyrosine in B. subtilis and other microorganisms. Both phenylalanine and tryptophan have been shown to be inhibitors of this activity in B. subtilis. Bifunctional chorismate mutase-PDH (TyrA) enzymes such as those seen in Escherichia coli do not contain an ACT domain. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=32.16 E-value=65 Score=24.94 Aligned_cols=26 Identities=27% Similarity=0.436 Sum_probs=22.7
Q ss_pred ccchhhHHHHHHHHHHhCCceEEEEE
Q 008693 405 MLGQYGFLAKVFSTFEDLGISVDVVA 430 (557)
Q Consensus 405 m~~~~g~la~If~~L~~~gI~Vd~Is 430 (557)
+.+.||.++++.+.|+++|+++.-+.
T Consensus 8 ~~d~~G~L~~l~~~l~~~~i~i~~~~ 33 (69)
T cd04909 8 VPDEPGVIAEVTQILGDAGISIKNIE 33 (69)
T ss_pred cCCCCCHHHHHHHHHHHcCCCceeeE
Confidence 45789999999999999999997663
No 296
>cd04899 ACT_ACR-UUR-like_2 C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains. This ACT domain family, ACT_ACR-UUR-like_2, includes the second of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the second and fourth ACT domains of a novel protein composed almost entirely of ACT domain repeats, the ACR protein. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=32.03 E-value=72 Score=24.62 Aligned_cols=30 Identities=27% Similarity=0.587 Sum_probs=24.6
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCceEEEE
Q 008693 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV 429 (557)
Q Consensus 397 lItI~~~~m~~~~g~la~If~~L~~~gI~Vd~I 429 (557)
++.+.. .+++|.++++...|++.+++|..+
T Consensus 2 ~l~v~~---~d~~gll~~i~~~l~~~~~~I~~~ 31 (70)
T cd04899 2 VLELTA---LDRPGLLADVTRVLAELGLNIHSA 31 (70)
T ss_pred EEEEEE---cCCccHHHHHHHHHHHCCCeEEEE
Confidence 455553 468999999999999999999765
No 297
>PRK00549 competence damage-inducible protein A; Provisional
Probab=31.90 E-value=1.8e+02 Score=31.73 Aligned_cols=69 Identities=22% Similarity=0.257 Sum_probs=46.2
Q ss_pred HHHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecC
Q 008693 204 MSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLG 283 (557)
Q Consensus 204 lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlg 283 (557)
-|+..++..|++.|++..... ++.+ +.+.+.+.+.. ..+..++.|++|.+|.+.
T Consensus 20 tN~~~L~~~L~~~G~~v~~~~-----~v~D-----------d~~~I~~~l~~-a~~~~DlVItTGGlGpt~--------- 73 (414)
T PRK00549 20 TNAQFLSEKLAELGIDVYHQT-----VVGD-----------NPERLLSALEI-AEERSDLIITTGGLGPTK--------- 73 (414)
T ss_pred hhHHHHHHHHHHCCCeEEEEE-----EeCC-----------CHHHHHHHHHH-hccCCCEEEECCCCCCCC---------
Confidence 467778899999999764432 2322 23445555543 234567889999776542
Q ss_pred CCcchhHHHHHHHHcCcC
Q 008693 284 RGGSDLTATTIGKALGLQ 301 (557)
Q Consensus 284 RgGSD~tAa~lA~~L~A~ 301 (557)
-|+|.-.++.+++.+
T Consensus 74 ---dD~t~ea~a~~~g~~ 88 (414)
T PRK00549 74 ---DDLTKETVAKFLGRE 88 (414)
T ss_pred ---CccHHHHHHHHhCCC
Confidence 788999999999854
No 298
>cd04876 ACT_RelA-SpoT ACT domain found C-terminal of the RelA/SpoT domains. ACT_RelA-SpoT: the ACT domain found C-terminal of the RelA/SpoT domains. Enzymes of the Rel/Spo family enable bacteria to survive prolonged periods of nutrient limitation by controlling guanosine-3'-diphosphate-5'-(tri)diphosphate ((p)ppGpp) production and subsequent rRNA repression (stringent response). Both the synthesis of (p)ppGpp from ATP and GDP(GTP), and its hydrolysis to GDP(GTP) and pyrophosphate, are catalyzed by Rel/Spo proteins. In Escherichia coli and its close relatives, the metabolism of (p)ppGpp is governed by two homologous proteins, RelA and SpoT. The RelA protein catalyzes (p)ppGpp synthesis in a reaction requiring its binding to ribosomes bearing codon-specified uncharged tRNA. The major role of the SpoT protein is the breakdown of (p)ppGpp by a manganese-dependent (p)ppGpp pyrophosphohydrolase activity. Although the stringent response appears to be tightly regulated by these two enzymes i
Probab=30.86 E-value=2.1e+02 Score=20.64 Aligned_cols=40 Identities=13% Similarity=0.183 Sum_probs=27.4
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCCc---eEEEEEEecc
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGASK---VNISLIVNDD 523 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~IsqgsSe---~sIs~vV~~~ 523 (557)
.+.++.+.++.+.|++.++++.-+....+. ..+.+.+...
T Consensus 6 ~~~~~~l~~i~~~l~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 48 (71)
T cd04876 6 IDRPGLLADITTVIAEEKINILSVNTRTDDDGLATIRLTLEVR 48 (71)
T ss_pred eccCcHHHHHHHHHHhCCCCEEEEEeEECCCCEEEEEEEEEEC
Confidence 356788999999999999999876553332 2344445433
No 299
>cd04896 ACT_ACR-like_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=30.82 E-value=2e+02 Score=23.60 Aligned_cols=38 Identities=18% Similarity=0.295 Sum_probs=28.3
Q ss_pred cccchHHHHHHHHHHhCCCcEEE--EE--e-cCCceEEEEEEec
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQM--IS--Q-GASKVNISLIVND 522 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~--Is--q-gsSe~sIs~vV~~ 522 (557)
.+.||++.++.++|.+.|++|.. |+ + |..... +|+|+.
T Consensus 8 ~DRpGLL~~i~~~l~~~~l~i~~AkI~~~T~Gerv~D-~Fyv~~ 50 (75)
T cd04896 8 VDQKGLLYDILRTSKDCNIQISYGRFSSKVKGYREVD-LFIVQS 50 (75)
T ss_pred CCcccHHHHHHHHHHHCCeEEEEEEEecCcccCEEEE-EEEEeC
Confidence 46799999999999999999986 66 3 434444 455544
No 300
>COG2150 Predicted regulator of amino acid metabolism, contains ACT domain [General function prediction only]
Probab=30.53 E-value=2.1e+02 Score=27.19 Aligned_cols=36 Identities=28% Similarity=0.346 Sum_probs=27.9
Q ss_pred chhhHHHHHHHHHHhCCceEEEEEcc------CceeEEEeCC
Q 008693 407 GQYGFLAKVFSTFEDLGISVDVVATS------EVSLSLTLDP 442 (557)
Q Consensus 407 ~~~g~la~If~~L~~~gI~Vd~IstS------e~sIS~~I~~ 442 (557)
..||.++.++..++++||+|..+... +..+.+..+.
T Consensus 104 ~~pgi~A~V~~~iak~gi~Irqi~~~dpe~~~e~~l~IVte~ 145 (167)
T COG2150 104 RYPGILAGVASLIAKRGISIRQIISEDPELQEEPKLTIVTER 145 (167)
T ss_pred CCccHHHHHHHHHHHcCceEEEEecCCcccCCCceEEEEEec
Confidence 47899999999999999999988533 3455665544
No 301
>PRK08577 hypothetical protein; Provisional
Probab=29.59 E-value=1.8e+02 Score=26.23 Aligned_cols=50 Identities=20% Similarity=0.213 Sum_probs=32.9
Q ss_pred eeEEEEEccccccchHHHHHHHHHHhCCCcEEEEEecCCc----eEEEEEEecccH
Q 008693 474 RSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASK----VNISLIVNDDEA 525 (557)
Q Consensus 474 ~aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~IsqgsSe----~sIs~vV~~~d~ 525 (557)
...+.+.+ .+.+|+++++.+.|++.++++..+.+.... ..+.+.++-++.
T Consensus 56 ~~~I~V~~--~Dr~GvLa~I~~~l~~~~inI~~i~~~~~~~~~~~~i~l~vev~~~ 109 (136)
T PRK08577 56 LVEIELVV--EDRPGVLAKITGLLAEHGVDILATECEELKRGELAECVIIVDLSKS 109 (136)
T ss_pred EEEEEEEE--cCCCCHHHHHHHHHHHCCCCEEEEEEEEecCCCEEEEEEEEEeCCc
Confidence 34455554 467899999999999999999866543322 234555554443
No 302
>COG0645 Predicted kinase [General function prediction only]
Probab=29.55 E-value=99 Score=29.54 Aligned_cols=64 Identities=20% Similarity=0.177 Sum_probs=34.8
Q ss_pred hHHHHHHHHcCcCcEEEeeCC-----Cc--cccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEE
Q 008693 289 LTATTIGKALGLQEIQVWKDV-----DG--VLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVR 361 (557)
Q Consensus 289 ~tAa~lA~~L~A~~l~i~TDV-----dG--V~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~ 361 (557)
+.|..++..|+|.. |-+|+ .| ..+.+| +.+-+.++.+..| ..|++.+. .+...|.+|.
T Consensus 16 tlA~~l~~~lgA~~--lrsD~irk~L~g~p~~~r~~---------~g~ys~~~~~~vy---~~l~~~A~-l~l~~G~~VV 80 (170)
T COG0645 16 TLARGLAELLGAIR--LRSDVIRKRLFGVPEETRGP---------AGLYSPAATAAVY---DELLGRAE-LLLSSGHSVV 80 (170)
T ss_pred HHHHHHHhhcCceE--EehHHHHHHhcCCcccccCC---------CCCCcHHHHHHHH---HHHHHHHH-HHHhCCCcEE
Confidence 36999999999854 45554 11 111222 2222333334333 34444433 4567888888
Q ss_pred EecCCC
Q 008693 362 VKNSYN 367 (557)
Q Consensus 362 I~n~~~ 367 (557)
+..+|.
T Consensus 81 lDa~~~ 86 (170)
T COG0645 81 LDATFD 86 (170)
T ss_pred EecccC
Confidence 776664
No 303
>cd04902 ACT_3PGDH-xct C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH). The C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH), with an extended C-terminal (xct) region from bacteria, archaea, fungi, and plants. 3PGDH is an enzyme that belongs to the D-isomer specific, 2-hydroxyacid dehydrogenase family and catalyzes the oxidation of D-3-phosphoglycerate to 3- phosphohydroxypyruvate, which is the first step in the biosynthesis of L-serine, using NAD+ as the oxidizing agent. In bacteria, 3PGDH is feedback-controlled by the end product L-serine in an allosteric manner. Some 3PGDH enzymes have an additional domain formed by an extended C-terminal region. This additional domain introduces significant asymmetry to the homotetramer. Adjacent ACT (regulatory) domains interact, creating two serine-binding sites, however, this asymmetric arrangement results in the formation of two different and distinct domain interfaces between iden
Probab=29.44 E-value=89 Score=24.15 Aligned_cols=25 Identities=20% Similarity=0.329 Sum_probs=21.7
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEE
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVA 430 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~Is 430 (557)
.+.+|.++++.+.|+++|+++..+.
T Consensus 7 ~d~~G~l~~i~~~l~~~~inI~~~~ 31 (73)
T cd04902 7 TDRPGVIGKVGTILGEAGINIAGMQ 31 (73)
T ss_pred CCCCCHHHHHHHHHHHcCcChhheE
Confidence 4689999999999999999997653
No 304
>cd04927 ACT_ACR-like_2 Second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=28.99 E-value=2.3e+02 Score=22.76 Aligned_cols=26 Identities=15% Similarity=0.197 Sum_probs=22.7
Q ss_pred cccchHHHHHHHHHHhCCCcEEE--EEe
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQM--ISQ 509 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~--Isq 509 (557)
.+.||+++++..+|++.|++|.. |++
T Consensus 8 ~Dr~gLfa~i~~~l~~~~l~I~~A~I~T 35 (76)
T cd04927 8 SDRKGLLHDVTEVLYELELTIERVKVST 35 (76)
T ss_pred CCCCCHHHHHHHHHHHCCCeEEEEEEEE
Confidence 36899999999999999999986 554
No 305
>cd04925 ACT_ACR_2 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=28.55 E-value=68 Score=25.70 Aligned_cols=30 Identities=27% Similarity=0.481 Sum_probs=25.1
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCceEEEE
Q 008693 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV 429 (557)
Q Consensus 397 lItI~~~~m~~~~g~la~If~~L~~~gI~Vd~I 429 (557)
++++.+. ++||+++++...|+++|++|...
T Consensus 2 ~~~v~~~---Dr~gLl~~i~~~l~~~~lnI~~A 31 (74)
T cd04925 2 AIELTGT---DRPGLLSEVFAVLADLHCNVVEA 31 (74)
T ss_pred EEEEEEC---CCCCHHHHHHHHHHHCCCcEEEE
Confidence 4666653 68999999999999999998864
No 306
>cd04926 ACT_ACR_4 C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=27.90 E-value=1.1e+02 Score=24.28 Aligned_cols=24 Identities=25% Similarity=0.451 Sum_probs=21.3
Q ss_pred cchhhHHHHHHHHHHhCCceEEEE
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVV 429 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~I 429 (557)
.+++|.++++...|+++|++|...
T Consensus 9 ~D~~Gll~~i~~~l~~~~lnI~sa 32 (72)
T cd04926 9 EDRVGLLSDVTRVFRENGLTVTRA 32 (72)
T ss_pred CCccCHHHHHHHHHHHCCcEEEEE
Confidence 468999999999999999999654
No 307
>PRK08198 threonine dehydratase; Provisional
Probab=27.33 E-value=1.6e+02 Score=31.74 Aligned_cols=39 Identities=28% Similarity=0.292 Sum_probs=30.2
Q ss_pred eeeccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEc
Q 008693 390 VLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT 431 (557)
Q Consensus 390 s~~~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~Ist 431 (557)
........+.+. +.+.||-++++++.+++.|.||.-+..
T Consensus 322 ~~~gr~~~l~v~---l~D~PG~L~~ll~~i~~~g~NI~~i~~ 360 (404)
T PRK08198 322 VAAGRYLKLRVR---LPDRPGQLAKLLSIIAELGANVIDVDH 360 (404)
T ss_pred hhcCCEEEEEEE---eCCCCCHHHHHHHHHhhCCCceEEEEE
Confidence 334555566665 567999999999999999999987653
No 308
>cd04930 ACT_TH ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, tyrosine hydroxylases (TH). ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, tyrosine hydroxylases (TH). TH catalyses the hydroxylation of L-Tyr to 3,4-dihydroxyphenylalanine, the rate limiting step in the biosynthesis of catecholamines (dopamine, noradrenaline and adrenaline), functioning as hormones and neurotransmitters. The enzyme is not regulated by its amino acid substrate, but instead by phosphorylation at several serine residues located N-terminal of the ACT domain, and by feedback inhibition by catecholamines at the active site. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=27.21 E-value=2.3e+02 Score=25.17 Aligned_cols=57 Identities=12% Similarity=0.269 Sum_probs=36.5
Q ss_pred EEEccccccchHHHHHHHHHHhCCCcEEEEEecCCceE---EEEEEecc----cHHHHHHHHHH
Q 008693 478 SLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASKVN---ISLIVNDD----EAEQCVRALHE 534 (557)
Q Consensus 478 sIVG~~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~s---Is~vV~~~----d~~kAv~~LH~ 534 (557)
+++=.+.+.||.+.++++.++.+|||+.-|..-++... -.|+|+-+ +..++++.|.+
T Consensus 43 Slifsl~~~pGsL~~iL~~Fa~~gINLt~IESRP~~~~~~eY~FfIdieg~~~~~~~aL~~L~~ 106 (115)
T cd04930 43 TLLFSLKEGFSSLSRILKVFETFEAKIHHLESRPSRKEGGDLEVLVRCEVHRSDLLQLISSLRQ 106 (115)
T ss_pred EEEEEeCCCCcHHHHHHHHHHHCCCCEEEEECCcCCCCCceEEEEEEEEeCHHHHHHHHHHHHH
Confidence 33333355789999999999999999999876554222 34555532 33445555543
No 309
>COG0462 PrsA Phosphoribosylpyrophosphate synthetase [Nucleotide transport and metabolism / Amino acid transport and metabolism]
Probab=26.93 E-value=6.1e+02 Score=26.72 Aligned_cols=149 Identities=19% Similarity=0.184 Sum_probs=74.0
Q ss_pred HHHHhhchHHHHHHHHHHHHHcCCceE-EeccceeEEEEecCCCCceeeec-chHHHHHHHhhchhcCCceEEEcCCCcc
Q 008693 195 DYLVSFGECMSTRIFAAYLNKIGVKAR-QYDAFDIGFITTDDFTNADILEA-TYPAVAKRLHGDWITDLAIPIVTGFLGK 272 (557)
Q Consensus 195 d~i~s~GE~lsa~ll~~~L~~~Gi~a~-~l~~~~~~iit~~~~~~a~i~~~-~~~~v~~~l~~~ll~~~~vpVv~Gfig~ 272 (557)
|..-.-||.+++++++..|+..|++-+ .+|...-.+ ..|-+--+... ..+.+.+.+.... ......|+++-.
T Consensus 99 Dk~~~~repIsaklvA~lL~~aG~drv~TvDlH~~qi---qgfFdipvdnl~a~p~l~~~~~~~~-~~~d~vVVSPD~-- 172 (314)
T COG0462 99 DKAFKPREPISAKLVANLLETAGADRVLTVDLHAPQI---QGFFDIPVDNLYAAPLLAEYIREKY-DLDDPVVVSPDK-- 172 (314)
T ss_pred CcccCCCCCEeHHHHHHHHHHcCCCeEEEEcCCchhh---cccCCCccccccchHHHHHHHHHhc-CCCCcEEECCCc--
Confidence 444356999999999999999998742 222111000 01111111111 1233333333221 111355665522
Q ss_pred cCCCCceeecCCCcchhHHHHHHHHcCcCcEEEeeCCCccccCCCCCCC-----------CCcccccc-----CH-HHHH
Q 008693 273 AWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHP-----------HAKPVPYL-----TF-DEAA 335 (557)
Q Consensus 273 ~~~~G~~ttlgRgGSD~tAa~lA~~L~A~~l~i~TDVdGV~taDP~~v~-----------~a~~i~~l-----s~-~Ea~ 335 (557)
|-+ --|..+|..|+++--+|.+.=+ .+|+.+. ++-+++.| |. +-|.
T Consensus 173 ----Ggv---------~RAr~~A~~L~~~~a~i~K~R~----~~~~~v~~~~~~gdV~gk~~iiVDDiIdTgGTi~~Aa~ 235 (314)
T COG0462 173 ----GGV---------KRARALADRLGAPLAIIDKRRD----SSPNVVEVMNLIGDVEGKDVVIVDDIIDTGGTIAKAAK 235 (314)
T ss_pred ----cHH---------HHHHHHHHHhCCCEEEEEEeec----CCCCeEEEeecccccCCCEEEEEeccccccHHHHHHHH
Confidence 322 2488999999988555555431 0222111 12222222 13 3344
Q ss_pred HHHHcCCC-----cchH----hHHHHHHhCCCC-EEEecCC
Q 008693 336 ELAYFGAQ-----VLHP----QSMRPAREGDIP-VRVKNSY 366 (557)
Q Consensus 336 eLa~~Ga~-----vlhp----~a~~~a~~~~Ip-v~I~n~~ 366 (557)
.|-..||+ .-|| .+.+......+. |.++||.
T Consensus 236 ~Lk~~GAk~V~a~~tH~vfs~~a~~~l~~~~i~~vivTnTi 276 (314)
T COG0462 236 ALKERGAKKVYAAATHGVFSGAALERLEASAIDEVIVTDTI 276 (314)
T ss_pred HHHHCCCCeEEEEEEchhhChHHHHHHhcCCCCEEEEeCCc
Confidence 55667997 3354 466665555574 7777765
No 310
>cd04885 ACT_ThrD-I Tandem C-terminal ACT domains of threonine dehydratase I (ThrD-I; L-threonine hydrolyase). This CD includes each of two tandem C-terminal ACT domains of threonine dehydratase I (ThrD-I; L-threonine hydrolyase) which catalyzes the committed step in branched chain amino acid biosynthesis in plants and microorganisms, the pyridoxal 5'-phosphate (PLP)-dependent dehydration/deamination of L-threonine (or L-serine) to 2-ketobutyrate (or pyruvate). ThrD-I is a cooperative, feedback-regulated (isoleucine and valine) allosteric enzyme that forms a tetramer and contains four pyridoxal phosphate moieties. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=26.92 E-value=2.9e+02 Score=21.46 Aligned_cols=42 Identities=10% Similarity=0.078 Sum_probs=32.0
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecC---CceEEEEEEecccH
Q 008693 483 VQRSSLILEKAFRVLRRSGVNVQMISQGA---SKVNISLIVNDDEA 525 (557)
Q Consensus 483 ~~~~~~v~~rif~~L~~~gInI~~Isqgs---Se~sIs~vV~~~d~ 525 (557)
+...||-+.++.+.+++ +.||..+.+.- ....+.+.+.-.+.
T Consensus 5 ipdkPG~l~~~~~~i~~-~~nI~~~~~~~~~~~~~~v~v~ie~~~~ 49 (68)
T cd04885 5 FPERPGALKKFLELLGP-PRNITEFHYRNQGGDEARVLVGIQVPDR 49 (68)
T ss_pred CCCCCCHHHHHHHHhCC-CCcEEEEEEEcCCCCceEEEEEEEeCCH
Confidence 45689999999999998 99999888753 34456666766554
No 311
>COG0303 MoeA Molybdopterin biosynthesis enzyme [Coenzyme metabolism]
Probab=26.67 E-value=2.1e+02 Score=31.16 Aligned_cols=72 Identities=17% Similarity=0.326 Sum_probs=48.3
Q ss_pred HHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCC
Q 008693 205 STRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGR 284 (557)
Q Consensus 205 sa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgR 284 (557)
|...++++|++.|.....+ |++.+ +++.+++.+.+. .+..++.|++|-... |
T Consensus 204 N~~~l~a~l~~~G~e~~~~-----giv~D-----------d~~~l~~~i~~a-~~~~DviItsGG~Sv----G------- 255 (404)
T COG0303 204 NSYMLAALLERAGGEVVDL-----GIVPD-----------DPEALREAIEKA-LSEADVIITSGGVSV----G------- 255 (404)
T ss_pred CHHHHHHHHHHcCCceeec-----cccCC-----------CHHHHHHHHHHh-hhcCCEEEEeCCccC----c-------
Confidence 5667888999999865443 34433 234556655543 344678899884332 2
Q ss_pred CcchhHHHHHHHHcCcCcEEEee
Q 008693 285 GGSDLTATTIGKALGLQEIQVWK 307 (557)
Q Consensus 285 gGSD~tAa~lA~~L~A~~l~i~T 307 (557)
..|++-.++...+| ++.+|.
T Consensus 256 -~~D~v~~~l~~~lG--~v~~~g 275 (404)
T COG0303 256 -DADYVKAALERELG--EVLFHG 275 (404)
T ss_pred -chHhHHHHHHhcCC--cEEEEe
Confidence 28999999998888 788774
No 312
>PRK11898 prephenate dehydratase; Provisional
Probab=26.30 E-value=6.6e+02 Score=25.81 Aligned_cols=113 Identities=17% Similarity=0.102 Sum_probs=64.3
Q ss_pred CCCCccccccCHHHHHHHHHcCC----CcchHhHHHHHHhCCCCEEEecCCCCCCCCeeEe---cCCCCCcceeeEEeee
Q 008693 320 HPHAKPVPYLTFDEAAELAYFGA----QVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR---RSRDMSKAVLTSIVLK 392 (557)
Q Consensus 320 v~~a~~i~~ls~~Ea~eLa~~Ga----~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~---~~~~~~~~~Vt~Is~~ 392 (557)
.|+.+.+..-|..+|.++...+. -.+-++ ..|..+|.++.-.|..+...-=|+.. ++.. ..+.. ..
T Consensus 121 ~p~~~~~~~~sTa~Aa~~v~~~~~~~~aAI~s~--~aa~~ygL~il~~~I~d~~~N~TRF~vi~~~~~--~~~~~---~~ 193 (283)
T PRK11898 121 LPGAELEPANSTAAAAQYVAEHPDEPIAAIASE--LAAELYGLEILAEDIQDYPNNRTRFWLLGRKKP--PPPLR---TG 193 (283)
T ss_pred CCCCEEEEcCchHHHHHHHhcCCCCCeEEECCH--HHHHHcCCcEehhcCCCCCccceEEEEEEcCcc--cCCCC---CC
Confidence 45788888889999998876432 122222 23456788888777665433345443 2211 00000 01
Q ss_pred ccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEEEccC-----ceeEEEeC
Q 008693 393 RNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSE-----VSLSLTLD 441 (557)
Q Consensus 393 ~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~IstSe-----~sIS~~I~ 441 (557)
.+-+.+-+.-. ...||.+.++++.|+++|||+-.|-+.. -...|.++
T Consensus 194 ~~ktslif~l~--~~~pGsL~~~L~~F~~~~INLt~IeSRP~~~~~~~y~F~vd 245 (283)
T PRK11898 194 GDKTSLVLTLP--NNLPGALYKALSEFAWRGINLTRIESRPTKTGLGTYFFFID 245 (283)
T ss_pred CCeEEEEEEeC--CCCccHHHHHHHHHHHCCCCeeeEecccCCCCCccEEEEEE
Confidence 11111222210 1248999999999999999999885332 23456665
No 313
>cd04906 ACT_ThrD-I_1 First of two tandem C-terminal ACT domains of threonine dehydratase I (ThrD-I; L-threonine hydrolyase). This CD includes the first of two tandem C-terminal ACT domains of threonine dehydratase I (ThrD-I; L-threonine hydrolyase) which catalyzes the committed step in branched chain amino acid biosynthesis in plants and microorganisms, the pyridoxal 5'-phosphate (PLP)-dependent dehydration/deamination of L-threonine (or L-serine) to 2-ketobutyrate (or pyruvate). ThrD-I is a cooperative, feedback-regulated (isoleucine and valine) allosteric enzyme that forms a tetramer and contains four pyridoxal phosphate moieties. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=26.30 E-value=2.8e+02 Score=22.75 Aligned_cols=51 Identities=8% Similarity=0.075 Sum_probs=35.5
Q ss_pred cccccchHHHHHHHHHHhCCCcEEEEEecC---CceEEEEEEeccc----HHHHHHHHHH
Q 008693 482 NVQRSSLILEKAFRVLRRSGVNVQMISQGA---SKVNISLIVNDDE----AEQCVRALHE 534 (557)
Q Consensus 482 ~~~~~~~v~~rif~~L~~~gInI~~Isqgs---Se~sIs~vV~~~d----~~kAv~~LH~ 534 (557)
.+.+.||-+.++.+.|+.++|+ -+.+.. ....+.++++-++ .+++++.|-+
T Consensus 7 ~ipD~PG~L~~ll~~l~~anI~--~~~y~~~~~~~~~v~i~ie~~~~~~~~~~i~~~L~~ 64 (85)
T cd04906 7 TIPERPGSFKKFCELIGPRNIT--EFNYRYADEKDAHIFVGVSVANGAEELAELLEDLKS 64 (85)
T ss_pred ecCCCCcHHHHHHHHhCCCcee--EEEEEccCCCeeEEEEEEEeCCcHHHHHHHHHHHHH
Confidence 3678899999999999966555 433322 4556777788555 6677777755
No 314
>COG3367 Uncharacterized conserved protein [Function unknown]
Probab=26.10 E-value=5.4e+02 Score=27.27 Aligned_cols=114 Identities=18% Similarity=0.202 Sum_probs=73.3
Q ss_pred CcCcEEEeeCCCccccCCCCCCCCCccccccCH-HHHHHHHHcCCCcc---h------HhHHHHHHhCCCCEEEecCCCC
Q 008693 299 GLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTF-DEAAELAYFGAQVL---H------PQSMRPAREGDIPVRVKNSYNP 368 (557)
Q Consensus 299 ~A~~l~i~TDVdGV~taDP~~v~~a~~i~~ls~-~Ea~eLa~~Ga~vl---h------p~a~~~a~~~~Ipv~I~n~~~p 368 (557)
.++.+++|+--+| . .-..+| +++.+-...|..|. | |.-.+.|.+.|. ++-|...|
T Consensus 67 ~~e~liIgia~~g--G-----------~~~~~~~~~i~eAl~~G~nVvsglh~~ls~dp~~~k~A~~~G~--rl~dvR~p 131 (339)
T COG3367 67 LAEALIIGIAPPG--G-----------VLPESWREYIVEALEAGMNVVSGLHSFLSDDPEFVKLAERTGV--RLDDVRKP 131 (339)
T ss_pred CcceEEEEeecCC--C-----------cCcHHHHHHHHHHHHhCchhhhhhHHHhhcChHHHHHHHHcCC--eeEeeccC
Confidence 4478888876554 1 122345 55666666788754 3 667788888887 44444455
Q ss_pred CCCCeeEecCCCCCcceeeEEeeeccEEEEEEEecCcc-chhhHHHHHHHHHHhCCceEEEEEccCceeE
Q 008693 369 NAPGTLIRRSRDMSKAVLTSIVLKRNVTMLDIVSTRML-GQYGFLAKVFSTFEDLGISVDVVATSEVSLS 437 (557)
Q Consensus 369 ~~~GT~I~~~~~~~~~~Vt~Is~~~nialItI~~~~m~-~~~g~la~If~~L~~~gI~Vd~IstSe~sIS 437 (557)
. +++-. ..++..-+.+..+|.+.|+++. |..-..-.+-+.+.+.|++..++.|.+.++-
T Consensus 132 ~--~~l~~--------~~tG~~~k~~a~~V~vvGTd~~vGKrTTa~~L~~~~~e~G~~a~fvaTgqtgil 191 (339)
T COG3367 132 P--LDLEY--------LCTGMARKVDAKVVLVVGTDCAVGKRTTALELREAAREEGIKAGFVATGQTGIL 191 (339)
T ss_pred c--cchhh--------hccCcccccCCcEEEEeccccccchhHHHHHHHHHHHHhCCccceEecCceeeE
Confidence 2 22221 1223333556778888888764 4444566777889999999999998887763
No 315
>cd04873 ACT_UUR-ACR-like ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD. This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted t
Probab=25.53 E-value=1.1e+02 Score=23.28 Aligned_cols=25 Identities=24% Similarity=0.448 Sum_probs=22.0
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEE
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVA 430 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~Is 430 (557)
.+.+|.++++...|+++|++|..+.
T Consensus 8 ~d~~g~l~~i~~~l~~~~~~I~~~~ 32 (70)
T cd04873 8 PDRPGLLADITRVLADLGLNIHDAR 32 (70)
T ss_pred CCCCCHHHHHHHHHHHCCCeEEEEE
Confidence 4689999999999999999997663
No 316
>cd04904 ACT_AAAH ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH). ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH): Phenylalanine hydroxylases (PAH), tyrosine hydroxylases (TH) and tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. This family of enzymes shares a common catalytic mechanism, in which dioxygen is used by an active site containing a single, reduced iron atom to hydroxylate an unactivated aromatic substrate, concomitant with a two-electron oxidation of tetrahydropterin (BH4) cofactor to its quinonoid dihydropterin form. PAH catalyzes the hydroxylation of L-Phe to L-Tyr, the first step in the catabolic degradation of L-Phe; TH catalyses the hydroxylation of L-Tyr to 3,4-dihydroxyphenylalanine, the rate limiting step in the biosynthesis of catecholamines; and TPH catalyses the hydroxylation of L-Trp to 5-hydroxytryptophan, the rate limiting step in the biosynthesis of 5-hydroxy
Probab=25.31 E-value=83 Score=25.25 Aligned_cols=25 Identities=24% Similarity=0.592 Sum_probs=22.4
Q ss_pred chhhHHHHHHHHHHhCCceEEEEEc
Q 008693 407 GQYGFLAKVFSTFEDLGISVDVVAT 431 (557)
Q Consensus 407 ~~~g~la~If~~L~~~gI~Vd~Ist 431 (557)
+.||-++++++.|+++|||+-.|-+
T Consensus 9 ~~pG~L~~vL~~f~~~~iNlt~IeS 33 (74)
T cd04904 9 EEVGALARALKLFEEFGVNLTHIES 33 (74)
T ss_pred CCCcHHHHHHHHHHHCCCcEEEEEC
Confidence 4799999999999999999998853
No 317
>TIGR00200 cinA_nterm competence/damage-inducible protein CinA N-terminal domain. cinA is a DNA damage- or competence-inducible protein that is polycistronic with recA in a number of species
Probab=25.20 E-value=3.1e+02 Score=29.99 Aligned_cols=68 Identities=24% Similarity=0.260 Sum_probs=45.4
Q ss_pred HHHHHHHHHHHcCCceEEeccceeEEEEecCCCCceeeecchHHHHHHHhhchhcCCceEEEcCCCcccCCCCceeecCC
Q 008693 205 STRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGR 284 (557)
Q Consensus 205 sa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~v~~~l~~~ll~~~~vpVv~Gfig~~~~~G~~ttlgR 284 (557)
|+..++..|++.|++..... ++. | +.+.+.+.+... .+..++.|++|.+|.+.
T Consensus 21 N~~~l~~~L~~~G~~v~~~~-----~v~-D----------d~~~i~~~l~~a-~~~~DlVIttGGlgpt~---------- 73 (413)
T TIGR00200 21 NAQWLADFLAHQGLPLSRRT-----TVG-D----------NPERLKTIIRIA-SERADVLIFNGGLGPTS---------- 73 (413)
T ss_pred hHHHHHHHHHHCCCeEEEEE-----EeC-C----------CHHHHHHHHHHH-hcCCCEEEEcCCCCCCC----------
Confidence 66678889999999865432 222 2 234455555443 35567889988666442
Q ss_pred CcchhHHHHHHHHcCcC
Q 008693 285 GGSDLTATTIGKALGLQ 301 (557)
Q Consensus 285 gGSD~tAa~lA~~L~A~ 301 (557)
-|+|.-.+|.++|-+
T Consensus 74 --dD~t~eava~~~g~~ 88 (413)
T TIGR00200 74 --DDLTAETIATAKGEP 88 (413)
T ss_pred --cccHHHHHHHHhCCC
Confidence 788999999999854
No 318
>cd04931 ACT_PAH ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, phenylalanine hydroxylases (PAH). ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, phenylalanine hydroxylases (PAH). PAH catalyzes the hydroxylation of L-Phe to L-Tyr, the first step in the catabolic degradation of L-Phe. In PAH, an autoregulatory sequence, N-terminal of the ACT domain, extends across the catalytic domain active site and regulates the enzyme by intrasteric regulation. It appears that the activation by L-Phe induces a conformational change that converts the enzyme to a high-affinity and high-activity state. Modulation of activity is achieved through inhibition by BH4 and activation by phosphorylation of serine residues of the autoregulatory region. The molecular basis for the cooperative activation process is not fully understood yet. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=24.87 E-value=2.5e+02 Score=23.74 Aligned_cols=35 Identities=23% Similarity=0.380 Sum_probs=26.8
Q ss_pred chhhHHHHHHHHHHhCCceEEEEEccC-----ceeEEEeC
Q 008693 407 GQYGFLAKVFSTFEDLGISVDVVATSE-----VSLSLTLD 441 (557)
Q Consensus 407 ~~~g~la~If~~L~~~gI~Vd~IstSe-----~sIS~~I~ 441 (557)
+.||-+.++++.|+++|||+..|-+.. -...|.|+
T Consensus 23 ~~pGsL~~vL~~Fa~~~INLt~IeSRP~~~~~~~Y~FfVD 62 (90)
T cd04931 23 EEVGALAKVLRLFEEKDINLTHIESRPSRLNKDEYEFFIN 62 (90)
T ss_pred CCCcHHHHHHHHHHHCCCCEEEEEeccCCCCCceEEEEEE
Confidence 469999999999999999999985321 23456665
No 319
>COG1707 ACT domain-containing protein [General function prediction only]
Probab=23.81 E-value=6e+02 Score=24.35 Aligned_cols=112 Identities=17% Similarity=0.280 Sum_probs=65.8
Q ss_pred chhhHHHHHHHHHHhCCceEEEEEcc-C-----ceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhh---eeecccce---
Q 008693 407 GQYGFLAKVFSTFEDLGISVDVVATS-E-----VSLSLTLDPSKLWSRELIQQELDHVVEELEKIA---IVNLLQHR--- 474 (557)
Q Consensus 407 ~~~g~la~If~~L~~~gI~Vd~IstS-e-----~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~---~i~~~~~~--- 474 (557)
+.||.+.++...+++.|.|+....+. + -.|-+-+..-+ .++.++++++... .++....+
T Consensus 11 nk~GvL~~ltgiiae~ggNIt~~q~~~~~~g~~~~iYmEiEgi~---------d~e~l~~~lks~d~v~ev~i~~sle~i 81 (218)
T COG1707 11 NKPGVLRDLTGIIAEEGGNITYAQQFLEKDGEKALIYMEIEGID---------DFEKLLERLKSFDYVIEVEIHRSLEEI 81 (218)
T ss_pred cCccHHHHHHHHHHhcCCceEeeehhhhccCceEEEEEEeeCCC---------CHHHHHHHhhccceEEEeeecchHHHH
Confidence 57999999999999999999887542 1 12333333211 1334445555432 22222211
Q ss_pred --eEEEEEccccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHH
Q 008693 475 --SIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRAL 532 (557)
Q Consensus 475 --aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~~kAv~~L 532 (557)
--|-++|.+.+.++++.-+.+--.+++|.=.-||- . .| =+|-+++..+|+++.
T Consensus 82 yGKRvIiiGGGAqVsqVA~GAIsEADRHNiRGERISv--D--Ti-PlVGEE~laEAVkAV 136 (218)
T COG1707 82 YGKRVIIIGGGAQVSQVARGAISEADRHNIRGERISV--D--TI-PLVGEEELAEAVKAV 136 (218)
T ss_pred hCcEEEEECCchhHHHHHHhhcchhhhcccccceeee--e--cc-cccChHHHHHHHHHH
Confidence 22456676666778888888888888777666654 1 12 245666665555544
No 320
>PRK05788 cobalamin biosynthesis protein CbiG; Validated
Probab=23.76 E-value=7e+02 Score=26.18 Aligned_cols=125 Identities=19% Similarity=0.231 Sum_probs=65.1
Q ss_pred CCcchhHHHHHHHHcCcCcE-EEeeCCCccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhH---HHHHHhCCCC
Q 008693 284 RGGSDLTATTIGKALGLQEI-QVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQS---MRPAREGDIP 359 (557)
Q Consensus 284 RgGSD~tAa~lA~~L~A~~l-~i~TDVdGV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a---~~~a~~~~Ip 359 (557)
.||++..|-.+|..|||.-+ +=-||+.|.+.-| +.. ..+|..+-.|+. +.-++-.|=|
T Consensus 99 ~GGAN~LA~~iA~~lga~pVITTAtd~~g~~avD----------------~la--~~~g~~i~~~~~~k~i~a~ll~g~~ 160 (315)
T PRK05788 99 HGGANELARDLAKILGAVPVITTATDVNGKAAVD----------------TIA--KQLNAKIVNRESTKKVNAALVNGEK 160 (315)
T ss_pred cccHHHHHHHHHHHhCCEEEEeCCccccCCccHH----------------HHH--HhcCCEecCHHHHHHHHHHHHCCCc
Confidence 47788899999999999865 4577888877643 111 113555555442 3344445555
Q ss_pred EEEecCCCCCCCCeeEecCCC-CCcceeeEEeeeccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEE
Q 008693 360 VRVKNSYNPNAPGTLIRRSRD-MSKAVLTSIVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV 429 (557)
Q Consensus 360 v~I~n~~~p~~~GT~I~~~~~-~~~~~Vt~Is~~~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~I 429 (557)
+.+..- +..+..+..... .....-..+.+....-.+-|-...-.....+...+.+.|+++|++.+-+
T Consensus 161 v~~~~~---~~~~~i~i~~~~~~~~~~~~~l~l~P~~l~vGIGcrrg~~~e~i~~ai~~~L~~~~i~~~~i 228 (315)
T PRK05788 161 VGLWGD---ELDPVIRVSLRNDVPELPKVTVKLRPKNVVLGIGCRKGVSAEEIAEAVERALEALNIDPRAV 228 (315)
T ss_pred eEEEcc---CCCceEEEeccccccCCCCceEEEecCeEEEeeccCCCCCHHHHHHHHHHHHHHcCCCHHHc
Confidence 555321 122233322211 0000111233333333333332222234456778888999999975543
No 321
>cd04899 ACT_ACR-UUR-like_2 C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains. This ACT domain family, ACT_ACR-UUR-like_2, includes the second of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the second and fourth ACT domains of a novel protein composed almost entirely of ACT domain repeats, the ACR protein. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=22.96 E-value=3.5e+02 Score=20.61 Aligned_cols=30 Identities=23% Similarity=0.337 Sum_probs=23.6
Q ss_pred EEEEccccccchHHHHHHHHHHhCCCcEEEEE
Q 008693 477 ISLIGNVQRSSLILEKAFRVLRRSGVNVQMIS 508 (557)
Q Consensus 477 IsIVG~~~~~~~v~~rif~~L~~~gInI~~Is 508 (557)
|.+.+ .+.+|+++++.+.|++.+++|..+.
T Consensus 3 l~v~~--~d~~gll~~i~~~l~~~~~~I~~~~ 32 (70)
T cd04899 3 LELTA--LDRPGLLADVTRVLAELGLNIHSAK 32 (70)
T ss_pred EEEEE--cCCccHHHHHHHHHHHCCCeEEEEE
Confidence 44444 4678999999999999999997533
No 322
>cd04929 ACT_TPH ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. TPH catalyses the hydroxylation of L-Trp to 5-hydroxytryptophan, the rate limiting step in the biosynthesis of 5-hydroxytryptamine (serotonin) and the first reaction in the synthesis of melatonin. Very little is known about the role of the ACT domain in TPH, which appears to be regulated by phosphorylation but not by its substrate or cofactor. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=22.26 E-value=1.1e+02 Score=24.91 Aligned_cols=35 Identities=29% Similarity=0.490 Sum_probs=26.8
Q ss_pred chhhHHHHHHHHHHhCCceEEEEEcc-----CceeEEEeC
Q 008693 407 GQYGFLAKVFSTFEDLGISVDVVATS-----EVSLSLTLD 441 (557)
Q Consensus 407 ~~~g~la~If~~L~~~gI~Vd~IstS-----e~sIS~~I~ 441 (557)
+.||-++++++.|+++|||+-.|-+. .-...|.++
T Consensus 9 ~~~g~L~~iL~~f~~~~inl~~IeSRP~~~~~~~y~F~id 48 (74)
T cd04929 9 NEVGGLAKALKLFQELGINVVHIESRKSKRRSSEFEIFVD 48 (74)
T ss_pred CCCcHHHHHHHHHHHCCCCEEEEEeccCCCCCceEEEEEE
Confidence 46899999999999999999998532 223456654
No 323
>PRK06349 homoserine dehydrogenase; Provisional
Probab=21.56 E-value=1.7e+02 Score=31.92 Aligned_cols=41 Identities=15% Similarity=0.327 Sum_probs=32.8
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCC---ceEEEEEEeccc
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQMISQGAS---KVNISLIVNDDE 524 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~IsqgsS---e~sIs~vV~~~d 524 (557)
.+.||+++++...|++.+|++..+.|... ...+.++++...
T Consensus 356 ~d~pGvLa~I~~~f~~~~vsI~si~q~~~~~~~~~ivivT~~~~ 399 (426)
T PRK06349 356 ADKPGVLAKIAAIFAENGISIESILQKGAGGEGAEIVIVTHETS 399 (426)
T ss_pred cCCcchHHHHHHHHhhcCccEEEEEeccCCCCceeEEEEEEeCC
Confidence 46789999999999999999999888652 245777877544
No 324
>cd04928 ACT_TyrKc Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=21.43 E-value=3.8e+02 Score=21.51 Aligned_cols=43 Identities=12% Similarity=0.088 Sum_probs=29.7
Q ss_pred cccchHHHHHHHHHHhCCCcEEE--EEecCCceE-EEEEEecccHH
Q 008693 484 QRSSLILEKAFRVLRRSGVNVQM--ISQGASKVN-ISLIVNDDEAE 526 (557)
Q Consensus 484 ~~~~~v~~rif~~L~~~gInI~~--IsqgsSe~s-Is~vV~~~d~~ 526 (557)
.+.|++++++..+|+..|.||+. |.+...... =+|.|.+.+.+
T Consensus 9 ~Dr~gLFa~iag~L~~~~LnI~~A~i~tt~dG~~LDtF~V~d~~~~ 54 (68)
T cd04928 9 GDKPKLLSQLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRG 54 (68)
T ss_pred CCCcchHHHHHHHHHHCCCceEEEEEEEcCCCeEEEEEEEecCCcc
Confidence 36899999999999999999985 443333333 34555555543
No 325
>PHA01735 hypothetical protein
Probab=20.33 E-value=3.1e+02 Score=22.24 Aligned_cols=31 Identities=19% Similarity=0.254 Sum_probs=21.3
Q ss_pred HHHhhchHHHHHHHH--HHHHHcCCceEEeccce
Q 008693 196 YLVSFGECMSTRIFA--AYLNKIGVKARQYDAFD 227 (557)
Q Consensus 196 ~i~s~GE~lsa~ll~--~~L~~~Gi~a~~l~~~~ 227 (557)
.|.+ ||--++.|=+ .+|++++|.++..++..
T Consensus 24 Riks-geATtaDL~AA~d~Lk~NdItgv~~~gsp 56 (76)
T PHA01735 24 RIKS-GEATTADLRAACDWLKSNDITGVAVDGSP 56 (76)
T ss_pred HHhc-CcccHHHHHHHHHHHHHCCCceeeCCCCH
Confidence 3444 6666665544 47899999998887754
No 326
>COG2716 GcvR Glycine cleavage system regulatory protein [Amino acid transport and metabolism]
Probab=20.30 E-value=4.6e+02 Score=25.20 Aligned_cols=104 Identities=13% Similarity=0.136 Sum_probs=60.7
Q ss_pred ccEEEEEEEecCccchhhHHHHHHHHHHhCCceEEEE--E--ccCceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhhee
Q 008693 393 RNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV--A--TSEVSLSLTLDPSKLWSRELIQQELDHVVEELEKIAIV 468 (557)
Q Consensus 393 ~nialItI~~~~m~~~~g~la~If~~L~~~gI~Vd~I--s--tSe~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~i 468 (557)
.+.-+|+..|. +.||....+.....++|-|+.-- + -.+....+.+.-+ |.. + ..++..+..+.+...+
T Consensus 3 ~~~LvItavg~---d~pgl~~~lar~v~s~Gcn~leSRla~~g~~~a~i~lisgs--~da--v-~~le~~l~~l~~~~~L 74 (176)
T COG2716 3 EHYLVITAVGA---DRPGLVNTLARAVASSGCNWLESRLAMLGEEFAGIMLISGS--WDA--V-TLLEATLPLLGAELDL 74 (176)
T ss_pred ccEEEEEEecC---CCcHHHHHHHHHHHhcCCcchHHHHHHhhcceeEEEEEeeC--HHH--H-HHHHHHhhcccccCCe
Confidence 34566788774 58999999999999999987632 1 1233444444322 211 1 1233333334331111
Q ss_pred e---------c-ccc--eeEEEEEccccccchHHHHHHHHHHhCCCcEEE
Q 008693 469 N---------L-LQH--RSIISLIGNVQRSSLILEKAFRVLRRSGVNVQM 506 (557)
Q Consensus 469 ~---------~-~~~--~aiIsIVG~~~~~~~v~~rif~~L~~~gInI~~ 506 (557)
. . ..+ --.+.++| .+.||+..++.+.|...||||.-
T Consensus 75 ~v~m~rt~~~~~~a~~~~v~v~v~a--~DrpgIv~~~T~lf~~~~inie~ 122 (176)
T COG2716 75 LVVMKRTGAHPTPANPAPVWVYVDA--NDRPGIVEEFTALFDGHGINIEN 122 (176)
T ss_pred EEEEeecCCCccCCCCceEEEEEEe--cCCccHHHHHHHHHHhcCCchhh
Confidence 1 1 001 12344444 57899999999999999999964
No 327
>PRK06349 homoserine dehydrogenase; Provisional
Probab=20.29 E-value=3.7e+02 Score=29.32 Aligned_cols=55 Identities=18% Similarity=0.358 Sum_probs=37.2
Q ss_pred cchhhHHHHHHHHHHhCCceEEEEEccC-----ceeEEEeCCchhhhHHHHHHHHHHHHHHHhhhhe
Q 008693 406 LGQYGFLAKVFSTFEDLGISVDVVATSE-----VSLSLTLDPSKLWSRELIQQELDHVVEELEKIAI 467 (557)
Q Consensus 406 ~~~~g~la~If~~L~~~gI~Vd~IstSe-----~sIS~~I~~~~~~~~~~~~~~l~~~~~~l~~~~~ 467 (557)
.+.||.++++-..|.+++|+++.+.+.+ ..+.++++...- ..+.+.+.+++++..
T Consensus 356 ~d~pGvLa~I~~~f~~~~vsI~si~q~~~~~~~~~ivivT~~~~e-------~~l~~~i~~L~~l~~ 415 (426)
T PRK06349 356 ADKPGVLAKIAAIFAENGISIESILQKGAGGEGAEIVIVTHETSE-------AALRAALAAIEALDV 415 (426)
T ss_pred cCCcchHHHHHHHHhhcCccEEEEEeccCCCCceeEEEEEEeCCH-------HHHHHHHHHHhcCcc
Confidence 4689999999999999999999886432 345666654331 235555566665433
No 328
>TIGR01127 ilvA_1Cterm threonine dehydratase, medium form. A form of threonine dehydratase with two copies of the C-terminal domain Pfam:PF00585 is described by TIGR01124. This model describes a phylogenetically distinct form with a single copy of pfam00585. This form branches with the catabolic threonine dehydratase of E. coli; many members are designated as catabolic for this reason. However, the catabolic form lacks any pfam00585 domain. Many members of this model are found in species with other Ile biosynthetic enzymes.
Probab=20.24 E-value=4.1e+02 Score=28.24 Aligned_cols=55 Identities=5% Similarity=0.091 Sum_probs=38.7
Q ss_pred cccccchHHHHHHHHHHhCCCcEEEEEec-------CCceEEEEEEecccHHHHHHHHHHHhc
Q 008693 482 NVQRSSLILEKAFRVLRRSGVNVQMISQG-------ASKVNISLIVNDDEAEQCVRALHETFF 537 (557)
Q Consensus 482 ~~~~~~~v~~rif~~L~~~gInI~~Isqg-------sSe~sIs~vV~~~d~~kAv~~LH~~f~ 537 (557)
.+.+.||.+.++.+.+++.|.||.-|.+. .....+.+.++..+ ..-.+.|.+.|-
T Consensus 311 ~l~D~pG~L~~v~~~i~~~~~NI~~i~~~r~~~~~~~~~~~v~v~vet~~-~~~~~~i~~~L~ 372 (380)
T TIGR01127 311 VLPDRPGALYHLLESIAEARANIVKIDHDRLSKEIPPGFAMVEITLETRG-KEHLDEILKILR 372 (380)
T ss_pred EeCCCCCHHHHHHHHHhcCCCcEEEEEeeccccCCCCceEEEEEEEEeCC-HHHHHHHHHHHH
Confidence 56788999999999999999999887443 23456777777754 333344444443
No 329
>cd04900 ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains. This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=20.09 E-value=1.4e+02 Score=23.64 Aligned_cols=29 Identities=17% Similarity=0.364 Sum_probs=24.1
Q ss_pred EEEEecCccchhhHHHHHHHHHHhCCceEEEE
Q 008693 398 LDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV 429 (557)
Q Consensus 398 ItI~~~~m~~~~g~la~If~~L~~~gI~Vd~I 429 (557)
|.|.. .++||.++++...|+.+|++|...
T Consensus 4 i~v~~---~Dr~gLl~~i~~~l~~~~l~I~~A 32 (73)
T cd04900 4 VFIYT---PDRPGLFARIAGALDQLGLNILDA 32 (73)
T ss_pred EEEEe---cCCCCHHHHHHHHHHHCCCCeEEe
Confidence 44553 468999999999999999999874
No 330
>PRK10629 EnvZ/OmpR regulon moderator; Provisional
Probab=20.06 E-value=2.5e+02 Score=25.45 Aligned_cols=50 Identities=12% Similarity=0.153 Sum_probs=37.0
Q ss_pred hHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccH-HHHHHHHHHHhccC
Q 008693 488 LILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEA-EQCVRALHETFFES 539 (557)
Q Consensus 488 ~v~~rif~~L~~~gInI~~IsqgsSe~sIs~vV~~~d~-~kAv~~LH~~f~~~ 539 (557)
....++-+.|.++||++..|.+ .+.++-+..+..+. -+|-+.|.+.+-.+
T Consensus 50 ~~~~~v~~~L~~~gI~~ksi~~--~~~~~~irf~~~~~Ql~Ak~vL~~~L~~~ 100 (127)
T PRK10629 50 PDGFYVYQHLDANGIHIKSITP--ENDSLLIRFDSPEQSAAAKEVLDRTLPHG 100 (127)
T ss_pred chHHHHHHHHHHCCCCcceEEe--eCCEEEEEECCHHHHHHHHHHHHHHcCCC
Confidence 3557899999999999999988 45566566555544 37888888877543
Done!